,title,url,time_published,authors,summary,banner_image,source,category_within_source,source_domain,topics,overall_sentiment_score,overall_sentiment_label,ticker_sentiment
0,"Three Biotech Stocks to Buy for the ""Golden Age of Medicine""",https://www.benzinga.com/personal-finance/24/08/40446326/three-biotech-stocks-to-buy-for-the-golden-age-of-medicine,20240819T174930,['Nic Chahine'],"A year ago, medical experts and Nobel Laureates interviewed by The New York Times proclaimed ""a Golden Age of Medicine"" is here. And in the 12 months since, a flurry of new drug and medical discoveries has proven them to be right.",https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/19133532/IDNA.png,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.839681'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.208491,Somewhat-Bullish,"[{'ticker': 'BLK', 'relevance_score': '0.05257', 'ticker_sentiment_score': '0.187654', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.05257', 'ticker_sentiment_score': '0.102342', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.05257', 'ticker_sentiment_score': '0.150608', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'RYTM', 'relevance_score': '0.258351', 'ticker_sentiment_score': '0.060263', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.05257', 'ticker_sentiment_score': '0.270014', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.447091', 'ticker_sentiment_score': '0.197109', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NYT', 'relevance_score': '0.05257', 'ticker_sentiment_score': '0.094611', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.05257', 'ticker_sentiment_score': '0.150608', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.104911', 'ticker_sentiment_score': '0.163211', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SNY', 'relevance_score': '0.1568', 'ticker_sentiment_score': '0.295768', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
1,Walmart Wins Bargain Games,https://www.fool.com/investing/2024/08/19/walmart-wins-bargain-games/,20240819T165100,['Motley Fool Staff'],The world's largest retailer is crushing the market.,https://g.foolcdn.com/editorial/images/787527/mfm_15.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.999921'}, {'topic': 'Earnings', 'relevance_score': '0.839681'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.360215'}]",0.176233,Somewhat-Bullish,"[{'ticker': 'WSM', 'relevance_score': '0.023229', 'ticker_sentiment_score': '0.073137', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.023229', 'ticker_sentiment_score': '0.043756', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRWD', 'relevance_score': '0.007744', 'ticker_sentiment_score': '0.038249', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KR', 'relevance_score': '0.023229', 'ticker_sentiment_score': '0.004514', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.023229', 'ticker_sentiment_score': '0.039413', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.007744', 'ticker_sentiment_score': '-0.002453', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HD', 'relevance_score': '0.015487', 'ticker_sentiment_score': '0.085152', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.11575', 'ticker_sentiment_score': '0.097565', 'ticker_sentiment_label': 'Neutral'}]"
2,"Pfizer  ( PFE ) , BioNTech COVID-Flu Combo Shot Study Falters",https://www.zacks.com/stock/news/2323673/pfizer-pfe-biontech-covid-flu-combo-shot-study-falters,20240819T132300,['Zacks Equity Research'],Pfizer's (PFE) COVID and flu combination vaccine demonstrates a continued trend of higher responses against influenza A but fails to show non-inferiority against the influenza B strain.,https://staticx-tuner.zacks.com/images/articles/main/cc/389.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.118219,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.129516', 'ticker_sentiment_score': '0.077191', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.255641', 'ticker_sentiment_score': '0.286019', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.536866', 'ticker_sentiment_score': '0.259627', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BNTX', 'relevance_score': '0.193207', 'ticker_sentiment_score': '0.164113', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
3,"Zacks Investment Ideas feature highlights: Walmart, Cardinal Health and Eli Lilly",https://www.zacks.com/stock/news/2323468/zacks-investment-ideas-feature-highlights-walmart-cardinal-health-and-eli-lilly,20240819T093200,['Zacks Investment Research'],"Walmart, Cardinal Health and Eli Lilly have been highlighted in this Investment Ideas article.",https://staticx-tuner.zacks.com/images/articles/main/2c/546.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Earnings', 'relevance_score': '0.993781'}]",0.371589,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.316168', 'ticker_sentiment_score': '0.210345', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CAH', 'relevance_score': '0.265666', 'ticker_sentiment_score': '0.270485', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WMT', 'relevance_score': '0.265666', 'ticker_sentiment_score': '0.357146', 'ticker_sentiment_label': 'Bullish'}]"
4,Prediction: These 2 Unstoppable Pharma Stocks Will Continue to Soar Through 2025 and Beyond,https://www.fool.com/investing/2024/08/19/prediction-these-2-unstoppable-pharma-stocks-will/,20240819T091100,['Alex Carchidi'],Impediments to growth are melting away while new opportunities begin to rise.,https://media.ycharts.com/charts/79abf809571885a9aab471411906d726.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.269828,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.250386', 'ticker_sentiment_score': '0.095444', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.250386', 'ticker_sentiment_score': '0.095444', 'ticker_sentiment_label': 'Neutral'}]"
5,Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrived,https://www.fool.com/investing/2024/08/18/forget-mounjaro-eli-lillys-next-big-blockbuster-ha/,20240818T181000,['Adam Spatacco'],Eli Lilly has a lot going for it.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F787061%2Fscreenshot-2024-08-13-131428.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.238917,Somewhat-Bullish,"[{'ticker': 'GS', 'relevance_score': '0.046273', 'ticker_sentiment_score': '0.044655', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.676093', 'ticker_sentiment_score': '0.416606', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.315397', 'ticker_sentiment_score': '0.25529', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
6,Prediction: This Hypergrowth Company Could Be the Next Trillion-Dollar Stock,https://www.fool.com/investing/2024/08/18/prediction-this-hypergrowth-company-could-be-the-n/,20240818T160500,['Prosper Junior Bakiny'],There's no stopping this incredible pharmaceutical stock.,https://g.foolcdn.com/editorial/images/786915/doctor-with-patient-talking.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.99737'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.288539,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.420705', 'ticker_sentiment_score': '0.401701', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'AVGO', 'relevance_score': '0.04912', 'ticker_sentiment_score': '0.123595', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.098054', 'ticker_sentiment_score': '0.132682', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.146618', 'ticker_sentiment_score': '0.143737', 'ticker_sentiment_label': 'Neutral'}]"
7,Novo Nordisk and Eli Lilly Could Have a Big Rival in the GLP-1 Market in a Few Years,https://www.fool.com/investing/2024/08/18/novo-nordisk-and-eli-lilly-could-have-a-big-rival/,20240818T101200,['David Jagielski'],Should Novo Nordisk and Eli Lilly investors be worried about Roche?,https://g.foolcdn.com/editorial/images/786781/person-standing-on-a-scale.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.088918,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.510588', 'ticker_sentiment_score': '0.170376', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.510588', 'ticker_sentiment_score': '0.170376', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
8,3 Fantastic Growth Stocks to Buy in August,https://www.fool.com/investing/2024/08/17/3-fantastic-growth-stocks-to-buy-in-august/,20240817T113000,"['Keith Speights', 'and Prosper Junior Bakiny', 'David Jagielski']",These stocks should keep up their winning ways.,https://g.foolcdn.com/editorial/images/787352/woman-smiling-looking-at-laptop.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}]",0.361236,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.374', 'ticker_sentiment_score': '0.277379', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.171485', 'ticker_sentiment_score': '0.179105', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FMBRY', 'relevance_score': '0.043186', 'ticker_sentiment_score': '0.236572', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.374', 'ticker_sentiment_score': '0.43317', 'ticker_sentiment_label': 'Bullish'}]"
9,"Eli Lilly's Top GLP-1 Drugs Now Account for Nearly 40% of Its Revenue, and That's Likely to Go Higher in Future Quarters",https://www.fool.com/investing/2024/08/17/eli-lillys-top-glp-1-drugs-now-account-for-nearly/,20240817T112100,['David Jagielski'],Mounjaro and Zepbound are likely to be Eli Lilly's top two products in the very near future.,https://g.foolcdn.com/editorial/images/786778/a-person-trying-to-lose-weight-and-who-is-measuring-their-waist.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.997405'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.214936,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.452295', 'ticker_sentiment_score': '0.333552', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
10,Why Lilly  ( LLY )  Might be Well Poised for a Surge,https://www.zacks.com/stock/news/2323318/why-lilly-lly-might-be-well-poised-for-a-surge,20240816T162008,['Zacks Equity Research'],"Lilly (LLY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.",https://staticx-tuner.zacks.com/images/default_article_images/default115.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.9545'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.432377,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.60098', 'ticker_sentiment_score': '0.67841', 'ticker_sentiment_label': 'Bullish'}]"
11,"Pharma Stock Roundup: AZN Gets Approvals for Imfinzi Expanded Use, MRK Inks New Deal",https://www.zacks.com/stock/news/2323142/pharma-stock-roundup-azn-gets-approvals-for-imfinzi-expanded-use-mrk-inks-new-deal,20240816T143500,['Kinjel Shah'],Merck (MRK) signs a new collaboration with a private drugmaker. AstraZeneca (AZN) gets approvals for expanded use of Imfinzi.,https://staticx-tuner.zacks.com/images/articles/main/52/873.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.05775,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.0864', 'ticker_sentiment_score': '-0.069855', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.2138', 'ticker_sentiment_score': '0.060893', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.17179', 'ticker_sentiment_score': '0.068314', 'ticker_sentiment_label': 'Neutral'}]"
12,"3 Companies Reporting Remarkable Results: WMT, LLY, CAH",https://www.zacks.com/commentary/2322741/3-companies-reporting-remarkable-results-wmt-lly-cah,20240816T141500,['Derek Lewis'],"All three companies posted robust results and upped their outlooks, a bullish pairing. Is it time to buy?",https://staticx-tuner.zacks.com/images/articles/main/0a/1429.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Earnings', 'relevance_score': '0.996675'}]",0.352543,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.366832', 'ticker_sentiment_score': '0.323142', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CAH', 'relevance_score': '0.317527', 'ticker_sentiment_score': '0.38479', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'WMT', 'relevance_score': '0.317527', 'ticker_sentiment_score': '0.447012', 'ticker_sentiment_label': 'Bullish'}]"
13,What Makes Eli Lilly  ( LLY )  a Strong Momentum Stock: Buy Now?,https://www.zacks.com/stock/news/2322724/what-makes-eli-lilly-lly-a-strong-momentum-stock-buy-now,20240815T160007,['Zacks Equity Research'],Does Eli Lilly (LLY) have what it takes to be a top stock pick for momentum investors? Let's find out.,https://staticx-tuner.zacks.com/images/default_article_images/default151.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}]",0.332142,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.575055', 'ticker_sentiment_score': '0.459043', 'ticker_sentiment_label': 'Bullish'}]"
14,Eli Lilly Unusual Options Activity For August 15 - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/08/40396876/eli-lilly-unusual-options-activity-for-august-15,20240815T141727,['Benzinga Insights'],"High-rolling investors have positioned themselves bearish on Eli Lilly LLY, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data.",https://www.benzinga.com/files/images/story/2024/1723731444_0.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.050417,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.764792', 'ticker_sentiment_score': '0.059792', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.085936', 'ticker_sentiment_score': '-0.114125', 'ticker_sentiment_label': 'Neutral'}]"
15,"Pharma ETFs in Focus Post Solid Q2 Earnings - Bristol-Myers Squibb  ( NYSE:BMY ) , First Trust Nasdaq Pharmaceuticals ETF  ( NASDAQ:FTXH ) ",https://www.benzinga.com/news/earnings/24/08/40374036/pharma-etfs-in-focus-post-solid-q2-earnings,20240814T200034,['Zacks'],"The second-quarter results of the healthcare sector have been impressive, with earnings of 78.8% of the sector participants that have reported so far up 17.1% on 7.6% revenue growth. The earnings beat ratio of 85.7% and the revenue beat ratio of 75.5% are also assuring.",https://cdn.benzinga.com/files/images/story/2024/08/14/ani-kolleshi-7jjnj-qa9fy-unsplash.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999992'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.188212,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.162255', 'ticker_sentiment_score': '0.196113', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'IVZ', 'relevance_score': '0.122062', 'ticker_sentiment_score': '0.082696', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.122062', 'ticker_sentiment_score': '0.074673', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.122062', 'ticker_sentiment_score': '0.078615', 'ticker_sentiment_label': 'Neutral'}]"
16,Pharma ETFs in Focus Post Solid Q2 Earnings,https://www.zacks.com/stock/news/2322190/pharma-etfs-in-focus-post-solid-q2-earnings,20240814T154900,['Sweta Killa'],"Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.",https://staticx-tuner.zacks.com/images/default_article_images/default125.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999989'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.173992,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.121445', 'ticker_sentiment_score': '0.166583', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'IVZ', 'relevance_score': '0.121445', 'ticker_sentiment_score': '0.071772', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.081138', 'ticker_sentiment_score': '0.066897', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.121445', 'ticker_sentiment_score': '0.073403', 'ticker_sentiment_label': 'Neutral'}]"
17,"Philips  ( PHG )  Extends Isala Partnership, Boosts Customer Base",https://www.zacks.com/stock/news/2322111/philips-phg-extends-isala-partnership-boosts-customer-base,20240814T145900,['Zacks Equity Research'],"Philips (PHG) extends its partnership Isala hospital to optimize the latter's healthcare processes, expanding its customer base.",https://staticx-tuner.zacks.com/images/articles/main/40/1670.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.438099,Bullish,"[{'ticker': 'ALC', 'relevance_score': '0.165409', 'ticker_sentiment_score': '0.168834', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.219312', 'ticker_sentiment_score': '0.152684', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DGX', 'relevance_score': '0.165409', 'ticker_sentiment_score': '0.168834', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PHG', 'relevance_score': '0.272181', 'ticker_sentiment_score': '0.426059', 'ticker_sentiment_label': 'Bullish'}]"
18,Eli Lilly Smashed Estimates Thanks To Unbelievable Demand For Its Diabetes And Weight Loss Blockbusters - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/news/24/08/40369350/eli-lilly-smashed-estimates-thanks-to-unbelievable-demand-for-its-diabetes-and-weight-loss-blockbust,20240814T142617,['Upwallstreet'],"On Thursday, Eli Lilly and Company LLY reported its second quarter results, smashing estimates fueled by the popularity of its blockbuster diabetes drug Mounjaro and weight loss injection Zepbound.",https://cdn.benzinga.com/files/fitness-training-concept-with-clipboard.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.650727'}]",0.160983,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.545493', 'ticker_sentiment_score': '0.328078', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.322233', 'ticker_sentiment_score': '0.027024', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.322233', 'ticker_sentiment_score': '0.134024', 'ticker_sentiment_label': 'Neutral'}]"
19,Is Eli Lilly  ( LLY )  a Buy Post Stellar Q2 Earnings & Raised View?,https://www.zacks.com/stock/news/2321929/is-eli-lilly-lly-a-buy-post-stellar-q2-earnings-raised-view,20240814T133400,['Kinjel Shah'],Eli Lilly (LLY) is a great stock to have in one's portfolio currently based on its strong overall financial performance and robust drug pipeline.,https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.99793'}, {'topic': 'Earnings', 'relevance_score': '0.996675'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.368089,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.575926', 'ticker_sentiment_score': '0.550738', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'VKTX', 'relevance_score': '0.037504', 'ticker_sentiment_score': '0.105947', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.074926', 'ticker_sentiment_score': '0.111082', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.074926', 'ticker_sentiment_score': '0.096786', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.074926', 'ticker_sentiment_score': '0.187769', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
20,"The Zacks Analyst Blog Highlights Eli Lilly, Pfizer, AbbVie and Biogen",https://www.zacks.com/stock/news/2322034/the-zacks-analyst-blog-highlights-eli-lilly-pfizer-abbvie-and-biogen,20240814T124900,['Zacks Equity Research'],"Eli Lilly, Pfizer, AbbVie and Biogen are part of the Zacks top Analyst Blog.",https://staticx-tuner.zacks.com/images/articles/main/ce/3721.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999365'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.684621'}]",0.252246,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.426105', 'ticker_sentiment_score': '0.33308', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.306144', 'ticker_sentiment_score': '0.197729', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.199767', 'ticker_sentiment_score': '0.11812', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.067221', 'ticker_sentiment_score': '0.10124', 'ticker_sentiment_label': 'Neutral'}]"
21,"Up 10% in 1 Day, Is It Too Late to Buy Eli Lilly Stock?",https://www.fool.com/investing/2024/08/14/up-10-in-1-day-is-it-too-late-to-buy-eli-lilly-sto/,20240814T103500,['Alex Carchidi'],How much upside could this juggernaut stock possibly have left?,https://g.foolcdn.com/editorial/images/786708/two-investors-look-at-figures.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.980509'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.127343,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.335367', 'ticker_sentiment_score': '0.256055', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
22,"3 Big Drug Stocks to Watch on Raised 2024 Earnings & Sales View - AbbVie  ( NYSE:ABBV ) , Biogen  ( NASDAQ:BIIB ) ",https://www.benzinga.com/general/biotech/24/08/40344193/3-big-drug-stocks-to-watch-on-raised-2024-earnings-sales-view,20240813T172417,['Zacks'],"The second-quarter earnings season has come to an end for large drug and biotech companies, with Eli Lilly LLY reporting its results last week. Per the Zacks classification, the pharma/biotech industry comes under the broader Medical sector, which comprises pharma/biotech as well as medical ...",https://staticx-tuner.zacks.com/images/articles/charts/cf/74103.jpg?v=720680589,Benzinga,General,www.benzinga.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.998356'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.684621'}]",0.257179,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.422599', 'ticker_sentiment_score': '0.362428', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.296969', 'ticker_sentiment_score': '0.213455', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.185484', 'ticker_sentiment_score': '0.134731', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.04677', 'ticker_sentiment_score': '0.216503', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
23,Lilly  ( LLY )  Upgraded to Buy: Here's Why,https://www.zacks.com/stock/news/2321510/lilly-lly-upgraded-to-buy-heres-why,20240813T160011,['Zacks Equity Research'],"Lilly (LLY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.",https://staticx-tuner.zacks.com/images/default_article_images/default351.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.997845'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.658903'}]",0.32033,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.368773', 'ticker_sentiment_score': '0.380439', 'ticker_sentiment_label': 'Bullish'}]"
24,Here's How to Play Novo Nordisk  ( NVO )  After Q2 Earnings Miss,https://www.zacks.com/stock/news/2321469/heres-how-to-play-novo-nordisk-nvo-after-q2-earnings-miss,20240813T153100,['Ahan Chakraborty'],"Novo Nordisk (NVO) is an excellent stock to buy for long-term gains, driven by the stellar performance of its GLP-1 drugs. New investors should utilize the existing opportunity to make an entry.",https://staticx-tuner.zacks.com/images/articles/main/de/2471.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.9545'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}]",0.309532,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.147366', 'ticker_sentiment_score': '0.228021', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMGN', 'relevance_score': '0.074001', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.596796', 'ticker_sentiment_score': '0.456144', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.074001', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
25,3 Big Drug Stocks to Watch on Raised 2024 Earnings & Sales View,https://www.zacks.com/stock/news/2321388/3-big-drug-stocks-to-watch-on-raised-2024-earnings-sales-view,20240813T142700,['Kinjel Shah'],"Here we discuss three drugmakers, Eli Lilly and Company (LLY), Pfizer (PFE) and AbbVie (ABBV), following their increase in sales and earnings guidance for 2024.",https://staticx-tuner.zacks.com/images/articles/main/66/1019.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.996023'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.684621'}]",0.252511,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.423718', 'ticker_sentiment_score': '0.357685', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.2978', 'ticker_sentiment_score': '0.213738', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.18602', 'ticker_sentiment_score': '0.131924', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.046907', 'ticker_sentiment_score': '0.20352', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
26,Wall Street Analysts See Lilly  ( LLY )  as a Buy: Should You Invest?,https://www.zacks.com/stock/news/2321243/wall-street-analysts-see-lilly-lly-as-a-buy-should-you-invest,20240813T133011,['Zacks Equity Research'],"According to the average brokerage recommendation (ABR), one should invest in Lilly (LLY). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",https://staticx-tuner.zacks.com/images/yesopchart/brokerage_bar/LLY_08132024.png,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.938238'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}]",0.32274,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.357783', 'ticker_sentiment_score': '0.197498', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
27,Investors Heavily Search Eli Lilly and Company  ( LLY ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2321168/investors-heavily-search-eli-lilly-and-company-lly-here-is-what-you-need-to-know,20240813T130016,['Zacks Equity Research'],"Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",https://staticx-tuner.zacks.com/images/default_article_images/default86.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.217696,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.488469', 'ticker_sentiment_score': '0.147379', 'ticker_sentiment_label': 'Neutral'}]"
28,This 1 Piece of Good News for Eli Lilly Is Bad News for Hims & Hers Health Stock,https://www.fool.com/investing/2024/08/13/this-1-piece-good-news-for-eli-lilly-is-bad-news-f/,20240813T110500,['Alex Carchidi'],A company's investments can easily ruin the plans of its competitors.,https://g.foolcdn.com/editorial/images/786530/investors-considers-papers-on-a-table-while-holding-a-tablet.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.972756'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.165112,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.197816', 'ticker_sentiment_score': '0.116569', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HIMS', 'relevance_score': '0.099683', 'ticker_sentiment_score': '0.159049', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.149038', 'ticker_sentiment_score': '0.137851', 'ticker_sentiment_label': 'Neutral'}]"
29,Why Eli Lilly Stock's Big Jump Last Week Could Be Just the Beginning of Another Huge Run,https://www.fool.com/investing/2024/08/13/why-eli-lilly-stocks-big-jump-last-week-could-be-j/,20240813T095000,['Keith Speights'],Many more quarters like Lilly's stellar second quarter could be on the way.,https://g.foolcdn.com/editorial/images/786875/woman-smiling-laptop.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.268674,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.581269', 'ticker_sentiment_score': '0.330063', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
30,Should Investors Buy Eli Lilly's  ( LLY )  Stock After Strong Q2 Results?,https://www.zacks.com/commentary/2320976/should-investors-buy-eli-lillys-lly-stock-after-strong-q2-results,20240812T220200,['Shaun Pruitt'],"As one of the largest pharmaceutical companies, Eli Lilly (LLY) said its growth trajectory accelerated during Q2 as its medicines are reaching more people worldwide.",https://staticx-tuner.zacks.com/images/articles/main/ff/2922.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.995015'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.229144,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.602879', 'ticker_sentiment_score': '0.41072', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.19117', 'ticker_sentiment_score': '0.088057', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.19117', 'ticker_sentiment_score': '0.088057', 'ticker_sentiment_label': 'Neutral'}]"
31,5 ETFs to Make the Most of Eli Lilly's Strength,https://www.zacks.com/stock/news/2320811/5-etfs-to-make-the-most-of-eli-lillys-strength,20240812T155000,['Sweta Killa'],"Impressed by Eli Lilly's (LLY) blowout earnings, several analysts raised their target price on the stock.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.795202'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.99998'}]",0.119227,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.368773', 'ticker_sentiment_score': '0.132166', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SLGDD', 'relevance_score': '0.142847', 'ticker_sentiment_score': '0.127447', 'ticker_sentiment_label': 'Neutral'}]"
32,International Markets and Lilly  ( LLY ) : A Deep Dive for Investors,https://www.zacks.com/stock/news/2320553/international-markets-and-lilly-lly-a-deep-dive-for-investors,20240812T131534,['Zacks Equity Research'],Review Lilly's (LLY) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.,https://staticx-tuner.zacks.com/images/default_article_images/default248.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.192111,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.060694', 'ticker_sentiment_score': '0.075', 'ticker_sentiment_label': 'Neutral'}]"
33,Prediction: Buying Biotech and Pharma Stocks During This Sell-Off Will Be a Smart Move,https://www.fool.com/investing/2024/08/12/prediction-buying-biotech-and-pharma-stocks-during/,20240812T131500,['Alex Carchidi'],There isn't much to suggest these businesses are actually vulnerable.,https://media.ycharts.com/charts/c77dbb5bd22548eae3acf96a5feddc01.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.108179'}]",-0.007295,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.269776', 'ticker_sentiment_score': '0.020662', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.054983', 'ticker_sentiment_score': '0.055994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.163909', 'ticker_sentiment_score': '0.095124', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RXRX', 'relevance_score': '0.163909', 'ticker_sentiment_score': '0.095124', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.269776', 'ticker_sentiment_score': '0.020662', 'ticker_sentiment_label': 'Neutral'}]"
34,A Blood Test Could Detect Early Alzheimer's. That Could Make These 2 Stocks Red-Hot Buys.,https://www.fool.com/investing/2024/08/11/a-blood-test-could-detect-early-alzheimers-that-co/,20240811T130500,['David Jagielski'],These companies have approved Alzheimer's treatments that could generate billions in revenue for their respective businesses.,https://g.foolcdn.com/editorial/images/785842/doctor-talking-to-a-patient-while-making-notes.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.858979'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.269987,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.410697', 'ticker_sentiment_score': '0.375109', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'TRMNF', 'relevance_score': '0.061473', 'ticker_sentiment_score': '0.084446', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESALF', 'relevance_score': '0.061473', 'ticker_sentiment_score': '0.050153', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.410697', 'ticker_sentiment_score': '0.256645', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
35,"Nektar's Q2 Earnings Lag Estimates, Revenues Top - Eli Lilly  ( NYSE:LLY ) , Nektar Therapeutics  ( NASDAQ:NKTR ) ",https://www.benzinga.com/general/biotech/24/08/40290042/nektars-q2-earnings-lag-estimates-revenues-top,20240809T200533,['Zacks'],"Nektar Therapeutics NKTR incurred a loss per share of 25 cents in the second quarter of 2024, which was wider than the Zacks Consensus Estimate of a loss of 21 cents.",https://staticx-tuner.zacks.com/images/articles/charts/fa/73847.jpg?v=1471947569,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '0.938238'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.052551,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.219477', 'ticker_sentiment_score': '-0.037607', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TRDA', 'relevance_score': '0.289748', 'ticker_sentiment_score': '0.081575', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EXAS', 'relevance_score': '0.289748', 'ticker_sentiment_score': '0.15608', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NKTR', 'relevance_score': '0.357636', 'ticker_sentiment_score': '-0.100917', 'ticker_sentiment_label': 'Neutral'}]"
36,"Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday - Expedia Group  ( NASDAQ:EXPE ) ",https://www.benzinga.com/news/24/08/40290461/expedia-posts-upbeat-earnings-joins-akamai-technologies-trade-desk-dxc-technology-and-other-big-stoc,20240809T165133,['Avi Kapoor'],"U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Friday. Shares of Expedia Group, Inc. EXPE rose sharply during Friday's session after the company reported better-than-expected second-quarter financial results.",https://cdn.benzinga.com/files/images/story/2024/08/09/Expedia-Group---logo.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.50876,Bullish,"[{'ticker': 'RNA', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.4101', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'TTD', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.26616', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'G', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.199731', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AKAM', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.282998', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EXPE', 'relevance_score': '0.267559', 'ticker_sentiment_score': '0.307071', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ADMA', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.327316', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PAY', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.289004', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'RKLB', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.194839', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CARG', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.374825', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'DXC', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.282998', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'IAG', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.425272', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'IOVA', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.374825', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SG', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.282998', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DOCN', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.289004', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EVH', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.282998', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.295005', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DOCS', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.36181', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BLND', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.448466', 'ticker_sentiment_label': 'Bullish'}]"
37,"Nektar's  ( NKTR )  Q2 Earnings Lag Estimates, Revenues Top",https://www.zacks.com/stock/news/2320141/nektars-nktr-q2-earnings-lag-estimates-revenues-top,20240809T145800,['Zacks Equity Research'],Nektar (NKTR) reports a wider-than-expected loss in the second quarter of 2024 while revenues beat estimates. Stock falls in after-hours trading.,https://staticx-tuner.zacks.com/images/articles/main/5d/2633.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.938238'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.021455,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.222838', 'ticker_sentiment_score': '-0.034536', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TRDA', 'relevance_score': '0.294093', 'ticker_sentiment_score': '0.059413', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EXAS', 'relevance_score': '0.362858', 'ticker_sentiment_score': '0.149238', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKTR', 'relevance_score': '0.362858', 'ticker_sentiment_score': '-0.09159', 'ticker_sentiment_label': 'Neutral'}]"
38,Eli Lilly Unusual Options Activity - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/08/40284878/eli-lilly-unusual-options-activity,20240809T134608,['Benzinga Insights'],"Investors with a lot of money to spend have taken a bullish stance on Eli Lilly LLY. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",https://www.benzinga.com/files/images/story/2024/1723211165_0.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}]",0.085641,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.740902', 'ticker_sentiment_score': '0.074197', 'ticker_sentiment_label': 'Neutral'}]"
39,"Pharma Stock Roundup: LLY, NVO, BAYRY Q2 Earnings, MRK's New Deal & Other Updates",https://www.zacks.com/stock/news/2319903/pharma-stock-roundup-lly-nvo-bayry-q2-earnings-mrks-new-deal-other-updates,20240809T132800,['Kinjel Shah'],"Eli Lilly (LLY), Novo Nordisk (NVO) and Bayer (BAYRY) announce second-quarter results. Merck (MRK) expands existing co-development deal with partner Daiichi Sankyo.",https://staticx-tuner.zacks.com/images/articles/main/52/873.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '0.976671'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.200917,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.248924', 'ticker_sentiment_score': '0.253651', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SKXJF', 'relevance_score': '0.108141', 'ticker_sentiment_score': '0.078756', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSKYF', 'relevance_score': '0.108141', 'ticker_sentiment_score': '0.078756', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.072217', 'ticker_sentiment_score': '0.013196', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.179254', 'ticker_sentiment_score': '0.101282', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.072217', 'ticker_sentiment_score': '0.0132', 'ticker_sentiment_label': 'Neutral'}]"
40,"Company News for Aug 9, 2024",https://www.zacks.com/stock/news/2319896/company-news-for-aug-9-2024,20240809T131800,['Zacks Equity Research'],"Companies in The News Are: CYBR, PH, ...",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.138482,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.595343', 'ticker_sentiment_score': '0.428516', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'PH', 'relevance_score': '0.595343', 'ticker_sentiment_score': '-0.088461', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CYBR', 'relevance_score': '0.595343', 'ticker_sentiment_score': '0.145581', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DDOG', 'relevance_score': '0.595343', 'ticker_sentiment_score': '0.300751', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
41,Twilio and Floor & Decor Holdings have been highlighted as Zacks Bull and Bear of the Day,https://www.zacks.com/stock/news/2319763/twilio-and-floor-decor-holdings-have-been-highlighted-as-zacks-bull-and-bear-of-the-day,20240809T103400,['Zacks Equity Research'],"Chicago, IL - August 9, 2024 - Zacks Equity Research shares Twilio ( TWLO Quick QuoteTWLO - ) as the Bull of the Day and Floor & Décor Holdings, Inc. ( FND ) asthe Bear of the Day.",https://staticx-tuner.zacks.com/images/articles/main/3b/3776.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.779048'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",0.242242,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.355906', 'ticker_sentiment_score': '0.362347', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'HD', 'relevance_score': '0.023035', 'ticker_sentiment_score': '0.165083', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FND', 'relevance_score': '0.069028', 'ticker_sentiment_score': '-0.034377', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HIMS', 'relevance_score': '0.205032', 'ticker_sentiment_score': '0.181487', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.160175', 'ticker_sentiment_score': '0.152533', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
42,2 Healthcare Stocks to Buy Hand Over Fist in August,https://www.fool.com/investing/2024/08/09/2-healthcare-stocks-buy-hand-over-fist-in-august/,20240809T100200,['Prosper Junior Bakiny'],These longtime winners still have a lot to offer.,https://g.foolcdn.com/editorial/images/786004/doctor-holding-elderly-patients-hand.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.87644'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.267759,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.053629', 'ticker_sentiment_score': '0.19601', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.498827', 'ticker_sentiment_score': '0.28759', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.362254', 'ticker_sentiment_score': '0.316795', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
43,"S&P 500 Records Best Session Since January 2023: Investor Sentiment Improves, But Greed Index Remains In 'Extreme Fear' Zone - Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/news/earnings/24/08/40277332/s-p-500-records-best-session-since-january-2023-investor-sentiment-improves-but-greed-index-remains,20240809T081653,['Avi Kapoor'],"The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the ""Extreme Fear"" zone on Thursday. U.S. stocks settled higher on Thursday, with the S&P 500 index, as tracked by the SPDR S&P 500 ETF Trust SPY, notching its best daily ...",https://cdn.benzinga.com/files/images/story/2024/08/09/Market-Sentiment--Fear-And-Greed-Index--.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",-0.017134,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.233556', 'ticker_sentiment_score': '0.531389', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'WBD', 'relevance_score': '0.118064', 'ticker_sentiment_score': '-0.220355', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'SATS', 'relevance_score': '0.233556', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'USFD', 'relevance_score': '0.233556', 'ticker_sentiment_score': '0.531389', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'AXL', 'relevance_score': '0.233556', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMCX', 'relevance_score': '0.233556', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
44,"Three Stocks: Palantir, Eli Lilly, and Lumen Technologies",https://moneymorning.com/2024/08/08/three-stocks-palantir-eli-lilly-and-lumen-technologies/,20240808T210108,['Chris Johnson'],"Palantir As if they needed it, Palantir ( PLTR ) announced this morning that the company has expanded their relationship with another AI leading company. The company announced an expansion of the existing partnership with Microsoft to bring some of the most sophisticated and secure cloud, AI, and ...",https://moneymorning.com/wp-content/blogs.dir/1/files/2024/08/pexels-markusspiske-225769-1200x800.jpg,Money Morning,RSS,moneymorning.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}, {'topic': 'Earnings', 'relevance_score': '0.999981'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.22198,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.334008', 'ticker_sentiment_score': '0.240259', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.114409', 'ticker_sentiment_score': '0.144306', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LUMN', 'relevance_score': '0.114409', 'ticker_sentiment_score': '0.009224', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.114409', 'ticker_sentiment_score': '-0.077618', 'ticker_sentiment_label': 'Neutral'}]"
45,Eli Lilly  ( LLY )  Q2 2024 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2024/08/08/eli-lilly-lly-q2-2024-earnings-call-transcript/,20240808T210021,['Motley Fool Transcribing'],"LLY earnings call for the period ending June 30, 2024.",https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999696'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.161647'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.23493,Somewhat-Bullish,"[{'ticker': 'EVR', 'relevance_score': '0.004144', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MORF', 'relevance_score': '0.012432', 'ticker_sentiment_score': '-0.003482', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.004144', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PTAIF', 'relevance_score': '0.004144', 'ticker_sentiment_score': '0.097557', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.004144', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTLT', 'relevance_score': '0.008288', 'ticker_sentiment_score': '-0.016345', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.004144', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.004144', 'ticker_sentiment_score': '-0.034382', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.099202', 'ticker_sentiment_score': '0.130419', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NYT', 'relevance_score': '0.004144', 'ticker_sentiment_score': '0.072099', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.004144', 'ticker_sentiment_score': '0.067848', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BNXYF', 'relevance_score': '0.004144', 'ticker_sentiment_score': '0.02958', 'ticker_sentiment_label': 'Neutral'}]"
46,Eli Lilly: The Next $1 Trillion Market Cap Stock?,https://www.zacks.com/commentary/2319475/eli-lilly-the-next-1-trillion-market-cap-stock,20240808T172900,['Ethan Feller'],Eli Lilly showcased the exceptional strength of its business during its quarterly earnings meeting on Thursday morning ...,https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999862'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.459462'}]",0.369497,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.655534', 'ticker_sentiment_score': '0.524655', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'HIMS', 'relevance_score': '0.38588', 'ticker_sentiment_score': '0.320121', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.294682', 'ticker_sentiment_score': '0.266737', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
47,Dow Jumps Over 500 Points; Eli Lilly Posts Upbeat Earnings - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/news/earnings/24/08/40259926/dow-jumps-over-500-points-eli-lilly-posts-upbeat-earnings,20240808T160632,['Avi Kapoor'],"U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 500 points on Thursday. The Dow traded up 1.40% to 39,307.07 while the NASDAQ rose 2.14% to 16,543.06. The S&P 500 also rose, gaining, 1.79% to 5,292.43. Information technology shares climbed by 1.6% on Thursday.",https://cdn.benzinga.com/files/images/story/2024/08/08/Bull-Wall-Street_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.193686,Somewhat-Bullish,"[{'ticker': 'GVP', 'relevance_score': '0.167904', 'ticker_sentiment_score': '0.400653', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.249531', 'ticker_sentiment_score': '0.211904', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VSAT', 'relevance_score': '0.167904', 'ticker_sentiment_score': '0.47663', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BMBL', 'relevance_score': '0.167904', 'ticker_sentiment_score': '0.053464', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CDLX', 'relevance_score': '0.167904', 'ticker_sentiment_score': '0.185537', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'OM', 'relevance_score': '0.167904', 'ticker_sentiment_score': '0.115137', 'ticker_sentiment_label': 'Neutral'}]"
48,"Parker-Hannifin Posts Upbeat Earnings, Joins Under Armour, Zillow Group, YETI Holdings, Eli Lilly And Other Big Stocks Moving Higher On Thursday - Sealed Air  ( NYSE:SEE ) ",https://www.benzinga.com/news/24/08/40257600/parker-hannifin-posts-upbeat-earnings-joins-under-armour-zillow-group-yeti-holdings-eli-lilly-and-ot,20240808T150943,['Avi Kapoor'],"U.S. stocks were higher, with the Dow Jones index gaining over 1% on Thursday. Shares of Parker-Hannifin Corporation PH rose sharply during Thursday's session following better-than-expected fourth-quarter financial results and upbeat FY25 guidance.",https://cdn.benzinga.com/files/images/story/2024/08/08/movers-image_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.999917'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}]",0.544135,Bullish,"[{'ticker': 'AXGN', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.463147', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVMI', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.344467', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FWRD', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.337765', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'YETI', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.411825', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ICUI', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.368459', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'UA', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.337765', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BOOT', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.324314', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LESL', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.344467', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SEE', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.337765', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'COMM', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.324314', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DCGO', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.344467', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.318916', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PH', 'relevance_score': '0.33628', 'ticker_sentiment_score': '0.488185', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'VSAT', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.480749', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'Z', 'relevance_score': '0.086556', 'ticker_sentiment_score': '0.368276', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SN', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.324314', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CLNE', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.337765', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ON', 'relevance_score': '0.086556', 'ticker_sentiment_score': '0.3547', 'ticker_sentiment_label': 'Bullish'}]"
49,"Eli Lilly  ( LLY )  Q2 Earnings Top, Mounjaro, Zepbound Drive View",https://www.zacks.com/stock/news/2319330/eli-lilly-lly-q2-earnings-top-mounjaro-zepbound-drive-view,20240808T145300,['Zacks Equity Research'],Eli Lilly (LLY) beats second-quarter estimates for earnings and sales. It raises its guidance for 2024 on strong demand for Mounjaro and Zepbound.,https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Earnings', 'relevance_score': '0.980509'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.251722,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.441059', 'ticker_sentiment_score': '0.393029', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'MORF', 'relevance_score': '0.093047', 'ticker_sentiment_score': '0.036684', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.093047', 'ticker_sentiment_score': '0.084616', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.06211', 'ticker_sentiment_score': '0.045296', 'ticker_sentiment_label': 'Neutral'}]"
50,Continuing Claims Hit Highest Since Nov 2021,https://www.zacks.com/stock/news/2319303/continuing-claims-hit-highest-since-nov-2021,20240808T142900,['Zacks Equity Research'],Continuing Claims Hit Highest Since Nov ...,https://staticx-tuner.zacks.com/images/articles/main/f6/47493.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",-0.088904,Neutral,"[{'ticker': 'QSR', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.105725', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TTD', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.028427', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'YETI', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.044866', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CYBR', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.049385', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DBX', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
51,"Jobless Claims Decline, Pre-Markets in the Green",https://www.zacks.com/stock/news/2319299/jobless-claims-decline-pre-markets-in-the-green,20240808T142100,['Zacks Equity Research'],"It???s a big day for Wall Street as the much-awaited Jobless Claims numbers are out, which could be a major factor in market moves for the rest of the week.",https://staticx-tuner.zacks.com/images/articles/main/be/54779.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.890401'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",-0.083911,Neutral,"[{'ticker': 'QSR', 'relevance_score': '0.241284', 'ticker_sentiment_score': '0.115211', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TTD', 'relevance_score': '0.162255', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.241284', 'ticker_sentiment_score': '0.0312', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'YETI', 'relevance_score': '0.241284', 'ticker_sentiment_score': '0.048347', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CYBR', 'relevance_score': '0.162255', 'ticker_sentiment_score': '0.047423', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DBX', 'relevance_score': '0.162255', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.162255', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
52,Why Is Eli Lilly Stock Surging On Thursday? - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/general/biotech/24/08/40251130/mounjaro-maker-eli-lillys-bumper-q2-earnings-exceeds-estimates-hikes-outlook-again-on-strong-diab,20240808T122557,['Vandana Singh'],"On Thursday, Eli Lilly And Co LLY reported second-quarter revenue of $11.3 billion, up 36% year over year, easily surpassing the consensus of $9.95 billion. The increase was driven by a 27% increase in volume and a 10% increase due to higher realized prices.",https://cdn.benzinga.com/files/images/story/2024/08/08/mounjaro-medication-for-weight-loss.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.298711,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.595343', 'ticker_sentiment_score': '0.465012', 'ticker_sentiment_label': 'Bullish'}]"
53,Eli Lilly  ( LLY )  Surpasses Q2 Earnings and Revenue Estimates,https://www.zacks.com/stock/news/2318864/eli-lilly-lly-surpasses-q2-earnings-and-revenue-estimates,20240808T115505,['Zacks Equity Research'],"Lilly (LLY) delivered earnings and revenue surprises of 48.48% and 14.99%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?",https://staticx-tuner.zacks.com/images/default_article_images/default19.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999992'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.168723,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.398148', 'ticker_sentiment_score': '0.207252', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PRPH', 'relevance_score': '0.205807', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
54,"Bears Betting Against Nvidia And Eli Lilly For 'Easy Money,' Says Jim Cramer: 'Those Are The Two Keys To This Market And Don't You Know It' - Apple  ( NASDAQ:AAPL ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/24/08/40245839/bears-betting-against-nvidia-and-eli-lilly-for-easy-money-says-jim-cramer-those-are-the-two-keys-to,20240808T101153,['Benzinga Neuro'],"Jim Cramer has issued a warning about the bearish pressure on Nvidia Corp. NVDA and Eli Lilly and Co LLY, stating that these two companies are crucial to the market's performance. What Happened: Cramer, the host of CNBC's ""Mad Money,"" took to social media platform X to highlight the increased ...",https://cdn.benzinga.com/files/images/story/2024/08/08/Jim-Cramer-Photo-by-s-bukley-on-Shutters_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.875462'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.012142,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.420083', 'ticker_sentiment_score': '-0.163922', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NVDA', 'relevance_score': '0.420083', 'ticker_sentiment_score': '0.028925', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.175221', 'ticker_sentiment_score': '0.110877', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.175221', 'ticker_sentiment_score': '-0.154703', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
55,US Stocks Decline As SMCI's Margin Miss Brings Nvidia And Other AI Stocks Under Pressure: Investor Sentiment Remains In 'Extreme Fear' Zone - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/news/earnings/24/08/40243140/us-stocks-decline-as-smcis-margin-miss-brings-nvidia-and-other-ai-stocks-under-pressure-investor-se,20240808T065822,['Avi Kapoor'],"The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the ""Extreme Fear"" zone on Wednesday. U.S. stocks settled lower on Wednesday, after recording gains earlier during the session.",https://cdn.benzinga.com/files/images/story/2024/08/08/Market-Sentiment--Fear-And-Greed-Index--.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",-0.249959,Somewhat-Bearish,"[{'ticker': 'NVDA', 'relevance_score': '0.224903', 'ticker_sentiment_score': '-0.101234', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.224903', 'ticker_sentiment_score': '-0.073248', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.224903', 'ticker_sentiment_score': '-0.101234', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.224903', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PH', 'relevance_score': '0.224903', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WBD', 'relevance_score': '0.113597', 'ticker_sentiment_score': '-0.401235', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'USFD', 'relevance_score': '0.224903', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
56,"Eli Lilly, US Foods And 3 Stocks To Watch Heading Into Thursday - Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/news/earnings/24/08/40242779/eli-lilly-us-foods-and-3-stocks-to-watch-heading-into-thursday,20240808T062632,['Avi Kapoor'],"With U.S. stock futures trading mixed this morning on Thursday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Eli Lilly and Company LLY to report quarterly earnings at $2.70 per share on revenue of $9.95 billion before the opening bell, according to ...",https://cdn.benzinga.com/files/images/story/2024/08/08/Eli-Lilly.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.986564'}]",0.29015,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.459624', 'ticker_sentiment_score': '0.219107', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PH', 'relevance_score': '0.459624', 'ticker_sentiment_score': '0.119226', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BLBD', 'relevance_score': '0.459624', 'ticker_sentiment_score': '0.72821', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'USFD', 'relevance_score': '0.459624', 'ticker_sentiment_score': '0.469951', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'OM', 'relevance_score': '0.459624', 'ticker_sentiment_score': '0.232068', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
57,Here's Why Eli Lilly Stock Dropped 12% Last Month,https://www.fool.com/investing/2024/08/08/heres-why-eli-lilly-stock-dropped-12-last-month/,20240808T050443,['Ryan Downie'],News from a competitor gave investors an unwelcome dose of reality.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F786437%2Fgettyimages-1488338820-1201x800-5b2df79.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.183467,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.502207', 'ticker_sentiment_score': '0.171369', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SPGI', 'relevance_score': '0.067536', 'ticker_sentiment_score': '0.073495', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.13459', 'ticker_sentiment_score': '0.105279', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.13459', 'ticker_sentiment_score': '0.105279', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.200688', 'ticker_sentiment_score': '0.069927', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.13459', 'ticker_sentiment_score': '0.105279', 'ticker_sentiment_label': 'Neutral'}]"
58,Eli Lilly: Bearish Signals Loom Over Zepbound Manufacturer Ahead Of Q2 Earnings - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/general/health-care/24/08/40231406/eli-lilly-bearish-signals-loom-over-weight-loss-stock-ahead-of-q2-earnings,20240807T192824,['Surbhi Jain'],"Eli Lilly and Co LLY will be reporting its second-quarter earnings on Thursday. Wall Street expects $2.70 in EPS and $9.9 billion in revenues as the company reports before market hours. The stock is up 69% over the past year, and has gained 30% YTD.",https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07140547/Screenshot-2024-08-07-at-11.32.23-PM.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999976'}]",0.028788,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.839046', 'ticker_sentiment_score': '-0.056971', 'ticker_sentiment_label': 'Neutral'}]"
59,What's Going On With Eli Lilly And Company Shares Wednesday? - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/news/24/08/40227163/whats-going-on-with-eli-lilly-and-company-shares-wednesday,20240807T162244,['Dylan Berman'],Eli Lilly And Company LLY stock is trading lower on Wednesday. The company is anticipated to release 2024 fiscal year earnings on Thursday before the market opens. What To Know: Analyst estimates EPS of $2.70 and sales of $9.94 billion.,https://cdn.benzinga.com/files/images/story/2024/08/07/Eli-Lilly_0.jpeg?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.98396'}, {'topic': 'Earnings', 'relevance_score': '0.918141'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.191657,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.776097', 'ticker_sentiment_score': '0.10329', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSTK', 'relevance_score': '0.107495', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.213048', 'ticker_sentiment_score': '0.167069', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
60,Amgen  ( AMGN )  Stock Down Despite Q2 Earnings & Sales Beat,https://www.zacks.com/stock/news/2318113/amgen-amgn-stock-down-despite-q2-earnings-sales-beat,20240807T135500,['Zacks Equity Research'],Amgen (AMGN) beats second-quarter 2024 estimates for earnings and sales. It tightens its revenue and earnings guidance range for 2024. Stock falls.,https://staticx-tuner.zacks.com/images/articles/main/62/5473.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.972476'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.127984,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.057284', 'ticker_sentiment_score': '0.051998', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.482178', 'ticker_sentiment_score': '0.207457', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AZN', 'relevance_score': '0.142565', 'ticker_sentiment_score': '0.266893', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.057284', 'ticker_sentiment_score': '0.051998', 'ticker_sentiment_label': 'Neutral'}]"
61,How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q2 Earnings - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/news/earnings/24/08/40221288/how-to-earn-500-a-month-from-eli-lilly-stock-ahead-of-q2-earnings,20240807T132625,['Avi Kapoor'],"Eli Lilly and Company LLY is expected to release earnings results for its second quarter, before the opening bell on Thursday, Aug. 8. Analysts expect the Indianapolis-based company to report quarterly earnings at $2.60 per share, up from $2.11 per share in the year-ago period.",https://cdn.benzinga.com/files/images/story/2024/08/07/Eli-Lilly.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.779048'}]",0.190871,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.689652', 'ticker_sentiment_score': '0.382264', 'ticker_sentiment_label': 'Bullish'}]"
62,Is It Too Late to Buy Novo Nordisk Stock After Its 57% Surge?,https://www.fool.com/investing/2024/08/07/is-it-too-late-to-buy-novo-nordisk-stock-after-its/,20240807T104000,['Adam Spatacco'],Novo Nordisk stock has surged thanks to booming sales of Ozempic and Wegovy.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F785577%2Fgettyimages-1665778558.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.302093,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.060694', 'ticker_sentiment_score': '-0.011009', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTLT', 'relevance_score': '0.060694', 'ticker_sentiment_score': '0.06532', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.677751', 'ticker_sentiment_score': '0.605931', 'ticker_sentiment_label': 'Bullish'}]"
63,Eli Lilly  ( LLY )  & Novo Nordisk  ( NVO )  Earnings: A Closer Look,https://www.zacks.com/stock/news/2317485/eli-lilly-lly-novo-nordisk-nvo-earnings-a-closer-look,20240806T222900,['Derek Lewis'],"Given their underperformance in 2024, a positive set of quarterly results could easily push both stocks higher.",https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999162'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.265974,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.427184', 'ticker_sentiment_score': '0.03446', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.264897', 'ticker_sentiment_score': '-0.071514', 'ticker_sentiment_label': 'Neutral'}]"
64,Can Mounjaro & Zepbound Drive Eli Lilly  ( LLY )  Q2 Earnings?,https://www.zacks.com/stock/news/2317100/can-mounjaro-zepbound-drive-eli-lilly-lly-q2-earnings,20240806T140900,['Zacks Equity Research'],Investor focus is likely to be on the sales numbers of Lilly's (LLY) tirzepatide medicines Mounjaro and Zepbound.,https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}]",0.157621,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.489057', 'ticker_sentiment_score': '0.221341', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MORF', 'relevance_score': '0.188928', 'ticker_sentiment_score': '0.059774', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.095138', 'ticker_sentiment_score': '0.231544', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
65,National Fuel Gas and Landstar System Industries have been highlighted as Zacks Bull and Bear of the Day,https://www.zacks.com/stock/news/2316944/national-fuel-gas-and-landstar-system-industries-have-been-highlighted-as-zacks-bull-and-bear-of-the-day,20240806T133600,['Zacks Equity Research'],"Chicago, IL - August 6, 2024 - Zacks Equity Research shares National Fuel Gas Company's ( NFG Quick QuoteNFG - ) as the Bull of the Day and Landstar System ( LSTR Quick QuoteLSTR - ) asthe Bear of the Day.",https://staticx-tuner.zacks.com/images/articles/main/98/1083.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.990678'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.133989,Neutral,"[{'ticker': 'BYDDF', 'relevance_score': '0.027103', 'ticker_sentiment_score': '0.053624', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LSTR', 'relevance_score': '0.040645', 'ticker_sentiment_score': '-0.091433', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.013553', 'ticker_sentiment_score': '0.181425', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SMCI', 'relevance_score': '0.027103', 'ticker_sentiment_score': '0.118681', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.027103', 'ticker_sentiment_score': '0.118681', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCA', 'relevance_score': '0.067689', 'ticker_sentiment_score': '0.123519', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.054175', 'ticker_sentiment_score': '0.074006', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BYDDY', 'relevance_score': '0.040645', 'ticker_sentiment_score': '0.009758', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SZIHF', 'relevance_score': '0.027103', 'ticker_sentiment_score': '-0.06195', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFG', 'relevance_score': '0.121513', 'ticker_sentiment_score': '0.201272', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
66,Prediction: These Could Be the Best-Performing Value Stocks Through 2030,https://www.fool.com/investing/2024/08/06/prediction-these-could-be-the-best-performing-valu/,20240806T093400,['Rachel Warren'],These tried-and-true businesses can deliver returns to investors for many years to come.,https://g.foolcdn.com/editorial/images/785275/stocks-investing-financial-empowerment.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}, {'topic': 'Earnings', 'relevance_score': '0.684621'}]",0.22956,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.245693', 'ticker_sentiment_score': '0.213345', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.035661', 'ticker_sentiment_score': '0.108312', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.312599', 'ticker_sentiment_score': '0.178864', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
67,"Eli Lilly's Zepbound Challenges Novo Nordisk's Wegovy Amid Supply Issues - Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/general/biotech/24/08/40165692/eli-lillys-zepbound-challenges-novo-nordisks-wegovy-amid-supply-issues,20240805T155928,['Vandana Singh'],"Eli Lilly And Company's LLY weight-loss drug, Zepbound ( tirzepatide ) , is gaining traction in the U.S., rivaling Novo Nordisk A/S's NVO Wegovy ( semaglutide ) . Due to ongoing supply issues, some doctors are prioritizing availability when prescribing these medications.",https://cdn.benzinga.com/files/images/story/2024/08/05/January-24--2024--Fort-Worth--Tx--Usa-A-.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.235061,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.682689', 'ticker_sentiment_score': '0.278118', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.524949', 'ticker_sentiment_score': '0.32511', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
68,Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?,https://www.zacks.com/stock/news/2316241/will-these-5-medical-stocks-surpass-q2-earnings-forecasts,20240805T153600,['Kanishka Das'],"Let's look at five biotech and drug companies, AMGN, GILD, LLY, VTRS & NVO, due to release their second-quarter 2024 results this week.",https://staticx-tuner.zacks.com/images/articles/main/e6/2070.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.203258,Somewhat-Bullish,"[{'ticker': 'AZN', 'relevance_score': '0.035555', 'ticker_sentiment_score': '0.023124', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.244987', 'ticker_sentiment_score': '0.038677', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VTRS', 'relevance_score': '0.278618', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.210884', 'ticker_sentiment_score': '0.050423', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.035555', 'ticker_sentiment_score': '0.023124', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.244987', 'ticker_sentiment_score': '-0.009196', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.244987', 'ticker_sentiment_score': '0.126514', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.035555', 'ticker_sentiment_score': '0.023124', 'ticker_sentiment_label': 'Neutral'}]"
69,Decoding Eli Lilly's Options Activity: What's the Big Picture? - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/08/40161870/decoding-eli-lillys-options-activity-whats-the-big-picture,20240805T141625,['Benzinga Insights'],"Financial giants have made a conspicuous bullish move on Eli Lilly. Our analysis of options history for Eli Lilly LLY revealed 14 unusual trades. Delving into the details, we found 42% of traders were bullish, while 42% showed bearish tendencies.",https://www.benzinga.com/files/images/story/2024/1722867381_0.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.072335,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.786972', 'ticker_sentiment_score': '-0.040297', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.090134', 'ticker_sentiment_score': '-0.115148', 'ticker_sentiment_label': 'Neutral'}]"
70,"Should You Buy, Sell or Hold Lilly  ( LLY )  Ahead of Q2 Earnings?",https://www.zacks.com/stock/news/2316000/should-you-buy-sell-or-hold-lilly-lly-ahead-of-q2-earnings,20240805T133600,['Kinjel Shah'],Investor focus is likely to be on the sales numbers of Lilly's (LLY) tirzepatide medicines Mounjaro and Zepbound.,https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.996023'}, {'topic': 'Earnings', 'relevance_score': '0.995869'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.280482,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.50235', 'ticker_sentiment_score': '0.47047', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.063594', 'ticker_sentiment_score': '0.19729', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.063594', 'ticker_sentiment_score': '0.107661', 'ticker_sentiment_label': 'Neutral'}]"
71,Lilly  ( LLY )  Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures,https://www.zacks.com/stock/news/2315866/lilly-lly-q2-earnings-on-the-horizon-analysts-insights-on-key-performance-measures,20240805T131611,['Zacks Equity Research'],"Besides Wall Street's top -and-bottom-line estimates for Lilly (LLY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2024.",https://staticx-tuner.zacks.com/images/default_article_images/default307.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.947132'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.097131,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.338119', 'ticker_sentiment_score': '0.173347', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
72,Should You Buy Eli Lilly Before Aug. 8?,https://www.fool.com/investing/2024/08/05/should-you-buy-eli-lilly-before-aug-8/,20240805T091000,['Adria Cimino'],There's reason to be optimistic about what's to come.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F785523%2Fgettyimages-1134003590.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.999816'}]",0.206088,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.533481', 'ticker_sentiment_score': '0.21543', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.01301', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.098019', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.01301', 'ticker_sentiment_label': 'Neutral'}]"
73,Here are 4 things we're watching closely in the stock market this week,https://www.cnbc.com/2024/08/04/here-are-4-things-were-watching-closely-in-the-stock-market-this-week.html,20240804T135944,[],"Expect earnings reports, and CEO commentaries, to drive the market action.",,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '0.98396'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '0.947132'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.007224,Neutral,"[{'ticker': 'APP', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MPC', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.097835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROAD', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIVN', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WYNN', 'relevance_score': '0.082582', 'ticker_sentiment_score': '0.004136', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GLW', 'relevance_score': '0.027571', 'ticker_sentiment_score': '0.090183', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MPW', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.094835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KVUE', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.097835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UPST', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CEG', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.097835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARRY', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.164881', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ILMN', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.027571', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BROS', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCO', 'relevance_score': '0.055109', 'ticker_sentiment_score': '-0.056855', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZI', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FTNT', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VST', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.094835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FSLY', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ERJ', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUBS', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HOOD', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CELH', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.097835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVS', 'relevance_score': '0.055109', 'ticker_sentiment_score': '-0.056855', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HIMS', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BLDR', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.097835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DDOG', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.094835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXON', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RKLB', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.164881', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HIMX', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.094835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'O', 'relevance_score': '0.027571', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SG', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.164881', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BCRX', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZTS', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.097835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ACMR', 'relevance_score': '0.055109', 'ticker_sentiment_score': '-0.056855', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SN', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.094835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CGC', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLTR', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ACB', 'relevance_score': '0.055109', 'ticker_sentiment_score': '-0.056855', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RDDT', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APPS', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VMC', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.097835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SEDG', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OSCR', 'relevance_score': '0.055109', 'ticker_sentiment_score': '-0.056855', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OGN', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.097835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GXO', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.097835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SRPT', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.055109', 'ticker_sentiment_score': '-0.056855', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DNUT', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.094835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABNB', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPG', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFE', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DT', 'relevance_score': '0.055109', 'ticker_sentiment_score': '-0.056855', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRON', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.094835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OXY', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VFC', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PZZA', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.094835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.027571', 'ticker_sentiment_score': '0.054424', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FIVN', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.164881', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'YUMC', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CLSK', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.164881', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MNKD', 'relevance_score': '0.055109', 'ticker_sentiment_score': '-0.056855', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMR', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EMR', 'relevance_score': '0.055109', 'ticker_sentiment_score': '-0.056855', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLUG', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.094835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ASPN', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSN', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ET', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNEJF', 'relevance_score': '0.055109', 'ticker_sentiment_score': '-0.056855', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'YUM', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.097835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAR', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WYNMF', 'relevance_score': '0.027571', 'ticker_sentiment_score': '0.004759', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.097835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.027571', 'ticker_sentiment_score': '0.054424', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PARA', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.164881', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TTD', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.164881', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LUMN', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXSM', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BNTX', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SHOP', 'relevance_score': '0.055109', 'ticker_sentiment_score': '-0.056855', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TDC', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SOUN', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.164881', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'OC', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.097835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKLA', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.082582', 'ticker_sentiment_score': '0.090235', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DUK', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.097835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVAX', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.094835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.097835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KRYS', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLNT', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.097835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CSX', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FRPT', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LCID', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MGNI', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAX', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.097835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CPNG', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GCT', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.164881', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DVN', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:GBP', 'relevance_score': '0.027571', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
74,Eli Lilly's Obesity Drug Shows a Heart Benefit. Is It Time to Buy?,https://www.fool.com/investing/2024/08/04/eli-lilly-a-buy-now/,20240804T092600,['Cory Renauer'],"Recent results from a clinical trial show that treatment with Zepbound significantly reduced patients' risk of heart failure outcomes, including cardiovascular death.",https://g.foolcdn.com/editorial/images/785688/investor-charts-closeup-getty.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}]",0.063433,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.470606', 'ticker_sentiment_score': '0.175086', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HIMS', 'relevance_score': '0.050148', 'ticker_sentiment_score': '-0.081967', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.050148', 'ticker_sentiment_score': '0.029852', 'ticker_sentiment_label': 'Neutral'}]"
75,Eli Lilly vs Novo Nordisk: A Recent Study Suggests This Company Has the Best Weight Loss Drug,https://www.fool.com/investing/2024/08/03/eli-lilly-vs-novo-nordisk-a-recent-study-suggests/,20240803T102000,['David Jagielski'],"These healthcare stocks are up more than 400% in the past five years, thanks to their dominance in the anti-obesity market.",https://g.foolcdn.com/editorial/images/784782/weight-loss-pills-with-measuring-tape.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.225302,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.542261', 'ticker_sentiment_score': '0.258336', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.396798', 'ticker_sentiment_score': '0.189059', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
76,Is This Decision by Pfizer Bad News for Eli Lilly?,https://www.fool.com/investing/2024/08/03/is-this-decision-by-pfizer-bad-news-for-eli-lilly/,20240803T081000,['Adria Cimino'],Lilly's revenue gains have helped its stock to roar higher.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F785370%2Fgettyimages-1292931102.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.684621'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.150152,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.752508', 'ticker_sentiment_score': '0.229261', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.054236', 'ticker_sentiment_score': '0.062', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.214462', 'ticker_sentiment_score': '0.070374', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.366061', 'ticker_sentiment_score': '0.228716', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
77,"ResMed Earnings Reflect Increased Demand For Sleep Devices, Performance Indicates Positive Dynamics, Opportunities - ResMed  ( NYSE:RMD ) ",https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40133504/resmed-earnings-reflect-increased-demand-for-sleep-devices-performance-indicates-po,20240802T144626,['Vandana Singh'],"ResMed Inc. RMD reported fourth-quarter 2024 revenue of $1.22 billion, up 9% year-over-year and up 10% on a constant currency basis, in line with the consensus of $1.22 billion. The growth was driven by increased demand for sleep devices and masks portfolio and strong growth across Software as a ...",https://cdn.benzinga.com/files/images/story/2024/08/02/ResMed---logo.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.87644'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.310554,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.258351', 'ticker_sentiment_score': '-0.040729', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RMD', 'relevance_score': '0.490323', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
78,What's Going On With Eli Lilly and Company Shares Friday - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/general/biotech/24/08/40133292/whats-going-on-with-eli-lilly-and-company-shares-friday,20240802T143942,['Dylan Berman'],"Eli Lilly and Company LLY stock is trading lower on Friday. The company is anticipated to release earnings on Aug. 8 for the 2024 fiscal year second quarter. Also, Eli Lilly announced promising results from its SUMMIT phase 3 clinical trial earlier this week.",https://cdn.benzinga.com/files/images/story/2024/08/02/Eli-Lilly.jpeg?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.01981,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.659096', 'ticker_sentiment_score': '-0.064028', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSTK', 'relevance_score': '0.126119', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
79,"Company News for Aug 2, 2024",https://www.zacks.com/stock/news/2315020/company-news-for-aug-2-2024,20240802T124800,['Zacks Equity Research'],"Companies In The Article Are: LLY,MGM,SO and TRP ...",https://staticx-tuner.zacks.com/images/articles/main/2c/68763.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.333333'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}]",0.012483,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.601928', 'ticker_sentiment_score': '-0.181803', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'MGM', 'relevance_score': '0.601928', 'ticker_sentiment_score': '-0.321868', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TRP', 'relevance_score': '0.601928', 'ticker_sentiment_score': '0.481028', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SO', 'relevance_score': '0.327366', 'ticker_sentiment_score': '0.106642', 'ticker_sentiment_label': 'Neutral'}]"
80,Eli Lilly  ( LLY )  Earnings Expected to Grow: What to Know Ahead of Next Week's Release,https://www.zacks.com/stock/news/2314332/eli-lilly-lly-earnings-expected-to-grow-what-to-know-ahead-of-next-weeks-release,20240801T140114,['Zacks Equity Research'],Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,https://staticx-tuner.zacks.com/images/default_article_images/default336.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.157097,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.3007', 'ticker_sentiment_score': '0.059967', 'ticker_sentiment_label': 'Neutral'}]"
81,Pfizer Just Confirmed It's a Dividend Investor's Dream Stock,https://www.fool.com/investing/2024/08/01/pfizer-confirmed-dividend-investors-dream-stock/,20240801T095000,['Keith Speights'],This big pharma stock gives investors juicy and reliable dividends plus the potential for future growth.,https://g.foolcdn.com/editorial/images/785266/pfizer_logo_on_glass_pfe.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.795202'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.318666,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.05339', 'ticker_sentiment_score': '0.211792', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BHVN', 'relevance_score': '0.05339', 'ticker_sentiment_score': '0.118024', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.05339', 'ticker_sentiment_score': '0.211792', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.684845', 'ticker_sentiment_score': '0.49371', 'ticker_sentiment_label': 'Bullish'}]"
82,Pfizer to Buy a GLP-1 Drugmaker? Here's Why You Shouldn't Count on That Happening,https://www.fool.com/investing/2024/08/01/pfizer-to-buy-a-glp-1-drugmaker-heres-why-you-shou/,20240801T082000,['David Jagielski'],Pfizer's debt load could inhibit the company's ability to take on acquisitions in the near term.,https://media.ycharts.com/charts/e0ce946b8ad486197d7378c66adb3cdb.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.214437,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.049019', 'ticker_sentiment_score': '0.105828', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.049019', 'ticker_sentiment_score': '0.132976', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.049019', 'ticker_sentiment_score': '0.105828', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.674691', 'ticker_sentiment_score': '0.327564', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
83,Here is What to Know Beyond Why Eli Lilly and Company  ( LLY )  is a Trending Stock,https://www.zacks.com/stock/news/2312779/here-is-what-to-know-beyond-why-eli-lilly-and-company-lly-is-a-trending-stock,20240731T130017,['Zacks Equity Research'],"Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default279.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}]",0.246161,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.482078', 'ticker_sentiment_score': '0.133767', 'ticker_sentiment_label': 'Neutral'}]"
84,What's Going On With Eli Lilly Today? - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/news/24/07/40053808/whats-going-on-with-eli-lilly-today,20240730T212805,['Vaishali Prayag'],Eli Lilly & Co LLY shares are trading lower Tuesday. Here's what you need to know. What To Know: The company is set to report its second-quarter earnings on Aug. 8. The upcoming earnings report is expected to show EPS of $2.70 and revenue of $9.949 billion.,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/30151759/LLY-2.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999897'}, {'topic': 'Earnings', 'relevance_score': '0.744043'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.234919,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.597525', 'ticker_sentiment_score': '0.294687', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BRK-A', 'relevance_score': '0.110973', 'ticker_sentiment_score': '0.185933', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
85,"Incyte's  ( INCY )  Q2 Earnings Lag Estimates, Revenues Top",https://www.zacks.com/stock/news/2312126/incytes-incy-q2-earnings-lag-estimates-revenues-top,20240730T140700,['Zacks Equity Research'],"Incyte's (INCY) second-quarter 2024 earnings miss estimates while revenues beat the same. The company raises the bottom end of the 2024 revenue guidance for its lead drug, Jakafi.",https://staticx-tuner.zacks.com/images/articles/main/67/1932.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.947132'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.173799,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.17813', 'ticker_sentiment_score': '0.051223', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INCY', 'relevance_score': '0.535653', 'ticker_sentiment_score': '0.273188', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MOR', 'relevance_score': '0.044885', 'ticker_sentiment_score': '0.213905', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HALO', 'relevance_score': '0.13409', 'ticker_sentiment_score': '0.217773', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
86,This Is What Whales Are Betting On Eli Lilly and Co - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/07/40038875/this-is-what-whales-are-betting-on-eli-lilly-and-co,20240730T134550,['Benzinga Insights'],"Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly and Co. Looking at options history for Eli Lilly and Co LLY we detected 20 trades. If we consider the specifics of each trade, it is accurate to state that 20% of the investors opened trades with bullish ...",https://www.benzinga.com/files/images/story/2024/1722347147_0.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.106915,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.837089', 'ticker_sentiment_score': '0.094002', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.079392', 'ticker_sentiment_score': '-0.095472', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.079392', 'ticker_sentiment_score': '-0.095472', 'ticker_sentiment_label': 'Neutral'}]"
87,Merck  ( MRK )  Q2 Earnings and Revenues Top Estimates,https://www.zacks.com/stock/news/2311559/merck-mrk-q2-earnings-and-revenues-top-estimates,20240730T114007,['Zacks Equity Research'],"Merck (MRK) delivered earnings and revenue surprises of 5.56% and 1.35%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?",https://staticx-tuner.zacks.com/images/default_article_images/default198.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999992'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.159566,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.139265', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
88,"1 Weight Loss Pharma Stock to Buy, and 1 to Consider",https://www.fool.com/investing/2024/07/30/1-weight-loss-pharma-stock-to-buy-1-to-consider/,20240730T110700,['Alex Carchidi'],There's more than one type of worthy opportunity in this space.,https://g.foolcdn.com/editorial/images/783281/investor-ponders-phone-and-laptop-stock-charts.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.190778,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.264897', 'ticker_sentiment_score': '0.235217', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.089797', 'ticker_sentiment_score': '0.214494', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
89,DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?,https://www.fool.com/investing/2024/07/30/dexcom-stock-plunged-eli-lilly-novo-nordisk/,20240730T094800,['Keith Speights'],"DexCom faces several challenges, but GLP-1 drugs aren't big problems for the company right now.",https://g.foolcdn.com/editorial/images/785036/diabetes-cgm-man-in-wheelchair.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.310843'}]",0.009701,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.224903', 'ticker_sentiment_score': '-0.056535', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.113597', 'ticker_sentiment_score': '-0.091966', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DXCM', 'relevance_score': '0.524949', 'ticker_sentiment_score': '0.019978', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.224903', 'ticker_sentiment_score': '-0.056535', 'ticker_sentiment_label': 'Neutral'}]"
90,Eli Lilly  ( LLY )  Beats Stock Market Upswing: What Investors Need to Know,https://www.zacks.com/stock/news/2311334/eli-lilly-lly-beats-stock-market-upswing-what-investors-need-to-know,20240729T214519,['Zacks Equity Research'],"In the most recent trading session, Eli Lilly (LLY) closed at $807.79, indicating a +0.39% shift from the previous trading day.",https://staticx-tuner.zacks.com/images/default_article_images/default48.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.99246'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.133092,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.514619', 'ticker_sentiment_score': '0.214088', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
91,Unpacking the Latest Options Trading Trends in Eli Lilly and Co - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/07/40014415/unpacking-the-latest-options-trading-trends-in-eli-lilly-and-co,20240729T144635,['Benzinga Insights'],"Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly and Co. Looking at options history for Eli Lilly and Co LLY we detected 51 trades. If we consider the specifics of each trade, it is accurate to state that 41% of the investors opened trades with bullish ...",https://www.benzinga.com/files/images/story/2024/1722264392_0.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.107088,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.84827', 'ticker_sentiment_score': '0.147589', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.081552', 'ticker_sentiment_score': '-0.103989', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.081552', 'ticker_sentiment_score': '-0.103989', 'ticker_sentiment_label': 'Neutral'}]"
92,"What Will Be the Best Weight Loss Drug Stock of 2030: Eli Lilly, or Novo Nordisk?",https://www.fool.com/investing/2024/07/29/what-will-be-the-best-weight-loss-drug-stock-2030/,20240729T132000,['Alex Carchidi'],There's reason to believe that one of these two players will eventually win.,https://g.foolcdn.com/editorial/images/783278/a-young-scientist-recording-her-findings-on-a-tablet.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.17958,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.268786', 'ticker_sentiment_score': '0.13338', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.268786', 'ticker_sentiment_score': '0.126106', 'ticker_sentiment_label': 'Neutral'}]"
93,Weight Loss Drug Stocks Just Took a Hit. Should You Buy the Stock That Caused It?,https://www.fool.com/investing/2024/07/29/weight-loss-drug-stocks-just-took-a-hit-should-you/,20240729T113000,['Alex Carchidi'],"Roche's latest breakthrough could be a game changer, but it's still too early to say.",https://g.foolcdn.com/editorial/images/784432/chart-reflected-on-investor-glasses.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.796627'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}]",0.198686,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.248343', 'ticker_sentiment_score': '0.147852', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALT', 'relevance_score': '0.150592', 'ticker_sentiment_score': '0.121016', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GPCR', 'relevance_score': '0.050465', 'ticker_sentiment_score': '-0.049863', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.150592', 'ticker_sentiment_score': '0.11568', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.248343', 'ticker_sentiment_score': '0.147852', 'ticker_sentiment_label': 'Neutral'}]"
94,Zacks Market Edge Highlights: LLY and NVO,https://www.zacks.com/stock/news/2310465/zacks-market-edge-highlights-lly-and-nvo,20240729T092400,['Zacks Investment Research'],LLY and NVO have been highlighted in this Market Edge article.,https://staticx-tuner.zacks.com/images/articles/main/ff/2922.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.977154'}]",0.099538,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.511256', 'ticker_sentiment_score': '-0.009697', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.436009', 'ticker_sentiment_score': '-0.122068', 'ticker_sentiment_label': 'Neutral'}]"
95,"Attention, Growth Investors: This Biotech Stock Is Crushing Nvidia.",https://www.fool.com/investing/2024/07/29/this-biotech-stock-is-crushing-nvidia/,20240729T082000,['Adria Cimino'],Should you get in on this stock now?,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F784762%2Fgettyimages-1172040755.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.266143'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.251835,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.051111', 'ticker_sentiment_score': '0.090895', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.391923', 'ticker_sentiment_score': '0.424944', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'VKTX', 'relevance_score': '0.102013', 'ticker_sentiment_score': '0.058322', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.051111', 'ticker_sentiment_score': '0.090895', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.051111', 'ticker_sentiment_score': '0.090895', 'ticker_sentiment_label': 'Neutral'}]"
96,"Home Depot Stock Turned $1,000 Into $17.5 Million, and One of Its Founders Just Revealed His Investing Secrets to Achieve Generational Wealth",https://www.fool.com/investing/2024/07/28/home-depot-stock-turned-1000-into-175-million-and/,20240728T130600,['Adam Spatacco'],Home Depot founder Ken Langone recently shared his investment wisdom on the American Optimist podcast.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F784466%2Fgetty-focus-on-the-long-term-planning-patience-diligence-goals-retirement-1.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999956'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",0.299257,Somewhat-Bullish,"[{'ticker': 'HD', 'relevance_score': '0.381463', 'ticker_sentiment_score': '0.314662', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.244354', 'ticker_sentiment_score': '0.187884', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
97,Is Eli Lilly Stock a Buy?,https://www.fool.com/investing/2024/07/28/is-eli-lilly-stock-a-buy/,20240728T085500,['Justin Pope'],The stock is up 250% in three years on growth in GLP-1 medications.,https://media.ycharts.com/charts/17d004bce79956a5f807eb1e794b6e1e.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.997405'}]",0.256102,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.458799', 'ticker_sentiment_score': '0.399481', 'ticker_sentiment_label': 'Bullish'}]"
98,Novo Nordisk's Next-Gen Diabetes Candidate Could Challenge Ozempic -- Is the Stock a Buy?,https://www.fool.com/investing/2024/07/27/novo-nordisks-next-gen-diabetes-candidate-could-ch/,20240727T150500,['Prosper Junior Bakiny'],The company should maintain its lead in this growing area.,https://g.foolcdn.com/editorial/images/783838/doctor-and-patient-talking.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.161647'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.283158,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.056143', 'ticker_sentiment_score': '0.061003', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.518708', 'ticker_sentiment_score': '0.280929', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
99,These 2 Growth Stocks Are Set to Soar This Summer and Beyond,https://www.fool.com/investing/2024/07/27/these-2-growth-stocks-are-set-to-soar-this-summer/,20240727T121500,['Rachel Warren'],It's a great time to invest in wonderful stocks.,https://g.foolcdn.com/editorial/images/784334/woman-finance-calculator-laptop-notebook.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.928769'}]",0.217682,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.220141', 'ticker_sentiment_score': '0.155497', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABNB', 'relevance_score': '0.391645', 'ticker_sentiment_score': '0.162087', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
100,Bull Market Buys: 2 Growth Stocks to Own for the Long Run,https://www.fool.com/investing/2024/07/27/bull-market-buys-2-growth-stocks-to-own-for-the/,20240727T111500,['Prosper Junior Bakiny'],These companies are no strangers to beating the market.,https://media.ycharts.com/charts/796d5ec30bcaa8ef406477cc309666b0.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.918141'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.26283,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.445352', 'ticker_sentiment_score': '0.36374', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'REGN', 'relevance_score': '0.104455', 'ticker_sentiment_score': '0.077383', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.05234', 'ticker_sentiment_score': '0.116889', 'ticker_sentiment_label': 'Neutral'}]"
101,Is Eli Lilly's Stock in a Bubble?,https://www.zacks.com/stock/news/2310243/is-eli-lillys-stock-in-a-bubble,20240726T161100,['Tracey Ryniec'],Shares of Eli Lilly are up 150% over the last 2 years as investors are bullish about the new weight loss drugs. Is it too hot to handle?,https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}]",0.042982,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.620083', 'ticker_sentiment_score': '-0.010796', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.535653', 'ticker_sentiment_score': '-0.138701', 'ticker_sentiment_label': 'Neutral'}]"
102,Analyzing Eli Lilly and Co In Comparison To Competitors In Pharmaceuticals Industry - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/news/24/07/39986767/analyzing-eli-lilly-and-co-in-comparison-to-competitors-in-pharmaceuticals-industry,20240726T150013,['Benzinga Insights'],"In today's rapidly changing and highly competitive business world, it is imperative for investors and industry observers to carefully assess companies before making investment choices.",https://www.benzinga.com/files/images/story/2024/1722006010_0.png,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.203115,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.517168', 'ticker_sentiment_score': '0.294437', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
103,Should You Invest in Novo Nordisk  ( NVO )  Ahead of Q2 Earnings?,https://www.zacks.com/stock/news/2310035/should-you-invest-in-novo-nordisk-nvo-ahead-of-q2-earnings,20240726T125500,['Ahan Chakraborty'],"Novo Nordisk's (NVO) second-quarter revenues are expected to have been driven by its diabetes and obesity care product sales, especially Wegovy, Ozempic and Rybelsus.",https://staticx-tuner.zacks.com/images/articles/main/5d/57943.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}, {'topic': 'Earnings', 'relevance_score': '0.999858'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.306721,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.112182', 'ticker_sentiment_score': '0.230537', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VKTX', 'relevance_score': '0.074926', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.037504', 'ticker_sentiment_score': '0.247561', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.427425', 'ticker_sentiment_score': '0.438799', 'ticker_sentiment_label': 'Bullish'}]"
104,Prediction: This Is What Eli Lilly Stock Will Do Next,https://www.fool.com/investing/2024/07/26/prediction-this-is-what-eli-lilly-stock-will-do/,20240726T114500,['Adam Spatacco'],"Shares of Eli Lilly are up more than 130% in the past year, but this company's moves are far from finished.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F784274%2Fgettyimages-1978065812.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.684621'}]",0.232982,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.61135', 'ticker_sentiment_score': '0.416174', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.04583', 'ticker_sentiment_score': '0.08747', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.04583', 'ticker_sentiment_score': '0.08747', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMG', 'relevance_score': '0.04583', 'ticker_sentiment_score': '0.08747', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.04583', 'ticker_sentiment_score': '-0.06371', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.04583', 'ticker_sentiment_score': '0.08747', 'ticker_sentiment_label': 'Neutral'}]"
105,"Novo Nordisk Shares Decline Amid Competitive Pressure - Novo Nordisk  ( NYSE:NVO ) , Eli Lilly and Co  ( NYSE:LLY ) ",https://www.benzinga.com/news/24/07/39970646/novo-nordisk-shares-decline-amid-competitive-pressure,20240725T202521,['Vaishali Prayag'],Novo Nordisk A/S Common Stock NVO experienced a notable decline on Thursday. This movement follows a significant announcement from competitor Viking Therapeutics Inc. VKTX. What To Know: Viking Therapeutics announced the company has advanced its obesity candidate VK2735 into late-stage trials.,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/25160653/NVO-1024x540.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}]",0.112337,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.297661', 'ticker_sentiment_score': '0.221664', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VKTX', 'relevance_score': '0.55533', 'ticker_sentiment_score': '0.226754', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.873652', 'ticker_sentiment_score': '0.062815', 'ticker_sentiment_label': 'Neutral'}]"
106,Pfizer  ( PFE )  Gains 7.3% in 2024 on its Weigh-Loss Drug Pipeline,https://www.zacks.com/stock/news/2308514/pfizer-pfe-gains-73-in-2024-on-its-weigh-loss-drug-pipeline,20240725T094900,['Zacks Equity Research'],"Shares of Pfizer (PFE) are up 7.3% in 2024, based on its weight-loss drug program. The stock must be watched for further developments.",https://staticx-tuner.zacks.com/images/articles/main/d6/2257.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.06152,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.270773', 'ticker_sentiment_score': '0.139623', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.700945', 'ticker_sentiment_score': '0.124358', 'ticker_sentiment_label': 'Neutral'}]"
107,Elon Musk Agrees With Former Executive Who Thinks 'Everyone' Has 'Strong' Opinions On Tesla Unlike In The Case Of Eli Lilly And LVMH - Tesla  ( NASDAQ:TSLA ) ,https://www.benzinga.com/news/24/07/39950408/elon-musk-agrees-with-former-executive-who-thinks-everyone-has-strong-opinions-on-tesla-unlike-in-th,20240725T074508,['Anan Ashraf'],"Investors have a strong opinion on Tesla Inc. TSLA unlike other companies such as LVMH Moët Hennessy Louis Vuitton SE LVMHF or Eli Lilly and Co LLY, former Tesla Investor Relations head Martin Viecha said on Wednesday and company CEO Elon Musk agrees.",https://cdn.benzinga.com/files/images/story/2024/07/25/Tesla-logo.jpeg?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}]",0.145423,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.421485', 'ticker_sentiment_score': '0.020033', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.733479', 'ticker_sentiment_score': '0.269455', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
108,What Lies in Store for Healthcare ETFs in Q2 Earnings?,https://www.zacks.com/stock/news/2308035/what-lies-in-store-for-healthcare-etfs-in-q2-earnings,20240724T150000,['Sweta Killa'],"The healthcare sector has gained momentum lately on market rotation, with investors rushing to buy beaten-down stocks while shunning the hot technology sector.",https://staticx-tuner.zacks.com/images/articles/main/d7/2961.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.980716'}]",0.169447,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.228073', 'ticker_sentiment_score': '0.052088', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.016864', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.228073', 'ticker_sentiment_score': '0.082674', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.228073', 'ticker_sentiment_score': '0.142692', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.007802', 'ticker_sentiment_label': 'Neutral'}]"
109,3 Dividend Growth Stocks That Have Doubled Their Payouts in 5 Years,https://www.fool.com/investing/2024/07/24/3-dividend-growth-stocks-that-have-doubled-their-p/,20240724T103900,['David Jagielski'],"Their yields may seem low, but these stocks have been growing their dividend payments at a fast pace.",https://g.foolcdn.com/editorial/images/784051/a-couple-reviewing-a-statement.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999976'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.891286'}]",0.348953,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.2589', 'ticker_sentiment_score': '0.265939', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MA', 'relevance_score': '0.308246', 'ticker_sentiment_score': '0.449581', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'AVGO', 'relevance_score': '0.308246', 'ticker_sentiment_score': '0.314766', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
110,"If You'd Invested $10,000 in Eli Lilly Stock 5 Years Ago, Here's How Much You'd Have Today",https://www.fool.com/investing/2024/07/24/if-youd-invested-10000-in-eli-lilly-stock-5-years/,20240724T081500,['Adria Cimino'],Could today's momentum continue?,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F784151%2Fdoctors-white-coat-healthcare.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.161647'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.340406,Somewhat-Bullish,"[{'ticker': 'GS', 'relevance_score': '0.112532', 'ticker_sentiment_score': '0.06635', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.742397', 'ticker_sentiment_score': '0.539549', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.112532', 'ticker_sentiment_score': '0.06635', 'ticker_sentiment_label': 'Neutral'}]"
111,Market Whales and Their Recent Bets on LLY Options - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/07/39907670/market-whales-and-their-recent-bets-on-lly-options,20240723T134658,['Benzinga Insights'],"Financial giants have made a conspicuous bearish move on Eli Lilly and Co. Our analysis of options history for Eli Lilly and Co LLY revealed 15 unusual trades. Delving into the details, we found 26% of traders were bullish, while 33% showed bearish tendencies.",https://www.benzinga.com/files/images/story/2024/1721742415_0.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.989041'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.014474,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.785534', 'ticker_sentiment_score': '-0.043984', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.082393', 'ticker_sentiment_score': '-0.118494', 'ticker_sentiment_label': 'Neutral'}]"
112,Time for Healthcare ETFs?,https://www.zacks.com/stock/news/2306667/time-for-healthcare-etfs,20240723T125100,['Sanghamitra Saha'],"Compelling valuation, innovation in specific growth areas and an aging population as well as increasing healthcare spending are the tailwinds of the medical sector.",https://staticx-tuner.zacks.com/images/default_article_images/default151.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.890401'}]",0.279458,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.178459', 'ticker_sentiment_score': '0.068617', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.178459', 'ticker_sentiment_score': '0.068617', 'ticker_sentiment_label': 'Neutral'}]"
113,"Look Out, Eli Lilly and Novo Nordisk: Could Roche Be the Obesity Drug Stock to Really Watch?",https://www.fool.com/investing/2024/07/23/look-out-eli-lilly-and-novo-nordisk-roches-obesity/,20240723T094800,['Keith Speights'],Roche might give Lilly and Novo Nordisk a run for their money -- sometime down the road.,https://g.foolcdn.com/editorial/images/784123/scales-feet-tape-measure.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.166524,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.464844', 'ticker_sentiment_score': '0.309865', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.464844', 'ticker_sentiment_score': '0.309865', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
114,Eli Lilly  ( LLY )  Advances But Underperforms Market: Key Facts,https://www.zacks.com/stock/news/2306385/eli-lilly-lly-advances-but-underperforms-market-key-facts,20240722T214521,['Zacks Equity Research'],"In the most recent trading session, Eli Lilly (LLY) closed at $865.97, indicating a +0.99% shift from the previous trading day.",https://staticx-tuner.zacks.com/images/default_article_images/default308.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Earnings', 'relevance_score': '0.986564'}]",0.198998,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.527969', 'ticker_sentiment_score': '0.264188', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
115,Should Viking  ( VKTX )  Stock be in Your Portfolio Pre-Q2 Earnings?,https://www.zacks.com/stock/news/2305388/should-viking-vktx-stock-be-in-your-portfolio-pre-q2-earnings,20240719T135100,['Sundeep Ganoria'],"Devoid of marketed drugs, investors will focus on Viking Therapeutics' (VKTX) pipeline updates when it reports second-quarter results.",https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}, {'topic': 'Earnings', 'relevance_score': '0.96136'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.193825,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.144491', 'ticker_sentiment_score': '0.086568', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDGL', 'relevance_score': '0.072545', 'ticker_sentiment_score': '0.023257', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.180056', 'ticker_sentiment_score': '0.09935', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.03631', 'ticker_sentiment_score': '0.105402', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.072545', 'ticker_sentiment_score': '0.023257', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.03631', 'ticker_sentiment_score': '0.022187', 'ticker_sentiment_label': 'Neutral'}]"
116,"Pharma Stock Roundup: JNJ, NVS Q2 Earnings, RHHBY's Positive Obesity Pill Data",https://www.zacks.com/stock/news/2305154/pharma-stock-roundup-jnj-nvs-q2-earnings-rhhbys-positive-obesity-pill-data,20240719T132600,['Kinjel Shah'],J&J (JNJ) and Novartis (NVS) beat estimates for earnings and sales. Roche's (RHHBY) oral weight loss GLP-1 therapy achieves positive results in an early-stage study.,https://staticx-tuner.zacks.com/images/articles/main/ab/2180.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.938238'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.143768,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.153797', 'ticker_sentiment_score': '-0.110727', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.349153', 'ticker_sentiment_score': '0.06668', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.051551', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.051551', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
117,Eli Lilly and Company  ( LLY )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2305089/eli-lilly-and-company-lly-is-attracting-investor-attention-here-is-what-you-should-know,20240719T130017,['Zacks Equity Research'],"Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default341.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}]",0.224032,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.487546', 'ticker_sentiment_score': '0.119797', 'ticker_sentiment_label': 'Neutral'}]"
118,Nvidia Recently Completed a 10-for-1 Stock Split: Here Are the 3 Likeliest Candidates to Become Wall Street's Next Stock-Split Stocks,https://www.fool.com/investing/2024/07/19/nvidia-recently-completed-a-10-for-1-stock-split/,20240719T090600,['Sean Williams'],Roughly a dozen amazing companies have announced a stock split in 2024. Three high-flying stocks look like logical candidates to join this exclusive club.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F783403%2Fstock-split-us-dollar-coin-certificate-forward-reverse-getty.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'IPO', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.933642'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",0.175196,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.15347', 'ticker_sentiment_score': '-0.010483', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.301315', 'ticker_sentiment_score': '0.095726', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.243194', 'ticker_sentiment_score': '0.145767', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMG', 'relevance_score': '0.030878', 'ticker_sentiment_score': '-0.190605', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'FICO', 'relevance_score': '0.183662', 'ticker_sentiment_score': '0.158498', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WMT', 'relevance_score': '0.06171', 'ticker_sentiment_score': '-0.054181', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.030878', 'ticker_sentiment_score': '0.038202', 'ticker_sentiment_label': 'Neutral'}]"
119,"VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday? - Alcoa  ( NYSE:AA ) ",https://www.benzinga.com/markets/cryptocurrency/24/07/39845998/vix-stages-double-digit-spike-as-risk-off-takes-over-chipmakers-fail-to-rebound-weight-los,20240718T180528,['Piero Cingari'],"It's another risk-off day on Wall Street, with all major U.S. indices trading in the red. The CBOE Volatility Index ( VIX ) , often referred to as the market's fear gauge, spiked over 10%, reaching levels last seen in late April.",https://cdn.benzinga.com/files/images/story/2024/07/18/Bull-and-bear-stock-market-index.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.650727'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",-0.061521,Neutral,"[{'ticker': 'AA', 'relevance_score': '0.117486', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALK', 'relevance_score': '0.117486', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.117486', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.117486', 'ticker_sentiment_score': '-0.079457', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KMI', 'relevance_score': '0.117486', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.175433', 'ticker_sentiment_score': '-0.06853', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVS', 'relevance_score': '0.117486', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.058903', 'ticker_sentiment_score': '0.018315', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.117486', 'ticker_sentiment_score': '0.059696', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DPZ', 'relevance_score': '0.117486', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SLG', 'relevance_score': '0.117486', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSM', 'relevance_score': '0.117486', 'ticker_sentiment_score': '-0.241445', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'DMPZF', 'relevance_score': '0.058903', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.117486', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BX', 'relevance_score': '0.117486', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.175433', 'ticker_sentiment_score': '-0.06853', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTAS', 'relevance_score': '0.117486', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.117486', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VIRT', 'relevance_score': '0.117486', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.117486', 'ticker_sentiment_score': '0.040451', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.117486', 'ticker_sentiment_score': '-0.446115', 'ticker_sentiment_label': 'Bearish'}]"
120,The 5 Most Important Stocks to Watch During Q2 Earnings Season,https://www.zacks.com/stock/news/2304630/the-5-most-important-stocks-to-watch-during-q2-earnings-season,20240718T150300,['Tracey Ryniec'],All eyes will be on these 5 companies over the next few weeks. Will another beat add fuel to this already red-hot stock market?,https://staticx-tuner.zacks.com/images/default_article_images/default331.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.9973'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.289877,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.403913', 'ticker_sentiment_score': '0.076277', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.541943', 'ticker_sentiment_score': '0.355901', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.403913', 'ticker_sentiment_score': '0.410105', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'CMG', 'relevance_score': '0.167904', 'ticker_sentiment_score': '0.162942', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SMCI', 'relevance_score': '0.403913', 'ticker_sentiment_score': '0.465427', 'ticker_sentiment_label': 'Bullish'}]"
121,Will Eli Lilly Do a Stock Split in 2024?,https://www.fool.com/investing/2024/07/18/will-eli-lilly-do-a-stock-split-in-2024/,20240718T092300,['David Jagielski'],Eli Lilly hasn't done a stock split in decades.,https://g.foolcdn.com/editorial/images/783383/investor-pointing-at-a-chart.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.897321'}, {'topic': 'Earnings', 'relevance_score': '0.538269'}]",0.187722,Somewhat-Bullish,"[{'ticker': 'CMG', 'relevance_score': '0.074926', 'ticker_sentiment_score': '-0.031047', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.699089', 'ticker_sentiment_score': '0.360716', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.074926', 'ticker_sentiment_score': '-0.031047', 'ticker_sentiment_label': 'Neutral'}]"
122,"Why Roche Stock Just Popped, but Eli Lilly and Novo Nordisk Dropped",https://www.fool.com/investing/2024/07/17/roche-group-stock-pops-eli-lilly-novo-nordisk-drop/,20240717T172154,['Rich Smith'],Roche has a new GLP-1 weight loss drug in the works -- and one very cheap stock.,https://g.foolcdn.com/editorial/images/783680/1-red-arrow-going-down-crosses-1-green-arrow-going-up.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}]",0.116688,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.648995', 'ticker_sentiment_score': '0.22517', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.648995', 'ticker_sentiment_score': '0.22517', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
123,"Zacks Industry Outlook Eli Lilly, Novo Nordisk, Merck and Pfizer",https://www.zacks.com/stock/news/2303338/zacks-industry-outlook-eli-lilly-novo-nordisk-merck-and-pfizer,20240717T133600,['Zacks Investment Research'],"Eli Lilly, Novo Nordisk, Merck and Pfizer have been highlighted in this Industry Outlook article.",https://staticx-tuner.zacks.com/images/articles/main/89/447.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999186'}, {'topic': 'Earnings', 'relevance_score': '0.995015'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.998932'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.221315,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.208824', 'ticker_sentiment_score': '0.141258', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.021124', 'ticker_sentiment_score': '0.009986', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTLT', 'relevance_score': '0.021124', 'ticker_sentiment_score': '0.086404', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.147044', 'ticker_sentiment_score': '0.145458', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.147044', 'ticker_sentiment_score': '0.066643', 'ticker_sentiment_label': 'Neutral'}]"
124,3 Unstoppable Stocks That You Can Buy and Hold for Years,https://www.fool.com/investing/2024/07/17/3-unstoppable-stocks-that-you-can-buy-and-hold-for/,20240717T121500,['David Jagielski'],These blue chip stocks are leaders within their respective industries.,https://g.foolcdn.com/editorial/images/783385/a-couple-shaking-hands-with-an-advisor.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.99393'}, {'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.266252,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.370733', 'ticker_sentiment_score': '0.292632', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NFLX', 'relevance_score': '0.320974', 'ticker_sentiment_score': '0.19589', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TKO', 'relevance_score': '0.054983', 'ticker_sentiment_score': '0.066838', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.269776', 'ticker_sentiment_score': '0.151875', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MORF', 'relevance_score': '0.054983', 'ticker_sentiment_score': '0.143631', 'ticker_sentiment_label': 'Neutral'}]"
125,Alphabet Retreats To Near 50-Day Line. Is Google Stock A Buy Or Sell?,https://www.investors.com/news/technology/google-stock-buy-now-alphabet/,20240717T115500,"[""Investor's Business Daily"", 'REINHARDT KRAUSE']","Cash Rich, Debt Light Alphabet Eyes Big Deals. Is Google Stock A Buy? Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2016/08/stock-Google-4-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.990893'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.14412,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.088472', 'ticker_sentiment_score': '0.011519', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.840693', 'ticker_sentiment_score': '0.170607', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.088472', 'ticker_sentiment_score': '-0.030273', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.088472', 'ticker_sentiment_score': '-0.030273', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.088472', 'ticker_sentiment_score': '-0.018029', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.059049', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCO', 'relevance_score': '0.059049', 'ticker_sentiment_score': '-0.038078', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUBS', 'relevance_score': '0.088472', 'ticker_sentiment_score': '-0.049474', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.059049', 'ticker_sentiment_score': '-0.029053', 'ticker_sentiment_label': 'Neutral'}]"
126,Eli Lilly  ( LLY )  Stock Slides as Market Rises: Facts to Know Before You Trade,https://www.zacks.com/stock/news/2302958/eli-lilly-lly-stock-slides-as-market-rises-facts-to-know-before-you-trade,20240716T214518,['Zacks Equity Research'],"Eli Lilly (LLY) concluded the recent trading session at $941.60, signifying a -0.93% move from its prior day's close.",https://staticx-tuner.zacks.com/images/default_article_images/default31.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.235658,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.543535', 'ticker_sentiment_score': '0.335446', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
127,Eli Lilly and Co's Options: A Look at What the Big Money is Thinking - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/07/39796638/eli-lilly-and-cos-options-a-look-at-what-the-big-money-is-thinking,20240716T143121,['Benzinga Insights'],"Deep-pocketed investors have adopted a bearish approach towards Eli Lilly and Co LLY, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.050599,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.754753', 'ticker_sentiment_score': '0.145352', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.084127', 'ticker_sentiment_score': '-0.096246', 'ticker_sentiment_label': 'Neutral'}]"
128,"4 Large Drug Stocks to Watch as Innovation, M&A Pick Up",https://www.zacks.com/commentary/2302224/4-large-drug-stocks-to-watch-as-innovation-ma-pick-up,20240716T125300,['Kinjel Shah'],"Drug and biotech companies are seeing significant innovation in 2024. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and Pfizer (PFE) are worth retaining in one's portfolio.",https://staticx-tuner.zacks.com/images/articles/main/66/1019.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.989041'}, {'topic': 'Earnings', 'relevance_score': '0.99737'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.998932'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.223572,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.197592', 'ticker_sentiment_score': '0.143355', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.022181', 'ticker_sentiment_score': '0.068758', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTLT', 'relevance_score': '0.022181', 'ticker_sentiment_score': '0.068758', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.132489', 'ticker_sentiment_score': '0.147328', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.132489', 'ticker_sentiment_score': '0.069107', 'ticker_sentiment_label': 'Neutral'}]"
129,"The Zacks Analyst Blog Eli Lilly, UnitedHealth and Tile Shop",https://www.zacks.com/stock/news/2302211/the-zacks-analyst-blog-eli-lilly-unitedhealth-and-tile-shop,20240716T104900,['Zacks Investment Research'],"Eli Lilly, UnitedHealth and Tile Shop are included in this Analyst Blog.",https://staticx-tuner.zacks.com/images/articles/main/fd/423.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.171992,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.298264', 'ticker_sentiment_score': '0.146925', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.201523', 'ticker_sentiment_score': '0.11345', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.201523', 'ticker_sentiment_score': '0.183352', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
130,"Q2 Earnings Season Scorecard and Analyst Reports for Microsoft, Eli Lilly & UnitedHealth",https://www.zacks.com/research-daily/2301382/q2-earnings-season-scorecard-and-analyst-reports-for-microsoft-eli-lilly-unitedhealth,20240715T190500,['Sheraz Mian'],"Today's Research Daily features a real-time update on the Q2 earnings season and new research reports on Microsoft (MSFT), Eli Lilly (LLY) and UnitedHealth (UNH), as well as a micro-cap stock Tile Shop Holdings (TTSH).",https://staticx-tuner.zacks.com/images/default_article_images/default258.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.999996'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.137166,Neutral,"[{'ticker': 'BLK', 'relevance_score': '0.045569', 'ticker_sentiment_score': '-0.109369', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.136113', 'ticker_sentiment_score': '0.129727', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.090989', 'ticker_sentiment_score': '0.202741', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.045569', 'ticker_sentiment_score': '-0.109369', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.045569', 'ticker_sentiment_score': '0.308464', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
131,"This Analyst Sees Potential Downside In Eli Lilly, Adjusts Model For Acquired IPR&D Charges - Eli Lilly and Co  ( NYSE:LLY ) ",https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39778341/this-analyst-sees-potential-downside-in-eli-lilly-adjusts-model-for-acquired-ipr-d-,20240715T171312,['Shivani Kumaresan'],Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating on the shares of Eli Lilly And Co LLY and maintained a price target of $885. The company is slated to report its second-quarter FY24 earnings on August 8.,https://cdn.benzinga.com/files/images/story/2024/07/15/Eli-Lilly.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.905476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.174618,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.577527', 'ticker_sentiment_score': '0.064894', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AKRO', 'relevance_score': '0.25168', 'ticker_sentiment_score': '0.088996', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.25168', 'ticker_sentiment_score': '0.088996', 'ticker_sentiment_label': 'Neutral'}]"
132,Novo Nordisk  ( NVO )  GLP-1 Drug Regarded Safe for Brain by Oxford,https://www.zacks.com/stock/news/2301936/novo-nordisk-nvo-glp-1-drug-regarded-safe-for-brain-by-oxford,20240715T154200,['Zacks Equity Research'],Oxford study demonstrates that Novo Nordisk's (NVO) semaglutide is not associated with a risk of adverse neuropsychiatric outcomes compared with other antidiabetic medications over one year.,https://staticx-tuner.zacks.com/images/articles/main/de/2471.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}]",0.229763,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.107016', 'ticker_sentiment_score': '0.031842', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARQT', 'relevance_score': '0.263373', 'ticker_sentiment_score': '0.083922', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.580434', 'ticker_sentiment_score': '0.28747', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.212115', 'ticker_sentiment_score': '0.194749', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
133,Americans Are Flying; Airline Stocks Are Not,https://www.fool.com/investing/2024/07/15/americans-are-flying-airline-stocks-are-not/,20240715T153251,['Motley Fool Staff'],"How the airline industry's focus on capacity and being able to supply more flights means fares are low, even in the face of record demand.",https://g.foolcdn.com/editorial/images/783010/mfm_08-copy.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.905476'}]",0.158069,Somewhat-Bullish,"[{'ticker': 'ENPH', 'relevance_score': '0.008765', 'ticker_sentiment_score': '-0.005749', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MORF', 'relevance_score': '0.061293', 'ticker_sentiment_score': '0.080175', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SVNDF', 'relevance_score': '0.008765', 'ticker_sentiment_score': '0.216074', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DICE', 'relevance_score': '0.008765', 'ticker_sentiment_score': '0.146251', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.096178', 'ticker_sentiment_score': '0.089974', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.008765', 'ticker_sentiment_score': '0.096247', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ERII', 'relevance_score': '0.008765', 'ticker_sentiment_score': '-0.005749', 'ticker_sentiment_label': 'Neutral'}]"
134,Eli Lilly and Co's Options: A Look at What the Big Money is Thinking - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/07/39772711/eli-lilly-and-cos-options-a-look-at-what-the-big-money-is-thinking,20240715T134718,['Benzinga Insights'],"Investors with a lot of money to spend have taken a bearish stance on Eli Lilly and Co LLY. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}]",0.014413,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.700759', 'ticker_sentiment_score': '0.034519', 'ticker_sentiment_label': 'Neutral'}]"
135,2 Unstoppable Growth Stocks to Buy and Hold for the Next Decade,https://www.fool.com/investing/2024/07/15/2-unstoppable-growth-stocks-to-buy-and-hold/,20240715T114500,['Joe Tenebruso'],These elite companies can help you build lasting wealth.,https://g.foolcdn.com/editorial/images/783221/robotics-gettyimages-1278639909.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.379179,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.210579', 'ticker_sentiment_score': '0.336855', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.406745', 'ticker_sentiment_score': '0.404865', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'GS', 'relevance_score': '0.070935', 'ticker_sentiment_score': '0.178207', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'OPTGF', 'relevance_score': '0.070935', 'ticker_sentiment_score': '0.070188', 'ticker_sentiment_label': 'Neutral'}]"
136,Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split,https://www.fool.com/investing/2024/07/15/stock-split-watch-2-stocks-that-could-split/,20240715T081500,['Adria Cimino'],Revenue is climbing at these two drug companies -- and the trend should continue.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F783050%2Fgettyimages-investor-uses-tablet-and-phone.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999998'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.999355'}]",0.266356,Somewhat-Bullish,"[{'ticker': 'NVDA', 'relevance_score': '0.045482', 'ticker_sentiment_score': '0.205092', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.090816', 'ticker_sentiment_score': '-0.056158', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.310283', 'ticker_sentiment_score': '0.203449', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.090816', 'ticker_sentiment_score': '0.37177', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'CMG', 'relevance_score': '0.045482', 'ticker_sentiment_score': '0.205092', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'REGN', 'relevance_score': '0.045482', 'ticker_sentiment_score': '0.059207', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.045482', 'ticker_sentiment_score': '0.059207', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.045482', 'ticker_sentiment_score': '0.059207', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.045482', 'ticker_sentiment_score': '0.205092', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
137,2 High-Flying Growth Stocks You Can Buy Right Now Before They Surge Even Higher,https://www.fool.com/investing/2024/07/14/2-high-flying-growth-stocks-you-can-buy-right-now/,20240714T134500,['Rachel Warren'],Shares are up for very good reasons.,https://g.foolcdn.com/editorial/images/783033/happy-person-at-laptop-success-winning-fists-up-victory-yes.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.248265,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.339356', 'ticker_sentiment_score': '0.179376', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BROS', 'relevance_score': '0.285526', 'ticker_sentiment_score': '0.291512', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SBUX', 'relevance_score': '0.05833', 'ticker_sentiment_score': '0.156127', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.116348', 'ticker_sentiment_score': '-0.022572', 'ticker_sentiment_label': 'Neutral'}]"
138,Is Eli Lilly a Good Dividend Stock to Buy Now?,https://www.fool.com/investing/2024/07/14/is-eli-lilly-a-good-dividend-stock-to-buy-now/,20240714T103100,['Cory Renauer'],A leading anti-obesity treatment plus a new Alzheimer's drug could drive profits through the roof.,https://g.foolcdn.com/editorial/images/783133/ozempic-injector-getty.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.143158,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.448513', 'ticker_sentiment_score': '0.172494', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BCS', 'relevance_score': '0.118354', 'ticker_sentiment_score': '0.140903', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESALF', 'relevance_score': '0.059341', 'ticker_sentiment_score': '0.124', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.118354', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.059341', 'ticker_sentiment_score': '0.124', 'ticker_sentiment_label': 'Neutral'}]"
139,Eli Lilly's Alzheimer's Drug Obtains FDA Approval. Here's Why the Stock Isn't Taking Off.,https://www.fool.com/investing/2024/07/13/eli-lillys-alzheimers-drug-obtains-fda-approval-he/,20240713T103100,['David Jagielski'],The news likely didn't come as a big surprise to investors.,https://g.foolcdn.com/editorial/images/782716/an-fda-approved-stamp-next-to-pills.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.905476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.197224,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.392948', 'ticker_sentiment_score': '0.280896', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.068306', 'ticker_sentiment_score': '0.093754', 'ticker_sentiment_label': 'Neutral'}]"
140,Did Eli Lilly Just Get a Leg Up on Novo Nordisk?,https://www.fool.com/investing/2024/07/13/did-eli-lilly-just-say-checkmate-to-novo-nordisk/,20240713T093000,['Adam Spatacco'],Eli Lilly's latest milestone sets it apart from its rival Novo Nordisk.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F782926%2Fgettyimages-1644169924.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.977154'}]",0.263571,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.805852', 'ticker_sentiment_score': '0.417777', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.318211', 'ticker_sentiment_score': '0.256065', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PMNT', 'relevance_score': '0.054483', 'ticker_sentiment_score': '-0.017987', 'ticker_sentiment_label': 'Neutral'}]"
141,Ozempic Maker Novo Nordisk Stock Stuck In Buy Zone; Is It A Buy Now?,https://www.investors.com/stock-lists/sector-leaders/novo-nordisk-stock-ozempic-2/,20240712T173700,"[""Investor's Business Daily"", 'RACHEL FOX']",Ozempic Maker Novo Nordisk Stock Stuck In Buy Zone. Is It A Buy Now? Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2024/02/Stock-novonordisk-building-03-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",-0.081311,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.004304', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.086556', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.33628', 'ticker_sentiment_score': '-0.11946', 'ticker_sentiment_label': 'Neutral'}]"
142,Small Caps Soar After Tame CPI: Weekly Review,https://www.investors.com/news/stock-market-shifts-small-caps-cpi-jpmorgan-tesla/,20240712T141400,"[""Investor's Business Daily"", 'IBD STAFF']","Stock Market Shifts Toward Small Caps After Tame CPI. JPMorgan, Taiwan Semi, Tesla In Focus: Weekly Review Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2019/05/STock-NYSEstockExchange-05-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.890401'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.961735'}]",-0.041305,Neutral,"[{'ticker': 'GOOG', 'relevance_score': '0.03642', 'ticker_sentiment_score': '-0.125076', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.072765', 'ticker_sentiment_score': '0.059364', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.072765', 'ticker_sentiment_score': '0.059364', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.250755', 'ticker_sentiment_score': '0.036195', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.072765', 'ticker_sentiment_score': '0.045559', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.03642', 'ticker_sentiment_score': '-0.028462', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.072765', 'ticker_sentiment_score': '0.045559', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DAL', 'relevance_score': '0.072765', 'ticker_sentiment_score': '-0.197496', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSM', 'relevance_score': '0.144926', 'ticker_sentiment_score': '0.104804', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.072765', 'ticker_sentiment_score': '0.018231', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MORF', 'relevance_score': '0.072765', 'ticker_sentiment_score': '0.045559', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.180595', 'ticker_sentiment_score': '0.094905', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LNTH', 'relevance_score': '0.108958', 'ticker_sentiment_score': '-0.038295', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.215894', 'ticker_sentiment_score': '0.032184', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.072765', 'ticker_sentiment_score': '0.045559', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUBS', 'relevance_score': '0.072765', 'ticker_sentiment_score': '-0.13101', 'ticker_sentiment_label': 'Neutral'}]"
143,Why Investors Need to Take Advantage of These 2 Medical Stocks Now,https://www.zacks.com/stock/news/2300584/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now,20240712T125010,['Zacks Equity Research'],The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.,https://staticx-tuner.zacks.com/images/default_article_images/default280.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999937'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}]",0.390546,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.194242', 'ticker_sentiment_score': '0.266671', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ELV', 'relevance_score': '0.377142', 'ticker_sentiment_score': '0.415002', 'ticker_sentiment_label': 'Bullish'}]"
144,Tesla And Nvidia Investors Dangerously Delude Themselves Of Reality,https://www.investors.com/etfs-and-funds/sectors/sp500-tesla-and-nvidia-investors-delude-themselves/,20240712T120000,"['MATT KRANTZ', ""Investor's Business Daily""]","Stock prices anticipate the future. But such wishful thinking is reaching extreme levels in some S&P 500 stocks. More than 80% of the prices of three S&P 500 stocks, Tesla ( TSLA ) , Eli Lilly ( LLY ) and Nvidia ( NVDA ) , are based on expected earnings in the future, says Nicholas Colas of ...",https://www.investors.com/wp-content/uploads/2020/06/Stock-upsetinvestor-02-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.459462'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.184304,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.185306', 'ticker_sentiment_score': '0.07581', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.185306', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.185306', 'ticker_sentiment_score': '0.07581', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.442082', 'ticker_sentiment_score': '0.142981', 'ticker_sentiment_label': 'Neutral'}]"
145,Should You Buy Eli Lilly Stock After Another Major Win?,https://www.fool.com/investing/2024/07/12/should-you-buy-eli-lilly-stock-after-another-major/,20240712T101300,['Prosper Junior Bakiny'],It was a buy even before this development.,https://g.foolcdn.com/editorial/images/782806/doctor-holding-elderly-patients-hand.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.938793'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.27627,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.454511', 'ticker_sentiment_score': '0.456989', 'ticker_sentiment_label': 'Bullish'}]"
146,Here's Why You Should Invest in Beam Therapeutics  ( BEAM )  Now,https://www.zacks.com/stock/news/2300260/heres-why-you-should-invest-in-beam-therapeutics-beam-now,20240711T165600,['Zacks Equity Research'],"Here, we discuss why investing in Beam Therapeutics (BEAM) stock now may be a prudent move.",https://staticx-tuner.zacks.com/images/articles/main/86/1981.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.890401'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.151426,Somewhat-Bullish,"[{'ticker': 'BEAM', 'relevance_score': '0.848651', 'ticker_sentiment_score': '0.242103', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.205807', 'ticker_sentiment_score': '0.323783', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ADPT', 'relevance_score': '0.205807', 'ticker_sentiment_score': '-0.006671', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RAPT', 'relevance_score': '0.205807', 'ticker_sentiment_score': '-0.006676', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.155118', 'ticker_sentiment_score': '0.06845', 'ticker_sentiment_label': 'Neutral'}]"
147,Novo Nordisk  ( NVO )  Soars 38% YTD: How Should You Play the Stock?,https://www.zacks.com/stock/news/2300219/novo-nordisk-nvo-soars-38-ytd-how-should-you-play-the-stock,20240711T160900,['Ahan Chakraborty'],"Novo Nordisk (NVO) is an excellent stock to retain as share prices continue to rise, driven by the stellar performance of GLP-1 drugs. New investors should look for stock price dips to make an entry.",https://staticx-tuner.zacks.com/images/articles/main/de/2471.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}, {'topic': 'Earnings', 'relevance_score': '0.988787'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.402052,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.148502', 'ticker_sentiment_score': '0.165469', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VKTX', 'relevance_score': '0.074576', 'ticker_sentiment_score': '0.076649', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.037329', 'ticker_sentiment_score': '0.137251', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.074576', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.600455', 'ticker_sentiment_score': '0.579738', 'ticker_sentiment_label': 'Bullish'}]"
148,Novo  ( NVO )  Gets CRL From FDA for Weekly Basal Insulin Icodec,https://www.zacks.com/stock/news/2300248/novo-nvo-gets-crl-from-fda-for-weekly-basal-insulin-icodec,20240711T153000,['Zacks Equity Research'],Novo's (NVO) efforts to get approval for once-weekly basal insulin icodec in the United States suffer a setback as the FDA issues a CRL.,https://staticx-tuner.zacks.com/images/articles/main/de/2471.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.134459,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.25168', 'ticker_sentiment_score': '-0.040786', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CORT', 'relevance_score': '0.190167', 'ticker_sentiment_score': '0.18454', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TRDA', 'relevance_score': '0.127456', 'ticker_sentiment_score': '0.069608', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.25168', 'ticker_sentiment_score': '0.055928', 'ticker_sentiment_label': 'Neutral'}]"
149,Pfizer Vs. Eli Lilly Stock - Which Is A Better Pick?,https://www.forbes.com/sites/greatspeculations/2024/07/11/pfizer-vs-eli-lilly-stock--which-is-a-better-pick/,20240711T133050,['Trefis Team'],"We believe that Eli Lilly stock ( NYSE: LLY ) is currently a better pick than its industry peer - Pfizer stock , given its better prospects. PFE stock trades at a much lower multiple of 2.8x revenues, versus 23.5x for LLY, and we think this gap in valuation will remain wide in favor of Eli Lilly.",https://imageio.forbes.com/specials-images/imageserve/662b6a87b3af139422324bac/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds,Forbes,n/a,www.forbes.com,"[{'topic': 'Earnings', 'relevance_score': '0.998333'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.692272'}]",0.204968,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.793468', 'ticker_sentiment_score': '0.350362', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.608634', 'ticker_sentiment_score': '0.336296', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
150,Why Investors Need to Take Advantage of These 2 Medical Stocks Now,https://www.zacks.com/stock/news/2299780/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now,20240711T125009,['Zacks Equity Research'],Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.,https://staticx-tuner.zacks.com/images/default_article_images/default209.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999973'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.340985,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.367865', 'ticker_sentiment_score': '0.366772', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'HCA', 'relevance_score': '0.250386', 'ticker_sentiment_score': '0.25838', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
151,Better Growth Play: Eli Lilly vs. Vanguard Growth Index Fund ETF Shares,https://www.fool.com/investing/2024/07/11/better-growth-play-eli-lilly-vs-vanguard-growth-in/,20240711T093000,['George Budwell'],Both equities have been incredible growth plays of late.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F783016%2Fgrowth-chart.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999998'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.332818,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.44622', 'ticker_sentiment_score': '0.268542', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.052455', 'ticker_sentiment_score': '0.209677', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.052455', 'ticker_sentiment_score': '0.209677', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
152,Eli Lilly  ( LLY )  Beats Stock Market Upswing: What Investors Need to Know,https://www.zacks.com/stock/news/2298774/eli-lilly-lly-beats-stock-market-upswing-what-investors-need-to-know,20240709T214518,['Zacks Equity Research'],"In the most recent trading session, Eli Lilly (LLY) closed at $932.50, indicating a +1.58% shift from the previous trading day.",https://staticx-tuner.zacks.com/images/default_article_images/default25.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.226093,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.587278', 'ticker_sentiment_score': '0.326366', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
153,Why Lilly  ( LLY )  is Poised to Beat Earnings Estimates Again,https://www.zacks.com/stock/news/2298695/why-lilly-lly-is-poised-to-beat-earnings-estimates-again,20240709T161013,['Zacks Equity Research'],Lilly (LLY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,https://staticx-tuner.zacks.com/images/default_article_images/default59.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.99998'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.317079,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.411848', 'ticker_sentiment_score': '0.434163', 'ticker_sentiment_label': 'Bullish'}]"
154,Study Shows Lilly's  ( LLY )  Obesity Drug More Effective Than NVO's,https://www.zacks.com/stock/news/2298718/study-shows-lillys-lly-obesity-drug-more-effective-than-nvos,20240709T160500,['Zacks Equity Research'],"Data from a new study, also published on the JAMA website, shows that patients taking Lilly's (LLY) obesity drug are likely to lose more weight than those taking Novo's drug.",https://staticx-tuner.zacks.com/images/articles/main/82/41137.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.133551,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.502693', 'ticker_sentiment_score': '0.213002', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VKTX', 'relevance_score': '0.107978', 'ticker_sentiment_score': '0.092408', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.141773', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.265666', 'ticker_sentiment_score': '0.174039', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.213988', 'ticker_sentiment_score': '0.109265', 'ticker_sentiment_label': 'Neutral'}]"
155,Unpacking the Latest Options Trading Trends in Eli Lilly and Co - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/07/39692752/unpacking-the-latest-options-trading-trends-in-eli-lilly-and-co,20240709T154645,['Benzinga Insights'],"Financial giants have made a conspicuous bullish move on Eli Lilly and Co. Our analysis of options history for Eli Lilly and Co LLY revealed 56 unusual trades. Delving into the details, we found 41% of traders were bullish, while 35% showed bearish tendencies.",https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}]",0.055588,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.677342', 'ticker_sentiment_score': '0.094204', 'ticker_sentiment_label': 'Neutral'}]"
156,Is Eli Lilly Stock a No-Brainer Buy After Its FDA Alzheimer's Disease Drug Win?,https://www.fool.com/investing/2024/07/09/is-eli-lilly-stock-a-no-brainer-buy-after-its-fda/,20240709T101500,['Keith Speights'],"No matter how you look at it, the FDA approval of Kisunla is big for Eli Lilly.",https://g.foolcdn.com/editorial/images/782797/scientists-smiling-and-shaking-hands.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.297209,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.737286', 'ticker_sentiment_score': '0.526207', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'MORN', 'relevance_score': '0.063763', 'ticker_sentiment_score': '-0.037011', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.063763', 'ticker_sentiment_score': '0.104861', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.063763', 'ticker_sentiment_score': '0.104861', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.063763', 'ticker_sentiment_score': '0.104861', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.063763', 'ticker_sentiment_score': '-0.037011', 'ticker_sentiment_label': 'Neutral'}]"
157,"Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half?",https://www.fool.com/investing/2024/07/09/can-eli-lilly-surpass-1000-this-year/,20240709T091500,['Adria Cimino'],This pharma company is posting double-digit revenue growth.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F782698%2Fgettyimages-1292931102.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.301168,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.680677', 'ticker_sentiment_score': '0.506886', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'VKTX', 'relevance_score': '0.049629', 'ticker_sentiment_score': '0.11247', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.049629', 'ticker_sentiment_score': '0.062656', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.049629', 'ticker_sentiment_score': '0.11247', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.049629', 'ticker_sentiment_score': '0.00799', 'ticker_sentiment_label': 'Neutral'}]"
158,S&P 500 Closes At Record High Ahead Of Inflation Data: Fear & Greed Index Remains In 'Neutral' Zone - PepsiCo  ( NASDAQ:PEP ) ,https://www.benzinga.com/news/earnings/24/07/39680466/s-p-500-closes-at-record-high-ahead-of-inflation-data-fear-greed-index-remains-in-neutral-zone,20240709T072730,['Avi Kapoor'],"The CNN Money Fear and Greed index showed a slight decline in the overall market sentiment, while the index remained in the ""Neutral"" zone on Monday. U.S. stocks closed mixed on Monday, with the S&P 500 closing at a record high during the session.",https://cdn.benzinga.com/files/images/story/2024/07/09/Market-Sentiment--Fear-And-Greed-Index--.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}]",-0.155479,Somewhat-Bearish,"[{'ticker': 'MORF', 'relevance_score': '0.213048', 'ticker_sentiment_score': '0.285234', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'C', 'relevance_score': '0.213048', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SGH', 'relevance_score': '0.213048', 'ticker_sentiment_score': '-0.192885', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'KRUS', 'relevance_score': '0.213048', 'ticker_sentiment_score': '-0.192885', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'HELE', 'relevance_score': '0.213048', 'ticker_sentiment_score': '-0.192885', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LLY', 'relevance_score': '0.213048', 'ticker_sentiment_score': '0.285234', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WBD', 'relevance_score': '0.107495', 'ticker_sentiment_score': '-0.297533', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PEP', 'relevance_score': '0.213048', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DAL', 'relevance_score': '0.213048', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
159,Eli Lilly and Company  ( LLY )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2298006/eli-lilly-and-company-lly-is-a-trending-stock-facts-to-know-before-betting-on-it,20240708T165056,['Zacks Equity Research'],"Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",https://staticx-tuner.zacks.com/images/default_article_images/default70.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}]",0.21509,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.489394', 'ticker_sentiment_score': '0.159245', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
160,Here's Why Eli Lilly  ( LLY )  is a Strong Momentum Stock,https://www.zacks.com/stock/news/2297922/heres-why-eli-lilly-lly-is-a-strong-momentum-stock,20240708T164330,['Zacks Equity Research'],"Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",https://staticx-tuner.zacks.com/images/default_article_images/default288.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.928139'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.977154'}]",0.394079,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.312423', 'ticker_sentiment_score': '0.218932', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
161,"If You Invested $1000 in Eli Lilly a Decade Ago, This is How Much It'd Be Worth Now",https://www.zacks.com/stock/news/2297887/if-you-invested-1000-in-eli-lilly-a-decade-ago-this-is-how-much-itd-be-worth-now,20240708T163324,['Zacks Equity Research'],"Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",https://staticx-tuner.zacks.com/images/default_article_images/default43.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.19057,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.614932', 'ticker_sentiment_score': '0.295879', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'INCY', 'relevance_score': '0.053271', 'ticker_sentiment_score': '0.025855', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ELAN', 'relevance_score': '0.210731', 'ticker_sentiment_score': '0.041732', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AKUS', 'relevance_score': '0.053271', 'ticker_sentiment_score': '0.047009', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DICE', 'relevance_score': '0.053271', 'ticker_sentiment_score': '0.047009', 'ticker_sentiment_label': 'Neutral'}]"
162,"Stock Market News From Amazon, Nike, McCormick, and More",https://www.fool.com/investing/2024/07/08/stock-market-news-from-amazon-nike-mccormick-and-m/,20240708T155600,['Motley Fool Staff'],"We also talk with author Nicola Twilley about her new book, ""Frostbite: How Refrigeration Changed Our Food, Our Planet, and Ourselves."" ...",https://g.foolcdn.com/editorial/images/782215/mfm_28.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.650727'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.999986'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.067362,Neutral,"[{'ticker': 'ITRI', 'relevance_score': '0.025679', 'ticker_sentiment_score': '0.161437', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.03851', 'ticker_sentiment_score': '0.022395', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WEN', 'relevance_score': '0.01926', 'ticker_sentiment_score': '0.099594', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.01926', 'ticker_sentiment_score': '0.045321', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.05133', 'ticker_sentiment_score': '0.059934', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RMD', 'relevance_score': '0.032095', 'ticker_sentiment_score': '0.048614', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKE', 'relevance_score': '0.057736', 'ticker_sentiment_score': '-0.020019', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ACN', 'relevance_score': '0.012841', 'ticker_sentiment_score': '-0.055571', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.012841', 'ticker_sentiment_score': '0.0764', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BYND', 'relevance_score': '0.006421', 'ticker_sentiment_score': '-0.036342', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WBA', 'relevance_score': '0.006421', 'ticker_sentiment_score': '-0.089129', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.006421', 'ticker_sentiment_score': '0.057281', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.03851', 'ticker_sentiment_score': '0.035219', 'ticker_sentiment_label': 'Neutral'}]"
163,"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Morphic Holding, Inc.  ( Nasdaq - MORF ) , Desktop Metal, Inc.  ( NYSE - DM ) , Alimera Sciences, Inc.  ( Nasdaq - ALIM ) , Avangrid, Inc.  ( NYSE - AGR ) ",https://www.benzinga.com/pressreleases/24/07/g39667973/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-morphic-holdi,20240708T141229,['Globe Newswire'],"BALA CYNWYD, Pa., July 08, 2024 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.214378'}]",0.237877,Somewhat-Bullish,"[{'ticker': 'ALIM', 'relevance_score': '0.072876', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MORF', 'relevance_score': '0.072876', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.216215', 'ticker_sentiment_score': '0.064783', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.285526', 'ticker_sentiment_score': '0.20535', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DM', 'relevance_score': '0.216215', 'ticker_sentiment_score': '0.165663', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ANIP', 'relevance_score': '0.145145', 'ticker_sentiment_score': '0.230799', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AGR', 'relevance_score': '0.285526', 'ticker_sentiment_score': '0.159262', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'IBDSF', 'relevance_score': '0.216215', 'ticker_sentiment_score': '0.136838', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NNDM', 'relevance_score': '0.285526', 'ticker_sentiment_score': '0.220987', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CRYPTO:NANO', 'relevance_score': '0.216215', 'ticker_sentiment_score': '0.178361', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
164,"Eli Lilly's First Biotech Deal Of 2024, Buys Chronic Disease Player Morphic For $3.2B Why Is Morphic Holding  ( MORF )  Stock Jumping Today? - Morphic Holding  ( NASDAQ:MORF ) , Eli Lilly and Co  ( NYSE:LLY ) ",https://www.benzinga.com/general/biotech/24/07/39665674/eli-lillys-first-biotech-deal-of-2024-buys-chronic-disease-player-morphic-for-3-2b,20240708T125513,['Vandana Singh'],"Monday, Eli Lilly And Co LLY agreed to acquire Morphic Holding Inc MORF for $57 per share in cash, an aggregate of approximately $3.2 billion. Morphic is a biopharmaceutical company developing a portfolio of oral integrin therapies for chronic diseases, including autoimmune, cardiovascular, and ...",https://cdn.benzinga.com/files/images/story/2024/07/08/Eli-Lilly.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}]",0.142959,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.396574', 'ticker_sentiment_score': '0.464791', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'MORF', 'relevance_score': '0.930964', 'ticker_sentiment_score': '0.223828', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SDGR', 'relevance_score': '0.103331', 'ticker_sentiment_score': '-0.107298', 'ticker_sentiment_label': 'Neutral'}]"
165,3 No-Brainer Stocks to Buy in July,https://www.fool.com/investing/2024/07/08/3-no-brainer-stocks-to-buy-in-july/,20240708T120000,"['and Prosper Junior Bakiny', 'Keith Speights', 'David Jagielski']",Investors shouldn't have to think too hard about these great stocks.,https://g.foolcdn.com/editorial/images/782643/scientists-in-a-lab-monitor-microscope.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.87644'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}]",0.340429,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.266828', 'ticker_sentiment_score': '0.355812', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.154455', 'ticker_sentiment_score': '0.140868', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REGN', 'relevance_score': '0.154455', 'ticker_sentiment_score': '0.120086', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.038843', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
166,Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease - PR Newswire,https://www.prnewswire.com/news-releases/lilly-to-acquire-morphic-to-improve-outcomes-for-patients-with-inflammatory-bowel-disease-302190489.html,20240708T104500,[],Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease PR ...,,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.998682'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.99998'}, {'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.262255,Somewhat-Bullish,"[{'ticker': 'EVR', 'relevance_score': '0.02105', 'ticker_sentiment_score': '0.108886', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.02105', 'ticker_sentiment_score': '0.13199', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MORF', 'relevance_score': '0.58661', 'ticker_sentiment_score': '0.359877', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'C', 'relevance_score': '0.042085', 'ticker_sentiment_score': '0.136706', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.555831', 'ticker_sentiment_score': '0.402242', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SDGR', 'relevance_score': '0.02105', 'ticker_sentiment_score': '-0.126565', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BNXYF', 'relevance_score': '0.02105', 'ticker_sentiment_score': '0.150917', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
167,Smart Money Is Betting Big In LLY Options - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/07/39646966/smart-money-is-betting-big-in-lly-options,20240705T134737,['Benzinga Insights'],"High-rolling investors have positioned themselves bearish on Eli Lilly and Co LLY, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data.",https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.038473,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.824317', 'ticker_sentiment_score': '0.077629', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.082963', 'ticker_sentiment_score': '-0.096041', 'ticker_sentiment_label': 'Neutral'}]"
168,Missed Out on Eli Lilly? This Much Smaller Biotech Has 2 Promising Weight Loss Assets in its Portfolio,https://www.fool.com/investing/2024/07/05/missed-out-on-eli-lilly-this-much-smaller-biotech/,20240705T102200,['David Jagielski'],Could Zealand Pharma be a better option for growth-oriented investors?,https://g.foolcdn.com/editorial/images/782123/investor-at-home-looking-at-multiple-charts.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}]",0.116207,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.323078', 'ticker_sentiment_score': '0.13516', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:DKK', 'relevance_score': '0.132368', 'ticker_sentiment_score': '-0.063338', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:NOK', 'relevance_score': '0.132368', 'ticker_sentiment_score': '-0.063338', 'ticker_sentiment_label': 'Neutral'}]"
169,"NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss",https://www.zacks.com/stock/news/2296877/nvo-lly-slip-after-study-links-obesity-drug-use-to-vision-loss,20240704T121900,['Sundeep Ganoria'],A new study led by investigators of a Harvard-affiliated teaching hospital found that Novo Nordisk's (NVO) GLP-1 drugs Ozempic and Wegovy could be linked to rare cases of vision loss.,https://staticx-tuner.zacks.com/images/articles/main/82/41137.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.080587,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.461468', 'ticker_sentiment_score': '0.259244', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VKTX', 'relevance_score': '0.108712', 'ticker_sentiment_score': '0.09481', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.054483', 'ticker_sentiment_score': '0.141808', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.267413', 'ticker_sentiment_score': '0.17688', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.108712', 'ticker_sentiment_score': '-0.025525', 'ticker_sentiment_label': 'Neutral'}]"
170,"Mounjaro and Zepbound Are Great, but This Is the Real Reason Why Eli Lilly Can Soar Past a $1 Trillion Valuation",https://www.fool.com/investing/2024/07/04/mounjaro-and-zepbound-are-great-but-this-is-the-re/,20240704T113000,['David Jagielski'],Investors shouldn't assume that all of the company's future growth is already priced into the stock's valuation.,https://g.foolcdn.com/editorial/images/782110/businessperson-giving-a-presentation.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.818451'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}]",0.198146,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.560379', 'ticker_sentiment_score': '0.313712', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
171,Forget Eli Lilly: 3 Biotech Stocks to Buy Instead,https://www.fool.com/investing/2024/07/04/forget-eli-lilly-3-biotech-stocks-to-buy-instead/,20240704T095000,['Keith Speights'],"Eli Lilly is a good stock to buy, but these should be even better.",https://g.foolcdn.com/editorial/images/782405/scientists-in-a-lab-smiling.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.795202'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.331406,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.574608', 'ticker_sentiment_score': '0.507325', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.140216', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.115232', 'ticker_sentiment_score': '-0.049168', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.43789', 'ticker_sentiment_score': '0.424724', 'ticker_sentiment_label': 'Bullish'}]"
172,Eli Lilly  ( LLY )  Gets FDA Nod for Alzheimer's Drug Donanemab,https://www.zacks.com/stock/news/2296481/eli-lilly-lly-gets-fda-nod-for-alzheimers-drug-donanemab,20240703T123400,['Zacks Equity Research'],"Eli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be the second drug on the market to treat the disease.",https://staticx-tuner.zacks.com/images/articles/main/67/1932.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.06643,Neutral,"[{'ticker': 'ACIU', 'relevance_score': '0.055621', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.219809', 'ticker_sentiment_score': '0.047636', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PRTA', 'relevance_score': '0.165788', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.219809', 'ticker_sentiment_score': '0.251132', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SAVA', 'relevance_score': '0.165788', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
173,How Great Is It to Have Customers That Absolutely Love You and Plan to Never Leave You?,https://www.fool.com/investing/2024/07/02/customers-for-life/,20240702T174748,['Motley Fool Staff'],"We also talk about weight loss drugs and sleep apnea, and other stock market news.",https://g.foolcdn.com/editorial/images/782157/mfm_24.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.928769'}, {'topic': 'Earnings', 'relevance_score': '0.818451'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.769861'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.148721,Neutral,"[{'ticker': 'SHOP', 'relevance_score': '0.072498', 'ticker_sentiment_score': '0.094323', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TGT', 'relevance_score': '0.123951', 'ticker_sentiment_score': '0.083051', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.123951', 'ticker_sentiment_score': '0.049118', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.031105', 'ticker_sentiment_score': '0.053374', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.010371', 'ticker_sentiment_score': '0.026485', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPOT', 'relevance_score': '0.123951', 'ticker_sentiment_score': '0.027274', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.010371', 'ticker_sentiment_score': '0.102792', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.02074', 'ticker_sentiment_score': '0.092794', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RMD', 'relevance_score': '0.113695', 'ticker_sentiment_score': '0.048062', 'ticker_sentiment_label': 'Neutral'}]"
174,Viking  ( VKTX )  Skyrockets 197% YTD: Is the Stock Worth a Buy?,https://www.zacks.com/stock/news/2296305/viking-vktx-skyrockets-197-ytd-is-the-stock-worth-a-buy,20240702T150600,['Sundeep Ganoria'],"Despite having no marketed drugs, Viking's (VKTX) stock continues to experience robust price movement, driven by the company's encouraging progress with its pipeline.",https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.268191,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.200273', 'ticker_sentiment_score': '0.004931', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDGL', 'relevance_score': '0.100941', 'ticker_sentiment_score': '0.057445', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.150906', 'ticker_sentiment_score': '0.433308', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'GS', 'relevance_score': '0.050572', 'ticker_sentiment_score': '0.15931', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.100941', 'ticker_sentiment_score': '-0.135925', 'ticker_sentiment_label': 'Neutral'}]"
175,Dow Jones Dips As Powell Says This On Rate Cuts; Tesla Deliveries Crush Views  ( Live Coverage ) ,https://www.investors.com/market-trend/stock-market-today/dow-jones-nasdaq-sp500-jerome-powell-fed-tesla-deliveries-amazon-nvidia/,20240702T144700,"['MICHAEL LARKIN', ""Investor's Business Daily""]",Dow Jones Dips As Powell Says This On Rate Cuts. Tesla Deliveries Crush Views ( Live Coverage ) Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2022/06/Stock-jeromepowell2022-05-gov.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.890401'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.682689'}]",0.182187,Somewhat-Bullish,"[{'ticker': 'TSLA', 'relevance_score': '0.246999', 'ticker_sentiment_score': '0.091045', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VZ', 'relevance_score': '0.083541', 'ticker_sentiment_score': '-0.348369', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'HON', 'relevance_score': '0.083541', 'ticker_sentiment_score': '0.257077', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SMCI', 'relevance_score': '0.125025', 'ticker_sentiment_score': '0.04207', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.083541', 'ticker_sentiment_score': '-0.02691', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKE', 'relevance_score': '0.083541', 'ticker_sentiment_score': '-0.348369', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'ALKT', 'relevance_score': '0.083541', 'ticker_sentiment_score': '0.213606', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.083541', 'ticker_sentiment_score': '0.115657', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.166169', 'ticker_sentiment_score': '0.111365', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ON', 'relevance_score': '0.041828', 'ticker_sentiment_score': '0.070014', 'ticker_sentiment_label': 'Neutral'}]"
176,5 Top-Performing S&P 500 Stocks of 1H Set to Shine Further,https://www.zacks.com/stock/news/2295833/5-top-performing-sp-500-stocks-of-1h-set-to-shine-further,20240701T135000,['Sweta Killa'],"The S&P 500 wraps up the first half with gains of 14%, representing one of the strongest performances since the late-1990s dot-com bubble.",https://staticx-tuner.zacks.com/images/articles/main/e4/61050.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.99998'}]",0.27945,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.099271', 'ticker_sentiment_score': '0.148867', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.049732', 'ticker_sentiment_score': '0.138543', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.382193', 'ticker_sentiment_score': '0.352544', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'CEG', 'relevance_score': '0.197011', 'ticker_sentiment_score': '0.231663', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SMCI', 'relevance_score': '0.099271', 'ticker_sentiment_score': '0.160245', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VST', 'relevance_score': '0.197011', 'ticker_sentiment_score': '0.224368', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.197011', 'ticker_sentiment_score': '0.248833', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
177,2 Top Healthcare Stocks to Buy in June,https://www.fool.com/investing/2024/06/30/2-top-healthcare-stocks-to-buy-in-june/,20240630T115200,['Rachel Warren'],Healthcare businesses tend to hold up through various economic cycles.,https://g.foolcdn.com/editorial/images/781624/dna-sequencing-genome-science-lab.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.94762'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.995077'}]",0.211862,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.281692', 'ticker_sentiment_score': '0.209486', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ISRG', 'relevance_score': '0.236281', 'ticker_sentiment_score': '0.039551', 'ticker_sentiment_label': 'Neutral'}]"
178,This Is Massive News for Eli Lilly Investors,https://www.fool.com/investing/2024/06/29/this-is-massive-news-for-eli-lilly-investors/,20240629T110000,['Adam Spatacco'],A panel of advisors to the Food and Drug Administration (FDA) recently recommended Eli Lilly's Alzheimer's candidate.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F781684%2Fgettyimages-1185122199.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.376812,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.485711', 'ticker_sentiment_score': '0.648024', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ESALF', 'relevance_score': '0.057767', 'ticker_sentiment_score': '0.157285', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.057767', 'ticker_sentiment_score': '0.157285', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
179,Eli Lilly Is Teaming Up With OpenAI. Here Are 3 Things Smart Investors Should Know.,https://www.fool.com/investing/2024/06/29/eli-lilly-is-teaming-up-with-openai-here-are-3-thi/,20240629T101500,['Adam Spatacco'],Eli Lilly is the latest major pharmaceutical company to bring artificial intelligence (AI) to the healthcare sector.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F781806%2Fgettyimages-1441663123.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",0.27641,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.687678', 'ticker_sentiment_score': '0.506307', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.061949', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.061949', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
180,HIMS Stock Tumbles: Here's Why It's a Buy Right Now,https://www.zacks.com/commentary/2295212/hims-stock-tumbles-heres-why-its-a-buy-right-now,20240628T190000,['Ethan Feller'],"Hims & Hers Health is a high growth, healthcare startup stepping into the GLP-1 space.",https://staticx-tuner.zacks.com/images/articles/main/88/898.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.280719,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.199584', 'ticker_sentiment_score': '0.351047', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'HIMS', 'relevance_score': '0.688096', 'ticker_sentiment_score': '0.469967', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.199584', 'ticker_sentiment_score': '0.351047', 'ticker_sentiment_label': 'Bullish'}]"
181,Insights Into Eli Lilly and Co's Performance Versus Peers In Pharmaceuticals Sector - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/news/24/06/39551314/insights-into-eli-lilly-and-cos-performance-versus-peers-in-pharmaceuticals-sector,20240628T150013,['Benzinga Insights'],"In the fast-paced and highly competitive business world of today, conducting thorough company analysis is essential for investors and industry observers. In this article, we will conduct an extensive industry comparison, evaluating Eli Lilly and Co LLY in relation to its major competitors in the ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}]",0.191717,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.477986', 'ticker_sentiment_score': '0.296171', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
182,Stock Split Watch: Is Eli Lilly Next?,https://www.fool.com/investing/2024/06/28/stock-split-watch-is-eli-lilly-next/,20240628T083500,['Adria Cimino'],"Eli Lilly's revenue has climbed, thanks to high demand for its weight loss drugs.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F781919%2Fscientists-work-in-lab-smiling.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.723405'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.929393'}]",0.216238,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.531147', 'ticker_sentiment_score': '0.28032', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.048133', 'ticker_sentiment_score': '0.08857', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMG', 'relevance_score': '0.048133', 'ticker_sentiment_score': '0.08857', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.048133', 'ticker_sentiment_score': '-0.035946', 'ticker_sentiment_label': 'Neutral'}]"
183,Eli Lilly  ( LLY )  Stock Drops Despite Market Gains: Important Facts to Note,https://www.zacks.com/stock/news/2293935/eli-lilly-lly-stock-drops-despite-market-gains-important-facts-to-note,20240626T214521,['Zacks Equity Research'],"In the most recent trading session, Eli Lilly (LLY) closed at $901.26, indicating a -0.37% shift from the previous trading day.",https://staticx-tuner.zacks.com/images/default_article_images/default180.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.239594,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.5341', 'ticker_sentiment_score': '0.280565', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
184,Why Investors Need to Take Advantage of These 2 Medical Stocks Now,https://www.zacks.com/stock/news/2293477/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now,20240626T125005,['Zacks Equity Research'],Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.,https://staticx-tuner.zacks.com/images/default_article_images/default28.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.99989'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.382262,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.252987', 'ticker_sentiment_score': '0.222419', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CNC', 'relevance_score': '0.313218', 'ticker_sentiment_score': '0.340067', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
185,La-Z-Boy and Winnebago have been highlighted as Zacks Bull and Bear of the Day,https://www.zacks.com/stock/news/2293447/la-z-boy-and-winnebago-have-been-highlighted-as-zacks-bull-and-bear-of-the-day,20240626T123200,['Zacks Equity Research'],"Chicago, IL - June 26, 2024 - Zacks Equity Research shares La-Z-Boy ( LZB Quick QuoteLZB - ) as the Bull of the Day and Winnebago Industries ( WGO Quick QuoteWGO - ) as the Bear of the Day.",https://staticx-tuner.zacks.com/images/articles/main/a3/1381.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.208412,Somewhat-Bullish,"[{'ticker': 'PRBZF', 'relevance_score': '0.019634', 'ticker_sentiment_score': '0.42442', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'MPX', 'relevance_score': '0.019634', 'ticker_sentiment_score': '-0.090554', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LZB', 'relevance_score': '0.213389', 'ticker_sentiment_score': '0.173672', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.078418', 'ticker_sentiment_score': '0.158756', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.250982', 'ticker_sentiment_score': '0.219819', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'THO', 'relevance_score': '0.039257', 'ticker_sentiment_score': '0.151903', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WGO', 'relevance_score': '0.058855', 'ticker_sentiment_score': '-0.009', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.078418', 'ticker_sentiment_score': '0.135047', 'ticker_sentiment_label': 'Neutral'}]"
186,2 Reasons Why Eli Lilly's Stock Likely Hasn't Peaked,https://www.fool.com/investing/2024/06/26/2-reasons-why-eli-lillys-stock-likely-hasnt-peaked/,20240626T083500,['David Jagielski'],"The stock may seem expensive right now, but that may not be the case in a few years.",https://g.foolcdn.com/editorial/images/781335/a-team-of-scientists-reviewing-results-in-a-lab.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}]",0.14553,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.500995', 'ticker_sentiment_score': '0.305068', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.067347', 'ticker_sentiment_score': '-0.029808', 'ticker_sentiment_label': 'Neutral'}]"
187,Novo Nordisk  ( NVO )  to Invest $4.1B in Clayton Facility Expansion,https://www.zacks.com/stock/news/2293002/novo-nordisk-nvo-to-invest-41b-in-clayton-facility-expansion,20240625T142200,['Zacks Equity Research'],"Novo Nordisk (NVO) plans to invest $4.1 billion in order to expand its Clayton facility with a second manufacturing plant, boosting capacity for injectable treatments and creating 1,000 new jobs.",https://staticx-tuner.zacks.com/images/articles/main/de/2471.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.237193,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.133593', 'ticker_sentiment_score': '0.125019', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALXO', 'relevance_score': '0.177475', 'ticker_sentiment_score': '-0.025494', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANVS', 'relevance_score': '0.177475', 'ticker_sentiment_score': '-0.025508', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.498987', 'ticker_sentiment_score': '0.297308', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
188,This Is What Whales Are Betting On Eli Lilly and Co - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/06/39480553/this-is-what-whales-are-betting-on-eli-lilly-and-co,20240625T134807,['Benzinga Insights'],"Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly and Co. Looking at options history for Eli Lilly and Co LLY we detected 12 trades. If we consider the specifics of each trade, it is accurate to state that 58% of the investors opened trades with bullish ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}]",0.094923,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.806275', 'ticker_sentiment_score': '0.120723', 'ticker_sentiment_label': 'Neutral'}]"
189,Is Eli Lilly  ( LLY )  a Buy on Tirzepatide Success in Sleep Apnea?,https://www.zacks.com/stock/news/2292780/is-eli-lilly-lly-a-buy-on-tirzepatide-success-in-sleep-apnea,20240625T130500,['Kinjel Shah'],"Eli Lilly (LLY) files for the approval of tirzepatide to treat obstructive sleep apnea in adults with obesity in the United States. If approved, sales of the blockbuster drug will rise further.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.459462'}, {'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.319276,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.503831', 'ticker_sentiment_score': '0.38817', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.135094', 'ticker_sentiment_score': '0.276936', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.135094', 'ticker_sentiment_score': '0.240279', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
190,Investors Heavily Search Eli Lilly and Company  ( LLY ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2292048/investors-heavily-search-eli-lilly-and-company-lly-here-is-what-you-need-to-know,20240624T130015,['Zacks Equity Research'],"Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",https://staticx-tuner.zacks.com/images/default_article_images/default314.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.248303,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.49407', 'ticker_sentiment_score': '0.177968', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
191,The Future of Weight-Loss Drugs for Investors,https://www.kiplinger.com/investing/healthcare-stocks/the-future-of-weight-loss-drugs-for-investors,20240624T111555,['Adam Shell'],Investing in shrinking waistlines might not have the wow factor of other market obsessions. But a new class of weight-loss drugs that help people shed pounds without dieting or doing cardio looks like a game-changer.,https://cdn.mos.cms.futurecdn.net/hwgJ7osrMtUWhk5koeVme7-320-80.png,Kiplinger,n/a,www.kiplinger.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999612'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.928769'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.215295,Somewhat-Bullish,"[{'ticker': 'NVDA', 'relevance_score': '0.017612', 'ticker_sentiment_score': '0.187721', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.035215', 'ticker_sentiment_score': '0.175147', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JHG', 'relevance_score': '0.017612', 'ticker_sentiment_score': '0.102883', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.174713', 'ticker_sentiment_score': '0.190248', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GPCR', 'relevance_score': '0.035215', 'ticker_sentiment_score': '0.008654', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MORN', 'relevance_score': '0.035215', 'ticker_sentiment_score': '0.142129', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.017612', 'ticker_sentiment_score': '-0.024444', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.052801', 'ticker_sentiment_score': '0.199704', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.035215', 'ticker_sentiment_score': '-0.099345', 'ticker_sentiment_label': 'Neutral'}]"
192,All Public Company News from PR Newswire,https://www.prnewswire.com/news-releases/all-public-company-news/,20240621T214040,[],All Public Company PR ...,https://www.prnewswire.com/content/dam/prnewswire/common/JournalistsBloggers.jpg,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.905476'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.185027,Somewhat-Bullish,"[{'ticker': 'ENPH', 'relevance_score': '0.10607', 'ticker_sentiment_score': '0.107088', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SAND', 'relevance_score': '0.158519', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.158519', 'ticker_sentiment_score': '0.356288', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'RNA', 'relevance_score': '0.158519', 'ticker_sentiment_score': '0.152404', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GL', 'relevance_score': '0.158519', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TMDX', 'relevance_score': '0.158519', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SAFE', 'relevance_score': '0.210274', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UA', 'relevance_score': '0.10607', 'ticker_sentiment_score': '0.24477', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PTCT', 'relevance_score': '0.10607', 'ticker_sentiment_score': '0.146314', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXTI', 'relevance_score': '0.10607', 'ticker_sentiment_score': '0.094042', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KORE', 'relevance_score': '0.158519', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.10607', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TM', 'relevance_score': '0.053153', 'ticker_sentiment_score': '-0.086679', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NRSN', 'relevance_score': '0.10607', 'ticker_sentiment_score': '-0.0195', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARGX', 'relevance_score': '0.053153', 'ticker_sentiment_score': '0.146676', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.10607', 'ticker_sentiment_score': '0.098389', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HALO', 'relevance_score': '0.10607', 'ticker_sentiment_score': '0.159415', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EC', 'relevance_score': '0.210274', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRVL', 'relevance_score': '0.10607', 'ticker_sentiment_score': '0.107088', 'ticker_sentiment_label': 'Neutral'}]"
193,"The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly - Johnson & Johnson  ( NYSE:JNJ ) , Eli Lilly and Co  ( NYSE:LLY ) ",https://www.benzinga.com/general/biotech/24/06/39432381/the-zacks-analyst-blog-highlights-pfizer-johnson-johnson-and-eli-lilly,20240621T193114,['Zacks'],"Chicago, IL - June 21, 2024 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.",https://cdn.benzinga.com/files/images/story/2024/06/21/jason-briscoe-amlfrl8lgls-unsplash.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.23596,Somewhat-Bullish,"[{'ticker': 'AZN', 'relevance_score': '0.040078', 'ticker_sentiment_score': '-0.063462', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.080055', 'ticker_sentiment_score': '0.208813', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.11983', 'ticker_sentiment_score': '0.133763', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.486415', 'ticker_sentiment_score': '0.240245', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.080055', 'ticker_sentiment_score': '0.069699', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.040078', 'ticker_sentiment_score': '-0.063462', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.159305', 'ticker_sentiment_score': '0.067239', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.040078', 'ticker_sentiment_score': '-0.063462', 'ticker_sentiment_label': 'Neutral'}]"
194,Here's How Much a $1000 Investment in Eli Lilly Made 10 Years Ago Would Be Worth Today,https://www.zacks.com/stock/news/2291308/heres-how-much-a-1000-investment-in-eli-lilly-made-10-years-ago-would-be-worth-today,20240621T123003,['Zacks Equity Research'],Holding on to popular or trending stocks for the long-term can make your portfolio a winner.,https://staticx-tuner.zacks.com/images/default_article_images/default131.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.151557,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.618121', 'ticker_sentiment_score': '0.240224', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'INCY', 'relevance_score': '0.053629', 'ticker_sentiment_score': '0.025867', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ELAN', 'relevance_score': '0.212115', 'ticker_sentiment_score': '0.041948', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AKUS', 'relevance_score': '0.053629', 'ticker_sentiment_score': '0.047013', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DICE', 'relevance_score': '0.053629', 'ticker_sentiment_score': '0.047013', 'ticker_sentiment_label': 'Neutral'}]"
195,"The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly",https://www.zacks.com/stock/news/2291339/the-zacks-analyst-blog-highlights-pfizer-johnson-johnson-and-eli-lilly,20240621T115900,['Zacks Equity Research'],"Pfizer, Johnson & Johnson and Eli Lilly are part of the Zacks top Analyst Blog.",https://staticx-tuner.zacks.com/images/articles/main/89/447.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.235581,Somewhat-Bullish,"[{'ticker': 'AZN', 'relevance_score': '0.039353', 'ticker_sentiment_score': '-0.06338', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.078611', 'ticker_sentiment_score': '0.208275', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.117678', 'ticker_sentiment_score': '0.120071', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.478768', 'ticker_sentiment_score': '0.243569', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.078611', 'ticker_sentiment_score': '0.069463', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.039353', 'ticker_sentiment_score': '-0.06338', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.156461', 'ticker_sentiment_score': '0.062196', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.039353', 'ticker_sentiment_score': '-0.06338', 'ticker_sentiment_label': 'Neutral'}]"
196,"Forget Eli Lilly, Buy This Magnificent Biotech Stock Instead",https://www.fool.com/investing/2024/06/21/forget-eli-lilly-buy-magnificent-biotech-stock/,20240621T095100,['Keith Speights'],Lilly is a good pick...but this one is better.,https://g.foolcdn.com/editorial/images/780926/scientist-in-lab-young-african-american-female.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.310445,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.583672', 'ticker_sentiment_score': '0.52003', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.175433', 'ticker_sentiment_score': '0.298239', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
197,Eli Lilly  ( LLY )  Registers a Bigger Fall Than the Market: Important Facts to Note,https://www.zacks.com/stock/news/2291076/eli-lilly-lly-registers-a-bigger-fall-than-the-market-important-facts-to-note,20240620T214519,['Zacks Equity Research'],"The latest trading day saw Eli Lilly (LLY) settling at $885.99, representing a -0.61% change from its previous close.",https://staticx-tuner.zacks.com/images/default_article_images/default159.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.961735'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.164536,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.52949', 'ticker_sentiment_score': '0.195861', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
198,Eli Lilly Has a New Drug That Could Push the Stock Higher,https://www.fool.com/investing/2024/06/20/eli-lilly-has-a-new-drug-that-could-push-the-stock/,20240620T182500,['Leo Miller'],The Alzheimer's treatment market is large and expected to grow.,https://g.foolcdn.com/editorial/images/781205/gettyimages-1296945064.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.178134,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.1789', 'ticker_sentiment_score': '0.03087', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESALF', 'relevance_score': '0.11983', 'ticker_sentiment_score': '0.179362', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.060085', 'ticker_sentiment_score': '-0.114418', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.060085', 'ticker_sentiment_score': '0.158017', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
199,Here's Why Eli Lilly  ( LLY )  is Probably the Best Drug Stock Now,https://www.zacks.com/stock/news/2290782/heres-why-eli-lilly-lly-is-probably-the-best-drug-stock-now,20240620T130100,['Kinjel Shah'],"Eli Lilly (LLY) enjoys strong fundamentals and is expected to consistently do well, mainly supported by its new drugs and its solid pipeline.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.233627,Somewhat-Bullish,"[{'ticker': 'AZN', 'relevance_score': '0.041975', 'ticker_sentiment_score': '-0.063648', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.166743', 'ticker_sentiment_score': '0.240335', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.083833', 'ticker_sentiment_score': '0.153717', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.538782', 'ticker_sentiment_score': '0.273532', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.083833', 'ticker_sentiment_score': '0.059562', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.041975', 'ticker_sentiment_score': '-0.063648', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.12546', 'ticker_sentiment_score': '0.068567', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.041975', 'ticker_sentiment_score': '-0.063648', 'ticker_sentiment_label': 'Neutral'}]"
200,Eli Lilly's Growth Prospects Just Got a Huge Upgrade,https://www.fool.com/investing/2024/06/20/eli-lillys-growth-prospects-just-got-huge-upgrade/,20240620T123000,['David Jagielski'],The company's promising Alzheimer's drug could soon obtain approval from regulators.,https://g.foolcdn.com/editorial/images/780718/person-reviewing-a-sample-in-a-lab.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}]",0.300179,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.445848', 'ticker_sentiment_score': '0.333639', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
201,"The Best Biotech Stock to Invest $1,000 in Right Now",https://www.fool.com/investing/2024/06/18/the-best-biotech-stock-to-invest-1000-in-right-now/,20240618T115000,['Alex Carchidi'],"This stock may not be a slam dunk, but it's looking very promising.",https://g.foolcdn.com/editorial/images/780622/doctors-at-table.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999365'}]",0.227574,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.049322', 'ticker_sentiment_score': '0.0559', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDGL', 'relevance_score': '0.049322', 'ticker_sentiment_score': '0.0559', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.147216', 'ticker_sentiment_score': '0.23147', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.049322', 'ticker_sentiment_score': '0.0559', 'ticker_sentiment_label': 'Neutral'}]"
202,Top Weight-Loss Rivals Share This Risk After Eye-Popping Runs,https://www.investors.com/research/how-to-find-the-best-stocks-to-buy/novo-nordisk-nvo-eli-lilly-lly-stock/,20240617T170100,"[""Investor's Business Daily"", 'MATTHEW GALGANI']","Novo Nordisk, Eli Lilly In Demand For Weight-Loss Drugs As Shares Face Elevated Risks Separator Investor's ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2024/06/Stock-bullsred-generatedai-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",0.202637,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.590482', 'ticker_sentiment_score': '0.216164', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.24289', 'ticker_sentiment_score': '-0.005607', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.697425', 'ticker_sentiment_score': '0.278366', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
203,Spotlight on Eli Lilly and Co: Analyzing the Surge in Options Activity - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/06/39358134/spotlight-on-eli-lilly-and-co-analyzing-the-surge-in-options-activity,20240617T134705,['Benzinga Insights'],"Deep-pocketed investors have adopted a bullish approach towards Eli Lilly and Co LLY, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.118913,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.746491', 'ticker_sentiment_score': '0.264415', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
204,"The Zacks Analyst Blog Highlights Berkshire Hathaway, Eli Lilly, PepsiCo, Hovnanian and IDT",https://www.zacks.com/stock/news/2289110/the-zacks-analyst-blog-highlights-berkshire-hathaway-eli-lilly-pepsico-hovnanian-and-idt,20240617T123100,['Zacks Equity Research'],"Berkshire Hathaway, Eli Lilly, PepsiCo, Hovnanian and IDT are part of the Zacks top Analyst Blog.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.235619,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.287441', 'ticker_sentiment_score': '0.132888', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HOVNP', 'relevance_score': '0.083833', 'ticker_sentiment_score': '0.03778', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.166743', 'ticker_sentiment_score': '0.114466', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.12546', 'ticker_sentiment_score': '0.042536', 'ticker_sentiment_label': 'Neutral'}]"
205,Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.,https://www.fool.com/investing/2024/06/16/thinking-of-buying-madrigal-pharmaceuticals-stock/,20240616T160500,['Alex Carchidi'],Eli Lilly just drizzled on Madrigal Pharmaceuticals' parade.,https://g.foolcdn.com/editorial/images/780409/researchers-work-in-the-lab.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.234355,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.244354', 'ticker_sentiment_score': '0.072335', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDGL', 'relevance_score': '0.099066', 'ticker_sentiment_score': '0.054597', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.049629', 'ticker_sentiment_score': '0.121597', 'ticker_sentiment_label': 'Neutral'}]"
206,Will Walmart Reach a Trillion-Dollar Market Cap by 2030?,https://www.fool.com/investing/2024/06/16/will-walmart-reach-trillion-dollar-market-cap-2030/,20240616T102000,['James Brumley'],This seemingly unlikely non-tech name quietly deserves to be on the list of contenders that could achieve the feat in the foreseeable future.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F780557%2F061324-walmart-revenue-eps-past-projected.png&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.980716'}]",0.184808,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.154455', 'ticker_sentiment_score': '-0.001348', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.154455', 'ticker_sentiment_score': '-0.001348', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VZIO', 'relevance_score': '0.077593', 'ticker_sentiment_score': '0.048908', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.116161', 'ticker_sentiment_score': '0.00463', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.077593', 'ticker_sentiment_score': '0.090793', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.038843', 'ticker_sentiment_score': '0.045656', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.077593', 'ticker_sentiment_score': '0.158021', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WMT', 'relevance_score': '0.373751', 'ticker_sentiment_score': '0.242741', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
207,Mounjaro Is Targeting Another Multibillion-Dollar Market: Is Eli Lilly Stock a Buy?,https://www.fool.com/investing/2024/06/15/mounjaro-is-targeting-another-multibillion-dollar/,20240615T180500,['Prosper Junior Bakiny'],The company has too many weapons at its disposal.,https://g.foolcdn.com/editorial/images/780296/patient-sitting-on-hospital-bed.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.744043'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.234679,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.360005', 'ticker_sentiment_score': '0.311241', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MDGL', 'relevance_score': '0.053271', 'ticker_sentiment_score': '0.079698', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.053271', 'ticker_sentiment_score': '0.079698', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.053271', 'ticker_sentiment_score': '0.079698', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.053271', 'ticker_sentiment_score': '0.079698', 'ticker_sentiment_label': 'Neutral'}]"
208,Eli Lilly Scores Another Major Win and Lines Up Its Next Blockbuster,https://www.fool.com/investing/2024/06/15/eli-lilly-scores-another-major-win-and-lines-up-it/,20240615T111500,['Prosper Junior Bakiny'],The drugmaker continues to make headlines for all the right reasons.,https://g.foolcdn.com/editorial/images/780428/doctor-holding-elderly-patients-hand.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.253204,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.370602', 'ticker_sentiment_score': '0.197338', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
209,3 Growth Stocks You Can Buy Right Now Without Any Hesitation,https://www.fool.com/investing/2024/06/15/3-growth-stocks-you-can-buy-right-now-without-any/,20240615T105000,"['Keith Speights', 'and Prosper Junior Bakiny', 'David Jagielski']",Want peace of mind about your investments? Consider these great stocks.,https://g.foolcdn.com/editorial/images/780514/happy-stock-investor-holding-smartphone.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}]",0.230394,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.308407', 'ticker_sentiment_score': '0.342258', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.157227', 'ticker_sentiment_score': '0.127925', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTLT', 'relevance_score': '0.039548', 'ticker_sentiment_score': '0.003901', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.414559', 'ticker_sentiment_score': '0.241327', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
210,"Top Stock Reports for Berkshire Hathaway, Eli Lilly & PepsiCo",https://www.zacks.com/research-daily/2288461/top-stock-reports-for-berkshire-hathaway-eli-lilly-pepsico,20240614T205000,['Mark Vickery'],"Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), Eli Lilly and Company (LLY) and PepsiCo, Inc. (PEP), as well as two micro-cap stocks Hovnanian Enterprises, Inc. (HOV) and IDT Corporation (IDT).",https://staticx-tuner.zacks.com/images/articles/main/72/1912.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.976913'}]",0.269345,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.157827', 'ticker_sentiment_score': '0.12357', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.052918', 'ticker_sentiment_score': '0.300089', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
211,Analyzing Eli Lilly and Co In Comparison To Competitors In Pharmaceuticals Industry - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/news/24/06/39334728/analyzing-eli-lilly-and-co-in-comparison-to-competitors-in-pharmaceuticals-industry,20240614T150014,['Benzinga Insights'],"In the dynamic and fiercely competitive business environment, conducting a thorough analysis of companies is crucial for investors and industry enthusiasts. In this article, we will perform an extensive industry comparison, evaluating Eli Lilly and Co LLY in relation to its major competitors in ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.202473,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.556946', 'ticker_sentiment_score': '0.296173', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
212,Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity Drug,https://www.fool.com/investing/2024/06/14/wegovys-precarious-position-3-drugs-most-likely-to/,20240614T095000,['Keith Speights'],Novo Nordisk's competition in the obesity drug market is heating up.,https://g.foolcdn.com/editorial/images/780375/ozempic.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.17509,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.601928', 'ticker_sentiment_score': '0.263643', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ALT', 'relevance_score': '0.056143', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GPCR', 'relevance_score': '0.056143', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.167322', 'ticker_sentiment_score': '0.159962', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.377958', 'ticker_sentiment_score': '0.175532', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
213,"Zacks Market Edge Highlights: CAVA, Abercrombie & Fitch, Eli Lilly, CrowdStrike and Deckers Outdoor",https://www.zacks.com/stock/news/2288189/zacks-market-edge-highlights-cava-abercrombie-fitch-eli-lilly-crowdstrike-and-deckers-outdoor,20240614T084600,['Zacks Investment Research'],"CAVA, Abercrombie & Fitch, Eli Lilly, CrowdStrike and Deckers Outdoor have been highlighted in this Market Edge article.",https://staticx-tuner.zacks.com/images/articles/main/68/1006.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.99489'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.304816,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.408949', 'ticker_sentiment_score': '0.093962', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANF', 'relevance_score': '0.408949', 'ticker_sentiment_score': '0.108349', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRWD', 'relevance_score': '0.345674', 'ticker_sentiment_score': '0.295941', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CAVA', 'relevance_score': '0.408949', 'ticker_sentiment_score': '0.347091', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DECK', 'relevance_score': '0.279813', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
214,5 Hot Growth Stocks: Buy on the Highs or Wait for a Pullback?,https://www.zacks.com/stock/news/2288059/5-hot-growth-stocks-buy-on-the-highs-or-wait-for-a-pullback,20240613T173800,['Tracey Ryniec'],These 5 stocks are red hot and hitting new all-time highs. Have you missed the trade?,https://staticx-tuner.zacks.com/images/default_article_images/default230.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.99489'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.307488,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.503018', 'ticker_sentiment_score': '0.107627', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANF', 'relevance_score': '0.503018', 'ticker_sentiment_score': '0.12433', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRWD', 'relevance_score': '0.428632', 'ticker_sentiment_score': '0.342584', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CAVA', 'relevance_score': '0.503018', 'ticker_sentiment_score': '0.393188', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'DECK', 'relevance_score': '0.349329', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
215,This portfolio chip stock is the second-best AI play behind Nvidia,https://www.cnbc.com/2024/06/13/this-portfolio-chip-stock-is-the-second-best-ai-play-behind-nvidia-.html,20240613T152829,['Morgan Chittum'],"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",https://image.cnbcfm.com/api/v1/image/107391096-1711047611808-gettyimages-2102403796-img_7514_nrpukd9a.jpeg?v=1711048000&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.967645'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",0.067586,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.353059', 'ticker_sentiment_score': '0.071201', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.181137', 'ticker_sentiment_score': '0.042372', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.181137', 'ticker_sentiment_score': '0.042372', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.091162', 'ticker_sentiment_score': '0.029842', 'ticker_sentiment_label': 'Neutral'}]"
216,FDA Expands AstraZeneca's  ( AZN )  Farxiga Label in Pediatric T2D,https://www.zacks.com/stock/news/2287930/fda-expands-astrazenecas-azn-farxiga-label-in-pediatric-t2d,20240613T141100,['Zacks Equity Research'],"Following the label expansion, AstraZeneca's (AZN) Farxiga is now approved to improve glycemic control in patients aged 10 years and older with T2D. It was previously approved for such use in adults.",https://staticx-tuner.zacks.com/images/articles/main/e5/1416.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.250174,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.196344', 'ticker_sentiment_score': '0.209607', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ARQT', 'relevance_score': '0.259727', 'ticker_sentiment_score': '0.066702', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.43816', 'ticker_sentiment_score': '0.195587', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HRTX', 'relevance_score': '0.321393', 'ticker_sentiment_score': '0.139035', 'ticker_sentiment_label': 'Neutral'}]"
217,Why Eli Lilly  ( LLY )  is a Top Momentum Stock for the Long-Term,https://www.zacks.com/stock/news/2287885/why-eli-lilly-lly-is-a-top-momentum-stock-for-the-long-term,20240613T135012,['Zacks Equity Research'],"Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",https://staticx-tuner.zacks.com/images/default_article_images/default126.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}]",0.324167,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.605937', 'ticker_sentiment_score': '0.330348', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
218,"Down 57%, Is AbCellera Biologics a Buy on the Dip?",https://www.fool.com/investing/2024/06/13/down-57-is-abcellera-biologics-a-buy-on-the-dip/,20240613T094000,['Cory Renauer'],Wall Street analysts say this drug developer can more than double your money.,https://g.foolcdn.com/editorial/images/780372/investor-looks-worried-at-computer-in-a-living-room-setting-getty.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}, {'topic': 'Earnings', 'relevance_score': '0.796627'}]",0.086499,Neutral,"[{'ticker': 'ABCL', 'relevance_score': '0.16099', 'ticker_sentiment_score': '0.079496', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.107736', 'ticker_sentiment_score': '0.122046', 'ticker_sentiment_label': 'Neutral'}]"
219,Eli Lilly's $50 Billion View From The Weight-Loss Arena,https://www.investors.com/research/the-new-america/eli-lilly-stock-weight-loss-drug-expectations/,20240612T120000,"['ALLISON GATLIN', ""Investor's Business Daily""]",Eli Lilly Stock Runs Up 48% Amid Lofty Expectations For Weight-Loss Drug Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2024/06/wNAsales061724.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.839681'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.459462'}]",0.137497,Neutral,"[{'ticker': 'VKTX', 'relevance_score': '0.062761', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.031405', 'ticker_sentiment_score': '0.092378', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.062761', 'ticker_sentiment_score': '-0.05814', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GLDAF', 'relevance_score': '0.062761', 'ticker_sentiment_score': '0.029003', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.49669', 'ticker_sentiment_score': '0.167766', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GPCR', 'relevance_score': '0.062761', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REGN', 'relevance_score': '0.062761', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.062761', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DXCM', 'relevance_score': '0.031405', 'ticker_sentiment_score': '0.230533', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.062761', 'ticker_sentiment_score': '0.032226', 'ticker_sentiment_label': 'Neutral'}]"
220,A Life Expansion Revolution Is Coming: 3 Stocks That Could Lead the Charge,https://www.fool.com/investing/2024/06/12/a-life-expansion-revolution-is-coming-3-stocks-tha/,20240612T113000,['George Budwell'],The integration of AI and healthcare is well underway.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F780297%2Fbiotech.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.495866'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.325863,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.143415', 'ticker_sentiment_score': '0.034246', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EXAI', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.226022', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.143415', 'ticker_sentiment_score': '0.400754', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SNY', 'relevance_score': '0.282234', 'ticker_sentiment_score': '0.204477', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
221,Is Eli Lilly the Best Pharmaceutical Stock for You?,https://www.fool.com/investing/2024/06/12/is-eli-lilly-the-best-pharmaceutical-stock-for-you/,20240612T092500,['Adria Cimino'],Eli Lilly is serving a market that may reach $100 billion.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F780158%2Fgettyimages-1226994628.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}, {'topic': 'Earnings', 'relevance_score': '0.998947'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.241736,Somewhat-Bullish,"[{'ticker': 'GS', 'relevance_score': '0.049629', 'ticker_sentiment_score': '0.245286', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.709986', 'ticker_sentiment_score': '0.373581', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.099066', 'ticker_sentiment_score': '0.064572', 'ticker_sentiment_label': 'Neutral'}]"
222,Stocks Fall On Inflation Jitters; Apple Hits Buy Point As Analyst Sees AI 'Supercycle' While Roaring Kitty Affirms This,https://www.investors.com/market-trend/stock-market-today/dow-jones-nasdaq-sp500-apple-stock-gamestop/,20240611T143600,"['VIDYA RAMAKRISHNAN', ""Investor's Business Daily""]",Stocks Fall On Inflation Jitters. Apple Hits Buy Point As Analyst Sees AI 'Supercycle' While Roaring Kitty Affirms This Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2024/03/Stock-apple-seoulretail-01-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.995015'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}]",0.052919,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.136499', 'ticker_sentiment_score': '0.328227', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ORCL', 'relevance_score': '0.136499', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.332658', 'ticker_sentiment_score': '0.046257', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CASY', 'relevance_score': '0.136499', 'ticker_sentiment_score': '0.155505', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GM', 'relevance_score': '0.136499', 'ticker_sentiment_score': '0.074447', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GME', 'relevance_score': '0.2035', 'ticker_sentiment_score': '-0.269683', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
223,Top 4 Health Care Stocks That May Keep You Up At Night This Month - Applied Therapeutics  ( NASDAQ:APLT ) ,https://www.benzinga.com/news/24/06/39269583/top-4-health-care-stocks-that-may-keep-you-up-at-night-this-month,20240611T124436,['Avi Kapoor'],"As of June 11, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when ...",https://cdn.benzinga.com/files/images/story/2024/06/11/health-care-workers-ai.png?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}]",0.348732,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.298264', 'ticker_sentiment_score': '0.299505', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'APLT', 'relevance_score': '0.390396', 'ticker_sentiment_score': '0.379996', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'TMDX', 'relevance_score': '0.298264', 'ticker_sentiment_score': '0.375932', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'INSM', 'relevance_score': '0.298264', 'ticker_sentiment_score': '0.319436', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
224,How To Bag Massive 9.1% Dividends As AI 'Bubble' Pops,https://www.forbes.com/sites/michaelfoster/2024/06/11/how-to-bag-massive-91-dividends-as-ai-bubble-pops/,20240611T114500,['Michael Foster'],"You probably remember the first time you heard about ChatGPT. The AI tool's lifelike responses seemed like magic-so much so that people were debating whether generative AI tools like it were actually conscious. Such a debate was honestly a bit silly, and it didn't last long.",https://imageio.forbes.com/specials-images/imageserve/6661fd1b6cf45409177bc5ed/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds,Forbes,n/a,www.forbes.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.451494'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}]",0.288136,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.146618', 'ticker_sentiment_score': '-0.04065', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.098054', 'ticker_sentiment_score': '-0.034098', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HLT', 'relevance_score': '0.146618', 'ticker_sentiment_score': '0.107247', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.098054', 'ticker_sentiment_score': '-0.034098', 'ticker_sentiment_label': 'Neutral'}]"
225,Eli Lilly Hits an All-Time High: Is the Soaring Pharma Stock Still a Buy?,https://www.fool.com/investing/2024/06/11/eli-lilly-all-time-high-buy-pharma-stock/,20240611T095000,['Keith Speights'],The world's biggest healthcare company might become even larger.,https://g.foolcdn.com/editorial/images/780172/scientists-smiling-and-shaking-hands.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.287937,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.683932', 'ticker_sentiment_score': '0.49332', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.061473', 'ticker_sentiment_score': '0.050001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.061473', 'ticker_sentiment_score': '0.050001', 'ticker_sentiment_label': 'Neutral'}]"
226,Unpacking the Latest Options Trading Trends in Eli Lilly and Co - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/06/39258323/unpacking-the-latest-options-trading-trends-in-eli-lilly-and-co,20240610T200140,['Benzinga Insights'],"Investors with a lot of money to spend have taken a bullish stance on Eli Lilly and Co LLY. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.12297,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.803061', 'ticker_sentiment_score': '0.151469', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
227,Eli Lilly and Company  ( LLY )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2285839/eli-lilly-and-company-lly-is-attracting-investor-attention-here-is-what-you-should-know,20240610T130016,['Zacks Equity Research'],"Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default293.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.623304'}]",0.2505,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.489394', 'ticker_sentiment_score': '0.185909', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
228,Is This Trend a Threat to Eli Lilly's Weight Loss Drug Dominance?,https://www.fool.com/investing/2024/06/07/is-this-trend-a-threat-to-eli-lillys-weight-loss-d/,20240607T094500,['Adria Cimino'],The weight loss drug market is growing rapidly.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F779850%2Fgettyimages-1213513544.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.161647'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.212041,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.469744', 'ticker_sentiment_score': '0.343258', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GPCR', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.107857', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.107857', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.246001', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.09989', 'ticker_sentiment_score': '0.102039', 'ticker_sentiment_label': 'Neutral'}]"
229,"Halozyme's ENHANZE Product Gets New Patent Grant in EU - AbbVie  ( NYSE:ABBV ) , Acumen Pharmaceuticals  ( NASDAQ:ABOS ) ",https://www.benzinga.com/news/24/06/39208619/halozymes-enhanze-product-gets-new-patent-grant-in-eu,20240606T193629,['Zacks'],"Halozyme Therapeutics HALO announced that it has been granted a new patent in the EU that covers the ENHANZE rHuPH20 product, which is produced using the company's proprietary ENHANZE manufacturing methods.",https://cdn.benzinga.com/files/images/story/2024/06/06/joshua-mayo-objbg2lzjmg-unsplash.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.177356,Somewhat-Bullish,"[{'ticker': 'ANVS', 'relevance_score': '0.228073', 'ticker_sentiment_score': '-0.090561', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CHGCF', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.093485', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.093485', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.093485', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABOS', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.093485', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALXO', 'relevance_score': '0.228073', 'ticker_sentiment_score': '-0.088707', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARGX', 'relevance_score': '0.057767', 'ticker_sentiment_score': '0.083964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HALO', 'relevance_score': '0.33628', 'ticker_sentiment_score': '0.350833', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.093485', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.093485', 'ticker_sentiment_label': 'Neutral'}]"
230,"Nvidia Stock, These Other Companies Make Waves As IBD Sector Leaders",https://www.investors.com/stock-lists/sector-leaders/nvidia-nvda-stock-novo-nordisk-wingstop-sector-leaders/,20240606T184700,"[""Investor's Business Daily"", 'RUSS BRITT']","Only a small handful of companies currently comprise the list of IBD Sector Leaders, but while the list of standouts is short, their recent performance has been huge. Among the players: Novo Nordisk ( NVO ) , Wingstop ( WING ) and the market's current superstar, Nvidia stock.",https://www.investors.com/wp-content/uploads/2024/06/Stock-Nvidia-cornice-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}]",0.256335,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.187463', 'ticker_sentiment_score': '0.188508', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.523202', 'ticker_sentiment_score': '0.390687', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'WING', 'relevance_score': '0.523202', 'ticker_sentiment_score': '0.291463', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.446742', 'ticker_sentiment_score': '0.282832', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
231,Market Whales and Their Recent Bets on LLY Options - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/06/39210072/market-whales-and-their-recent-bets-on-lly-options,20240606T153052,['Benzinga Insights'],"Deep-pocketed investors have adopted a bearish approach towards Eli Lilly and Co LLY, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.099576,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.769861', 'ticker_sentiment_score': '0.106816', 'ticker_sentiment_label': 'Neutral'}]"
232,Eli Lilly  ( LLY )  Veteran Anat Ashkenazi to Join Alphabet as CFO,https://www.zacks.com/stock/news/2284718/eli-lilly-lly-veteran-anat-ashkenazi-to-join-alphabet-as-cfo,20240606T142100,['Zacks Equity Research'],"Eli Lilly (LLY) CFO Anat Ashkenazi joins Google's parent company Alphabet as CFO and senior vice president, effective from ...",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Earnings', 'relevance_score': '0.795202'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.148998,Neutral,"[{'ticker': 'ACRV', 'relevance_score': '0.303175', 'ticker_sentiment_score': '0.157738', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.650245', 'ticker_sentiment_score': '0.18603', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GOOG', 'relevance_score': '0.244723', 'ticker_sentiment_score': '0.194661', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HRTX', 'relevance_score': '0.303175', 'ticker_sentiment_score': '0.19016', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
233,Google And Eli Lilly Have Things In Common Besides Being Mutual Fund Favorites,https://www.investors.com/research/google-googl-stock-netflix-nflx-eli-lilly/,20240605T201100,"[""Investor's Business Daily"", 'KIMBERLEY KOENIG']","Google Stock, Eli Lilly Have These Things In Common Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2021/07/Stock-googlecloudserver-02-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.993856'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.211227,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.37643', 'ticker_sentiment_score': '0.220804', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NFLX', 'relevance_score': '0.240965', 'ticker_sentiment_score': '0.058102', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.460452', 'ticker_sentiment_score': '0.361946', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'XOM', 'relevance_score': '0.097655', 'ticker_sentiment_score': '-0.126866', 'ticker_sentiment_label': 'Neutral'}]"
234,Google Parent Alphabet Appoints Eli Lilly's Finance Chief Ashkenazi As CFO - Alphabet  ( NASDAQ:GOOGL ) ,https://www.benzinga.com/news/24/06/39185867/google-parent-alphabet-appoints-eli-lillys-finance-chief-ashkenazi-as-cfo,20240605T141149,['Vandana Singh'],"On Wednesday, Eli Lilly And Co LLY announced that Anat Ashkenazi has resigned as chief financial officer to pursue a career opportunity outside of the pharmaceutical industry. Ms. Ashkenazi will continue to serve at full capacity in her role and as a member of Lilly's Executive Committee through ...",https://cdn.benzinga.com/files/images/story/2024/06/05/google-shuter.jpeg?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.236066,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.410059', 'ticker_sentiment_score': '0.047285', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.630923', 'ticker_sentiment_score': '0.107887', 'ticker_sentiment_label': 'Neutral'}]"
235,"Lilly announces departure of Anat Ashkenazi, chief financial officer",https://www.prnewswire.com/news-releases/lilly-announces-departure-of-anat-ashkenazi-chief-financial-officer-302163882.html,20240605T114500,['Eli Lilly and Company'],"INDIANAPOLIS, June 5, 2024 /PRNewswire/ -- Eli Lilly and Company ( NYSE: LLY ) announced today that Anat Ashkenazi has resigned as chief financial officer to pursue a career opportunity outside of the pharmaceutical industry.",https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.451494'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.143234,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.383995', 'ticker_sentiment_score': '0.08894', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CURN', 'relevance_score': '0.036365', 'ticker_sentiment_score': '0.005889', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.036365', 'ticker_sentiment_score': '0.139471', 'ticker_sentiment_label': 'Neutral'}]"
236,Melissa Seymour to join Lilly as executive vice president of Global Quality,https://investingnews.com/melissa-seymour-to-join-lilly-as-executive-vice-president-of-global-quality/,20240604T132550,['Investing News Network'],"Eli Lilly and Company ( NYSE: LLY ) announced today that Melissa Seymour will join the company as executive vice president of Global Quality and member of the company's Executive Committee, effective July 22, 2024 .",https://investingnews.com/media-library/image.gif?id=32908904&width=1200&height=600&coordinates=0%2C2%2C0%2C3,Investing News Network,n/a,investingnews.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.451494'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.205757,Somewhat-Bullish,"[{'ticker': 'CURN', 'relevance_score': '0.033656', 'ticker_sentiment_score': '0.005842', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.033656', 'ticker_sentiment_score': '0.138518', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.033656', 'ticker_sentiment_score': '0.135491', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.033656', 'ticker_sentiment_score': '0.135491', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.23228', 'ticker_sentiment_score': '0.129198', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.033656', 'ticker_sentiment_score': '0.135491', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.067252', 'ticker_sentiment_score': '0.113535', 'ticker_sentiment_label': 'Neutral'}]"
237,"Beyond Nvidia: 2 Chip Giants, 2 Drugmakers In Spotlight",https://www.investors.com/research/how-to-find-the-best-stocks-to-buy/nvidia-stock-amd-tsm-lly-nvo/,20240603T181400,"['MATTHEW GALGANI', ""Investor's Business Daily""]","Nvidia Stock Seeks Market-Cap Supremacy As AMD, TSM Etch Buy Points Alngside Two Drugmakers Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2024/06/Stock-spotlight-02-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.153547,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.217346', 'ticker_sentiment_score': '0.064997', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.465196', 'ticker_sentiment_score': '0.079545', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.320974', 'ticker_sentiment_score': '0.13364', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FSLR', 'relevance_score': '0.217346', 'ticker_sentiment_score': '0.168784', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CAVA', 'relevance_score': '0.109705', 'ticker_sentiment_score': '0.209892', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.217346', 'ticker_sentiment_score': '0.302179', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMD', 'relevance_score': '0.269776', 'ticker_sentiment_score': '-0.022496', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.320974', 'ticker_sentiment_score': '0.289967', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
238,Eli Lilly and Co's Options: A Look at What the Big Money is Thinking - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/06/39137913/eli-lilly-and-cos-options-a-look-at-what-the-big-money-is-thinking,20240603T140104,['Benzinga Insights'],"Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly and Co. Looking at options history for Eli Lilly and Co LLY we detected 22 trades. If we consider the specifics of each trade, it is accurate to state that 45% of the investors opened trades with bullish ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}]",0.118115,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.807885', 'ticker_sentiment_score': '0.120088', 'ticker_sentiment_label': 'Neutral'}]"
239,Watch Out Wegovy: Here Comes Another Promising Anti-Obesity Candidate,https://www.fool.com/investing/2024/06/03/watch-out-wegovy-here-comes-another-promising-anti/,20240603T134500,['Prosper Junior Bakiny'],The fight for dominance in the weight loss market is just getting started.,https://g.foolcdn.com/editorial/images/778465/doctor-with-patient-talking.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.147539,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.611103', 'ticker_sentiment_score': '0.345227', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VKTX', 'relevance_score': '0.062434', 'ticker_sentiment_score': '0.240151', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'IVBXF', 'relevance_score': '0.062434', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
240,"The Zacks Analyst Blog Highlights Eli Lilly, T-Mobile US, BHP, American International and Exelon",https://www.zacks.com/stock/news/2282776/the-zacks-analyst-blog-highlights-eli-lilly-t-mobile-us-bhp-american-international-and-exelon,20240603T133300,['Zacks Equity Research'],"Eli Lilly, T-Mobile US, BHP, American International and Exelon are part of the Zacks Analyst Blog.",https://staticx-tuner.zacks.com/images/articles/main/e3/536.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.23547,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.305437', 'ticker_sentiment_score': '0.11247', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TMUS', 'relevance_score': '0.186259', 'ticker_sentiment_score': '0.004456', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EXC', 'relevance_score': '0.124809', 'ticker_sentiment_score': '0.003484', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BHP', 'relevance_score': '0.186259', 'ticker_sentiment_score': '0.004456', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AIG', 'relevance_score': '0.124809', 'ticker_sentiment_score': '0.003484', 'ticker_sentiment_label': 'Neutral'}]"
241,Stocks To Watch: AstraZeneca ADR Sees RS Rating Jump To 83,https://www.investors.com/ibd-data-stories/stocks-to-watch-astrazeneca-adr-sees-rs-rating-jump-to-83/,20240603T070000,"[""INVESTOR'S BUSINESS DAILY"", ""Investor's Business Daily""]","AstraZeneca ADR ( AZN ) saw a positive improvement to its Relative Strength ( RS ) Rating on Monday, with an upgrade from 80 to 83. X IBD's unique RS Rating tracks market leadership by showing how a stock's price movement over the last 52 weeks compares to that of other stocks on the major ...",https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.77141'}]",0.329086,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.377142', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.377142', 'ticker_sentiment_score': '0.717153', 'ticker_sentiment_label': 'Bullish'}]"
242,Prediction: These Could Be the Best-Performing Pharmaceutical Stocks Through 2030,https://www.fool.com/investing/2024/06/02/prediction-these-could-be-the-best-pharmaceutical/,20240602T133000,['Prosper Junior Bakiny'],These two drugmakers have a lot more in common than their market-beating potential.,https://g.foolcdn.com/editorial/images/778278/doctor-with-patient-talking.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}]",0.270066,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.486729', 'ticker_sentiment_score': '0.382851', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.486729', 'ticker_sentiment_score': '0.386445', 'ticker_sentiment_label': 'Bullish'}]"
243,This Is the Biggest Risk for Eli Lilly and Novo Nordisk Investors,https://www.fool.com/investing/2024/06/01/this-biggest-risk-for-eli-lilly-and-novo-nordisk/,20240601T142500,['David Jagielski'],These stocks are trading at sky-high valuations which could make them vulnerable to sell-offs.,https://g.foolcdn.com/editorial/images/778643/worried-investor-looking-at-their-laptop.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.112622,Neutral,"[{'ticker': 'GS', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.074272', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.616612', 'ticker_sentiment_score': '0.15042', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.616612', 'ticker_sentiment_score': '0.15042', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
244,S&P 500 Giants Lead Five Healthy Stocks Near Buy Points,https://www.investors.com/news/sp-500-giants-stocks-near-buy-points/,20240601T120000,"[""Investor's Business Daily"", 'HARRISON MILLER']","With many leading stocks in need of some repair, investors may want to seek medical attention. Eli Lilly ( LLY ) , Novo Nordisk ( NVO ) , Vertex Pharmaceuticals ( VRTX ) , Intuitive Surgical ( ISRG ) and Universal Health ( UHS ) are all trading in or near buy zones.",https://www.investors.com/wp-content/uploads/2018/05/Stock-HealthCloud-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.94762'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.124906,Neutral,"[{'ticker': 'CTLT', 'relevance_score': '0.064018', 'ticker_sentiment_score': '-0.132137', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.312026', 'ticker_sentiment_score': '0.139665', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCA', 'relevance_score': '0.064018', 'ticker_sentiment_score': '-0.408769', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.064018', 'ticker_sentiment_score': '0.094068', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.252006', 'ticker_sentiment_score': '0.092848', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.159148', 'ticker_sentiment_score': '0.132957', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.064018', 'ticker_sentiment_score': '0.094068', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.312026', 'ticker_sentiment_score': '0.136597', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.032035', 'ticker_sentiment_score': '-0.073241', 'ticker_sentiment_label': 'Neutral'}]"
245,"Ozempic Maker Novo Nordisk Stock Is Up More Than 31% In 2024, Trades Near Buy Zone",https://www.investors.com/stock-lists/sector-leaders/novo-nordisk-stock-ozempic/,20240531T172000,"['RACHEL FOX', ""Investor's Business Daily""]","Among top medical stocks to watch on the IBD Sector Leaders list, Novo Nordisk ( NVO ) traded close to a buy point Friday as shares bounced from their 21-day exponential moving average the past few days. The Denmark-based drugmaker is a leader in the weight-loss drugs race, alongside Eli Lilly ...",https://www.investors.com/wp-content/uploads/2024/02/Stock-novonordisk-building-03-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.179704,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.186738', 'ticker_sentiment_score': '0.115979', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.09402', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTLT', 'relevance_score': '0.186738', 'ticker_sentiment_score': '0.228874', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.521465', 'ticker_sentiment_score': '0.145673', 'ticker_sentiment_label': 'Neutral'}]"
246,Performance Comparison: Eli Lilly and Co And Competitors In Pharmaceuticals Industry - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/news/24/05/39113388/performance-comparison-eli-lilly-and-co-and-competitors-in-pharmaceuticals-industry,20240531T150014,['Benzinga Insights'],"In the ever-evolving and intensely competitive business landscape, conducting a thorough company analysis is of utmost importance for investors and industry followers. In this article, we will carry out an in-depth industry comparison, assessing Eli Lilly and Co LLY alongside its primary ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}]",0.180317,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.469253', 'ticker_sentiment_score': '0.269983', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
247,"Nvidia CEO, CrowdStrike, Jobs Report Headline Action Plan",https://www.investors.com/research/investing-action-plan/nvidia-ceo-crowdstrike-jobs-report/,20240531T142300,"['ED CARSON', ""Investor's Business Daily""]","Here is this week's Investing Action Plan, what you need to know for the week ahead. Economic data dominates the week, capped by the May jobs report on Friday. As for earnings, cybersecurity leader CrowdStrike ( CRWD ) headlines a small lineup of earnings reports.",https://www.investors.com/wp-content/uploads/2017/09/econ01-jobs-090117-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.918141'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.999975'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.125102,Neutral,"[{'ticker': 'NVDA', 'relevance_score': '0.090304', 'ticker_sentiment_score': '0.064197', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRWD', 'relevance_score': '0.179454', 'ticker_sentiment_score': '0.071209', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.135094', 'ticker_sentiment_score': '0.0738', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.090304', 'ticker_sentiment_score': '0.064197', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HPQ', 'relevance_score': '0.045224', 'ticker_sentiment_score': '-0.069689', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.090304', 'ticker_sentiment_score': '0.126669', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.045224', 'ticker_sentiment_score': '0.057548', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IOT', 'relevance_score': '0.135094', 'ticker_sentiment_score': '0.071161', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LULU', 'relevance_score': '0.090304', 'ticker_sentiment_score': '0.12349', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FIVE', 'relevance_score': '0.135094', 'ticker_sentiment_score': '0.105249', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.090304', 'ticker_sentiment_score': '0.064197', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.090304', 'ticker_sentiment_score': '0.064197', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.135094', 'ticker_sentiment_score': '0.0738', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARM', 'relevance_score': '0.090304', 'ticker_sentiment_score': '0.064197', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HPE', 'relevance_score': '0.090304', 'ticker_sentiment_score': '-0.073547', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.135094', 'ticker_sentiment_score': '0.0738', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OLLI', 'relevance_score': '0.090304', 'ticker_sentiment_score': '0.089852', 'ticker_sentiment_label': 'Neutral'}]"
248,Why Is Lilly  ( LLY )  Up 4.5% Since Last Earnings Report?,https://www.zacks.com/stock/news/2281505/why-is-lilly-lly-up-45-since-last-earnings-report,20240530T153109,['Zacks Equity Research'],Lilly (LLY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,https://staticx-tuner.zacks.com/images/default_article_images/default41.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999998'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}]",0.14522,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.434252', 'ticker_sentiment_score': '0.248318', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
249,Incyte  ( INCY )  Up 7.5% Since Last Earnings Report: Can It Continue?,https://www.zacks.com/stock/news/2281515/incyte-incy-up-75-since-last-earnings-report-can-it-continue,20240530T153107,['Zacks Equity Research'],Incyte (INCY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,https://staticx-tuner.zacks.com/images/default_article_images/default225.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.890401'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.095103,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.125898', 'ticker_sentiment_score': '0.04632', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INCY', 'relevance_score': '0.507678', 'ticker_sentiment_score': '0.187793', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MOR', 'relevance_score': '0.042122', 'ticker_sentiment_score': '0.212853', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
250,"Costco, Eli Lilly Near New Highs; That Doesn't Scare Mutual Funds",https://www.investors.com/research/costco-stock-cost-mutual-funds-lly-stock/,20240530T123000,"['KIMBERLEY KOENIG', ""Investor's Business Daily""]","Costco Stock, Eli Lilly Among Fund Favorites Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2018/10/Stock-Costco-05-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.999976'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.928139'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}]",0.306446,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.286864', 'ticker_sentiment_score': '0.234508', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'COST', 'relevance_score': '0.340915', 'ticker_sentiment_score': '0.352582', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'AVGO', 'relevance_score': '0.174587', 'ticker_sentiment_score': '0.05933', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.116914', 'ticker_sentiment_score': '0.09986', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.058615', 'ticker_sentiment_score': '0.135999', 'ticker_sentiment_label': 'Neutral'}]"
251,"Urban Outfitters, Eli Lilly And 2 Other Stocks Insiders Are Selling - Eli Lilly and Co  ( NYSE:LLY ) ",https://www.benzinga.com/news/24/05/39084569/urban-outfitters-eli-lilly-and-2-other-stocks-insiders-are-selling,20240530T122246,['Avi Kapoor'],"The Nasdaq 100 closed lower by over 100 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced.",https://cdn.benzinga.com/files/images/story/2024/05/30/xrdDAFj0FUZspA2-j5351515556-t23052408.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.133313,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.472338', 'ticker_sentiment_score': '0.024712', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'Z', 'relevance_score': '0.326283', 'ticker_sentiment_score': '0.256547', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EA', 'relevance_score': '0.401331', 'ticker_sentiment_score': '-0.019255', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'URBN', 'relevance_score': '0.401331', 'ticker_sentiment_score': '0.281746', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
252,"Jim Cramer Recommends Buying Apple, Finds This Tech Stock 'Very Interesting' - Apple  ( NASDAQ:AAPL ) , Axcelis Technologies  ( NASDAQ:ACLS ) ",https://www.benzinga.com/trading-ideas/long-ideas/24/05/39062320/jim-cramer-recommends-buying-apple-finds-this-tech-stock-very-interesting,20240529T124714,['Avi Kapoor'],"On CNBC's ""Mad Money Lightning Round,"" Jim Cramer said Apple Inc. AAPL is a ""buy here."" Apple's iPhone sales in China increased by 52% year-on-year in April, Reuters cited from industry reports. When asked about Palantir Technologies Inc.",https://cdn.benzinga.com/files/images/story/2024/05/29/West-Bangal--India---April-20--2022--App.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '0.795202'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.242843,Somewhat-Bullish,"[{'ticker': 'TGNA', 'relevance_score': '0.317869', 'ticker_sentiment_score': '0.123185', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.241284', 'ticker_sentiment_score': '-0.067926', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GLDD', 'relevance_score': '0.241284', 'ticker_sentiment_score': '0.451569', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.317869', 'ticker_sentiment_score': '0.325594', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ACLS', 'relevance_score': '0.317869', 'ticker_sentiment_score': '0.559078', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'DDOG', 'relevance_score': '0.317869', 'ticker_sentiment_score': '-0.152174', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LLY', 'relevance_score': '0.162255', 'ticker_sentiment_score': '0.554844', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'WDAY', 'relevance_score': '0.162255', 'ticker_sentiment_score': '-0.123917', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLTR', 'relevance_score': '0.241284', 'ticker_sentiment_score': '-0.072199', 'ticker_sentiment_label': 'Neutral'}]"
253,Could Eli Lilly Be the Next to Join the Trillion-Dollar Club?,https://www.fool.com/investing/2024/05/29/could-eli-lilly-be-the-next-to-join-the-trillion-d/,20240529T101500,['Adria Cimino'],"Today, Eli Lilly's market value tops $700 billion.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F778758%2Fscientists-high-five-smile.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Earnings', 'relevance_score': '0.999759'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.358063,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.680543', 'ticker_sentiment_score': '0.4855', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.052918', 'ticker_sentiment_score': '0.321931', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.052918', 'ticker_sentiment_score': '0.054014', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.052918', 'ticker_sentiment_score': '0.121073', 'ticker_sentiment_label': 'Neutral'}]"
254,A New Name in Weight Loss Drugs,https://www.fool.com/investing/2024/05/28/a-new-name-in-weight-loss-drugs/,20240528T163300,['Motley Fool Staff'],Novo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on the action with a more available and affordable option.,https://g.foolcdn.com/editorial/images/778379/mfm_20.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}]",0.175127,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.038268', 'ticker_sentiment_score': '0.038033', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKE', 'relevance_score': '0.009571', 'ticker_sentiment_score': '0.166872', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.038268', 'ticker_sentiment_score': '0.038033', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XPOF', 'relevance_score': '0.009571', 'ticker_sentiment_score': '0.080371', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BNXYF', 'relevance_score': '0.009571', 'ticker_sentiment_score': '0.017847', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLNT', 'relevance_score': '0.057375', 'ticker_sentiment_score': '0.037081', 'ticker_sentiment_label': 'Neutral'}]"
255,Eli Lilly and Company  ( LLY )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2279892/eli-lilly-and-company-lly-is-a-trending-stock-facts-to-know-before-betting-on-it,20240528T130017,['Zacks Equity Research'],"Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default93.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.237399,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.490323', 'ticker_sentiment_score': '0.162466', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
256,Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?,https://www.fool.com/investing/2024/05/28/eli-lilly-stock-could-soar-24-according-to-a-wall/,20240528T083900,['Cory Renauer'],Plowing $9 billion into a manufacturing facility could help a successful tirzepatide launch reach new heights.,https://g.foolcdn.com/editorial/images/778632/individual-investor-devices-getty.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}]",0.053192,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.541149', 'ticker_sentiment_score': '0.060841', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTLT', 'relevance_score': '0.059049', 'ticker_sentiment_score': '0.010027', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HIMS', 'relevance_score': '0.059049', 'ticker_sentiment_score': '0.055072', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.117774', 'ticker_sentiment_score': '0.044032', 'ticker_sentiment_label': 'Neutral'}]"
257,'Not Just A Weight Loss Story:' Eli Lilly CEO Thinks It's Possible To Meet BofA's $60B Revenue Projection From New Drug Launches - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/general/biotech/24/05/39032738/not-just-a-weight-loss-story-eli-lilly-ceo-thinks-its-possible-to-meet-bofas-60b-revenue-projecti,20240528T063857,['Benzinga Neuro'],"David Ricks, CEO of Eli Lilly and Co LLY, expressed confidence in meeting the lofty revenue expectations set by Bank of America for the company's upcoming drug launches.",https://cdn.benzinga.com/files/images/story/2024/05/28/Eli-Lilly.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.234675,Somewhat-Bullish,"[{'ticker': 'BAC', 'relevance_score': '0.280615', 'ticker_sentiment_score': '0.107363', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.630923', 'ticker_sentiment_score': '0.489293', 'ticker_sentiment_label': 'Bullish'}]"
258,10 Best Vanguard Funds to Buy Right Now,https://www.fool.com/investing/2024/05/27/10-best-vanguard-funds-to-buy-right-now/,20240527T123000,['George Budwell'],These 10 Vanguard stock ETFs can help you build a top-notch portfolio.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F778686%2Fetf.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.391095,Bullish,"[{'ticker': 'TRGP', 'relevance_score': '0.022729', 'ticker_sentiment_score': '0.300559', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.113276', 'ticker_sentiment_score': '0.092723', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.090731', 'ticker_sentiment_score': '0.122297', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.045439', 'ticker_sentiment_score': '0.217094', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CEG', 'relevance_score': '0.022729', 'ticker_sentiment_score': '0.036053', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BLDR', 'relevance_score': '0.022729', 'ticker_sentiment_score': '0.300559', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BRK-A', 'relevance_score': '0.022729', 'ticker_sentiment_score': '0.24951', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.022729', 'ticker_sentiment_score': '0.246548', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AXON', 'relevance_score': '0.022729', 'ticker_sentiment_score': '0.300559', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.022729', 'ticker_sentiment_score': '0.246548', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.090731', 'ticker_sentiment_score': '0.122297', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TDG', 'relevance_score': '0.022729', 'ticker_sentiment_score': '0.036053', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.068112', 'ticker_sentiment_score': '0.158611', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'APH', 'relevance_score': '0.022729', 'ticker_sentiment_score': '0.036053', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TM', 'relevance_score': '0.022729', 'ticker_sentiment_score': '0.180777', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMZN', 'relevance_score': '0.022729', 'ticker_sentiment_score': '0.034958', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NSRGF', 'relevance_score': '0.022729', 'ticker_sentiment_score': '0.180777', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
259,"Eli Lilly  ( LLY )  to Ramp Up Indiana Site for Mounjaro, Zepbound",https://www.zacks.com/stock/news/2279236/eli-lilly-lly-to-ramp-up-indiana-site-for-mounjaro-zepbound,20240527T120200,['Zacks Equity Research'],"Since 2020, Eli Lilly (LLY) has committed more than $18 billion to building new manufacturing sites as well as updating existing manufacturing facilities.",https://staticx-tuner.zacks.com/images/articles/main/5d/2633.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.5'}]",0.262807,Somewhat-Bullish,"[{'ticker': 'APG', 'relevance_score': '0.054236', 'ticker_sentiment_score': '0.176824', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.659096', 'ticker_sentiment_score': '0.386355', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'VKTX', 'relevance_score': '0.16171', 'ticker_sentiment_score': '0.072099', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.214462', 'ticker_sentiment_score': '0.101099', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.108222', 'ticker_sentiment_score': '0.261237', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
260,What To Do As Rally Narrows But Keeps Rising,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rally-narrows-stocks-near-buy-points/,20240526T144600,"[""Investor's Business Daily"", 'ED CARSON']","Dow Jones futures will open Sunday evening, along with S&P 500 futures and Nasdaq futures. The stock market rally had a mixed week, despite Nvidia ( NVDA ) soaring on booming earnings and guidance. The Nasdaq hit a record high, shrugging off Thursday's ugly downside reversal.",https://www.investors.com/wp-content/uploads/2020/05/Stock-Greenarrowsup-02-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}]",0.014538,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.184129', 'ticker_sentiment_score': '-0.014866', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.184129', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.243803', 'ticker_sentiment_score': '-0.130748', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANET', 'relevance_score': '0.123367', 'ticker_sentiment_score': '-0.071998', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.092688', 'ticker_sentiment_score': '-0.074022', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PSTG', 'relevance_score': '0.092688', 'ticker_sentiment_score': '-0.074022', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DECK', 'relevance_score': '0.061869', 'ticker_sentiment_score': '0.171431', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CROX', 'relevance_score': '0.214123', 'ticker_sentiment_score': '0.151602', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.184129', 'ticker_sentiment_score': '-0.004471', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANF', 'relevance_score': '0.092688', 'ticker_sentiment_score': '-0.074022', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.030958', 'ticker_sentiment_score': '-0.149561', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DELL', 'relevance_score': '0.061869', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
261,Got $500? 3 Pharma Stocks to Buy and Hold Forever,https://www.fool.com/investing/2024/05/26/got-500-3-pharma-stocks-to-buy-and-hold-forever/,20240526T141500,['Alex Carchidi'],These players might even beat the market when the conditions are right.,https://g.foolcdn.com/editorial/images/778164/investor-thinks-while-looking-out-a-window.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}]",0.265035,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.164656', 'ticker_sentiment_score': '0.244994', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.110209', 'ticker_sentiment_score': '0.239132', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.110209', 'ticker_sentiment_score': '0.18474', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
262,3 High-Flying Stocks That Could Soar Even More,https://www.fool.com/investing/2024/05/25/3-high-flying-stocks-that-could-soar-even-more/,20240525T104700,"['David Jagielski', 'Keith Speights', 'and Prosper Junior Bakiny']","The momentum should continue for Eli Lilly, Novo Nordisk, and Vertex Pharmaceuticals.",https://g.foolcdn.com/editorial/images/778486/stock-chart-rocket.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.203016,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.410505', 'ticker_sentiment_score': '0.21727', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.334008', 'ticker_sentiment_score': '0.116918', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CURN', 'relevance_score': '0.04303', 'ticker_sentiment_score': '0.062785', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.212674', 'ticker_sentiment_score': '0.062603', 'ticker_sentiment_label': 'Neutral'}]"
263,Rally Narrows But Dow Giants Lead 7 Stocks Near Buy Points,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rally-narrows-dow-giants-lead-7-stocks-near-buy-points/,20240524T211200,"['ED CARSON', ""Investor's Business Daily""]","Dow Jones futures will open Sunday evening, along with S&P 500 futures and Nasdaq futures. The stock market rally had a mixed week, despite Nvidia ( NVDA ) soaring on booming earnings and guidance. The Nasdaq hit a record high, shrugging off Thursday's ugly downside reversal.",https://www.investors.com/wp-content/uploads/2020/05/Stock-Greenarrowsup-02-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}]",0.016983,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.18046', 'ticker_sentiment_score': '-0.014649', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.18046', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.239011', 'ticker_sentiment_score': '-0.128713', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANET', 'relevance_score': '0.120885', 'ticker_sentiment_score': '-0.071339', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.090816', 'ticker_sentiment_score': '-0.073654', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PSTG', 'relevance_score': '0.090816', 'ticker_sentiment_score': '-0.073654', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DECK', 'relevance_score': '0.060617', 'ticker_sentiment_score': '0.171303', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CROX', 'relevance_score': '0.209884', 'ticker_sentiment_score': '0.149272', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.18046', 'ticker_sentiment_score': '-0.004406', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANF', 'relevance_score': '0.090816', 'ticker_sentiment_score': '-0.073654', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.030331', 'ticker_sentiment_score': '-0.149174', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DELL', 'relevance_score': '0.060617', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
264,Stocks Hit A Wall Despite Booming Nvidia: Weekly Review,https://www.investors.com/news/stock-market-hits-wall-despite-nvidia/,20240524T135600,"[""Investor's Business Daily"", 'IBD STAFF']",Stock Market Hits A Wall Despite Booming Nvidia: Weekly Review Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2020/04/Stock-BullAndMarket-07-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.996023'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.048906,Neutral,"[{'ticker': 'TGT', 'relevance_score': '0.098984', 'ticker_sentiment_score': '0.029132', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LPG', 'relevance_score': '0.059488', 'ticker_sentiment_score': '-0.051036', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTU', 'relevance_score': '0.039679', 'ticker_sentiment_score': '0.029637', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADI', 'relevance_score': '0.039679', 'ticker_sentiment_score': '0.029375', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.019846', 'ticker_sentiment_score': '-0.030649', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'M', 'relevance_score': '0.019846', 'ticker_sentiment_score': '0.176327', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'URBN', 'relevance_score': '0.098984', 'ticker_sentiment_score': '0.09459', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.079261', 'ticker_sentiment_score': '0.021451', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PDD', 'relevance_score': '0.079261', 'ticker_sentiment_score': '0.07713', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.039679', 'ticker_sentiment_score': '0.020469', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.039679', 'ticker_sentiment_score': '0.037332', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPGI', 'relevance_score': '0.019846', 'ticker_sentiment_score': '0.003706', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.039679', 'ticker_sentiment_score': '-0.143801', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PANW', 'relevance_score': '0.039679', 'ticker_sentiment_score': '0.001969', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.196451', 'ticker_sentiment_score': '-0.004959', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MOD', 'relevance_score': '0.039679', 'ticker_sentiment_score': '-0.129767', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNOW', 'relevance_score': '0.039679', 'ticker_sentiment_score': '-0.070546', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBLK', 'relevance_score': '0.059488', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAH', 'relevance_score': '0.039679', 'ticker_sentiment_score': '0.113589', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TOL', 'relevance_score': '0.079261', 'ticker_sentiment_score': '0.047708', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WSM', 'relevance_score': '0.059488', 'ticker_sentiment_score': '0.004071', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DECK', 'relevance_score': '0.039679', 'ticker_sentiment_score': '0.043392', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.039679', 'ticker_sentiment_score': '0.020469', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROST', 'relevance_score': '0.039679', 'ticker_sentiment_score': '0.153264', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SNPS', 'relevance_score': '0.059488', 'ticker_sentiment_score': '0.071995', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EXP', 'relevance_score': '0.039679', 'ticker_sentiment_score': '-0.113268', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.039679', 'ticker_sentiment_score': '-0.032794', 'ticker_sentiment_label': 'Neutral'}]"
265,"Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More",https://www.zacks.com/stock/news/2278490/pharma-stock-roundup-azns-2030-sales-target-pfes-new-cost-cut-plan-more,20240524T131900,['Kinjel Shah'],"AstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer (PFE) announces a multi-year, multi-phase cost reduction program.",https://staticx-tuner.zacks.com/images/articles/main/55/1135.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}]",0.045562,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.449723', 'ticker_sentiment_score': '0.024054', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.052918', 'ticker_sentiment_score': '-0.124637', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.404563', 'ticker_sentiment_score': '0.057649', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.449723', 'ticker_sentiment_score': '0.07411', 'ticker_sentiment_label': 'Neutral'}]"
266,"Jim Cramer: This Basic Materials Stock Is 'Too Dicey,' Shares His Take On Arista Networks - Sigma Lithium  ( NASDAQ:SGML ) ",https://www.benzinga.com/trading-ideas/long-ideas/24/05/39007136/jim-cramer-says-this-basic-materials-stock-is-too-dicey-shares-his-take-on-arista-networ,20240524T131150,['Avi Kapoor'],"On CNBC's ""Mad Money Lightning Round,"" Jim Cramer said Arista Networks, Inc. ANET reported an ""unbelievable"" quarter, and the company's CEO Jayshree Ullal is doing a ""terrific"" job. He added, ""All of these stocks are a little volatile right now, but I think you want to own it and buy it into the ...",https://cdn.benzinga.com/files/images/story/2024/05/24/jim-cramer-shutterstock2.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.196397,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.396574', 'ticker_sentiment_score': '0.572774', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SNEJF', 'relevance_score': '0.396574', 'ticker_sentiment_score': '0.337062', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ANET', 'relevance_score': '0.396574', 'ticker_sentiment_score': '0.288251', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SGML', 'relevance_score': '0.396574', 'ticker_sentiment_score': '-0.218279', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'DJT', 'relevance_score': '0.396574', 'ticker_sentiment_score': '-0.090244', 'ticker_sentiment_label': 'Neutral'}]"
267,LLY: Eli Lilly  ( LLY )  vs. Novo Nordisk  ( NVO ) : Which Pharma Stock Is Driving Long-Term 2024 Profits?,https://stocknews.com/news/lly-nvo-eli-lilly-lly-vs-novo-nordisk-nvo-which-pharma-stock/,20240523T131712,['StockNews.com Staff'],"The pharmaceutical industry is thriving due to the increasing incidence of chronic diseases, the rising number of elderly individuals, higher healthcare spending by governmental bodies worldwide, and extensive initiatives aimed at enhancing the affordability and availability of pharma products.",https://stocknews.com/wp-content/uploads/2023/03/Nidhi-Agarwal_Headshot-3.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.692272'}]",0.278409,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.455797', 'ticker_sentiment_score': '0.424742', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.314017', 'ticker_sentiment_score': '0.312523', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
268,3 Blue Chip Stocks That You Can Buy and Hold for Years,https://www.fool.com/investing/2024/05/23/3-blue-chip-stocks-that-you-can-buy-and-hold-for-y/,20240523T120500,['David Jagielski'],You won't be taking on much risk by investing in these stalwarts.,https://g.foolcdn.com/editorial/images/777830/a-family-reviewing-financial-results-with-an-advisor.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.996023'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.77141'}]",0.31243,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.292922', 'ticker_sentiment_score': '0.311145', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.427024', 'ticker_sentiment_score': '0.373697', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'VZIO', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.050502', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.245835', 'ticker_sentiment_score': '0.086859', 'ticker_sentiment_label': 'Neutral'}]"
269,Surprise: Eli Lilly Is Racing Toward Yet Another Blockbuster,https://www.fool.com/investing/2024/05/23/surprise-eli-lilly-is-racing-toward-yet-another/,20240523T104500,['Prosper Junior Bakiny'],This winner can't stop winning.,https://g.foolcdn.com/editorial/images/777989/physician-talking-to-patient.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.218495,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.450496', 'ticker_sentiment_score': '0.3666', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.177584', 'ticker_sentiment_score': '0.017459', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.059636', 'ticker_sentiment_score': '-0.011025', 'ticker_sentiment_label': 'Neutral'}]"
270,Futures: Two Titans Flash Buy Signals; Nvidia Up Next,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-target-but-here-comes-nvidia/,20240522T105200,"[""Investor's Business Daily"", 'ED CARSON']",Dow Jones Futures Fall As Target Tumbles. Here Comes Nvidia Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2021/02/Stock-Nvidia-devbox-02-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '0.99237'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.057586,Neutral,"[{'ticker': 'TGT', 'relevance_score': '0.114409', 'ticker_sentiment_score': '-0.148752', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARES', 'relevance_score': '0.057352', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.307661', 'ticker_sentiment_score': '0.121648', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.057352', 'ticker_sentiment_score': '0.331088', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MOD', 'relevance_score': '0.114409', 'ticker_sentiment_score': '0.035098', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADI', 'relevance_score': '0.114409', 'ticker_sentiment_score': '-0.055994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NU', 'relevance_score': '0.114409', 'ticker_sentiment_score': '-0.100763', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'URBN', 'relevance_score': '0.170878', 'ticker_sentiment_score': '0.011393', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.226477', 'ticker_sentiment_score': '0.042461', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TOL', 'relevance_score': '0.170878', 'ticker_sentiment_score': '0.112242', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WSM', 'relevance_score': '0.114409', 'ticker_sentiment_score': '0.056765', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PDD', 'relevance_score': '0.114409', 'ticker_sentiment_score': '-0.023256', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.226477', 'ticker_sentiment_score': '-0.012266', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRCX', 'relevance_score': '0.142734', 'ticker_sentiment_score': '-0.086115', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BKNG', 'relevance_score': '0.114409', 'ticker_sentiment_score': '-0.086534', 'ticker_sentiment_label': 'Neutral'}]"
271,Nasdaq Hits New High But Here Comes Nvidia,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-nasdaq-hits-high-eli-lilly-breaks-out-but-here-comes-nvidia/,20240521T205800,"['ED CARSON', ""Investor's Business Daily""]","Dow Jones Futures: Nasdaq Hits High, Eli Lilly Breaks Out, But Here Comes Nvidia Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2021/02/Stock-Nvidia-devbox-02-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '0.976671'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.05745,Neutral,"[{'ticker': 'TGT', 'relevance_score': '0.089573', 'ticker_sentiment_score': '-0.202727', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'ARES', 'relevance_score': '0.059785', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.320027', 'ticker_sentiment_score': '0.147489', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.059785', 'ticker_sentiment_score': '0.331329', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MOD', 'relevance_score': '0.119235', 'ticker_sentiment_score': '0.019195', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADI', 'relevance_score': '0.119235', 'ticker_sentiment_score': '-0.051549', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NU', 'relevance_score': '0.119235', 'ticker_sentiment_score': '-0.102542', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'URBN', 'relevance_score': '0.178021', 'ticker_sentiment_score': '0.03631', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.235823', 'ticker_sentiment_score': '0.043857', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TOL', 'relevance_score': '0.148731', 'ticker_sentiment_score': '0.079946', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WSM', 'relevance_score': '0.119235', 'ticker_sentiment_score': '0.090239', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PDD', 'relevance_score': '0.119235', 'ticker_sentiment_score': '-0.072112', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.235823', 'ticker_sentiment_score': '-0.012671', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRCX', 'relevance_score': '0.148731', 'ticker_sentiment_score': '-0.088217', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BKNG', 'relevance_score': '0.119235', 'ticker_sentiment_score': '-0.087971', 'ticker_sentiment_label': 'Neutral'}]"
272,Eli Lilly stock hits new highs after a regulatory win in China. This is a big deal,https://www.cnbc.com/2024/05/21/eli-lilly-stock-hits-new-highs-after-a-regulatory-win-in-china-this-is-a-big-deal.html,20240521T154228,['Morgan Chittum'],"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",https://image.cnbcfm.com/api/v1/image/107361860-1705686940016-gettyimages-1945282910-_s1_4831_x1nimfpp.jpeg?v=1716304466&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.967645'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.188567,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.171485', 'ticker_sentiment_score': '0.114495', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PANW', 'relevance_score': '0.171485', 'ticker_sentiment_score': '0.114495', 'ticker_sentiment_label': 'Neutral'}]"
273,"If You'd Invested $10,000 in Eli Lilly Stock 5 Years Ago, Here's How Much You'd Have Today",https://www.fool.com/investing/2024/05/21/if-youd-invested-10000-in-eli-lilly-stock-5-years/,20240521T144126,['Adria Cimino'],Have Eli Lilly's successes translated into stock performance?,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F777819%2Fgettyimages-531714398.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.818451'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.234307,Somewhat-Bullish,"[{'ticker': 'GS', 'relevance_score': '0.119235', 'ticker_sentiment_score': '0.019563', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.706282', 'ticker_sentiment_score': '0.365674', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.119235', 'ticker_sentiment_score': '0.036161', 'ticker_sentiment_label': 'Neutral'}]"
274,Just Two Magnificent Seven Stocks Meet This Criteria,https://www.investors.com/news/sp-500-magnificent-seven-earnings-criteria/,20240520T120000,"[""Investor's Business Daily"", 'ED CARSON']","The Magnificent Seven stocks - S&P 500 giants Amazon.com ( AMZN ) , Apple ( AAPL ) , Google parent Alphabet ( GOOGL ) , Meta Platforms ( META ) , Microsoft ( MSFT ) , Nvidia ( NVDA ) and Tesla ( TSLA ) - have been grouped together since the start of the bull market in January 2023.",https://www.investors.com/wp-content/uploads/2024/01/Stock-TwoLeaps-sunset-shut.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.999997'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.315541,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.208764', 'ticker_sentiment_score': '0.333188', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GOOG', 'relevance_score': '0.208764', 'ticker_sentiment_score': '0.352707', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'META', 'relevance_score': '0.208764', 'ticker_sentiment_score': '0.385655', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.340915', 'ticker_sentiment_score': '0.410668', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.208764', 'ticker_sentiment_score': '0.008607', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.340915', 'ticker_sentiment_score': '0.121141', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.140076', 'ticker_sentiment_score': '0.031399', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.340915', 'ticker_sentiment_score': '0.264248', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMZN', 'relevance_score': '0.340915', 'ticker_sentiment_score': '0.333551', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
275,"The Zacks Analyst Blog Highlights Microsoft, Eli Lilly, Costco and Koss",https://www.zacks.com/stock/news/2275828/the-zacks-analyst-blog-highlights-microsoft-eli-lilly-costco-and-koss,20240520T111200,['Zacks Investment Research'],"Microsoft, Eli Lilly, Costco and Koss are included in this Analyst Blog.",https://staticx-tuner.zacks.com/images/articles/main/fd/423.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.273721,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.339356', 'ticker_sentiment_score': '0.226258', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.230235', 'ticker_sentiment_score': '0.137292', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNEJF', 'relevance_score': '0.05833', 'ticker_sentiment_score': '0.057256', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.230235', 'ticker_sentiment_score': '0.302208', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KOSS', 'relevance_score': '0.173749', 'ticker_sentiment_score': '0.065409', 'ticker_sentiment_label': 'Neutral'}]"
276,"The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen",https://www.zacks.com/stock/news/2275810/the-zacks-analyst-blog-highlights-stocks-recently-featured-in-the-blog-include-novo-nordisk-eli-lillys-viking-altimmune-roche-and-amgen,20240520T104200,['Zacks Investment Research'],"Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen are included in this Analyst Blog.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.167697,Somewhat-Bullish,"[{'ticker': 'VKTX', 'relevance_score': '0.282234', 'ticker_sentiment_score': '0.154464', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.095899', 'ticker_sentiment_score': '0.086129', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.095899', 'ticker_sentiment_score': '0.029675', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALT', 'relevance_score': '0.282234', 'ticker_sentiment_score': '0.053625', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.032035', 'ticker_sentiment_score': '0.116226', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.032035', 'ticker_sentiment_score': '0.020964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.221385', 'ticker_sentiment_score': '0.07018', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.032035', 'ticker_sentiment_score': '0.020964', 'ticker_sentiment_label': 'Neutral'}]"
277,Is Amgen a Threat to Eli Lilly in This Billion-Dollar Market?,https://www.fool.com/investing/2024/05/19/is-amgen-a-threat-to-eli-lilly-in-this-market/,20240519T101500,['Adria Cimino'],Eli Lilly's biggest growth drivers today are its weight loss drugs.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F777578%2Fgettyimages-investor-works-at-computer.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.140873,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.447091', 'ticker_sentiment_score': '0.211884', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.05257', 'ticker_sentiment_score': '0.070167', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.208017', 'ticker_sentiment_score': '-0.009861', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.1568', 'ticker_sentiment_score': '0.110599', 'ticker_sentiment_label': 'Neutral'}]"
278,"Top Research Reports for Microsoft, Eli Lilly & Costco",https://www.zacks.com/research-daily/2275480/top-research-reports-for-microsoft-eli-lilly-costco,20240517T192900,['Mark Vickery'],"Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Eli Lilly and Company (LLY) and Costco Wholesale Corporation (COST), as well a micro-cap stock Koss Corporation (KOSS).",https://staticx-tuner.zacks.com/images/articles/main/fa/1036.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.314644,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.223522', 'ticker_sentiment_score': '0.277081', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.075397', 'ticker_sentiment_score': '0.16724', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SNEJF', 'relevance_score': '0.075397', 'ticker_sentiment_score': '0.059762', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.075397', 'ticker_sentiment_score': '0.424399', 'ticker_sentiment_label': 'Bullish'}]"
279,"4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly - Altimmune  ( NASDAQ:ALT ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/news/earnings/24/05/38897093/4-stocks-that-could-break-novo-nordisk-lillys-obesity-duopoly,20240517T192425,['Zacks'],"The obesity market has garnered much interest lately, ever since Novo Nordisk NVO received FDA approval for its obesity drug Wegovy in 2021. It was only after a couple of years that the market gained a second entrant - Eli Lilly's LLY Zepbound, which received FDA approval last year in November.",https://cdn.benzinga.com/files/images/story/2024/05/17/nick-chong-n__bnvq_w18-unsplash.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.179517,Somewhat-Bullish,"[{'ticker': 'VKTX', 'relevance_score': '0.266828', 'ticker_sentiment_score': '0.212936', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.067919', 'ticker_sentiment_score': '0.204913', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.101725', 'ticker_sentiment_score': '0.09978', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALT', 'relevance_score': '0.266828', 'ticker_sentiment_score': '0.069335', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.067919', 'ticker_sentiment_score': '0.121379', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.03399', 'ticker_sentiment_score': '0.020157', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.201803', 'ticker_sentiment_score': '0.096423', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.067919', 'ticker_sentiment_score': '0.021146', 'ticker_sentiment_label': 'Neutral'}]"
280,Eli Lilly's  ( LLY )  Efsitora Matches Daily Insulins in A1C Control,https://www.zacks.com/stock/news/2275599/eli-lillys-lly-efsitora-matches-daily-insulins-in-a1c-control,20240517T155700,['Zacks Equity Research'],"Eli Lilly's (LLY) two phase III studies on its once-weekly insulin, efsitora alfa, meet their primary endpoint of non-inferior reduction in blood sugar levels compared with daily basal insulins.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.9545'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.17446,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.381255', 'ticker_sentiment_score': '0.268786', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ANIP', 'relevance_score': '0.277748', 'ticker_sentiment_score': '0.190231', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LGND', 'relevance_score': '0.168884', 'ticker_sentiment_score': '0.15197', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ANVS', 'relevance_score': '0.223866', 'ticker_sentiment_score': '-0.028534', 'ticker_sentiment_label': 'Neutral'}]"
281,"Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates",https://www.zacks.com/stock/news/2275562/pharma-stock-roundup-bayrys-q1-earnings-jnjs-new-buyout-pipeline-updates,20240517T153900,['Kinjel Shah'],"Bayer (BAYRY) releases Q1 results. J&J (JNJ) set to acquire private biotech, Proteologix, which will add atopic dermatitis candidates.",https://staticx-tuner.zacks.com/images/articles/main/ab/2180.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.795202'}]",0.026274,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.279414', 'ticker_sentiment_score': '-0.008256', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.035661', 'ticker_sentiment_score': '-0.119857', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.141935', 'ticker_sentiment_score': '0.0639', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.071251', 'ticker_sentiment_score': '-0.079184', 'ticker_sentiment_label': 'Neutral'}]"
282,Evaluating Eli Lilly and Co Against Peers In Pharmaceuticals Industry - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/news/24/05/38896380/evaluating-eli-lilly-and-co-against-peers-in-pharmaceuticals-industry,20240517T150016,['Benzinga Insights'],"In today's rapidly changing and fiercely competitive business landscape, it is vital for investors and industry enthusiasts to carefully evaluate companies. In this article, we will perform a comprehensive industry comparison, evaluating Eli Lilly and Co LLY against its key competitors in the ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.623304'}]",0.135675,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.461997', 'ticker_sentiment_score': '0.1212', 'ticker_sentiment_label': 'Neutral'}]"
283,"4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly",https://www.zacks.com/stock/news/2275514/4-stocks-that-could-break-novo-nordisk-lillys-obesity-duopoly,20240517T140400,['Sundeep Ganoria'],"Though obesity drugs continue to gain traction, it is currently a duopoly market. As analysts expect demand to grow at an encouraging pace, several biotech/pharma companies are rushing to enter this space.",https://staticx-tuner.zacks.com/images/articles/main/c8/39674.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.165572,Somewhat-Bullish,"[{'ticker': 'VKTX', 'relevance_score': '0.271274', 'ticker_sentiment_score': '0.211874', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.069094', 'ticker_sentiment_score': '0.17789', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.103479', 'ticker_sentiment_score': '0.09697', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALT', 'relevance_score': '0.271274', 'ticker_sentiment_score': '0.070244', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.03458', 'ticker_sentiment_score': '0.117428', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.03458', 'ticker_sentiment_score': '0.021179', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.205225', 'ticker_sentiment_score': '0.096103', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.03458', 'ticker_sentiment_score': '0.021179', 'ticker_sentiment_label': 'Neutral'}]"
284,Eli Lilly and Company  ( LLY )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2275263/eli-lilly-and-company-lly-is-attracting-investor-attention-here-is-what-you-should-know,20240517T130014,['Zacks Equity Research'],"Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",https://staticx-tuner.zacks.com/images/default_article_images/default282.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.233149,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.491255', 'ticker_sentiment_score': '0.168709', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
285,Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk,https://www.fool.com/investing/2024/05/17/meet-the-glp-1-drug-that-could-be-the-biggest-conc/,20240517T122400,['David Jagielski'],Could Amgen be the next stock to soar due to a GLP-1 drug?,https://g.foolcdn.com/editorial/images/776990/doctor-meeting-a-salesperson.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}]",0.268795,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.123209', 'ticker_sentiment_score': '0.241651', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMGN', 'relevance_score': '0.514619', 'ticker_sentiment_score': '0.514875', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.123209', 'ticker_sentiment_score': '0.241651', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
286,"Zacks Investment Ideas feature highlights: Apple, Eli Lilly and Crocs",https://www.zacks.com/stock/news/2275146/zacks-investment-ideas-feature-highlights-apple-eli-lilly-and-crocs,20240517T093200,['Zacks Investment Research'],"Apple, Eli Lilly and Crocs have been highlighted in this Investment Ideas article.",https://staticx-tuner.zacks.com/images/articles/main/7f/511.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.999994'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.471244,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.33628', 'ticker_sentiment_score': '0.329721', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.272029', 'ticker_sentiment_score': '0.264107', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CROX', 'relevance_score': '0.33628', 'ticker_sentiment_score': '0.417001', 'ticker_sentiment_label': 'Bullish'}]"
287,3 Stocks to Buy Following Positive Earnings Results,https://www.zacks.com/commentary/2275096/3-stocks-to-buy-following-positive-earnings-results,20240516T200900,['Derek Lewis'],"All three of these companies saw buyers step up post-earnings, reflecting the positivity of their results.",https://staticx-tuner.zacks.com/images/articles/main/31/650.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.455985,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.408949', 'ticker_sentiment_score': '0.417081', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.345674', 'ticker_sentiment_score': '0.359167', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'CROX', 'relevance_score': '0.408949', 'ticker_sentiment_score': '0.483905', 'ticker_sentiment_label': 'Bullish'}]"
288,3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance,https://www.zacks.com/stock/news/2274825/3-drug-stocks-to-watch-on-raised-2024-earnings-sales-guidance,20240516T141300,['Kinjel Shah'],"Here we discuss three drugmakers, Eli Lilly and Company (LLY), Novo Nordisk (NVO) and Merck (MRK), that have raised their earnings as well as sales guidance for 2024.",https://staticx-tuner.zacks.com/images/articles/main/f5/952.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.995077'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.258832,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.274149', 'ticker_sentiment_score': '0.235708', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.184834', 'ticker_sentiment_score': '0.246548', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
289,These 2 No-Brainer Growth Stocks Are Breaking New Ground,https://www.fool.com/investing/2024/05/16/these-2-no-brainer-growth-stocks-are-breaking-new/,20240516T111500,['Prosper Junior Bakiny'],The future keeps getting brighter for these companies.,https://g.foolcdn.com/editorial/images/777182/doctor-with-patient-talking.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.796627'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.26523,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.366061', 'ticker_sentiment_score': '0.222011', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'REGN', 'relevance_score': '0.108222', 'ticker_sentiment_score': '0.246391', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
290,"Market Rally Hits Highs, Nvidia Leads 12 Buys; What To Do Now",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-sp-500-nasdaq-highs-nvidia-leads-new-buys/,20240515T205000,"[""Investor's Business Daily"", 'ED CARSON']","Market Rally Hits Highs, Nvidia Leads 12 Buys. What To Do Now Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2018/07/stock-bull-charge-02-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.769861'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.080983,Neutral,"[{'ticker': 'DKNG', 'relevance_score': '0.173126', 'ticker_sentiment_score': '0.025795', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KLAC', 'relevance_score': '0.115927', 'ticker_sentiment_score': '-0.020505', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.25714', 'ticker_sentiment_score': '-0.013788', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CSCO', 'relevance_score': '0.115927', 'ticker_sentiment_score': '-0.038164', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.029078', 'ticker_sentiment_score': '0.199115', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.058117', 'ticker_sentiment_score': '-0.068056', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.058117', 'ticker_sentiment_score': '-0.039005', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KBH', 'relevance_score': '0.058117', 'ticker_sentiment_score': '-0.04497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NTAP', 'relevance_score': '0.08708', 'ticker_sentiment_score': '0.035372', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PSTG', 'relevance_score': '0.058117', 'ticker_sentiment_score': '0.048969', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NTNX', 'relevance_score': '0.058117', 'ticker_sentiment_score': '0.048969', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PHM', 'relevance_score': '0.115927', 'ticker_sentiment_score': '0.041048', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOW', 'relevance_score': '0.115927', 'ticker_sentiment_score': '0.01257', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.144621', 'ticker_sentiment_score': '0.026877', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.173126', 'ticker_sentiment_score': '0.058129', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DELL', 'relevance_score': '0.058117', 'ticker_sentiment_score': '0.024035', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CB', 'relevance_score': '0.08708', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.08708', 'ticker_sentiment_score': '-0.187043', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
291,Biogen  ( BIIB )  Partner Begins Filing for Leqembi SC Autoinjector,https://www.zacks.com/stock/news/2274368/biogen-biib-partner-begins-filing-for-leqembi-sc-autoinjector,20240515T161200,['Zacks Equity Research'],Biogen (BIIB) and Eisai start the rolling submission of a biologics license application to the FDA for Leqembi subcutaneous autoinjector as a weekly maintenance dosing regimen for early Alzheimer's disease.,https://staticx-tuner.zacks.com/images/articles/main/49/1007.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.19481,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.22335', 'ticker_sentiment_score': '0.005135', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'THRD', 'relevance_score': '0.16849', 'ticker_sentiment_score': '0.14796', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PRTA', 'relevance_score': '0.05654', 'ticker_sentiment_score': '0.039932', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESALF', 'relevance_score': '0.521812', 'ticker_sentiment_score': '0.29949', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.429541', 'ticker_sentiment_score': '0.230135', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
292,These 2 Words Explain Why Eli Lilly Stock Is a Buy Right Now,https://www.fool.com/investing/2024/05/15/these-2-words-explain-why-eli-lilly-stock-is-a-buy/,20240515T094400,['Alex Carchidi'],Its latest medicines for obesity and type 2 diabetes are selling rapidly.,https://g.foolcdn.com/editorial/images/775253/chemist-team-looking-beaker-of-green-chemical.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.212551,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.33446', 'ticker_sentiment_score': '0.237471', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
293,2 Top Pharma Stocks That Just Keep Getting Better and Better,https://www.fool.com/investing/2024/05/14/2-top-pharma-stocks-that-just-keep-getting-better/,20240514T135300,['Alex Carchidi'],Both of these businesses are finding traction in a pair of major markets.,https://g.foolcdn.com/editorial/images/776216/lab-research-scientists-women-in-stem.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.161647'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}]",0.244712,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.222327', 'ticker_sentiment_score': '0.154459', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WLDS', 'relevance_score': '0.056275', 'ticker_sentiment_score': '0.109912', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.222327', 'ticker_sentiment_score': '0.131457', 'ticker_sentiment_label': 'Neutral'}]"
294,Is Eli Lilly's Latest Deal a Gamechanger?,https://www.fool.com/investing/2024/05/14/is-eli-lillys-latest-deal-a-gamechanger/,20240514T113000,['Adam Spatacco'],Eli Lilly just took a page out of Novo Nordisk's book.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F776744%2Fgettyimages-1393991949.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.203064,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.620262', 'ticker_sentiment_score': '0.372595', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'CTLT', 'relevance_score': '0.05387', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.31482', 'ticker_sentiment_score': '0.124175', 'ticker_sentiment_label': 'Neutral'}]"
295,3 Magnificent Stocks That Are Passive Income Machines,https://www.fool.com/investing/2024/05/14/3-magnificent-stocks-that-are-passive-income-machi/,20240514T103000,"['and David Jagielski', 'Prosper Junior Bakiny', 'Keith Speights']",These three companies have track records that should please investors.,https://g.foolcdn.com/editorial/images/776733/physician-shaking-patients-hand.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.459462'}, {'topic': 'Earnings', 'relevance_score': '0.839681'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.29313,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.342685', 'ticker_sentiment_score': '0.330403', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CERE', 'relevance_score': '0.044222', 'ticker_sentiment_score': '0.142799', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.30211', 'ticker_sentiment_score': '0.416428', 'ticker_sentiment_label': 'Bullish'}]"
296,Is Eli Lilly Stock A Better Pick Over Amgen?,https://www.forbes.com/sites/greatspeculations/2024/05/13/is-eli-lilly-stock-a-better-pick-over-amgen/,20240513T123029,['Trefis Team'],"Given its better prospects, we believe Eli Lilly stock ( NYSE: LLY ) is a better pick than Amgen stock ( NASDAQ : AMGN ) . Both stocks have been in the limelight lately, given their focus on the lucrative weight-loss treatment market. Eli Lilly trades at a higher valuation multiple of 20.4x ...",https://imageio.forbes.com/specials-images/imageserve/664190bb712984adff6f12fe/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds,Forbes,n/a,www.forbes.com,"[{'topic': 'Earnings', 'relevance_score': '0.999606'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}]",0.30196,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.633079', 'ticker_sentiment_score': '0.45982', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'AMGN', 'relevance_score': '0.633079', 'ticker_sentiment_score': '0.476129', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.035983', 'ticker_sentiment_score': '0.051342', 'ticker_sentiment_label': 'Neutral'}]"
297,1 No-Brainer Growth Stock to Buy and Hold,https://www.fool.com/investing/2024/05/11/1-no-brainer-growth-stock-to-buy-and-hold/,20240511T124500,['Prosper Junior Bakiny'],It's hard to bet against this high-flying stock.,https://g.foolcdn.com/editorial/images/775317/patient-talking-with-a-physician.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.917436'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.156289,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.551295', 'ticker_sentiment_score': '0.298279', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
298,Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.,https://www.fool.com/investing/2024/05/11/want-decades-of-passive-income-3-stocks-to-buy-now/,20240511T075000,['Justin Pope'],These pharmaceutical companies are top-notch dividend growth stocks for the future.,https://media.ycharts.com/charts/de54d771ee8c900e644a4c59d571e905.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.967321'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.304021,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.370831', 'ticker_sentiment_score': '0.163728', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.327366', 'ticker_sentiment_score': '0.135875', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.370831', 'ticker_sentiment_score': '0.440998', 'ticker_sentiment_label': 'Bullish'}]"
299,Nektar's  ( NKTR )  Q1 Earnings and Revenues Surpass Estimates,https://www.zacks.com/stock/news/2272336/nektars-nktr-q1-earnings-and-revenues-surpass-estimates,20240510T153300,['Zacks Equity Research'],Nektar (NKTR) reports a narrower-than-expected loss in the first quarter of 2024 and tops revenue estimates.,https://staticx-tuner.zacks.com/images/articles/main/f5/284.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.928139'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.081218,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.185306', 'ticker_sentiment_score': '-0.031499', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANIP', 'relevance_score': '0.303926', 'ticker_sentiment_score': '0.351756', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LGND', 'relevance_score': '0.360752', 'ticker_sentiment_score': '0.396604', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NKTR', 'relevance_score': '0.360752', 'ticker_sentiment_score': '-0.094984', 'ticker_sentiment_label': 'Neutral'}]"
300,How A Top Fund Beats The Market By Owning Future Leaders,https://www.investors.com/etfs-and-funds/mutual-funds/best-mutual-fund-beats-the-market-by-owning-future-leaders/,20240510T110000,"[""Investor's Business Daily"", 'ADAM SHELL']","Julianne McHugh, lead manager of best mutual fund BNY Mellon Large Cap Securities ( DREVX ) , isn't interested in blue-chip stars of yesteryear. When it comes to stock picking, she's more of a futurist than a rear-view-mirror type.",https://www.investors.com/wp-content/uploads/2024/05/MFprof051324-959x1024.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.999355'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}]",0.328806,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.126284', 'ticker_sentiment_score': '0.183787', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.188437', 'ticker_sentiment_score': '0.2235', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'IR', 'relevance_score': '0.063341', 'ticker_sentiment_score': '0.177244', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.157483', 'ticker_sentiment_score': '0.185016', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.063341', 'ticker_sentiment_score': '0.103831', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.157483', 'ticker_sentiment_score': '0.31664', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
301,"Zacks Investment Ideas feature highlights: Eaton, Eli Lilly and Arista Networks",https://www.zacks.com/stock/news/2271906/zacks-investment-ideas-feature-highlights-eaton-eli-lilly-and-arista-networks,20240510T093700,['Zacks Investment Research'],"Eaton, Eli Lilly and Arista Networks have been highlighted in this Investment Ideas article.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}, {'topic': 'Earnings', 'relevance_score': '0.998947'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.384695,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.385286', 'ticker_sentiment_score': '0.263123', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ANET', 'relevance_score': '0.31282', 'ticker_sentiment_score': '0.122269', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ETN', 'relevance_score': '0.385286', 'ticker_sentiment_score': '0.278042', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
302,3 Stocks to Buy Following Guidance Upgrades,https://www.zacks.com/commentary/2271746/3-stocks-to-buy-following-guidance-upgrades,20240509T191900,['Derek Lewis'],"Guidance lifts are among the most positive announcements shareholders can hear, injecting confidence in the long-term picture. And that's precisely what these three companies have recently announced.",https://staticx-tuner.zacks.com/images/articles/main/ad/30383.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '0.999606'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.361941,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.468029', 'ticker_sentiment_score': '0.292248', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ANET', 'relevance_score': '0.397517', 'ticker_sentiment_score': '0.161504', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ETN', 'relevance_score': '0.468029', 'ticker_sentiment_score': '0.306125', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
303,"A Look at Pharma ETFs Post Q1 Earnings - Bristol-Myers Squibb  ( NYSE:BMY ) , First Trust Nasdaq Pharmaceuticals ETF  ( NASDAQ:FTXH ) ",https://www.benzinga.com/news/earnings/24/05/38676365/a-look-at-pharma-etfs-post-q1-earnings,20240509T144107,['Zacks'],"The first-quarter results of the healthcare sector have been unimpressive, with earnings of 78% of the sector participants that have reported so far down 31.2% despite 4.4% revenue growth. The earnings beat ratio of 93.9% and the revenue beat ratio of 75.8% are assuring, though.",https://cdn.benzinga.com/files/images/story/2024/05/07/kenny-eliason-8fdhgan5zg0-unsplash.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999992'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.081562,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.161982', 'ticker_sentiment_score': '0.054951', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.121856', 'ticker_sentiment_score': '0.038677', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.121856', 'ticker_sentiment_score': '-0.002404', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.121856', 'ticker_sentiment_score': '0.060941', 'ticker_sentiment_label': 'Neutral'}]"
304,"This 1 Simple ETF Could Turn $100 a Month Into $93,200",https://www.fool.com/investing/2024/05/09/this-1-simple-etf-could-turn-100-a-month-into-9320/,20240509T071900,['Anders Bylund'],Turn small investments into big returns with this surprisingly simple strategy -- and a hands-off ETF investment for the ages.,https://media.ycharts.com/charts/a45af0a2091db2e17ca3b626bbb34aa2.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}]",0.325681,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.050359', 'ticker_sentiment_score': '0.253903', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
305,Danaher Sees Relative Strength Rating Climb To 71,https://www.investors.com/ibd-data-stories/danaher-sees-relative-strength-rating-climb-to-71/,20240509T070000,"[""Investor's Business Daily"", ""INVESTOR'S BUSINESS DAILY""]","Danaher ( DHR ) had its Relative Strength ( RS ) Rating upgraded from 68 to 71 Thursday - a welcome improvement, but still shy of the 80 or higher score you look for. X IBD's unique rating identifies price performance with a 1 ( worst ) to 99 ( best ) score.",https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}]",0.394743,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.350564', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.179788', 'ticker_sentiment_score': '0.152952', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DHR', 'relevance_score': '0.744196', 'ticker_sentiment_score': '0.478197', 'ticker_sentiment_label': 'Bullish'}]"
306,AstraZeneca ADR Shows Rising Relative Strength; Still Shy Of Key Benchmark,https://www.investors.com/ibd-data-stories/astrazeneca-adr-shows-rising-relative-strength-still-shy-of-key-benchmark/,20240509T070000,"[""Investor's Business Daily"", ""INVESTOR'S BUSINESS DAILY""]",AstraZeneca ADR Shows Rising Relative Strength. Still Shy Of Key Benchmark Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}]",0.389121,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.327366', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.709186', 'ticker_sentiment_score': '0.56029', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'AWON', 'relevance_score': '0.167322', 'ticker_sentiment_score': '0.234011', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
307,This Is What Whales Are Betting On Eli Lilly and Co - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/05/38703781/this-is-what-whales-are-betting-on-eli-lilly-and-co,20240508T144608,['Benzinga Insights'],"Financial giants have made a conspicuous bearish move on Eli Lilly and Co. Our analysis of options history for Eli Lilly and Co LLY revealed 18 unusual trades. Delving into the details, we found 27% of traders were bullish, while 38% showed bearish tendencies.",https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.055419,Neutral,"[{'ticker': 'GS', 'relevance_score': '0.08183', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.782378', 'ticker_sentiment_score': '0.028099', 'ticker_sentiment_label': 'Neutral'}]"
308,Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick,https://www.zacks.com/stock/news/2270578/are-you-a-momentum-investor-this-1-stock-could-be-the-perfect-pick,20240508T135010,['Zacks Equity Research'],"Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",https://staticx-tuner.zacks.com/images/default_article_images/default274.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}]",0.353038,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.390092', 'ticker_sentiment_score': '0.254755', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
309,A Look at Pharma ETFs Post Q1 Earnings,https://www.zacks.com/stock/news/2269782/a-look-at-pharma-etfs-post-q1-earnings,20240507T153000,['Sweta Killa'],"Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.",https://staticx-tuner.zacks.com/images/articles/main/5d/2633.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999989'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.05748,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.156207', 'ticker_sentiment_score': '0.043449', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.117486', 'ticker_sentiment_score': '0.032119', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.078482', 'ticker_sentiment_score': '-0.002079', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.156207', 'ticker_sentiment_score': '0.035777', 'ticker_sentiment_label': 'Neutral'}]"
310,Mutual Funds Scoop Up Amazon And Broadcom,https://www.investors.com/research/mutual-funds-amazon-stock-amzn-avgo/,20240507T120000,"['KIMBERLEY KOENIG', ""Investor's Business Daily""]","Amazon Stock: Mutual Funds Can't Get Enough Of It, Along With Broadcom Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2023/07/Stock-Amazon-doorstep-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.999993'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.999986'}]",0.250445,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.280294', 'ticker_sentiment_score': '0.189443', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GOOG', 'relevance_score': '0.114137', 'ticker_sentiment_score': '-0.094096', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.057215', 'ticker_sentiment_score': '0.238002', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AVGO', 'relevance_score': '0.333257', 'ticker_sentiment_score': '0.232692', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMZN', 'relevance_score': '0.52706', 'ticker_sentiment_score': '0.474748', 'ticker_sentiment_label': 'Bullish'}]"
311,This Is What Whales Are Betting On Eli Lilly and Co - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/05/38647415/this-is-what-whales-are-betting-on-eli-lilly-and-co,20240506T154549,['Benzinga Insights'],"Deep-pocketed investors have adopted a bullish approach towards Eli Lilly and Co LLY, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.142103,Neutral,"[{'ticker': 'GS', 'relevance_score': '0.078099', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.830107', 'ticker_sentiment_score': '0.282235', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
312,Lilly  ( LLY )  Reliance on International Sales: What Investors Need to Know,https://www.zacks.com/stock/news/2268816/lilly-lly-reliance-on-international-sales-what-investors-need-to-know,20240506T131800,['Zacks Equity Research'],Examine the evolution of Lilly's (LLY) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.,https://staticx-tuner.zacks.com/images/default_article_images/default323.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.206461,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.245835', 'ticker_sentiment_score': '0.063722', 'ticker_sentiment_label': 'Neutral'}]"
313,Eli Lilly and Company  ( LLY )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2268511/eli-lilly-and-company-lly-is-a-trending-stock-facts-to-know-before-betting-on-it,20240506T130015,['Zacks Equity Research'],"Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default160.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.203781,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.491255', 'ticker_sentiment_score': '0.135357', 'ticker_sentiment_label': 'Neutral'}]"
314,2 Top Stocks That Could Make You Richer in 2024,https://www.fool.com/investing/2024/05/06/2-top-stocks-that-will-make-you-richer-in-2024/,20240506T081000,['Joe Tenebruso'],Here are a couple of great ideas on where to invest your money today.,https://g.foolcdn.com/editorial/images/775823/investors-gettyimages-1295534838.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.361265,Bullish,"[{'ticker': 'GS', 'relevance_score': '0.058472', 'ticker_sentiment_score': '0.166048', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.230782', 'ticker_sentiment_score': '0.157854', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GOOG', 'relevance_score': '0.286193', 'ticker_sentiment_score': '0.286924', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
315,3 Super-Safe Dividend Stocks That Have Been Making Recurring Payments for 130+ Years,https://www.fool.com/investing/2024/05/05/3-super-safe-dividend-stocks-that-have-been-making/,20240505T184900,['David Jagielski'],These stocks have rock-solid businesses and they have impressive track records for paying dividends.,https://g.foolcdn.com/editorial/images/774677/a-rich-person-counting-money.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.420887,Bullish,"[{'ticker': 'KO', 'relevance_score': '0.244109', 'ticker_sentiment_score': '0.293423', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.359014', 'ticker_sentiment_score': '0.410426', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'TD', 'relevance_score': '0.359014', 'ticker_sentiment_score': '0.439669', 'ticker_sentiment_label': 'Bullish'}]"
316,3 No-Brainer Stocks to Buy in May,https://www.fool.com/investing/2024/05/05/3-no-brainer-stocks-to-buy-in-may/,20240505T105500,"['Keith Speights', 'David Jagielski', 'and Prosper Junior Bakiny']",These great stocks are great picks for investors as spring winds down.,https://g.foolcdn.com/editorial/images/775632/person-pleasantly-surprised-with-laptop.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.961735'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999976'}]",0.30299,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.271489', 'ticker_sentiment_score': '0.364937', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.157227', 'ticker_sentiment_score': '0.036643', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.195814', 'ticker_sentiment_score': '0.039621', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALPN', 'relevance_score': '0.039548', 'ticker_sentiment_score': '-0.014494', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BNXYF', 'relevance_score': '0.039548', 'ticker_sentiment_score': '0.020745', 'ticker_sentiment_label': 'Neutral'}]"
317,"Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making",https://www.fool.com/investing/2024/05/04/move-over-mounjaro-eli-lilly-has-another-blockbust/,20240504T123000,['Adam Spatacco'],"Eli Lilly has made inroads in the red-hot weight-loss market thanks to its diabetes blockbuster, Mounjaro.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F775313%2Fgettyimages-1379960412.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.918141'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.395213,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.618922', 'ticker_sentiment_score': '0.568349', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.173333', 'ticker_sentiment_score': '0.370204', 'ticker_sentiment_label': 'Bullish'}]"
318,How Dividend Investors Can Profit As AI Changes Everything,https://www.forbes.com/sites/michaelfoster/2024/05/04/how-dividend-investors-can-profit--as-ai-changes-everything/,20240504T120000,['Michael Foster'],"If you've been following the AI space lately ( and honestly, who hasn't? ) , you've probably seen stories about tech investors feeling a bit shortchanged on the profits they're getting. That's actually good news for the rest of us-a sign the market is maturing and ripe to be tapped for income.",https://imageio.forbes.com/specials-images/imageserve/60803617d7b099e7fee76763/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds,Forbes,n/a,www.forbes.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.77141'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}]",0.252136,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.043342', 'ticker_sentiment_score': '0.242391', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.129516', 'ticker_sentiment_score': '-0.034987', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.255641', 'ticker_sentiment_score': '0.256317', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.028219', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MA', 'relevance_score': '0.043342', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HON', 'relevance_score': '0.086556', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.086556', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.086556', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.086556', 'ticker_sentiment_score': '-0.030778', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.043342', 'ticker_sentiment_score': '0.204341', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
319,Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?,https://www.fool.com/investing/2024/05/04/eli-lilly-raised-its-outlook-is-the-stock-a-buy-no/,20240504T092600,['Cory Renauer'],"The anti-obesity medication stock is way up, and there could be more fuel in the tank.",https://g.foolcdn.com/editorial/images/775225/investor-dark-room-devices-getty.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.623304'}, {'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.087955,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.567746', 'ticker_sentiment_score': '0.214476', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VKTX', 'relevance_score': '0.062597', 'ticker_sentiment_score': '0.095189', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.062597', 'ticker_sentiment_score': '0.049006', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.124809', 'ticker_sentiment_score': '0.052796', 'ticker_sentiment_label': 'Neutral'}]"
320,Why Amgen Stock Zoomed Nearly 12% Higher Today,https://www.fool.com/investing/2024/05/03/why-amgen-stock-zoomed-nearly-12-higher-today/,20240503T221534,['Eric Volkman'],"The company delivered solid quarterly results, but its discussion of an investigational drug is what really gave its shares a pop.",https://g.foolcdn.com/editorial/images/775812/medical-professional-holding-dollar-sign-paperweight.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.972476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.337486,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.129516', 'ticker_sentiment_score': '0.231231', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMGN', 'relevance_score': '0.585052', 'ticker_sentiment_score': '0.404777', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.129516', 'ticker_sentiment_score': '0.231231', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
321,"Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims - Comfort Systems USA  ( NYSE:FIX ) , AbbVie  ( NYSE:ABBV ) ",https://www.benzinga.com/news/earnings/24/05/38619689/pharma-stock-roundup-lly-nvo-pfe-q1-results-jnjs-new-plan-to-resolve-talc-claims,20240503T200026,['Zacks'],"The first-quarter 2024 earnings season is almost over as far as large drugmakers are concerned. Eli Lilly LLY, Novo Nordisk NVO, Pfizer PFE and AbbVie ABBV announced their first-quarter results this week. J&J JNJ announced a new plan to completely resolve its talc-related lawsuits.",https://cdn.benzinga.com/files/images/story/2024/05/03/christina-victoria-craft-zhys6xn7sue-unsplash.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '0.999919'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.127813,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.27317', 'ticker_sentiment_score': '0.172176', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.206685', 'ticker_sentiment_score': '-0.02327', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.172836', 'ticker_sentiment_score': '0.211201', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.172836', 'ticker_sentiment_score': '-0.086207', 'ticker_sentiment_label': 'Neutral'}]"
322,"Stock Market Rallies On Fed, Jobs Report, Apple: Weekly Review",https://www.investors.com/news/stock-market-rallies-fed-jobs-report-apple/,20240503T171800,"['IBD STAFF', ""Investor's Business Daily""]","The stock market rallied for the week, with Friday's weaker-than-expected jobs report bolstering a relatively dovish Federal Reserve and Fed chief Jerome Powell on Wednesday. The S&P 500 and Nasdaq tested key levels. Apple ( AAPL ) soared on a record buyback and earnings that were better than ...",https://www.investors.com/wp-content/uploads/2018/12/Stock-NYSE-09-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.838487'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.996023'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",0.019613,Neutral,"[{'ticker': 'XPEV', 'relevance_score': '0.041004', 'ticker_sentiment_score': '-0.021579', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WEN', 'relevance_score': '0.041004', 'ticker_sentiment_score': '-0.029769', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.0819', 'ticker_sentiment_score': '0.106072', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.020509', 'ticker_sentiment_score': '-0.027632', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.061473', 'ticker_sentiment_score': '-0.015047', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NBIX', 'relevance_score': '0.041004', 'ticker_sentiment_score': '-0.122221', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.020509', 'ticker_sentiment_score': '-0.013582', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.0819', 'ticker_sentiment_score': '-0.015523', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DASH', 'relevance_score': '0.041004', 'ticker_sentiment_score': '-0.05416', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.061473', 'ticker_sentiment_score': '-0.092699', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DTST', 'relevance_score': '0.020509', 'ticker_sentiment_score': '0.009351', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.102274', 'ticker_sentiment_score': '0.10427', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MA', 'relevance_score': '0.020509', 'ticker_sentiment_score': '-0.059575', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.041004', 'ticker_sentiment_score': '-0.029769', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.102274', 'ticker_sentiment_score': '0.056179', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.102274', 'ticker_sentiment_score': '-0.016434', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SHAK', 'relevance_score': '0.061473', 'ticker_sentiment_score': '-0.030166', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SFM', 'relevance_score': '0.0819', 'ticker_sentiment_score': '0.15427', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TXRH', 'relevance_score': '0.061473', 'ticker_sentiment_score': '-0.030166', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SQ', 'relevance_score': '0.041004', 'ticker_sentiment_score': '-0.028699', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DKNG', 'relevance_score': '0.041004', 'ticker_sentiment_score': '-0.056596', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PYPL', 'relevance_score': '0.041004', 'ticker_sentiment_score': '-0.028699', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WING', 'relevance_score': '0.061473', 'ticker_sentiment_score': '-0.030166', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.0819', 'ticker_sentiment_score': '0.125874', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NXPI', 'relevance_score': '0.041004', 'ticker_sentiment_score': '0.009968', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QSR', 'relevance_score': '0.041004', 'ticker_sentiment_score': '-0.029769', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NIO', 'relevance_score': '0.041004', 'ticker_sentiment_score': '-0.021579', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVNA', 'relevance_score': '0.0819', 'ticker_sentiment_score': '0.058097', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GNRC', 'relevance_score': '0.041004', 'ticker_sentiment_score': '-0.010997', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QRVO', 'relevance_score': '0.061473', 'ticker_sentiment_score': '0.010096', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REGN', 'relevance_score': '0.041004', 'ticker_sentiment_score': '-0.122221', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LI', 'relevance_score': '0.041004', 'ticker_sentiment_score': '-0.021579', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.0819', 'ticker_sentiment_score': '0.087864', 'ticker_sentiment_label': 'Neutral'}]"
323,"Amgen  ( AMGN )  Q1 Earnings Top, Stock Up on Obesity Drug Update",https://www.zacks.com/stock/news/2268117/amgen-amgn-q1-earnings-top-stock-up-on-obesity-drug-update,20240503T154800,['Zacks Equity Research'],"Amgen (AMGN) beats first-quarter 2024 estimates for earnings and sales. Amgen is ""very encouraged"" by interim data from the phase II study on obesity candidate MariTide.",https://staticx-tuner.zacks.com/images/articles/main/f4/2111.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.988787'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.178125,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.08687', 'ticker_sentiment_score': '0.165849', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMGN', 'relevance_score': '0.414559', 'ticker_sentiment_score': '0.15669', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AZN', 'relevance_score': '0.172713', 'ticker_sentiment_score': '0.163419', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.057977', 'ticker_sentiment_score': '0.197001', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
324,"Here's what's driving Friday's stock action in Apple, Coterra and Eli Lilly",https://www.cnbc.com/2024/05/03/heres-whats-driving-fridays-moves-in-apple-coterra-and-eli-lilly.html,20240503T153158,['Morgan Chittum'],"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",https://image.cnbcfm.com/api/v1/image/107374404-1708024054818-gettyimages-2013247027-js2_0524_hk5bxrx4.jpeg?v=1714748643&w=600&h=300&vtcrop=y,CNBC,Earnings,www.cnbc.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.980716'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.242832,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.283323', 'ticker_sentiment_score': '0.216765', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.19117', 'ticker_sentiment_score': '0.160125', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CTRA', 'relevance_score': '0.19117', 'ticker_sentiment_score': '0.160125', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
325,"Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims",https://www.zacks.com/stock/news/2268082/pharma-stock-roundup-lly-nvo-pfe-q1-results-jnjs-new-plan-to-resolve-talc-claims,20240503T152900,['Kinjel Shah'],"Eli Lilly (LLY), Novo Nordisk (NVO), Pfizer (PFE) and AbbVie (ABBV) announce their first-quarter results.",https://staticx-tuner.zacks.com/images/articles/main/39/612.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '0.999919'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.115606,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.267926', 'ticker_sentiment_score': '0.164976', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.202648', 'ticker_sentiment_score': '0.003265', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.169437', 'ticker_sentiment_score': '0.188599', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.169437', 'ticker_sentiment_score': '-0.033654', 'ticker_sentiment_label': 'Neutral'}]"
326,Comparative Study: Eli Lilly and Co And Industry Competitors In Pharmaceuticals Industry - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/news/24/05/38616660/comparative-study-eli-lilly-and-co-and-industry-competitors-in-pharmaceuticals-industry,20240503T150017,['Benzinga Insights'],"In the fast-paced and cutthroat world of business, conducting thorough company analysis is essential for investors and industry experts. In this article, we will undertake a comprehensive industry comparison, evaluating Eli Lilly and Co LLY in comparison to its major competitors within the ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.623304'}]",0.121746,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.472959', 'ticker_sentiment_score': '0.162826', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
327,"Dow Jones Soars 400 Points As Amgen, Apple Surge; Nvidia Jumps Again, Tempts New Buyers",https://www.investors.com/market-trend/stock-market-today/dow-jones-sp500-nasdaq-apple-amgen-aapl-amgn-stock/,20240503T144100,"['KEN SHREVE', ""Investor's Business Daily""]","Stock Market Today: Dow Jones Surges, Led By Amgen, Apple. Nvidia Jumps Above Key Level Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2019/01/stock-bull-20-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.999999'}, {'topic': 'Earnings', 'relevance_score': '0.999981'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}]",0.232682,Somewhat-Bullish,"[{'ticker': 'DKNG', 'relevance_score': '0.170075', 'ticker_sentiment_score': '0.026809', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TOL', 'relevance_score': '0.113866', 'ticker_sentiment_score': '0.319204', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MELI', 'relevance_score': '0.113866', 'ticker_sentiment_score': '0.074693', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.279653', 'ticker_sentiment_score': '0.283304', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CEG', 'relevance_score': '0.113866', 'ticker_sentiment_score': '0.043073', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PHM', 'relevance_score': '0.113866', 'ticker_sentiment_score': '0.238609', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.113866', 'ticker_sentiment_score': '-0.155187', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'EXPE', 'relevance_score': '0.113866', 'ticker_sentiment_score': '-0.088545', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.113866', 'ticker_sentiment_score': '-0.155187', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AMGN', 'relevance_score': '0.170075', 'ticker_sentiment_score': '0.250183', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BKNG', 'relevance_score': '0.113866', 'ticker_sentiment_score': '0.228899', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SQ', 'relevance_score': '0.113866', 'ticker_sentiment_score': '0.140678', 'ticker_sentiment_label': 'Neutral'}]"
328,1 Wall Street Analyst Thinks Eli Lilly Stock Is Going to $892. Is It a Buy?,https://www.fool.com/investing/2024/05/02/1-wall-street-analyst-thinks-eli-lilly-stock-is-go/,20240502T232300,['Eric Volkman'],The company seems to be going from strength to strength lately.,https://g.foolcdn.com/editorial/images/775445/stethescope-atop-us-currency-and-coins.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}]",0.394751,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.42503', 'ticker_sentiment_score': '0.544862', 'ticker_sentiment_label': 'Bullish'}]"
329,Earnings Season: 3 Companies Boosting Guidance,https://www.zacks.com/stock/news/2267373/earnings-season-3-companies-boosting-guidance,20240502T185900,['Derek Lewis'],"Earnings season continues to chug along, with results from many companies already delivered. And concerning positivity, all three of these companies' report fit the criteria, lifting outlooks following the results.",https://staticx-tuner.zacks.com/images/articles/main/8d/57606.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.996023'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.43188,Bullish,"[{'ticker': 'KO', 'relevance_score': '0.504646', 'ticker_sentiment_score': '0.388488', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.504646', 'ticker_sentiment_score': '0.335014', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ETN', 'relevance_score': '0.430088', 'ticker_sentiment_score': '0.273328', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
330,Unpacking the Latest Options Trading Trends in Eli Lilly and Co - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/05/38588563/unpacking-the-latest-options-trading-trends-in-eli-lilly-and-co,20240502T151945,['Benzinga Insights'],"Investors with a lot of money to spend have taken a bullish stance on Eli Lilly and Co LLY. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.142203,Neutral,"[{'ticker': 'GS', 'relevance_score': '0.077094', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.791632', 'ticker_sentiment_score': '0.262814', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
331,"Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition - Catalent  ( NYSE:CTLT ) , Eli Lilly and Co  ( NYSE:LLY ) ",https://www.benzinga.com/markets/equities/24/05/38575293/demand-soars-for-novo-nordisks-weight-loss-drug-wegovy-despite-supply-constraints-and-eli-lilly-,20240502T094844,['Benzinga Neuro'],"Novo Nordisk A/S NVO is witnessing a surge in the number of patients starting on its weight-loss drug, Wegovy, in the U.S. This increase comes despite supply constraints and competition from Eli Lilly & Co. LLY.",https://cdn.benzinga.com/files/images/story/2024/05/02/Ozempic-and-other-drugs-for-weight-loss.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.116438,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.371523', 'ticker_sentiment_score': '0.148545', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTLT', 'relevance_score': '0.15347', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.43852', 'ticker_sentiment_score': '0.162779', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
332,Here's Why Eli Lilly Stock Remains a Screaming Buy,https://www.fool.com/investing/2024/05/02/heres-why-eli-lilly-stock-remains-a-screaming-buy/,20240502T094500,['Keith Speights'],The biggest healthcare company in the world could grow much larger over the next decade.,https://g.foolcdn.com/editorial/images/775234/ozempic.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.146329,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.73822', 'ticker_sentiment_score': '0.188468', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BNXYF', 'relevance_score': '0.059636', 'ticker_sentiment_score': '0.020001', 'ticker_sentiment_label': 'Neutral'}]"
333,Stocks Round-Trip Fed Gains; Carvana Spikes Late,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fed-powell-ai-plays-carvana-skyrockets/,20240501T205400,"['ED CARSON', ""Investor's Business Daily""]",Dow Jones Futures: Stock Market Round-Trips Fed Gains As AI Plays Struggle. Carvana Skyrockets Late Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2019/09/Stock-Carvana-19-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.976671'}]",-0.017032,Neutral,"[{'ticker': 'NVDA', 'relevance_score': '0.18967', 'ticker_sentiment_score': '-0.019555', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.063763', 'ticker_sentiment_score': '-0.139413', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.127119', 'ticker_sentiment_score': '0.100025', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.063763', 'ticker_sentiment_score': '-0.103073', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TMDX', 'relevance_score': '0.063763', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DASH', 'relevance_score': '0.158519', 'ticker_sentiment_score': '-0.232671', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'GRMN', 'relevance_score': '0.063763', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'POWL', 'relevance_score': '0.063763', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.18967', 'ticker_sentiment_score': '0.148562', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.127119', 'ticker_sentiment_score': '-0.078553', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.063763', 'ticker_sentiment_score': '0.061167', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVNA', 'relevance_score': '0.18967', 'ticker_sentiment_score': '0.172327', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PINS', 'relevance_score': '0.063763', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SFM', 'relevance_score': '0.095517', 'ticker_sentiment_score': '-0.010664', 'ticker_sentiment_label': 'Neutral'}]"
334,"Eli Lilly 'On Its Way' To $1 Trillion Market Cap, Analysts Say: It's A 'Have' In A Sea Of 'Have Nots' - Eli Lilly and Co  ( NYSE:LLY ) ",https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38563149/eli-lilly-on-its-way-to-1-trillion-market-cap-analysts-say-its-a-have-in-a-sea-of-h,20240501T192650,['Vandana Singh'],"Eli Lilly And Co LLY ""could be on its way to becoming a $1 trillion market cap company,"" according to analysts at Cantor Fitzgerald. The assessment comes on the heels of an earnings report that shows first-quarter revenue of $8.77 billion.",https://cdn.benzinga.com/files/images/story/2024/05/01/Eli-Lilly.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.818451'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}]",0.273555,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.461699', 'ticker_sentiment_score': '-0.035975', 'ticker_sentiment_label': 'Neutral'}]"
335,"ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook",https://www.zacks.com/stock/news/2266174/etfs-to-buy-as-eli-lilly-beats-q1-earnings-lifts-outlook,20240501T150000,['Sweta Killa'],"Eli Lilly and Company (LLY) raised its outlook for 2024 on rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.938238'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.99998'}]",0.1901,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.368773', 'ticker_sentiment_score': '0.279539', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
336,What's Going With Pfizer Stock On Wednesday? - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/24/05/38554240/pfizer-embraces-direct-to-consumer-model-for-covid-antiviral-says-comirnaty-revenues-continue-to-,20240501T143835,['Vandana Singh'],"On Wednesday, Pfizer Inc. PFE reported first-quarter adjusted EPS of $0.82, down 33% year over year, beating the consensus of $0.54. The company witnesses a significant decrease in Comirnaty and Paxlovid revenues globally and an unfavorable impact of foreign exchange of $107 million, or 1%.",https://cdn.benzinga.com/files/images/story/2024/05/01/Pfizer-shutterstock2.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.214378'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}]",0.04049,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.254751', 'ticker_sentiment_score': '0.013458', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.551622', 'ticker_sentiment_score': '0.149321', 'ticker_sentiment_label': 'Neutral'}]"
337,"Company News for May 1, 2024",https://www.zacks.com/stock/news/2265595/company-news-for-may-1-2024,20240501T092100,['Zacks Equity Research'],"Companies In The News Are: PYPL, LLY, MMM, GLW.",https://staticx-tuner.zacks.com/images/articles/main/84/473.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.990678'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.298007,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.595343', 'ticker_sentiment_score': '0.387675', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'PYPL', 'relevance_score': '0.595343', 'ticker_sentiment_score': '0.417006', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'GLW', 'relevance_score': '0.595343', 'ticker_sentiment_score': '0.662425', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'MMM', 'relevance_score': '0.595343', 'ticker_sentiment_score': '0.156644', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
338,Eli Lilly Joins Rank Of Stocks With 95-Plus Composite Rating,https://www.investors.com/ibd-data-stories/eli-lilly-joins-rank-of-stocks-with-95-plus-composite-rating-3/,20240501T070000,"[""Investor's Business Daily"", ""INVESTOR'S BUSINESS DAILY""]","Eli Lilly ( LLY ) saw an improvement in its IBD SmartSelect Composite Rating Wednesday, from 89 to 98. X The new score means the company is now outperforming 98% of all stocks in terms of the most important fundamental and technical stock-picking criteria.",https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.967645'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}]",0.287598,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.468029', 'ticker_sentiment_score': '-0.122784', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.245339', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
339,These 3 Companies Recently Lifted Guidance,https://www.zacks.com/stock/news/2265464/these-3-companies-recently-lifted-guidance,20240430T215100,['Derek Lewis'],"Guidance lifts are among the most positive announcements shareholders can hear, injecting confidence in the long-term picture.",https://staticx-tuner.zacks.com/images/articles/main/bb/14622.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.459462'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.465555,Bullish,"[{'ticker': 'KO', 'relevance_score': '0.550532', 'ticker_sentiment_score': '0.445362', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.550532', 'ticker_sentiment_score': '0.375157', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ETN', 'relevance_score': '0.47147', 'ticker_sentiment_score': '0.289738', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
340,"Stocks Skid Into Fed; Amazon Rises Late As AMD, Super Micro Fall",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-sp500-skids-into-fed-amazon-amd-super-micro-earnings/,20240430T205600,"['ED CARSON', ""Investor's Business Daily""]","Stocks Skid Into Fed. Amazon Rises Late As AMD, Super Micro Fall Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2018/04/stock-Federal-Reserve-06-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.999336'}]",-0.012142,Neutral,"[{'ticker': 'XPEV', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.269445', 'ticker_sentiment_score': '-0.046731', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.061003', 'ticker_sentiment_score': '-0.082975', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MOD', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WING', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CEG', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRS', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.12165', 'ticker_sentiment_score': '-0.03197', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NBIX', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TMDX', 'relevance_score': '0.12165', 'ticker_sentiment_score': '0.026053', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.15173', 'ticker_sentiment_score': '-0.008112', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MA', 'relevance_score': '0.030524', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NIO', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.211191', 'ticker_sentiment_score': '-0.059555', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.269445', 'ticker_sentiment_score': '0.020248', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GNRC', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PINS', 'relevance_score': '0.091393', 'ticker_sentiment_score': '0.053948', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LI', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.15173', 'ticker_sentiment_score': '0.058426', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.030524', 'ticker_sentiment_score': '-0.350147', 'ticker_sentiment_label': 'Bearish'}]"
341,Stock Market Today: Stocks Sell Off Ahead of Fed Decision,https://www.kiplinger.com/investing/stocks/stock-market-today-stocks-sell-off-ahead-of-fed-decision,20240430T201046,['Karee Venema'],"Stocks opened in negative territory Tuesday, with losses accelerating into the close. Investors were already skittish ahead of tomorrow's Fed decision and this morning's disappointing inflation data did little to calm nerves.",https://cdn.mos.cms.futurecdn.net/hwgJ7osrMtUWhk5koeVme7-320-80.png,Kiplinger,n/a,www.kiplinger.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.838487'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.947132'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.106387,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.196344', 'ticker_sentiment_score': '0.053027', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.131643', 'ticker_sentiment_score': '-0.095216', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.066047', 'ticker_sentiment_score': '-0.077834', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMA', 'relevance_score': '0.066047', 'ticker_sentiment_score': '-0.049372', 'ticker_sentiment_label': 'Neutral'}]"
342,"Americans Swap $5 Burgers For $1,000 Weight Loss Drugs - Is Soda Getting Left Behind Too? Americans Swap $5 Burgers For $1,000 Weight Loss Drugs, Like Ozempic, Wegovy - Is Soda Getting Left Behind Too? - Coca-Cola  ( NYSE:KO ) , Eli Lilly and Co  ( NYSE:LLY ) ",https://www.benzinga.com/general/education/24/04/38532194/americans-swap-5-burgers-for-1-000-weight-loss-drugs-is-soda-getting-left-behind-too,20240430T192236,['Aaron Bry'],"A trio of earnings reports Tuesday morning may have given us a glimpse into how Americans' consumption habits are shifting. Eli Lilly LLY, which makes Mounjaro, one of the leading weight-loss drugs in the United States, beat EPS estimates and also raised its 2024 revenue guidance, sending the ...",https://cdn.benzinga.com/files/images/story/2024/04/30/burger-ai.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.538269'}]",0.042983,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.273807', 'ticker_sentiment_score': '0.184168', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EAT', 'relevance_score': '0.092927', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.359447', 'ticker_sentiment_score': '-0.053341', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.440549', 'ticker_sentiment_score': '-0.11423', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZBRA', 'relevance_score': '0.092927', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
343,"Goldman Scrutinizes Hits, Misses, And Growth Trajectory Concerns For Eli Lilly And Its Its Obesity and Diabetes Drugs - Eli Lilly and Co  ( NYSE:LLY ) ",https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38531968/goldman-scrutinizes-hits-misses-and-growth-trajectory-concerns-for-eli-lilly-and-it,20240430T191132,['Vandana Singh'],"Tuesday, Eli Lilly And Co LLY reported first-quarter revenue of $8.77 billion, up 26% year over year, marginally missing the consensus of $8.92 billion, driven by increases of 16% in volume and 10% due to higher realized prices.",https://cdn.benzinga.com/files/images/story/2024/04/30/January-24--2024--Fort-Worth--Tx--Usa-A-.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.149723,Neutral,"[{'ticker': 'GS', 'relevance_score': '0.47672', 'ticker_sentiment_score': '0.151465', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.534294', 'ticker_sentiment_score': '0.00654', 'ticker_sentiment_label': 'Neutral'}]"
344,"Dexcom Stock Continues To Post Very Healthy Profits, Returns",https://www.investors.com/news/technology/stocks-with-rising-relative-strength-dexcom-2/,20240430T190300,"[""INVESTOR'S BUSINESS DAILY"", 'JAMES DETAR', ""Investor's Business Daily""]","Dexcom Stock Posts Healthy Profits, Returns Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2023/04/Stock-Dexcom-03-company.jpeg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.795202'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.998356'}]",0.314944,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.15347', 'ticker_sentiment_score': '-0.221697', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LFMD', 'relevance_score': '0.15347', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.077094', 'ticker_sentiment_score': '0.174265', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DXCM', 'relevance_score': '0.616228', 'ticker_sentiment_score': '0.404791', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.15347', 'ticker_sentiment_score': '-0.221697', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
345,Eli Lilly  ( LLY )  Q1 2024 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2024/04/30/eli-lilly-lly-q1-2024-earnings-call-transcript/,20240430T183016,['Motley Fool Transcribing'],"LLY earnings call for the period ending March 31, 2024.",https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.986714'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.108179'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.25265,Somewhat-Bullish,"[{'ticker': 'EVR', 'relevance_score': '0.004487', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.004487', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.004487', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.004487', 'ticker_sentiment_score': '0.107168', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.004487', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.004487', 'ticker_sentiment_score': '0.123608', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APG', 'relevance_score': '0.008973', 'ticker_sentiment_score': '0.075414', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.07169', 'ticker_sentiment_score': '0.092739', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.004487', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
346,Eli Lilly's Q1: Another Quarter of Strong Growth,https://www.fool.com/data-news/2024/04/30/eli-lillys-q1-another-quarter-of-strong-growth/,20240430T182456,['JesterAI'],"Eli Lilly's earnings exceeded estimates, powered by significant sales growth despite supply issues.",https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.998962'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.397455,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.428632', 'ticker_sentiment_score': '0.493382', 'ticker_sentiment_label': 'Bullish'}]"
347,"Stocks Dive On Fears Of Hawkish Fed; Treasury Yields Rise, Bitcoin Tumbles To $60,000: What's Driving Markets Tuesday? - Arch Capital Group  ( NASDAQ:ACGL ) ",https://www.benzinga.com/markets/equities/24/04/38529736/stocks-dive-on-fears-of-hawkish-fed-treasury-yields-rise-bitcoin-tumbles-to-60-000-whats-driving,20240430T173513,['Piero Cingari'],"Investor apprehension grips Wall Street with major indices showing midday losses on Tuesday in New York trading, ahead of the Federal Reserve's potentially hawkish pivot in Wednesday's meeting. The S&P 500 retraced 0.9% after a 2-day positive streak, with the tech-heavy Nasdaq 100 slightly ...",https://cdn.benzinga.com/files/images/story/2024/04/30/Man-Markets-Shutterstock.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.928769'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",-0.004925,Neutral,"[{'ticker': 'PYPL', 'relevance_score': '0.134968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TT', 'relevance_score': '0.134968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MPC', 'relevance_score': '0.134968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.134968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.067727', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.067727', 'ticker_sentiment_score': '0.005059', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.134968', 'ticker_sentiment_score': '0.076161', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MMM', 'relevance_score': '0.134968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCD', 'relevance_score': '0.134968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.134968', 'ticker_sentiment_score': '0.006244', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.134968', 'ticker_sentiment_score': '-0.225719', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'GEHC', 'relevance_score': '0.134968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.134968', 'ticker_sentiment_score': '0.298969', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ACGL', 'relevance_score': '0.134968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CCZ', 'relevance_score': '0.067727', 'ticker_sentiment_score': '-0.263389', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'ETN', 'relevance_score': '0.134968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.201244', 'ticker_sentiment_score': '-0.032127', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.134968', 'ticker_sentiment_score': '-0.231721', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
348,IBD Stock Of The Day Pops After Obesity Drug Crushes Sales Views,https://www.investors.com/research/ibd-stock-of-the-day/eli-lilly-stock-eli-lilly-earnings-q1-2024/,20240430T162100,"['ALLISON GATLIN', ""Investor's Business Daily""]",Eli Lilly Stock Surges After Weight-Loss Drug Zepbound Obliterates Sales Views Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2024/04/SOTD-4-30-2024LLY.png,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.99676'}]",0.092769,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.606385', 'ticker_sentiment_score': '0.116572', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.168884', 'ticker_sentiment_score': '-0.056852', 'ticker_sentiment_label': 'Neutral'}]"
349,Eli Lilly Stock Surges on Demand for Weight-Loss Drugs,https://www.kiplinger.com/investing/stocks/eli-lilly-stock-surges-on-demand-for-weight-loss-drugs,20240430T160829,['Joey Solitro'],"Eli Lilly ( LLY ) stock is rallying more than 5% in Thursday's session after the pharmaceutical giant reported strong first-quarter earnings results and raised its full-year outlook. In the three months ended March 31, Eli Lilly's revenue increased 26% from the year-ago period to $8.8 billion.",https://cdn.mos.cms.futurecdn.net/hwgJ7osrMtUWhk5koeVme7-320-80.png,Kiplinger,n/a,www.kiplinger.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}, {'topic': 'Earnings', 'relevance_score': '0.99992'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.401504,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.504646', 'ticker_sentiment_score': '0.565374', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SPGI', 'relevance_score': '0.108466', 'ticker_sentiment_score': '0.246579', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MORN', 'relevance_score': '0.108466', 'ticker_sentiment_score': '0.129822', 'ticker_sentiment_label': 'Neutral'}]"
350,Incyte's  ( INCY )  Q1 Earnings & Revenues Fall Shy of Estimates,https://www.zacks.com/stock/news/2265278/incytes-incy-q1-earnings-revenues-fall-shy-of-estimates,20240430T155000,['Zacks Equity Research'],"Incyte's (INCY) first-quarter 2024 earnings and revenues miss estimates. The company maintains 2024 revenue guidance for its lead drug, Jakafi.",https://staticx-tuner.zacks.com/images/articles/main/37/2337.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.076129,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.19117', 'ticker_sentiment_score': '0.053955', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INCY', 'relevance_score': '0.63573', 'ticker_sentiment_score': '0.098365', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MOR', 'relevance_score': '0.04823', 'ticker_sentiment_score': '0.21489', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SNDX', 'relevance_score': '0.096283', 'ticker_sentiment_score': '0.034242', 'ticker_sentiment_label': 'Neutral'}]"
351,"Eli Lilly  ( LLY )  Q1 Earnings Top, Sales Miss, 2024 View Raised",https://www.zacks.com/stock/news/2265271/eli-lilly-lly-q1-earnings-top-sales-miss-2024-view-raised,20240430T154500,['Zacks Equity Research'],Eli Lilly (LLY) beats first-quarter estimates for earnings but misses the same for sales. It raises its guidance for 2024 on strong demand for Mounjaro and Zepbound.,https://staticx-tuner.zacks.com/images/articles/main/62/5473.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.998917'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}]",0.194861,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.394494', 'ticker_sentiment_score': '0.238953', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ANIP', 'relevance_score': '0.170395', 'ticker_sentiment_score': '0.239558', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LGND', 'relevance_score': '0.203786', 'ticker_sentiment_score': '0.235123', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.102741', 'ticker_sentiment_score': '0.199248', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
352,Why Eli Lilly Stock Is Jumping Today,https://www.fool.com/investing/2024/04/30/why-eli-lilly-stock-is-jumping-today/,20240430T152600,['Keith Speights'],Investors are cheering the big-pharma company's improved outlook.,https://g.foolcdn.com/editorial/images/775011/scientist-in-lab-young-african-american-female.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.37527,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.893234', 'ticker_sentiment_score': '0.584559', 'ticker_sentiment_label': 'Bullish'}]"
353,"FOMC Meeting Samsung Over Takes Apple, AI Demand Indication Ahead From AMD, Amazon And Super Micro - iShares 20+ Year Treasury Bond ETF  ( NASDAQ:TLT ) ",https://www.benzinga.com/markets/24/04/38524946/fomc-meeting-samsung-over-takes-apple-ai-demand-indication-ahead-from-amd-amazon-and-super-micro,20240430T151941,['The Arora Report'],"To gain an edge, this is what you need to know today. Please click here for an enlarged chart of 20+ year iShares 20+ Year Treasury Bond ETF TLT. Samsung has quadrupled its net profit due to demand from artificial intelligence. Its high bandwidth memory is flying off the shelves.",https://cdn.benzinga.com/files/nicholas-cappello-wb63zqj5gne-unsplash_4_4.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.999993'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.795202'}]",0.225713,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.097655', 'ticker_sentiment_score': '-0.189753', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'SSNLF', 'relevance_score': '0.048919', 'ticker_sentiment_score': '0.141855', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.097655', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.097655', 'ticker_sentiment_score': '-0.189753', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NVDA', 'relevance_score': '0.097655', 'ticker_sentiment_score': '-0.189753', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSLA', 'relevance_score': '0.097655', 'ticker_sentiment_score': '-0.189753', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NXPI', 'relevance_score': '0.193852', 'ticker_sentiment_score': '0.099572', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.2872', 'ticker_sentiment_score': '0.161094', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'IVZ', 'relevance_score': '0.048919', 'ticker_sentiment_score': '0.099131', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.097655', 'ticker_sentiment_score': '0.045358', 'ticker_sentiment_label': 'Neutral'}]"
354,"Eli Lilly Increases FY24 Outlook, Joins Brinker International, Zebra Technologies, 3M And Other Big Stocks Moving Higher On Tuesday - Eli Lilly and Co  ( NYSE:LLY ) , Brinker International  ( NYSE:EAT ) , 3M  ( NYSE:MMM ) , Zebra Technologies  ( NASDAQ:ZBRA ) ",https://www.benzinga.com/news/24/04/38523584/eli-lilly-increases-fy24-outlook-joins-brinker-international-zebra-technologies-3m-and-other-big-sto,20240430T145337,['Avi Kapoor'],"U.S. stocks were lower, with the Dow Jones index falling over 100 points on Tuesday. Shares of Eli Lilly and Company LLY rose sharply during Tuesday's session after the company raised its FY24 revenue guidance.",https://cdn.benzinga.com/files/images/story/2024/04/30/Eli-Lilly.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",0.431723,Bullish,"[{'ticker': 'TT', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.254038', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ST', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.146324', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WGS', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.372572', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'CVLT', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.347874', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WWD', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.280282', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ETWO', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.522657', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NXPI', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.340795', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LXU', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.319501', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MMM', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.199011', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMKR', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.421524', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ACIW', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.444589', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'HLIT', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'THC', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.539271', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'CLW', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.395963', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'GLW', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.366704', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ATI', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.298135', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.38489', 'ticker_sentiment_score': '0.07759', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EAT', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.296946', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TREE', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.327791', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TKR', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.298135', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ZBRA', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.451474', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BLND', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.112839', 'ticker_sentiment_label': 'Neutral'}]"
355,Earnings Data Deluge,https://www.zacks.com/stock/news/2265192/earnings-data-deluge,20240430T144800,['Zacks Equity Research'],"Pre-market indices are in a giving mood. Specifically, the Dow is selling off -175 points at the hour, the S&P 500 is -21 and the Nasdaq is -78 points. Today we close out April, is likely to be the first negative month since October of last year.",https://staticx-tuner.zacks.com/images/articles/main/a5/1022.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.983605'}]",0.1322,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.143415', 'ticker_sentiment_score': '0.278867', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KO', 'relevance_score': '0.143415', 'ticker_sentiment_score': '0.146037', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.072', 'ticker_sentiment_score': '-0.082631', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.143415', 'ticker_sentiment_score': '0.023661', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.143415', 'ticker_sentiment_score': '0.023661', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.143415', 'ticker_sentiment_score': '0.023661', 'ticker_sentiment_label': 'Neutral'}]"
356,Stocks Retreat As Lilly Pops and Tesla Drops,https://www.investors.com/market-trend/stock-market-today/dow-jones-sp500-nasdaq-tesla-eli-lilly-stock/,20240430T144400,"['KIMBERLEY KOENIG', ""Investor's Business Daily""]",Stock Market Today: Dow Jones Sinks While Tesla Retreats Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/07/Stock-Tesla-RedSilo-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.999919'}]",0.035915,Neutral,"[{'ticker': 'MSTR', 'relevance_score': '0.097457', 'ticker_sentiment_score': '-0.19499', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'SOLV', 'relevance_score': '0.097457', 'ticker_sentiment_score': '0.255927', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.04882', 'ticker_sentiment_score': '0.237087', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.14573', 'ticker_sentiment_score': '0.021508', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.097457', 'ticker_sentiment_score': '0.120423', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.04882', 'ticker_sentiment_score': '-0.020013', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NXPI', 'relevance_score': '0.097457', 'ticker_sentiment_score': '0.127471', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.28664', 'ticker_sentiment_score': '-0.023115', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RMBS', 'relevance_score': '0.097457', 'ticker_sentiment_score': '0.031199', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.04882', 'ticker_sentiment_score': '-0.064021', 'ticker_sentiment_label': 'Neutral'}]"
357,Pre-Markets Sell on Last Trading Day of April,https://www.zacks.com/stock/news/2265160/pre-markets-sell-on-last-trading-day-of-april,20240430T141700,['Mark Vickery'],Today we close out a month that's likely to be the first negative one since October of last year.,https://staticx-tuner.zacks.com/images/articles/main/2d/65907.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.9973'}]",0.127345,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.136499', 'ticker_sentiment_score': '0.14304', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.136499', 'ticker_sentiment_score': '0.14304', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.068502', 'ticker_sentiment_score': '0.027355', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.136499', 'ticker_sentiment_score': '0.023021', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.136499', 'ticker_sentiment_score': '0.023021', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.136499', 'ticker_sentiment_score': '0.023021', 'ticker_sentiment_label': 'Neutral'}]"
358,Why Is Eli Lilly Stock Trading Higher On Tuesday? - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/general/biotech/24/04/38521126/eli-lillys-weight-loss-drug-still-going-strong-boosts-annual-forecast,20240430T134107,['Vandana Singh'],"Tuesday, Eli Lilly And Co LLY reported first-quarter revenue of $8.77 billion, up 26% year over year, marginally missing the consensus of $8.92 billion, driven by increases of 16% in volume and 10% due to higher realized prices.",https://cdn.benzinga.com/files/images/story/2024/04/30/mounjaro-medication-for-weight-loss.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.266143'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.263761,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.510588', 'ticker_sentiment_score': '0.041802', 'ticker_sentiment_label': 'Neutral'}]"
359,Eli Lilly  ( LLY )  Tops Q1 Earnings Estimates,https://www.zacks.com/stock/news/2264689/eli-lilly-lly-tops-q1-earnings-estimates,20240430T115505,['Zacks Equity Research'],"Lilly (LLY) delivered earnings and revenue surprises of 1.98% and 0.47%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?",https://staticx-tuner.zacks.com/images/default_article_images/default97.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999997'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.155276,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.40348', 'ticker_sentiment_score': '0.181105', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.140076', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
360,"Eli Lilly Jumps On Strong Earnings, Guidance As Zepbound Sales Beat",https://www.investors.com/news/technology/eli-lilly-stock-eli-lilly-earnings-q1-2024/,20240430T114400,"[""Investor's Business Daily"", 'ALLISON GATLIN']","Eli Lilly ( LLY ) jumped early Tuesday after the pharma behemoth reported adjusted earnings of $2.58 per share on $8.77 billion in first-quarter sales. On average, analysts polled by FactSet expected Lilly to earn $2.47 per share on $8.94 billion in sales.",https://www.investors.com/wp-content/uploads/2018/12/stock-Eli-Lilly-02-Shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}]",0.120265,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.619618', 'ticker_sentiment_score': '0.228673', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.401331', 'ticker_sentiment_score': '-0.144057', 'ticker_sentiment_label': 'Neutral'}]"
361,"S&P 500, Nasdaq Set To Open Lower Ahead Of Fed Decision: What's Dragging Stock Futures? - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/24/04/38514380/wall-street-on-edge-ahead-of-fed-decision-spotlight-falls-on-amazon-and-amd-earnings-analyst-says-s,20240430T105722,['Shanthi Rexaline'],"U.S. stocks appear to be on the back foot early on Tuesday, with index futures trading modestly lower in early pre-market activity. Caution reigns supreme as traders anxiously await the Federal Reserve's interest rate decision on Wednesday.",https://cdn.benzinga.com/files/images/story/2024/04/30/Wall-Street-illustration.png?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.769861'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.682689'}]",0.028952,Neutral,"[{'ticker': 'MSTR', 'relevance_score': '0.088472', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PYPL', 'relevance_score': '0.088472', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ST', 'relevance_score': '0.088472', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TAP', 'relevance_score': '0.088472', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.088472', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LSCC', 'relevance_score': '0.088472', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.044304', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADM', 'relevance_score': '0.088472', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RMBS', 'relevance_score': '0.088472', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MMM', 'relevance_score': '0.088472', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FFIV', 'relevance_score': '0.088472', 'ticker_sentiment_score': '-0.222081', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'THC', 'relevance_score': '0.088472', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCD', 'relevance_score': '0.088472', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.132368', 'ticker_sentiment_score': '0.148054', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GEHC', 'relevance_score': '0.088472', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.088472', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'YUMC', 'relevance_score': '0.088472', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WT', 'relevance_score': '0.044304', 'ticker_sentiment_score': '-0.147805', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:JPY', 'relevance_score': '0.044304', 'ticker_sentiment_score': '-0.11699', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.088472', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
362,"Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum",https://www.prnewswire.com/news-releases/lilly-reports-first-quarter-2024-financial-results-and-raises-full-year-revenue-guidance-by-2-billion-highlights-pipeline-momentum-302130768.html,20240430T104500,['Eli Lilly and Company'],"Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights ... PR ...",https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.99676'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.266143'}]",0.191572,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.363663', 'ticker_sentiment_score': '0.197735', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CURN', 'relevance_score': '0.013008', 'ticker_sentiment_score': '-0.012355', 'ticker_sentiment_label': 'Neutral'}]"
363,"Markets Up on Tesla, Q1 Earnings; Q1 Beats After the Bell",https://www.zacks.com/stock/news/2264549/markets-up-on-tesla-q1-earnings-q1-beats-after-the-bell,20240429T221000,['Mark Vickery'],"It's now the third straight day higher going back to Thursday of last week, and recovered from a quick drop into the red.",https://staticx-tuner.zacks.com/images/articles/main/ce/2151.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.838487'}]",0.226322,Somewhat-Bullish,"[{'ticker': 'TSLA', 'relevance_score': '0.204072', 'ticker_sentiment_score': '0.345756', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KO', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.058859', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.068698', 'ticker_sentiment_score': '0.049127', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.058859', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PARA', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.092489', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.058859', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'YUMC', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.074551', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.058859', 'ticker_sentiment_label': 'Neutral'}]"
364,Should You Invest in Novo Nordisk  ( NVO )  Ahead of Q1 Earnings?,https://www.zacks.com/stock/news/2264446/should-you-invest-in-novo-nordisk-nvo-ahead-of-q1-earnings,20240429T173300,['Zacks Equity Research'],"Novo Nordisk's (NVO) revenues in the first quarter of 2024 are expected to have been driven by its diabetes and obesity care product sales, especially Ozempic, Rybelsus and Wegovy.",https://staticx-tuner.zacks.com/images/articles/main/de/2471.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.967321'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.319288,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.073773', 'ticker_sentiment_score': '0.19049', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'OMGA', 'relevance_score': '0.146916', 'ticker_sentiment_score': '0.201017', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CTLT', 'relevance_score': '0.073773', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.541149', 'ticker_sentiment_score': '0.315963', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
365,How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q1 Earnings Report - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/news/earnings/24/04/38488543/how-to-earn-500-a-month-from-eli-lilly-stock-ahead-of-q1-earnings-report,20240429T123214,['Avi Kapoor'],"Eli Lilly and Company LLY is set to report first-quarter earnings on Tuesday, April 30. Analysts expect the Indianapolis, Indiana-based company's quarterly earnings to be $2.46 per share, up from $1.62 per share in the year-ago period.",https://cdn.benzinga.com/files/images/story/2024/04/29/Eli-Lilly.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.723405'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}]",0.180433,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.617765', 'ticker_sentiment_score': '0.394508', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'DMPZF', 'relevance_score': '0.115787', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'YUMC', 'relevance_score': '0.115787', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DPZ', 'relevance_score': '0.115787', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
366,"Futures Rise After Market Roars, But Watch For This",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-nvidia-leads-new-buys-tesla-stock-runs-elon-musk/,20240429T092900,"[""Investor's Business Daily"", 'ED CARSON']",Dow Jones Futures Rise: Nvidia Leads New Buys. Tesla Runs Past Resistance On Elon Musk Move Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/02/Stock-lion-closeup-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'IPO', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.928139'}]",0.160587,Somewhat-Bullish,"[{'ticker': 'KLAC', 'relevance_score': '0.141448', 'ticker_sentiment_score': '0.050601', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APP', 'relevance_score': '0.094576', 'ticker_sentiment_score': '0.025368', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.023696', 'ticker_sentiment_score': '0.135094', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.047371', 'ticker_sentiment_score': '-0.206972', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NVDA', 'relevance_score': '0.233556', 'ticker_sentiment_score': '-0.042152', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.071005', 'ticker_sentiment_score': '0.078751', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.164709', 'ticker_sentiment_score': '-0.050732', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WING', 'relevance_score': '0.071005', 'ticker_sentiment_score': '0.048207', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.118064', 'ticker_sentiment_score': '0.131418', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.071005', 'ticker_sentiment_score': '0.170137', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FRBA', 'relevance_score': '0.023696', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUBB', 'relevance_score': '0.094576', 'ticker_sentiment_score': '0.050161', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.047371', 'ticker_sentiment_score': '0.146646', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALAB', 'relevance_score': '0.118064', 'ticker_sentiment_score': '0.011358', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.118064', 'ticker_sentiment_score': '0.1589', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CAVA', 'relevance_score': '0.047371', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FULT', 'relevance_score': '0.023696', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.118064', 'ticker_sentiment_score': '0.15391', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.164709', 'ticker_sentiment_score': '0.172093', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GNRC', 'relevance_score': '0.071005', 'ticker_sentiment_score': '0.048207', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ERJ', 'relevance_score': '0.047371', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TXRH', 'relevance_score': '0.071005', 'ticker_sentiment_score': '0.048207', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.071005', 'ticker_sentiment_score': '0.170137', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
367,Nasdaq Bull Market: Here's the Best Investing Move You Can Make Right Now,https://www.fool.com/investing/2024/04/29/nasdaq-bull-market-best-investing-move/,20240429T091000,['Adria Cimino'],"Many technology stocks are soaring, and you may be wondering if they've gotten too expensive.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F774545%2Fgettyimages-bull-market.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.98396'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}]",0.345083,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.137671', 'ticker_sentiment_score': '0.364908', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.046095', 'ticker_sentiment_score': '0.024957', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.046095', 'ticker_sentiment_score': '0.132371', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.137671', 'ticker_sentiment_score': '0.044763', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.046095', 'ticker_sentiment_score': '0.024957', 'ticker_sentiment_label': 'Neutral'}]"
368,Eli Lilly Just Announced More Good News: Time to Buy?,https://www.fool.com/investing/2024/04/28/eli-lilly-just-announced-more-good-news-time-to-bu/,20240428T171700,['Prosper Junior Bakiny'],There's no stopping this high-flying biotech.,https://g.foolcdn.com/editorial/images/774345/physician-talking-to-patient.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.858979'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.187399,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.574608', 'ticker_sentiment_score': '0.293327', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
369,Earnings And Artificial Intelligence Save Stocks Despite Inflation,https://www.forbes.com/sites/bill_stone/2024/04/28/earnings-and-artificial-intelligence-save-stocks-despite-inflation/,20240428T110000,['Bill Stone'],"The pace of earnings picked up steam last week, with 159 S&P 500 companies reporting, and will be followed by the busiest week with 175 scheduled to report. After the relative drag from bank and healthcare earnings over the previous weeks, the more diversified company mix boosted earnings ...",https://imageio.forbes.com/specials-images/imageserve/662d107592feda028773740a/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds,Forbes,n/a,www.forbes.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.928139'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.999992'}]",0.111837,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.195419', 'ticker_sentiment_score': '0.094901', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.289462', 'ticker_sentiment_score': '0.177081', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.098456', 'ticker_sentiment_score': '0.084905', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.24289', 'ticker_sentiment_score': '0.024787', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.098456', 'ticker_sentiment_score': '0.084905', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.098456', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.049322', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.098456', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.049322', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.098456', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.147216', 'ticker_sentiment_score': '0.141706', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.098456', 'ticker_sentiment_score': '0.118021', 'ticker_sentiment_label': 'Neutral'}]"
370,"Forget Nvidia, These Unstoppable Stocks Are Better Buys",https://www.fool.com/investing/2024/04/27/forget-nvidia-these-unstoppable-stocks-are-better/,20240427T151000,['David Jagielski'],"These stocks have tremendous potential, and it doesn't depend on the growth prospects for artificial intelligence.",https://g.foolcdn.com/editorial/images/773650/a-couple-meeting-with-an-advisor.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.997405'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.818451'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.257992,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.33514', 'ticker_sentiment_score': '0.300605', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.086245', 'ticker_sentiment_score': '0.137289', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMED', 'relevance_score': '0.043186', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.295358', 'ticker_sentiment_score': '0.270426', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.254751', 'ticker_sentiment_score': '0.189594', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
371,1 Unstoppable Pharmaceutical Stock Investors Shouldn't Sleep On,https://www.fool.com/investing/2024/04/27/1-unstoppable-pharmaceutical-stock-investors/,20240427T131500,['Adam Spatacco'],"Eli Lilly may be on the verge of another breakthrough, thanks to its hit GLP-1 medications.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F773981%2Fgettyimages-170619155.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.202672,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.507932', 'ticker_sentiment_score': '0.43694', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.181137', 'ticker_sentiment_score': '0.068321', 'ticker_sentiment_label': 'Neutral'}]"
372,3 Dividend Stocks to Buy and Hold for the Next Decade,https://www.fool.com/investing/2024/04/27/3-dividend-stocks-to-buy-and-hold-for-the-next-dec/,20240427T111500,"['Keith Speights', 'and Prosper Junior Bakiny', 'David Jagielski']",You'll get dividends and more with these great stocks.,https://g.foolcdn.com/editorial/images/774374/light-bulbs-with-dollar-sign-person-looking-up.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.998962'}, {'topic': 'Earnings', 'relevance_score': '0.94762'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.273184,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.396888', 'ticker_sentiment_score': '0.293766', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.360171', 'ticker_sentiment_score': '0.156442', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABT', 'relevance_score': '0.041466', 'ticker_sentiment_score': '0.176676', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FCAP', 'relevance_score': '0.041466', 'ticker_sentiment_score': '0.086608', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.284106', 'ticker_sentiment_score': '0.173062', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
373,"Jim Cramer Weighs In Ahead Of Apple, Amazon, Eli Lilly Earnings: 'We Have To Run Such A Ridiculous Gauntlet Next Week' - Apple  ( NASDAQ:AAPL ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/general/market-summary/24/04/38474759/jim-cramer-weighs-in-ahead-of-apple-amazon-eli-lilly-earnings-we-have-to-run-such-a-ridicu,20240427T023316,['Ananya Gairola'],"Jim Cramer, the host of CNBC's ""Mad Money,"" has outlined the key events that investors should keep an eye on in the upcoming week. What Happened: Cramer highlighted the significant events scheduled for the week, including earnings reports from Apple Inc. AAPL, Amazon.com Inc.",https://cdn.benzinga.com/files/images/story/2024/04/26/Photo-Courtesy-of-Scott-Beale-on-Flickr.jpeg?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}]",0.074813,Neutral,"[{'ticker': 'CVS', 'relevance_score': '0.096671', 'ticker_sentiment_score': '0.056746', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.191929', 'ticker_sentiment_score': '-0.004983', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.096671', 'ticker_sentiment_score': '0.138544', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.28442', 'ticker_sentiment_score': '0.211366', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WING', 'relevance_score': '0.096671', 'ticker_sentiment_score': '0.056746', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.096671', 'ticker_sentiment_score': '0.056746', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.096671', 'ticker_sentiment_score': '0.056746', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DPZ', 'relevance_score': '0.096671', 'ticker_sentiment_score': '0.056746', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.191929', 'ticker_sentiment_score': '-0.004983', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DMPZF', 'relevance_score': '0.096671', 'ticker_sentiment_score': '0.056746', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.096671', 'ticker_sentiment_score': '-0.176479', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'SBUX', 'relevance_score': '0.096671', 'ticker_sentiment_score': '0.056746', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.28442', 'ticker_sentiment_score': '0.116715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.191929', 'ticker_sentiment_score': '0.085316', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.096671', 'ticker_sentiment_score': '-0.176479', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
374,"Apple, Amazon, Big Pharma And The Fed: Investing Action Plan",https://www.investors.com/research/investing-action-plan/stock-market-apple-amazon-big-pharma-the-fed/,20240426T221700,"['ALAN R. ELLIOTT', ""Investor's Business Daily""]","A Big Week For The Stock Market: Apple, Amazon, Big Pharma And The Fed Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2024/01/Stock-FedBldg-flag-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.999606'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",0.189522,Somewhat-Bullish,"[{'ticker': 'AAPL', 'relevance_score': '0.270149', 'ticker_sentiment_score': '0.056371', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.03443', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.068797', 'ticker_sentiment_score': '0.040372', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DDOG', 'relevance_score': '0.103035', 'ticker_sentiment_score': '0.122123', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.03443', 'ticker_sentiment_score': '0.151018', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMGN', 'relevance_score': '0.170878', 'ticker_sentiment_score': '0.032061', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.170878', 'ticker_sentiment_score': '0.043458', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DPZ', 'relevance_score': '0.068797', 'ticker_sentiment_score': '0.326415', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MA', 'relevance_score': '0.03443', 'ticker_sentiment_score': '0.10474', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.068797', 'ticker_sentiment_score': '0.104639', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.103035', 'ticker_sentiment_score': '0.123387', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.103035', 'ticker_sentiment_score': '0.043751', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DELL', 'relevance_score': '0.068797', 'ticker_sentiment_score': '0.113638', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SQ', 'relevance_score': '0.068797', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PYPL', 'relevance_score': '0.137083', 'ticker_sentiment_score': '0.109307', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.068797', 'ticker_sentiment_score': '0.067624', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.103035', 'ticker_sentiment_score': '0.122123', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.103035', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.068797', 'ticker_sentiment_score': '0.044114', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CCJ', 'relevance_score': '0.103035', 'ticker_sentiment_score': '0.122123', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DMPZF', 'relevance_score': '0.03443', 'ticker_sentiment_score': '0.316853', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EBAY', 'relevance_score': '0.137083', 'ticker_sentiment_score': '0.109307', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ETSY', 'relevance_score': '0.103035', 'ticker_sentiment_score': '0.096925', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.103035', 'ticker_sentiment_score': '0.049741', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.103035', 'ticker_sentiment_score': '0.122123', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.03443', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
375,Nvidia Leads 7 Stocks Flashing Buy Signals; As Market Roars Back,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-nvidia-new-buys-market-roars-fed-apple-super-micro/,20240426T212000,"['ED CARSON', ""Investor's Business Daily""]","Dow Jones Futures: Nvidia Leads 7 New Buys As Market Roars. Fed, Apple, Super Micro Loom Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2023/02/Stock-lion-closeup-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'IPO', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.928139'}]",0.155746,Somewhat-Bullish,"[{'ticker': 'KLAC', 'relevance_score': '0.149656', 'ticker_sentiment_score': '0.05357', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APP', 'relevance_score': '0.100099', 'ticker_sentiment_score': '0.02576', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.025087', 'ticker_sentiment_score': '0.136081', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.050148', 'ticker_sentiment_score': '-0.207017', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NVDA', 'relevance_score': '0.270591', 'ticker_sentiment_score': '-0.043192', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.075161', 'ticker_sentiment_score': '0.074084', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.174227', 'ticker_sentiment_score': '-0.052775', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WING', 'relevance_score': '0.075161', 'ticker_sentiment_score': '0.047399', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.124939', 'ticker_sentiment_score': '0.133604', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.075161', 'ticker_sentiment_score': '0.168945', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HUBB', 'relevance_score': '0.100099', 'ticker_sentiment_score': '0.049818', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.050148', 'ticker_sentiment_score': '0.147231', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALAB', 'relevance_score': '0.124939', 'ticker_sentiment_score': '0.011649', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAVA', 'relevance_score': '0.050148', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.124939', 'ticker_sentiment_score': '0.15066', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.174227', 'ticker_sentiment_score': '0.178736', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GNRC', 'relevance_score': '0.075161', 'ticker_sentiment_score': '0.047399', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ERJ', 'relevance_score': '0.050148', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TXRH', 'relevance_score': '0.075161', 'ticker_sentiment_score': '0.047399', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.075161', 'ticker_sentiment_score': '0.168945', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
376,"Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates",https://www.zacks.com/stock/news/2263464/pharma-stock-roundup-mrk-sny-azn-nvs-q1-results-pipeline-regulatory-updates,20240426T153400,['Kinjel Shah'],"Merck (MRK), Sanofi (SNY), Novartis (NVS) and AstraZeneca (AZN) announce their first-quarter results.",https://staticx-tuner.zacks.com/images/articles/main/96/702.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999953'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.158632,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.104835', 'ticker_sentiment_score': '0.014231', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.207868', 'ticker_sentiment_score': '0.026596', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.070002', 'ticker_sentiment_score': '-0.068262', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.070002', 'ticker_sentiment_score': '-0.068262', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.139467', 'ticker_sentiment_score': '0.024867', 'ticker_sentiment_label': 'Neutral'}]"
377,CPAP Stock Rockets As Quarterly Report Wipes Out Weight-Loss Woes,https://www.investors.com/news/technology/resmed-stock-resmed-earnings-q1-2024-cpaps-weight-loss-drugs/,20240426T140000,"[""Investor's Business Daily"", 'ALLISON GATLIN']",ResMed Stock Hits 8-Month High After Quarterly Beat Wipes Out Weight-Loss Drug Woes Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2024/04/Stock-Resmed-bldg-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.977154'}]",0.234376,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.174587', 'ticker_sentiment_score': '0.038661', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RMD', 'relevance_score': '0.729947', 'ticker_sentiment_score': '0.392607', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.087824', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
378,A 3x Expected Rise In Mounjaro Sales Is Likely To Drive Eli Lilly's Q1,https://www.forbes.com/sites/greatspeculations/2024/04/26/a-3x-expected-rise-in-mounjaro-sales-is-likely-to-drive-eli-lillys-q1/,20240426T130042,['Trefis Team'],"Eli Lilly stock ( NYSE: LLY ) will report its Q1 results on Tuesday, April 30. The pharmaceutical giant is expected to garner $8.9 billion in sales and $2.46 in adjusted earnings per share, per the consensus estimates. All eyes will be on Eli Lilly's diabetes drug - Mounjaro - and its weight-loss ...",https://imageio.forbes.com/specials-images/imageserve/662b6a87b3af139422324bac/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds,Forbes,n/a,www.forbes.com,"[{'topic': 'Earnings', 'relevance_score': '0.980509'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.254501,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.64741', 'ticker_sentiment_score': '0.414163', 'ticker_sentiment_label': 'Bullish'}]"
379,GSK ADR Trying To Close In On Key Technical Measure,https://www.investors.com/ibd-data-stories/gsk-adr-trying-to-close-in-on-key-technical-measure-2/,20240426T070000,"[""INVESTOR'S BUSINESS DAILY"", ""Investor's Business Daily""]","GSK ADR ( GSK ) saw a positive improvement to its Relative Strength ( RS ) Rating on Friday, rising from 68 to 72. X This exclusive rating from Investor's Business Daily tracks market leadership with a 1 ( worst ) to 99 ( best ) score.",https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}]",0.238383,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.338582', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.338582', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
380,Gear Up for Lilly  ( LLY )  Q1 Earnings: Wall Street Estimates for Key Metrics,https://www.zacks.com/stock/news/2262065/gear-up-for-lilly-lly-q1-earnings-wall-street-estimates-for-key-metrics,20240425T131526,['Zacks Equity Research'],"Besides Wall Street's top -and-bottom-line estimates for Lilly (LLY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.",https://staticx-tuner.zacks.com/images/default_article_images/default329.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.947132'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.142583,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.346642', 'ticker_sentiment_score': '0.204806', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
381,"Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie",https://www.zacks.com/stock/news/2262167/zacks-industry-outlook-highlights-eli-lilly-novo-nordisk-merck-and-abbvie,20240425T123300,['Zacks Equity Research'],"Eli Lilly, Novo Nordisk, Merck and AbbVie are part of the Zacks Industry Outlook article.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999701'}, {'topic': 'Earnings', 'relevance_score': '0.998947'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.9545'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.219201,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.128937', 'ticker_sentiment_score': '0.112011', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.021581', 'ticker_sentiment_score': '0.010009', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.171333', 'ticker_sentiment_score': '0.209828', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CTLT', 'relevance_score': '0.021581', 'ticker_sentiment_score': '0.061809', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.150189', 'ticker_sentiment_score': '0.150982', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ALPN', 'relevance_score': '0.021581', 'ticker_sentiment_score': '0.061809', 'ticker_sentiment_label': 'Neutral'}]"
382,Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?,https://www.zacks.com/stock/news/2261491/will-healthcare-etfs-lose-momentum-as-q1-earnings-unfold,20240424T160500,['Sweta Killa'],"While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.",https://staticx-tuner.zacks.com/images/articles/main/b3/30471.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.988915'}]",0.094139,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.234119', 'ticker_sentiment_score': '0.030354', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.176717', 'ticker_sentiment_score': '-0.00714', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.234119', 'ticker_sentiment_score': '0.080874', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.234119', 'ticker_sentiment_score': '0.078127', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.118354', 'ticker_sentiment_score': '0.007886', 'ticker_sentiment_label': 'Neutral'}]"
383,4 Large Drug Stocks to Hold on to Amid Industry Challenges,https://www.zacks.com/commentary/2260758/4-large-drug-stocks-to-hold-on-to-amid-industry-challenges,20240424T140900,['Kinjel Shah'],"Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and AbbVie (ABBV) are worth retaining in one's portfolio.",https://staticx-tuner.zacks.com/images/articles/main/f5/284.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.989041'}, {'topic': 'Earnings', 'relevance_score': '0.999491'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.9545'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.221236,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.11349', 'ticker_sentiment_score': '0.144552', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.022772', 'ticker_sentiment_score': '0.06641', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.135985', 'ticker_sentiment_score': '0.157325', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CTLT', 'relevance_score': '0.022772', 'ticker_sentiment_score': '0.06641', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.135985', 'ticker_sentiment_score': '0.157325', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
384,Analysts Estimate Pfizer  ( PFE )  to Report a Decline in Earnings: What to Look Out for,https://www.zacks.com/stock/news/2261226/analysts-estimate-pfizer-pfe-to-report-a-decline-in-earnings-what-to-look-out-for,20240424T140154,['Zacks Equity Research'],Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,https://staticx-tuner.zacks.com/images/default_article_images/default65.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.10056,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.175221', 'ticker_sentiment_score': '-0.001426', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.260189', 'ticker_sentiment_score': '-0.045929', 'ticker_sentiment_label': 'Neutral'}]"
385,Should Eli Lilly  ( LLY )  Be in Your Portfolio Ahead of Q1 Earnings?,https://www.zacks.com/stock/news/2261017/should-eli-lilly-lly-be-in-your-portfolio-ahead-of-q1-earnings,20240424T132500,['Kinjel Shah'],"Eli Lilly (LLY) enjoys strong fundamentals and is expected to consistently do well, mainly supported by its new drugs and its solid pipeline.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.272056,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.427973', 'ticker_sentiment_score': '0.337137', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ADMA', 'relevance_score': '0.242084', 'ticker_sentiment_score': '0.241224', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.122477', 'ticker_sentiment_score': '0.191306', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DICE', 'relevance_score': '0.040969', 'ticker_sentiment_score': '0.032769', 'ticker_sentiment_label': 'Neutral'}]"
386,"Roche  ( RHHBY )  Q1 Hit by Currency Headwinds, Lower COVID-19 Sales",https://www.zacks.com/stock/news/2261355/roche-rhhby-q1-hit-by-currency-headwinds-lower-covid-19-sales,20240424T131100,['Zacks Equity Research'],Roche's (RHHBY) performance in first-quarter 2024 is pretty ho-hum as COVID-19-test sales continue to decline. The top line suffers due to the appreciation of the Swiss franc against most currencies.,https://staticx-tuner.zacks.com/images/articles/main/49/1007.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.002437,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.104835', 'ticker_sentiment_score': '0.260238', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CURN', 'relevance_score': '0.035035', 'ticker_sentiment_score': '-0.251035', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'FOREX:CHF', 'relevance_score': '0.746555', 'ticker_sentiment_score': '-0.273034', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
387,Investors Heavily Search Eli Lilly and Company  ( LLY ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2260940/investors-heavily-search-eli-lilly-and-company-lly-here-is-what-you-need-to-know,20240424T130014,['Zacks Equity Research'],"Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",https://staticx-tuner.zacks.com/images/default_article_images/default214.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.221909,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.524949', 'ticker_sentiment_score': '0.134534', 'ticker_sentiment_label': 'Neutral'}]"
388,Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight-Loss Drug Market,https://www.fool.com/investing/2024/04/24/meet-lilly-secret-weapon-in-weight-loss-market/,20240424T104000,['Adria Cimino'],Lilly recently announced news that could solve a big problem.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F773935%2Fgettyimages-woman-points-at-computer-with-a-pen-to-show-something-to-a-colleague.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.161647'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.126673,Neutral,"[{'ticker': 'GS', 'relevance_score': '0.056808', 'ticker_sentiment_score': '0.087055', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.478692', 'ticker_sentiment_score': '0.161343', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.113329', 'ticker_sentiment_score': '0.082674', 'ticker_sentiment_label': 'Neutral'}]"
389,Market Whales and Their Recent Bets on LLY Options - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/04/38383934/market-whales-and-their-recent-bets-on-lly-options,20240423T154548,['Benzinga Insights'],"Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly and Co. Looking at options history for Eli Lilly and Co LLY we detected 54 trades. If we consider the specifics of each trade, it is accurate to state that 55% of the investors opened trades with bullish ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.137445,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.823417', 'ticker_sentiment_score': '0.149834', 'ticker_sentiment_label': 'Neutral'}]"
390,Eli Lilly  ( LLY )  Reports Next Week: Wall Street Expects Earnings Growth,https://www.zacks.com/stock/news/2260247/eli-lilly-lly-reports-next-week-wall-street-expects-earnings-growth,20240423T140101,['Zacks Equity Research'],Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,https://staticx-tuner.zacks.com/images/default_article_images/default280.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.137784,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.261117', 'ticker_sentiment_score': '0.057509', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.175859', 'ticker_sentiment_score': '0.022696', 'ticker_sentiment_label': 'Neutral'}]"
391,Better Buy: Pfizer vs. Viking Therapeutics,https://www.fool.com/investing/2024/04/23/better-buy-pfizer-vs-viking-therapeutics/,20240423T131500,['George Budwell'],These two pharma stocks have followed distinct paths of late. Which is the better investment?,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F773859%2Fhealthcare.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.658903'}]",0.281154,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.058472', 'ticker_sentiment_score': '0.003002', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.230782', 'ticker_sentiment_score': '0.374191', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'AMGN', 'relevance_score': '0.058472', 'ticker_sentiment_score': '0.008004', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.058472', 'ticker_sentiment_score': '0.003002', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.44266', 'ticker_sentiment_score': '0.561378', 'ticker_sentiment_label': 'Bullish'}]"
392,Eli Lilly  ( LLY )  Advances But Underperforms Market: Key Facts,https://www.zacks.com/stock/news/2259608/eli-lilly-lly-advances-but-underperforms-market-key-facts,20240422T214519,['Zacks Equity Research'],"Eli Lilly (LLY) concluded the recent trading session at $731.33, signifying a +0.69% move from its prior day's close.",https://staticx-tuner.zacks.com/images/default_article_images/default331.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.961735'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}]",0.108153,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.44622', 'ticker_sentiment_score': '0.249266', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
393,3 Relatively Safe Growth Stocks You Can Buy and Hold,https://www.fool.com/investing/2024/04/20/relatively-safe-growth-stocks-you-can-buy-and-hold/,20240420T104800,"['David Jagielski', 'and Prosper Junior Bakiny', 'Keith Speights']",Low risk and high-reward potential? These stocks could offer both.,https://g.foolcdn.com/editorial/images/773405/hands-behind-head-young-woman.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.875462'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.99393'}]",0.300536,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.356154', 'ticker_sentiment_score': '0.337205', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.162802', 'ticker_sentiment_score': '0.020054', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.280846', 'ticker_sentiment_score': '0.1808', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ALPN', 'relevance_score': '0.040969', 'ticker_sentiment_score': '0.100232', 'ticker_sentiment_label': 'Neutral'}]"
394,Even Medical Products Stocks Don't All Look Healthy In This Sick Market,https://www.investors.com/stock-lists/ibd-50/dexcom-dxcm-stock-medical-companies/,20240419T183900,"[""Investor's Business Daily"", 'KIMBERLEY KOENIG']","Investors often turn to defensive types of stocks including medical companies in times of market turmoil, but even those can produce mixed results. Take IBD 50 medical products stocks such as Dexcom ( DXCM ) , which has wavered in a buy zone but ultimately slipped below its entry point.",https://www.investors.com/wp-content/uploads/2023/03/Stock-dexcom-one-04-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.996023'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.124833,Neutral,"[{'ticker': 'INSP', 'relevance_score': '0.180685', 'ticker_sentiment_score': '0.172044', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.060694', 'ticker_sentiment_score': '0.238152', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ITCI', 'relevance_score': '0.121037', 'ticker_sentiment_score': '-0.295614', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PRCT', 'relevance_score': '0.180685', 'ticker_sentiment_score': '0.153094', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.287972', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TMDX', 'relevance_score': '0.180685', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DXCM', 'relevance_score': '0.457566', 'ticker_sentiment_score': '0.260041', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
395,Stock Market Shows Bearish Action: Weekly Review,https://www.investors.com/news/stock-market-taiwan-semiconductor-asml-netflix-united-airlines-weekly-review/,20240419T165100,"['IBD STAFF', ""Investor's Business Daily""]","Stock Market Sells Off. Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2020/10/Stock-NYSEbuilding-09-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}]",0.041784,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.172097', 'ticker_sentiment_score': '-0.148103', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.098862', 'ticker_sentiment_score': '-0.034689', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IBKR', 'relevance_score': '0.098862', 'ticker_sentiment_score': '0.102009', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.07423', 'ticker_sentiment_score': '0.108439', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.07423', 'ticker_sentiment_score': '0.108439', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.049526', 'ticker_sentiment_score': '0.071953', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SLB', 'relevance_score': '0.123399', 'ticker_sentiment_score': '0.018007', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BK', 'relevance_score': '0.07423', 'ticker_sentiment_score': '0.108439', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.049526', 'ticker_sentiment_score': '0.105983', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.07423', 'ticker_sentiment_score': '0.108869', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSM', 'relevance_score': '0.07423', 'ticker_sentiment_score': '0.004134', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KBH', 'relevance_score': '0.049526', 'ticker_sentiment_score': '0.102972', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.049526', 'ticker_sentiment_score': '0.071953', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ITCI', 'relevance_score': '0.049526', 'ticker_sentiment_score': '-0.127853', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.172097', 'ticker_sentiment_score': '-0.076438', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.049526', 'ticker_sentiment_score': '0.107278', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.07423', 'ticker_sentiment_score': '0.101928', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.049526', 'ticker_sentiment_score': '0.012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.07423', 'ticker_sentiment_score': '0.095435', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.07423', 'ticker_sentiment_score': '0.088742', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.07423', 'ticker_sentiment_score': '0.0156', 'ticker_sentiment_label': 'Neutral'}]"
396,Exploring The Competitive Space: Eli Lilly and Co Versus Industry Peers In Pharmaceuticals - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/news/24/04/38336360/exploring-the-competitive-space-eli-lilly-and-co-versus-industry-peers-in-pharmaceuticals,20240419T150021,['Benzinga Insights'],"Amidst today's fast-paced and highly competitive business environment, it is crucial for investors and industry enthusiasts to conduct comprehensive company evaluations.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.179898,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.52759', 'ticker_sentiment_score': '0.236352', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
397,"Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data",https://www.zacks.com/stock/news/2258354/pharma-stock-roundup-jnjs-q1-results-lly-abbv-rhhbys-successful-study-data,20240419T131500,['Kinjel Shah'],J&J (JNJ) posts mixed first-quarter 2024 results. Lilly's (LLY) tirzepatide meets key goals in late-stage studies for obstructive sleep apnea.,https://staticx-tuner.zacks.com/images/articles/main/52/873.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.928139'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.035644,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.194242', 'ticker_sentiment_score': '0.054754', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.155954', 'ticker_sentiment_score': '0.042066', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.039224', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.078354', 'ticker_sentiment_score': '-0.191191', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'SWAV', 'relevance_score': '0.039224', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.039224', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
398,Dexcom In Buy Zone After Launch Of Prescription-Free Diabetes Monitor; Earnings Due Next Week,https://www.investors.com/stock-lists/sector-leaders/dexcom-stock-dxcm-diabetes-insulin/,20240419T123000,"[""Investor's Business Daily"", 'VIDYA RAMAKRISHNAN']",Dexcom Stock Is In Buy Zone Ahead Of Earnings Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2020/02/stock-Dexcom-02-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.938238'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}]",0.327633,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.184598', 'ticker_sentiment_score': '0.135154', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DXCM', 'relevance_score': '0.440549', 'ticker_sentiment_score': '0.428074', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ABT', 'relevance_score': '0.184598', 'ticker_sentiment_score': '0.135154', 'ticker_sentiment_label': 'Neutral'}]"
399,Could Eli Lilly's Sleep Apnea News Actually Help This CPAP Maker?,https://www.investors.com/news/technology/resmed-stock-eli-lilly-obstructive-sleep-apnea-cpaps/,20240418T143300,"['ALLISON GATLIN', ""Investor's Business Daily""]",ResMed Stock Reverses Higher As Weight-Loss Drugs Seen Bolstering Its Devices Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2019/01/stock-ResMed-01-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}]",0.152847,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.186738', 'ticker_sentiment_score': '0.054941', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RMD', 'relevance_score': '0.521465', 'ticker_sentiment_score': '0.330111', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DVA', 'relevance_score': '0.186738', 'ticker_sentiment_score': '0.134704', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DXCM', 'relevance_score': '0.186738', 'ticker_sentiment_score': '0.134704', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.186738', 'ticker_sentiment_score': '0.178018', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
400,"2 Growth Stocks That Turned $10,000 Into More Than $100,000 in Just 10 Years",https://www.fool.com/investing/2024/04/18/growth-stocks-turn-10k-into-more-than-100k/,20240418T091000,['David Jagielski'],"These stocks have taken different paths to where they are today, but both have been exceptional investments.",https://g.foolcdn.com/editorial/images/772800/investor-looking-at-a-chart.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999995'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.94762'}]",0.134214,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.308891', 'ticker_sentiment_score': '0.150874', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.357049', 'ticker_sentiment_score': '0.088389', 'ticker_sentiment_label': 'Neutral'}]"
401,Eli Lilly and Co's Options Frenzy: What You Need to Know - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/04/38299357/eli-lilly-and-cos-options-frenzy-what-you-need-to-know,20240417T180135,['Benzinga Insights'],"Whales with a lot of money to spend have taken a noticeably bearish stance on Eli Lilly and Co. Looking at options history for Eli Lilly and Co LLY we detected 87 trades. If we consider the specifics of each trade, it is accurate to state that 47% of the investors opened trades with bullish ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.154723,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.782378', 'ticker_sentiment_score': '0.080076', 'ticker_sentiment_label': 'Neutral'}]"
402,Eli Lilly  ( LLY )  Stock Dips While Market Gains: Key Facts,https://www.zacks.com/stock/news/2256381/eli-lilly-lly-stock-dips-while-market-gains-key-facts,20240416T214518,['Zacks Equity Research'],"In the closing of the recent trading day, Eli Lilly (LLY) stood at $749.26, denoting a -0.2% change from the preceding trading day.",https://staticx-tuner.zacks.com/images/default_article_images/default59.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.990786'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.216075,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.593715', 'ticker_sentiment_score': '0.443594', 'ticker_sentiment_label': 'Bullish'}]"
403,Better Buy: Bristol Myers Squibb or the Vanguard S&P 500 ETF?,https://www.fool.com/investing/2024/04/15/better-buy-bristol-myers-squibb-or-the-vanguard-sp/,20240415T133000,['George Budwell'],Bristol Myers Squibb stock sports an attractive valuation and dividend yield. Is it a more compelling buy than the Vanguard S&P 500 ETF?,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F772855%2Fgrowth.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}]",0.213272,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.062434', 'ticker_sentiment_score': '0.106159', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.062434', 'ticker_sentiment_score': '0.106159', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.185781', 'ticker_sentiment_score': '0.361919', 'ticker_sentiment_label': 'Bullish'}]"
404,Better Growth Play: Merck or The Vanguard Growth Index Fund?,https://www.fool.com/investing/2024/04/15/better-growth-play-merck-or-the-vanguard-growth-in/,20240415T130000,['George Budwell'],Merck's shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F772854%2Fgrowth-stock.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.857896'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.99977'}]",0.258783,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.062926', 'ticker_sentiment_score': '0.011109', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.062926', 'ticker_sentiment_score': '0.055011', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.062926', 'ticker_sentiment_score': '0.011109', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.062926', 'ticker_sentiment_score': '0.055011', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.062926', 'ticker_sentiment_score': '0.055011', 'ticker_sentiment_label': 'Neutral'}]"
405,3 Magnificent Stocks That Could Double or More by 2030,https://www.fool.com/investing/2024/04/13/magnificent-stocks-could-double-or-more-by-2030/,20240413T124700,"['David Jagielski', 'and Prosper Junior Bakiny', 'Keith Speights']","There's no guarantee these stocks will double by 2030, but their growth prospects look great.",https://g.foolcdn.com/editorial/images/772646/african-american-young-couple-dancing.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.317862,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.298113', 'ticker_sentiment_score': '0.219395', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.038162', 'ticker_sentiment_score': '0.120138', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.151778', 'ticker_sentiment_score': '-0.107742', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.038162', 'ticker_sentiment_score': '0.134657', 'ticker_sentiment_label': 'Neutral'}]"
406,This Vanguard ETF Has Skyrocketed 40% in 12 Months. Is It a No-Brainer Buy Right Now?,https://www.fool.com/investing/2024/04/13/this-vanguard-etf-has-skyrocketed-40-in-12-months/,20240413T095100,['Keith Speights'],You can own a basket of tremendously successful stocks with this ETF.,https://g.foolcdn.com/editorial/images/772431/stock-chart-rocket.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.99989'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.221527,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.067727', 'ticker_sentiment_score': '0.071162', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.067727', 'ticker_sentiment_score': '0.171645', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.067727', 'ticker_sentiment_score': '0.147499', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.067727', 'ticker_sentiment_score': '0.147499', 'ticker_sentiment_label': 'Neutral'}]"
407,Here is What to Know Beyond Why Eli Lilly and Company  ( LLY )  is a Trending Stock,https://www.zacks.com/stock/news/2254326/here-is-what-to-know-beyond-why-eli-lilly-and-company-lly-is-a-trending-stock,20240412T130016,['Zacks Equity Research'],"Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default17.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.226282,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.528798', 'ticker_sentiment_score': '0.119414', 'ticker_sentiment_label': 'Neutral'}]"
408,Why Roche Holdings Stock Popped Today,https://www.fool.com/investing/2024/04/11/why-roche-holdings-stock-popped-today/,20240411T223321,['Rich Smith'],"Roche's new Alzheimer's test has a long road ahead of it, but it may help boost the pharmaceutical company's slow growth rate.",https://g.foolcdn.com/editorial/images/772667/lady-scientist-in-lab-coat-and-goggles-pours-blue-liquid-from-a-test-tube-into-a-beaker.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.254283,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.328819', 'ticker_sentiment_score': '0.325149', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
409,Eli Lilly  ( LLY )  Increases Despite Market Slip: Here's What You Need to Know,https://www.zacks.com/stock/news/2253643/eli-lilly-lly-increases-despite-market-slip-heres-what-you-need-to-know,20240410T214519,['Zacks Equity Research'],"Eli Lilly (LLY) reachead $761.98 at the closing of the latest trading day, reflecting a +0.63% change compared to its last close.",https://staticx-tuner.zacks.com/images/default_article_images/default343.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.961735'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.168251,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.511734', 'ticker_sentiment_score': '0.184077', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
410,Eli Lilly and Co's Options: A Look at What the Big Money is Thinking - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/04/38163261/eli-lilly-and-cos-options-a-look-at-what-the-big-money-is-thinking,20240409T134547,['Benzinga Insights'],"Investors with a lot of money to spend have taken a bearish stance on Eli Lilly and Co LLY. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.088238,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.764287', 'ticker_sentiment_score': '0.102607', 'ticker_sentiment_label': 'Neutral'}]"
411,Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.,https://www.fool.com/investing/2024/04/09/missed-out-on-eli-lilly-2-stocks-with-catalysts/,20240409T103500,['Adria Cimino'],These companies are close to launching new products that could supercharge revenue.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F772200%2Fscientists-high-five-smile.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.268179,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.11894', 'ticker_sentiment_score': '0.079945', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.11894', 'ticker_sentiment_score': '0.070731', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.499254', 'ticker_sentiment_score': '0.217058', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.11894', 'ticker_sentiment_score': '0.054324', 'ticker_sentiment_label': 'Neutral'}]"
412,Bull Market and Beyond: 3 Stocks Just Waiting to Soar,https://www.fool.com/investing/2024/04/09/bull-market-and-beyond-3-stocks-waiting-to-soar/,20240409T085000,['Adria Cimino'],"These stocks, a bargain today, are players to hold on to for the long term.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F772058%2Fgettyimages-1134003590.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.839681'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}]",0.360038,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.056407', 'ticker_sentiment_score': '0.332036', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MRNA', 'relevance_score': '0.222838', 'ticker_sentiment_score': '0.166308', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DNA', 'relevance_score': '0.168099', 'ticker_sentiment_score': '0.202699', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.056407', 'ticker_sentiment_score': '0.332036', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NTLA', 'relevance_score': '0.276491', 'ticker_sentiment_score': '0.124612', 'ticker_sentiment_label': 'Neutral'}]"
413,2 Growth Stocks to Buy Hand Over Fist in April,https://www.fool.com/investing/2024/04/08/2-growth-stocks-to-buy-hand-over-fist-in-april/,20240408T123000,['Prosper Junior Bakiny'],These healthcare companies' target markets substantially overlap.,https://g.foolcdn.com/editorial/images/771856/physician-shaking-patients-hand.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.818451'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}]",0.199123,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.427726', 'ticker_sentiment_score': '0.348689', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DXCM', 'relevance_score': '0.474763', 'ticker_sentiment_score': '0.163199', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
414,This 1 Number May Ensure Eli Lilly's Dominance in the Weight Loss Drug Market,https://www.fool.com/investing/2024/04/08/this-may-ensure-lilly-weight-loss-leadership/,20240408T103000,['Adria Cimino'],Lilly's stock has climbed in the triple digits over the past 12 months.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F771977%2Fgettyimages-scientist_computer_others-in-background.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.905476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.230043,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.502693', 'ticker_sentiment_score': '0.192971', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.107978', 'ticker_sentiment_score': '0.041565', 'ticker_sentiment_label': 'Neutral'}]"
415,Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It.,https://www.fool.com/investing/2024/04/08/viking-therapeutics-is-great-but-you-shouldnt-buy/,20240408T095500,['Adria Cimino'],Shares of the clinical-stage biotech have skyrocketed on recent good news.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F771950%2Fgettyimages-1203044156.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.267497,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.318211', 'ticker_sentiment_score': '0.258078', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VKTX', 'relevance_score': '0.108712', 'ticker_sentiment_score': '0.121577', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.054483', 'ticker_sentiment_score': '0.060165', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.215415', 'ticker_sentiment_score': '0.196275', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
416,Modelo maker Constellation Brands is primed for market share gains but we still see one issue with the company,https://www.cnbc.com/2024/04/07/modelo-maker-constellation-brands-is-primed-for-market-share-gains.html,20240407T140001,['Paulina Likos'],Constellation Brands is positioned for market share gains with a strong business outlook despite this one overhang.,https://image.cnbcfm.com/api/v1/image/107355010-1704487446557-gettyimages-1910383648-img_5772_oyumebml.jpeg?v=1704487567&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.998962'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.229898,Somewhat-Bullish,"[{'ticker': 'BUD', 'relevance_score': '0.03792', 'ticker_sentiment_score': '0.096031', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.075754', 'ticker_sentiment_score': '0.099982', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STZ', 'relevance_score': '0.1879', 'ticker_sentiment_score': '0.14927', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.03792', 'ticker_sentiment_score': '0.096031', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.150827', 'ticker_sentiment_score': '0.128593', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRD-A', 'relevance_score': '0.03792', 'ticker_sentiment_score': '0.096031', 'ticker_sentiment_label': 'Neutral'}]"
417,Eli Lilly's Wegovy Competitor Is Causing Supply Constraints: What It Means for the Stock,https://www.fool.com/investing/2024/04/06/eli-lillys-wegovy-competitor-is-causing-supply-con/,20240406T123000,['Prosper Junior Bakiny'],Things are going exactly as planned for the biotech giant.,https://g.foolcdn.com/editorial/images/771534/physician-talking-to-patient.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.16125,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.415535', 'ticker_sentiment_score': '0.140382', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.124164', 'ticker_sentiment_score': '0.136348', 'ticker_sentiment_label': 'Neutral'}]"
418,Understanding Eli Lilly and Co's Position In Pharmaceuticals Industry Compared To Competitors - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/news/24/04/38111799/understanding-eli-lilly-and-cos-position-in-pharmaceuticals-industry-compared-to-competitors,20240405T150016,['Benzinga Insights'],"In today's rapidly changing and highly competitive business world, it is vital for investors and industry enthusiasts to carefully assess companies. In this article, we will perform a comprehensive industry comparison, evaluating Eli Lilly and Co LLY against its key competitors in the ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.181517,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.461997', 'ticker_sentiment_score': '0.274107', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
419,Eli Lilly and Co Options Trading: A Deep Dive into Market Sentiment - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/04/38111253/eli-lilly-and-co-options-trading-a-deep-dive-into-market-sentiment,20240405T143133,['Benzinga Insights'],"Whales with a lot of money to spend have taken a noticeably bearish stance on Eli Lilly and Co. Looking at options history for Eli Lilly and Co LLY we detected 22 trades. If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.130804,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.821469', 'ticker_sentiment_score': '0.166043', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
420,Could This 1 Detail Help Viking Therapeutics Top Eli Lilly and Novo Nordisk in the Weight Loss Drug Market?,https://www.fool.com/investing/2024/04/04/could-this-1-detail-help-viking-top-lilly-novo/,20240404T085500,['Adria Cimino'],Viking shares have soared recently on optimism about its program.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F771655%2Fgettyimages-1351333930.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.239522,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.417995', 'ticker_sentiment_score': '0.302808', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VKTX', 'relevance_score': '0.109455', 'ticker_sentiment_score': '0.104156', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.054857', 'ticker_sentiment_score': '0.130001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.417995', 'ticker_sentiment_score': '0.302808', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
421,Why Eli Lilly Stock Topped the Market Today,https://www.fool.com/investing/2024/04/03/why-eli-lilly-stock-topped-the-market-today/,20240403T203102,['Eric Volkman'],One analyst following the company believes it could grow its revenue meaningfully this year.,https://g.foolcdn.com/editorial/images/771731/stethescope-atop-us-currency-and-coins.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.684621'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.279871,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.549581', 'ticker_sentiment_score': '0.361821', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.294093', 'ticker_sentiment_score': '0.259711', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
422,"Eli Lilly Struggles To Keep Pace With Mounjaro, Zepbound Demand: 'Currently Unavailable' On Amazon Pharmacy - Eli Lilly and Co  ( NYSE:LLY ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/markets/equities/24/04/38077966/eli-lilly-struggles-to-keep-pace-with-mounjaro-zepbound-demand-currently-unavailable-on-amazon-p,20240403T200742,['Neil Dennis'],"After a blistering performance based on the success of its weight-loss treatments Mounjaro and Zepbound, Eli Lilly & Company LLY stock has been trading sideways for the last five weeks as the company struggles to keep pace with demand for the drugs.",https://cdn.benzinga.com/files/images/story/2024/weight-loss-ai.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",-0.033528,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.493442', 'ticker_sentiment_score': '-0.157577', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AMZN', 'relevance_score': '0.260189', 'ticker_sentiment_score': '0.083065', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTLT', 'relevance_score': '0.088147', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.260189', 'ticker_sentiment_score': '-0.18623', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
423,"Verve  ( VERV )  Pauses Enrollment in Cholesterol Study, Stock Falls",https://www.zacks.com/stock/news/2250054/verve-verv-pauses-enrollment-in-cholesterol-study-stock-falls,20240403T174000,['Zacks Equity Research'],Verve (VERV) stops enrollment in the phase Ib study of gene therapy candidate VERVE-10 to reduce disease-driving low-density lipoprotein cholesterol due to safety issues. Stock plunges on the news.,https://staticx-tuner.zacks.com/images/articles/main/ba/1149.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.818451'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.108569,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.176717', 'ticker_sentiment_score': '0.278914', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ADMA', 'relevance_score': '0.290262', 'ticker_sentiment_score': '0.221413', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ANIP', 'relevance_score': '0.290262', 'ticker_sentiment_score': '0.201066', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VERV', 'relevance_score': '0.176717', 'ticker_sentiment_score': '0.158941', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
424,Unpacking the Latest Options Trading Trends in Eli Lilly and Co - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/04/38071716/unpacking-the-latest-options-trading-trends-in-eli-lilly-and-co,20240403T150119,['Benzinga Insights'],"Financial giants have made a conspicuous bearish move on Eli Lilly and Co. Our analysis of options history for Eli Lilly and Co LLY revealed 41 unusual trades. Delving into the details, we found 26% of traders were bullish, while 73% showed bearish tendencies.",https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.065172,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.799128', 'ticker_sentiment_score': '0.056879', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.092569', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
425,Rally Holds Support; Five Stocks Eye Buy Points,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rally-holds-support-meta-near-buy-point-tesla-skid/,20240403T120900,"[""Investor's Business Daily"", 'ED CARSON']","Dow Jones Futures: Stock Market Rally Holds Support, Meta Near Buy Point. Tesla Skids Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2018/05/Stock-bullBearFrankfurt-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.614606'}]",0.029155,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.129795', 'ticker_sentiment_score': '-0.051452', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVS', 'relevance_score': '0.052112', 'ticker_sentiment_score': '-0.085286', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUM', 'relevance_score': '0.052112', 'ticker_sentiment_score': '-0.085286', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.180943', 'ticker_sentiment_score': '0.100045', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.280762', 'ticker_sentiment_score': '0.038775', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PVH', 'relevance_score': '0.078099', 'ticker_sentiment_score': '-0.089248', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.256179', 'ticker_sentiment_score': '-0.214866', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'INTC', 'relevance_score': '0.104002', 'ticker_sentiment_score': '-0.07445', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.155451', 'ticker_sentiment_score': '0.089337', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIVN', 'relevance_score': '0.052112', 'ticker_sentiment_score': '0.09456', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.180943', 'ticker_sentiment_score': '0.088684', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.104002', 'ticker_sentiment_score': '-0.054697', 'ticker_sentiment_label': 'Neutral'}]"
426,Eli Lilly  ( LLY )  Ascends While Market Falls: Some Facts to Note,https://www.zacks.com/stock/news/2249391/eli-lilly-lly-ascends-while-market-falls-some-facts-to-note,20240402T214518,['Zacks Equity Research'],"The latest trading day saw Eli Lilly (LLY) settling at $763.96, representing a +0.45% change from its previous close.",https://staticx-tuner.zacks.com/images/default_article_images/default349.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.128657,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.520477', 'ticker_sentiment_score': '0.185292', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
427,Market Bends As Yields Jump; Tesla Skids As 5 Stocks Hang Tough,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-slides-tesla-skids-meta-buy-point/,20240402T205300,"[""Investor's Business Daily"", 'ED CARSON']",Dow Jones Futures: Market Slides But Holds Key Levels. Tesla Skids As Meta Eyes Buy Point Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2018/05/Stock-bullBearFrankfurt-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}]",0.058028,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.141893', 'ticker_sentiment_score': '-0.053992', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVS', 'relevance_score': '0.057011', 'ticker_sentiment_score': '-0.085698', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUM', 'relevance_score': '0.057011', 'ticker_sentiment_score': '-0.085698', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.197643', 'ticker_sentiment_score': '0.106808', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.305921', 'ticker_sentiment_score': '0.032325', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PVH', 'relevance_score': '0.085426', 'ticker_sentiment_score': '-0.082956', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.252405', 'ticker_sentiment_score': '-0.184414', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LLY', 'relevance_score': '0.169875', 'ticker_sentiment_score': '0.09468', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIVN', 'relevance_score': '0.057011', 'ticker_sentiment_score': '0.09494', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.197643', 'ticker_sentiment_score': '0.094691', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.113731', 'ticker_sentiment_score': '-0.051179', 'ticker_sentiment_label': 'Neutral'}]"
428,AstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss Race - AstraZeneca  ( NASDAQ:AZN ) ,https://www.benzinga.com/general/biotech/24/04/38055367/astrazeneca-ceo-highlights-decade-long-sales-goal-of-45b-along-with-investor-doubts-as-it-lags-in,20240402T185401,['Vandana Singh'],"AstraZeneca Plc's AZN Chief Executive Pascal Soriot says the company achieved a significant milestone by reaching a sales target of $45 billion by 2023, a goal set a decade ago amid pressure from U.S. rival Pfizer Inc PFE.",https://cdn.benzinga.com/files/images/story/2024/AstraZeneca-HQ-in-Cambridge-UK_5.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.214279,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.192694', 'ticker_sentiment_score': '-0.093594', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FUSN', 'relevance_score': '0.192694', 'ticker_sentiment_score': '-0.111146', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.727604', 'ticker_sentiment_score': '0.189804', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.192694', 'ticker_sentiment_score': '-0.093594', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.285526', 'ticker_sentiment_score': '-0.124969', 'ticker_sentiment_label': 'Neutral'}]"
429,Jim Cramer says Microsoft's unbundling of Teams and Office is good news for this portfolio stock,https://www.cnbc.com/2024/04/02/jim-cramer-microsoft-teams-office-unbundling-good-news-for-salesforce.html,20240402T160800,['Morgan Chittum'],"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",https://image.cnbcfm.com/api/v1/image/107356114-1704816779151-gettyimages-1228524873-AFP_8PZ69L.jpeg?v=1712070146&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.980716'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.139618,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.247838', 'ticker_sentiment_score': '0.111864', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.326283', 'ticker_sentiment_score': '0.138622', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.166743', 'ticker_sentiment_score': '0.082876', 'ticker_sentiment_label': 'Neutral'}]"
430,"Ten Stocks Showing This Bullish Action, Including A Mag 7 Titan",https://www.investors.com/news/meta-platforms-amd-10-stocks-bullish-action/,20240402T114500,"['ED CARSON', ""Investor's Business Daily""]","Meta Platforms, AMD Lead 10 Stocks Showing This Bullish Action Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2019/08/stock-bounce-back-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.18806,Somewhat-Bullish,"[{'ticker': 'META', 'relevance_score': '0.192694', 'ticker_sentiment_score': '0.153314', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CRWD', 'relevance_score': '0.239541', 'ticker_sentiment_score': '0.13668', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.145145', 'ticker_sentiment_score': '0.227132', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.145145', 'ticker_sentiment_score': '0.103429', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CYBR', 'relevance_score': '0.145145', 'ticker_sentiment_score': '0.137013', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NET', 'relevance_score': '0.239541', 'ticker_sentiment_score': '0.105097', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.192694', 'ticker_sentiment_score': '0.297427', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UBER', 'relevance_score': '0.239541', 'ticker_sentiment_score': '0.068878', 'ticker_sentiment_label': 'Neutral'}]"
431,"The Zacks Analyst Blog Highlights Apple, NVIDIA, Eli Lilly, American Tower and McKesson",https://www.zacks.com/stock/news/2248815/the-zacks-analyst-blog-highlights-apple-nvidia-eli-lilly-american-tower-and-mckesson,20240402T093700,['Zacks Investment Research'],"Apple, NVIDIA, Eli Lilly, American Tower and McKesson are included in this Analyst Blog.",https://staticx-tuner.zacks.com/images/articles/main/ad/429.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}]",0.23177,Somewhat-Bullish,"[{'ticker': 'AMT', 'relevance_score': '0.16117', 'ticker_sentiment_score': '0.040951', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.45825', 'ticker_sentiment_score': '0.203377', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.31583', 'ticker_sentiment_score': '0.06747', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.45825', 'ticker_sentiment_score': '0.374601', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'MCK', 'relevance_score': '0.16117', 'ticker_sentiment_score': '0.040951', 'ticker_sentiment_label': 'Neutral'}]"
432,Is It Too Late to Buy Eli Lilly Stock?,https://www.fool.com/investing/2024/04/02/is-it-too-late-to-buy-eli-lilly-stock/,20240402T091000,['Adria Cimino'],There's more to the Lilly story than just excellence in one treatment area.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F771415%2Fgettyimages-613345556.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.972756'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.25364,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.50287', 'ticker_sentiment_score': '0.312039', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.049221', 'ticker_sentiment_score': '0.190076', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.049221', 'ticker_sentiment_score': '0.190076', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.049221', 'ticker_sentiment_score': '-0.10048', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.049221', 'ticker_sentiment_score': '-0.10048', 'ticker_sentiment_label': 'Neutral'}]"
433,"Top Stock Reports for Apple, NVIDIA & Eli Lilly",https://www.zacks.com/research-daily/2248263/top-stock-reports-for-apple-nvidia-eli-lilly,20240401T183800,['Sheraz Mian'],"Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), NVIDIA Corporation (NVDA) and Eli Lilly and Company (LLY).",https://staticx-tuner.zacks.com/images/default_article_images/default59.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.239366,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.295867', 'ticker_sentiment_score': '0.225728', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.100729', 'ticker_sentiment_score': '0.029195', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.387374', 'ticker_sentiment_score': '0.386666', 'ticker_sentiment_label': 'Bullish'}]"
434,Eli Lilly and Company  ( LLY )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2248231/eli-lilly-and-company-lly-is-attracting-investor-attention-here-is-what-you-should-know,20240401T130014,['Zacks Equity Research'],"Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.",https://staticx-tuner.zacks.com/images/default_article_images/default313.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.235146,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.523044', 'ticker_sentiment_score': '0.153181', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
435,"Missed the ""Magnificent Seven""? Try Buying These 3 Forever Stocks Instead",https://www.fool.com/investing/2024/04/01/missed-the-magnificent-seven-try-buying-these-3/,20240401T130000,['Alex Carchidi'],All three companies have very long runways for growth ahead.,https://g.foolcdn.com/editorial/images/768661/two-investors-consider-a-laptop.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.918141'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.297572,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.166935', 'ticker_sentiment_score': '0.06688', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.056011', 'ticker_sentiment_score': '0.177046', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.111747', 'ticker_sentiment_score': '0.206816', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.056011', 'ticker_sentiment_score': '0.177046', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'COST', 'relevance_score': '0.221313', 'ticker_sentiment_score': '0.128312', 'ticker_sentiment_label': 'Neutral'}]"
436,Futures Rise In Reaction To 'Good' Inflation Data,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-inflation-data-nvidia-ai-chip-ipo/,20240401T113600,"['ED CARSON', ""Investor's Business Daily""]",Dow Jones Futures Rise After 'Good' Inflation Data. Nvidia AI Chip Peer Works On Base Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/02/Stock-Chip-glows-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.769861'}, {'topic': 'IPO', 'relevance_score': '0.769861'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.875462'}]",0.168314,Somewhat-Bullish,"[{'ticker': 'MEDP', 'relevance_score': '0.041466', 'ticker_sentiment_score': '0.21857', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'XPEV', 'relevance_score': '0.041466', 'ticker_sentiment_score': '-0.02974', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.08282', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.225093', 'ticker_sentiment_score': '0.166637', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CRWD', 'relevance_score': '0.123951', 'ticker_sentiment_score': '0.071468', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RDDT', 'relevance_score': '0.02074', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.02074', 'ticker_sentiment_score': '0.203432', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AXON', 'relevance_score': '0.041466', 'ticker_sentiment_score': '0.21857', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'IVZ', 'relevance_score': '0.02074', 'ticker_sentiment_score': '0.150771', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.123951', 'ticker_sentiment_score': '0.027496', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALAB', 'relevance_score': '0.123951', 'ticker_sentiment_score': '0.176455', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EWBC', 'relevance_score': '0.041466', 'ticker_sentiment_score': '0.21857', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.184991', 'ticker_sentiment_score': '0.019752', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NIO', 'relevance_score': '0.041466', 'ticker_sentiment_score': '-0.02974', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOW', 'relevance_score': '0.02074', 'ticker_sentiment_score': '0.248366', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.041466', 'ticker_sentiment_score': '0.21857', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CYBR', 'relevance_score': '0.041466', 'ticker_sentiment_score': '0.264658', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'RCL', 'relevance_score': '0.041466', 'ticker_sentiment_score': '0.21857', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HUBS', 'relevance_score': '0.041466', 'ticker_sentiment_score': '0.264658', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NET', 'relevance_score': '0.041466', 'ticker_sentiment_score': '0.264658', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'XIACY', 'relevance_score': '0.02074', 'ticker_sentiment_score': '-0.033494', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LI', 'relevance_score': '0.041466', 'ticker_sentiment_score': '-0.02974', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.041466', 'ticker_sentiment_score': '0.21857', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NXT(EXP20091224)', 'relevance_score': '0.02074', 'ticker_sentiment_score': '0.203432', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CRYPTO:NXT', 'relevance_score': '0.02074', 'ticker_sentiment_score': '0.203432', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
437,"Meet The ""Magnificent Seven"" of Healthcare Stocks",https://www.fool.com/investing/2024/04/01/meet-the-magnificent-seven-of-healthcare-stocks/,20240401T083000,['Prosper Junior Bakiny'],The tech sector doesn't have a monopoly on magnificent corporations.,https://g.foolcdn.com/editorial/images/770839/person-sitting-and-working-at-a-desk.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.24052,Somewhat-Bullish,"[{'ticker': 'ABT', 'relevance_score': '0.042048', 'ticker_sentiment_score': '0.180009', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.125679', 'ticker_sentiment_score': '0.255601', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HCA', 'relevance_score': '0.248259', 'ticker_sentiment_score': '0.115038', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.207928', 'ticker_sentiment_score': '0.28535', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.167032', 'ticker_sentiment_score': '0.306284', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.167032', 'ticker_sentiment_score': '0.286408', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ISRG', 'relevance_score': '0.207928', 'ticker_sentiment_score': '0.134207', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.207928', 'ticker_sentiment_score': '0.100054', 'ticker_sentiment_label': 'Neutral'}]"
438,"Have $1,500? 2 Top Growth Stocks to Buy Right Now for 2024 and Beyond",https://www.fool.com/investing/2024/03/31/have-1500-2-top-growth-stocks-to-buy-right-now/,20240331T134500,['Rachel Warren'],Great companies in steadily growing industries can deliver enviable returns through the years.,https://g.foolcdn.com/editorial/images/770818/person-looking-thoughtfully-at-screen-computer.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.999174'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.162909,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.361626', 'ticker_sentiment_score': '0.193373', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SHOP', 'relevance_score': '0.361626', 'ticker_sentiment_score': '0.229426', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
439,3 Unstoppable Stocks to Buy Hand Over Fist in April,https://www.fool.com/investing/2024/03/30/unstoppable-stocks-to-buy-hand-over-fist-in-april/,20240330T105000,"['and Prosper Junior Bakiny', 'David Jagielski', 'Keith Speights']",These stocks have exceptionally bright prospects.,https://g.foolcdn.com/editorial/images/771014/happy-woman-because-the-stock-market-went-up.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.166515,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.293339', 'ticker_sentiment_score': '0.024678', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.21193', 'ticker_sentiment_score': '0.117682', 'ticker_sentiment_label': 'Neutral'}]"
440,Market Strong Before Inflation Data; Will Nvidia Peer Forge Base?,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-will-nvidia-ai-chip-ipo-forge-base/,20240328T205027,"[""Investor's Business Daily"", 'ED CARSON']",Market Strong Before Inflation Data. Will Nvidia Peer Forge Base? Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/02/Stock-Chip-glows-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'IPO', 'relevance_score': '0.838487'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.875462'}]",0.175286,Somewhat-Bullish,"[{'ticker': 'MEDP', 'relevance_score': '0.045267', 'ticker_sentiment_score': '0.220043', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'XPEV', 'relevance_score': '0.045267', 'ticker_sentiment_score': '-0.070684', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.090389', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.245115', 'ticker_sentiment_score': '0.214774', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CRWD', 'relevance_score': '0.135221', 'ticker_sentiment_score': '0.074766', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RDDT', 'relevance_score': '0.022643', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.022643', 'ticker_sentiment_score': '0.2053', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AXON', 'relevance_score': '0.045267', 'ticker_sentiment_score': '0.220043', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'IVZ', 'relevance_score': '0.022643', 'ticker_sentiment_score': '0.15234', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.135221', 'ticker_sentiment_score': '0.028776', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALAB', 'relevance_score': '0.135221', 'ticker_sentiment_score': '0.184368', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EWBC', 'relevance_score': '0.045267', 'ticker_sentiment_score': '0.220043', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.135221', 'ticker_sentiment_score': '-0.019606', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NIO', 'relevance_score': '0.067855', 'ticker_sentiment_score': '-0.072171', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOW', 'relevance_score': '0.022643', 'ticker_sentiment_score': '0.250408', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.045267', 'ticker_sentiment_score': '0.220043', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CYBR', 'relevance_score': '0.045267', 'ticker_sentiment_score': '0.266176', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'RCL', 'relevance_score': '0.045267', 'ticker_sentiment_score': '0.220043', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HUBS', 'relevance_score': '0.045267', 'ticker_sentiment_score': '0.266176', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NET', 'relevance_score': '0.045267', 'ticker_sentiment_score': '0.266176', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'XIACY', 'relevance_score': '0.022643', 'ticker_sentiment_score': '-0.034813', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LI', 'relevance_score': '0.067855', 'ticker_sentiment_score': '-0.072171', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.045267', 'ticker_sentiment_score': '0.220043', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NXT(EXP20091224)', 'relevance_score': '0.022643', 'ticker_sentiment_score': '0.2053', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CRYPTO:NXT', 'relevance_score': '0.022643', 'ticker_sentiment_score': '0.2053', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
441,Market Shows Breadth As Leaders Take A Breath: Weekly Review,https://www.investors.com/news/stock-market-rally-breadth-leaders-take-a-breath/,20240328T145250,"['IBD STAFF', ""Investor's Business Daily""]",The stock market rally was mixed in a holiday-shortened week. The Nasdaq fell modestly while the Russell 2000 rose solidly. Many AI and other growth leaders suffered solid to sharp losses. DraftKings ( DKNG ) fell sharply as the NCAA moved to ban special prop bets following claims regarding a pro ...,https://www.investors.com/wp-content/uploads/2021/03/Stock-BullPortrait-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.744043'}]",0.04615,Neutral,"[{'ticker': 'DKNG', 'relevance_score': '0.187949', 'ticker_sentiment_score': '-0.020614', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.063174', 'ticker_sentiment_score': '0.028481', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.063174', 'ticker_sentiment_score': '0.072062', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANET', 'relevance_score': '0.094638', 'ticker_sentiment_score': '-0.051824', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.094638', 'ticker_sentiment_score': '-0.021015', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FLUT', 'relevance_score': '0.063174', 'ticker_sentiment_score': '0.011055', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.063174', 'ticker_sentiment_score': '-0.01012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALT', 'relevance_score': '0.063174', 'ticker_sentiment_score': '-0.01012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DNUT', 'relevance_score': '0.157073', 'ticker_sentiment_score': '-0.027108', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.125953', 'ticker_sentiment_score': '-0.037416', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.157073', 'ticker_sentiment_score': '0.012638', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NCLH', 'relevance_score': '0.063174', 'ticker_sentiment_score': '-0.042335', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADBE', 'relevance_score': '0.094638', 'ticker_sentiment_score': '0.092167', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.063174', 'ticker_sentiment_score': '-0.01012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RCL', 'relevance_score': '0.063174', 'ticker_sentiment_score': '-0.042335', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HD', 'relevance_score': '0.063174', 'ticker_sentiment_score': '0.268541', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BA', 'relevance_score': '0.125953', 'ticker_sentiment_score': '0.08374', 'ticker_sentiment_label': 'Neutral'}]"
442,Eli Lilly vs. Berkshire Hathaway: Which Stock Will Become the Next Member of the $1 Trillion Club?,https://www.fool.com/investing/2024/03/28/eli-lilly-vs-berkshire-hathaway-which-stock-will-b/,20240328T130500,['David Jagielski'],"Don't assume that because Berkshire is worth nearly $900 billion, it's sure to get to $1 trillion first.",https://g.foolcdn.com/editorial/images/770397/stock-traders-looking-at-a-chart.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.459462'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.208619,Somewhat-Bullish,"[{'ticker': 'GS', 'relevance_score': '0.060236', 'ticker_sentiment_score': '0.040012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.594159', 'ticker_sentiment_score': '0.395934', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BRK-A', 'relevance_score': '0.12013', 'ticker_sentiment_score': '0.268975', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
443,Bull Market Buys: 3 Dividend Stocks to Own for the Long Run,https://www.fool.com/investing/2024/03/28/bull-market-buys-3-dividend-stocks-to-own-for-the/,20240328T123000,['Marc Rapport'],"Invest in stability, dividends, and growth with these three accomplished real estate operators.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F770757%2Freit-and-stock-chart.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.333333'}]",0.356204,Bullish,"[{'ticker': 'ARE', 'relevance_score': '0.061159', 'ticker_sentiment_score': '0.17707', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'T', 'relevance_score': '0.061159', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VZ', 'relevance_score': '0.061159', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.061159', 'ticker_sentiment_score': '0.149038', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMT', 'relevance_score': '0.408791', 'ticker_sentiment_score': '0.153084', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.061159', 'ticker_sentiment_score': '0.149038', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.061159', 'ticker_sentiment_score': '0.149038', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'O', 'relevance_score': '0.298749', 'ticker_sentiment_score': '0.234734', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
444,"Prediction: This Will Be the Next ""Magnificent Seven"" Stock",https://www.fool.com/investing/2024/03/28/this-will-be-next-magnificent-seven-stock/,20240328T105000,['Adria Cimino'],This particular company's growth is set to take off...,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F770699%2Fgettyimages-1191849990.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.614606'}]",0.336254,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.140213', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.140213', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.149346', 'ticker_sentiment_score': '0.313833', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.140213', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.09989', 'ticker_sentiment_score': '-0.018311', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.191248', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.050044', 'ticker_sentiment_score': '-0.063004', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.653512', 'ticker_sentiment_score': '0.469235', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'GS', 'relevance_score': '0.050044', 'ticker_sentiment_score': '-0.063004', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.140213', 'ticker_sentiment_label': 'Neutral'}]"
445,"Futures: Small Caps Jump But Nvidia, Growth Leaders Retreat",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-small-caps-power-higher-nvidia-growth-leaders-retreat/,20240327T204100,"[""Investor's Business Daily"", 'ED CARSON']","Dow Jones Futures: Small Caps Power Higher While Nvidia, Growth Leaders Retreat Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2017/11/stock-bull-tongue-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'IPO', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}]",0.103096,Neutral,"[{'ticker': 'DKNG', 'relevance_score': '0.138663', 'ticker_sentiment_score': '0.09456', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.337657', 'ticker_sentiment_score': '-0.100758', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALAB', 'relevance_score': '0.138663', 'ticker_sentiment_score': '-0.074302', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.206685', 'ticker_sentiment_score': '-0.092805', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRWD', 'relevance_score': '0.206685', 'ticker_sentiment_score': '-0.075383', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EWBC', 'relevance_score': '0.104228', 'ticker_sentiment_score': '-0.080418', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NCLH', 'relevance_score': '0.138663', 'ticker_sentiment_score': '0.053608', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOW', 'relevance_score': '0.172836', 'ticker_sentiment_score': '-0.064357', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.206685', 'ticker_sentiment_score': '0.143742', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RCL', 'relevance_score': '0.069596', 'ticker_sentiment_score': '0.080597', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARM', 'relevance_score': '0.138663', 'ticker_sentiment_score': '-0.074302', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.034831', 'ticker_sentiment_score': '0.112676', 'ticker_sentiment_label': 'Neutral'}]"
446,Amazon  ( AMZN )  Expands Same-Day Medication Delivery Service,https://www.zacks.com/stock/news/2246746/amazon-amzn-expands-same-day-medication-delivery-service,20240327T142300,['Zacks Equity Research'],Amazon (AMZN) expands same-day delivery of prescription medication to New York City and Los Angeles.,https://staticx-tuner.zacks.com/images/articles/main/4d/2657.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}]",0.262472,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.190667', 'ticker_sentiment_score': '0.006074', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LTTHF', 'relevance_score': '0.064104', 'ticker_sentiment_score': '0.074045', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EBAY', 'relevance_score': '0.127795', 'ticker_sentiment_score': '0.130543', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.828466', 'ticker_sentiment_score': '0.49868', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'KR', 'relevance_score': '0.252332', 'ticker_sentiment_score': '0.207383', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
447,Eli Lilly and Co's Options: A Look at What the Big Money is Thinking - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/03/37959034/eli-lilly-and-cos-options-a-look-at-what-the-big-money-is-thinking,20240327T134621,['Benzinga Insights'],"Investors with a lot of money to spend have taken a bearish stance on Eli Lilly and Co LLY. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.94762'}]",0.078676,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.827318', 'ticker_sentiment_score': '0.106044', 'ticker_sentiment_label': 'Neutral'}]"
448,Eli Lilly  ( LLY )  Advances While Market Declines: Some Information for Investors,https://www.zacks.com/stock/news/2246297/eli-lilly-lly-advances-while-market-declines-some-information-for-investors,20240326T214519,['Zacks Equity Research'],"In the most recent trading session, Eli Lilly (LLY) closed at $774.90, indicating a +0.23% shift from the previous trading day.",https://staticx-tuner.zacks.com/images/default_article_images/default144.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.961735'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.158274,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.592095', 'ticker_sentiment_score': '0.175739', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
449,"Dexcom Stock Shows Market Leadership, Gets Rating Upgrade. Prognosis Good.",https://www.investors.com/news/technology/dexcom-shows-market-leadership-with-jump-to-85-rs-rating/,20240326T175600,"['JAMES DETAR', ""INVESTOR'S BUSINESS DAILY"", ""Investor's Business Daily""]",Dexcom Stock A Leader. Prognosis Good Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2020/06/Stock-Diabetes-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999922'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.904684'}]",0.241901,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.132004', 'ticker_sentiment_score': '0.180181', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LFMD', 'relevance_score': '0.132004', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ITGR', 'relevance_score': '0.196877', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DXCM', 'relevance_score': '0.63935', 'ticker_sentiment_score': '0.28814', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.132004', 'ticker_sentiment_score': '0.180181', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
450,"CHMP to Delay Nod on Biogen  ( BIIB ) , Eisai's Alzheimer's Drug",https://www.zacks.com/stock/news/2246241/chmp-to-delay-nod-on-biogen-biib-eisais-alzheimers-drug,20240326T152100,['Zacks Equity Research'],"Per Biogen (BIIB)/Eisai, the delay in CHMP recommendation for lecanemab is entirely related to procedural reasons at the EMA and is not related to the companies' regulatory filing.",https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.070826,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.204072', 'ticker_sentiment_score': '0.052298', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANIP', 'relevance_score': '0.253514', 'ticker_sentiment_score': '0.165783', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PRTA', 'relevance_score': '0.301933', 'ticker_sentiment_score': '-0.021795', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESALF', 'relevance_score': '0.301933', 'ticker_sentiment_score': '0.223693', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.349153', 'ticker_sentiment_score': '0.225126', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
451,How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings,https://www.zacks.com/stock/news/2245863/how-to-boost-your-portfolio-with-top-medical-stocks-set-to-beat-earnings,20240326T125011,['Zacks Equity Research'],Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.,https://staticx-tuner.zacks.com/images/default_article_images/default5.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Earnings', 'relevance_score': '0.999756'}]",0.385942,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.390904', 'ticker_sentiment_score': '0.418501', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'CAH', 'relevance_score': '0.266828', 'ticker_sentiment_score': '0.271409', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
452,Futures Fall With Market At Highs; 3 Stocks Near Buy Points,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fed-ai-boom-drive/,20240325T111338,"[""Investor's Business Daily"", 'ED CARSON']","Dow Jones Futures Fall: Fed, AI Boom Keep Driving Stock Market. 3 Stocks Near Buy Points Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2019/10/stock-Federal-Reserve-fall-12-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.211205,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.234968', 'ticker_sentiment_score': '0.161222', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.346077', 'ticker_sentiment_score': '0.228016', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AVGO', 'relevance_score': '0.263309', 'ticker_sentiment_score': '0.192294', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CRWD', 'relevance_score': '0.177367', 'ticker_sentiment_score': '0.059004', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.08924', 'ticker_sentiment_score': '-0.097246', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.08924', 'ticker_sentiment_score': '-0.097246', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.118793', 'ticker_sentiment_score': '0.105486', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MU', 'relevance_score': '0.059562', 'ticker_sentiment_score': '0.287018', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UBER', 'relevance_score': '0.148182', 'ticker_sentiment_score': '0.050944', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.118793', 'ticker_sentiment_score': '-0.134343', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PANW', 'relevance_score': '0.059562', 'ticker_sentiment_score': '0.105167', 'ticker_sentiment_label': 'Neutral'}]"
453,"The Best Stocks to Invest $10,000 in Right Now",https://www.fool.com/investing/2024/03/25/the-best-stocks-to-invest-10000-in-right-now/,20240325T075500,['Joe Tenebruso'],These elite enterprises can help you grow richer.,https://g.foolcdn.com/editorial/images/770331/investor-gettyimages-1125967385.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.77141'}, {'topic': 'Earnings', 'relevance_score': '0.961735'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.36328,Bullish,"[{'ticker': 'EVR', 'relevance_score': '0.066047', 'ticker_sentiment_score': '0.179479', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.131643', 'ticker_sentiment_score': '0.115837', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.380978', 'ticker_sentiment_score': '0.378059', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'GS', 'relevance_score': '0.066047', 'ticker_sentiment_score': '0.132272', 'ticker_sentiment_label': 'Neutral'}]"
454,"59% of This Vanguard ETF Is Invested in the ""Magnificent Seven"" Stocks. Is It a No-Brainer Buy Right Now?",https://www.fool.com/investing/2024/03/24/vanguard-etf-magnificent-seven-buy-right-now/,20240324T105000,['Keith Speights'],"If you want to own all of the Magnificent Seven stocks plus other megacap winners, this ETF could be right up your alley.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F770060%2Fetf-board-and-person.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.999937'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.351336,Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.067536', 'ticker_sentiment_score': '0.187514', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.067536', 'ticker_sentiment_score': '0.178665', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.13459', 'ticker_sentiment_score': '0.218182', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.067536', 'ticker_sentiment_score': '0.187514', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.067536', 'ticker_sentiment_score': '0.178665', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'V', 'relevance_score': '0.067536', 'ticker_sentiment_score': '0.043078', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.067536', 'ticker_sentiment_score': '0.043078', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRCX', 'relevance_score': '0.067536', 'ticker_sentiment_score': '0.043078', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.067536', 'ticker_sentiment_score': '0.178665', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BA', 'relevance_score': '0.067536', 'ticker_sentiment_score': '0.043078', 'ticker_sentiment_label': 'Neutral'}]"
455,Two Tailwinds Continue To Fuel Market; 3 Stocks Setting Up Again,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-dovish-fed-nvidia-ai-boom-new-highs/,20240322T205833,"[""Investor's Business Daily"", 'ED CARSON']","Dow Jones Futures: Dovish Fed, Nvidia-Led AI Boom Keep Driving Stock Market. 3 Stocks Near Buy Points Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2019/10/stock-Federal-Reserve-fall-12-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.257842,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.252987', 'ticker_sentiment_score': '0.17094', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.342631', 'ticker_sentiment_score': '0.238243', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AVGO', 'relevance_score': '0.283323', 'ticker_sentiment_score': '0.203655', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CRWD', 'relevance_score': '0.19117', 'ticker_sentiment_score': '0.062342', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.128135', 'ticker_sentiment_score': '0.109337', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MU', 'relevance_score': '0.064276', 'ticker_sentiment_score': '0.288282', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UBER', 'relevance_score': '0.159781', 'ticker_sentiment_score': '0.053405', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PANW', 'relevance_score': '0.064276', 'ticker_sentiment_score': '0.105524', 'ticker_sentiment_label': 'Neutral'}]"
456,Comparative Study: Eli Lilly and Co And Industry Competitors In Pharmaceuticals Industry - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/news/24/03/37894869/comparative-study-eli-lilly-and-co-and-industry-competitors-in-pharmaceuticals-industry,20240322T160014,['Benzinga Insights'],"In the dynamic and cutthroat world of business, conducting thorough company analysis is essential for investors and industry experts. In this article, we will undertake a comprehensive industry comparison, evaluating Eli Lilly and Co LLY and its primary competitors in the Pharmaceuticals industry.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}]",0.189915,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.48182', 'ticker_sentiment_score': '0.231327', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
457,Learn How The Best Mutual Funds Deliver Benchmark-Beating Returns,https://www.investors.com/etfs-and-funds/mutual-funds/best-performing-mutual-funds-2024-beat-benchmarks/,20240322T123014,"['ADAM SHELL', ""Investor's Business Daily""]",Best Performing Mutual Funds Top Benchmarks Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2024/03/w.Vitrus032524eps-300x127.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.769861'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.818451'}]",0.312476,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.025219', 'ticker_sentiment_score': '0.136201', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVMI', 'relevance_score': '0.025219', 'ticker_sentiment_score': '0.051195', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.050412', 'ticker_sentiment_score': '0.108971', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.025219', 'ticker_sentiment_score': '0.136201', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LASR', 'relevance_score': '0.03782', 'ticker_sentiment_score': '-0.124863', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NXPI', 'relevance_score': '0.025219', 'ticker_sentiment_score': '0.087165', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.025219', 'ticker_sentiment_score': '0.136201', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MORN', 'relevance_score': '0.012611', 'ticker_sentiment_score': '0.164502', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AWON', 'relevance_score': '0.012611', 'ticker_sentiment_score': '0.046671', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRVL', 'relevance_score': '0.025219', 'ticker_sentiment_score': '0.087165', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSM', 'relevance_score': '0.012611', 'ticker_sentiment_score': '0.079997', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.03782', 'ticker_sentiment_score': '0.24374', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
458,Could Viking Therapeutics Become the Next Eli Lilly?,https://www.fool.com/investing/2024/03/22/could-viking-therapeutics-become-next-eli-lilly/,20240322T085500,['Adria Cimino'],Viking shares have skyrocketed on its recent good news.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F770100%2Fgettyimages-1220595235.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.459462'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.153814,Somewhat-Bullish,"[{'ticker': 'GS', 'relevance_score': '0.050894', 'ticker_sentiment_score': '0.123928', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.556298', 'ticker_sentiment_score': '0.243268', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VKTX', 'relevance_score': '0.151858', 'ticker_sentiment_score': '0.02695', 'ticker_sentiment_label': 'Neutral'}]"
459,"Is Pfizer Stock, At A Nine-Year Low, A Sell Amid The Search For Its Big Break?",https://www.investors.com/news/technology/pfizer-stock-buy-now/,20240320T170719,"[""Investor's Business Daily"", 'ALLISON GATLIN']","Pfizer ( PFE ) stock is trading at its lowest point in nine years as the drugmaker looks for its next big break after developing the first Covid vaccine with Germany's BioNTech ( BNTX ) . This month, the European Commission approved Pfizer's Prevnar 20, a vaccine to help protect babies and ...",https://www.investors.com/wp-content/uploads/2019/05/PFE-evergreen-051419-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.999981'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999976'}]",0.120598,Neutral,"[{'ticker': 'NVO', 'relevance_score': '0.061869', 'ticker_sentiment_score': '-0.125315', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.061869', 'ticker_sentiment_score': '-0.125315', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVAX', 'relevance_score': '0.061869', 'ticker_sentiment_score': '0.075008', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.061869', 'ticker_sentiment_score': '0.075008', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.061869', 'ticker_sentiment_score': '-0.14606', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.687052', 'ticker_sentiment_score': '0.203831', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BMY', 'relevance_score': '0.061869', 'ticker_sentiment_score': '0.059184', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BNTX', 'relevance_score': '0.061869', 'ticker_sentiment_score': '-0.14606', 'ticker_sentiment_label': 'Neutral'}]"
460,Eli Lilly and Co's Options Frenzy: What You Need to Know - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/03/37847944/eli-lilly-and-cos-options-frenzy-what-you-need-to-know,20240320T140206,['Benzinga Insights'],"Investors with a lot of money to spend have taken a bearish stance on Eli Lilly and Co LLY. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}]",0.107187,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.76213', 'ticker_sentiment_score': '0.106972', 'ticker_sentiment_label': 'Neutral'}]"
461,Will Novo Nordisk Overtake Eli Lilly as the Most Valuable Healthcare Stock?,https://www.fool.com/investing/2024/03/20/novo-nordisk-versus-eli-lilly/,20240320T123000,['David Jagielski'],The gap has been shrinking between these stocks over the past month.,https://g.foolcdn.com/editorial/images/769568/a-doctor-using-a-stethoscope.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.684621'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}]",0.119613,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.412861', 'ticker_sentiment_score': '0.219186', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.622414', 'ticker_sentiment_score': '0.216856', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
462,Eli Lilly  ( LLY )  Surpasses Market Returns: Some Facts Worth Knowing,https://www.zacks.com/stock/news/2243059/eli-lilly-lly-surpasses-market-returns-some-facts-worth-knowing,20240319T214520,['Zacks Equity Research'],"Eli Lilly (LLY) closed the most recent trading day at $772.78, moving +1.33% from the previous trading session.",https://staticx-tuner.zacks.com/images/default_article_images/default276.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.961735'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.185834,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.543535', 'ticker_sentiment_score': '0.280139', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
463,"Cramer Calls Datadog 'Dynamite,' Puts SoFi In Dog House: 'What The Heck Is Going On' - Datadog  ( NASDAQ:DDOG ) , Altimmune  ( NASDAQ:ALT ) ",https://www.benzinga.com/trading-ideas/long-ideas/24/03/37812350/cramer-calls-datadog-dynamite-puts-sofi-in-dog-house-what-the-heck-is-going-on,20240319T135514,['Avi Kapoor'],"On CNBC's ""Mad Money Lightning Round,"" Jim Cramer said Marvell Technology, Inc. MRVL reported a mixed quarter. ""We got to wait,"" he added.",https://cdn.benzinga.com/files/images/story/2024/03/19/datadog_cramer.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.26512,Somewhat-Bullish,"[{'ticker': 'LNTH', 'relevance_score': '0.31583', 'ticker_sentiment_score': '0.312008', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DDOG', 'relevance_score': '0.31583', 'ticker_sentiment_score': '0.294909', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.16117', 'ticker_sentiment_score': '0.139368', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALT', 'relevance_score': '0.239698', 'ticker_sentiment_score': '0.244588', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SOFI', 'relevance_score': '0.239698', 'ticker_sentiment_score': '-0.042238', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RDNT', 'relevance_score': '0.16117', 'ticker_sentiment_score': '0.272036', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MRVL', 'relevance_score': '0.31583', 'ticker_sentiment_score': '0.216086', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSM', 'relevance_score': '0.16117', 'ticker_sentiment_score': '0.204587', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOREX:RON', 'relevance_score': '0.081001', 'ticker_sentiment_score': '0.262039', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
464,Eli Lilly and Company  ( LLY )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2242689/eli-lilly-and-company-lly-is-a-trending-stock-facts-to-know-before-betting-on-it,20240319T130016,['Zacks Equity Research'],"Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",https://staticx-tuner.zacks.com/images/default_article_images/default345.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}]",0.224118,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.532696', 'ticker_sentiment_score': '0.154837', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
465,Should You Pick Eli Lilly Stock After A 4x Rise In Three Years?,https://www.forbes.com/sites/greatspeculations/2024/03/19/should-you-pick-eli-lilly-stock-after-a-4x-rise-in-three-years/,20240319T120031,['Trefis Team'],"Eli Lilly stock ( NYSE: LLY ) has seen phenomenal gains of 345% from levels of $170 in early January 2021 to around $755 now, vs. an increase of about 35% for the S&P 500 over this roughly three-year period. This can primarily be attributed to a significant 236% rise in the company's P/S ratio to ...",https://imageio.forbes.com/specials-images/imageserve/65f933b2ce306ad3e0975eb8/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds,Forbes,n/a,www.forbes.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.317785,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.702129', 'ticker_sentiment_score': '0.562014', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.075397', 'ticker_sentiment_score': '0.229058', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
466,Is Madrigal Pharmaceuticals Stock a Better Buy Than Eli Lilly and Novo Nordisk After Its Huge FDA Win?,https://www.fool.com/investing/2024/03/19/madrigal-eli-lilly-novo-nordisk-better-stock-buy/,20240319T095000,['Keith Speights'],Madrigal has one key advantage over its two huge potential future rivals.,https://g.foolcdn.com/editorial/images/769602/fda-blocks-in-hand.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.188805,Somewhat-Bullish,"[{'ticker': 'EVR', 'relevance_score': '0.047185', 'ticker_sentiment_score': '0.113464', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.558244', 'ticker_sentiment_score': '0.256798', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MDGL', 'relevance_score': '0.094204', 'ticker_sentiment_score': '0.25377', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.484881', 'ticker_sentiment_score': '0.272744', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
467,Forget Eli Lilly. Buy This Magnificent Biotech Stock Instead,https://www.fool.com/investing/2024/03/18/forget-eli-lilly-buy-this-magnificent-biotech-stoc/,20240318T060000,['Alex Carchidi'],This company's growth story is about to get moving with gusto.,https://g.foolcdn.com/editorial/images/769498/investors-discuss-investment-at-table.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.169366,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.128135', 'ticker_sentiment_score': '0.241596', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'IOVA', 'relevance_score': '0.128135', 'ticker_sentiment_score': '0.289351', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
468,3 Unstoppable Stocks You Can Buy Now Without Any Hesitation,https://www.fool.com/investing/2024/03/17/3-unstoppable-stocks-you-can-buy-now-without-any/,20240317T130000,"['Keith Speights', 'and Prosper Junior Bakiny', 'David Jagielski']",There's no need for delays in buying these great stocks.,https://g.foolcdn.com/editorial/images/769331/young-woman-smiling-hands-behind-head.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.127458,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.2256', 'ticker_sentiment_score': '-0.115588', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.151539', 'ticker_sentiment_score': '-0.165219', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NVO', 'relevance_score': '0.367141', 'ticker_sentiment_score': '0.252288', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
469,Eli Lilly Taps Amazon to Deliver Its Weight Management Blockbuster. Is It Time to Buy the Pharma Stock?,https://www.fool.com/investing/2024/03/17/eli-lilly-taps-amazon-to-deliver-its-weight-manage/,20240317T072400,['Cory Renauer'],Free two-day shipping for Prime members and a direct-to-consumer sales model could accelerate sales of Eli Lilly's Zepbound.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F769141%2Finvestor-looks-worried-at-computer-in-a-living-room-setting-getty.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}]",0.237044,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.51768', 'ticker_sentiment_score': '0.326446', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.056011', 'ticker_sentiment_score': '0.03811', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.221313', 'ticker_sentiment_score': '0.322193', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.111747', 'ticker_sentiment_score': '0.043944', 'ticker_sentiment_label': 'Neutral'}]"
470,The Trillion-Dollar Crystal Ball: 3 Companies Next in Line for the Market Milestone,https://markets.businessinsider.com/news/stocks/the-trillion-dollar-crystal-ball-3-companies-next-in-line-for-the-market-milestone-1033169865,20240316T180000,['Rick Orford'],"There are only six trillion-dollar stocks worldwide, every one of which is a popular name. And they all rightfully sit at the top of their sectors. There's a certain allure to reaching $1 trillion, and investors are always looking for the next one to breach that valuation.",https://investorplace.com/wp-content/uploads/2022/12/brk-3-300x169.jpg,Business Insider,GoogleRSS,markets.businessinsider.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.977154'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.999822'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.249159,Somewhat-Bullish,"[{'ticker': 'NVDA', 'relevance_score': '0.041828', 'ticker_sentiment_score': '0.133089', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.041828', 'ticker_sentiment_score': '0.133089', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.041828', 'ticker_sentiment_score': '0.219729', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'QCOM', 'relevance_score': '0.041828', 'ticker_sentiment_score': '0.133089', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.041828', 'ticker_sentiment_score': '0.219729', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BRK-A', 'relevance_score': '0.083541', 'ticker_sentiment_score': '0.161462', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.125025', 'ticker_sentiment_score': '0.158757', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
471,Eli Lilly Just Had a Setback. Is Its Stock Still a Buy?,https://www.fool.com/investing/2024/03/16/eli-lilly-just-had-a-setback-is-its-stock-still-a/,20240316T131500,['Alex Carchidi'],The drugmaker is caught up in an unexpected situation with regulators.,https://g.foolcdn.com/editorial/images/769169/stressed-investor-at-laptop.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.050877,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.272788', 'ticker_sentiment_score': '0.151333', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.069495', 'ticker_sentiment_score': '-0.095282', 'ticker_sentiment_label': 'Neutral'}]"
472,"Nasdaq, S&P 500 Extend Losses; Adobe Sell-Off Casts Pall On Tech; Ulta Beauty Tumbles",https://www.investors.com/market-trend/stock-market-today/dow-jones-sp500-nasdaq-adobe-stock/,20240315T144448,"['KEN SHREVE', ""Investor's Business Daily""]","Nasdaq, S&P 500 Extend Losses. Adobe Sell-Off Casts Pall On Tech. Ulta Beauty Tumbles Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2021/02/Stock-MarketBoard-Blue42-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.999921'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.839681'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.073182,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.155451', 'ticker_sentiment_score': '-0.128398', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSTR', 'relevance_score': '0.155451', 'ticker_sentiment_score': '-0.077214', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.231332', 'ticker_sentiment_score': '-0.001903', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ULTA', 'relevance_score': '0.155451', 'ticker_sentiment_score': '0.080304', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.155451', 'ticker_sentiment_score': '0.242862', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ADBE', 'relevance_score': '0.305058', 'ticker_sentiment_score': '0.011581', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.155451', 'ticker_sentiment_score': '0.242862', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MDGL', 'relevance_score': '0.155451', 'ticker_sentiment_score': '0.242862', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CLSK', 'relevance_score': '0.155451', 'ticker_sentiment_score': '-0.077214', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COIN', 'relevance_score': '0.155451', 'ticker_sentiment_score': '-0.077214', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.231332', 'ticker_sentiment_score': '-0.103425', 'ticker_sentiment_label': 'Neutral'}]"
473,Can Eli Lilly Stock Double in 5 Years? Here's What It Would Take.,https://www.fool.com/investing/2024/03/15/can-eli-lilly-stock-double-in-5-years-heres-what/,20240315T131500,['David Jagielski'],The company's valuation may be high but that doesn't mean Eli Lilly is anywhere near its peak.,https://g.foolcdn.com/editorial/images/768802/a-doctor-looking-at-a-tablet-with-another-person.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.684621'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.459462'}]",0.261434,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.601928', 'ticker_sentiment_score': '0.3645', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'AWON', 'relevance_score': '0.056143', 'ticker_sentiment_score': '0.012002', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.056143', 'ticker_sentiment_score': '0.042051', 'ticker_sentiment_label': 'Neutral'}]"
474,"Move Over, Tesla! These 6 Stocks Could Replace It in the ""Magnificent 7""",https://www.fool.com/investing/2024/03/15/move-over-tesla-these-6-stocks-could-replace-it-in/,20240315T114600,['Justin Pope'],Tesla is failing to keep pace with the rest of the Magnificent Seven.,https://g.foolcdn.com/editorial/images/769058/brk-4.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.308524,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.051886', 'ticker_sentiment_score': '0.202585', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.051886', 'ticker_sentiment_score': '0.202585', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.20537', 'ticker_sentiment_score': '0.246414', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AVGO', 'relevance_score': '0.103554', 'ticker_sentiment_score': '0.095498', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.154785', 'ticker_sentiment_score': '0.181921', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.154785', 'ticker_sentiment_score': '0.092116', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.255106', 'ticker_sentiment_score': '0.030308', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.051886', 'ticker_sentiment_score': '0.093536', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.3038', 'ticker_sentiment_score': '0.258595', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSM', 'relevance_score': '0.3038', 'ticker_sentiment_score': '0.237763', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
475,Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?,https://www.fool.com/investing/2024/03/15/pfizer-viking-therapeutics-eli-lilly-novo-nordisk/,20240315T095000,['Keith Speights'],Viking Therapeutics just might be an attractive acquisition target for Pfizer.,https://g.foolcdn.com/editorial/images/769056/big-fish-eating-little-fish.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.143119,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.168884', 'ticker_sentiment_score': '0.149347', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALT', 'relevance_score': '0.056674', 'ticker_sentiment_score': '0.037', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BHVN', 'relevance_score': '0.056674', 'ticker_sentiment_score': '0.16697', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VKTX', 'relevance_score': '0.223866', 'ticker_sentiment_score': '0.212839', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.168884', 'ticker_sentiment_score': '0.149347', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.823212', 'ticker_sentiment_score': '0.234987', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
476,Amazon  ( AMZN )  Boosts Pharmacy Efforts With Lilly's Partnership,https://www.zacks.com/stock/news/2240963/amazon-amzn-boosts-pharmacy-efforts-with-lillys-partnership,20240314T155000,['Zacks Equity Research'],"Amazon (AMZN) teams up with Lilly to deliver drug prescriptions that are sent to the latter's direct-to-consumer service, LillyDirect.",https://staticx-tuner.zacks.com/images/articles/main/4d/2657.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}]",0.233733,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.284696', 'ticker_sentiment_score': '0.093314', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EBAY', 'relevance_score': '0.144708', 'ticker_sentiment_score': '0.094316', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.798255', 'ticker_sentiment_score': '0.459306', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'KR', 'relevance_score': '0.284696', 'ticker_sentiment_score': '0.155542', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
477,Should Investors Worry About Eli Lilly's Latest Regulatory Setback?,https://www.fool.com/investing/2024/03/14/should-investors-worry-about-eli-lillys-latest-reg/,20240314T123000,['Prosper Junior Bakiny'],There are good reasons to remain optimistic.,https://g.foolcdn.com/editorial/images/768907/doctor-and-patient-talking.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}]",0.155591,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.510952', 'ticker_sentiment_score': '0.288214', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
478,Eli Lilly  ( LLY )  Ascends While Market Falls: Some Facts to Note,https://www.zacks.com/stock/news/2240274/eli-lilly-lly-ascends-while-market-falls-some-facts-to-note,20240313T214519,['Zacks Equity Research'],"Eli Lilly (LLY) reachead $757.84 at the closing of the latest trading day, reflecting a +0.38% change compared to its last close.",https://staticx-tuner.zacks.com/images/default_article_images/default306.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.986564'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.192562,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.580956', 'ticker_sentiment_score': '0.249981', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
479,Lilly Teams Up With Amazon To Deliver Weight-Loss Drug,https://www.investors.com/news/technology/eli-lilly-amazon-pharmacy-lillydirect-weight-loss-drug-zepbound/,20240313T171932,"[""Investor's Business Daily"", 'ALLISON GATLIN']","Eli Lilly Taps Amazon Pharmacy To Help Deliver Weight-Loss Drug, Zepbound Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2018/05/Stock-Lilly-01-Shutterstock.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.035732,Neutral,"[{'ticker': 'EVR', 'relevance_score': '0.075635', 'ticker_sentiment_score': '-0.041654', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.552443', 'ticker_sentiment_score': '-0.070742', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.075635', 'ticker_sentiment_score': '-0.242397', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AMZN', 'relevance_score': '0.364987', 'ticker_sentiment_score': '0.088979', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.150592', 'ticker_sentiment_score': '-0.127667', 'ticker_sentiment_label': 'Neutral'}]"
480,IBD Stock Of The Day Lingers In Buy Zone As Diabetes Play Eyes Obesity,https://www.investors.com/research/ibd-stock-of-the-day/dexcom-stock-buy-zone-diabetes-obesity-continuous-glucose-monitors/,20240313T160442,"['ALLISON GATLIN', ""Investor's Business Daily""]","Dexcom ( DXCM ) is Wednesday's IBD Stock Of The Day. Dexcom stock is lingering in a buy zone, bolstered by U.S. clearance of a new body-worn glucose monitor. The company developed Stelo, its newest continuous glucose monitor, for the roughly 25 million people in the U.S. with type 2 diabetes ...",https://www.investors.com/wp-content/uploads/2024/03/SOTD-3-13-24DXCM.png,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.996023'}]",0.138038,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.053149', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.10132', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.10132', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.057767', 'ticker_sentiment_score': '-0.23901', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'DXCM', 'relevance_score': '0.531326', 'ticker_sentiment_score': '0.152339', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.053149', 'ticker_sentiment_label': 'Neutral'}]"
481,"2 No-Brainer Stocks I'd Add to the ""Magnificent Seven""",https://www.fool.com/investing/2024/03/13/2-no-brainer-stocks-id-add-to-magnificent-seven/,20240313T134500,['Prosper Junior Bakiny'],They fit right in.,https://media.ycharts.com/charts/e88a70f1dbaeb58217edf59cea01b1d9.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.839681'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.394698,Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.099476', 'ticker_sentiment_score': '0.22383', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NFLX', 'relevance_score': '0.508232', 'ticker_sentiment_score': '0.4881', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'GOOG', 'relevance_score': '0.099476', 'ticker_sentiment_score': '0.096535', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.049835', 'ticker_sentiment_score': '0.167998', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.099476', 'ticker_sentiment_score': '0.228793', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.049835', 'ticker_sentiment_score': '0.167998', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.049835', 'ticker_sentiment_score': '0.126736', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.338251', 'ticker_sentiment_score': '0.465553', 'ticker_sentiment_label': 'Bullish'}]"
482,"Jim Cramer Says Tuesday Rally Was Driven By Nvidia, Eli Lilly And Other 'Stocks Reacting Positively To Good Earnings Per Share News' - Costco Wholesale  ( NASDAQ:COST ) , Broadcom  ( NASDAQ:AVGO ) ",https://www.benzinga.com/markets/equities/24/03/37648583/jim-cramer-says-tuesday-rally-was-driven-by-nvidia-eli-lilly-and-other-stocks-reacting-positivel,20240313T082542,['Benzinga Neuro'],U.S. stocks experienced a rise on Tuesday following consecutive losses for the S&P 500 and Nasdaq. What Happened: This positive turn occurred despite a slightly warmer-than-expected February consumer price index.,https://cdn.benzinga.com/files/images/story/2024/Financial-Analyst-Using-Smartphone-With-_18.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}]",0.344907,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.193465', 'ticker_sentiment_score': '-0.245996', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NVDA', 'relevance_score': '0.28664', 'ticker_sentiment_score': '-0.004381', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.193465', 'ticker_sentiment_score': '-0.245996', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AVGO', 'relevance_score': '0.193465', 'ticker_sentiment_score': '0.27628', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
483,Skin Disease-Focused AnaptysBio Earns Analyst Upgrade On Positive Outlook For Clinical Triggers - AnaptysBio  ( NASDAQ:ANAB ) ,https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37631577/skin-disease-focused-anaptysbio-earns-analyst-upgrade-on-positive-outlook-for-clini,20240312T184852,['Vandana Singh'],"Monday, AnaptysBio Inc ANAB reported a fourth-quarter 2023 EPS of $ ( 1.59 ) , slightly better than the consensus of $ ( 1.60 ) . The company reported sales of $9.01 million, surpassing the consensus of $2.23 million.",https://cdn.benzinga.com/files/images/story/2024/Chem-Lab_1.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}]",0.242434,Somewhat-Bullish,"[{'ticker': 'ANAB', 'relevance_score': '0.682689', 'ticker_sentiment_score': '0.405936', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.261117', 'ticker_sentiment_score': '0.078327', 'ticker_sentiment_label': 'Neutral'}]"
484,Unpacking the Latest Options Trading Trends in Eli Lilly and Co - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/03/37620871/unpacking-the-latest-options-trading-trends-in-eli-lilly-and-co,20240312T140118,['Benzinga Insights'],"Financial giants have made a conspicuous bearish move on Eli Lilly and Co. Our analysis of options history for Eli Lilly and Co LLY revealed 19 unusual trades. Delving into the details, we found 42% of traders were bullish, while 57% showed bearish tendencies.",https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.977154'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.002411,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.814341', 'ticker_sentiment_score': '-0.028518', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.087824', 'ticker_sentiment_score': '-0.10524', 'ticker_sentiment_label': 'Neutral'}]"
485,"Meet the Unknown Small-Cap Company That's Been Paying a Dividend for at Least 66 Years Longer Than Coca-Cola, ExxonMobil, and Eli Lilly",https://www.fool.com/investing/2024/03/12/pay-dividend-66-years-longer-coca-cola-exxonmobil/,20240312T092100,['Sean Williams'],A relatively tiny company ($508 million market cap) that most investors have never heard of has been doling out a consecutive dividend for over two centuries -- including 104 years longer than Coca-Cola!,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F768822%2Fgetting-paid-dividends-getty.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}]",0.171844,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.267926', 'ticker_sentiment_score': '0.060302', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'YORW', 'relevance_score': '0.169437', 'ticker_sentiment_score': '-0.024071', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.299884', 'ticker_sentiment_score': '0.088436', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.299884', 'ticker_sentiment_score': '0.158856', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
486,Behind the Scenes of Eli Lilly and Co's Latest Options Trends - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/03/37597261/behind-the-scenes-of-eli-lilly-and-cos-latest-options-trends,20240311T190111,['Benzinga Insights'],"Whales with a lot of money to spend have taken a noticeably bearish stance on Eli Lilly and Co. Looking at options history for Eli Lilly and Co LLY we detected 128 trades. If we consider the specifics of each trade, it is accurate to state that 30% of the investors opened trades with bullish ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",-0.007185,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.819198', 'ticker_sentiment_score': '0.040833', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.088799', 'ticker_sentiment_score': '-0.105459', 'ticker_sentiment_label': 'Neutral'}]"
487,"The Zacks Analyst Blog Highlights Nvidia, Constellation Energy, Meta Platforms, Advanced Micro Devices and Eli Lilly",https://www.zacks.com/stock/news/2238727/the-zacks-analyst-blog-highlights-nvidia-constellation-energy-meta-platforms-advanced-micro-devices-and-eli-lilly,20240311T141400,['Zacks Equity Research'],"Nvidia, Constellation Energy, Meta Platforms, Advanced Micro Devices and Eli Lilly are part of the Zacks top Analyst Blog.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.928139'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.995015'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.928139'}]",0.18251,Somewhat-Bullish,"[{'ticker': 'AMD', 'relevance_score': '0.224072', 'ticker_sentiment_score': '0.079315', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.224072', 'ticker_sentiment_score': '0.165376', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.267315', 'ticker_sentiment_score': '0.100265', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.224072', 'ticker_sentiment_score': '0.108054', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CEG', 'relevance_score': '0.224072', 'ticker_sentiment_score': '0.15192', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
488,Novo Nordisk's  ( NVO )  Wegovy Gets FDA Nod to Reduce Heart Risk,https://www.zacks.com/stock/news/2238445/novo-nordisks-nvo-wegovy-gets-fda-nod-to-reduce-heart-risk,20240311T105900,['Zacks Equity Research'],Novo Nordisk (NVO) announces FDA approval of its application seeking label expansion for Wegovy to reduce the risks of major adverse cardiovascular events.,https://staticx-tuner.zacks.com/images/articles/main/de/2471.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.07767,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.225425', 'ticker_sentiment_score': '0.229078', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FGEN', 'relevance_score': '0.225425', 'ticker_sentiment_score': '-0.028692', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.433215', 'ticker_sentiment_score': '-0.103756', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ACET', 'relevance_score': '0.225425', 'ticker_sentiment_score': '-0.028666', 'ticker_sentiment_label': 'Neutral'}]"
489,Lilly  ( LLY )  Stock Down as FDA Delays Decision on Donanemab,https://www.zacks.com/stock/news/2238437/lilly-lly-stock-down-as-fda-delays-decision-on-donanemab,20240311T103400,['Zacks Equity Research'],"The FDA decision on Eli Lilly's (LLY) Alzheimer's candidate, donanemab, was expected in the first quarter of 2024, which has now been delayed.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.769861'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.050558,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.409742', 'ticker_sentiment_score': '0.036375', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VNDA', 'relevance_score': '0.299478', 'ticker_sentiment_score': '0.035593', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESALF', 'relevance_score': '0.061315', 'ticker_sentiment_score': '0.089066', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GSK', 'relevance_score': '0.299478', 'ticker_sentiment_score': '0.260577', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.299478', 'ticker_sentiment_score': '0.098991', 'ticker_sentiment_label': 'Neutral'}]"
490,"Forget Tesla: I Think This Stock Should Replace It in the ""Magnificent Seven""",https://www.fool.com/investing/2024/03/10/forget-tesla-i-think-this-stock-should-replace-it/,20240310T132900,['Keith Speights'],Tesla doesn't look very magnificent these days. But there's another stock that does.,https://g.foolcdn.com/editorial/images/768602/scientist-smiling-holding-tablet-computer.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}]",0.17247,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.110973', 'ticker_sentiment_score': '0.191625', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.469935', 'ticker_sentiment_score': '0.031351', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.514619', 'ticker_sentiment_score': '0.12536', 'ticker_sentiment_label': 'Neutral'}]"
491,Meet the 5 Stocks That Have Contributed Almost All of the S&P 500's 2024 Gains,https://www.fool.com/investing/2024/03/10/5-stocks-contributed-almost-all-market-2024-gains/,20240310T100500,['Daniel Foelber'],These companies have contributed the lion's share of the S&P 500's 7% year-to-date gain.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F767902%2Fgettyimages-1473086836-1201x686-332c1f1.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.905476'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.204433,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.214937', 'ticker_sentiment_score': '0.102298', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.214937', 'ticker_sentiment_score': '0.102298', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.162073', 'ticker_sentiment_score': '0.097419', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.214937', 'ticker_sentiment_score': '0.158636', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.054359', 'ticker_sentiment_score': '0.013996', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.162073', 'ticker_sentiment_score': '0.013969', 'ticker_sentiment_label': 'Neutral'}]"
492,Is Novo Nordisk a Buy After Its New Obesity Candidate's Success in a Clinical Trial?,https://www.fool.com/investing/2024/03/10/is-novo-nordisk-a-buy-after-its-new-obesity-candid/,20240310T083300,['Cory Renauer'],Encouraging results recently pushed the pharma stock up to new heights.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F768402%2Finvestors-evaluating-a-stock-purchase-getty.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.217219,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.113866', 'ticker_sentiment_score': '0.112083', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CURN', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.130125', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.526003', 'ticker_sentiment_score': '0.344971', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
493,"The Best Stocks to Invest $50,000 in Right Now",https://www.fool.com/investing/2024/03/09/the-best-stocks-to-invest-50000-in-right-now/,20240309T150000,['Joe Tenebruso'],These stalwart companies can help you grow your wealth.,https://g.foolcdn.com/editorial/images/768289/investor-gettyimages-694072990.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.414581,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.12013', 'ticker_sentiment_score': '0.003805', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.34974', 'ticker_sentiment_score': '0.548612', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'COST', 'relevance_score': '0.294446', 'ticker_sentiment_score': '0.479203', 'ticker_sentiment_label': 'Bullish'}]"
494,Is Eli Lilly the Best Pharmaceutical Stock for You?,https://www.fool.com/investing/2024/03/09/is-eli-lilly-the-best-pharmaceutical-stock-for-you/,20240309T100700,['Adria Cimino'],Lilly's recently approved weight-loss drug is off to a good start.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F768573%2Fgettyimages-1276837766.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Earnings', 'relevance_score': '0.999986'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.271218,Somewhat-Bullish,"[{'ticker': 'GS', 'relevance_score': '0.055364', 'ticker_sentiment_score': '0.037895', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.555067', 'ticker_sentiment_score': '0.35693', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.055364', 'ticker_sentiment_score': '0.034028', 'ticker_sentiment_label': 'Neutral'}]"
495,Ozempic or Tesla? Markets are in no doubt which is hotter | Business,https://www.cnn.com/2024/03/08/business/novo-nordisk-share-price-wegovy/index.html,20240308T162300,['Anna Cooban'],Ozempic or Tesla? Markets are in no doubt which is hotter ...,"https://media.cnn.com/api/v1/images/stellar/prod/gettyimages-1812475431.jpg?c=16x9&q=h_144,w_256,c_fill",CNN,Economy,www.cnn.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",0.034036,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.155451', 'ticker_sentiment_score': '0.198439', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.256179', 'ticker_sentiment_score': '-0.003894', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DNSKF', 'relevance_score': '0.052112', 'ticker_sentiment_score': '0.068617', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.305058', 'ticker_sentiment_score': '0.242631', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
496,S&P 500 Soars to New Highs: 5 Best Stocks YTD,https://www.zacks.com/stock/news/2238098/sp-500-soars-to-new-highs-5-best-stocks-ytd,20240308T160500,['Sweta Killa'],"The S&P 500 soared to new all-time highs on reassuring comments regarding potential interest rate declines. SPDR S&P 500 ETF Trust (SPY), the proxy version of the S&P 500 Index, has risen 8.3% so far this year.",https://staticx-tuner.zacks.com/images/default_article_images/default186.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.928139'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.980716'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.928139'}]",0.180612,Somewhat-Bullish,"[{'ticker': 'AMD', 'relevance_score': '0.200273', 'ticker_sentiment_score': '0.105162', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.200273', 'ticker_sentiment_score': '0.216301', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.248851', 'ticker_sentiment_score': '0.130328', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.150906', 'ticker_sentiment_score': '0.12481', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CEG', 'relevance_score': '0.200273', 'ticker_sentiment_score': '0.190196', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
497,In-Depth Analysis: Eli Lilly and Co Versus Competitors In Pharmaceuticals Industry - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/news/24/03/37562337/in-depth-analysis-eli-lilly-and-co-versus-competitors-in-pharmaceuticals-industry,20240308T160013,['Benzinga Insights'],"In today's rapidly changing and highly competitive business world, it is vital for investors and industry enthusiasts to carefully assess companies. In this article, we will perform a comprehensive industry comparison, evaluating Eli Lilly and Co LLY against its key competitors in the ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.193839,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.551009', 'ticker_sentiment_score': '0.289642', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
498,"Market Rally Hits Fresh Highs As Nvidia, Bitcoin Soar: Weekly Review",https://www.investors.com/news/stock-market-rally-hits-fresh-highs-as-nvidia-novo-nordisk-bitcoin-soar-weekly-review/,20240308T155800,"['IBD STAFF', ""Investor's Business Daily""]","The stock market rally suffered a sharp loss Tuesday but quickly rebounded, with the S&P 500 and Nasdaq composite hitting record highs. The Dow Jones fell modestly, but pared losses. Nvidia ( NVDA ) and chipmakers led the advance, while some software names struggled.",https://www.investors.com/wp-content/uploads/2019/05/STock-NYSEstockExchange-05-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.995077'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.032056,Neutral,"[{'ticker': 'BLK', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.073763', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TGT', 'relevance_score': '0.145145', 'ticker_sentiment_score': '0.161391', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VMW', 'relevance_score': '0.020848', 'ticker_sentiment_score': '0.095449', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GTLB', 'relevance_score': '0.041682', 'ticker_sentiment_score': '-0.029991', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.062488', 'ticker_sentiment_score': '0.105246', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.083251', 'ticker_sentiment_score': '-0.095245', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIVN', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.096651', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDB', 'relevance_score': '0.062488', 'ticker_sentiment_score': '-0.011132', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GPS', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.102577', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COIN', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.073763', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BASE', 'relevance_score': '0.041682', 'ticker_sentiment_score': '-0.061438', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.020848', 'ticker_sentiment_score': '0.082144', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BURL', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.164906', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SE', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.026943', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.124593', 'ticker_sentiment_score': '-0.138354', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.041682', 'ticker_sentiment_score': '-0.01093', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLTR', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.067953', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JWN', 'relevance_score': '0.041682', 'ticker_sentiment_score': '-0.074982', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MARA', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.073763', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.041682', 'ticker_sentiment_score': '-0.165265', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CRWD', 'relevance_score': '0.103957', 'ticker_sentiment_score': '-0.108494', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IOT', 'relevance_score': '0.083251', 'ticker_sentiment_score': '-0.134097', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVAV', 'relevance_score': '0.041682', 'ticker_sentiment_score': '-0.102717', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NIO', 'relevance_score': '0.083251', 'ticker_sentiment_score': '-0.114471', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROST', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.164906', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ANF', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.102577', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.123255', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRVL', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.103521', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.123255', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.062488', 'ticker_sentiment_score': '-0.031232', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:ETH', 'relevance_score': '0.020848', 'ticker_sentiment_score': '0.067571', 'ticker_sentiment_label': 'Neutral'}]"
499,S&P 500 Soars to New Highs: 5 Best Stocks YTD,https://www.zacks.com/stock/news/2238098/sp-500-soars-to-new-highs-5-best-stocks-ytd,20240308T150500,['Sweta Killa'],"The S&P 500 soared to new all-time highs on reassuring comments regarding potential interest rate declines. SPDR S&P 500 ETF Trust (SPY), the proxy version of the S&P 500 Index, has risen 8.3% so far this year.",https://staticx-tuner.zacks.com/images/default_article_images/default186.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.928139'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.980716'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.928139'}]",0.180612,Somewhat-Bullish,"[{'ticker': 'AMD', 'relevance_score': '0.200273', 'ticker_sentiment_score': '0.105162', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.200273', 'ticker_sentiment_score': '0.216301', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.248851', 'ticker_sentiment_score': '0.130328', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.150906', 'ticker_sentiment_score': '0.12481', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CEG', 'relevance_score': '0.200273', 'ticker_sentiment_score': '0.190196', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
500,Investors Heavily Search Eli Lilly and Company  ( LLY ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2237910/investors-heavily-search-eli-lilly-and-company-lly-here-is-what-you-need-to-know,20240308T140017,['Zacks Equity Research'],"Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.",https://staticx-tuner.zacks.com/images/default_article_images/default6.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}]",0.248212,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.525907', 'ticker_sentiment_score': '0.178495', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
501,"Zacks Market Edge Highlights: NVDA, DELL, LLY, CMG and CAVA",https://www.zacks.com/stock/news/2237763/zacks-market-edge-highlights-nvda-dell-lly-cmg-and-cava,20240308T110000,['Zacks Investment Research'],"NVDA, DELL, LLY, CMG and CAVA have been highlighted in this Market Edge article.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.998962'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.838487'}]",0.151223,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.269776', 'ticker_sentiment_score': '0.03231', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.465196', 'ticker_sentiment_score': '0.11575', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMG', 'relevance_score': '0.163909', 'ticker_sentiment_score': '0.167831', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CAVA', 'relevance_score': '0.320974', 'ticker_sentiment_score': '0.150918', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DELL', 'relevance_score': '0.217346', 'ticker_sentiment_score': '0.177879', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
502,"Retail Traders Ditch Tesla, Apple, Google For Pharma Stocks Like Ozempic-Maker Novo Nordisk And Eli Lilly: JPMorgan - Alphabet  ( NASDAQ:GOOG ) , Apple  ( NASDAQ:AAPL ) ",https://www.benzinga.com/markets/equities/24/03/37552341/retail-traders-ditch-tesla-apple-google-for-pharma-stocks-like-ozempic-maker-novo-nordisk-and-el,20240308T052253,['Benzinga Neuro'],"Retail traders have been observed to be selling off their shares in the 'Magnificent Seven' tech stocks, with a noticeable shift towards pharmaceutical stocks, according to a recent report by JPMorgan.",https://cdn.benzinga.com/files/images/story/2024/stock-market-bse-nse_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.121711,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.195814', 'ticker_sentiment_score': '0.159718', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GOOG', 'relevance_score': '0.195814', 'ticker_sentiment_score': '0.159718', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.195814', 'ticker_sentiment_score': '0.088137', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.290033', 'ticker_sentiment_score': '0.104868', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.290033', 'ticker_sentiment_score': '0.104868', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.195814', 'ticker_sentiment_score': '0.088137', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.290033', 'ticker_sentiment_score': '0.159927', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.098659', 'ticker_sentiment_score': '0.037937', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APOS', 'relevance_score': '0.098659', 'ticker_sentiment_score': '-0.199911', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PFE', 'relevance_score': '0.195814', 'ticker_sentiment_score': '0.088137', 'ticker_sentiment_label': 'Neutral'}]"
503,Insurance Coverage For Weight Loss Drugs - Cigna Unveils Efforts To Limit Health Plans/Employers Spending - Cigna Group  ( NYSE:CI ) ,https://www.benzinga.com/news/earnings/24/03/37542349/insurance-coverage-for-weight-loss-drugs-cigna-unveils-efforts-to-limit-health-plansemployers-spend,20240307T181842,['Vandana Singh'],"Thursday, Evernorth Health Services, a subsidiary of Cigna Group CI introduced a financial guarantee within its EncircleRx program. The move aims to provide clients with predictability when covering GLP-1s, ultimately empowering companies and health plans to exercise better control over their ...",https://cdn.benzinga.com/files/images/story/2024/Ozempic-and-other-drugs-for-weight-loss_1.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.281036,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.208464', 'ticker_sentiment_score': '0.150868', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.208464', 'ticker_sentiment_score': '0.150868', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
504,Lilly  ( LLY )  Up 7.5% Since Last Earnings Report: Can It Continue?,https://www.zacks.com/stock/news/2237480/lilly-lly-up-75-since-last-earnings-report-can-it-continue,20240307T163058,['Zacks Equity Research'],Lilly (LLY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,https://staticx-tuner.zacks.com/images/default_article_images/default251.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.108179'}]",0.117098,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.395669', 'ticker_sentiment_score': '0.157298', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.08687', 'ticker_sentiment_score': '0.036966', 'ticker_sentiment_label': 'Neutral'}]"
505,Should You Buy Red-Hot Stocks Now or Wait?,https://www.zacks.com/stock/news/2237396/should-you-buy-red-hot-stocks-now-or-wait,20240307T153300,['Tracey Ryniec'],"After a mesmerizing rally to start 2024, is it too late to buy the hottest stocks?",https://staticx-tuner.zacks.com/images/articles/main/02/36829.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.918141'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.838487'}]",0.123746,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.318897', 'ticker_sentiment_score': '0.036922', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.540534', 'ticker_sentiment_score': '0.12672', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMG', 'relevance_score': '0.194763', 'ticker_sentiment_score': '0.189309', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CAVA', 'relevance_score': '0.378094', 'ticker_sentiment_score': '0.170819', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DELL', 'relevance_score': '0.257668', 'ticker_sentiment_score': '0.203418', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
506,Nektar  ( NKTR )  Begins Phase IIb Study Rezpeg in Alopecia Areata,https://www.zacks.com/stock/news/2236911/nektar-nktr-begins-phase-iib-study-rezpeg-in-alopecia-areata,20240306T173300,['Zacks Equity Research'],"The placebo-controlled, phase IIb study will investigate the efficacy and safety of Nektar's (NKTR) rezpeg in patients with severe to very severe alopecia areata.",https://staticx-tuner.zacks.com/images/articles/main/67/1932.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",-0.023958,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.276909', 'ticker_sentiment_score': '0.046072', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INDV', 'relevance_score': '0.276909', 'ticker_sentiment_score': '0.258128', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VNDA', 'relevance_score': '0.445179', 'ticker_sentiment_score': '0.176086', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NKTR', 'relevance_score': '0.276909', 'ticker_sentiment_score': '-0.256197', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
507,Is Viking Therapeutics Stock a Better Buy Than Eli Lilly and Novo Nordisk After the Latest Weight-Loss Drug News?,https://www.fool.com/investing/2024/03/06/is-viking-therapeutics-stock-a-better-buy-than-eli/,20240306T105000,['Keith Speights'],A new player in the multibillion-dollar weight-loss drug market could be waiting in the wings.,https://g.foolcdn.com/editorial/images/768024/scientists-smiling-and-shaking-hands.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.209691,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.63878', 'ticker_sentiment_score': '0.405744', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'VKTX', 'relevance_score': '0.398148', 'ticker_sentiment_score': '0.207258', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.603465', 'ticker_sentiment_score': '0.395508', 'ticker_sentiment_label': 'Bullish'}]"
508,Better Weight Loss Drug Stock: Viking Therapeutics vs. Eli Lilly,https://www.fool.com/investing/2024/03/05/better-weight-loss-drug-stock-viking-therapeutics/,20240305T111500,['Alex Carchidi'],"One is a reigning champion, and the other is a burgeoning contender.",https://g.foolcdn.com/editorial/images/767463/scientists-lab-testing-blood-draw.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.135374,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.274834', 'ticker_sentiment_score': '0.159272', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VKTX', 'relevance_score': '0.230454', 'ticker_sentiment_score': '0.152596', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.046724', 'ticker_sentiment_score': '-0.000999', 'ticker_sentiment_label': 'Neutral'}]"
509,"Jim Cramer Says Nvidia, Eli Lilly, Novo Nordisk Are Not Overvalued: 'Will Be Ready To Buy If This Market Sells Off' - NVIDIA  ( NASDAQ:NVDA ) , Eli Lilly and Co  ( NYSE:LLY ) ",https://www.benzinga.com/markets/equities/24/03/37474512/jim-cramer-says-nvidia-eli-lilly-novo-nordisk-are-not-overvalued-will-be-ready-to-buy-if-this-ma,20240305T063337,['Benzinga Neuro'],"CNBC host Jim Cramer advised investors to gear up for a potential market sell-off, asserting that they should be ready to make purchases if undervalued stocks dip.",https://cdn.benzinga.com/files/images/story/2024/Jim-Cramer_2.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.248444,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.277958', 'ticker_sentiment_score': '0.227008', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.277958', 'ticker_sentiment_score': '0.264682', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.277958', 'ticker_sentiment_score': '0.227008', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
510,Eli Lilly  ( LLY )  Increases Despite Market Slip: Here's What You Need to Know,https://www.zacks.com/stock/news/2235647/eli-lilly-lly-increases-despite-market-slip-heres-what-you-need-to-know,20240304T224518,['Zacks Equity Research'],"In the latest trading session, Eli Lilly (LLY) closed at $792.28, marking a +1.3% move from the previous day.",https://staticx-tuner.zacks.com/images/default_article_images/default165.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.95493'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.199086,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.636698', 'ticker_sentiment_score': '0.254963', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
511,Eli Lilly and Co Options Trading: A Deep Dive into Market Sentiment - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/03/37460353/eli-lilly-and-co-options-trading-a-deep-dive-into-market-sentiment,20240304T160205,['Benzinga Insights'],"Financial giants have made a conspicuous bearish move on Eli Lilly and Co. Our analysis of options history for Eli Lilly and Co LLY revealed 80 unusual trades. Delving into the details, we found 35% of traders were bullish, while 65% showed bearish tendencies.",https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.028882,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.771557', 'ticker_sentiment_score': '0.068128', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.087185', 'ticker_sentiment_score': '-0.096824', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.087185', 'ticker_sentiment_score': '-0.021063', 'ticker_sentiment_label': 'Neutral'}]"
512,1 Wall Street Analyst Thinks Eli Lilly Stock Is Going to $1000. Is It a Buy Around $782?,https://www.fool.com/investing/2024/03/04/1-analyst-thinks-eli-lilly-stock-is-going-to-1000/,20240304T112500,['Rich Smith'],There are two big reasons why Eli Lilly stock is as much as 5x more expensive than Pfizer.,https://g.foolcdn.com/editorial/images/767709/origami-dollar-folded-into-an-arrow-pointing-up.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.947132'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.107831,Neutral,"[{'ticker': 'BAC', 'relevance_score': '0.110462', 'ticker_sentiment_score': '0.055756', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.733479', 'ticker_sentiment_score': '0.171272', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.218817', 'ticker_sentiment_score': '-0.083832', 'ticker_sentiment_label': 'Neutral'}]"
513,"Here's How Much You'd Have If You Invested $10,000 in Eli Lilly Stock When Billionaire George Soros First Bought It",https://www.fool.com/investing/2024/03/04/invested-eli-lilly-stock-george-soros/,20240304T104800,['Keith Speights'],The tricky part would have been to not sell the pharmaceutical giant's shares when Soros did.,https://media.ycharts.com/charts/12df98e3752c74616e6161b640865a2b.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.177895,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.77688', 'ticker_sentiment_score': '0.278347', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MORN', 'relevance_score': '0.060694', 'ticker_sentiment_score': '0.244166', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
514,"This Is the Biggest Company Not in the ""Magnificent Seven"" -- but It Deserves to Be",https://www.fool.com/investing/2024/03/04/big-company-not-in-magnificent-seven-lilly/,20240304T095500,['James Brumley'],"It's in a distinctly different business than the ""Magnificent Seven"" companies, but it deserves the same attention.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F767518%2F022924-eli-lilly-results.png&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.305234,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.46341', 'ticker_sentiment_score': '0.414854', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'META', 'relevance_score': '0.044801', 'ticker_sentiment_score': '0.139985', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.089462', 'ticker_sentiment_score': '0.127166', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.044801', 'ticker_sentiment_score': '0.071754', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.044801', 'ticker_sentiment_score': '0.104019', 'ticker_sentiment_label': 'Neutral'}]"
515,Better Buy: Eli Lilly vs. Viking Therapeutics,https://www.fool.com/investing/2024/03/03/better-buy-eli-lilly-vs-viking-therapeutics/,20240303T143500,['Prosper Junior Bakiny'],These two biotechs could eventually go head to head in a fast-growing market.,https://g.foolcdn.com/editorial/images/767192/patient-talking-with-a-physician.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}, {'topic': 'Earnings', 'relevance_score': '0.818451'}]",0.18215,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.497609', 'ticker_sentiment_score': '0.258264', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VKTX', 'relevance_score': '0.457977', 'ticker_sentiment_score': '0.156752', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
516,3 Magnificent Growth Stocks to Buy in March,https://www.fool.com/investing/2024/03/02/3-magnificent-growth-stocks-to-buy-in-march/,20240302T143000,"['and Prosper Junior Bakiny', 'David Jagielski', 'Keith Speights']",These three stocks have two important common denominators: the same industry and tremendous growth prospects.,https://g.foolcdn.com/editorial/images/767491/happy-woman-because-the-stock-market-went-up.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.211721,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.262052', 'ticker_sentiment_score': '0.24374', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.262052', 'ticker_sentiment_score': '0.240059', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MRNA', 'relevance_score': '0.344473', 'ticker_sentiment_score': '0.130278', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.044469', 'ticker_sentiment_score': '0.153986', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.044469', 'ticker_sentiment_score': '0.060995', 'ticker_sentiment_label': 'Neutral'}]"
517,Is It Too Late to Buy Eli Lilly Stock Now?,https://www.fool.com/investing/2024/03/02/is-it-too-late-to-buy-eli-lilly-stock-now/,20240302T131500,['Adam Spatacco'],"Eli Lilly stock is having a moment, but the company could easily continue soaring.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F766723%2Fa-doctor-writing-a-prescription.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.250494,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.539306', 'ticker_sentiment_score': '0.300425', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.097854', 'ticker_sentiment_score': '0.10883', 'ticker_sentiment_label': 'Neutral'}]"
518,Market Rally At Highs; Here's What To Do Now,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-nasdaq-hits-high-taiwan-semi-jumps/,20240301T215300,"['ED CARSON', ""Investor's Business Daily""]","Dow Jones Futures: Nasdaq Hits Record High, Taiwan Semi Jumps. Here's What To Do Now Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2023/11/Stock-greenishbull-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.769861'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.192437,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.217346', 'ticker_sentiment_score': '0.129721', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.116911', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.054983', 'ticker_sentiment_score': '0.145853', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.082393', 'ticker_sentiment_score': '0.047008', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.027508', 'ticker_sentiment_score': '0.135793', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.054983', 'ticker_sentiment_score': '0.218934', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.163909', 'ticker_sentiment_score': '0.08363', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.06972', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.054983', 'ticker_sentiment_score': '0.013989', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLTR', 'relevance_score': '0.082393', 'ticker_sentiment_score': '0.052243', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSM', 'relevance_score': '0.082393', 'ticker_sentiment_score': '0.079567', 'ticker_sentiment_label': 'Neutral'}]"
519,Why Is Eli Lilly Stock Trading Higher Today? - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37430399/eli-lillys-commercial-moat-competitor-landscape-bofa-emphasizes-strength-in-increti,20240301T204459,['Vandana Singh'],"BofA Securities says Eli Lilly and Company LLY remains a top choice in Biopharma analysis, boasting a remarkable year-to-date performance of +29% ( compared to the DRG index's +10% ) .",https://cdn.benzinga.com/files/images/story/2024/mounjaro-medication-for-weight-loss_6.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.495866'}]",0.412925,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.597525', 'ticker_sentiment_score': '0.545815', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.324495', 'ticker_sentiment_score': '0.432372', 'ticker_sentiment_label': 'Bullish'}]"
520,How investors can ride along as a global commodity market shifts away from China,https://www.marketwatch.com/story/heres-how-investors-can-ride-along-as-a-major-global-commodity-market-shifts-away-from-china-2d122885,20240301T175200,['Philip van Doorn'],"China has long dominated the world market for rare earth minerals, which are required components of many devices.",https://images.mktw.net/im-99051667?width=700&height=486,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '0.999995'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.650727'}]",0.092941,Neutral,"[{'ticker': 'GOOG', 'relevance_score': '0.037563', 'ticker_sentiment_score': '0.119251', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.075043', 'ticker_sentiment_score': '0.124097', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.258351', 'ticker_sentiment_score': '0.255928', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.112357', 'ticker_sentiment_score': '0.088038', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.037563', 'ticker_sentiment_score': '-0.022334', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.037563', 'ticker_sentiment_score': '0.047489', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNOW', 'relevance_score': '0.149424', 'ticker_sentiment_score': '-0.008163', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.075043', 'ticker_sentiment_score': '0.102997', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NYCB', 'relevance_score': '0.258351', 'ticker_sentiment_score': '-0.136767', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.075043', 'ticker_sentiment_score': '0.124097', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.112357', 'ticker_sentiment_score': '0.164847', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.075043', 'ticker_sentiment_score': '0.124097', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.075043', 'ticker_sentiment_score': '0.102997', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBNY', 'relevance_score': '0.037563', 'ticker_sentiment_score': '-0.068027', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.075043', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
521,"Rally At Highs After Big Earnings, Inflation Data: Weekly Review",https://www.investors.com/news/stock-market-rally-at-highs-after-big-earnings-inflation-data-weekly-review/,20240301T171100,"['IBD STAFF', ""Investor's Business Daily""]",Market Rally At High: Weekly Review Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2017/08/HTI-WALLSTREET-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.838487'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.998356'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.072772,Neutral,"[{'ticker': 'CELH', 'relevance_score': '0.127795', 'ticker_sentiment_score': '0.070199', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FRO', 'relevance_score': '0.064104', 'ticker_sentiment_score': '0.170246', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOUR', 'relevance_score': '0.042762', 'ticker_sentiment_score': '-0.07846', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HPQ', 'relevance_score': '0.064104', 'ticker_sentiment_score': '-0.045922', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VEEV', 'relevance_score': '0.042762', 'ticker_sentiment_score': '0.051869', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALT', 'relevance_score': '0.064104', 'ticker_sentiment_score': '0.009016', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.021388', 'ticker_sentiment_score': '-0.032482', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DPZ', 'relevance_score': '0.042762', 'ticker_sentiment_score': '0.109933', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DTST', 'relevance_score': '0.042762', 'ticker_sentiment_score': '0.029796', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NTAP', 'relevance_score': '0.064104', 'ticker_sentiment_score': '0.126281', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.0854', 'ticker_sentiment_score': '-0.003141', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PSTG', 'relevance_score': '0.127795', 'ticker_sentiment_score': '0.069585', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BBY', 'relevance_score': '0.064104', 'ticker_sentiment_score': '-0.061484', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.042762', 'ticker_sentiment_score': '0.008818', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DELL', 'relevance_score': '0.0854', 'ticker_sentiment_score': '0.006503', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MARA', 'relevance_score': '0.042762', 'ticker_sentiment_score': '0.092845', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADSK', 'relevance_score': '0.042762', 'ticker_sentiment_score': '0.043757', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNOW', 'relevance_score': '0.064104', 'ticker_sentiment_score': '-0.048304', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMR', 'relevance_score': '0.042762', 'ticker_sentiment_score': '-0.003994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MNST', 'relevance_score': '0.0854', 'ticker_sentiment_score': '0.146294', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WDAY', 'relevance_score': '0.106636', 'ticker_sentiment_score': '-0.053552', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DMPZF', 'relevance_score': '0.021388', 'ticker_sentiment_score': '0.10193', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NTNX', 'relevance_score': '0.042762', 'ticker_sentiment_score': '0.124126', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZS', 'relevance_score': '0.106636', 'ticker_sentiment_score': '0.019519', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HPE', 'relevance_score': '0.042762', 'ticker_sentiment_score': '-0.228129', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.106636', 'ticker_sentiment_score': '0.037225', 'ticker_sentiment_label': 'Neutral'}]"
522,An analyst call on red-hot Broadcom indicates a possible buying opportunity ahead,https://www.cnbc.com/2024/03/01/an-analyst-call-on-red-hot-broadcom-indicates-a-possible-buying-opportunity-ahead.html,20240301T164206,['Morgan Chittum'],"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",https://image.cnbcfm.com/api/v1/image/107380684-1709241555094-gettyimages-2040800689-europapress_5784984_dell_technologies_ceo_michael_dell_speak.jpeg?v=1709241804&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.938793'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.22537,Somewhat-Bullish,"[{'ticker': 'BAC', 'relevance_score': '0.181819', 'ticker_sentiment_score': '0.142524', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.181819', 'ticker_sentiment_score': '0.142524', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.354319', 'ticker_sentiment_score': '0.237812', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
523,3 Healthcare Stocks That Have Outperformed Nvidia Since 2022,https://www.fool.com/investing/2024/03/01/3-healthcare-stocks-that-have-outperformed-nvidia/,20240301T134500,['David Jagielski'],The healthcare sector is no slouch when it comes to top-performing growth stocks.,https://g.foolcdn.com/editorial/images/766658/a-couple-of-investors-looking-at-a-series-of-charts.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.967645'}]",0.267726,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.293741', 'ticker_sentiment_score': '0.260399', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.11983', 'ticker_sentiment_score': '0.261673', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TMDX', 'relevance_score': '0.348919', 'ticker_sentiment_score': '0.502508', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'VRNA', 'relevance_score': '0.236972', 'ticker_sentiment_score': '0.100096', 'ticker_sentiment_label': 'Neutral'}]"
524,"These 4 Stocks Are the ""Magnificent Seven"" of Healthcare",https://www.fool.com/investing/2024/03/01/these-stocks-are-magnificent-seven-of-healthcare/,20240301T065900,['Alex Carchidi'],"Their growth trajectories aren't as meteoric, but they're still notable.",https://media.ycharts.com/charts/13eb85c054da9d0aa6615994f237628d.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.27987,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.155786', 'ticker_sentiment_score': '0.028625', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.052226', 'ticker_sentiment_score': '0.154565', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.188971', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.052226', 'ticker_sentiment_score': '0.154565', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ISRG', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.083806', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.155786', 'ticker_sentiment_score': '0.137514', 'ticker_sentiment_label': 'Neutral'}]"
525,"Could These 3 Companies Headline a ""Magnificent Seven"" of Biotech Stocks?",https://www.fool.com/investing/2024/02/29/could-these-3-companies-headline-magnificent-seven/,20240229T140000,['Prosper Junior Bakiny'],These stocks meet many of the criteria long-term investors look for.,https://media.ycharts.com/charts/a0139fd0df9b9ac5ba1cc3d6745e3b8b.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}]",0.303241,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.442767', 'ticker_sentiment_score': '0.443683', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.205807', 'ticker_sentiment_score': '0.163124', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.442767', 'ticker_sentiment_score': '0.372147', 'ticker_sentiment_label': 'Bullish'}]"
526,Viking Therapeutics Just Soared 120% on Optimism About Its Weight Loss Candidate. Too Late to Buy?,https://www.fool.com/investing/2024/02/29/viking-soared-120-percent-is-it-a-buy/,20240229T114200,['Adria Cimino'],Viking stock surged in the triple digits in one trading session.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F767161%2Fgettyimages-1226994628.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.149498,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.150278', 'ticker_sentiment_score': '0.129045', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.100518', 'ticker_sentiment_score': '0.058149', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.050359', 'ticker_sentiment_score': '0.163047', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.150278', 'ticker_sentiment_score': '0.129045', 'ticker_sentiment_label': 'Neutral'}]"
527,One down one to go - what we learned from TJX's great quarter and hope to hear from Salesforce,https://www.cnbc.com/2024/02/28/tjxs-quarter-delivers-and-what-cramer-hopes-to-hear-from-salesforce.html,20240228T162915,['Morgan Chittum'],"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",https://image.cnbcfm.com/api/v1/image/105048046-GettyImages-878554390.jpg?v=1709136479&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.98396'}, {'topic': 'Earnings', 'relevance_score': '0.682689'}]",0.122912,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.330654', 'ticker_sentiment_score': '0.123265', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.085022', 'ticker_sentiment_score': '0.053508', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TJX', 'relevance_score': '0.330654', 'ticker_sentiment_score': '0.123265', 'ticker_sentiment_label': 'Neutral'}]"
528,"Jim Cramer Weighs In On Palo Alto, Eli Lilly And Salesforce, Says Price Target Bump For This Stock A 'Red Flag' - Eli Lilly and Co  ( NYSE:LLY ) , Salesforce  ( NYSE:CRM ) ",https://www.benzinga.com/news/earnings/24/02/37356894/jim-cramer-weighs-in-on-palo-alto-eli-lilly-and-salesforce-says-price-target-bump-for-this-stock-a-,20240228T085914,['Benzinga Neuro'],"During Tuesday's CNBC Investing Club Morning Meeting, U.S. stocks exhibited mixed performance, prompting a closer look at prevailing market themes. Cybersecurity emerged as a key focus, with Jim Cramer emphasizing heightened threats following a recent breach at UnitedHealth.",https://cdn.benzinga.com/files/images/story/2024/jim-cramer-shutterstock_17.png?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.070275,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.287762', 'ticker_sentiment_score': '-0.06943', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.194242', 'ticker_sentiment_score': '-0.051147', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.097854', 'ticker_sentiment_score': '0.067322', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.194242', 'ticker_sentiment_score': '0.065095', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.097854', 'ticker_sentiment_score': '-0.147166', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PANW', 'relevance_score': '0.287762', 'ticker_sentiment_score': '0.285591', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
529,Stock Market Today: Stocks End Mixed After Disappointing Economic Data,https://www.kiplinger.com/investing/stocks/stock-market-today-stocks-end-mixed-after-disappointing-economic-data,20240227T210737,['Karee Venema'],Tuesday marked another choppy day for stocks as investors looked ahead to this week's key inflation update and the impact it may or may not have on the Fed's plans for interest rates.,https://cdn.mos.cms.futurecdn.net/hbRMDVRhfJobMQLXddLEdj-415-80.jpg,Kiplinger,n/a,www.kiplinger.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.838487'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}]",-0.004874,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.125789', 'ticker_sentiment_score': '0.061894', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.187705', 'ticker_sentiment_score': '0.079591', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'M', 'relevance_score': '0.125789', 'ticker_sentiment_score': '0.107479', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.125789', 'ticker_sentiment_score': '0.061894', 'ticker_sentiment_label': 'Neutral'}]"
530,"Nvidia, Eli Lilly, AMD Enjoy High Equity Valuations: Do Higher Rates Put Them In Peril? - Advanced Micro Devices  ( NASDAQ:AMD ) , Eli Lilly and Co  ( NYSE:LLY ) ",https://www.benzinga.com/analyst-ratings/analyst-color/24/02/37346557/are-nvidia-eli-lilly-amds-high-equity-valuations-in-peril-from-higher-rates,20240227T203553,['Neil Dennis'],"Higher long-term rates typically matter a lot to equity valuations. However, according to DataTrek, today's mega-cap stocks are likely to weather the current higher rate environment. Nvidia Corporation NVDA has a price-to-earnings ( P/E ) ratio of 65.8 Eli Lilly And Company LLY even higher ...",https://cdn.benzinga.com/files/images/story/2024/nvidia-chart-shutter2_2.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",-0.101636,Neutral,"[{'ticker': 'AMD', 'relevance_score': '0.245339', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.245339', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.245339', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
531,"How Beam, Up 28% Today, Is Planning To Take On Crispr",https://www.investors.com/news/technology/beam-stock-rockets-to-year-high-as-efforts-to-take-on-crispr-deepen/,20240227T192800,"[""Investor's Business Daily"", 'ALLISON GATLIN']",Beam Stock Rockets To Year High As Efforts To Take On Crispr Deepen Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2022/10/Stock-beamtherapeutics-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999186'}]",0.12433,Neutral,"[{'ticker': 'BEAM', 'relevance_score': '0.177584', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.177584', 'ticker_sentiment_score': '0.06926', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.11894', 'ticker_sentiment_score': '0.38104', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'VERV', 'relevance_score': '0.11894', 'ticker_sentiment_score': '0.055094', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BLUE', 'relevance_score': '0.11894', 'ticker_sentiment_score': '0.38104', 'ticker_sentiment_label': 'Bullish'}]"
532,Viking Therapeutics' stock doubles after company reports positive results in trial of weight-loss drug,https://www.marketwatch.com/story/viking-therapeutics-stock-soars-61-premarket-after-company-reports-positive-results-in-trial-of-weight-loss-drug-50e81767,20240227T122200,['Ciara Linnane'],Investors cheer what may be a cheap way to play the current weight-loss drug mania.,https://images.mktw.net/im-832731/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.070779,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.317254', 'ticker_sentiment_score': '0.12217', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.129866', 'ticker_sentiment_score': '0.02259', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.193723', 'ticker_sentiment_score': '0.173518', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
533,"Hims & Hers' stock jumps on hopes of a first profitable year, as it floats opportunities in weight loss",https://www.marketwatch.com/story/hims-hers-stock-jumps-on-forecasts-4290103d,20240227T005100,['Bill Peters'],"Shares of Hims & Hers Health Inc. rallied after hours on Monday, after the online wellness platform said 2024 would be its first year of positive net income and forecast first-quarter and full-year sales that were above expectations.",https://images.mktw.net/im-30342026/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Earnings', 'relevance_score': '0.95493'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.18338,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.130571', 'ticker_sentiment_score': '0.065268', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WW', 'relevance_score': '0.194763', 'ticker_sentiment_score': '0.084826', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TDOC', 'relevance_score': '0.130571', 'ticker_sentiment_score': '-0.025719', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HIMS', 'relevance_score': '0.065506', 'ticker_sentiment_score': '0.263916', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
534,Another Reason Why Nvidia Is King Of Tech,https://www.investors.com/research/nvidia-nvda-stock-warren-buffett-berkshire-hathaway-sp500-lly-meta-stock/,20240226T183200,"['KIMBERLEY KOENIG', ""Investor's Business Daily""]",Nvidia Stock: Another Reason Why It's The King Of Tech Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2017/11/Stock-NVIDIA09-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.99977'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.219213,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.22861', 'ticker_sentiment_score': '0.243106', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.283542', 'ticker_sentiment_score': '0.284156', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.337044', 'ticker_sentiment_score': '0.331382', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BRK-A', 'relevance_score': '0.115509', 'ticker_sentiment_score': '0.068861', 'ticker_sentiment_label': 'Neutral'}]"
535,"Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors - AstraZeneca  ( NASDAQ:AZN ) , Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/news/earnings/24/02/37315592/eli-lilly-novo-nordisks-strategies-against-new-weight-loss-drug-competitors,20240226T163135,['Neil Dennis'],"The race for new drugs to fight obesity and associated diabetes and cardiovascular diseases heated up on Monday after positive results from trials by Zealand Pharma were published, pushing the Danish company's shares 30% higher.",https://cdn.benzinga.com/files/images/story/2024/weight-loss-shutter2.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.744043'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.182634,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.5341', 'ticker_sentiment_score': '0.262817', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AZN', 'relevance_score': '0.165031', 'ticker_sentiment_score': '-0.009696', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTLT', 'relevance_score': '0.165031', 'ticker_sentiment_score': '0.072593', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.082963', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.165031', 'ticker_sentiment_score': '0.059846', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.165031', 'ticker_sentiment_score': '-0.009696', 'ticker_sentiment_label': 'Neutral'}]"
536,Here is What to Know Beyond Why Eli Lilly and Company  ( LLY )  is a Trending Stock,https://www.zacks.com/stock/news/2231511/here-is-what-to-know-beyond-why-eli-lilly-and-company-lly-is-a-trending-stock,20240226T140014,['Zacks Equity Research'],"Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default114.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.623304'}]",0.256927,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.523044', 'ticker_sentiment_score': '0.184155', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
537,Warren Buffett's Berkshire Is On Cusp Of Joining The $1 Trillion Club,https://www.investors.com/news/warren-buffett-stock-berkshire-hathaway-on-cusp-of-1-trillion-market-cap/,20240226T123000,"['ED CARSON', ""Investor's Business Daily""]","The trillion-dollar club is largely the preserve of tech titans such as Apple ( AAPL ) and Nvidia ( NVDA ) , with Meta Platforms ( META ) rejoining that level this year. But Warren Buffett's Berkshire Hathaway ( BRKB ) is knocking on the door. Berkshire Hathaway has a $952.75 billion ...",https://www.investors.com/wp-content/uploads/2019/05/stock-Buffett-Warren-02-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.999897'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}]",0.087538,Neutral,"[{'ticker': 'META', 'relevance_score': '0.201803', 'ticker_sentiment_score': '0.034126', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.329992', 'ticker_sentiment_score': '0.034596', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VMW', 'relevance_score': '0.067919', 'ticker_sentiment_score': '0.081763', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.329992', 'ticker_sentiment_score': '0.078441', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.201803', 'ticker_sentiment_score': '0.130867', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.201803', 'ticker_sentiment_score': '0.034126', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.449219', 'ticker_sentiment_score': '0.224219', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AWON', 'relevance_score': '0.067919', 'ticker_sentiment_score': '-0.145508', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.135347', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.329992', 'ticker_sentiment_score': '-0.479514', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'V', 'relevance_score': '0.201803', 'ticker_sentiment_score': '0.060578', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.329992', 'ticker_sentiment_score': '0.15192', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WMT', 'relevance_score': '0.135347', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
538,3 Dividend Stocks That Are No-Brainer Buys Right Now,https://www.fool.com/investing/2024/02/24/3-dividend-stocks-that-are-no-brainer-buys-right-n/,20240224T120400,"['Keith Speights', 'David Jagielski', 'and Prosper Junior Bakiny']",These stocks check off multiple boxes for investors.,https://g.foolcdn.com/editorial/images/766429/man-with-arms-behind-head-looking-at-laptop.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.214378'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}]",0.279267,Somewhat-Bullish,"[{'ticker': 'CBAY', 'relevance_score': '0.045224', 'ticker_sentiment_score': '0.090452', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.308614', 'ticker_sentiment_score': '0.305134', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CERE', 'relevance_score': '0.045224', 'ticker_sentiment_score': '0.153058', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.349945', 'ticker_sentiment_score': '0.191869', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GILD', 'relevance_score': '0.179454', 'ticker_sentiment_score': '0.239576', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
539,A growing number of stocks are joining the market rally - even as Big Tech still gets the most attention,https://www.marketwatch.com/story/a-growing-number-of-stocks-are-joining-the-market-rally-even-as-big-tech-still-gets-most-of-the-attention-a0231a08,20240224T001900,['Joseph Adinolfi'],Nvidia's blockbuster earnings report helped all 11 of the S&P 500's sectors finish the week in the green for the first time this year.,https://images.mktw.net/im-20169731/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.769861'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.996023'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}]",0.114012,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.066139', 'ticker_sentiment_score': '0.057072', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.033098', 'ticker_sentiment_score': '0.147807', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.099066', 'ticker_sentiment_score': '0.189099', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'COST', 'relevance_score': '0.066139', 'ticker_sentiment_score': '0.123246', 'ticker_sentiment_label': 'Neutral'}]"
540,Assessing Eli Lilly and Co's Performance Against Competitors In Pharmaceuticals Industry - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/news/24/02/37287232/assessing-eli-lilly-and-cos-performance-against-competitors-in-pharmaceuticals-industry,20240223T160015,['Benzinga Insights'],"Amidst today's fast-paced and highly competitive business environment, it is crucial for investors and industry enthusiasts to conduct comprehensive company evaluations.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.207499,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.530253', 'ticker_sentiment_score': '0.293242', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
541,What the Options Market Tells Us About Eli Lilly and Co - Eli Lilly and Co  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/02/37285613/what-the-options-market-tells-us-about-eli-lilly-and-co,20240223T150104,['Benzinga Insights'],"Investors with a lot of money to spend have taken a bearish stance on Eli Lilly and Co LLY. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",-0.028638,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.790287', 'ticker_sentiment_score': '-0.036237', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.083251', 'ticker_sentiment_score': '-0.1043', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.083251', 'ticker_sentiment_score': '-0.1043', 'ticker_sentiment_label': 'Neutral'}]"
542,Could Eli Lilly Stock Help You Become a Millionaire?,https://www.fool.com/investing/2024/02/23/could-eli-lilly-stock-help-you-become-millionaire/,20240223T111100,['David Jagielski'],"Shares of Eli Lilly have risen by roughly 1,190% over the past 10 years.",https://g.foolcdn.com/editorial/images/765978/rich-couple-on-a-boat.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.87644'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.30401,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.616842', 'ticker_sentiment_score': '0.438468', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.069495', 'ticker_sentiment_score': '0.214295', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.069495', 'ticker_sentiment_score': '0.214295', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
543,"Zacks Market Edge Highlights: AAPL, COST, WSM, LLY and HLT",https://www.zacks.com/stock/news/2230610/zacks-market-edge-highlights-aapl-cost-wsm-lly-and-hlt,20240223T083500,['Zacks Investment Research'],"AAPL, COST, WSM, LLY and HLT have been highlighted in this Market Edge article.",https://staticx-tuner.zacks.com/images/articles/main/ad/429.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.999994'}, {'topic': 'Earnings', 'relevance_score': '0.769861'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.199463,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.250386', 'ticker_sentiment_score': '0.16987', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.042421', 'ticker_sentiment_score': '-0.080945', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WSM', 'relevance_score': '0.329551', 'ticker_sentiment_score': '0.252923', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HLT', 'relevance_score': '0.250386', 'ticker_sentiment_score': '0.247198', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.367865', 'ticker_sentiment_score': '0.171849', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'COST', 'relevance_score': '0.250386', 'ticker_sentiment_score': '0.352875', 'ticker_sentiment_label': 'Bullish'}]"
544,How to Start Stock Investing in Your 50s,https://www.zacks.com/stock/news/2230305/how-to-start-stock-investing-in-your-50s,20240222T160200,['Tracey Ryniec'],Think you're too old to start buying stocks? Think again. Here's some tips.,https://staticx-tuner.zacks.com/images/articles/main/75/2558.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.997874'}, {'topic': 'Earnings', 'relevance_score': '0.769861'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.186205,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.273297', 'ticker_sentiment_score': '0.143963', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.046452', 'ticker_sentiment_score': '-0.081777', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WSM', 'relevance_score': '0.358798', 'ticker_sentiment_score': '0.269233', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HLT', 'relevance_score': '0.273297', 'ticker_sentiment_score': '0.264543', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.399911', 'ticker_sentiment_score': '0.137556', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.273297', 'ticker_sentiment_score': '0.376233', 'ticker_sentiment_label': 'Bullish'}]"
545,Here's 1 Pharmaceutical Stock That Looks Unstoppable. Hint: It's Not Novo Nordisk.,https://www.fool.com/investing/2024/02/22/1-pharmaceutical-stock-that-looks-unstoppable/,20240222T120000,['Adam Spatacco'],"Eli Lilly is home to many blockbuster drugs including Mounjaro, Jardiance, Zepbound, and more.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F765806%2Fnurse-checking-elderly-patients-blood-pressure-long-term-care-senior-nursing-home-poc.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.307091,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.6979', 'ticker_sentiment_score': '0.507042', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.1172', 'ticker_sentiment_score': '0.131827', 'ticker_sentiment_label': 'Neutral'}]"
546,Why Eli Lilly Stock Was Feeling Sickly on Wednesday,https://www.fool.com/investing/2024/02/21/why-eli-lilly-stock-was-feeling-sickly-on-wednesda/,20240221T225659,['Eric Volkman'],The company's surging popularity has made it expensive in terms of valuation.,https://g.foolcdn.com/editorial/images/766315/stethescope-atop-us-currency-and-coins.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.087313,Neutral,"[{'ticker': 'BAC', 'relevance_score': '0.146916', 'ticker_sentiment_score': '0.051227', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.733479', 'ticker_sentiment_score': '0.242681', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.146916', 'ticker_sentiment_score': '0.051227', 'ticker_sentiment_label': 'Neutral'}]"
547,Eli Lilly Unusual Options Activity - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/02/37237588/eli-lilly-unusual-options-activity,20240221T150132,['Benzinga Insights'],"Investors with a lot of money to spend have taken a bearish stance on Eli Lilly LLY. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.050296,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.751437', 'ticker_sentiment_score': '0.047479', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.083541', 'ticker_sentiment_score': '-0.131082', 'ticker_sentiment_label': 'Neutral'}]"
548,Eli Lilly Has More Than an Ozempic Competitor -- Much More,https://www.fool.com/investing/2024/02/21/eli-lilly-has-more-than-an-ozempic-competitor-much/,20240221T113900,['Adam Spatacco'],"Eli Lilly's hottest treatment might be Mounjaro, but the company has a lot more at its disposal.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F765536%2Fdoctors-office-checkup-patient-hospital.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.684621'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.220724,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.467176', 'ticker_sentiment_score': '0.300582', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TFC', 'relevance_score': '0.049732', 'ticker_sentiment_score': '-0.05942', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.049732', 'ticker_sentiment_score': '-0.05942', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.049732', 'ticker_sentiment_score': '-0.05942', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.049732', 'ticker_sentiment_score': '0.147153', 'ticker_sentiment_label': 'Neutral'}]"
549,Abbott Laboratories Stock Gets A Healthy Technical Rating Upgrade,https://www.investors.com/news/abbott-laboratories-stock-gets-a-healthy-technical-rating-upgrade/,20240221T080000,"[""INVESTOR'S BUSINESS DAILY"", ""Investor's Business Daily"", 'JULIE MAK']","In a welcome move, Abbott Laboratories ( ABT ) stock saw its Relative Strength Rating improve from 67 to 73 on Wednesday. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",https://www.investors.com/wp-content/uploads/2017/05/IRU77.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}]",0.448462,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.268294', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.769861', 'ticker_sentiment_score': '0.685395', 'ticker_sentiment_label': 'Bullish'}]"
550,3 ways a 'Magnificent Seven' stock-market bubble could burst,https://www.marketwatch.com/story/3-ways-a-magnificent-seven-stock-market-bubble-could-burst-df8716d2,20240220T173300,['William Watts'],"If the megacap tech rally is indeed a bubble, how might it end?",https://images.mktw.net/im-44847525?width=700&height=560,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.977154'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.972193'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.101301,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.09347', 'ticker_sentiment_score': '0.104925', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.09347', 'ticker_sentiment_score': '0.104925', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.09347', 'ticker_sentiment_score': '0.104925', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.139804', 'ticker_sentiment_score': '0.129381', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.139804', 'ticker_sentiment_score': '0.123643', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.139804', 'ticker_sentiment_score': '0.123643', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.09347', 'ticker_sentiment_score': '0.085872', 'ticker_sentiment_label': 'Neutral'}]"
551,5 Best-Performing S&P 500 Stocks Halfway Through Q1,https://www.zacks.com/stock/news/2228329/5-best-performing-sp-500-stocks-halfway-through-q1,20240220T130700,['Sweta Killa'],"Nvidia (NVDA), Eli Lilly (LLY), Meta Platforms (META), Uber Technologies (UBER) and Ralph Lauren (RL) are the five best-performing stocks in the S&P 500.",https://staticx-tuner.zacks.com/images/articles/main/8a/52792.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.999998'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.256075,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.228073', 'ticker_sentiment_score': '0.148091', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.282886', 'ticker_sentiment_score': '0.135755', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.099699', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RL', 'relevance_score': '0.228073', 'ticker_sentiment_score': '0.113019', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.228073', 'ticker_sentiment_score': '0.141555', 'ticker_sentiment_label': 'Neutral'}]"
552,8 Companies' Profit Is Expected To Outgrow Even Nvidia's This Year,https://www.investors.com/etfs-and-funds/sectors/sp500-companies-profit-is-expected-to-outgrow-even-nvidia-this-year/,20240220T130000,"[""Investor's Business Daily"", 'MATT KRANTZ']",Investors are understandably jazzed about Nvidia's upcoming earnings report for last year. Growth should be impressive. But analysts think a surprisingly large number of companies will grow even faster this year.,https://www.investors.com/wp-content/uploads/2016/11/it01-chips-111616-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.409819,Bullish,"[{'ticker': 'NVDA', 'relevance_score': '0.460808', 'ticker_sentiment_score': '0.477789', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.139265', 'ticker_sentiment_score': '0.388141', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SKXJF', 'relevance_score': '0.0699', 'ticker_sentiment_score': '0.012243', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPGI', 'relevance_score': '0.0699', 'ticker_sentiment_score': '0.15583', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DSKYF', 'relevance_score': '0.0699', 'ticker_sentiment_score': '0.012243', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RXDX', 'relevance_score': '0.0699', 'ticker_sentiment_score': '0.012243', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSN', 'relevance_score': '0.27432', 'ticker_sentiment_score': '0.271547', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
553,3 Magnificent Growth Stocks to Buy Right Now,https://www.fool.com/investing/2024/02/19/3-magnificent-growth-stocks-to-buy-right-now/,20240219T151500,"['Keith Speights', 'and Prosper Junior Bakiny', 'David Jagielski']",These stocks share at least two common denominators: a biopharmaceutical focus and great long-term prospects.,https://g.foolcdn.com/editorial/images/765520/happy-stock-investor-holding-smartphone.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.947132'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999365'}]",0.264978,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.27676', 'ticker_sentiment_score': '0.342352', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.160365', 'ticker_sentiment_score': '0.311688', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CERE', 'relevance_score': '0.040348', 'ticker_sentiment_score': '0.044696', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.387075', 'ticker_sentiment_score': '0.271117', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
554,What The Future Holds For Google's 'Other Bets',https://www.investors.com/news/technology/other-bets-x-moonshots-future-google-stock/,20240216T154800,"[""Investor's Business Daily"", 'REINHARDT KRAUSE']",Other Bets And X Moonshots Key Google Stock's Future Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2024/02/wGoog_2c201924.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.999999'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.998333'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.538269'}]",0.159278,Somewhat-Bullish,"[{'ticker': 'BLK', 'relevance_score': '0.015149', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.647825', 'ticker_sentiment_score': '0.257439', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.045425', 'ticker_sentiment_score': '-0.050985', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.030292', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.030292', 'ticker_sentiment_score': '-0.035944', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.030292', 'ticker_sentiment_score': '0.050832', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVGI', 'relevance_score': '0.015149', 'ticker_sentiment_score': '0.147619', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.015149', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.045425', 'ticker_sentiment_score': '-0.050985', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.030292', 'ticker_sentiment_score': '0.081926', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VWAGY', 'relevance_score': '0.015149', 'ticker_sentiment_score': '-0.032837', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.045425', 'ticker_sentiment_score': '0.116286', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CCZ', 'relevance_score': '0.015149', 'ticker_sentiment_score': '0.074076', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.030292', 'ticker_sentiment_score': '0.034053', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.030292', 'ticker_sentiment_score': '0.025574', 'ticker_sentiment_label': 'Neutral'}]"
555,Time To Revisit Amphastar As It Calms After A Plunge,https://www.investors.com/stock-lists/sector-leaders/drug-stock-time-to-revisit-amphastar-as-it-settles-after-a-plunge/,20240216T130000,"['KIMBERLEY KOENIG', ""Investor's Business Daily""]","Drug stock Amphastar Pharmaceuticals ( AMPH ) has formed a cup base and settled down after a steep sell-off in January. Now, as an IBD Sector Leader, Amphastar stock is about 18% off its all-time high. Amphastar develops injectable, inhalation and intranasal medical and insulin products.",https://www.investors.com/wp-content/uploads/2023/06/Stock-amphastarpharma-01-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999365'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.996675'}]",0.162205,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.173333', 'ticker_sentiment_score': '0.137582', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.087185', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMPH', 'relevance_score': '0.173333', 'ticker_sentiment_score': '-0.084832', 'ticker_sentiment_label': 'Neutral'}]"
556,3 Perfect Stocks to Buy This Valentine's Day,https://www.fool.com/investing/2024/02/14/3-perfect-stocks-to-buy-this-valentines-day/,20240214T105000,['Keith Speights'],These stocks have sweet long-term prospects.,https://g.foolcdn.com/editorial/images/765046/flowers.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.289897,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.252987', 'ticker_sentiment_score': '0.252645', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.064276', 'ticker_sentiment_score': '-0.057031', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HSY', 'relevance_score': '0.371523', 'ticker_sentiment_score': '0.207879', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
557,"Amgen Takes Aim at Novo Nordisk and Eli Lilly, but Is the Stock a Buy?",https://www.fool.com/investing/2024/02/14/amgen-takes-aim-at-novo-nordisk-and-eli-lilly-but/,20240214T075900,['Alex Carchidi'],"It faces both clinical and competitive barriers, but they might not matter.",https://g.foolcdn.com/editorial/images/764673/lab-worker-women-in-stem-science-research.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.190769,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.185662', 'ticker_sentiment_score': '0.188728', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMGN', 'relevance_score': '0.230892', 'ticker_sentiment_score': '0.215529', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.046816', 'ticker_sentiment_score': '0.062609', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.230892', 'ticker_sentiment_score': '0.185687', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
558,Here's why we would be considering buying more Eli Lilly shares if they were down Tuesday,https://www.cnbc.com/2024/02/13/why-we-would-be-considering-buying-more-eli-lilly-shares-if-they-were-down.html,20240213T171555,['Morgan Chittum'],"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",https://image.cnbcfm.com/api/v1/image/107372911-17078386721707838668-33318611669-1080pnbcnews.jpg?v=1707838672&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.967645'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.306676,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.216215', 'ticker_sentiment_score': '0.223262', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.072876', 'ticker_sentiment_score': '0.134232', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.072876', 'ticker_sentiment_score': '0.134232', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PANW', 'relevance_score': '0.145145', 'ticker_sentiment_score': '0.169681', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
559,Incyte's  ( INCY )  Q4 Earnings & Revenues Fall Shy of Estimates,https://www.zacks.com/stock/news/2225655/incytes-incy-q4-earnings-revenues-fall-shy-of-estimates,20240213T163700,['Zacks Equity Research'],Incyte's (INCY) fourth-quarter 2023 earnings and revenues miss estimates. Quarterly revenues cross the $1 billion mark for the first time on the continued growth of Jakafi and the strong launch of Opzelura.,https://staticx-tuner.zacks.com/images/articles/main/5d/2633.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.857896'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.129819,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.18046', 'ticker_sentiment_score': '0.094203', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INCY', 'relevance_score': '0.607733', 'ticker_sentiment_score': '0.117481', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MOR', 'relevance_score': '0.045482', 'ticker_sentiment_score': '0.156125', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SNDX', 'relevance_score': '0.135857', 'ticker_sentiment_score': '-0.021199', 'ticker_sentiment_label': 'Neutral'}]"
560,Eli Lilly and Company  ( LLY )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2225357/eli-lilly-and-company-lly-is-attracting-investor-attention-here-is-what-you-should-know,20240213T140012,['Zacks Equity Research'],"Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.",https://staticx-tuner.zacks.com/images/default_article_images/default8.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}]",0.250252,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.522096', 'ticker_sentiment_score': '0.180854', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
561,Biogen's quarterly results miss expectations amid slow launch of Alzheimer's treatment,https://www.marketwatch.com/story/biogens-quarterly-results-miss-expectations-amid-slow-launch-of-alzheimers-treatment-2d5edeaf,20240213T122100,['Eleanor Laise'],Biogen on Tuesday reported fourth-quarter results that fell short of Wall Street expectations as uptake of its newer drugs failed to offset declining multiple-sclerosis product sales.,https://images.mktw.net/im-31052601/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Earnings', 'relevance_score': '0.988787'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.069737,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.151064', 'ticker_sentiment_score': '0.196613', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ESALF', 'relevance_score': '0.224903', 'ticker_sentiment_score': '0.108138', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.608634', 'ticker_sentiment_score': '-0.046896', 'ticker_sentiment_label': 'Neutral'}]"
562,"Move Aside, Eli Lilly and Novo Nordisk. Wall Street Thinks This Stock Will Be a Bigger Winner Over the Next 12 Months.",https://www.fool.com/investing/2024/02/13/move-aside-eli-lilly-and-novo-nordisk-wall-street/,20240213T105000,['Keith Speights'],There's more for investors to get excited about in the biopharma world than just weight-loss drugs.,https://g.foolcdn.com/editorial/images/764848/scientists-happy.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}]",0.29916,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.570165', 'ticker_sentiment_score': '0.488445', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'AZN', 'relevance_score': '0.570165', 'ticker_sentiment_score': '0.479945', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.472338', 'ticker_sentiment_score': '0.427854', 'ticker_sentiment_label': 'Bullish'}]"
563,"Eli Lilly's Weight Loss Drug Tripeptide Is Expanding Market Share, Analyst Outlines What Lies Ahead - Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/analyst-ratings/analyst-color/24/02/37077761/eli-lillys-weight-loss-drug-tripeptide-is-expanding-market-share-analyst-outline-wh,20240212T195417,['Vandana Singh'],"In support of expectations for Eli Lilly And Company's LLY tripeptide, BMO Capital Markets is tracking weekly Mounjaro, Zepbound, GLP-1 category TRx ( total prescriptions ) , and NRx ( new prescriptions ) . The analyst models $12.78 billion for the fiscal year 2024 tripeptide revenues.",https://cdn.benzinga.com/files/images/story/2024/mounjaro-medication-for-weight-loss_4.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.328248,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.360752', 'ticker_sentiment_score': '0.23962', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
564,A Look at Pharma ETFs After Q4 Earnings,https://www.zacks.com/stock/news/2224986/a-look-at-pharma-etfs-after-q4-earnings,20240212T175900,['Sweta Killa'],"The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth. However, many industry bigwigs reported solid results, with some beating on earnings or revenues or both.",https://staticx-tuner.zacks.com/images/default_article_images/default282.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999996'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.054971,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.082251', 'ticker_sentiment_score': '0.071368', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.123104', 'ticker_sentiment_score': '0.058563', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.082251', 'ticker_sentiment_score': '-0.003144', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.123104', 'ticker_sentiment_score': '0.110586', 'ticker_sentiment_label': 'Neutral'}]"
565,2 Value Stocks With Monster Yields,https://www.fool.com/investing/2024/02/12/2-value-stocks-with-monster-yields/,20240212T141500,['George Budwell'],These two low-priced large-cap stocks sport ginormous yields.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F764890%2Fvalue-vs-price.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.15026,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.056275', 'ticker_sentiment_score': '0.088091', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'T', 'relevance_score': '0.378777', 'ticker_sentiment_score': '-0.032375', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.056275', 'ticker_sentiment_score': '0.088091', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.222327', 'ticker_sentiment_score': '-0.02711', 'ticker_sentiment_label': 'Neutral'}]"
566,This Unstoppable Growth Stock Just Announced More Good News: Is It a Buy?,https://www.fool.com/investing/2024/02/12/this-unstoppable-growth-stock-just-announced-more/,20240212T134500,['Prosper Junior Bakiny'],The drugmaker continues to impress investors.,https://g.foolcdn.com/editorial/images/764366/doctor-and-patient-talking.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.94762'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.217867,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.449503', 'ticker_sentiment_score': '0.281777', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
567,Could Eli Lilly's Zepbound Become the World's Best-Selling Drug?,https://www.fool.com/investing/2024/02/12/could-lillys-zepbound-become-worlds-best-seller/,20240212T100300,['Adria Cimino'],"Everyone is excited about Zepbound, from patients to investors...",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F764827%2Fgettyimages-three-investors-look-at-a-computer_in-office.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.938793'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.1742,Somewhat-Bullish,"[{'ticker': 'GS', 'relevance_score': '0.04531', 'ticker_sentiment_score': '0.070678', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.390904', 'ticker_sentiment_score': '0.270324', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.04531', 'ticker_sentiment_score': '0.070678', 'ticker_sentiment_label': 'Neutral'}]"
568,Novo Nordisk Is Scaling a Barrier to Growth. Should You Buy Its Stock Now?,https://www.fool.com/investing/2024/02/11/novo-nordisk-is-scaling-a-barrier-to-growth-should/,20240211T172500,['Alex Carchidi'],Even more revenue is on the way from additional sales of Wegovy.,https://g.foolcdn.com/editorial/images/764279/tablet-thinking-office.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.905476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.839681'}]",0.161313,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.048621', 'ticker_sentiment_score': '0.061823', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTLT', 'relevance_score': '0.048621', 'ticker_sentiment_score': '0.008959', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.416844', 'ticker_sentiment_score': '0.16777', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
569,3 Stocks That Could Trounce the Market in 2024,https://www.fool.com/investing/2024/02/10/3-stocks-that-could-trounce-the-market-in-2024/,20240210T114900,"['David Jagielski', 'and Prosper Junior Bakiny', 'Keith Speights']",These stocks appear to have what it takes to beat the market this year.,https://g.foolcdn.com/editorial/images/764580/person-smiling-and-looking-at-laptop.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Earnings', 'relevance_score': '0.998932'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.285154,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.196132', 'ticker_sentiment_score': '0.143278', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.157483', 'ticker_sentiment_score': '0.154214', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.039614', 'ticker_sentiment_score': '0.153045', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CTLT', 'relevance_score': '0.039614', 'ticker_sentiment_score': '0.096768', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.234307', 'ticker_sentiment_score': '0.179938', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
570,Why Shares of Eli Lilly Popped This Week,https://www.fool.com/investing/2024/02/09/why-shares-of-eli-lilly-popped-this-week/,20240209T193401,['Brett Schafer'],"The pharmaceutical giant is gaining momentum, and investors are excited.",https://media.ycharts.com/charts/6adc7901c4a88659abaceda0365bf270.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.995973'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.184299,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.733479', 'ticker_sentiment_score': '0.295235', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SPGI', 'relevance_score': '0.110462', 'ticker_sentiment_score': '0.13519', 'ticker_sentiment_label': 'Neutral'}]"
571,What to think about 'Peak 65',https://www.marketwatch.com/story/what-to-think-about-peak-65-d23f2413,20240209T190600,['Philip van Doorn'],"Also: Strategies to build a retirement nest egg and make it last, and a different way for investors to play the weight-loss-drug craze.",https://images.mktw.net/im-74524387?width=700&height=486,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.992549'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.095345,Neutral,"[{'ticker': 'VKTX', 'relevance_score': '0.085936', 'ticker_sentiment_score': '0.071851', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.04303', 'ticker_sentiment_score': '0.012989', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.128592', 'ticker_sentiment_score': '-0.025551', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.085936', 'ticker_sentiment_score': '-0.062043', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.128592', 'ticker_sentiment_score': '0.022061', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WEWOW', 'relevance_score': '0.04303', 'ticker_sentiment_score': '0.093845', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NYCB', 'relevance_score': '0.085936', 'ticker_sentiment_score': '-0.045374', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.085936', 'ticker_sentiment_score': '-0.062043', 'ticker_sentiment_label': 'Neutral'}]"
572,"Pharma Stock Roundup: AZN & LLY's Q4 Earnings, NVO, NVS & MRK's M&A Deals",https://www.zacks.com/stock/news/2224190/pharma-stock-roundup-azn-llys-q4-earnings-nvo-nvs-mrks-ma-deals,20240209T153600,['Kinjel Shah'],"Eli Lilly (LLY) and AstraZeneca (AZN) announce fourth-quarter results. Novo Nordisk (NVO), Merck (MRK) and Novartis (NVS) make M&A announcements.",https://staticx-tuner.zacks.com/images/articles/main/52/873.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '0.976671'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.080745,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.291182', 'ticker_sentiment_score': '0.088229', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MOR', 'relevance_score': '0.099066', 'ticker_sentiment_score': '0.005453', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.244354', 'ticker_sentiment_score': '0.109061', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTLT', 'relevance_score': '0.148121', 'ticker_sentiment_score': '0.043887', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.291182', 'ticker_sentiment_score': '0.037556', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.099066', 'ticker_sentiment_score': '-0.074089', 'ticker_sentiment_label': 'Neutral'}]"
573,Foghorn  ( FHTX )  Jumps 55% as Lilly Takes Up FHD-909 Development,https://www.zacks.com/stock/news/2224167/foghorn-fhtx-jumps-55-as-lilly-takes-up-fhd-909-development,20240209T150200,['Zacks Equity Research'],"Foghorn (FHTX) gains 55% as its strategic collaboration partner, Lilly, selects the pre-clinical candidate, FHD-909, for clinical development.",https://staticx-tuner.zacks.com/images/articles/main/c3/648.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.938793'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.173802,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.353562', 'ticker_sentiment_score': '0.289334', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FHTX', 'relevance_score': '0.28636', 'ticker_sentiment_score': '0.213203', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PBYI', 'relevance_score': '0.28636', 'ticker_sentiment_score': '0.153793', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
574,"Is Tesla Still A Magnificent 7 Stock? Berkshire Hathaway, Broadcom, Eli Lilly Line Up As Contenders - Broadcom  ( NASDAQ:AVGO ) , iShares U.S. Financial Services ETF  ( ARCA:IYG ) ",https://www.benzinga.com/news/earnings/24/02/37035036/is-tesla-still-a-magnificent-7-stock-ev-maker-could-get-bumped-by-these-companies,20240209T143835,['Neil Dennis'],"Tesla's TSLA standing within the Magnificent Seven is in question. What Happened: The Austin, Texas-based electric vehicle ( EV ) company now stands at number nine on the list of biggest companies on the S&P 500 index.",https://cdn.benzinga.com/files/images/story/2024/musk-tesla-red-shutter_2.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.967645'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.9545'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.201139,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.108958', 'ticker_sentiment_score': '0.475072', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'AVGO', 'relevance_score': '0.215894', 'ticker_sentiment_score': '0.223963', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BCS', 'relevance_score': '0.108958', 'ticker_sentiment_score': '0.102561', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.41627', 'ticker_sentiment_score': '-0.002894', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.162802', 'ticker_sentiment_score': '0.095426', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.054607', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
575,Warren Buffett And Disney Share A $543 Billion Money-Making Secret,https://www.investors.com/etfs-and-funds/sectors/sp500-warren-buffett-and-disney-share-billion-moneymaking-secret/,20240209T130000,"['MATT KRANTZ', ""Investor's Business Daily""]",S&P 500: Warren Buffett And Disney Share $543 Billion Moneymaking Secret Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2017/11/Stock-WarrenBuffett-01-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.4244,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.18967', 'ticker_sentiment_score': '0.256351', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SPGI', 'relevance_score': '0.095517', 'ticker_sentiment_score': '-0.083961', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.18967', 'ticker_sentiment_score': '0.398988', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'IBKR', 'relevance_score': '0.18967', 'ticker_sentiment_score': '0.165025', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.18967', 'ticker_sentiment_score': '0.398988', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BRK-A', 'relevance_score': '0.281153', 'ticker_sentiment_score': '0.312127', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
576,Is Eli Lilly Stock a Buy Now?,https://www.fool.com/investing/2024/02/09/is-eli-lilly-stock-a-buy-now/,20240209T121500,['David Jagielski'],Eli Lilly's valuation is approaching $700 billion.,https://g.foolcdn.com/editorial/images/764145/person-reviewing-a-sample-in-a-lab.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.988915'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.102609,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.726705', 'ticker_sentiment_score': '0.150642', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
577,"Zacks Market Edge Highlights: NVDA, LLY, CMG, DECK and VRT",https://www.zacks.com/stock/news/2223834/zacks-market-edge-highlights-nvda-lly-cmg-deck-and-vrt,20240209T110000,['Zacks Investment Research'],"NVDA, LLY, CMG, DECK and VRT have been highlighted in this Market Edge article.",https://staticx-tuner.zacks.com/images/articles/main/93/534.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999612'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.998626'}]",0.208369,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.26224', 'ticker_sentiment_score': '0.191647', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.312158', 'ticker_sentiment_score': '0.116942', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRT', 'relevance_score': '0.407844', 'ticker_sentiment_score': '0.17501', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CMG', 'relevance_score': '0.211191', 'ticker_sentiment_score': '0.143426', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DECK', 'relevance_score': '0.26224', 'ticker_sentiment_score': '0.315243', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
578,Stock Market Hits Highs As AI Plays Skyrocket: Weekly Review,https://www.investors.com/news/stock-market-hits-highs-as-arm-palantir-cloudflare-skyrocket/,20240209T001300,"['IBD STAFF', ""Investor's Business Daily""]","The stock market rally generally advanced with the S&P 500 hitting 5,000 for the first time and the Nasdaq at its best levels in over two years. The Dow Jones held just below its all-time highs while the Russell 2000 rebounded back above key levels.",https://www.investors.com/wp-content/uploads/2024/01/Stock-colorfullightbulb-generatedai-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.088082,Neutral,"[{'ticker': 'MDNDF', 'relevance_score': '0.017902', 'ticker_sentiment_score': '-0.147329', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TEX', 'relevance_score': '0.053669', 'ticker_sentiment_score': '0.066999', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NBIX', 'relevance_score': '0.035794', 'ticker_sentiment_score': '0.051683', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RPD', 'relevance_score': '0.053669', 'ticker_sentiment_score': '-0.012012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EXPE', 'relevance_score': '0.053669', 'ticker_sentiment_score': '0.049042', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVGI', 'relevance_score': '0.017902', 'ticker_sentiment_score': '0.067321', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.071517', 'ticker_sentiment_score': '0.053795', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARCB', 'relevance_score': '0.071517', 'ticker_sentiment_score': '0.054344', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DT', 'relevance_score': '0.035794', 'ticker_sentiment_score': '-0.078802', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.035794', 'ticker_sentiment_score': '0.069261', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QLYS', 'relevance_score': '0.053669', 'ticker_sentiment_score': '-0.004005', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HLT', 'relevance_score': '0.035794', 'ticker_sentiment_score': '0.048215', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRUS', 'relevance_score': '0.035794', 'ticker_sentiment_score': '0.09861', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ORLY', 'relevance_score': '0.035794', 'ticker_sentiment_score': '-0.129876', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.089328', 'ticker_sentiment_score': '0.118465', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AOSL', 'relevance_score': '0.035794', 'ticker_sentiment_score': '0.09861', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CYBR', 'relevance_score': '0.035794', 'ticker_sentiment_score': '-0.101404', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RBLX', 'relevance_score': '0.035794', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PINS', 'relevance_score': '0.053669', 'ticker_sentiment_score': '-0.224249', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CMG', 'relevance_score': '0.035794', 'ticker_sentiment_score': '-0.158803', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'UBER', 'relevance_score': '0.035794', 'ticker_sentiment_score': '-0.016619', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HMC', 'relevance_score': '0.035794', 'ticker_sentiment_score': '0.072035', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BABA', 'relevance_score': '0.035794', 'ticker_sentiment_score': '-0.07722', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PYPL', 'relevance_score': '0.035794', 'ticker_sentiment_score': '0.037818', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPOT', 'relevance_score': '0.035794', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.035794', 'ticker_sentiment_score': '0.072035', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NXPI', 'relevance_score': '0.035794', 'ticker_sentiment_score': '0.09861', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.035794', 'ticker_sentiment_score': '0.051683', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RMBS', 'relevance_score': '0.035794', 'ticker_sentiment_score': '0.09861', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTA', 'relevance_score': '0.035794', 'ticker_sentiment_score': '-0.151575', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'YUM', 'relevance_score': '0.035794', 'ticker_sentiment_score': '-0.158803', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'FTNT', 'relevance_score': '0.053669', 'ticker_sentiment_score': '-0.074739', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PI', 'relevance_score': '0.035794', 'ticker_sentiment_score': '0.09861', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DIOD', 'relevance_score': '0.035794', 'ticker_sentiment_score': '0.09861', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.035794', 'ticker_sentiment_score': '0.051683', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARM', 'relevance_score': '0.071517', 'ticker_sentiment_score': '0.07345', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NET', 'relevance_score': '0.035794', 'ticker_sentiment_score': '0.018656', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AFRM', 'relevance_score': '0.035794', 'ticker_sentiment_score': '0.037818', 'ticker_sentiment_label': 'Neutral'}]"
579,"Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month",https://www.fool.com/investing/2024/02/08/heres-why-merck-eli-lilly-and-novo-nordisk-stocks/,20240208T215600,['Ryan Downie'],Investors are still excited about obesity treatments and weight-management drugs.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F764656%2Fgettyimages-663845678-600x400-bf06395.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.928769'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.238796,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.399506', 'ticker_sentiment_score': '0.12975', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPGI', 'relevance_score': '0.059636', 'ticker_sentiment_score': '0.101', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HARP', 'relevance_score': '0.11894', 'ticker_sentiment_score': '0.227826', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.177584', 'ticker_sentiment_score': '0.195563', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
580,Viking Therapeutics may offer investors a cheap entry to the weight-loss drug craze,https://www.marketwatch.com/story/viking-therapeutics-may-offer-investors-a-cheap-entry-to-the-weight-loss-drug-craze-8d5d623a,20240208T191800,['Ciara Linnane'],Stock is trading at $28 compared with Eli Lilly's $739 price tag. That could change if a trial of a pill version of its GLP-1 drug proves effective.,https://images.mktw.net/im-832731/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.196705,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.204072', 'ticker_sentiment_score': '0.306761', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VKTX', 'relevance_score': '0.204072', 'ticker_sentiment_score': '0.158504', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.218866', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
581,Should You Buy a Stock on its All-Time Highs?,https://www.zacks.com/stock/news/2223610/should-you-buy-a-stock-on-its-all-time-highs,20240208T171800,['Tracey Ryniec'],There is a stock you love but it's red hot and has gone vertical. Do you dive in or wait for a sell-off?,https://staticx-tuner.zacks.com/images/articles/main/98/53604.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.977154'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.998626'}]",0.197259,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.293741', 'ticker_sentiment_score': '0.209306', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.348919', 'ticker_sentiment_score': '0.127529', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRT', 'relevance_score': '0.453501', 'ticker_sentiment_score': '0.188051', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CMG', 'relevance_score': '0.236972', 'ticker_sentiment_score': '0.157067', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DECK', 'relevance_score': '0.293741', 'ticker_sentiment_score': '0.343094', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
582,4 Reasons Why 2024 Could Be Eli Lilly's Worst Year for the Rest of This Decade,https://www.fool.com/investing/2024/02/08/4-reasons-why-2024-could-be-eli-lillys-worst-year/,20240208T105000,['Keith Speights'],Lilly's headwinds in 2024 should only be temporary challenges.,https://g.foolcdn.com/editorial/images/764351/ozempic.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.796627'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.139906,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.665529', 'ticker_sentiment_score': '0.343664', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
583,"Apple, Chipotle And Eli Lilly Stocks Baffle Jim Cramer With Unusual Moves: 'Authentic Stupidity Is A Perfectly Plausible Explanation' - Apple  ( NASDAQ:AAPL ) , Chipotle Mexican Grill  ( NYSE:CMG ) ",https://www.benzinga.com/analyst-ratings/analyst-color/24/02/36997732/apple-chipotle-and-eli-lilly-stocks-baffle-jim-cramer-with-recent-unusual-movements,20240208T020536,['Benzinga Neuro'],"Jim Cramer, the host of CNBC's ""Mad Money,"" expressed skepticism regarding the recent market movements of Apple Inc AAPL, Chipotle Mexican Grill, Inc. CMG, and Eli Lilly And Co LLY.",https://cdn.benzinga.com/files/images/story/2024/jim-cramer-shutterstock_10.png?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.048811,Neutral,"[{'ticker': 'CMG', 'relevance_score': '0.345674', 'ticker_sentiment_score': '-0.10424', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.262994', 'ticker_sentiment_score': '-0.04475', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.345674', 'ticker_sentiment_score': '0.120584', 'ticker_sentiment_label': 'Neutral'}]"
584,"Triple Threat Of Key Reversals: Warning Shots Fired In High Fliers Nvidia, Eli Lilly, Super Micro Computers - NVIDIA  ( NASDAQ:NVDA ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/trading-ideas/technicals/24/02/36964497/triple-threat-of-key-reversals-warning-shots-fired-in-3-high-fliers,20240207T234520,['Aaron Bry'],"In a potential warning sign to investors, three high-flying stocks had key reversals on Tuesday. This means the stocks opened to new highs before trading below their previous closing price.",https://cdn.benzinga.com/files/images/story/2024/02/07/market.man_.up_.shutterstock_139983946.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.183233,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.495015', 'ticker_sentiment_score': '0.348391', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.817578', 'ticker_sentiment_score': '0.414446', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SMCI', 'relevance_score': '0.495015', 'ticker_sentiment_score': '0.398493', 'ticker_sentiment_label': 'Bullish'}]"
585,"Analysts Boost Eli Lilly's Forecast With High Hopes On Mounjaro, Zepbound Performance - Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/analyst-ratings/analyst-color/24/02/36990258/analysts-boost-eli-lillys-forecast-with-high-hopes-on-mounjaro-zepbound-performance,20240207T194942,['Vandana Singh'],"Tuesday, Eli Lilly And Co LLY reported fourth-quarter of 2023 revenue of $9.35 billion, up 28% Y/Y, beating the consensus of $8.93 billion driven by increases of 16% due to higher realized prices, 11% in volume, and 1% from the favorable impact of foreign exchange rates.",https://cdn.benzinga.com/files/images/story/2024/mounjaro-medication-for-weight-loss_3.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.495866'}, {'topic': 'Earnings', 'relevance_score': '0.796627'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.155368,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.448316', 'ticker_sentiment_score': '0.09135', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.094762', 'ticker_sentiment_score': '0.060669', 'ticker_sentiment_label': 'Neutral'}]"
586,Abbott Laboratories Stock Getting Closer To Key Technical Benchmark,https://www.investors.com/news/abbott-laboratories-getting-closer-to-key-technical-benchmark/,20240207T161100,"['GLENN LARKIN', ""INVESTOR'S BUSINESS DAILY"", ""Investor's Business Daily""]","In a welcome move, Abbott Laboratories ( ABT ) saw its Relative Strength Rating improve from 67 to 73 on Wednesday. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",https://www.investors.com/wp-content/uploads/2017/05/IRU4.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.371044,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.250386', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.661658', 'ticker_sentiment_score': '0.346743', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
587,ETFs to Buy as Mounjaro Powers Eli Lilly's Q4 Earnings Beat,https://www.zacks.com/stock/news/2222669/etfs-to-buy-as-mounjaro-powers-eli-lillys-q4-earnings-beat,20240207T150500,['Sweta Killa'],"Eli Lilly and Company (LLY) posted robust fourth-quarter 2023 earnings, beating estimates on both the top and bottom lines driven by strong sales of its diabetes and weight-loss treatments.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.947132'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999965'}]",0.229502,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.337427', 'ticker_sentiment_score': '0.312048', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
588,Market Whales and Their Recent Bets on LLY Options - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/02/36982491/market-whales-and-their-recent-bets-on-lly-options,20240207T144556,['Benzinga Insights'],"Investors with a lot of money to spend have taken a bearish stance on Eli Lilly LLY. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",-0.009605,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.702434', 'ticker_sentiment_score': '-0.173123', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'WFC', 'relevance_score': '0.165031', 'ticker_sentiment_score': '-0.15371', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
589,Eli Lilly Earns IBD Stock Rating Upgrade,https://www.investors.com/ibd-data-stories/eli-lilly-earns-ibd-stock-rating-upgrade/,20240207T080000,"[""Investor's Business Daily"", ""INVESTOR'S BUSINESS DAILY""]","On Wednesday, Eli Lilly ( LLY ) got an upgrade for its IBD SmartSelect Composite Rating from 90 to 96. X The new score means the company is now outperforming 96% of all stocks in terms of the most important fundamental and technical stock-picking criteria.",https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.818451'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.225151,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.666827', 'ticker_sentiment_score': '-0.116293', 'ticker_sentiment_label': 'Neutral'}]"
590,Abbott Laboratories Getting Closer To Key Technical Benchmark,https://www.investors.com/ibd-data-stories/abbott-laboratories-getting-closer-to-key-technical-benchmark/,20240207T080000,"[""INVESTOR'S BUSINESS DAILY"", ""Investor's Business Daily""]","In a welcome move, Abbott Laboratories ( ABT ) saw its Relative Strength Rating improve from 67 to 73 on Wednesday. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.744043'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.362319,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.29234', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.739411', 'ticker_sentiment_score': '0.422149', 'ticker_sentiment_label': 'Bullish'}]"
591,Eli Lilly  ( LLY )  Q4 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2024/02/06/eli-lilly-lly-q4-2023-earnings-call-transcript/,20240207T003018,['Motley Fool Transcribing'],"LLY earnings call for the period ending December 31, 2023.",https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.99999'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.316726'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}]",0.255016,Somewhat-Bullish,"[{'ticker': 'EVR', 'relevance_score': '0.003584', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.003584', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.003584', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTLT', 'relevance_score': '0.010751', 'ticker_sentiment_score': '0.11558', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.003584', 'ticker_sentiment_score': '0.058669', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DICE', 'relevance_score': '0.003584', 'ticker_sentiment_score': '0.116534', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.003584', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.003584', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.003584', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AKUS', 'relevance_score': '0.003584', 'ticker_sentiment_score': '0.128229', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APG', 'relevance_score': '0.007168', 'ticker_sentiment_score': '0.073354', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.078717', 'ticker_sentiment_score': '0.13047', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SGTX', 'relevance_score': '0.003584', 'ticker_sentiment_score': '0.116534', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LBTSF', 'relevance_score': '0.007168', 'ticker_sentiment_score': '0.110952', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:GBP', 'relevance_score': '0.003584', 'ticker_sentiment_score': '0.138176', 'ticker_sentiment_label': 'Neutral'}]"
592,Amgen's quarterly results top expectations despite Enbrel sales decline,https://www.marketwatch.com/story/amgens-quarterly-results-top-expectations-despite-enbrel-sales-decline-3720269d,20240206T214300,['Eleanor Laise'],Amgen on Tuesday reported fourth quarter profits and sales that topped analyst expectations even as revenues dropped for one of its top-selling drugs.,https://images.mktw.net/im-814193/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Earnings', 'relevance_score': '0.769861'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.023871,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.181819', 'ticker_sentiment_score': '0.190188', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMGN', 'relevance_score': '0.578948', 'ticker_sentiment_score': '0.127919', 'ticker_sentiment_label': 'Neutral'}]"
593,"Stock Market Today: Higher Close for Stocks, Palantir Soars on AI Optimism",https://www.kiplinger.com/investing/stocks/stock-market-today-higher-close-for-stocks-palantir-soars-on-ai-optimism,20240206T211241,['Karee Venema'],"Stocks opened higher Tuesday as investors attempted to look past Federal Reserve Chair Jerome Powell's hawkish appearance on ""60 Minutes."" However, the main indexes ran out of steam as the session wore on as more central bankers took the wait-and-see route toward rate cuts.",https://cdn.mos.cms.futurecdn.net/HPGpPu8yev3y9BJ9WaSXu7-415-80.jpg,Kiplinger,n/a,www.kiplinger.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.980716'}]",0.248,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.213048', 'ticker_sentiment_score': '0.29933', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NKE', 'relevance_score': '0.142989', 'ticker_sentiment_score': '0.349454', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PLTR', 'relevance_score': '0.213048', 'ticker_sentiment_score': '0.220181', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WBA', 'relevance_score': '0.142989', 'ticker_sentiment_score': '0.349454', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
594,"Tech Slides, Chinese Stocks Rebound, New York Community Bancorp Tumbles: What's Driving Markets Tuesday? - Amgen  ( NASDAQ:AMGN ) , BP  ( NYSE:BP ) ",https://www.benzinga.com/markets/equities/24/02/36964052/tech-slides-chinese-stocks-rebound-new-york-community-bancorp-tumbles-whats-driving-markets-tues,20240206T192404,['Piero Cingari'],"At noon trading in New York, major equity indices on Wall Street remain directionless as traders evaluate the future course of monetary policy ahead of several speeches by Federal Reserve officials in the days ahead.",https://cdn.benzinga.com/files/images/story/2024/Wall-Street_4.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.961735'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",0.132785,Neutral,"[{'ticker': 'SPOT', 'relevance_score': '0.177802', 'ticker_sentiment_score': '0.062224', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'F', 'relevance_score': '0.177802', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBS', 'relevance_score': '0.177802', 'ticker_sentiment_score': '0.062224', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CCK', 'relevance_score': '0.177802', 'ticker_sentiment_score': '0.062224', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.089462', 'ticker_sentiment_score': '0.130458', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNAP', 'relevance_score': '0.177802', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.177802', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NYCB', 'relevance_score': '0.177802', 'ticker_sentiment_score': '-0.143048', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EW', 'relevance_score': '0.177802', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FTNT', 'relevance_score': '0.177802', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GEHC', 'relevance_score': '0.177802', 'ticker_sentiment_score': '0.062224', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.177802', 'ticker_sentiment_score': '0.062224', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.177802', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMG', 'relevance_score': '0.177802', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FMC', 'relevance_score': '0.177802', 'ticker_sentiment_score': '0.062224', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLTR', 'relevance_score': '0.177802', 'ticker_sentiment_score': '0.42926', 'ticker_sentiment_label': 'Bullish'}]"
595,"Eli Lilly rides the weight-loss-drug wave to a new record high, and is now worth more than $700 billion",https://markets.businessinsider.com/news/stocks/eli-lilly-stock-price-q4-earnings-glp-drugs-700-billion-2024-2,20240206T170000,['Matthew Fox'],"Eli Lilly Rides the Weight-Loss-Drug Wave to Record, Hits $700 Billion - Markets Insider ...",,Business Insider,GoogleRSS,markets.businessinsider.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.980509'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.224787,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.555911', 'ticker_sentiment_score': '0.347831', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BRK-A', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
596,Wall Street says Big Tech needs to take a breather after huge run. Here's our take,https://www.cnbc.com/2024/02/06/why-wall-street-analysts-think-big-tech-stocks-will-take-a-breather.html,20240206T164237,['Morgan Chittum'],"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",https://image.cnbcfm.com/api/v1/image/107306647-1695737403194-gettyimages-1580864430-AFP_33QR73W.jpeg?v=1702925323&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.938793'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.744043'}]",0.211554,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.270773', 'ticker_sentiment_score': '0.181956', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.182506', 'ticker_sentiment_score': '0.134213', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.182506', 'ticker_sentiment_score': '0.134213', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.09186', 'ticker_sentiment_score': '0.095197', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.182506', 'ticker_sentiment_score': '0.134213', 'ticker_sentiment_label': 'Neutral'}]"
597,Why Eli Lilly Stock Jumped as Much as 5.1% Today Then Gave Up Its Gains,https://www.fool.com/investing/2024/02/06/why-eli-lilly-stock-jumped-as-much-as-51-today/,20240206T164140,['Keith Speights'],Investors shouldn't worry that Lilly's gains quickly evaporated.,https://g.foolcdn.com/editorial/images/764189/scientists-in-a-lab-monitor-microscope.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.997902'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.245766,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.684999', 'ticker_sentiment_score': '0.511454', 'ticker_sentiment_label': 'Bullish'}]"
598,"Stocks In China Flying, Lifting Sentiment In Stock Markets Across The Globe, AI And Weight Loss Drugs Get Hotter - NVIDIA  ( NASDAQ:NVDA ) ",https://www.benzinga.com/markets/24/02/36960189/stocks-in-china-flying-lifting-sentiment-in-stock-markets-across-the-globe-ai-and-weight-loss-drugs,20240206T163135,['The Arora Report'],"To gain an edge, this is what you need to know today. Please click here for an enlarged version of the chart of iShares China Large-Cap ETF FXI. Earlier today, NVIDIA Corp NVDA crossed $700. NVDA is in The Arora Report ZYX Buy Model Portfolio.",https://cdn.benzinga.com/files/regularguy-eth-w9codxtsfts-unsplash_19.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Financial Markets', 'relevance_score': '0.996718'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}]",0.22034,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.101582', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.101582', 'ticker_sentiment_score': '0.197234', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.101582', 'ticker_sentiment_score': '0.197234', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.201523', 'ticker_sentiment_score': '0.156997', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.101582', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.101582', 'ticker_sentiment_score': '-0.238309', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LLY', 'relevance_score': '0.151858', 'ticker_sentiment_score': '0.017067', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.050894', 'ticker_sentiment_score': '0.247528', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.101582', 'ticker_sentiment_score': '0.386374', 'ticker_sentiment_label': 'Bullish'}]"
599,Earnings Data Deluge,https://www.zacks.com/stock/news/2221920/earnings-data-deluge,20240206T160200,['Zacks Equity Research'],"We have a big day of stock market information on deck, most of which doesn't happen until after the opening bell rings this morning. We have a full docket of Fed presidents reporting later today, including Cleveland's Loretta Mester, Minneapolis' Neel Kashkari, Boston's Susan Collins and ...",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.052206,Neutral,"[{'ticker': 'CMG', 'relevance_score': '0.203215', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.3007', 'ticker_sentiment_score': '0.077165', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPOT', 'relevance_score': '0.3007', 'ticker_sentiment_score': '0.074298', 'ticker_sentiment_label': 'Neutral'}]"
600,Stock Market Mixed With Dow Jones Pulling Ahead; Palantir Soars After Earnings,https://www.investors.com/market-trend/stock-market-today/stock-market-struggles-dow-jones-leads-nasdaq-palantir-spy-stock/,20240206T155300,"[""Investor's Business Daily"", 'KIMBERLEY KOENIG']","Stock Market Struggles, Dow Jones Leads, Nasdaq Eases. Palantir Soars Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2023/02/Stock-Palantir-04-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.990786'}]",0.09589,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.103778', 'ticker_sentiment_score': '0.062377', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.103778', 'ticker_sentiment_score': '0.111245', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.103778', 'ticker_sentiment_score': '0.111245', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.103778', 'ticker_sentiment_score': '0.062377', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.155118', 'ticker_sentiment_score': '0.065084', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPOT', 'relevance_score': '0.155118', 'ticker_sentiment_score': '0.009552', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.103778', 'ticker_sentiment_score': '0.102795', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CDNS', 'relevance_score': '0.051999', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RMBS', 'relevance_score': '0.103778', 'ticker_sentiment_score': '-0.132313', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.051999', 'ticker_sentiment_score': '0.049031', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DOCU', 'relevance_score': '0.155118', 'ticker_sentiment_score': '-0.090737', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.103778', 'ticker_sentiment_score': '0.062377', 'ticker_sentiment_label': 'Neutral'}]"
601,"Eli Lilly  ( LLY )  Q4 Earnings Beat, Mounjaro, Zepbound Drive Sales",https://www.zacks.com/stock/news/2221913/eli-lilly-lly-q4-earnings-beat-mounjaro-zepbound-drive-sales,20240206T154800,['Zacks Equity Research'],Eli Lilly (LLY) beats fourth-quarter estimates for earnings as well as sales. The company issues an upbeat guidance for 2024.,https://staticx-tuner.zacks.com/images/articles/main/62/5473.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999997'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.77141'}]",0.177494,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.337951', 'ticker_sentiment_score': '0.152966', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ARQT', 'relevance_score': '0.219099', 'ticker_sentiment_score': '0.025828', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.126284', 'ticker_sentiment_score': '0.035026', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PBYI', 'relevance_score': '0.188437', 'ticker_sentiment_score': '0.119642', 'ticker_sentiment_label': 'Neutral'}]"
602,"Earnings, Fed Speakers Dominate Activity; Lilly Beats, Spotify Misses",https://www.zacks.com/stock/news/2221907/earnings-fed-speakers-dominate-activity-lilly-beats-spotify-misses,20240206T154100,['Mark Vickery'],Investors of Lilly (LLY) are responding to the eye-opening efficacy of obesity drugs Mounjaro and Zepbound.,https://staticx-tuner.zacks.com/images/articles/main/4d/60715.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Earnings', 'relevance_score': '0.928139'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.054458,Neutral,"[{'ticker': 'CMG', 'relevance_score': '0.19117', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.283323', 'ticker_sentiment_score': '0.069326', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPOT', 'relevance_score': '0.283323', 'ticker_sentiment_score': '0.0538', 'ticker_sentiment_label': 'Neutral'}]"
603,"Dow Jumps Over 100 Points; Eli Lilly Posts Upbeat Earnings - Agrify  ( NASDAQ:AGFY ) , BioRestorative Therapies  ( NASDAQ:BRTX ) ",https://www.benzinga.com/news/earnings/24/02/36957085/dow-jumps-over-100-points-eli-lilly-posts-upbeat-earnings,20240206T145204,['Avi Kapoor'],"U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.34% to 38,509.84 while the NASDAQ rose 0.21% to 15,629.82. The S&P 500 also rose, gaining, 0.17% to 4,951.38.",https://cdn.benzinga.com/files/images/story/2024/02/06/image30.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.744043'}]",0.016939,Neutral,"[{'ticker': 'NVIV', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.175165', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AGFY', 'relevance_score': '0.204072', 'ticker_sentiment_score': '0.311293', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.269776', 'ticker_sentiment_score': '0.028824', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPGI', 'relevance_score': '0.136888', 'ticker_sentiment_score': '-0.084219', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRTX', 'relevance_score': '0.204072', 'ticker_sentiment_score': '-0.044273', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PRSO', 'relevance_score': '0.136888', 'ticker_sentiment_score': '-0.098739', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SUNW', 'relevance_score': '0.204072', 'ticker_sentiment_score': '0.248732', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TENX', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.20693', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CRYPTO:PAY', 'relevance_score': '0.068698', 'ticker_sentiment_score': '0.166607', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
604,"Eli Lilly Soars On Diabetes And Obesity Drug Boom, Projects 20% Revenue Increase In 2024 - Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/markets/equities/24/02/36955955/eli-lilly-soars-on-diabetes-and-obesity-drug-boom-projects-20-revenue-increase-in-2024,20240206T141519,['Benzinga Neuro'],"In a recent announcement, Eli Lilly and Co LLY has projected a significant revenue increase for 2024, driven by the demand for its diabetes and obesity drugs. What Happened: The pharmaceutical giant anticipates a 20% rise in sales, propelling its revenues to over $40 billion, reported the ...",https://cdn.benzinga.com/files/images/story/2024/Eli-Lilly_2.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.224494,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.345674', 'ticker_sentiment_score': '0.253218', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
605,Eli Lilly's stock leaps toward a record as a 16% jump in prices boosted profit,https://www.marketwatch.com/story/eli-lillys-stock-surges-toward-a-5th-straight-record-after-an-earnings-beat-and-upbeat-outlook-5a298405,20240206T133200,['Tomi Kilgore'],"U.S. prices for Lilly's drugs climbed 27%, driven by diabetes treatment Mounjaro, while prices outside the U.S. fell.",https://images.mktw.net/im-84642168/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Earnings', 'relevance_score': '0.98396'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}]",0.168429,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.31482', 'ticker_sentiment_score': '0.161944', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
606,Why Is Eli Lilly Stock Trading Higher Today? - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/general/biotech/24/02/36954087/investors-cheer-highly-awaited-eli-lilly-earnings-q4-performance-surpass-expectations-thanks-to-s,20240206T132936,['Vandana Singh'],"Tuesday, Eli Lilly And Co LLY reported fourth-quarter of 2023 revenue of $9.35 billion, up 28% Y/Y, beating the consensus of $8.93 billion driven by increases of 16% due to higher realized prices, 11% in volume, and 1% from the favorable impact of foreign exchange rates.",https://cdn.benzinga.com/files/images/story/2024/mounjaro-medication-for-weight-loss_2.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.266143'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}]",0.074302,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.68732', 'ticker_sentiment_score': '-0.019044', 'ticker_sentiment_label': 'Neutral'}]"
607,Futures Dip; Palantir Soars On Surging AI Demand,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-palantir-soars-on-surging-ai-demand/,20240206T131700,"['SCOTT LEHTONEN', ""Investor's Business Daily""]",Dow Jones Futures Fall As Tesla Slides On Downgrade. Palantir Soars On Surging AI Demand Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2021/09/Stock-wallstreetflag-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '0.795202'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.205444,Somewhat-Bullish,"[{'ticker': 'NVDA', 'relevance_score': '0.157741', 'ticker_sentiment_score': '0.110092', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.196451', 'ticker_sentiment_score': '0.134443', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPOT', 'relevance_score': '0.118647', 'ticker_sentiment_score': '0.130868', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EXPE', 'relevance_score': '0.157741', 'ticker_sentiment_score': '0.107195', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.079261', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDB', 'relevance_score': '0.157741', 'ticker_sentiment_score': '0.015246', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.039679', 'ticker_sentiment_score': '0.117525', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.118647', 'ticker_sentiment_score': '0.081445', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.196451', 'ticker_sentiment_score': '0.077388', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LEN', 'relevance_score': '0.157741', 'ticker_sentiment_score': '0.059783', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.118647', 'ticker_sentiment_score': '0.130868', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLTR', 'relevance_score': '0.079261', 'ticker_sentiment_score': '-0.054554', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.157741', 'ticker_sentiment_score': '0.008044', 'ticker_sentiment_label': 'Neutral'}]"
608,Eli Lilly  ( LLY )  Tops Q4 Earnings and Revenue Estimates,https://www.zacks.com/stock/news/2221562/eli-lilly-lly-tops-q4-earnings-and-revenue-estimates,20240206T125503,['Zacks Equity Research'],"Lilly (LLY) delivered earnings and revenue surprises of 0.81% and 5.53%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?",https://staticx-tuner.zacks.com/images/default_article_images/default145.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999981'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.144094,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.399204', 'ticker_sentiment_score': '0.207635', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ARDX', 'relevance_score': '0.138464', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
609,"S&P, Nasdaq Futures Point To Another Day Of Weakness: What's Going On With Stocks? - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/24/02/36952531/us-stocks-brace-for-another-day-in-the-red-as-rally-loses-steam-analyst-sees-market-pullback-on-thi,20240206T123737,['Shanthi Rexaline'],"U.S. stocks are poised for another day of weakness, although some positive tech earnings may provide a modest lift to the sector. The market appears to be digesting information following a rally that began after the early January downturn.",https://cdn.benzinga.com/files/images/story/2024/nyse-shutter_4.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.99676'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.928139'}]",-0.024063,Neutral,"[{'ticker': 'DD', 'relevance_score': '0.091162', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSTR', 'relevance_score': '0.091162', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPOT', 'relevance_score': '0.091162', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'F', 'relevance_score': '0.091162', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RMBS', 'relevance_score': '0.091162', 'ticker_sentiment_score': '-0.208732', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'IVZ', 'relevance_score': '0.045655', 'ticker_sentiment_score': '0.212156', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMGN', 'relevance_score': '0.091162', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HTZ', 'relevance_score': '0.091162', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JJSF', 'relevance_score': '0.091162', 'ticker_sentiment_score': '-0.348877', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CRUS', 'relevance_score': '0.091162', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EW', 'relevance_score': '0.091162', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CHKP', 'relevance_score': '0.091162', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMA', 'relevance_score': '0.045655', 'ticker_sentiment_score': '-0.132222', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GEHC', 'relevance_score': '0.091162', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.091162', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HRB', 'relevance_score': '0.091162', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LPLA', 'relevance_score': '0.045655', 'ticker_sentiment_score': '0.176076', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'YUMC', 'relevance_score': '0.091162', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMG', 'relevance_score': '0.091162', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SQ', 'relevance_score': '0.045655', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WU', 'relevance_score': '0.091162', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLTR', 'relevance_score': '0.091162', 'ticker_sentiment_score': '0.309859', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
610,Eli Lilly Veers Higher On Fourth-Quarter Beat,https://www.investors.com/news/technology/eli-lilly-stock-eli-lilly-earnings-q4-2023/,20240206T123200,"['ALLISON GATLIN', ""Investor's Business Daily""]","Eli Lilly ( LLY ) stock jetted higher early Tuesday after the pharmaceutical company reported adjusted profit of $2.49 per share on $9.35 billion in fourth-quarter sales. On average, analysts surveyed by FactSet expected Lilly to earn $2.30 per share on $8.95 billion in sales.",https://www.investors.com/wp-content/uploads/2018/04/stock-Eli-Lilly-01-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}]",0.232148,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.941495', 'ticker_sentiment_score': '0.411227', 'ticker_sentiment_label': 'Bullish'}]"
611,Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance,https://www.prnewswire.com/news-releases/lilly-reports-strong-fourth-quarter-2023-financial-results-and-provides-2024-guidance-302053915.html,20240206T114500,['Eli Lilly and Company'],"( i ) Lilly defines New Products as select products launched since 2022, which currently consist of Ebglyss, Jaypirca, Mounjaro, Omvoh and Zepbound. ( ii ) Lilly defines Growth Products as select products launched prior to 2022, which currently consist of Cyramza, Emgality, Jardiance, Olumiant, ...",https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999998'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.316726'}]",0.145433,Neutral,"[{'ticker': 'BEAM', 'relevance_score': '0.01102', 'ticker_sentiment_score': '-0.072984', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.331478', 'ticker_sentiment_score': '0.17446', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CURN', 'relevance_score': '0.01102', 'ticker_sentiment_score': '-0.014773', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AKUS', 'relevance_score': '0.01102', 'ticker_sentiment_score': '0.118355', 'ticker_sentiment_label': 'Neutral'}]"
612,The first Wall Street bank to make a recession call now expects a narrow landing,https://www.marketwatch.com/story/the-first-wall-street-bank-to-make-a-recession-call-now-expects-a-narrow-landing-660b7549,20240206T114000,['Barbara Kollmeyer'],"The U.S. economy will land on a ""narrow path"" this year, and avoid a recession, thanks in part to a better consumer picture, says Deutsche Bank.",https://images.mktw.net/im-54030136?width=700&height=559,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.977154'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.067508,Neutral,"[{'ticker': 'BABA', 'relevance_score': '0.087985', 'ticker_sentiment_score': '0.138488', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPOT', 'relevance_score': '0.04406', 'ticker_sentiment_score': '0.047851', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.087985', 'ticker_sentiment_score': '-0.073181', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMG', 'relevance_score': '0.087985', 'ticker_sentiment_score': '-0.073181', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRLCF', 'relevance_score': '0.04406', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.087985', 'ticker_sentiment_score': '-0.073181', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLTR', 'relevance_score': '0.087985', 'ticker_sentiment_score': '-0.093878', 'ticker_sentiment_label': 'Neutral'}]"
613,"Ford, Eli Lilly And 3 Stocks To Watch Heading Into Tuesday - Ford Motor  ( NYSE:F ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/news/earnings/24/02/36947833/ford-eli-lilly-and-3-stocks-to-watch-heading-into-tuesday,20240206T070649,['Avi Kapoor'],"With U.S. stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Eli Lilly and Company LLY to report quarterly earnings at $2.19 per share on revenue of $8.93 billion before the opening bell, according to data ...",https://cdn.benzinga.com/files/images/story/2024/02/06/ford_-_logo.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.972476'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.268213,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.47672', 'ticker_sentiment_score': '0.412575', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'AMKR', 'relevance_score': '0.47672', 'ticker_sentiment_score': '-0.180827', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CMI', 'relevance_score': '0.47672', 'ticker_sentiment_score': '0.32771', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'F', 'relevance_score': '0.329551', 'ticker_sentiment_score': '0.438952', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NXPI', 'relevance_score': '0.47672', 'ticker_sentiment_score': '0.676595', 'ticker_sentiment_label': 'Bullish'}]"
614,Eli Lilly Likely To Report Higher Q4 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/news/earnings/24/02/36947735/eli-lilly-likely-to-report-higher-q4-earnings-here-are-the-recent-forecast-changes-from-wall-street,20240206T060540,['Avi Kapoor'],"Eli Lilly and Company LLY is expected to release earnings results for its fourth quarter, before the opening bell on Feb. 6, 2024. Analysts expect the company to report quarterly earnings at $2.19 per share, up from year-ago earnings of $2.09 per share.",https://cdn.benzinga.com/files/images/story/2024/02/06/eli_lilly_-_logo.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.049154,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.390904', 'ticker_sentiment_score': '0.162099', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'C', 'relevance_score': '0.135347', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.135347', 'ticker_sentiment_score': '-0.098155', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.135347', 'ticker_sentiment_score': '-0.016125', 'ticker_sentiment_label': 'Neutral'}]"
615,"PLTR, NVDA, LLY, SYM, TSLA: Top 5 Trending Stocks Today - NVIDIA  ( NASDAQ:NVDA ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/markets/equities/24/02/36946343/palantir-nvidia-eli-lilly-symbotic-tesla-why-these-5-stocks-are-on-investors-radars-today,20240206T014514,['Benzinga Neuro'],"U.S. stocks traded lower at the end of trading on Monday with the Dow Jones Industrial Average declining 0.7% to 38,380.12 and the S&P 500 dropping 0.3% to 4,942.81. The Nasdaq ended Monday lower by 0.2% at 15,597.68. These are the top stocks that gained the attention of retail traders and ...",https://cdn.benzinga.com/files/images/story/2024/Stocks-Photo-by-Phongphan-on-Shutterstoc_7.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.796627'}]",0.287582,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.163354', 'ticker_sentiment_score': '0.191244', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.24289', 'ticker_sentiment_score': '0.47824', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.24289', 'ticker_sentiment_score': '-0.095762', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.082111', 'ticker_sentiment_score': '0.285316', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SYM', 'relevance_score': '0.163354', 'ticker_sentiment_score': '0.297278', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PLTR', 'relevance_score': '0.163354', 'ticker_sentiment_score': '0.214982', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
616,"Markets Take a Powder; PLTR, NXPI Beat in Q4",https://www.zacks.com/stock/news/2221393/markets-take-a-powder-pltr-nxpi-beat-in-q4,20240205T225900,['Mark Vickery'],Market indices were reluctant to drag a stock market higher amid all-time high ranges on the Dow and S&P 500.,https://staticx-tuner.zacks.com/images/articles/main/ed/2520.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.769861'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.12853,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.173958', 'ticker_sentiment_score': '0.071056', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.173958', 'ticker_sentiment_score': '0.153666', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CMG', 'relevance_score': '0.258351', 'ticker_sentiment_score': '0.096598', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NXPI', 'relevance_score': '0.173958', 'ticker_sentiment_score': '0.078085', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLTR', 'relevance_score': '0.173958', 'ticker_sentiment_score': '0.20444', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
617,Why Amgen's Weight-Loss News Just Sent Lilly To A Record High,https://www.investors.com/news/technology/amgen-stock-slumps-as-it-looks-to-take-on-weight-loss-drugs-leaders-lilly-novo/,20240205T180800,"[""Investor's Business Daily"", 'ALLISON GATLIN']","Amgen Stock Slumps As It Looks To Take On Weight-Loss Drugs Leaders Lilly, Novo Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2022/11/Stock-amgen-08-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.99977'}]",0.125806,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.459624', 'ticker_sentiment_score': '0.267818', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.081276', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.524949', 'ticker_sentiment_score': '0.07163', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTLT', 'relevance_score': '0.316846', 'ticker_sentiment_score': '0.262422', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.316846', 'ticker_sentiment_score': '0.087971', 'ticker_sentiment_label': 'Neutral'}]"
618,"Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Adverum Biotechnologies  ( NASDAQ:ADVM ) , Air Products & Chemicals  ( NYSE:APD ) ",https://www.benzinga.com/news/24/02/36935399/why-air-products-and-chemicals-shares-are-trading-lower-by-around-15-here-are-other-stocks-moving-in,20240205T175650,['Avi Kapoor'],"Shares of Air Products and Chemicals, Inc. APD fell sharply during Monday's session after the company reported worse-than-expected first-quarter financial results and lowered FY24 adjusted EPS guidance below estimates.",https://cdn.benzinga.com/files/images/story/2024/02/05/image32.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '0.857896'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.538269'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",-0.043999,Neutral,"[{'ticker': 'SAN', 'relevance_score': '0.137671', 'ticker_sentiment_score': '-0.136457', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEGY', 'relevance_score': '0.092036', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADVM', 'relevance_score': '0.137671', 'ticker_sentiment_score': '0.122608', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FDMT', 'relevance_score': '0.092036', 'ticker_sentiment_score': '-0.076688', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CORZQ', 'relevance_score': '0.092036', 'ticker_sentiment_score': '0.199688', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NOVA', 'relevance_score': '0.092036', 'ticker_sentiment_score': '-0.393938', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'GRRR', 'relevance_score': '0.092036', 'ticker_sentiment_score': '0.163916', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JT', 'relevance_score': '0.092036', 'ticker_sentiment_score': '0.359106', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'CCTG', 'relevance_score': '0.092036', 'ticker_sentiment_score': '0.021801', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LXEH', 'relevance_score': '0.092036', 'ticker_sentiment_score': '-0.393938', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'NEXI', 'relevance_score': '0.137671', 'ticker_sentiment_score': '-0.173255', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'COCH', 'relevance_score': '0.092036', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COIN', 'relevance_score': '0.092036', 'ticker_sentiment_score': '-0.393938', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'SRM', 'relevance_score': '0.092036', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QLYS', 'relevance_score': '0.092036', 'ticker_sentiment_score': '-0.393938', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'GRDI', 'relevance_score': '0.092036', 'ticker_sentiment_score': '0.15131', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'INBS', 'relevance_score': '0.092036', 'ticker_sentiment_score': '-0.254523', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'EXPR', 'relevance_score': '0.092036', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SGML', 'relevance_score': '0.092036', 'ticker_sentiment_score': '-0.393938', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'EVBG', 'relevance_score': '0.092036', 'ticker_sentiment_score': '0.213384', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SJ', 'relevance_score': '0.092036', 'ticker_sentiment_score': '-0.393938', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'LLY', 'relevance_score': '0.137671', 'ticker_sentiment_score': '0.09661', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DMAQR', 'relevance_score': '0.046095', 'ticker_sentiment_score': '-0.298581', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LYG', 'relevance_score': '0.046095', 'ticker_sentiment_score': '-0.10694', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NEXPF', 'relevance_score': '0.046095', 'ticker_sentiment_score': '-0.141338', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NSTG', 'relevance_score': '0.092036', 'ticker_sentiment_score': '0.241858', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BETS', 'relevance_score': '0.137671', 'ticker_sentiment_score': '-0.157259', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CAMP', 'relevance_score': '0.137671', 'ticker_sentiment_score': '0.143831', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CHEA', 'relevance_score': '0.092036', 'ticker_sentiment_score': '0.305224', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SPWR', 'relevance_score': '0.092036', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ON', 'relevance_score': '0.046095', 'ticker_sentiment_score': '0.233339', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WRAP', 'relevance_score': '0.137671', 'ticker_sentiment_score': '0.247469', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DMK', 'relevance_score': '0.092036', 'ticker_sentiment_score': '-0.199843', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CTLT', 'relevance_score': '0.092036', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLRX', 'relevance_score': '0.092036', 'ticker_sentiment_score': '-0.070706', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLUG', 'relevance_score': '0.092036', 'ticker_sentiment_score': '-0.393938', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'YTEN', 'relevance_score': '0.092036', 'ticker_sentiment_score': '0.280924', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SWIN', 'relevance_score': '0.092036', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MIRA', 'relevance_score': '0.137671', 'ticker_sentiment_score': '-0.358345', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'MOR', 'relevance_score': '0.092036', 'ticker_sentiment_score': '0.359106', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'APD', 'relevance_score': '0.182851', 'ticker_sentiment_score': '0.045478', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BTOG', 'relevance_score': '0.092036', 'ticker_sentiment_score': '-0.393938', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'RVSN', 'relevance_score': '0.137671', 'ticker_sentiment_score': '-0.211207', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.046095', 'ticker_sentiment_score': '0.189271', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
619,In-Depth Analysis: Eli Lilly Versus Competitors In Pharmaceuticals Industry - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/insights/news/24/02/36935452/in-depth-analysis-eli-lilly-versus-competitors-in-pharmaceuticals-industry,20240205T160034,['Benzinga Insights'],"In today's fast-paced and competitive business landscape, it is essential for investors and industry enthusiasts to thoroughly analyze companies before making investment decisions. In this article, we will conduct a comprehensive industry comparison, evaluating Eli Lilly LLY against its key ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.928769'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.152108,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.479258', 'ticker_sentiment_score': '0.283947', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
620,"Estée Lauder Posts Upbeat Earnings, Joins ON Semiconductor, Tyson Foods And Other Big Stocks Moving Higher On Monday - Estee Lauder Cos  ( NYSE:EL ) , Tyson Foods  ( NYSE:TSN ) , ON Semiconductor  ( NASDAQ:ON ) ",https://www.benzinga.com/news/24/02/36934947/est-e-lauder-posts-upbeat-earnings-joins-on-semiconductor-tyson-foods-and-other-big-stocks-moving-hi,20240205T153252,['Avi Kapoor'],"U.S. stocks traded lower, with the Dow Jones falling over 300 points on Monday. Shares of The Estée Lauder Companies Inc.",https://cdn.benzinga.com/files/images/story/2024/02/05/estee_lauder_-_logo.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.161647'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.214337,Somewhat-Bullish,"[{'ticker': 'FDMT', 'relevance_score': '0.215894', 'ticker_sentiment_score': '-0.233714', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CTLT', 'relevance_score': '0.215894', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.215894', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CORZQ', 'relevance_score': '0.215894', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ACRXF', 'relevance_score': '0.108958', 'ticker_sentiment_score': '0.207188', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSN', 'relevance_score': '0.215894', 'ticker_sentiment_score': '0.582744', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'HAYN', 'relevance_score': '0.215894', 'ticker_sentiment_score': '0.306985', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NSSC', 'relevance_score': '0.215894', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ELAN', 'relevance_score': '0.215894', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DWAC', 'relevance_score': '0.215894', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EVBG', 'relevance_score': '0.215894', 'ticker_sentiment_score': '0.294378', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CNA', 'relevance_score': '0.215894', 'ticker_sentiment_score': '0.310127', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.318897', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ON', 'relevance_score': '0.108958', 'ticker_sentiment_score': '0.390197', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.108958', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
621,Is It Too Late to Buy Eli Lilly Stock?,https://www.fool.com/investing/2024/02/05/is-it-too-late-to-buy-eli-lilly-stock/,20240205T151500,['Alex Carchidi'],"Growth may slow, and its valuation is looking precarious.",https://g.foolcdn.com/editorial/images/763737/investor-looks-at-phone-in-cafe-while-drinking-espresso.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}]",0.216411,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.325924', 'ticker_sentiment_score': '0.324367', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
622,"Drug, Biotech Stocks' Q4 Earnings Due on Feb 6: AMGN, LLY & More",https://www.zacks.com/stock/news/2221113/drug-biotech-stocks-q4-earnings-due-on-feb-6-amgn-lly-more,20240205T150900,['Zacks Equity Research'],"Let's take a look at four biotech, drug companies, AMGN, LLY, GILD and EXEL, slated to release quarterly results on Feb 6.",https://staticx-tuner.zacks.com/images/articles/main/49/1007.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.090594,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.313674', 'ticker_sentiment_score': '0.01809', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EXEL', 'relevance_score': '0.270773', 'ticker_sentiment_score': '-0.072387', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.046006', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.182506', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.313674', 'ticker_sentiment_score': '0.14336', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.046006', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
623,How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q4 Earnings Report - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/news/earnings/24/02/36927090/how-to-earn-500-a-month-from-eli-lilly-stock-ahead-of-q4-earnings-report,20240205T133602,['Avi Kapoor'],"Eli Lilly and Company LLY is expected to release earnings results for its fourth quarter, before the opening bell on Feb. 6, 2024. Analysts expect the Indianapolis-based company to report quarterly earnings at $2.19 per share, up from $2.09 per share in the year-ago period.",https://cdn.benzinga.com/files/images/story/2024/02/05/eli-lilly_shutterstock.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.999993'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}]",0.125892,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.671304', 'ticker_sentiment_score': '0.396845', 'ticker_sentiment_label': 'Bullish'}]"
624,"Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, AbbVie and Novartis",https://www.zacks.com/stock/news/2220698/zacks-industry-outlook-highlights-eli-lilly-novo-nordisk-abbvie-and-novartis,20240205T110000,['Zacks Investment Research'],"Eli Lilly, Novo Nordisk, AbbVie and Novartis have been highlighted in this Industry Outlook article.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}, {'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.938238'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.215514,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.023013', 'ticker_sentiment_score': '0.011097', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.023013', 'ticker_sentiment_score': '0.152636', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.137409', 'ticker_sentiment_score': '0.13715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DICE', 'relevance_score': '0.023013', 'ticker_sentiment_score': '0.030885', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.24899', 'ticker_sentiment_score': '0.156217', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.20484', 'ticker_sentiment_score': '0.234708', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.023013', 'ticker_sentiment_score': '0.062277', 'ticker_sentiment_label': 'Neutral'}]"
625,"The Zacks Analyst Blog Highlights Eli Lilly, Danaher, Citigroup, Shopify and Canadian Pacific Kansas",https://www.zacks.com/stock/news/2220682/the-zacks-analyst-blog-highlights-eli-lilly-danaher-citigroup-shopify-and-canadian-pacific-kansas,20240205T095000,['Zacks Investment Research'],"Eli Lilly, Danaher, Citigroup, Shopify and Canadian Pacific Kansas are included in this Analyst Blog.",https://staticx-tuner.zacks.com/images/articles/main/33/496.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.221674,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.423843', 'ticker_sentiment_score': '0.162899', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SHOP', 'relevance_score': '0.147818', 'ticker_sentiment_score': '0.038811', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.220141', 'ticker_sentiment_score': '0.051533', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABCZF', 'relevance_score': '0.07423', 'ticker_sentiment_score': '0.169296', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CP', 'relevance_score': '0.147818', 'ticker_sentiment_score': '0.038811', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DHR', 'relevance_score': '0.423843', 'ticker_sentiment_score': '0.105431', 'ticker_sentiment_label': 'Neutral'}]"
626,Futures: Five Stocks In Buy Areas,https://www.investors.com/market-trend/stock-market-today/dow-jones-future-5-stocks-in-buy-areas-as-market-rally-powers-higher/,20240204T152900,"['ED CARSON', ""Investor's Business Daily""]",Futures: 5 Stocks In Buy Areas As Rally Powers Higher Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2020/09/Stock-BullHead-91-adobe-1.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.967321'}]",0.065161,Neutral,"[{'ticker': 'GOOG', 'relevance_score': '0.044469', 'ticker_sentiment_score': '0.022946', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.088799', 'ticker_sentiment_score': '0.162718', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.088799', 'ticker_sentiment_score': '0.056491', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.044469', 'ticker_sentiment_score': '0.130352', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.044469', 'ticker_sentiment_score': '-0.14785', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXON', 'relevance_score': '0.022243', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDB', 'relevance_score': '0.11087', 'ticker_sentiment_score': '0.082417', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.022243', 'ticker_sentiment_score': '0.025406', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IOT', 'relevance_score': '0.11087', 'ticker_sentiment_score': '-0.011089', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.044469', 'ticker_sentiment_score': '0.130352', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.176502', 'ticker_sentiment_score': '-0.137966', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.11087', 'ticker_sentiment_score': '-0.106411', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.044469', 'ticker_sentiment_score': '0.18076', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SNPS', 'relevance_score': '0.132855', 'ticker_sentiment_score': '0.025322', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PINS', 'relevance_score': '0.044469', 'ticker_sentiment_score': '0.18076', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ARM', 'relevance_score': '0.044469', 'ticker_sentiment_score': '0.18076', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CMG', 'relevance_score': '0.044469', 'ticker_sentiment_score': '0.18076', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMZN', 'relevance_score': '0.06666', 'ticker_sentiment_score': '0.105074', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.06666', 'ticker_sentiment_score': '-0.019266', 'ticker_sentiment_label': 'Neutral'}]"
627,Futures: 5 Stocks In Buy Areas As Rally Powers Higher,https://www.investors.com/market-trend/stock-market-today/dow-jones-future-5-stocks-in-buy-areas-as-market-rally-powers-higher/,20240204T135800,"[""Investor's Business Daily"", 'ED CARSON']",Market Powers To Highs Despite This. 5 New Stocks In Buy Areas Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2020/09/Stock-BullHead-91-adobe-1.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.938238'}]",0.100894,Neutral,"[{'ticker': 'GOOG', 'relevance_score': '0.052226', 'ticker_sentiment_score': '0.023007', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.169832', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.052226', 'ticker_sentiment_score': '0.15957', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.052226', 'ticker_sentiment_score': '0.130999', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXON', 'relevance_score': '0.026127', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDB', 'relevance_score': '0.130076', 'ticker_sentiment_score': '0.088441', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.026127', 'ticker_sentiment_score': '0.025975', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IOT', 'relevance_score': '0.130076', 'ticker_sentiment_score': '-0.011893', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.052226', 'ticker_sentiment_score': '0.130999', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.155786', 'ticker_sentiment_score': '-0.208682', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CAT', 'relevance_score': '0.052226', 'ticker_sentiment_score': '0.136554', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.052226', 'ticker_sentiment_score': '0.136554', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNPS', 'relevance_score': '0.155786', 'ticker_sentiment_score': '0.02778', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PINS', 'relevance_score': '0.052226', 'ticker_sentiment_score': '0.136554', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARM', 'relevance_score': '0.052226', 'ticker_sentiment_score': '0.136554', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMG', 'relevance_score': '0.052226', 'ticker_sentiment_score': '0.136554', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.078269', 'ticker_sentiment_score': '0.107195', 'ticker_sentiment_label': 'Neutral'}]"
628,"Earnings, Jobs, And The Magnificent 7 Soar",https://www.forbes.com/sites/bill_stone/2024/02/04/earnings-jobs-and-the-magnificent-7-soar/,20240204T120000,['Bill Stone'],"Last week was the busiest of earnings season, with 106 S&P 500 companies reporting. The S&P 500 rose 1.4% for the week, driven primarily by earnings and the Magnificent 7. The 10-year Treasury yield was fractionally lower at 4.0%.",https://imageio.forbes.com/specials-images/imageserve/65be6a5b3de8507b84cf569c/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds,Forbes,n/a,www.forbes.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.928139'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.99998'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.198921,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.224903', 'ticker_sentiment_score': '0.320847', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.224903', 'ticker_sentiment_score': '0.320847', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.113597', 'ticker_sentiment_score': '0.212136', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.224903', 'ticker_sentiment_score': '0.306357', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.113597', 'ticker_sentiment_score': '0.212136', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MDNDF', 'relevance_score': '0.056943', 'ticker_sentiment_score': '-0.198994', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CAT', 'relevance_score': '0.113597', 'ticker_sentiment_score': '-0.22152', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LLY', 'relevance_score': '0.113597', 'ticker_sentiment_score': '-0.22152', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'UBER', 'relevance_score': '0.113597', 'ticker_sentiment_score': '-0.22152', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
629,"After a 90% Gain, Is It Too Late to Buy Eli Lilly?",https://www.fool.com/investing/2024/02/04/after-a-90-gain-is-it-too-late-to-buy-eli-lilly/,20240204T090500,['Adria Cimino'],Its drug tirzepatide showed top efficacy as a weight-loss treatment according to the latest real-world data.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F763686%2Fgettyimages-903626078.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Earnings', 'relevance_score': '0.961735'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.236494,Somewhat-Bullish,"[{'ticker': 'GS', 'relevance_score': '0.055236', 'ticker_sentiment_score': '0.04908', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.554014', 'ticker_sentiment_score': '0.356177', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.164656', 'ticker_sentiment_score': '0.052794', 'ticker_sentiment_label': 'Neutral'}]"
630,"Disney, Caterpillar, McDonald's, Ford: Investing Action Plan",https://www.investors.com/research/investing-action-plan/disney-stock-caterpillar-mcdonalds-ford-investing-action-plan/,20240202T230000,"['ALAN R. ELLIOTT', ""Investor's Business Daily""]","Disney Stock, Caterpillar, McDonald's, Ford: Investing Action Plan Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2019/01/stock-NYSE-05-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.998356'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.115657,Neutral,"[{'ticker': 'PYPL', 'relevance_score': '0.053931', 'ticker_sentiment_score': '-0.065969', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TENB', 'relevance_score': '0.080819', 'ticker_sentiment_score': '0.021495', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.026981', 'ticker_sentiment_score': '0.028291', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.053931', 'ticker_sentiment_score': '0.094', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ILMN', 'relevance_score': '0.053931', 'ticker_sentiment_score': '-0.017985', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NXPI', 'relevance_score': '0.053931', 'ticker_sentiment_score': '0.070764', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDB', 'relevance_score': '0.080819', 'ticker_sentiment_score': '0.098148', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPG', 'relevance_score': '0.080819', 'ticker_sentiment_score': '0.065573', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.053931', 'ticker_sentiment_score': '0.030931', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LITE', 'relevance_score': '0.053931', 'ticker_sentiment_score': '-0.046811', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'URI', 'relevance_score': '0.080819', 'ticker_sentiment_score': '0.091947', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LEN', 'relevance_score': '0.080819', 'ticker_sentiment_score': '0.098148', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCK', 'relevance_score': '0.053931', 'ticker_sentiment_score': '0.141', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FTNT', 'relevance_score': '0.053931', 'ticker_sentiment_score': '0.020982', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ORLY', 'relevance_score': '0.080819', 'ticker_sentiment_score': '0.007181', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.134289', 'ticker_sentiment_score': '0.074545', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ENB', 'relevance_score': '0.080819', 'ticker_sentiment_score': '0.027839', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.080819', 'ticker_sentiment_score': '0.0255', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNPS', 'relevance_score': '0.080819', 'ticker_sentiment_score': '0.098148', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GLOB', 'relevance_score': '0.080819', 'ticker_sentiment_score': '0.098148', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.053931', 'ticker_sentiment_score': '0.11074', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TTWO', 'relevance_score': '0.053931', 'ticker_sentiment_score': '0.05579', 'ticker_sentiment_label': 'Neutral'}]"
631,S&P 500 Hits High In Stock Picker's Market; Five New Buys,https://www.investors.com/market-trend/stock-market-today/dow-jones-sp-500-hit-highs-stock-pickers-market-5-new-buys-tesla-leads-losers/,20240202T224900,"['ED CARSON', ""Investor's Business Daily""]",S&P 500 Hits High In Stock Picker's Market. Five New Buys Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2020/09/Stock-BullHead-91-adobe-1.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.938238'}]",0.098442,Neutral,"[{'ticker': 'GOOG', 'relevance_score': '0.054857', 'ticker_sentiment_score': '0.023029', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.109455', 'ticker_sentiment_score': '0.172706', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.054857', 'ticker_sentiment_score': '0.159857', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.054857', 'ticker_sentiment_score': '0.13103', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXON', 'relevance_score': '0.027445', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDB', 'relevance_score': '0.136577', 'ticker_sentiment_score': '0.09451', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.027445', 'ticker_sentiment_score': '0.026153', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IOT', 'relevance_score': '0.109455', 'ticker_sentiment_score': '-0.015541', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.054857', 'ticker_sentiment_score': '0.13103', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.163539', 'ticker_sentiment_score': '-0.215236', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CAT', 'relevance_score': '0.054857', 'ticker_sentiment_score': '0.136835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.054857', 'ticker_sentiment_score': '0.136835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNPS', 'relevance_score': '0.163539', 'ticker_sentiment_score': '0.030049', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PINS', 'relevance_score': '0.054857', 'ticker_sentiment_score': '0.136835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARM', 'relevance_score': '0.054857', 'ticker_sentiment_score': '0.136835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMG', 'relevance_score': '0.054857', 'ticker_sentiment_score': '0.136835', 'ticker_sentiment_label': 'Neutral'}]"
632,"Top Stock Reports for Eli Lilly, Danaher & Citigroup",https://www.zacks.com/research-daily/2220146/top-stock-reports-for-eli-lilly-danaher-citigroup,20240202T215900,['Mark Vickery'],"Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Danaher Corporation (DHR) and Citigroup Inc. (C).",https://staticx-tuner.zacks.com/images/articles/main/af/51929.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.260398,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.298264', 'ticker_sentiment_score': '0.202381', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'C', 'relevance_score': '0.101582', 'ticker_sentiment_score': '0.158795', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABCZF', 'relevance_score': '0.101582', 'ticker_sentiment_score': '0.183981', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DHR', 'relevance_score': '0.298264', 'ticker_sentiment_score': '0.097043', 'ticker_sentiment_label': 'Neutral'}]"
633,A Closer Look At The Disruption Of Medifast,https://www.forbes.com/sites/gurufocus/2024/02/02/a-closer-look-at-the-disruption-of-medifast/,20240202T173126,['GuruFocus'],"The weight loss and nutrition product company is coping with the GLP-1 drug tsunami • The new diabetes and diet drugs appear to have disrupted the company's extremely profitable business model. Weight loss and wellness product company Medifast Inc. ( MED, Financial ) has experienced a significant ...",https://imageio.forbes.com/specials-images/imageserve/65bd2469f0bee498c099bcba/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds,Forbes,n/a,www.forbes.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.967645'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.098847,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.069294', 'ticker_sentiment_score': '-0.170101', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LFMD', 'relevance_score': '0.03468', 'ticker_sentiment_score': '-0.012375', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VALU', 'relevance_score': '0.03468', 'ticker_sentiment_score': '-0.163211', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'MED', 'relevance_score': '0.33628', 'ticker_sentiment_score': '0.10894', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.069294', 'ticker_sentiment_score': '-0.170101', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
634,What's Going On With Eli Lilly Stock Today? - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/analyst-ratings/analyst-color/24/02/36913823/whats-going-on-with-eli-lilly-stock-today,20240202T172909,['Vandana Singh'],"Eli Lilly And Co LLY is set to announce its fourth quarter 2023 financial results next week on Tuesday, 6 February. The analysts expect Eli Lilly to report $2.19 per share earnings and sales of $8.932 billion, according to data from Benzinga Pro.",https://cdn.benzinga.com/files/images/story/2024/Eli-Lilly_0.jpeg?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",-0.009466,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.817578', 'ticker_sentiment_score': '0.163751', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
635,"ELF Beauty, Palantir, Arm Holdings, Chipotle Headline Busy Earnings Calendar",https://www.investors.com/research/earnings-preview/earnings-calendar-spotlight-sellers-hit-palantir-stock-growth-concerns/,20240202T163900,"['KEN SHREVE', ""Investor's Business Daily""]",Earnings Calendar Spotlight: Sellers Hit Palantir Stock Amid Growth Concerns. Expectations High For ELF Beauty Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2024/02/EARNwatch020524.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",0.148699,Neutral,"[{'ticker': 'NVDA', 'relevance_score': '0.063091', 'ticker_sentiment_score': '-0.084032', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPOT', 'relevance_score': '0.063091', 'ticker_sentiment_score': '0.192228', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SFTBF', 'relevance_score': '0.03157', 'ticker_sentiment_score': '-0.078621', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.063091', 'ticker_sentiment_score': '0.106054', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PINS', 'relevance_score': '0.063091', 'ticker_sentiment_score': '0.106054', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARM', 'relevance_score': '0.094514', 'ticker_sentiment_score': '0.099503', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMG', 'relevance_score': '0.156868', 'ticker_sentiment_score': '0.106841', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NET', 'relevance_score': '0.063091', 'ticker_sentiment_score': '0.106054', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBNY', 'relevance_score': '0.03157', 'ticker_sentiment_score': '-0.18159', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'APOS', 'relevance_score': '0.03157', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NYCB', 'relevance_score': '0.063091', 'ticker_sentiment_score': '-0.188672', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
636,4 Large Drug Stocks Trying to Survive the Industry Challenges,https://www.zacks.com/commentary/2220023/4-large-drug-stocks-trying-to-survive-the-industry-challenges,20240202T134700,['Kinjel Shah'],"Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), AbbVie (ABBV) and Novartis (NVS) are worth retaining in one's portfolio.",https://staticx-tuner.zacks.com/images/articles/main/85/906.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}, {'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.938238'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.215569,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.235366', 'ticker_sentiment_score': '0.15857', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GOOG', 'relevance_score': '0.023885', 'ticker_sentiment_score': '0.065458', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.189298', 'ticker_sentiment_score': '0.236489', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.118999', 'ticker_sentiment_score': '0.140653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.023885', 'ticker_sentiment_score': '0.065458', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DICE', 'relevance_score': '0.023885', 'ticker_sentiment_score': '0.031019', 'ticker_sentiment_label': 'Neutral'}]"
637,AbbVie  ( ABBV )  Q4 Earnings and Revenues Top Estimates,https://www.zacks.com/stock/news/2220125/abbvie-abbv-q4-earnings-and-revenues-top-estimates,20240202T134502,['Zacks Equity Research'],"AbbVie (ABBV) delivered earnings and revenue surprises of 1.09% and 1.78%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?",https://staticx-tuner.zacks.com/images/default_article_images/default188.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999997'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.16185,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.139669', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.402403', 'ticker_sentiment_score': '0.208814', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
638,Market Whales and Their Recent Bets on LLY Options - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/02/36889771/market-whales-and-their-recent-bets-on-lly-options,20240201T144710,['Benzinga Insights'],"Investors with a lot of money to spend have taken a bearish stance on Eli Lilly LLY. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.002398,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.764792', 'ticker_sentiment_score': '-0.102214', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.085936', 'ticker_sentiment_score': '-0.104834', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.085936', 'ticker_sentiment_score': '-0.131693', 'ticker_sentiment_label': 'Neutral'}]"
639,Lilly  ( LLY )  Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures,https://www.zacks.com/stock/news/2219391/lilly-lly-q4-earnings-on-the-horizon-analysts-insights-on-key-performance-measures,20240201T141522,['Zacks Equity Research'],"Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Lilly (LLY), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.",https://staticx-tuner.zacks.com/images/default_article_images/default45.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.972476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.126879,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.359707', 'ticker_sentiment_score': '0.224852', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
640,Why Eli Lilly Stock Topped the Market Today,https://www.fool.com/investing/2024/01/31/why-eli-lilly-stock-topped-the-market-today/,20240131T231600,['Eric Volkman'],One of its more recently approved drugs will be launched into a white-hot market.,https://g.foolcdn.com/editorial/images/763435/patient-and-physician-smiling-during-a-visit.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}]",0.265184,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.614086', 'ticker_sentiment_score': '0.456209', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.512093', 'ticker_sentiment_score': '0.509193', 'ticker_sentiment_label': 'Bullish'}]"
641,Eli Lilly  ( LLY )  to Report Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2218932/eli-lilly-lly-to-report-q4-earnings-whats-in-the-cards,20240131T164800,['Zacks Equity Research'],"On Eli Lilly's (LLY) fourth-quarter conference call, investor focus is likely to be on the sales performance of its tirzepatide medicines, Mounjaro and Zepbound.",https://staticx-tuner.zacks.com/images/articles/main/39/612.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.99998'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}]",0.138198,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.400691', 'ticker_sentiment_score': '0.13284', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.207216', 'ticker_sentiment_score': '0.058657', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.207216', 'ticker_sentiment_score': '0.047535', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.207216', 'ticker_sentiment_score': '-0.001617', 'ticker_sentiment_label': 'Neutral'}]"
642,Eli Lilly and Company  ( LLY )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2218601/eli-lilly-and-company-lly-is-a-trending-stock-facts-to-know-before-betting-on-it,20240131T140010,['Zacks Equity Research'],"Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default286.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.219612,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.528798', 'ticker_sentiment_score': '0.154158', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
643,"Take Your Ozempic: Why Late Entry Of Rival Weight-Loss Drugs Won't Floor Novo, Eli Shares - AstraZeneca  ( NASDAQ:AZN ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/analyst-ratings/analyst-color/24/01/36866023/take-your-ozempic-why-late-entry-of-rival-weight-loss-drugs-wont-floor-novo-eli-sha,20240131T134944,['Neil Dennis'],"Eli Lilly LLY reports its fourth quarter earnings next week and, as Novo Nordisk NVO did on Wednesday, is expected to wow investors with earnings and revenue beats thanks, in large part, to the overwhelming success of its diabetes treatments that have become popular weight-loss solutions.",https://cdn.benzinga.com/files/images/story/2024/ozempic-shutter.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '0.928769'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.187068,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.211191', 'ticker_sentiment_score': '0.249005', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.141726', 'ticker_sentiment_score': '-0.039113', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PTAIF', 'relevance_score': '0.071145', 'ticker_sentiment_score': '0.119694', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.211191', 'ticker_sentiment_score': '0.289771', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.211191', 'ticker_sentiment_score': '0.262369', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.211191', 'ticker_sentiment_score': '0.092059', 'ticker_sentiment_label': 'Neutral'}]"
644,Ozempic maker Novo Nordisk reports 62% surge in profit,https://www.marketwatch.com/story/ozempic-maker-novo-nordisk-reports-62-surge-in-profit-584a5064,20240131T085200,['Steve Goldstein'],"Novo Nordisk on Wednesday said its fourth-quarter profit surged by nearly two-thirds, driven by the popularity of its weight-loss drugs that have made it Europe's largest company.",https://images.mktw.net/im-809249/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.239467,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.224903', 'ticker_sentiment_score': '-0.059165', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.746902', 'ticker_sentiment_score': '0.417184', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'C', 'relevance_score': '0.113597', 'ticker_sentiment_score': '-0.038291', 'ticker_sentiment_label': 'Neutral'}]"
645,Eli Lilly  ( LLY )  Earnings Expected to Grow: Should You Buy?,https://www.zacks.com/stock/news/2217983/eli-lilly-lly-earnings-expected-to-grow-should-you-buy,20240130T150056,['Zacks Equity Research'],Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,https://staticx-tuner.zacks.com/images/default_article_images/default302.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.149619,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.259727', 'ticker_sentiment_score': '0.127026', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.174903', 'ticker_sentiment_score': '-0.001424', 'ticker_sentiment_label': 'Neutral'}]"
646,Is Lilly  ( LLY )  a Buy as Wall Street Analysts Look Optimistic?,https://www.zacks.com/stock/news/2217883/is-lilly-lly-a-buy-as-wall-street-analysts-look-optimistic,20240130T143006,['Zacks Equity Research'],"According to the average brokerage recommendation (ABR), one should invest in Lilly (LLY). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",https://staticx-tuner.zacks.com/images/yesopchart/brokerage_bar/LLY_01302024.png,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.938238'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.459462'}]",0.283192,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.362254', 'ticker_sentiment_score': '0.180653', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
647,Eli Lilly  ( LLY )  Beats Stock Market Upswing: What Investors Need to Know,https://www.zacks.com/stock/news/2217450/eli-lilly-lly-beats-stock-market-upswing-what-investors-need-to-know,20240129T224519,['Zacks Equity Research'],"Eli Lilly (LLY) concluded the recent trading session at $645, signifying a +0.9% move from its prior day's close.",https://staticx-tuner.zacks.com/images/default_article_images/default37.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Earnings', 'relevance_score': '0.917436'}]",0.20128,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.598621', 'ticker_sentiment_score': '0.27535', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
648,"We're calling up a health care stock from our Bullpen watch list, starting a new position",https://www.cnbc.com/2024/01/29/were-calling-up-a-health-care-stock-from-our-bullpen-watch-list-starting-a-new-position.html,20240129T140341,['Jim Cramer'],"Now that expectations have cooled down, we think this pullback is one worth buying.",https://image.cnbcfm.com/api/v1/image/107250871-1685970222341-gettyimages-1258453480-Port_Trade_Growth_In_Lianyungang.jpeg?v=1698261998&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.96136'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.905476'}]",0.209243,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.074809', 'ticker_sentiment_score': '0.090625', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.037446', 'ticker_sentiment_score': '0.087033', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.221819', 'ticker_sentiment_score': '0.153796', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
649,How to Find Strong Medical Stocks Slated for Positive Earnings Surprises,https://www.zacks.com/stock/news/2216951/how-to-find-strong-medical-stocks-slated-for-positive-earnings-surprises,20240129T135006,['Zacks Equity Research'],The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.,https://staticx-tuner.zacks.com/images/default_article_images/default283.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999989'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.371141,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.392948', 'ticker_sentiment_score': '0.333286', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
650,Futures Await Huge Market News,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-microsoft-leads-huge-earnings-wave/,20240129T131000,"['ED CARSON', ""Investor's Business Daily""]",Dow Jones Futures: Microsoft Leads Huge Earnings Wave Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2020/04/Stock-BigWavePipe-08-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.890401'}]",0.128441,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.450828', 'ticker_sentiment_score': '0.05364', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.235442', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUM', 'relevance_score': '0.079524', 'ticker_sentiment_score': '-0.178319', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'META', 'relevance_score': '0.079524', 'ticker_sentiment_score': '0.004122', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.273224', 'ticker_sentiment_score': '0.063015', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.079524', 'ticker_sentiment_score': '-0.178319', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'INTC', 'relevance_score': '0.119038', 'ticker_sentiment_score': '-0.043251', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.235442', 'ticker_sentiment_score': '0.001774', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.235442', 'ticker_sentiment_score': '0.029396', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.119038', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.158259', 'ticker_sentiment_score': '0.001322', 'ticker_sentiment_label': 'Neutral'}]"
651,"Better Buy in 2024: The ""Magnificent Seven"" or the ""Terrific 10""?",https://www.fool.com/investing/2024/01/29/better-buy-the-magnificent-seven-or-terrific-ten/,20240129T112600,['Daniel Foelber'],The financial and healthcare sectors make up a massive amount of the market.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F762431%2Fgettyimages-1419726675-1201x633-65d4be6.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.999956'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.857896'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.333127,Somewhat-Bullish,"[{'ticker': 'META', 'relevance_score': '0.068995', 'ticker_sentiment_score': '0.101721', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.03453', 'ticker_sentiment_score': '0.122273', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.03453', 'ticker_sentiment_score': '0.201917', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.068995', 'ticker_sentiment_score': '0.120472', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.137474', 'ticker_sentiment_score': '0.163389', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.068995', 'ticker_sentiment_score': '0.111863', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.204936', 'ticker_sentiment_score': '0.271149', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.068995', 'ticker_sentiment_score': '0.101721', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.03453', 'ticker_sentiment_score': '0.122273', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MA', 'relevance_score': '0.171363', 'ticker_sentiment_score': '0.256013', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WFC', 'relevance_score': '0.03453', 'ticker_sentiment_score': '0.103812', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.068995', 'ticker_sentiment_score': '0.144218', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.137474', 'ticker_sentiment_score': '0.127343', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.238133', 'ticker_sentiment_score': '0.303144', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HD', 'relevance_score': '0.171363', 'ticker_sentiment_score': '0.277563', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
652,2 Unstoppable Stocks to Buy and Hold For at Least 10 Years,https://www.fool.com/investing/2024/01/29/2-unstoppable-stocks-to-buy-and-hold-for-at-least/,20240129T082900,['Prosper Junior Bakiny'],It's hard to bet against these companies right now.,https://g.foolcdn.com/editorial/images/762585/patient-talking-with-a-physician.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '0.744043'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.5'}]",0.372593,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.484697', 'ticker_sentiment_score': '0.428275', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BKNG', 'relevance_score': '0.573492', 'ticker_sentiment_score': '0.557749', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ABNB', 'relevance_score': '0.057628', 'ticker_sentiment_score': '0.232005', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
653,Monthly Meeting Q&A with Jim Cramer: Everything from health care to industrials to portfolio management,https://www.cnbc.com/2024/01/28/monthly-meeting-qa-with-jim-cramer-everything-from-health-care-to-industrials.html,20240128T180102,['Paulina Likos'],"During the January Monthly Meeting, we took questions directly from Investing Club members.",https://image.cnbcfm.com/api/v1/image/107200470-1677528554271-NUP_200782_00237.jpg?v=1697057003&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.928139'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.07939,Neutral,"[{'ticker': 'BABA', 'relevance_score': '0.019086', 'ticker_sentiment_score': '0.029932', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DKNG', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.033849', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.038162', 'ticker_sentiment_score': '0.032468', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.033849', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIDU', 'relevance_score': '0.019086', 'ticker_sentiment_score': '0.029932', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WYNN', 'relevance_score': '0.038162', 'ticker_sentiment_score': '0.032468', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.038162', 'ticker_sentiment_score': '0.032468', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.057215', 'ticker_sentiment_score': '0.033046', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.019086', 'ticker_sentiment_score': '0.029932', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.189076', 'ticker_sentiment_score': '0.051361', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.057215', 'ticker_sentiment_score': '0.033046', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ETN', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.033849', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTRA', 'relevance_score': '0.057215', 'ticker_sentiment_score': '0.033046', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PANW', 'relevance_score': '0.038162', 'ticker_sentiment_score': '0.032468', 'ticker_sentiment_label': 'Neutral'}]"
654,Forget The Magnificent Seven. Focus On These Fab Five.,https://www.investors.com/news/sp-500-forget-magnificent-seven-focus-on-fab-five/,20240128T130000,"[""Investor's Business Daily"", 'ED CARSON']","The Magnificent Seven stocks - S&P 500 giants Amazon.com ( AMZN ) , Apple ( AAPL ) , Google parent Alphabet ( GOOGL ) , Meta Platforms ( META ) , Microsoft ( MSFT ) , Nvidia ( NVDA ) and Tesla ( TSLA ) - have been grouped together since the start of the bull market in January 2023.",https://www.investors.com/wp-content/uploads/2023/11/Stock-AImachinelearning-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",0.181552,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.321927', 'ticker_sentiment_score': '0.294393', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HUM', 'relevance_score': '0.060161', 'ticker_sentiment_score': '-0.1661', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'META', 'relevance_score': '0.149656', 'ticker_sentiment_score': '0.218425', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.526614', 'ticker_sentiment_score': '0.312372', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.265859', 'ticker_sentiment_score': '0.210761', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNPR', 'relevance_score': '0.060161', 'ticker_sentiment_score': '0.107001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.060161', 'ticker_sentiment_score': '0.100001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADM', 'relevance_score': '0.060161', 'ticker_sentiment_score': '-0.1661', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSM', 'relevance_score': '0.090134', 'ticker_sentiment_score': '0.176881', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.40271', 'ticker_sentiment_score': '0.274766', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.321927', 'ticker_sentiment_score': '0.083558', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.090134', 'ticker_sentiment_score': '-0.081834', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.149656', 'ticker_sentiment_score': '0.185532', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMZN', 'relevance_score': '0.294093', 'ticker_sentiment_score': '0.246411', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BA', 'relevance_score': '0.060161', 'ticker_sentiment_score': '-0.1661', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
655,Could Eli Lilly Be a Trillion-Dollar Company by 2030?,https://www.fool.com/investing/2024/01/27/could-eli-lilly-be-a-trillion-dollar-company-by-20/,20240127T132500,['Adam Spatacco'],"Eli Lilly is the world's largest healthcare company by market cap, and the 10th most valuable business in the world.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F762341%2Fdoctor-showing-patient-a-chart.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.986714'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}]",0.305641,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.766317', 'ticker_sentiment_score': '0.468276', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.090304', 'ticker_sentiment_score': '0.097646', 'ticker_sentiment_label': 'Neutral'}]"
656,Earnings Tsunami Looms For Market Rally; Seven Stocks To Watch,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-earnings-tsunami-looms-microsoft-apple-lead-7-stocks-to-watch/,20240126T214100,"['ED CARSON', ""Investor's Business Daily""]","Dow Jones Futures: Earnings Tsunami Looms. Microsoft, Apple Lead 7 Stocks To Watch Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2020/04/Stock-BigWavePipe-08-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.890401'}]",0.121082,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.443626', 'ticker_sentiment_score': '0.090942', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.210823', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUM', 'relevance_score': '0.085173', 'ticker_sentiment_score': '-0.180785', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'META', 'relevance_score': '0.085173', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.291842', 'ticker_sentiment_score': '0.108265', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.085173', 'ticker_sentiment_score': '-0.180785', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'INTC', 'relevance_score': '0.085173', 'ticker_sentiment_score': '-0.180785', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NVO', 'relevance_score': '0.25168', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.25168', 'ticker_sentiment_score': '0.030817', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.127456', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.169378', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
657,Eli Lilly Unusual Options Activity - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/01/36802049/eli-lilly-unusual-options-activity,20240126T144602,['Benzinga Insights'],"Deep-pocketed investors have adopted a bearish approach towards Eli Lilly LLY, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.026409,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.769861', 'ticker_sentiment_score': '0.00799', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.08687', 'ticker_sentiment_score': '-0.131944', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.08687', 'ticker_sentiment_score': '-0.105032', 'ticker_sentiment_label': 'Neutral'}]"
658,"Tesla's Market Cap Dips Below Eli Lilly Following Q4 Revenue Miss: Report - Tesla  ( NASDAQ:TSLA ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/news/24/01/36794521/teslas-market-cap-dips-below-eli-lilly-following-q4-revenue-miss-report,20240126T005853,['Benzinga Neuro'],"Tesla Inc. TSLA has been surpassed in market value by pharmaceutical giant Eli Lilly LLY, following a 12% single-day plunge in Tesla's stock. What Happened: Tesla's fourth-quarter earnings report, which fell short of revenue and profit expectations, triggered a significant drop in its stock price.",https://cdn.benzinga.com/files/images/story/2024/NeuroImage_0.png?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.904684'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.117845,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.328455', 'ticker_sentiment_score': '0.140541', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.328455', 'ticker_sentiment_score': '0.161825', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.084423', 'ticker_sentiment_score': '0.048427', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.084423', 'ticker_sentiment_score': '-0.208128', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
659,Johna Norton to Retire as Lilly Executive Vice President of Global Quality,https://www.prnewswire.com/news-releases/johna-norton-to-retire-as-lilly-executive-vice-president-of-global-quality-302043876.html,20240125T130000,['Eli Lilly and Company'],"INDIANAPOLIS, Jan. 25, 2024 /PRNewswire/ -- Eli Lilly and Company ( NYSE: LLY ) today announced that Johna Norton, executive vice president of Global Quality, will be retiring after 34 years of service with the company, effective July 31, 2024.",https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.451494'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.196394,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.452639', 'ticker_sentiment_score': '0.230674', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CURN', 'relevance_score': '0.034282', 'ticker_sentiment_score': '0.005853', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.034282', 'ticker_sentiment_score': '0.138739', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AKUS', 'relevance_score': '0.034282', 'ticker_sentiment_score': '0.134834', 'ticker_sentiment_label': 'Neutral'}]"
660,Stock Of The Day Lilly Is In A Buy Zone. And It's Not Related To Obesity.,https://www.investors.com/research/ibd-stock-of-the-day/eli-lilly-stock-rallies-into-buy-zone-on-surprising-results-in-treating-deafness/,20240124T171200,"['ALLISON GATLIN', ""Investor's Business Daily""]",Eli Lilly Stock Rallies Into Buy Zone On Surprising Results In Treating Deafness Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2024/01/SOTD-1-24-2024LLY.png,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}]",0.053361,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.55533', 'ticker_sentiment_score': '0.145116', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AKUS', 'relevance_score': '0.151539', 'ticker_sentiment_score': '0.063005', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.151539', 'ticker_sentiment_score': '-0.049141', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.101367', 'ticker_sentiment_score': '-0.043919', 'ticker_sentiment_label': 'Neutral'}]"
661,Eli Lilly Unusual Options Activity - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/insights/options/24/01/36759493/eli-lilly-unusual-options-activity,20240124T144708,['Benzinga Insights'],"Whales with a lot of money to spend have taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 13 trades. If we consider the specifics of each trade, it is accurate to state that 38% of the investors opened trades with bullish expectations and ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.011968,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.737428', 'ticker_sentiment_score': '-0.119866', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.099066', 'ticker_sentiment_score': '-0.117744', 'ticker_sentiment_label': 'Neutral'}]"
662,Abbott Labs' fourth-quarter sales top estimates amid strong medical-device demand,https://www.marketwatch.com/story/abbott-labs-fourth-quarter-sales-top-estimates-amid-strong-medical-device-demand-4d68669e,20240124T125700,['Eleanor Laise'],Abbott Laboratories on Wednesday reported fourth-quarter sales that topped expectations amid strength in its medical-device and nutrition segments.,https://images.mktw.net/im-549400/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Earnings', 'relevance_score': '0.890401'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.162117,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.148273', 'ticker_sentiment_score': '0.197008', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TNDM', 'relevance_score': '0.148273', 'ticker_sentiment_score': '0.111972', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.148273', 'ticker_sentiment_score': '0.006598', 'ticker_sentiment_label': 'Neutral'}]"
663,Eli Lilly  ( LLY )  Stock Sinks As Market Gains: Here's Why,https://www.zacks.com/stock/news/2214575/eli-lilly-lly-stock-sinks-as-market-gains-heres-why,20240123T224518,['Zacks Equity Research'],"The latest trading day saw Eli Lilly (LLY) settling at $629.68, representing a -0.19% change from its previous close.",https://staticx-tuner.zacks.com/images/default_article_images/default314.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.95493'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.191838,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.565003', 'ticker_sentiment_score': '0.229546', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
664,These 2 Growth Stocks Are Brilliant Buys for the New Year,https://www.fool.com/investing/2024/01/23/these-2-growth-stocks-are-brilliant-buys-for-the/,20240123T144500,['Rachel Warren'],"Business is booming for these stocks, and investors might want to stop and take note.",https://g.foolcdn.com/editorial/images/761836/family-cuddling-on-sofa-at-home.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.94762'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.260007,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.247418', 'ticker_sentiment_score': '0.258839', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TRMNF', 'relevance_score': '0.041901', 'ticker_sentiment_score': '0.122225', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DXCM', 'relevance_score': '0.28696', 'ticker_sentiment_score': '0.271791', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
665,2 Monster Stocks to Buy Without Any Hesitation,https://www.fool.com/investing/2024/01/23/2-monster-stocks-to-buy-without-any-hesitation/,20240123T110000,['Adria Cimino'],These stocks both could deliver great rewards over time.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F762141%2Fgettyimages-468679176.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.77141'}, {'topic': 'Earnings', 'relevance_score': '0.99246'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.321362,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.551295', 'ticker_sentiment_score': '0.204225', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.060388', 'ticker_sentiment_score': '0.065101', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.504646', 'ticker_sentiment_score': '0.53287', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.013032', 'ticker_sentiment_label': 'Neutral'}]"
666,Don't Be Fooled by These 3 Misleading Facts About Eli Lilly Stock,https://www.fool.com/investing/2024/01/23/3-misleading-facts-about-eli-lilly-stock/,20240123T065900,['Alex Carchidi'],Don't let a few disparate facts dominate your view of this company.,https://g.foolcdn.com/editorial/images/761493/investor-considers-papers-while-sitting-near-books.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.007331,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.312158', 'ticker_sentiment_score': '-0.120877', 'ticker_sentiment_label': 'Neutral'}]"
667,"Jim Cramer Says Eli Lilly Could Replace Tesla In 'Magnificent Seven' List: 'To Ignore...Is To Reject The Facts' - Apple  ( NASDAQ:AAPL ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/markets/equities/24/01/36729974/jim-cramer-says-eli-lilly-could-replace-tesla-in-magnificent-seven-list-to-ignore-is-to-reject-t,20240123T030212,['Benzinga Neuro'],"Jim Cramer, the host of CNBC's ""Mad Money,"" has hinted at the possibility of Tesla Inc TSLA being replaced by Eli Lilly and Co LLY in the ""Magnificent Seven"" list of mega-cap stocks.",https://cdn.benzinga.com/files/images/story/2024/Jim-Cramer-Photo-by-s-bukley-on-Shutters_1.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.132447,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.18602', 'ticker_sentiment_score': '0.24853', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GOOG', 'relevance_score': '0.18602', 'ticker_sentiment_score': '0.24853', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.18602', 'ticker_sentiment_score': '0.24853', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.18602', 'ticker_sentiment_score': '0.24853', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.18602', 'ticker_sentiment_score': '0.24853', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.589793', 'ticker_sentiment_score': '0.050007', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.18602', 'ticker_sentiment_score': '-0.151246', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NVO', 'relevance_score': '0.18602', 'ticker_sentiment_score': '0.254895', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.589793', 'ticker_sentiment_score': '0.144922', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HTZ', 'relevance_score': '0.18602', 'ticker_sentiment_score': '-0.151246', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
668,"These 5 Wildly Popular High-Flying Stocks of 2023 Could Be Duds in the Rest of 2024, According to Wall Street",https://www.fool.com/investing/2024/01/22/these-5-wildly-popular-high-flying-stocks-of-2023/,20240122T105000,['Keith Speights'],Analysts have not-so-great expectations going forward for these huge winners.,https://g.foolcdn.com/editorial/images/761848/young-woman-frustrated-laptop.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.459462'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.839681'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.182612,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.224903', 'ticker_sentiment_score': '0.124941', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.310843', 'ticker_sentiment_score': '0.138121', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.136113', 'ticker_sentiment_score': '0.088872', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.268294', 'ticker_sentiment_score': '0.102004', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.268294', 'ticker_sentiment_score': '0.25253', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
669,Prediction: This Will Be the First Trillion-Dollar Healthcare Stock,https://www.fool.com/investing/2024/01/21/prediction-this-will-be-the-first-trillion-dollar/,20240121T160200,['Prosper Junior Bakiny'],This company is currently firing on all cylinders.,https://g.foolcdn.com/editorial/images/761056/doctor-with-patient-talking.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}, {'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.267579,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.637818', 'ticker_sentiment_score': '0.397667', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.220809', 'ticker_sentiment_score': '0.191225', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.220809', 'ticker_sentiment_score': '0.213931', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.166551', 'ticker_sentiment_score': '0.132619', 'ticker_sentiment_label': 'Neutral'}]"
670,24 Dividend Growth Stocks to Buy and Hold in 2024,https://www.fool.com/investing/2024/01/21/24-dividend-growth-stocks-to-buy-and-hold-in-2024/,20240121T105100,['Keith Speights'],Dividends are good. Growing dividends are even better.,https://g.foolcdn.com/editorial/images/761751/excited-investor-looks-at-financial-charts-on-computer.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.658903'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.360211,Bullish,"[{'ticker': 'IIPR', 'relevance_score': '0.030958', 'ticker_sentiment_score': '0.140815', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.153863', 'ticker_sentiment_score': '0.303904', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LMT', 'relevance_score': '0.061869', 'ticker_sentiment_score': '0.190566', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.092688', 'ticker_sentiment_score': '0.175204', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MA', 'relevance_score': '0.030958', 'ticker_sentiment_score': '0.391015', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.030958', 'ticker_sentiment_score': '0.141351', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.030958', 'ticker_sentiment_score': '0.225235', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KVUE', 'relevance_score': '0.030958', 'ticker_sentiment_score': '0.141351', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.061869', 'ticker_sentiment_score': '0.127185', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.030958', 'ticker_sentiment_score': '0.391015', 'ticker_sentiment_label': 'Bullish'}]"
671,Here's What Investors Should Expect From Eli Lilly Stock in 2024,https://www.fool.com/investing/2024/01/20/heres-what-investors-should-expect-from-eli-lilly/,20240120T212900,['Alex Carchidi'],More headlines on the horizon.,https://g.foolcdn.com/editorial/images/761474/investors-watch-a-presentation-around-a-table.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.243767,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.544246', 'ticker_sentiment_score': '0.335515', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.066047', 'ticker_sentiment_score': '0.110251', 'ticker_sentiment_label': 'Neutral'}]"
672,Will Eli Lilly Be Worth More Than Meta Platforms by 2030?,https://www.fool.com/investing/2024/01/20/will-eli-lilly-be-worth-more-than-meta-platforms/,20240120T144500,['Prosper Junior Bakiny'],It would be quite the accomplishment for the drugmaker.,https://media.ycharts.com/charts/46557cd62ae4e92e49f1f7c9ac145684.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.183138,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.70749', 'ticker_sentiment_score': '0.240222', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.642977', 'ticker_sentiment_score': '0.280435', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
673,3 High-Flying Stocks That Could Soar Even More in 2024,https://www.fool.com/investing/2024/01/20/3-high-flying-stocks-that-could-soar-even-more-in/,20240120T115000,"['David Jagielski', 'Keith Speights', 'and Prosper Junior Bakiny']",These big winners could keep the momentum going.,https://g.foolcdn.com/editorial/images/761822/dna-on-monitor-scientists.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.284698,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.260652', 'ticker_sentiment_score': '0.195213', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.044222', 'ticker_sentiment_score': '0.26179', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.044222', 'ticker_sentiment_score': '0.056817', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.30211', 'ticker_sentiment_score': '0.160317', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.044222', 'ticker_sentiment_score': '-0.005924', 'ticker_sentiment_label': 'Neutral'}]"
674,"The Zacks Analyst Blog Highlights Eli Lilly, Linde, NextEra Energy, Honda Motor, Arthur J. Gallagher and Block",https://www.zacks.com/stock/news/2212548/the-zacks-analyst-blog-highlights-eli-lilly-linde-nextera-energy-honda-motor-arthur-j-gallagher-and-block,20240119T094000,['Zacks Investment Research'],"Eli Lilly, Linde, NextEra Energy, Honda Motor, Arthur J. Gallagher and Block are included in this Analyst Blog.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.183774,Somewhat-Bullish,"[{'ticker': 'LIN', 'relevance_score': '0.413425', 'ticker_sentiment_score': '0.322251', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.349575', 'ticker_sentiment_score': '0.168288', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SQ', 'relevance_score': '0.143843', 'ticker_sentiment_score': '0.034497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HMC', 'relevance_score': '0.143843', 'ticker_sentiment_score': '0.034497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NEE', 'relevance_score': '0.349575', 'ticker_sentiment_score': '0.159724', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
675,"Top Analyst Reports for Eli Lilly, Linde & NextEra Energy",https://www.zacks.com/research-daily/2211986/top-analyst-reports-for-eli-lilly-linde-nextera-energy,20240118T174200,['Sheraz Mian'],"Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Linde plc (LIN) and NextEra Energy, Inc. (NEE).",https://staticx-tuner.zacks.com/images/articles/main/96/702.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.5'}]",0.229808,Somewhat-Bullish,"[{'ticker': 'LIN', 'relevance_score': '0.30569', 'ticker_sentiment_score': '0.498644', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.206685', 'ticker_sentiment_score': '0.280479', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NEE', 'relevance_score': '0.206685', 'ticker_sentiment_score': '0.209828', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
676,Why Eli Lilly  ( LLY )  Dipped More Than Broader Market Today,https://www.zacks.com/stock/news/2211728/why-eli-lilly-lly-dipped-more-than-broader-market-today,20240117T224517,['Zacks Equity Research'],"Eli Lilly (LLY) reachead $628.91 at the closing of the latest trading day, reflecting a -0.89% change compared to its last close.",https://staticx-tuner.zacks.com/images/default_article_images/default101.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.983783'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.210888,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.558244', 'ticker_sentiment_score': '0.26377', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
677,"Balancing Act: The Ultimate Guide To Large-Cap Growth Stocks With Low Risk - Apple  ( NASDAQ:AAPL ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/general/24/01/36663650/balancing-act-the-ultimate-guide-to-large-cap-growth-stocks-with-low-risk,20240117T164342,['Aditi Ganguly'],"The stock market has rebounded from a weak start to the year, with the benchmark S&P 500 index rising by over 1.8% over the past five days. The tech-focused Nasdaq Composite Index has fared better as the tech rally resumes momentum, gaining over 3% in the second trading week of 2024.",https://cdn.benzinga.com/files/images/story/2024/Middle-Aged-Hispanic-Business-Manager-Ce.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.998962'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.992549'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.202814,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.176502', 'ticker_sentiment_score': '-0.00436', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.21961', 'ticker_sentiment_score': '0.067022', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.21961', 'ticker_sentiment_score': '0.434536', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.088799', 'ticker_sentiment_score': '0.053643', 'ticker_sentiment_label': 'Neutral'}]"
678,Bull of the Day: Regeneron Pharmaceuticals  ( REGN ) ,https://www.zacks.com/commentary/2211051/bull-of-the-day-regeneron-pharmaceuticals-regn,20240117T093000,['Ethan Feller'],The Biotechnology company enjoys a litany of bullish catalysts on the horizon ...,https://staticx-tuner.zacks.com/images/default_article_images/default21.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.839681'}]",0.242725,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.20698', 'ticker_sentiment_score': '0.072522', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REGN', 'relevance_score': '0.20698', 'ticker_sentiment_score': '0.231906', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.20698', 'ticker_sentiment_score': '0.072522', 'ticker_sentiment_label': 'Neutral'}]"
679,Zacks Investment Ideas feature highlights: Eli Lilly and Novartis,https://www.zacks.com/stock/news/2211164/zacks-investment-ideas-feature-highlights-eli-lilly-and-novartis,20240117T084300,['Zacks Investment Research'],Eli Lilly and Novartis have been highlighted in this Investment Ideas article.,https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.650727'}]",0.229073,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.158173', 'ticker_sentiment_score': '0.167993', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
680,Unpacking the Latest Options Trading Trends in Eli Lilly - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/24/01/36647588/unpacking-the-latest-options-trading-trends-in-eli-lilly,20240116T183219,['Benzinga Insights'],"Deep-pocketed investors have adopted a bearish approach towards Eli Lilly LLY, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.104602,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.651499', 'ticker_sentiment_score': '0.077542', 'ticker_sentiment_label': 'Neutral'}]"
681,These Stocks Are Showing Relative Strength as S&P 500 Stalls Near Record High,https://www.zacks.com/commentary/2211005/these-stocks-are-showing-relative-strength-as-sp-500-stalls-near-record-high,20240116T174900,['Bryan Hayes'],"As investors, our job isn't to predict an unknowable future.",https://staticx-tuner.zacks.com/images/articles/charts/06/59517.png?v=596080559,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.650727'}]",0.22225,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.158868', 'ticker_sentiment_score': '0.168458', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
682,Charts turn bullish on health-care stocks as sector takes early lead in 2024,https://www.marketwatch.com/story/charts-turn-bullish-on-health-care-stocks-as-sector-takes-early-lead-in-2024-12272495,20240116T162900,['Joseph Adinolfi'],"Health-care stocks are off to a strong start in 2024, and Wall Street analysts are taking notice.",https://images.mktw.net/im-735118/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.744043'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.342773,Somewhat-Bullish,"[{'ticker': 'MCK', 'relevance_score': '0.15697', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VTRS', 'relevance_score': '0.15697', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.15697', 'ticker_sentiment_score': '0.294849', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.15697', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DXCM', 'relevance_score': '0.15697', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.15697', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DHR', 'relevance_score': '0.15697', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
683,Investors Heavily Search Eli Lilly and Company  ( LLY ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2210683/investors-heavily-search-eli-lilly-and-company-lly-here-is-what-you-need-to-know,20240116T140011,['Zacks Equity Research'],"Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default227.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}]",0.235186,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.529767', 'ticker_sentiment_score': '0.170174', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
684,These 2 Top Healthcare Stocks Declared Dividend Raises in 2023,https://www.fool.com/investing/2024/01/15/these-2-top-healthcare-stocks-declared-dividend-ra/,20240115T114600,['Eric Volkman'],"For different reasons, both Eli Lilly and UnitedHealth are doing well enough to enact substantial dividend raises.",https://g.foolcdn.com/editorial/images/760775/medical-professionals-conferring-in-a-hospial-corridor.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.200385,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.290262', 'ticker_sentiment_score': '0.153969', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.059341', 'ticker_sentiment_score': '0.132101', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.234119', 'ticker_sentiment_score': '0.150481', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
685,"Move Over, Novo Nordisk -- This Is the Pharmaceutical Company I am Most Bullish On in 2024",https://www.fool.com/investing/2024/01/14/move-over-novo-nordisk-this-is-the-pharmaceutical/,20240114T114500,['Adam Spatacco'],"Novo Nordisk may dominate the weight management space, but pharma giant Eli Lilly is quickly gaining steam.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F760470%2Fbreast-cancer-awareness-doctor.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.210943,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.436009', 'ticker_sentiment_score': '0.40443', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.436009', 'ticker_sentiment_score': '0.315391', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
686,3 Unstoppable Stocks to Buy in 2024,https://www.fool.com/investing/2024/01/13/3-unstoppable-stocks-to-buy-in-2024/,20240113T124800,"['Keith Speights', 'David Jagielski', 'and Prosper Junior Bakiny']",These stocks appear to be on a clear path to continued growth.,https://g.foolcdn.com/editorial/images/761021/scientists-in-a-lab-smiling.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.25543,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.266343', 'ticker_sentiment_score': '0.049266', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.349945', 'ticker_sentiment_score': '0.133208', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MORN', 'relevance_score': '0.045224', 'ticker_sentiment_score': '0.143626', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.308614', 'ticker_sentiment_score': '0.308668', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOREX:DKK', 'relevance_score': '0.045224', 'ticker_sentiment_score': '0.270178', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOREX:NOK', 'relevance_score': '0.045224', 'ticker_sentiment_score': '0.270178', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
687,Two Health Care Leaders Scale New Highs On Big Wins,https://www.investors.com/stock-lists/new-highs/lly-stock-is-at-a-new-high-after-a-new-website-launch/,20240112T204900,"[""Investor's Business Daily"", 'VIDYA RAMAKRISHNAN']",LLY stock is at a high after a website launch Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2017/10/Stock-EliLilly-01-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999186'}]",0.232753,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.645887', 'ticker_sentiment_score': '0.223424', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SYK', 'relevance_score': '0.645887', 'ticker_sentiment_score': '0.255609', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
688,Why Eli Lilly Stock Skyrocketed 59% in 2023,https://www.fool.com/investing/2024/01/11/why-eli-lilly-stock-skyrocketed-59-in-2023/,20240111T104900,['Keith Speights'],Lilly's pipeline success in 2023 allowed it to to claim the crown as the biggest drugmaker on the planet by market cap.,https://g.foolcdn.com/editorial/images/760865/scientists-smiling-and-shaking-hands.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '0.857896'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.163735,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.722311', 'ticker_sentiment_score': '0.243335', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DICE', 'relevance_score': '0.078611', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.078611', 'ticker_sentiment_score': '0.155496', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
689,Why Eli Lilly  ( LLY )  Outpaced the Stock Market Today,https://www.zacks.com/stock/news/2208495/why-eli-lilly-lly-outpaced-the-stock-market-today,20240110T224520,['Zacks Equity Research'],"Eli Lilly (LLY) closed the most recent trading day at $630.19, moving +0.75% from the previous trading session.",https://staticx-tuner.zacks.com/images/default_article_images/default327.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.947132'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.252041,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.673811', 'ticker_sentiment_score': '0.351443', 'ticker_sentiment_label': 'Bullish'}]"
690,Eli Lilly's Options: A Look at What the Big Money is Thinking - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/24/01/36581006/eli-lillys-options-a-look-at-what-the-big-money-is-thinking,20240110T174609,['Benzinga Insights'],"Whales with a lot of money to spend have taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 50 trades. If we consider the specifics of each trade, it is accurate to state that 38% of the investors opened trades with bullish expectations and ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.085924,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.645091', 'ticker_sentiment_score': '-0.113283', 'ticker_sentiment_label': 'Neutral'}]"
691,Wall Street Doesn't Expect Eli Lilly Stock to Move Much Higher in 2024. Here's Why Analysts Could Be Wrong.,https://www.fool.com/investing/2024/01/10/wall-street-doesnt-expect-eli-lilly-stock-to-move/,20240110T105100,['Keith Speights'],Lilly's sizzle might not fizzle in the new year.,https://g.foolcdn.com/editorial/images/760650/stock-charts-on-screen-analysts.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}]",0.164182,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.759979', 'ticker_sentiment_score': '0.161885', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.062434', 'ticker_sentiment_score': '0.020019', 'ticker_sentiment_label': 'Neutral'}]"
692,How To Buy Hot And Promising - But Uncertain - Biotech Stocks,https://www.investors.com/research/how-to-find-the-best-stocks-to-buy/xbi-etf-how-to-buy-hot-and-promising-but-uncertain-biotech-stocks/,20240108T173400,"[""Investor's Business Daily"", 'MATTHEW GALGANI']","A mix of choppy or nonexistent earnings alongside the promise of game-changing breakthroughs make biotech stocks a challenge for investors. The SPDR S&P Biotech ETF ( XBI ) , now on the IBD Leaderboard watchlist, offers an alternative to betting on a single biotech name.",https://www.investors.com/wp-content/uploads/2024/01/Stock-petridishmolecule-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.972476'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.268824,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.083541', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARWR', 'relevance_score': '0.166169', 'ticker_sentiment_score': '0.070153', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.166169', 'ticker_sentiment_score': '0.200529', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.166169', 'ticker_sentiment_score': '0.200529', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KRTX', 'relevance_score': '0.246999', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.400052', 'ticker_sentiment_score': '0.433085', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'MRNA', 'relevance_score': '0.166169', 'ticker_sentiment_score': '0.070153', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.246999', 'ticker_sentiment_score': '0.430266', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BMY', 'relevance_score': '0.166169', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
693,"AAPL: Are AAPL, MSFT, and GOOGL Solid 2024 Buys?",https://stocknews.com/news/aapl-msft-googl-lly-nvs-are-aapl-msft-and-googl-solid-2024-buys/,20240108T162405,['StockNews.com Staff'],"The Magnificent Seven stocks, which include Apple Inc. ( AAPL ) , Microsoft Corporation ( MSFT ) and Alphabet Inc. ( GOOGL ) , concluded a stellar year, outperforming the S&P 500 index. Vanguard Mega Cap Growth Index Fund ETF Shares ( MGK ) secured a 6.9% gain over the past six months, surpassing ...",https://stocknews.com/wp-content/uploads/2022/12/Aanchal-Sugandh_Headshot.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999365'}, {'topic': 'Earnings', 'relevance_score': '0.999982'}, {'topic': 'Technology', 'relevance_score': '0.5'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}]",0.355517,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.051441', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.301315', 'ticker_sentiment_score': '0.420556', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'GOOG', 'relevance_score': '0.077094', 'ticker_sentiment_score': '0.20494', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.178648', 'ticker_sentiment_score': '0.356535', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVS', 'relevance_score': '0.051441', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.025734', 'ticker_sentiment_score': '0.060904', 'ticker_sentiment_label': 'Neutral'}]"
694,Futures Fall As Boeing Tumbles,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-boeing-plunges-on-737-max-woes-can-market-rally-hold-key-levels/,20240108T112800,"[""Investor's Business Daily"", 'ED CARSON']",Dow Jones Futures Fall As Boeing Plunges On 737 Max Woes. Can Market Rally Hold Key Levels? Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2016/02/Biz05-airshow-022216-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.026516,Neutral,"[{'ticker': 'ALK', 'relevance_score': '0.073849', 'ticker_sentiment_score': '-0.059431', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MARA', 'relevance_score': '0.073849', 'ticker_sentiment_score': '-0.097112', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.024648', 'ticker_sentiment_score': '-0.137676', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.289178', 'ticker_sentiment_score': '0.02146', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.049271', 'ticker_sentiment_score': '0.05937', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.024648', 'ticker_sentiment_score': '0.038323', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPOT', 'relevance_score': '0.049271', 'ticker_sentiment_score': '-0.094177', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNOW', 'relevance_score': '0.147066', 'ticker_sentiment_score': '0.049267', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.073849', 'ticker_sentiment_score': '0.060439', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.073849', 'ticker_sentiment_score': '0.007117', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.049271', 'ticker_sentiment_score': '0.05937', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MELI', 'relevance_score': '0.171224', 'ticker_sentiment_score': '-0.004301', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PHM', 'relevance_score': '0.122769', 'ticker_sentiment_score': '0.045676', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.171224', 'ticker_sentiment_score': '0.049832', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.122769', 'ticker_sentiment_score': '-0.126965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.195222', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
695,Market Rally At Key Level; Nvidia Leads 6 Stocks To Watch,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rally-at-key-levels-nvidia-leads-6-stocks-near-buy-points/,20240106T224600,"[""Investor's Business Daily"", 'ED CARSON']",Dow Jones Futures: Market Rally At Key Levels. Nvidia Leads 6 Stocks Near Buy Points Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/03/Stock-nvidia-ceojensenhuang-01-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.055121,Neutral,"[{'ticker': 'ALK', 'relevance_score': '0.02665', 'ticker_sentiment_score': '-0.050722', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MARA', 'relevance_score': '0.079832', 'ticker_sentiment_score': '-0.040916', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.286741', 'ticker_sentiment_score': '0.002141', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.053271', 'ticker_sentiment_score': '0.066721', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.02665', 'ticker_sentiment_score': '0.038808', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPOT', 'relevance_score': '0.053271', 'ticker_sentiment_score': '-0.094682', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNOW', 'relevance_score': '0.158868', 'ticker_sentiment_score': '0.051729', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.079832', 'ticker_sentiment_score': '0.068036', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.079832', 'ticker_sentiment_score': '0.007196', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.053271', 'ticker_sentiment_score': '0.066721', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MELI', 'relevance_score': '0.184901', 'ticker_sentiment_score': '-0.004546', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PHM', 'relevance_score': '0.13266', 'ticker_sentiment_score': '0.047474', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.158868', 'ticker_sentiment_score': '0.080575', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.106305', 'ticker_sentiment_score': '-0.060459', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.158868', 'ticker_sentiment_score': '0.025606', 'ticker_sentiment_label': 'Neutral'}]"
696,Nvidia And Spotify Lead Five Stocks Near Buy Points,https://www.investors.com/news/nvidia-spotify-lead-five-stocks-near-buy-points/,20240106T161200,"['JED GRAHAM', ""Investor's Business Daily""]","Nvidia ( NVDA ) , one of the Magnificent Seven stocks, and digital audio streaming leader Spotify ( SPOT ) head this weekend's watchlist of stocks near buy points.",https://www.investors.com/wp-content/uploads/2023/05/Stock-nvidia-hq-04-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.818451'}]",0.141748,Neutral,"[{'ticker': 'TGT', 'relevance_score': '0.060236', 'ticker_sentiment_score': '0.173176', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CELH', 'relevance_score': '0.32231', 'ticker_sentiment_score': '0.198665', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.294446', 'ticker_sentiment_score': '0.241706', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ULTA', 'relevance_score': '0.060236', 'ticker_sentiment_score': '0.173176', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.03014', 'ticker_sentiment_score': '0.070517', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.03014', 'ticker_sentiment_score': '0.068427', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPOT', 'relevance_score': '0.34974', 'ticker_sentiment_score': '0.242228', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MNST', 'relevance_score': '0.090247', 'ticker_sentiment_score': '-0.130828', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.237551', 'ticker_sentiment_score': '0.119502', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.060236', 'ticker_sentiment_score': '0.041072', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.060236', 'ticker_sentiment_score': '0.073016', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OMGA', 'relevance_score': '0.060236', 'ticker_sentiment_score': '-0.004022', 'ticker_sentiment_label': 'Neutral'}]"
697,2 Top Healthcare Stocks to Buy Right Now,https://www.fool.com/investing/2024/01/06/2-top-healthcare-stocks-to-buy-right-now/,20240106T151500,['Prosper Junior Bakiny'],It's always a good time to invest in these excellent stocks.,https://g.foolcdn.com/editorial/images/759940/patient-talking-with-a-physician.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}]",0.236189,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.322374', 'ticker_sentiment_score': '0.211863', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MFCSF', 'relevance_score': '0.110209', 'ticker_sentiment_score': '0.087754', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCSG', 'relevance_score': '0.055236', 'ticker_sentiment_score': '0.243008', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HCA', 'relevance_score': '0.51159', 'ticker_sentiment_score': '0.344214', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
698,"JPMorgan Healthcare, CES Show, Bank Earnings, Inflation Data",https://www.investors.com/research/investing-action-plan/jpmorgan-healthcare-ces-show-bank-earnings-inflation-data-investing-action-plan/,20240105T222900,"[""Investor's Business Daily"", 'IBD STAFF']","The big benchmarks launched the New Year by posting their first weekly slip since October. The Dow trimmed less than 1% while the Nasdaq lopped off 3%. Chips faltered, but solar stocks and auto retailers were the hardest hit industries. Big Pharma names had a good week, as Merck ( MRK ) led the ...",https://www.investors.com/wp-content/uploads/2022/07/Stock-marketgrowth-03-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.890401'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.650727'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.173993,Somewhat-Bullish,"[{'ticker': 'CELH', 'relevance_score': '0.123526', 'ticker_sentiment_score': '0.144722', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.123526', 'ticker_sentiment_score': '0.144722', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WDFC', 'relevance_score': '0.123526', 'ticker_sentiment_score': '0.013892', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.123526', 'ticker_sentiment_score': '0.021094', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WIT', 'relevance_score': '0.082535', 'ticker_sentiment_score': '0.064744', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.164188', 'ticker_sentiment_score': '0.1163', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPOT', 'relevance_score': '0.123526', 'ticker_sentiment_score': '0.144722', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.123526', 'ticker_sentiment_score': '0.021094', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.123526', 'ticker_sentiment_score': '0.144722', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BK', 'relevance_score': '0.082535', 'ticker_sentiment_score': '0.018562', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.082535', 'ticker_sentiment_score': '0.133922', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.082535', 'ticker_sentiment_score': '0.018562', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KBH', 'relevance_score': '0.164188', 'ticker_sentiment_score': '0.107238', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AYI', 'relevance_score': '0.123526', 'ticker_sentiment_score': '0.091327', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.082535', 'ticker_sentiment_score': '0.088799', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.164188', 'ticker_sentiment_score': '0.024866', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.164188', 'ticker_sentiment_score': '0.109444', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BBY', 'relevance_score': '0.082535', 'ticker_sentiment_score': '0.088799', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.082535', 'ticker_sentiment_score': '0.133922', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INFY', 'relevance_score': '0.082535', 'ticker_sentiment_score': '0.064744', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRLCF', 'relevance_score': '0.041323', 'ticker_sentiment_score': '0.084607', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.082535', 'ticker_sentiment_score': '0.088799', 'ticker_sentiment_label': 'Neutral'}]"
699,"Market At Key Levels, Here's What To Do; Nvidia Nears Breakout",https://www.investors.com/market-trend/stock-market-today/market-rally-at-key-levels-bitcoin-etf-nvidia-near-buy-point-on-100-billion-forecast/,20240105T221800,"['ED CARSON', ""Investor's Business Daily""]","Market At Key Levels, Here's What To Do. Nvidia Nears Breakout Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2023/03/Stock-nvidia-ceojensenhuang-01-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}]",0.05755,Neutral,"[{'ticker': 'MARA', 'relevance_score': '0.085022', 'ticker_sentiment_score': '-0.040301', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MELI', 'relevance_score': '0.196725', 'ticker_sentiment_score': '-0.004762', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.278063', 'ticker_sentiment_score': '-0.031214', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.056741', 'ticker_sentiment_score': '0.064925', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.028388', 'ticker_sentiment_score': '0.039211', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PHM', 'relevance_score': '0.141227', 'ticker_sentiment_score': '0.049142', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPOT', 'relevance_score': '0.056741', 'ticker_sentiment_score': '-0.094929', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNOW', 'relevance_score': '0.169081', 'ticker_sentiment_score': '0.053951', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.085022', 'ticker_sentiment_score': '0.066588', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.085022', 'ticker_sentiment_score': '0.007278', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.169081', 'ticker_sentiment_score': '0.084005', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.056741', 'ticker_sentiment_score': '0.064925', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.169081', 'ticker_sentiment_score': '0.026688', 'ticker_sentiment_label': 'Neutral'}]"
700,Stock Market Skids To Start 2024: Weekly Review,https://www.investors.com/news/stock-market-skids-to-start-2024-as-tesla-apple-stumble-mobileye-crashes-weekly-review/,20240105T172600,"['IBD STAFF', ""Investor's Business Daily""]","Stock Market Skids To Start 2024 As Tesla, Apple Stumble, Mobileye Crashes: Weekly Review Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2021/03/Stock-BullBearMarket-88-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Blockchain', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '0.999186'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.918141'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.004903,Neutral,"[{'ticker': 'MARA', 'relevance_score': '0.122425', 'ticker_sentiment_score': '0.031073', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XPEV', 'relevance_score': '0.061394', 'ticker_sentiment_score': '0.043033', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.182736', 'ticker_sentiment_score': '-0.254609', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'ADI', 'relevance_score': '0.061394', 'ticker_sentiment_score': '-0.10812', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.061394', 'ticker_sentiment_score': '0.097219', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.122425', 'ticker_sentiment_score': '-0.020511', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NXPI', 'relevance_score': '0.061394', 'ticker_sentiment_score': '-0.10812', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAG', 'relevance_score': '0.061394', 'ticker_sentiment_score': '-0.048948', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.03072', 'ticker_sentiment_score': '0.092757', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LW', 'relevance_score': '0.091977', 'ticker_sentiment_score': '-0.053265', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TXN', 'relevance_score': '0.061394', 'ticker_sentiment_score': '-0.10812', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STM', 'relevance_score': '0.061394', 'ticker_sentiment_score': '-0.10812', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COIN', 'relevance_score': '0.122425', 'ticker_sentiment_score': '0.031073', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMPL', 'relevance_score': '0.091977', 'ticker_sentiment_score': '-0.053265', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.03072', 'ticker_sentiment_score': '-0.282869', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSLA', 'relevance_score': '0.212514', 'ticker_sentiment_score': '0.010321', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NIO', 'relevance_score': '0.061394', 'ticker_sentiment_score': '0.043033', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.182736', 'ticker_sentiment_score': '-0.026343', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CPE', 'relevance_score': '0.091977', 'ticker_sentiment_score': '-0.085615', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LI', 'relevance_score': '0.122425', 'ticker_sentiment_score': '-0.019092', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OMGA', 'relevance_score': '0.061394', 'ticker_sentiment_score': '0.036136', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.122425', 'ticker_sentiment_score': '0.031073', 'ticker_sentiment_label': 'Neutral'}]"
701,NVS or LLY: Which Is the Better Value Stock Right Now?,https://www.zacks.com/stock/news/2206412/nvs-or-lly-which-is-the-better-value-stock-right-now,20240105T164006,['Zacks Equity Research'],NVS vs. LLY: Which Stock Is the Better Value Option?,https://staticx-tuner.zacks.com/images/default_article_images/default15.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.795202'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.504108,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.622414', 'ticker_sentiment_score': '0.51906', 'ticker_sentiment_label': 'Bullish'}]"
702,"Short Sellers' Nightmare: $195B Evaporates In 2023's Market Surge - Apple  ( NASDAQ:AAPL ) , Coinbase Glb  ( NASDAQ:COIN ) ",https://www.benzinga.com/markets/equities/24/01/36510120/short-sellers-nightmare-195b-evaporates-in-2023s-market-surge,20240105T142522,['Neil Dennis'],"In a year when equity markets rallied strongly, short sellers - traders who position for losses on assets - had an extremely tough time in 2023. Data published on Friday by S3 Partners showed that short sellers in the U.S. and Canada were down $194.9 billion in 2023 - down 20.4% on an average ...",https://cdn.benzinga.com/files/images/story/2024/bear-chart-shutter3.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.99246'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Finance', 'relevance_score': '0.333333'}, {'topic': 'Blockchain', 'relevance_score': '0.310843'}]",-0.019588,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.188193', 'ticker_sentiment_score': '-0.042676', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.188193', 'ticker_sentiment_score': '-0.435133', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'MRNA', 'relevance_score': '0.188193', 'ticker_sentiment_score': '-0.042676', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COIN', 'relevance_score': '0.188193', 'ticker_sentiment_score': '-0.289687', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'FRC', 'relevance_score': '0.094762', 'ticker_sentiment_score': '-0.272366', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PFE', 'relevance_score': '0.188193', 'ticker_sentiment_score': '-0.042676', 'ticker_sentiment_label': 'Neutral'}]"
703,7 Stocks Are Taking Off Already - And The Year Just Started,https://www.investors.com/etfs-and-funds/sectors/sp500-stocks-are-taking-off-already-and-the-year-just-started/,20240105T130000,"['MATT KRANTZ', ""Investor's Business Daily""]",The calendar just flipped to 2024 - and investors already have their favorite S&P 500 stocks. And none of them are the Big Tech giants that dominated in 2023.,https://www.investors.com/wp-content/uploads/2021/04/Stock-cranesmoney-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}]",0.227189,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.276909', 'ticker_sentiment_score': '0.332128', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MRNA', 'relevance_score': '0.521465', 'ticker_sentiment_score': '0.232629', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SPGI', 'relevance_score': '0.09402', 'ticker_sentiment_score': '0.162601', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
0,7 Stocks Are Taking Off Already - And The Year Just Started,https://www.investors.com/etfs-and-funds/sectors/sp500-stocks-are-taking-off-already-and-the-year-just-started/,20240105T130000,"['MATT KRANTZ', ""Investor's Business Daily""]",The calendar just flipped to 2024 - and investors already have their favorite S&P 500 stocks. And none of them are the Big Tech giants that dominated in 2023.,https://www.investors.com/wp-content/uploads/2021/04/Stock-cranesmoney-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}]",0.227189,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.276909', 'ticker_sentiment_score': '0.332128', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MRNA', 'relevance_score': '0.521465', 'ticker_sentiment_score': '0.232629', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SPGI', 'relevance_score': '0.09402', 'ticker_sentiment_score': '0.162601', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
1,Eli Lilly  ( LLY )  Sees a More Significant Dip Than Broader Market: Some Facts to Know,https://www.zacks.com/stock/news/2205914/eli-lilly-lly-sees-a-more-significant-dip-than-broader-market-some-facts-to-know,20240104T224517,['Zacks Equity Research'],"In the latest trading session, Eli Lilly (LLY) closed at $614.50, marking a -0.52% move from the previous day.",https://staticx-tuner.zacks.com/images/default_article_images/default181.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.983783'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.223926,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.478198', 'ticker_sentiment_score': '0.334743', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
2,"Bulls, Bears Duel Ahead Of Jobs Report; 6 Stocks To Watch",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-bulls-bears-duel-ahead-of-jobs-report-spot-bitcoin-etfs/,20240104T213800,"[""Investor's Business Daily"", 'ED CARSON']","Bulls, Bears Duel Ahead Of Jobs Report. 6 Stocks To Watch Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2017/04/Bear.Bull_.NYSE_.png,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Blockchain', 'relevance_score': '0.451494'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}]",0.069233,Neutral,"[{'ticker': 'MARA', 'relevance_score': '0.09245', 'ticker_sentiment_score': '0.031714', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MELI', 'relevance_score': '0.213584', 'ticker_sentiment_score': '0.019936', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.183662', 'ticker_sentiment_score': '0.021055', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.213584', 'ticker_sentiment_score': '0.001713', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPOT', 'relevance_score': '0.15347', 'ticker_sentiment_score': '-0.011738', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.213584', 'ticker_sentiment_score': '0.052874', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.183662', 'ticker_sentiment_score': '-0.099095', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COIN', 'relevance_score': '0.123052', 'ticker_sentiment_score': '0.042128', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.272451', 'ticker_sentiment_score': '0.140486', 'ticker_sentiment_label': 'Neutral'}]"
3,Indexes Mixed After Jobs Data Surprise; Chip Glut Shock Hits EV Plays As Apple Sells Off On Second Downgrade,https://www.investors.com/market-trend/stock-market-today/dow-jones-rises-in-bumpy-new-year-rally-chip-glut-hits-ev-plays-as-apple-gets-second-downgrade/,20240104T204500,"['VIDYA RAMAKRISHNAN', ""Investor's Business Daily""]",Indexes Mixed After Jobs Data Surprise. Chip Glut Shock Hits EV Plays As Apple Sells Off On Second Downgrade Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/03/Stock-apple-iphone14colors-01-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.999763'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",-0.002415,Neutral,"[{'ticker': 'MARA', 'relevance_score': '0.111747', 'ticker_sentiment_score': '0.100159', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.111747', 'ticker_sentiment_score': '-0.311501', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'ADI', 'relevance_score': '0.111747', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.166935', 'ticker_sentiment_score': '-0.274083', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'WBA', 'relevance_score': '0.111747', 'ticker_sentiment_score': '-0.160875', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LLY', 'relevance_score': '0.111747', 'ticker_sentiment_score': '0.039477', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIOT', 'relevance_score': '0.111747', 'ticker_sentiment_score': '0.100159', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OMGA', 'relevance_score': '0.111747', 'ticker_sentiment_score': '-0.223527', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'STM', 'relevance_score': '0.111747', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COIN', 'relevance_score': '0.111747', 'ticker_sentiment_score': '0.019962', 'ticker_sentiment_label': 'Neutral'}]"
4,"EXCLUSIVE: Buy The Dip - There's A Lot More Upside To Come, Says Marc Chaikin - Boise Cascade  ( NYSE:BCC ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/analyst-ratings/analyst-color/24/01/36497683/exclusive-buy-the-dip-theres-a-lot-more-upside-to-come-says-marc-chaikin,20240104T192933,['Neil Dennis'],"Stocks have experienced a shaky beginning in 2024, with initial losses followed by slight gains on Thursday. However, Marc Chaikin, founder and CEO of Chaikin Analytics, believes that this does not signify an end to the rally that began in late October.",https://cdn.benzinga.com/files/images/story/2024/MarcChaikin.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.986714'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.103974,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.137671', 'ticker_sentiment_score': '0.089327', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.137671', 'ticker_sentiment_score': '-0.050921', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.137671', 'ticker_sentiment_score': '-0.050921', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCC', 'relevance_score': '0.137671', 'ticker_sentiment_score': '0.120912', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MMM', 'relevance_score': '0.137671', 'ticker_sentiment_score': '-0.097381', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.137671', 'ticker_sentiment_score': '0.167166', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
5,Check Out What Whales Are Doing With LLY - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/24/01/36492031/check-out-what-whales-are-doing-with-lly,20240104T151640,['Benzinga Insights'],"Investors with a lot of money to spend have taken a bearish stance on Eli Lilly LLY. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.07853,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.672712', 'ticker_sentiment_score': '-0.059707', 'ticker_sentiment_label': 'Neutral'}]"
6,"The Best Stocks to Invest $1,000 in Right Now",https://www.fool.com/investing/2024/01/04/the-best-stocks-to-invest-1000-in-right-now/,20240104T140000,['Prosper Junior Bakiny'],It's not too late to get in on these market beaters.,https://g.foolcdn.com/editorial/images/759414/pharmacist-talking-to-patient.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}]",0.270989,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.276491', 'ticker_sentiment_score': '0.36389', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.168099', 'ticker_sentiment_score': '0.264564', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.3796', 'ticker_sentiment_score': '0.27009', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
7,Everyone Is Talking About Eli Lilly. Is It a Good Long-Term Option?,https://www.fool.com/investing/2024/01/04/everyone-is-talking-about-eli-lilly-is-it-a-good-l/,20240104T100000,['Adria Cimino'],Eli Lilly shares advanced in the double digits last year.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F759865%2Fgettyimages-1199696916.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.230327,Somewhat-Bullish,"[{'ticker': 'GS', 'relevance_score': '0.101797', 'ticker_sentiment_score': '0.053861', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.693907', 'ticker_sentiment_score': '0.323484', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.051003', 'ticker_sentiment_score': '0.003', 'ticker_sentiment_label': 'Neutral'}]"
8,Futures Rise; Cathie Wood Buys Tesla,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-losses-broaden-cathie-wood-buys-tesla-sells-bitcoin-stock-coinbase/,20240104T025400,"[""Investor's Business Daily"", 'ED CARSON']","Dow Jones Futures: Market Losses Broaden. Cathie Wood Buys Tesla, Sells Bitcoin Stock Coinbase Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2021/11/Stock-CathieWoods-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Blockchain', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}]",-0.012157,Neutral,"[{'ticker': 'MARA', 'relevance_score': '0.164356', 'ticker_sentiment_score': '-0.129879', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.066139', 'ticker_sentiment_score': '-0.110203', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSTR', 'relevance_score': '0.066139', 'ticker_sentiment_score': '-0.013364', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.066139', 'ticker_sentiment_score': '-0.110203', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.410402', 'ticker_sentiment_score': '0.04251', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOW', 'relevance_score': '0.033098', 'ticker_sentiment_score': '-0.10417', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.131823', 'ticker_sentiment_score': '0.131849', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.033098', 'ticker_sentiment_score': '-0.150818', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'COIN', 'relevance_score': '0.260073', 'ticker_sentiment_score': '0.040517', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.228533', 'ticker_sentiment_score': '-0.122188', 'ticker_sentiment_label': 'Neutral'}]"
9,Market Losses Widen; Why Tesla's Slide May Be Bullish,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-losses-broaden-bitcoin-skids-why-teslas-slide-may-be-bullish/,20240103T221600,"[""Investor's Business Daily"", 'ED CARSON']",Market Losses Widen. Why Tesla's Slide May Be Bullish Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2022/05/Stock-elonmusk-grumpy-01-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Blockchain', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}]",-0.036382,Neutral,"[{'ticker': 'MARA', 'relevance_score': '0.179788', 'ticker_sentiment_score': '-0.138269', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.072435', 'ticker_sentiment_score': '-0.110765', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSTR', 'relevance_score': '0.072435', 'ticker_sentiment_score': '-0.01356', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.072435', 'ticker_sentiment_score': '-0.110765', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.317527', 'ticker_sentiment_score': '-0.061006', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOW', 'relevance_score': '0.036255', 'ticker_sentiment_score': '-0.105474', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.144275', 'ticker_sentiment_score': '0.138464', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.036255', 'ticker_sentiment_score': '-0.152493', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'COIN', 'relevance_score': '0.214937', 'ticker_sentiment_score': '-0.038652', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.249653', 'ticker_sentiment_score': '-0.140816', 'ticker_sentiment_label': 'Neutral'}]"
10,"Top Research Reports for Amazon.com, Berkshire Hathaway & Eli Lilly",https://www.zacks.com/research-daily/2204956/top-research-reports-for-amazoncom-berkshire-hathaway-eli-lilly,20240103T173700,['Sheraz Mian'],"Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Berkshire Hathaway Inc. (BRK.B) and Eli Lilly and Company (LLY).",https://staticx-tuner.zacks.com/images/default_article_images/default329.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.269929,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.282234', 'ticker_sentiment_score': '0.372257', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'AMZN', 'relevance_score': '0.095899', 'ticker_sentiment_score': '0.352939', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BRK-A', 'relevance_score': '0.095899', 'ticker_sentiment_score': '0.107515', 'ticker_sentiment_label': 'Neutral'}]"
11,Why Eli Lilly Stock Is Jumping Today While the Overall Market Is Slumping,https://www.fool.com/investing/2024/01/03/why-eli-lilly-stock-is-jumping-today-while-the-ove/,20240103T172011,['Keith Speights'],Here's how the big pharma stock is swimming against the current.,https://g.foolcdn.com/editorial/images/760035/ozempic.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.165653,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.822443', 'ticker_sentiment_score': '0.223974', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.133841', 'ticker_sentiment_score': '0.108366', 'ticker_sentiment_label': 'Neutral'}]"
12,Missed Out on Eli Lilly? My Best Pharmaceutical Stock to Buy And Hold,https://www.fool.com/investing/2024/01/03/missed-out-eli-lilly-best-pharmaceutical-stock/,20240103T160850,['Justin Pope'],"The past three years were bliss for Eli Lilly shareholders, but those not already on board should look at its rival instead.",https://media.ycharts.com/charts/14da68206118d21fd87def9a5d059da6.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.658903'}]",0.225488,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.592095', 'ticker_sentiment_score': '0.308965', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.465196', 'ticker_sentiment_score': '0.240351', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
13,Dow Jones Weakens After Economic Data; Tesla Hits Nasdaq,https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-as-fed-minutes-loom-tesla-hits-nasdaq/,20240103T155600,"[""Investor's Business Daily"", 'VIDYA RAMAKRISHNAN']",Dow Jones Falls As Fed Minutes Loom. Tesla Hits Nasdaq Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2020/04/stock-tesla-store-04-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.995015'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",0.016843,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.127119', 'ticker_sentiment_score': '0.161207', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GOOG', 'relevance_score': '0.063763', 'ticker_sentiment_score': '-0.068032', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.127119', 'ticker_sentiment_score': '-0.110408', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.127119', 'ticker_sentiment_score': '0.161207', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.251032', 'ticker_sentiment_score': '0.007865', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.127119', 'ticker_sentiment_score': '-0.001233', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.127119', 'ticker_sentiment_score': '-0.001233', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.127119', 'ticker_sentiment_score': '0.25909', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CAH', 'relevance_score': '0.127119', 'ticker_sentiment_score': '0.25909', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LW', 'relevance_score': '0.127119', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.127119', 'ticker_sentiment_score': '0.161207', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
14,Here is What to Know Beyond Why Eli Lilly and Company  ( LLY )  is a Trending Stock,https://www.zacks.com/stock/news/2204917/here-is-what-to-know-beyond-why-eli-lilly-and-company-lly-is-a-trending-stock,20240103T140011,['Zacks Equity Research'],"Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default108.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}]",0.254969,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.523044', 'ticker_sentiment_score': '0.181048', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
15,Techs Skid To Start 2024; Two Weight-Loss Stocks Flash Buy Signals,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-techs-slump-to-start-2024-celsius-eli-lilly-flash-buy-signals/,20240102T214700,"['ED CARSON', ""Investor's Business Daily""]","Dow Jones Futures: Techs Slump To Start 2024. Celsius, Eli Lilly Flash Buy Signals Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2019/01/Skifall-EG-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.0584,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.243498', 'ticker_sentiment_score': '-0.003766', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CELH', 'relevance_score': '0.243498', 'ticker_sentiment_score': '0.159344', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.153666', 'ticker_sentiment_score': '-0.137704', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.030918', 'ticker_sentiment_score': '-0.114986', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.330152', 'ticker_sentiment_score': '-0.057055', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.272788', 'ticker_sentiment_score': '0.129941', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'URI', 'relevance_score': '0.030918', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
16,Eli Lilly  ( LLY )  Stock Up 57% in 2023: Will the Uptrend Continue?,https://www.zacks.com/stock/news/2204399/eli-lilly-lly-stock-up-57-in-2023-will-the-uptrend-continue,20240102T134300,['Zacks Equity Research'],"Lilly (LLY) is making rapid pipeline progress in areas like obesity, diabetes and Alzheimer's. Mounjaro and Zepbound are expected to be key top-line drivers for Lilly.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.243868,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.598368', 'ticker_sentiment_score': '0.380988', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'RIGL', 'relevance_score': '0.203643', 'ticker_sentiment_score': '0.133485', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.15347', 'ticker_sentiment_score': '0.044317', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AQST', 'relevance_score': '0.203643', 'ticker_sentiment_score': '0.070763', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DICE', 'relevance_score': '0.051441', 'ticker_sentiment_score': '0.033004', 'ticker_sentiment_label': 'Neutral'}]"
17,Futures: Rally Looks Strong As 2024 Kicks Off; What To Do,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rally-2024-tesla-deliveries-due/,20240101T193700,"[""Investor's Business Daily"", 'ED CARSON']",Dow Jones Futures: Market Rally Strong Heading Into 2024: Tesla Deliveries Due Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/11/Stock-technologytrends2024-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.95493'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.106809,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.163117', 'ticker_sentiment_score': '0.024947', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XPEV', 'relevance_score': '0.07031', 'ticker_sentiment_score': '-0.031392', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CELH', 'relevance_score': '0.18602', 'ticker_sentiment_score': '0.016434', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MELI', 'relevance_score': '0.231332', 'ticker_sentiment_score': '0.139106', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.253706', 'ticker_sentiment_score': '0.034788', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.231332', 'ticker_sentiment_score': '0.076734', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NIO', 'relevance_score': '0.07031', 'ticker_sentiment_score': '0.028402', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.163117', 'ticker_sentiment_score': '0.064293', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIVN', 'relevance_score': '0.07031', 'ticker_sentiment_score': '-0.025177', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LI', 'relevance_score': '0.093653', 'ticker_sentiment_score': '-0.015711', 'ticker_sentiment_label': 'Neutral'}]"
18,Why Eli Lilly Stock Could Start Off 2024 With a Bang,https://www.fool.com/investing/2024/01/01/why-eli-lilly-could-start-off-2024-with-a-bang/,20240101T121500,['David Jagielski'],Investors shouldn't assume Eli Lilly's stock has peaked.,https://g.foolcdn.com/editorial/images/759509/businessperson-giving-a-presentation.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.270091,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.480056', 'ticker_sentiment_score': '0.320178', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
19,Eli Lilly Stock Jumped 59% in 2023. Is It a Good Stock to Buy in 2024?,https://www.fool.com/investing/2023/12/31/eli-lilly-stock-jumped-59-in-2023-is-it-a-good-sto/,20231231T103600,['Cory Renauer'],Sales of its new weight-management drug could be off the charts next year.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F759654%2Finvestment-advisor-getty.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}]",0.279304,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.533678', 'ticker_sentiment_score': '0.416847', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.052801', 'ticker_sentiment_score': '0.173663', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
20,Gear Up For 2024; Five Big Winners Setting Up Again,https://www.investors.com/market-trend/stock-market-today/stock-market-2024-nvidia-sets-up-after-monster-run-tesla-deliveries-due/,20231229T221600,"[""Investor's Business Daily"", 'ED CARSON']","Stock Market 2024, Here's How To Prep: Nvidia Sets Up After Monster Run. Tesla Deliveries Due Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2023/11/Stock-technologytrends2024-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.95493'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.113966,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.178837', 'ticker_sentiment_score': '0.026604', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XPEV', 'relevance_score': '0.077177', 'ticker_sentiment_score': '-0.029516', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CELH', 'relevance_score': '0.203857', 'ticker_sentiment_score': '0.017617', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MELI', 'relevance_score': '0.25325', 'ticker_sentiment_score': '0.149522', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.277576', 'ticker_sentiment_score': '0.037403', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.22867', 'ticker_sentiment_score': '0.087926', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NIO', 'relevance_score': '0.077177', 'ticker_sentiment_score': '-0.029516', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.178837', 'ticker_sentiment_score': '0.068536', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIVN', 'relevance_score': '0.077177', 'ticker_sentiment_score': '-0.025409', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LI', 'relevance_score': '0.128272', 'ticker_sentiment_score': '-0.017589', 'ticker_sentiment_label': 'Neutral'}]"
21,Unpacking the Latest Options Trading Trends in Eli Lilly - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/12/36428493/unpacking-the-latest-options-trading-trends-in-eli-lilly,20231229T151557,['Benzinga Insights'],"Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 11 trades. If we consider the specifics of each trade, it is accurate to state that 54% of the investors opened trades with bullish expectations and ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.141992,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.655824', 'ticker_sentiment_score': '0.03718', 'ticker_sentiment_label': 'Neutral'}]"
22,Which Mutual Funds Are Positioned Perfectly For 2024?,https://www.investors.com/etfs-and-funds/mutual-funds/best-mutual-funds-are-positioned-perfectly-for-2024/,20231229T120000,"[""Investor's Business Daily"", 'ADAM SHELL']",Best Mutual Funds: Which Are Positioned Perfectly For 2024? Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2021/04/Stock-marketBoard-29-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.838487'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.266261,Somewhat-Bullish,"[{'ticker': 'ENPH', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.276091', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.143593', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.057444', 'ticker_sentiment_score': '0.142039', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.057444', 'ticker_sentiment_score': '0.206', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SWK', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.182612', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SWKH', 'relevance_score': '0.019163', 'ticker_sentiment_score': '0.17269', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'USEG', 'relevance_score': '0.019163', 'ticker_sentiment_score': '0.116482', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADMA', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.198468', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.1224', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DEO', 'relevance_score': '0.019163', 'ticker_sentiment_score': '0.099371', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.07654', 'ticker_sentiment_score': '0.187525', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CECO', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.297189', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ASHTF', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.293549', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABT', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.044768', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SEDG', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.276091', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.143593', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RNR', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.1224', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.057444', 'ticker_sentiment_score': '0.160299', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MORN', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.143593', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.044768', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.057444', 'ticker_sentiment_score': '0.142039', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STLD', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.293549', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
23,Eli Lilly  ( LLY )  Stock Declines While Market Improves: Some Information for Investors,https://www.zacks.com/stock/news/2203352/eli-lilly-lly-stock-declines-while-market-improves-some-information-for-investors,20231228T224518,['Zacks Equity Research'],"The latest trading day saw Eli Lilly (LLY) settling at $580.85, representing a -0.11% change from its previous close.",https://staticx-tuner.zacks.com/images/default_article_images/default169.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.961735'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.220419,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.481177', 'ticker_sentiment_score': '0.23999', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
24,"Interested in the Weight-Loss Market? Here's 1 Stock to Buy Hand Over Fist in 2024, and 1 to Avoid Like the Plague.",https://www.fool.com/investing/2023/12/28/interested-in-the-weight-loss-market-heres-1-stock/,20231228T133000,['Adam Spatacco'],"While Novo Nordisk dominates the weight-loss market, there are two other stocks to consider as well.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F759102%2Fa-doctor-writing-a-prescription.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.839681'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}]",0.249927,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.532043', 'ticker_sentiment_score': '0.439982', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SGEN', 'relevance_score': '0.096283', 'ticker_sentiment_score': '-0.030773', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.19117', 'ticker_sentiment_score': '0.124512', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.454714', 'ticker_sentiment_score': '0.146467', 'ticker_sentiment_label': 'Neutral'}]"
25,The 10 days that moved the stock market the most in 2023,https://www.marketwatch.com/story/the-10-days-that-moved-the-stock-market-the-most-in-2023-611837d9,20231227T144300,['William Watts'],Here are the 5 biggest up days and 5 biggest down days for the S&P 500 this year.,https://images.mktw.net/im-75295800?width=700&height=502,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.769861'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.99393'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.017011,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.103778', 'ticker_sentiment_score': '0.035989', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.103778', 'ticker_sentiment_score': '0.035989', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.103778', 'ticker_sentiment_score': '0.035989', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.155118', 'ticker_sentiment_score': '0.110232', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.103778', 'ticker_sentiment_score': '0.035989', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.103778', 'ticker_sentiment_score': '0.117166', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.103778', 'ticker_sentiment_score': '0.035989', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.103778', 'ticker_sentiment_score': '0.117166', 'ticker_sentiment_label': 'Neutral'}]"
26,A Closer Look at Eli Lilly's Options Market Dynamics - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/12/36388514/a-closer-look-at-eli-lillys-options-market-dynamics,20231226T180043,['Benzinga Insights'],"Financial giants have made a conspicuous bullish move on Eli Lilly. Our analysis of options history for Eli Lilly LLY revealed 16 unusual trades. Delving into the details, we found 56% of traders were bullish, while 43% showed bearish tendencies.",https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}]",0.098201,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.649352', 'ticker_sentiment_score': '0.070795', 'ticker_sentiment_label': 'Neutral'}]"
27,Where To Invest Your 401 ( K ) ,https://www.kiplinger.com/retirement/401ks/where-to-invest-your-401k,20231225T170013,['Nellie S. Huang'],"These days, 401 ( k ) plans make it relatively easy to save for retirement, but the task of figuring out which funds to invest in is still tricky. A good target-date fund is an easy box to check - and most plans offer one. Low-cost index funds are another no-brainer.",https://cdn.mos.cms.futurecdn.net/zN3tuwiHZ3YvvYxLNgSy2G-415-80.jpg,Kiplinger,n/a,www.kiplinger.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.247887,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.063258', 'ticker_sentiment_score': '0.037124', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.063258', 'ticker_sentiment_score': '0.010014', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.042196', 'ticker_sentiment_score': '0.047582', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADBE', 'relevance_score': '0.042196', 'ticker_sentiment_score': '0.160021', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.042196', 'ticker_sentiment_score': '0.160021', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.042196', 'ticker_sentiment_score': '0.160021', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NSC', 'relevance_score': '0.042196', 'ticker_sentiment_score': '-0.005885', 'ticker_sentiment_label': 'Neutral'}]"
28,Should First Trust Capital Strength ETF  ( FTCS )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2201872/should-first-trust-capital-strength-etf-ftcs-be-on-your-investing-radar,20231225T112008,['Zacks Equity Research'],Style Box ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default193.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.277959,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.125789', 'ticker_sentiment_score': '0.059923', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CSCO', 'relevance_score': '0.125789', 'ticker_sentiment_score': '0.059923', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TJX', 'relevance_score': '0.125789', 'ticker_sentiment_score': '0.059923', 'ticker_sentiment_label': 'Neutral'}]"
29,Can This Red-Hot Stock Beat the Market Again in 2024?,https://www.fool.com/investing/2023/12/22/can-this-red-hot-stock-beat-the-market-again-2024/,20231222T210000,['Prosper Junior Bakiny'],I wouldn't bet against it.,https://g.foolcdn.com/editorial/images/758459/physician-shaking-patients-hand.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}]",0.262531,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.596532', 'ticker_sentiment_score': '0.265499', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
30,Market In Merry Mood Heading Into Christmas: Weekly Review,https://www.investors.com/news/stock-market-rally-is-in-merry-mood-heading-into-christmas-weekend-weekly-review/,20231222T173000,"[""Investor's Business Daily"", 'IBD STAFF']","The stock market rally suffered a sharp sell-off Wednesday, but the major indexes were flat to slightly higher for the week. Micron Technology ( MU ) jumped on strong earnings and guidance, lifting key chip-gear makers and other semiconductor plays.",https://www.investors.com/wp-content/uploads/2020/12/Stock-ChristmasTree-NYSE-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.928139'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",-0.123408,Neutral,"[{'ticker': 'IMVT', 'relevance_score': '0.064161', 'ticker_sentiment_score': '-0.170562', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AMAT', 'relevance_score': '0.0428', 'ticker_sentiment_score': '0.10249', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TRMNF', 'relevance_score': '0.021408', 'ticker_sentiment_score': '-0.249094', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LPG', 'relevance_score': '0.0428', 'ticker_sentiment_score': '-0.004971', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NISTF', 'relevance_score': '0.021408', 'ticker_sentiment_score': '-0.027664', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KRTX', 'relevance_score': '0.064161', 'ticker_sentiment_score': '0.159217', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TCTZF', 'relevance_score': '0.021408', 'ticker_sentiment_score': '-0.249094', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NTES', 'relevance_score': '0.0428', 'ticker_sentiment_score': '-0.265243', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSLA', 'relevance_score': '0.127908', 'ticker_sentiment_score': '-0.099146', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.0428', 'ticker_sentiment_score': '-0.094598', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRCX', 'relevance_score': '0.0428', 'ticker_sentiment_score': '0.10249', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BILI', 'relevance_score': '0.0428', 'ticker_sentiment_score': '-0.265243', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'FDX', 'relevance_score': '0.148994', 'ticker_sentiment_score': '-0.214209', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AYX', 'relevance_score': '0.064161', 'ticker_sentiment_score': '0.148185', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ILMN', 'relevance_score': '0.064161', 'ticker_sentiment_score': '-0.017067', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MU', 'relevance_score': '0.085476', 'ticker_sentiment_score': '-0.005311', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKE', 'relevance_score': '0.169975', 'ticker_sentiment_score': '-0.176036', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AIR', 'relevance_score': '0.021408', 'ticker_sentiment_score': '0.043908', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ACN', 'relevance_score': '0.0428', 'ticker_sentiment_score': '-0.130435', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOGL', 'relevance_score': '0.0428', 'ticker_sentiment_score': '-0.004971', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HEI', 'relevance_score': '0.0428', 'ticker_sentiment_score': '0.043648', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.0428', 'ticker_sentiment_score': '0.15626', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KMX', 'relevance_score': '0.0428', 'ticker_sentiment_score': '-0.071178', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TGI', 'relevance_score': '0.021408', 'ticker_sentiment_score': '0.043908', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADBE', 'relevance_score': '0.148994', 'ticker_sentiment_score': '-0.058615', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GPCR', 'relevance_score': '0.0428', 'ticker_sentiment_score': '-0.094598', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WOR', 'relevance_score': '0.0428', 'ticker_sentiment_score': '0.148808', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARGX', 'relevance_score': '0.0428', 'ticker_sentiment_score': '-0.164222', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CTAS', 'relevance_score': '0.0428', 'ticker_sentiment_score': '0.012956', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STNG', 'relevance_score': '0.0428', 'ticker_sentiment_score': '-0.004971', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AFRM', 'relevance_score': '0.064161', 'ticker_sentiment_score': '0.054092', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.085476', 'ticker_sentiment_score': '0.055684', 'ticker_sentiment_label': 'Neutral'}]"
31,Eli Lilly  ( LLY )  Rises Yet Lags Behind Market: Some Facts Worth Knowing,https://www.zacks.com/stock/news/2201265/eli-lilly-lly-rises-yet-lags-behind-market-some-facts-worth-knowing,20231221T224517,['Zacks Equity Research'],"The latest trading day saw Eli Lilly (LLY) settling at $572, representing a +0.31% change from its previous close.",https://staticx-tuner.zacks.com/images/default_article_images/default209.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.961735'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.185775,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.527969', 'ticker_sentiment_score': '0.284696', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
32,Stocks Bounce With Inflation Data Due; Six Stocks To Watch,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rebounds-with-key-inflation-data-due-apple-leads-stocks-to-watch/,20231221T214800,"['ED CARSON', ""Investor's Business Daily""]",Dow Jones Futures: Market Rebounds With Key Inflation Data Due. Apple Leads Stocks To Watch Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2019/08/stock-bounce-back-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.818451'}]",0.13611,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.205308', 'ticker_sentiment_score': '0.084713', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.059268', 'ticker_sentiment_score': '-0.019059', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.262052', 'ticker_sentiment_score': '0.006002', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.176502', 'ticker_sentiment_score': '0.010328', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.088799', 'ticker_sentiment_score': '0.069807', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.059268', 'ticker_sentiment_score': '0.012047', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MASI', 'relevance_score': '0.059268', 'ticker_sentiment_score': '0.044035', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKE', 'relevance_score': '0.176502', 'ticker_sentiment_score': '0.072379', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CCL', 'relevance_score': '0.088799', 'ticker_sentiment_score': '0.004201', 'ticker_sentiment_label': 'Neutral'}]"
33,Monthly Meeting Q&A with Jim Cramer: Stock buying and selling strategies into year end,https://www.cnbc.com/2023/12/21/monthly-meeting-qa-with-jim-cramer-stock-buying-and-selling-strategies-into-year-end.html,20231221T180706,['Paulina Likos'],"During the December Monthly Meeting, we took questions directly from Investing Club members.",https://image.cnbcfm.com/api/v1/image/107204415-1678206782470-Eaton_Corporation-OB-Photo-MW-20230307-0001-PRESS-1.JPG?v=1678381479&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.769861'}]",0.10348,Neutral,"[{'ticker': 'HUM', 'relevance_score': '0.136666', 'ticker_sentiment_score': '0.054069', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.058807', 'ticker_sentiment_score': '0.043109', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VMW', 'relevance_score': '0.058807', 'ticker_sentiment_score': '0.043109', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.058807', 'ticker_sentiment_score': '0.043109', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.019618', 'ticker_sentiment_score': '0.039266', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.019618', 'ticker_sentiment_score': '0.039266', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.019618', 'ticker_sentiment_score': '0.039266', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NYT', 'relevance_score': '0.019618', 'ticker_sentiment_score': '0.039266', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SLB', 'relevance_score': '0.019618', 'ticker_sentiment_score': '0.039266', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.078354', 'ticker_sentiment_score': '0.044336', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.039224', 'ticker_sentiment_score': '0.042455', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.058807', 'ticker_sentiment_score': '0.043109', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.117295', 'ticker_sentiment_score': '0.050055', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.019618', 'ticker_sentiment_score': '0.039266', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FDX', 'relevance_score': '0.019618', 'ticker_sentiment_score': '0.039266', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HD', 'relevance_score': '0.019618', 'ticker_sentiment_score': '0.039266', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.155954', 'ticker_sentiment_score': '0.058574', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTRA', 'relevance_score': '0.058807', 'ticker_sentiment_score': '0.043109', 'ticker_sentiment_label': 'Neutral'}]"
34,Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry,https://www.fool.com/investing/2023/12/21/weighing-their-chances-5-leading-healthcare-compan/,20231221T144500,['David Jagielski'],Which weight-loss stocks are good buys today?,https://g.foolcdn.com/editorial/images/758496/a-doctor-looking-at-a-tablet-with-another-person.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.18264,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.290607', 'ticker_sentiment_score': '0.215295', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.049526', 'ticker_sentiment_score': '0.131126', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.33628', 'ticker_sentiment_score': '0.091332', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.290607', 'ticker_sentiment_score': '0.215295', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.243864', 'ticker_sentiment_score': '0.100877', 'ticker_sentiment_label': 'Neutral'}]"
35,Will Eli Lilly's Emergency Diabetes Drug Give Amphastar Wings?,https://www.investors.com/research/amph-stock-will-eli-lillys-emergency-diabetes-drug-give-amphastar-wings/,20231221T130000,"['VIDYA RAMAKRISHNAN', ""Investor's Business Daily""]","Amphastar Pharmaceuticals ( AMPH ) is in a buy zone again after the biotech stock staged a massive 2023 rally. So AMPH stock is Wednesday's pick for IBD 50 Stocks To Watch. According to the IBD MarketSmith pattern recognition tool, AMPH stock sits just above an entry at 58.35 out of a cup with ...",https://www.investors.com/wp-content/uploads/2023/06/Stock-amphastarpharma-01-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999966'}, {'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.225237,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.245339', 'ticker_sentiment_score': '0.0283', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMPH', 'relevance_score': '0.5341', 'ticker_sentiment_score': '0.284713', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'IVZ', 'relevance_score': '0.082963', 'ticker_sentiment_score': '0.147395', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FHI', 'relevance_score': '0.082963', 'ticker_sentiment_score': '0.100143', 'ticker_sentiment_label': 'Neutral'}]"
36,2 Unstoppable Growth Stocks to Buy in 2024,https://www.fool.com/investing/2023/12/20/2-unstoppable-growth-stocks-to-buy-in-2024/,20231220T143000,['David Jagielski'],Don't let their valuations scare you off -- these stocks still have more room to rise higher next year.,https://g.foolcdn.com/editorial/images/758495/a-family-meeting-with-an-advisor.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.891286'}]",0.263013,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.356609', 'ticker_sentiment_score': '0.315354', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PDD', 'relevance_score': '0.356609', 'ticker_sentiment_score': '0.264231', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DG', 'relevance_score': '0.073773', 'ticker_sentiment_score': '0.087028', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DLTR', 'relevance_score': '0.073773', 'ticker_sentiment_score': '0.087028', 'ticker_sentiment_label': 'Neutral'}]"
37,3 Top Dividend Stocks That Recently Hiked Their Payouts,https://www.fool.com/investing/2023/12/20/top-dividend-stocks-recently-hiked-their-payouts/,20231220T101000,['David Jagielski'],These stocks give investors an incentive to buy and hold.,https://g.foolcdn.com/editorial/images/758498/a-couple-reviewing-a-statement.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.623304'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.5'}]",0.376582,Bullish,"[{'ticker': 'ENB', 'relevance_score': '0.381255', 'ticker_sentiment_score': '0.369226', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.277748', 'ticker_sentiment_score': '0.3916', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'D', 'relevance_score': '0.056674', 'ticker_sentiment_score': '0.034022', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MA', 'relevance_score': '0.113062', 'ticker_sentiment_score': '0.152949', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
38,What the Options Market Tells Us About Eli Lilly - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/12/36307677/what-the-options-market-tells-us-about-eli-lilly,20231219T160139,['Benzinga Insights'],"Whales with a lot of money to spend have taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 13 trades. If we consider the specifics of each trade, it is accurate to state that 38% of the investors opened trades with bullish expectations and ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}]",0.009604,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.68471', 'ticker_sentiment_score': '-0.071665', 'ticker_sentiment_label': 'Neutral'}]"
39,"The Zacks Analyst Blog Highlights Novo Nordisk, Eli Lilly, Vertex Pharmaceuticals, Regeneron and GSK",https://www.zacks.com/stock/news/2199740/the-zacks-analyst-blog-highlights-novo-nordisk-eli-lilly-vertex-pharmaceuticals-regeneron-and-gsk,20231219T093400,['Zacks Investment Research'],"Novo Nordisk, Eli Lilly, Vertex Pharmaceuticals, Regeneron and GSK are included in this Analyst Blog.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}, {'topic': 'Earnings', 'relevance_score': '0.890401'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.451494'}]",0.198286,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.200134', 'ticker_sentiment_score': '0.176485', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.067347', 'ticker_sentiment_score': '0.08218', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GSK', 'relevance_score': '0.156316', 'ticker_sentiment_score': '0.133696', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.200134', 'ticker_sentiment_score': '0.143776', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.022473', 'ticker_sentiment_score': '0.021801', 'ticker_sentiment_label': 'Neutral'}]"
40,"Obesity/Diabetes Drug Class GLP-1s' Cost-Saving Potential: Decoding Impact on Healthcare Spending - Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/12/36287829/obesitydiabetes-drug-class-glp-1s-cost-saving-potential-decoding-impact-on-healthca,20231218T193936,['Vandana Singh'],"Due to the recent achievements of GLP-1s, Goldman Sachs sees significant potential for Eli Lilly And Co LLY, Novo Nordisk A/S NVO, and other companies to venture into categories that exceed the scope of consideration for most investors at present.",https://cdn.benzinga.com/files/images/story/2023/12/18/ozempic.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.154855,Somewhat-Bullish,"[{'ticker': 'GS', 'relevance_score': '0.094762', 'ticker_sentiment_score': '0.171373', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.188193', 'ticker_sentiment_score': '0.240368', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.188193', 'ticker_sentiment_score': '0.240368', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
41,5 Big Drug Stocks That May Continue to Outperform in 2024,https://www.zacks.com/stock/news/2199316/5-big-drug-stocks-that-may-continue-to-outperform-in-2024,20231218T135400,['Kinjel Shah'],"Novo Nordisk (NVO), Eli Lilly (LLY), Vertex Pharmaceuticals (VRTX), Regeneron (REGN) and GSK (GSK) have been performing well this year. These stocks are poised to keep the momentum alive in 2024.",https://staticx-tuner.zacks.com/images/articles/main/6e/37920.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}, {'topic': 'Earnings', 'relevance_score': '0.890401'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.451494'}]",0.200783,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.184775', 'ticker_sentiment_score': '0.189145', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.046588', 'ticker_sentiment_score': '0.141465', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GSK', 'relevance_score': '0.139131', 'ticker_sentiment_score': '0.152648', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.184775', 'ticker_sentiment_score': '0.155351', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SNY', 'relevance_score': '0.023304', 'ticker_sentiment_score': '0.021882', 'ticker_sentiment_label': 'Neutral'}]"
42,"As 2023 Comes To A Close And Updates Are Expected From Many Companies, Are These Three Unique Biotech Names On Your Watchlist? - Ginkgo Bioworks Holdings  ( NYSE:DNA ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/general/biotech/23/12/36281714/as-2023-comes-to-a-close-and-updates-are-expected-from-many-companies-are-these-three-unique-biot,20231218T134542,['Meg Flippin'],"Biotech stocks have had a tough run in 2023 so far. As of early November, the iShares Biotechnology ETF ( IBB ) was down 7.5% while the S&P 500 was up more than 14%. But that doesn't mean investors should count them out.",https://cdn.benzinga.com/files/images/story/2023/12/18/screenshot_2023-12-18_at_7.31.58_pm.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.650727'}]",0.139724,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.195419', 'ticker_sentiment_score': '0.080088', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DNA', 'relevance_score': '0.098456', 'ticker_sentiment_score': '0.135255', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.098456', 'ticker_sentiment_score': '0.214798', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.098456', 'ticker_sentiment_score': '0.214798', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
43,Eli Lilly  ( LLY )  Dips More Than Broader Market: What You Should Know,https://www.zacks.com/stock/news/2199019/eli-lilly-lly-dips-more-than-broader-market-what-you-should-know,20231215T224513,['Zacks Equity Research'],"Eli Lilly (LLY) closed at $572.04 in the latest trading session, marking a -0.28% move from the prior day.",https://staticx-tuner.zacks.com/images/default_article_images/default203.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.972476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.199586,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.606946', 'ticker_sentiment_score': '0.258514', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
44,Market Surges To 2023 Highs As Fed Pivots Toward Rate Cuts: Weekly Review,https://www.investors.com/news/stock-market-rally-surges-to-2023-highs-as-fed-pivots-toward-rate-cuts-weekly-review/,20231215T155400,"[""Investor's Business Daily"", 'IBD STAFF']","The stock market rally raced higher in a powerful, broad advance as the Federal Reserve signaled it could cut rates three times in 2024. The Dow Jones hit a record high while the S&P 500, Nasdaq composite, S&P MidCap 400 and small-cap Russell 2023 all set 2023 bests. Treasury yields plunged.",https://www.investors.com/wp-content/uploads/2021/03/LSSECRETS-peak-040221.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.972193'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '0.980716'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '0.992549'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",-0.065812,Neutral,"[{'ticker': 'NVDA', 'relevance_score': '0.059935', 'ticker_sentiment_score': '0.086', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.029989', 'ticker_sentiment_score': '-0.028872', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.119532', 'ticker_sentiment_score': '-0.108167', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ORCL', 'relevance_score': '0.178459', 'ticker_sentiment_score': '-0.007668', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.059935', 'ticker_sentiment_score': '-0.441897', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'OXY', 'relevance_score': '0.089797', 'ticker_sentiment_score': '-0.031906', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.119532', 'ticker_sentiment_score': '0.106769', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.029989', 'ticker_sentiment_score': '0.217562', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LEN', 'relevance_score': '0.059935', 'ticker_sentiment_score': '-0.003011', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.1491', 'ticker_sentiment_score': '0.10867', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADBE', 'relevance_score': '0.178459', 'ticker_sentiment_score': '0.058147', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.059935', 'ticker_sentiment_score': '-0.141007', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.059935', 'ticker_sentiment_score': '-0.2386', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
45,"Pharma Stock Roundup: PFE Issues Weak 2024 View, AZN to Buy Icosavax & More",https://www.zacks.com/stock/news/2198513/pharma-stock-roundup-pfe-issues-weak-2024-view-azn-to-buy-icosavax-more,20231215T133400,['Kinjel Shah'],"Pfizer (PFE) issues a disappointing outlook for 2024. AstraZeneca (AZN) announces that it is buying vaccine company, Icosavax.",https://staticx-tuner.zacks.com/images/articles/main/52/873.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.938793'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.156532,Somewhat-Bullish,"[{'ticker': 'AZN', 'relevance_score': '0.271489', 'ticker_sentiment_score': '0.219964', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.079', 'ticker_sentiment_score': '-0.064902', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.079', 'ticker_sentiment_score': '-0.065918', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SGEN', 'relevance_score': '0.195814', 'ticker_sentiment_score': '0.070548', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.195814', 'ticker_sentiment_score': '-0.045716', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ICVX', 'relevance_score': '0.157227', 'ticker_sentiment_score': '0.105049', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.344606', 'ticker_sentiment_score': '0.047034', 'ticker_sentiment_label': 'Neutral'}]"
46,Where Will Eli Lilly Be in 5 Years?,https://www.fool.com/investing/2023/12/15/where-will-eli-lilly-be-in-5years/,20231215T111500,['David Jagielski'],There's a lot of growth still to come for this healthcare behemoth.,https://g.foolcdn.com/editorial/images/757824/businessman-checking-his-phone.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.858979'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}]",0.330525,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.70295', 'ticker_sentiment_score': '0.500778', 'ticker_sentiment_label': 'Bullish'}]"
47,Ozempic Isn't the Best Weight-Loss Treatment Anymore. Here's Why That Shouldn't Matter to Novo Nordisk Investors.,https://www.fool.com/investing/2023/12/14/ozempic-isnt-the-best-weight-loss-treatment-anymor/,20231214T141000,['David Jagielski'],Investors shouldn't be quick to discount Novo Nordisk's long-term potential.,https://g.foolcdn.com/editorial/images/757809/doctor-discussing-a-report-with-people.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.04371,Neutral,"[{'ticker': 'GS', 'relevance_score': '0.061631', 'ticker_sentiment_score': '-0.067078', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.24289', 'ticker_sentiment_score': '0.169559', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.463792', 'ticker_sentiment_score': '0.170344', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
48,"Futures Rise Ahead Of Jobless Claims, Retail Sales",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-jobless-claims-retail-sales-adobe-dives-on-earnings/,20231214T131400,"[""Investor's Business Daily"", 'SCOTT LEHTONEN']","Dow Jones Futures Rally Ahead Of Jobless Claims, Retail Sales. Adobe Dives On Earnings Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2017/02/stock-wallStreet-1-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}]",0.095261,Neutral,"[{'ticker': 'NVDA', 'relevance_score': '0.066784', 'ticker_sentiment_score': '0.163675', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.16594', 'ticker_sentiment_score': '0.208618', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SNOW', 'relevance_score': '0.230704', 'ticker_sentiment_score': '0.084278', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.004905', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.033421', 'ticker_sentiment_score': '0.10721', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.100029', 'ticker_sentiment_score': '0.174637', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.195569', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JBL', 'relevance_score': '0.100029', 'ticker_sentiment_score': '-0.09502', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.068678', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADBE', 'relevance_score': '0.16594', 'ticker_sentiment_score': '-0.256888', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LLY', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.097526', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BKNG', 'relevance_score': '0.1331', 'ticker_sentiment_score': '-0.011018', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.103756', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.094141', 'ticker_sentiment_label': 'Neutral'}]"
49,Dow Hits New High In Fed-Led Rally; Adobe Falls Late,https://www.investors.com/market-trend/stock-market-today/dow-jones-hits-record-high-as-fed-sees-three-rate-cuts-markets-bet-on-six-adobe-falls-late/,20231213T215300,"[""Investor's Business Daily"", 'ED CARSON']",Dow Jones Hits Record High As Fed Sees Three Rate Cuts. Markets Bet On Six. Adobe Falls Late Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2018/04/stock-Federal-Reserve-06-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",0.016808,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.148915', 'ticker_sentiment_score': '0.025646', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.207317', 'ticker_sentiment_score': '-0.006493', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.236109', 'ticker_sentiment_score': '0.014658', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DDOG', 'relevance_score': '0.264578', 'ticker_sentiment_score': '-0.005916', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADBE', 'relevance_score': '0.207317', 'ticker_sentiment_score': '-0.08465', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.089685', 'ticker_sentiment_score': '0.123366', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.05986', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARM', 'relevance_score': '0.119383', 'ticker_sentiment_score': '0.029449', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.029951', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IOT', 'relevance_score': '0.05986', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
50,"Nvidia, Disney and Tesla are among 2023's buzziest stocks. Can they continue to sizzle in 2024?",https://www.marketwatch.com/story/nvidia-disney-and-tesla-are-among-2023s-buzziest-stocks-can-they-continue-to-sizzle-in-2024-bcea3881,20231213T172800,"['', 'Ciara Linnane', 'Emily Bary']",Here's a look at what MarketWatch staffers and readers consider to be 2023's most talked-about stocks - and the key issues that will drive their performances in the year to come.,https://images.mktw.net/im-882031?width=700&height=392,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Blockchain', 'relevance_score': '0.451494'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.999976'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.108179'}]",0.146293,Neutral,"[{'ticker': 'TGT', 'relevance_score': '0.043147', 'ticker_sentiment_score': '0.105782', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WW', 'relevance_score': '0.043147', 'ticker_sentiment_score': '0.146279', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.021581', 'ticker_sentiment_score': '0.079279', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.064681', 'ticker_sentiment_score': '0.182753', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.171333', 'ticker_sentiment_score': '0.13932', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TAP', 'relevance_score': '0.043147', 'ticker_sentiment_score': '-0.102156', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.043147', 'ticker_sentiment_score': '0.200728', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'COIN', 'relevance_score': '0.107591', 'ticker_sentiment_score': '0.038125', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BUD', 'relevance_score': '0.043147', 'ticker_sentiment_score': '-0.041962', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.086167', 'ticker_sentiment_score': '0.089536', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.128937', 'ticker_sentiment_score': '0.067554', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.043147', 'ticker_sentiment_score': '0.021957', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.064681', 'ticker_sentiment_score': '0.203605', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GME', 'relevance_score': '0.086167', 'ticker_sentiment_score': '0.092222', 'ticker_sentiment_label': 'Neutral'}]"
51,What Are The Best Stocks To Invest In Now? 2 Health Care Stocks To Watch,https://stockmarket.com/featured/what-are-the-best-stocks-to-invest-in-now-2-health-care-stocks-to-watch-2023-12-13,20231213T162958,['Jonathan Phillip'],"The healthcare sector encompasses a wide range of companies involved in medical services, pharmaceuticals, medical equipment, and health insurance. This sector is essential due to its direct impact on human health and well-being.",https://u3j7m9h7.rocketcdn.me/wp-content/uploads/2020/12/LLY-stock.jpg,StockMarket.com,n/a,stockmarket.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999982'}]",0.197958,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.461006', 'ticker_sentiment_score': '0.266389', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HCSG', 'relevance_score': '0.081552', 'ticker_sentiment_score': '0.101044', 'ticker_sentiment_label': 'Neutral'}]"
52,Eli Lilly and Company  ( LLY )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2197261/eli-lilly-and-company-lly-is-attracting-investor-attention-here-is-what-you-should-know,20231213T140010,['Zacks Equity Research'],"Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default99.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.215098,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.523995', 'ticker_sentiment_score': '0.156507', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
53,Here's why Eaton could be our next play after exiting Oracle,https://www.cnbc.com/2023/12/12/heres-why-eaton-could-be-our-next-play-after-exiting-oracle-.html,20231212T160740,['Jeff Marks'],The Investing Club holds its Morning Meeting every weekday at 10:20 a.m. ET.,https://image.cnbcfm.com/api/v1/image/107346448-17023959171702395913-32422662783-1080pnbcnews.jpg?v=1702395917&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.967645'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.077053,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.229872', 'ticker_sentiment_score': '0.058', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ETN', 'relevance_score': '0.154455', 'ticker_sentiment_score': '0.043283', 'ticker_sentiment_label': 'Neutral'}]"
54,Futures Rise Ahead Of CPI Inflation Report,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-cpi-inflation-report-ai-giant-oracle-dives-on-earnings/,20231212T131500,"['SCOTT LEHTONEN', ""Investor's Business Daily""]","Dow Jones futures rose modestly Tuesday morning ahead of a critical inflation report, while other major indexes came along for the ride. Meanwhile, artificial intelligence player Oracle ( ORCL ) took a dive after reporting weak sales results. The Labor Department's Consumer Price Index is due ...",https://www.investors.com/wp-content/uploads/2017/03/stock-wallstreet-031317-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}]",0.144773,Neutral,"[{'ticker': 'NVDA', 'relevance_score': '0.104835', 'ticker_sentiment_score': '0.129742', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNOW', 'relevance_score': '0.241512', 'ticker_sentiment_score': '0.026101', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ORCL', 'relevance_score': '0.104835', 'ticker_sentiment_score': '-0.068395', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.035035', 'ticker_sentiment_score': '0.058375', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.035035', 'ticker_sentiment_score': '0.107903', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.139467', 'ticker_sentiment_score': '0.149251', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.104835', 'ticker_sentiment_score': '0.129742', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.139467', 'ticker_sentiment_score': '0.147157', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.139467', 'ticker_sentiment_score': '0.040733', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.139467', 'ticker_sentiment_score': '0.067645', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CASY', 'relevance_score': '0.104835', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BKNG', 'relevance_score': '0.173832', 'ticker_sentiment_score': '-0.011533', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.139467', 'ticker_sentiment_score': '0.07295', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.139467', 'ticker_sentiment_score': '0.092766', 'ticker_sentiment_label': 'Neutral'}]"
55,Better Weight Loss Stock: Eli Lilly or Novo Nordisk?,https://www.fool.com/investing/2023/12/12/better-weight-loss-stock-eli-lilly-or-novo-nordisk/,20231212T123000,['George Budwell'],"Both of these pharma stocks have been top performers in 2023. One stock is the better long-term buy, however.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F757950%2Fgrowth-trend.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.918141'}]",0.223546,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.457274', 'ticker_sentiment_score': '0.31369', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.138066', 'ticker_sentiment_score': '0.338499', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
56,Futures: Magnificent 7 Stocks Slide; CPI Next,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-magnificent-seven-stocks-slide-ai-giant-oracle-dives-on-earnings-cpi-next/,20231211T223300,"[""Investor's Business Daily"", 'SCOTT LEHTONEN']",Dow Jones Futures: Magnificent Seven Stocks Slide. AI Giant Oracle Dives On Earnings. CPI Next Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2021/04/Stock-inflation-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.146548,Neutral,"[{'ticker': 'META', 'relevance_score': '0.075279', 'ticker_sentiment_score': '0.021662', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.112709', 'ticker_sentiment_score': '0.009323', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.112709', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNOW', 'relevance_score': '0.223179', 'ticker_sentiment_score': '0.024582', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ORCL', 'relevance_score': '0.075279', 'ticker_sentiment_score': '-0.105053', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.037681', 'ticker_sentiment_score': '0.072953', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.112709', 'ticker_sentiment_score': '0.149903', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.112709', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.259135', 'ticker_sentiment_score': '0.136515', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LEN', 'relevance_score': '0.075279', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.149889', 'ticker_sentiment_score': '0.042501', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADBE', 'relevance_score': '0.075279', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.149889', 'ticker_sentiment_score': '0.105591', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DRI', 'relevance_score': '0.075279', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BKNG', 'relevance_score': '0.186738', 'ticker_sentiment_score': '-0.01213', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.186738', 'ticker_sentiment_score': '0.06518', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.149889', 'ticker_sentiment_score': '0.048804', 'ticker_sentiment_label': 'Neutral'}]"
57,Futures Dip; Apple Headlines 9 Stocks To Buy And Watch,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-apple-stock-headlines-best-stocks-to-buy-and-watch/,20231211T131600,"[""Investor's Business Daily"", 'SCOTT LEHTONEN']",Futures Dip. Apple Headlines 9 Stocks To Buy And Watch Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2021/09/Stock-wallstreetflag-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.151691,Somewhat-Bullish,"[{'ticker': 'NVDA', 'relevance_score': '0.10607', 'ticker_sentiment_score': '0.090263', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.210274', 'ticker_sentiment_score': '0.166199', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SNOW', 'relevance_score': '0.141102', 'ticker_sentiment_score': '0.099783', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ORCL', 'relevance_score': '0.07083', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.07083', 'ticker_sentiment_score': '0.255099', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'IVZ', 'relevance_score': '0.03545', 'ticker_sentiment_score': '0.030263', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.141102', 'ticker_sentiment_score': '0.121311', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.175859', 'ticker_sentiment_score': '0.11143', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.141102', 'ticker_sentiment_score': '0.102936', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LEN', 'relevance_score': '0.07083', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.141102', 'ticker_sentiment_score': '0.039736', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADBE', 'relevance_score': '0.07083', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.141102', 'ticker_sentiment_score': '0.098099', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DRI', 'relevance_score': '0.07083', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NET', 'relevance_score': '0.03545', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BKNG', 'relevance_score': '0.141102', 'ticker_sentiment_score': '-0.080916', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.141102', 'ticker_sentiment_score': '0.036687', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.210274', 'ticker_sentiment_score': '0.215322', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
58,3 Unstoppable Stocks to Buy Right Now,https://www.fool.com/investing/2023/12/10/3-unstoppable-stocks-to-buy-right-now/,20231210T115600,"['Keith Speights', 'David Jagielski', 'and Prosper Junior Bakiny']",These stocks could be just the ticket for investors seeking strong growth.,https://g.foolcdn.com/editorial/images/757538/two-people-with-ipad-and-laptop.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}, {'topic': 'Earnings', 'relevance_score': '0.99393'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.265592,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.411176', 'ticker_sentiment_score': '0.233842', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.171181', 'ticker_sentiment_score': '0.189008', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MORN', 'relevance_score': '0.043108', 'ticker_sentiment_score': '0.134502', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JAZZ', 'relevance_score': '0.043108', 'ticker_sentiment_score': '-0.011888', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXSM', 'relevance_score': '0.171181', 'ticker_sentiment_score': '0.154166', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
59,Eli Lilly  ( LLY )  Rises Higher Than Market: Key Facts,https://www.zacks.com/stock/news/2195769/eli-lilly-lly-rises-higher-than-market-key-facts,20231208T224512,['Zacks Equity Research'],"The latest trading day saw Eli Lilly (LLY) settling at $598.05, representing a +1.66% change from its previous close.",https://staticx-tuner.zacks.com/images/default_article_images/default288.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.928769'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.215981,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.675573', 'ticker_sentiment_score': '0.384319', 'ticker_sentiment_label': 'Bullish'}]"
60,"Bernie Sanders To Take On Ozempic, Wegovy, Weight Loss Drugs: 'Could Be Helpful, But They're Not Going To Be Helpful If People Can't Afford Them' - Novo Nordisk  ( NYSE:NVO ) ",https://www.benzinga.com/general/biotech/23/12/36161067/bernie-sanders-to-take-on-ozempic-wegovy-weight-loss-drugs-could-be-helpful-but-theyre-not-going-,20231208T210741,['Chris Katje'],"Congressman Bernie Sanders ( I-Vt. ) has been known to tussle with public companies over their high prices or anticompetitive behavior, including pharmaceutical companies and their high costs. In his newest battle, Sanders is taking on the growing popularity of weight-loss drugs and diabetes ...",https://cdn.benzinga.com/files/images/story/2023/BernieSanders-Ozempic-Shutterstock.png?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.089381,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.214937', 'ticker_sentiment_score': '0.010354', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALT', 'relevance_score': '0.144275', 'ticker_sentiment_score': '0.198951', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.28387', 'ticker_sentiment_score': '-0.081186', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.144275', 'ticker_sentiment_score': '0.027719', 'ticker_sentiment_label': 'Neutral'}]"
61,Pharma Giant Eli Lilly's Shareholder Bonanza: Announces Hefty 15% Dividend Hike For Q1 - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/equities/23/12/36156535/pharma-giant-eli-lillys-shareholder-bonanza-announces-hefty-15-dividend-hike-for-q1,20231208T171816,['Nabaparna Bhattacharya'],"Eli Lilly and Company LLY has boosted its quarterly dividend by an impressive 15%, announcing a payout of $1.30 per share for the first quarter of 2024, signaling strong financial confidence. The dividend is payable on March 8, 2024, to shareholders of record at the close of business on February ...",https://cdn.benzinga.com/files/images/story/2023/12/08/lly_co.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.162993,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.729067', 'ticker_sentiment_score': '0.675183', 'ticker_sentiment_label': 'Bullish'}]"
62,"Pharma Stock Roundup: ABBV to Buy CERE, JNJ's 2024 View, LLY & NVS Get FDA Nod",https://www.zacks.com/stock/news/2195315/pharma-stock-roundup-abbv-to-buy-cere-jnjs-2024-view-lly-nvs-get-fda-nod,20231208T131200,['Kinjel Shah'],AbbVie (ABBV) offers to acquire Cerevel Therapeutics for $8.7 billion. J&J (JNJ) announces sales and earnings growth expectations for 2024.,https://staticx-tuner.zacks.com/images/articles/main/52/873.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.095039,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.069294', 'ticker_sentiment_score': '0.004039', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CERE', 'relevance_score': '0.103778', 'ticker_sentiment_score': '0.080373', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.071082', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.205807', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
63,Futures Lower Ahead Of Imminent Jobs Report,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-imminent-jobs-report-lulu-stock-tumbles-on-earnings/,20231208T131100,"['SCOTT LEHTONEN', ""Investor's Business Daily""]",Dow Jones Futures Fall Ahead Of Imminent Jobs Report. LULU Stock Tumbles On Earnings Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2017/08/WallStreetFinance-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}]",0.116378,Neutral,"[{'ticker': 'NVDA', 'relevance_score': '0.110632', 'ticker_sentiment_score': '0.127159', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.073886', 'ticker_sentiment_score': '0.116277', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.036983', 'ticker_sentiment_score': '0.008865', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.147141', 'ticker_sentiment_score': '0.15667', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.147141', 'ticker_sentiment_score': '0.145716', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LULU', 'relevance_score': '0.147141', 'ticker_sentiment_score': '-0.182264', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSLA', 'relevance_score': '0.110632', 'ticker_sentiment_score': '0.127159', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RH', 'relevance_score': '0.036983', 'ticker_sentiment_score': '-0.115744', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.147141', 'ticker_sentiment_score': '0.079078', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.147141', 'ticker_sentiment_score': '0.075151', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.147141', 'ticker_sentiment_score': '0.126032', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NET', 'relevance_score': '0.036983', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BKNG', 'relevance_score': '0.183337', 'ticker_sentiment_score': '-0.083549', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DOCU', 'relevance_score': '0.036983', 'ticker_sentiment_score': '-0.115744', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.147141', 'ticker_sentiment_score': '0.071416', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.183337', 'ticker_sentiment_score': '0.110386', 'ticker_sentiment_label': 'Neutral'}]"
64,Could Eli Lilly Beat Novo Nordisk in the Billion-Dollar Weight Loss Market?,https://www.fool.com/investing/2023/12/08/could-lilly-beat-novo-nordisk-in-weight-loss/,20231208T103000,['Adria Cimino'],These drugs address a rapidly growing market.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F757481%2Fgettyimages-1292931102.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.156735,Somewhat-Bullish,"[{'ticker': 'GS', 'relevance_score': '0.052685', 'ticker_sentiment_score': '0.15863', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.491255', 'ticker_sentiment_score': '0.187817', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.356317', 'ticker_sentiment_score': '0.135845', 'ticker_sentiment_label': 'Neutral'}]"
65,"Zacks Market Edge Highlights: SAIC, ANET, LLY, PFE and SIG",https://www.zacks.com/stock/news/2195206/zacks-market-edge-highlights-saic-anet-lly-pfe-and-sig,20231208T083500,['Zacks Investment Research'],"SAIC, ANET, LLY, PFE and SIG have been highlighted in this Market Edge article.",https://staticx-tuner.zacks.com/images/articles/main/89/447.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.972756'}, {'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.019138,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.328236', 'ticker_sentiment_score': '-0.057021', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SIG', 'relevance_score': '0.200688', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANET', 'relevance_score': '0.446966', 'ticker_sentiment_score': '-0.104395', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.067536', 'ticker_sentiment_score': '0.05663', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.446966', 'ticker_sentiment_score': '-0.275549', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'SAIC', 'relevance_score': '0.502207', 'ticker_sentiment_score': '0.083988', 'ticker_sentiment_label': 'Neutral'}]"
66,Will There Be a Recession in 2024?,https://www.zacks.com/stock/news/2195010/will-there-be-a-recession-in-2024,20231207T165800,['Tracey Ryniec'],Tracey Ryniec and John Blank examine whether a recession is looming and how to invest in the new year.,https://staticx-tuner.zacks.com/images/articles/main/21/40864.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}, {'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.004799,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.359707', 'ticker_sentiment_score': '-0.061115', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SIG', 'relevance_score': '0.220809', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANET', 'relevance_score': '0.487021', 'ticker_sentiment_score': '-0.110238', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.07446', 'ticker_sentiment_score': '0.057267', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.487021', 'ticker_sentiment_score': '-0.290289', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'SAIC', 'relevance_score': '0.545337', 'ticker_sentiment_score': '0.088259', 'ticker_sentiment_label': 'Neutral'}]"
67,Better Large-Cap Growth Fund: Schwab U.S. Large-Cap Growth or Vanguard Growth Index Fund?,https://www.fool.com/investing/2023/12/07/better-large-cap-growth-fund-schwab-us-large-cap-g/,20231207T134500,['George Budwell'],Which of these top-performing growth funds is the better buy?,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F757401%2Fgrowth-trend.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.961735'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.251414,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.184834', 'ticker_sentiment_score': '0.04941', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.06211', 'ticker_sentiment_score': '0.19115', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.06211', 'ticker_sentiment_score': '0.19115', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.06211', 'ticker_sentiment_score': '0.19115', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.06211', 'ticker_sentiment_score': '0.19115', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.06211', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
68,Should You Buy Eli Lilly Stock Now or Wait for a Dip?,https://www.fool.com/investing/2023/12/07/should-you-buy-eli-lilly-stock-now-or-wait-for-a/,20231207T133000,['David Jagielski'],"Eli Lilly's P/E ratio of more than 100 looks steep, but the company is on the cusp of further huge growth.",https://media.ycharts.com/charts/6499460126ec73f86fcde80468338c03.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.723405'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.614606'}]",0.206619,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.570165', 'ticker_sentiment_score': '0.280983', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.062926', 'ticker_sentiment_score': '0.219737', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.062926', 'ticker_sentiment_score': '0.219737', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
69,Stocks Mixed Ahead Of Jobless Claims,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-ahead-of-jobless-claims-ai-stock-c3-ai-plunges-on-earnings/,20231207T132000,"[""Investor's Business Daily"", 'SCOTT LEHTONEN']",Dow Jones Futures Fall Ahead Of Jobless Claims. C3.ai Plunges On Earnings Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2019/10/stock-wall-street-flags-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}]",0.104997,Neutral,"[{'ticker': 'NVDA', 'relevance_score': '0.109789', 'ticker_sentiment_score': '0.133047', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.146025', 'ticker_sentiment_score': '0.152446', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VEEV', 'relevance_score': '0.0367', 'ticker_sentiment_score': '-0.043702', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.0367', 'ticker_sentiment_score': '0.10467', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.146025', 'ticker_sentiment_score': '0.202868', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.146025', 'ticker_sentiment_score': '0.152446', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.109789', 'ticker_sentiment_score': '0.133047', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.146025', 'ticker_sentiment_score': '0.078722', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.109789', 'ticker_sentiment_score': '0.063403', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.146025', 'ticker_sentiment_score': '0.125469', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NET', 'relevance_score': '0.181956', 'ticker_sentiment_score': '0.079084', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.146025', 'ticker_sentiment_score': '0.025052', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GME', 'relevance_score': '0.0367', 'ticker_sentiment_score': '-0.043702', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.181956', 'ticker_sentiment_score': '0.108302', 'ticker_sentiment_label': 'Neutral'}]"
70,Which Stock Is More Likely to Help You Retire as a Millionaire: AbbVie or Eli Lilly?,https://www.fool.com/investing/2023/12/07/which-stock-is-more-likely-to-help-you-retire-as-a/,20231207T105000,['Keith Speights'],There's no guarantee that either of these big pharma stocks can help you retire as a millionaire. But one has a clear edge.,https://g.foolcdn.com/editorial/images/757225/man-with-arms-behind-head-looking-at-laptop.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.297769,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.642329', 'ticker_sentiment_score': '0.56052', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'MORN', 'relevance_score': '0.056407', 'ticker_sentiment_score': '0.248', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.47574', 'ticker_sentiment_score': '0.513515', 'ticker_sentiment_label': 'Bullish'}]"
71,Eli Lilly's Options Frenzy: What You Need to Know - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/12/36115004/eli-lillys-options-frenzy-what-you-need-to-know,20231206T153145,['Benzinga Insights'],"Investors with a lot of money to spend have taken a bearish stance on Eli Lilly LLY. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.102355,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.694939', 'ticker_sentiment_score': '0.022921', 'ticker_sentiment_label': 'Neutral'}]"
72,Is it a Good Idea to Invest in AC Immune  ( ACIU )  Stock Now?,https://www.zacks.com/stock/news/2193345/is-it-a-good-idea-to-invest-in-ac-immune-aciu-stock-now,20231205T105900,['Zacks Equity Research'],"Here, we discuss some reasons why investing in AC Immune (ACIU) stock now may turn out to be a prudent move.",https://staticx-tuner.zacks.com/images/articles/main/07/905.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.9545'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.162188,Somewhat-Bullish,"[{'ticker': 'ACIU', 'relevance_score': '0.472959', 'ticker_sentiment_score': '0.172325', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.213674', 'ticker_sentiment_score': '0.050324', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTMX', 'relevance_score': '0.282234', 'ticker_sentiment_score': '0.14456', 'ticker_sentiment_label': 'Neutral'}]"
73,"Amphastar, Stock Of The Day, Breaks Out As It Sees Upside From Eli Lilly Deal",https://www.investors.com/research/ibd-stock-of-the-day/amphastar-amph-stock-breaks-out-as-it-sees-upside-from-eli-lilly-deal/,20231204T200200,"[""Investor's Business Daily"", 'JED GRAHAM']","Amphastar, Stock Of The Day, Breaks Out As It Sees Upside From ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2023/12/AMPH.png,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.996023'}, {'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.212475,Somewhat-Bullish,"[{'ticker': 'BAC', 'relevance_score': '0.070725', 'ticker_sentiment_score': '0.075344', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.522333', 'ticker_sentiment_score': '0.311976', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMPH', 'relevance_score': '0.405651', 'ticker_sentiment_score': '0.246756', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
74,What the Options Market Tells Us About Eli Lilly - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/12/36076107/what-the-options-market-tells-us-about-eli-lilly,20231204T184539,['Benzinga Insights'],"Financial giants have made a conspicuous bearish move on Eli Lilly. Our analysis of options history for Eli Lilly LLY revealed 47 unusual trades. Delving into the details, we found 40% of traders were bullish, while 59% showed bearish tendencies.",https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.052881,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.703874', 'ticker_sentiment_score': '-0.181689', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
75,1 Monster Dividend Stock Growth Investors Should Load Up On Right Now,https://www.fool.com/investing/2023/12/04/1-monster-dividend-stock-growth-investors-should-l/,20231204T140000,['George Budwell'],This dividend-paying pharma stock is on a roll.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F756997%2Fdividends.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}]",0.291513,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.50746', 'ticker_sentiment_score': '0.408967', 'ticker_sentiment_label': 'Bullish'}]"
76,3 No-Brainer Growth Stocks to Buy in December,https://www.fool.com/investing/2023/12/03/3-no-brainer-growth-stocks-to-buy-in-december/,20231203T115400,"['Keith Speights', 'and Prosper Junior Bakiny', 'David Jagielski']",No analysis paralysis is required with these great stocks.,https://g.foolcdn.com/editorial/images/756702/dna-scientist-test-tube.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.226255,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.34675', 'ticker_sentiment_score': '0.318621', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.158259', 'ticker_sentiment_score': '-0.054183', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.273224', 'ticker_sentiment_score': '0.220697', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
77,An Important History Lesson for Gene-Editing Investors,https://www.fool.com/investing/2023/12/02/an-important-history-lesson-for-gene-editing-inves/,20231202T133000,['George Budwell'],Gene editing holds tremendous promise for patients and investors alike. But the road to success won't be easy.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F756820%2Fbiotech-researcher.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.127419,Neutral,"[{'ticker': 'TRMNF', 'relevance_score': '0.040691', 'ticker_sentiment_score': '-0.095989', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.081276', 'ticker_sentiment_score': '0.096784', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.12165', 'ticker_sentiment_score': '0.115922', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.040691', 'ticker_sentiment_score': '0.050122', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SGEN', 'relevance_score': '0.040691', 'ticker_sentiment_score': '0.094399', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REGN', 'relevance_score': '0.040691', 'ticker_sentiment_score': '0.050122', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.12165', 'ticker_sentiment_score': '-0.003598', 'ticker_sentiment_label': 'Neutral'}]"
78,Is Eli Lilly a Better Stock to Buy and Hold Over the Next 10 Years Than Novo Nordisk?,https://www.fool.com/investing/2023/12/02/eli-lilly-better-stock-buy-hold-novo-nordisk/,20231202T105300,['Keith Speights'],Both of these stocks have been big winners this year. But one could be better positioned to extend that winning streak over the next decade.,https://g.foolcdn.com/editorial/images/756714/scientist-in-lab-young-african-american-female.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.193651,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.669232', 'ticker_sentiment_score': '0.291227', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.450496', 'ticker_sentiment_score': '0.288295', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
79,5 Top Stocks to Buy Before 2024,https://www.fool.com/investing/2023/12/02/5-top-stocks-to-buy-before-2024/,20231202T100000,['Adria Cimino'],These stocks have room to run -- next year and over the long term.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F756622%2Fgettyimages-1323758599.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.999606'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}]",0.309374,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.223522', 'ticker_sentiment_score': '0.23701', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.075397', 'ticker_sentiment_score': '0.147665', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.075397', 'ticker_sentiment_score': '0.285192', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.259529', 'ticker_sentiment_score': '0.252343', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
80,Annovis Bio  ( ANVS )  Stock Surges 38% in a Month: Here's Why,https://www.zacks.com/stock/news/2192301/annovis-bio-anvs-stock-surges-38-in-a-month-heres-why,20231201T161200,['Zacks Equity Research'],Annovis' (ANVS) shares surge on the successful development of its lead candidate in Alzheimer's disease.,https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.132141,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.235366', 'ticker_sentiment_score': '0.116995', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTMX', 'relevance_score': '0.235366', 'ticker_sentiment_score': '0.069513', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANVS', 'relevance_score': '0.324902', 'ticker_sentiment_score': '0.006998', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.142565', 'ticker_sentiment_score': '0.146836', 'ticker_sentiment_label': 'Neutral'}]"
81,Dow Hits 2023 High; Cybertruck Deliveries Begin: Weekly Review,https://www.investors.com/news/dow-jones-hits-2023-high-nasdaq-slips-tesla-cybertruck-salesforce-in-focus-weekly-review/,20231201T153300,"['IBD STAFF', ""Investor's Business Daily""]","Dow Hits '23 High, Nasdaq Slips. Cybertruck Debuts: Weekly Review Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2023/11/Stock-cybertruck-new-01-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",0.033931,Neutral,"[{'ticker': 'IMVT', 'relevance_score': '0.043698', 'ticker_sentiment_score': '-0.072731', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PATH', 'relevance_score': '0.065506', 'ticker_sentiment_score': '-0.023254', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XPEV', 'relevance_score': '0.043698', 'ticker_sentiment_score': '0.070395', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FRO', 'relevance_score': '0.065506', 'ticker_sentiment_score': '-0.101281', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTU', 'relevance_score': '0.043698', 'ticker_sentiment_score': '0.015905', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.043698', 'ticker_sentiment_score': '-0.065377', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.021857', 'ticker_sentiment_score': '0.075399', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.043698', 'ticker_sentiment_score': '-0.158559', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'UNH', 'relevance_score': '0.043698', 'ticker_sentiment_score': '0.029968', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SHOP', 'relevance_score': '0.043698', 'ticker_sentiment_score': '-0.017503', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DTST', 'relevance_score': '0.021857', 'ticker_sentiment_score': '0.062006', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NTAP', 'relevance_score': '0.043698', 'ticker_sentiment_score': '0.066641', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PDD', 'relevance_score': '0.065506', 'ticker_sentiment_score': '0.142486', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PSTG', 'relevance_score': '0.087265', 'ticker_sentiment_score': '0.070487', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.130571', 'ticker_sentiment_score': '-0.020666', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JBL', 'relevance_score': '0.043698', 'ticker_sentiment_score': '-0.027781', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.043698', 'ticker_sentiment_score': '-0.065377', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DELL', 'relevance_score': '0.043698', 'ticker_sentiment_score': '-0.186514', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'BABA', 'relevance_score': '0.043698', 'ticker_sentiment_score': '0.139972', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.043698', 'ticker_sentiment_score': '-0.047801', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRWD', 'relevance_score': '0.108958', 'ticker_sentiment_score': '0.070753', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNOW', 'relevance_score': '0.043698', 'ticker_sentiment_score': '0.049762', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.087265', 'ticker_sentiment_score': '-0.086479', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.043698', 'ticker_sentiment_score': '-0.029', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WDAY', 'relevance_score': '0.065506', 'ticker_sentiment_score': '0.003043', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IOT', 'relevance_score': '0.108958', 'ticker_sentiment_score': '0.091975', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NTNX', 'relevance_score': '0.043698', 'ticker_sentiment_score': '0.032738', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NIO', 'relevance_score': '0.043698', 'ticker_sentiment_score': '0.070395', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNPS', 'relevance_score': '0.043698', 'ticker_sentiment_score': '0.188661', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ZS', 'relevance_score': '0.087265', 'ticker_sentiment_score': '0.147331', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARGX', 'relevance_score': '0.065506', 'ticker_sentiment_score': '-0.073733', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LI', 'relevance_score': '0.043698', 'ticker_sentiment_score': '0.070395', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AFRM', 'relevance_score': '0.043698', 'ticker_sentiment_score': '-0.017503', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.043698', 'ticker_sentiment_score': '-0.017503', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRVL', 'relevance_score': '0.043698', 'ticker_sentiment_score': '-0.002991', 'ticker_sentiment_label': 'Neutral'}]"
82,1 Underrated Reason to Buy Eli Lilly Stock,https://www.fool.com/investing/2023/12/01/1-underrated-reason-to-buy-eli-lilly-stock/,20231201T144500,['David Jagielski'],Eli Lilly has a well-rounded business that can be a good fit for all types of investors.,https://media.ycharts.com/charts/222a363a44940e5b07e73a2947efb7f9.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.723405'}]",0.327042,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.496741', 'ticker_sentiment_score': '0.468567', 'ticker_sentiment_label': 'Bullish'}]"
83,Eli Lilly and Company  ( LLY )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2192122/eli-lilly-and-company-lly-is-a-trending-stock-facts-to-know-before-betting-on-it,20231201T140010,['Zacks Equity Research'],"Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.",https://staticx-tuner.zacks.com/images/default_article_images/default323.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.239417,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.529767', 'ticker_sentiment_score': '0.154338', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
84,This Biotech Stock Nears A Buy Point After 200% Profit Growth,https://www.investors.com/stock-lists/sector-leaders/this-biotech-stock-nears-a-buy-point-after-profit-growth/,20231130T231300,"['KIMBERLEY KOENIG', ""Investor's Business Daily""]","Biotech Amphastar Pharmaceuticals ( AMPH ) sits in a base after a big earnings move and is poised for a breakout. The IBD Sector Leader gained around 24% since its earnings report in early November. Amphastar Pharmaceuticals develops injectable, inhalation and intranasal medical products.",https://www.investors.com/wp-content/uploads/2023/06/Stock-amphastarpharma-01-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.996675'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.986714'}]",0.316705,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.172713', 'ticker_sentiment_score': '-0.138974', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMPH', 'relevance_score': '0.48724', 'ticker_sentiment_score': '0.31807', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
85,Why Is Incyte  ( INCY )  Down 1.8% Since Last Earnings Report?,https://www.zacks.com/stock/news/2191659/why-is-incyte-incy-down-18-since-last-earnings-report,20231130T163101,['Zacks Equity Research'],Incyte (INCY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,https://staticx-tuner.zacks.com/images/default_article_images/default301.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.976671'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.124792,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.109789', 'ticker_sentiment_score': '0.041379', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INCY', 'relevance_score': '0.450266', 'ticker_sentiment_score': '0.147121', 'ticker_sentiment_label': 'Neutral'}]"
86,Eli Lilly's Weight-Management Drug Outperformed Ozempic. Is It Time to Buy?,https://www.fool.com/investing/2023/11/30/eli-lillys-weight-management-drug-outperformed-oze/,20231130T102600,['Cory Renauer'],"Electronic health records say tirzepatide, the active ingredient in Mounjaro and Zepbound, is better at reducing weight than semaglutide, the active ingredient in Ozempic and Wegovy.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F756222%2Fwall-street-analyst-with-laptop-getty.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.202678,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.271274', 'ticker_sentiment_score': '0.207697', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.069094', 'ticker_sentiment_score': '0.052515', 'ticker_sentiment_label': 'Neutral'}]"
87,Ozempic Receives Some Very Bad News: Is It Time to Sell Novo Nordisk Stock?,https://www.fool.com/investing/2023/11/29/ozempic-bad-news-time-to-sell-novo-nordisk-stock/,20231129T105000,['Keith Speights'],Real-world data showed some real-world advantages for Ozempic's top rival.,https://g.foolcdn.com/editorial/images/756269/ozempic.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.151467,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.254973', 'ticker_sentiment_score': '0.165545', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.430716', 'ticker_sentiment_score': '0.151452', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
88,Eli Lilly's Options: A Look at What the Big Money is Thinking - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/11/35987423/eli-lillys-options-a-look-at-what-the-big-money-is-thinking,20231128T193049,['Benzinga Insights'],"Deep-pocketed investors have adopted a bearish approach towards Eli Lilly LLY, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.036029,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.755086', 'ticker_sentiment_score': '0.122038', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.092569', 'ticker_sentiment_score': '-0.13364', 'ticker_sentiment_label': 'Neutral'}]"
89,3 Large Drug Stocks That Have Outperformed Industry YTD,https://www.zacks.com/stock/news/2190256/3-large-drug-stocks-that-have-outperformed-industry-ytd,20231128T140800,['Kinjel Shah'],"Eli Lilly (LLY), Novo Nordisk (NVO) and Novartis (NVS) have outperformed the industry this year.",https://staticx-tuner.zacks.com/images/articles/main/ab/2180.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '0.875462'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.451494'}]",0.159874,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.351184', 'ticker_sentiment_score': '0.138445', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.224072', 'ticker_sentiment_score': '0.184503', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KDNY', 'relevance_score': '0.045396', 'ticker_sentiment_score': '0.096936', 'ticker_sentiment_label': 'Neutral'}]"
90,3 Top Stocks That'll Make Smart Investors Rich,https://www.fool.com/investing/2023/11/27/3-top-stocks-thatll-make-smart-investors-rich/,20231127T100000,['Adria Cimino'],Long-term investing is one possible path to riches.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F755924%2Fhappy-person-at-laptop-success-winning-fists-up-victory-yes.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Earnings', 'relevance_score': '0.818451'}]",0.332593,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.219312', 'ticker_sentiment_score': '0.229806', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMZN', 'relevance_score': '0.323785', 'ticker_sentiment_score': '0.261844', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
91,"The Zacks Analyst Blog Highlights Eli Lilly, Accenture, TJX, Novo Nordisk and Salesforce",https://www.zacks.com/stock/news/2189455/the-zacks-analyst-blog-highlights-eli-lilly-accenture-tjx-novo-nordisk-and-salesforce,20231127T091300,['Zacks Investment Research'],"Eli Lilly, Accenture, TJX, Novo Nordisk and Salesforce are included in this Analyst Blog.",https://staticx-tuner.zacks.com/images/articles/main/ff/2922.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.275414,Somewhat-Bullish,"[{'ticker': 'CURN', 'relevance_score': '0.068896', 'ticker_sentiment_score': '-0.105477', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TJX', 'relevance_score': '0.33446', 'ticker_sentiment_score': '0.113551', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.137278', 'ticker_sentiment_score': '0.036033', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'G', 'relevance_score': '0.068896', 'ticker_sentiment_score': '-0.105477', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.396052', 'ticker_sentiment_score': '0.12645', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INFY', 'relevance_score': '0.068896', 'ticker_sentiment_score': '-0.105477', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ACN', 'relevance_score': '0.33446', 'ticker_sentiment_score': '0.370877', 'ticker_sentiment_label': 'Bullish'}]"
92,Is Pfizer Stock a Buy Ahead of This Highly Anticipated Weight Loss Readout?,https://www.fool.com/investing/2023/11/26/is-pfizer-stock-a-buy-ahead-of-this-highly-anticip/,20231126T190000,['George Budwell'],An upcoming mid-stage readout may not spark a trend reversal in the big pharma's shares.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F756106%2Ftime-to-buy.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.036021,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.199037', 'ticker_sentiment_score': '-0.016043', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.13347', 'ticker_sentiment_score': '0.041475', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.325637', 'ticker_sentiment_score': '-0.112992', 'ticker_sentiment_label': 'Neutral'}]"
93,3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later,https://www.fool.com/investing/2023/11/26/3-fantastic-dividend-stocks-to-buy-sooner-rather-t/,20231126T115500,"['and Prosper Junior Bakiny', 'Keith Speights', 'David Jagielski']",There's no time like the present to buy these stocks.,https://g.foolcdn.com/editorial/images/755957/retired-woman-investing-laptop-401k-ira.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.995015'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.658903'}]",0.300996,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.393634', 'ticker_sentiment_score': '0.433055', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.393634', 'ticker_sentiment_score': '0.213478', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GILD', 'relevance_score': '0.225321', 'ticker_sentiment_score': '0.13405', 'ticker_sentiment_label': 'Neutral'}]"
94,Five S&P 500 Stocks Near Buy Points,https://www.investors.com/news/sp-500-google-leads-5-stocks-near-buy-points/,20231125T133300,"[""Investor's Business Daily"", 'JED GRAHAM']",S&P 500: Google Leads Five Stocks Near Buy Points Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/01/Stock-googleworkers-01-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.999966'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}]",0.095782,Neutral,"[{'ticker': 'GOOG', 'relevance_score': '0.091393', 'ticker_sentiment_score': '0.091357', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HLT', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.030524', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRWD', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MA', 'relevance_score': '0.12165', 'ticker_sentiment_score': '0.107881', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.127018', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EXPE', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.15173', 'ticker_sentiment_score': '0.076155', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZS', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MAR', 'relevance_score': '0.240489', 'ticker_sentiment_score': '0.058275', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PANW', 'relevance_score': '0.15173', 'ticker_sentiment_score': '0.072302', 'ticker_sentiment_label': 'Neutral'}]"
95,Could Ozempic Harm These 3 Medical Device Stocks?,https://www.fool.com/investing/2023/11/25/could-ozempic-harm-these-3-medical-device-stocks/,20231125T115800,['Alex Carchidi'],The drug is on track to cause massive competitive shifts in the healthcare sector.,https://g.foolcdn.com/editorial/images/755826/investors-discuss-investment-at-table.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.043378,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.102231', 'ticker_sentiment_score': '0.086548', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EW', 'relevance_score': '0.152821', 'ticker_sentiment_score': '0.056489', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.102231', 'ticker_sentiment_score': '-0.044851', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.152821', 'ticker_sentiment_score': '0.034841', 'ticker_sentiment_label': 'Neutral'}]"
96,"Salesforce.com, Pure Storage And The Nasdaq's November Hurdle: Investing Action Plan",https://www.investors.com/research/investing-action-plan/salesforce-com-pure-storage-and-nasdaqs-november-hurdle-investing-action-plan/,20231124T211500,"[""Investor's Business Daily"", 'IBD STAFF']","Salesforce.com, Pure Storage And The Nasdaq's November Hurdle ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2020/11/Stock-TurkeyCarThanksgiving-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.999186'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.1234,Neutral,"[{'ticker': 'C', 'relevance_score': '0.025569', 'ticker_sentiment_score': '0.065952', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CSCO', 'relevance_score': '0.051111', 'ticker_sentiment_score': '0.103421', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DG', 'relevance_score': '0.127321', 'ticker_sentiment_score': '-0.007338', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTU', 'relevance_score': '0.102013', 'ticker_sentiment_score': '0.024686', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FL', 'relevance_score': '0.051111', 'ticker_sentiment_score': '-0.237539', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JPM', 'relevance_score': '0.051111', 'ticker_sentiment_score': '0.061857', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HPQ', 'relevance_score': '0.025569', 'ticker_sentiment_score': '0.057721', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TITN', 'relevance_score': '0.076602', 'ticker_sentiment_score': '0.045899', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NTAP', 'relevance_score': '0.076602', 'ticker_sentiment_score': '0.063061', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PDD', 'relevance_score': '0.076602', 'ticker_sentiment_score': '0.163174', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PSTG', 'relevance_score': '0.102013', 'ticker_sentiment_score': '0.060241', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MA', 'relevance_score': '0.051111', 'ticker_sentiment_score': '-0.024983', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.076602', 'ticker_sentiment_score': '-0.025545', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DELL', 'relevance_score': '0.076602', 'ticker_sentiment_score': '0.045459', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PANW', 'relevance_score': '0.076602', 'ticker_sentiment_score': '-0.025545', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIG', 'relevance_score': '0.076602', 'ticker_sentiment_score': '-0.006192', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.051111', 'ticker_sentiment_score': '-0.024983', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.025569', 'ticker_sentiment_score': '0.207993', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CRWD', 'relevance_score': '0.051111', 'ticker_sentiment_score': '0.105698', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ULTA', 'relevance_score': '0.051111', 'ticker_sentiment_score': '0.101116', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DLTR', 'relevance_score': '0.102013', 'ticker_sentiment_score': '-0.006663', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.025569', 'ticker_sentiment_score': '0.044518', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KR', 'relevance_score': '0.051111', 'ticker_sentiment_score': '0.047945', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.025569', 'ticker_sentiment_score': '-0.005686', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WDAY', 'relevance_score': '0.051111', 'ticker_sentiment_score': '0.003993', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LZB', 'relevance_score': '0.127321', 'ticker_sentiment_score': '0.096582', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNPS', 'relevance_score': '0.051111', 'ticker_sentiment_score': '0.06354', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZS', 'relevance_score': '0.051111', 'ticker_sentiment_score': '0.105698', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPLK', 'relevance_score': '0.102013', 'ticker_sentiment_score': '0.11119', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HPE', 'relevance_score': '0.051111', 'ticker_sentiment_score': '0.06354', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MAR', 'relevance_score': '0.076602', 'ticker_sentiment_score': '-0.025545', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRVL', 'relevance_score': '0.051111', 'ticker_sentiment_score': '0.058563', 'ticker_sentiment_label': 'Neutral'}]"
97,"Top Stock Reports for Eli Lilly, Accenture & The TJX Companies",https://www.zacks.com/research-daily/2188872/top-stock-reports-for-eli-lilly-accenture-the-tjx-companies,20231124T174700,['Sheraz Mian'],"Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Accenture plc (ACN) and The TJX Companies, Inc. (TJX).",https://staticx-tuner.zacks.com/images/default_article_images/default200.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.335543,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.277958', 'ticker_sentiment_score': '0.140756', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CURN', 'relevance_score': '0.09439', 'ticker_sentiment_score': '-0.11299', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INFY', 'relevance_score': '0.09439', 'ticker_sentiment_score': '-0.11299', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TJX', 'relevance_score': '0.277958', 'ticker_sentiment_score': '0.282967', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ACN', 'relevance_score': '0.187463', 'ticker_sentiment_score': '0.458965', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'G', 'relevance_score': '0.09439', 'ticker_sentiment_score': '-0.11299', 'ticker_sentiment_label': 'Neutral'}]"
98,Will Eli Lilly Be Worth More Than Tesla by 2027?,https://www.fool.com/investing/2023/11/23/will-eli-lilly-be-worth-more-than-tesla-by-2027/,20231123T140500,['Alex Carchidi'],It's a lot more likely than it sounds.,https://g.foolcdn.com/editorial/images/755823/woman-stock-broker-investor-tracking-stocks.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.990786'}]",0.292276,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.413049', 'ticker_sentiment_score': '0.371741', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.282777', 'ticker_sentiment_score': '0.316733', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
99,Eli Lilly  ( LLY )  Stock Outperforms Industry YTD: Here's Why,https://www.zacks.com/stock/news/2188291/eli-lilly-lly-stock-outperforms-industry-ytd-heres-why,20231123T131600,['Zacks Equity Research'],"Lilly (LLY) is making rapid pipeline progress in areas like obesity, diabetes and Alzheimer's. Mounjaro and Zepbound are expected to be key top-line drivers for Lilly.",https://staticx-tuner.zacks.com/images/articles/main/ff/2922.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.99237'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}]",0.200803,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.547615', 'ticker_sentiment_score': '0.27041', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DVAX', 'relevance_score': '0.227432', 'ticker_sentiment_score': '0.150556', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HARP', 'relevance_score': '0.271274', 'ticker_sentiment_score': '0.113804', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.182851', 'ticker_sentiment_score': '0.04394', 'ticker_sentiment_label': 'Neutral'}]"
100,"The Best Stocks to Invest $5,000 in Right Now",https://www.fool.com/investing/2023/11/22/the-best-stocks-to-invest-5000-in-right-now/,20231122T130000,['Joe Tenebruso'],Here's how to safeguard your money and grow richer.,https://g.foolcdn.com/editorial/images/755596/investor-gettyimages-1150017950.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.31959,Somewhat-Bullish,"[{'ticker': 'GS', 'relevance_score': '0.070935', 'ticker_sentiment_score': '-0.053085', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.14131', 'ticker_sentiment_score': '0.01183', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.343755', 'ticker_sentiment_score': '0.380224', 'ticker_sentiment_label': 'Bullish'}]"
101,ABBV vs. LLY: Which Stock Should Value Investors Buy Now?,https://www.zacks.com/stock/news/2187390/abbv-vs-lly-which-stock-should-value-investors-buy-now,20231121T164006,['Zacks Equity Research'],ABBV vs. LLY: Which Stock Is the Better Value Option?,https://staticx-tuner.zacks.com/images/default_article_images/default172.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.48939,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.69701', 'ticker_sentiment_score': '0.58128', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.802099', 'ticker_sentiment_score': '0.607342', 'ticker_sentiment_label': 'Bullish'}]"
102,Should Invesco Large Cap Growth ETF  ( PWB )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2187018/should-invesco-large-cap-growth-etf-pwb-be-on-your-investing-radar,20231121T112007,['Zacks Equity Research'],Style Box ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default333.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.999999'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.289113,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.121343', 'ticker_sentiment_score': '0.061251', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.121343', 'ticker_sentiment_score': '0.061251', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.121343', 'ticker_sentiment_score': '0.061251', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.297301', 'ticker_sentiment_score': '0.269385', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
103,Ignore Eli Lilly. These 2 Stocks Are Better Buys Right Now,https://www.fool.com/investing/2023/11/21/ignore-eli-lilly-these-2-stocks-are-better-buys/,20231121T103000,['Adria Cimino'],Investors have favored an exciting billion-dollar opportunity at Eli Lilly.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F755638%2Fgettyimages-1320686310.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.999822'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.245009,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.3796', 'ticker_sentiment_score': '0.458528', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.428632', 'ticker_sentiment_score': '0.15879', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.47574', 'ticker_sentiment_score': '0.237818', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
104,Investors Heavily Search Eli Lilly and Company  ( LLY ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2186534/investors-heavily-search-eli-lilly-and-company-lly-here-is-what-you-need-to-know,20231120T140011,['Zacks Equity Research'],"Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default340.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}]",0.223965,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.528798', 'ticker_sentiment_score': '0.14785', 'ticker_sentiment_label': 'Neutral'}]"
105,A Look Into Eli Lilly Inc's Price Over Earnings - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/news/23/11/35872137/a-look-into-eli-lilly-incs-price-over-earnings,20231120T134517,['Benzinga Insights'],"In the current session, the stock is trading at $593.00, after a 0.22% increase. Over the past month, Eli Lilly Inc. LLY stock increased by 0.10%, and in the past year, by 64.32%.",https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}]",0.221002,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.443626', 'ticker_sentiment_score': '0.240819', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
106,Eli Lilly Just Got One Step Closer to Dethroning Ozempic. Time to Buy the Stock?,https://www.fool.com/investing/2023/11/19/eli-lilly-just-got-one-step-closer-to-dethroning-o/,20231119T110500,['Adam Spatacco'],"Eli Lilly just received FDA approval for its obesity medication Zepbound, the sister treatment to its blockbuster drug Mounjaro.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F755134%2Fa-doctor-writing-a-prescription.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.210864,Somewhat-Bullish,"[{'ticker': 'BCS', 'relevance_score': '0.033328', 'ticker_sentiment_score': '0.130891', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.033328', 'ticker_sentiment_score': '0.105236', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.033328', 'ticker_sentiment_score': '0.130891', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.132733', 'ticker_sentiment_score': '0.064572', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.522486', 'ticker_sentiment_score': '0.289301', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.033328', 'ticker_sentiment_score': '0.105236', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.033328', 'ticker_sentiment_score': '0.105236', 'ticker_sentiment_label': 'Neutral'}]"
107,Goldman Sachs expects below-average returns for the next 2 years. It shares 3 strategies to beat the market and 23 stock picks across them.,https://www.businessinsider.com/goldman-sachs-2024-top-stocks-to-buy-beat-market-2023-11,20231118T093300,['Laila Maidan'],Goldman Sachs: Buy These 23 Stocks to Beat the Market in 2024 - Business Insider ...,https://i.insider.com/6557d41336d588dc55d2b002?width=1200&format=jpeg,Business Insider,GoogleRSS,www.businessinsider.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.209774,Somewhat-Bullish,"[{'ticker': 'ALK', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.080374', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ENPH', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.176304', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MPC', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.113417', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.176304', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TTC', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.080374', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SHW', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.113417', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CROX', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.080374', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMT', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.113417', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EQT', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.176304', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ICE', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.113417', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.060388', 'ticker_sentiment_score': '-0.026199', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DAL', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.080374', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ELV', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.113417', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROL', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.113417', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TFC', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.113417', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWK', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.113417', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ORLY', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.113417', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALB', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.176304', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NOW', 'relevance_score': '0.060388', 'ticker_sentiment_score': '0.155022', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.176304', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JBT', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.080374', 'ticker_sentiment_label': 'Neutral'}]"
108,Eli Lilly Options Trading: A Deep Dive into Market Sentiment - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/11/35852293/eli-lilly-options-trading-a-deep-dive-into-market-sentiment,20231117T164552,['Benzinga Insights'],"Whales with a lot of money to spend have taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 16 trades. If we consider the specifics of each trade, it is accurate to state that 43% of the investors opened trades with bullish expectations and ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.045373,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.718485', 'ticker_sentiment_score': '-0.081152', 'ticker_sentiment_label': 'Neutral'}]"
109,Pharma Stock Roundup: FDA Okays AZN's Capivasertib & MRK's Keytruda Expanded Use,https://www.zacks.com/stock/news/2185842/pharma-stock-roundup-fda-okays-azns-capivasertib-mrks-keytruda-expanded-use,20231117T131400,['Kinjel Shah'],"FDA approves AstraZeneca's (AZN) new breast cancer drug, Truqap, and the expanded use of Merck's (MRK) Keytruda in a gastric cancer indication ...",https://staticx-tuner.zacks.com/images/articles/main/cf/2377.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.036697,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.113597', 'ticker_sentiment_score': '0.002274', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.113597', 'ticker_sentiment_score': '-0.068544', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.224903', 'ticker_sentiment_score': '-0.061435', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.113597', 'ticker_sentiment_score': '0.002274', 'ticker_sentiment_label': 'Neutral'}]"
110,"13F Rundown: Tepper, Buffett, Druckenmiller",https://www.zacks.com/commentary/2185646/13f-rundown-tepper-buffett-druckenmiller,20231117T130000,['Andrew Rocco'],Stock Strategist Andrew Rocco divulges valuable insights from the world's best and brightest investors.,https://staticx-tuner.zacks.com/images/articles/main/1d/26991.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.918141'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}]",0.234041,Somewhat-Bullish,"[{'ticker': 'BABA', 'relevance_score': '0.146025', 'ticker_sentiment_score': '0.196542', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.2872', 'ticker_sentiment_score': '0.208936', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.146025', 'ticker_sentiment_score': '0.196542', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.354572', 'ticker_sentiment_score': '0.244913', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.146025', 'ticker_sentiment_score': '0.206432', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.146025', 'ticker_sentiment_score': '-0.052481', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.146025', 'ticker_sentiment_score': '0.206432', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.146025', 'ticker_sentiment_score': '0.206432', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.146025', 'ticker_sentiment_score': '0.074495', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CPNG', 'relevance_score': '0.146025', 'ticker_sentiment_score': '0.074495', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.146025', 'ticker_sentiment_score': '0.196542', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TCKRF', 'relevance_score': '0.073321', 'ticker_sentiment_score': '0.058869', 'ticker_sentiment_label': 'Neutral'}]"
111,"10 'better values' in the stock market, selected for the next two years",https://www.marketwatch.com/story/10-better-values-in-the-stock-market-selected-for-the-next-two-years-5b9bc809,20231116T174900,['Philip van Doorn'],"William Blair's list of favored stocks for the next 24 months includes Five Below, Chewy and Allstate.",https://images.mktw.net/im-33766063/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'IPO', 'relevance_score': '0.451494'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.99992'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.219504,Somewhat-Bullish,"[{'ticker': 'DT', 'relevance_score': '0.096932', 'ticker_sentiment_score': '0.076614', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.06471', 'ticker_sentiment_score': '0.001002', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.06471', 'ticker_sentiment_score': '0.001002', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FIVE', 'relevance_score': '0.06471', 'ticker_sentiment_score': '0.405966', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'HOLX', 'relevance_score': '0.06471', 'ticker_sentiment_score': '0.090227', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FI', 'relevance_score': '0.06471', 'ticker_sentiment_score': '0.127165', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PNT', 'relevance_score': '0.06471', 'ticker_sentiment_score': '0.005044', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CHWY', 'relevance_score': '0.096932', 'ticker_sentiment_score': '0.047679', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.06471', 'ticker_sentiment_score': '0.005044', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FUSN', 'relevance_score': '0.096932', 'ticker_sentiment_score': '0.02274', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOVT', 'relevance_score': '0.06471', 'ticker_sentiment_score': '0.024203', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALGN', 'relevance_score': '0.06471', 'ticker_sentiment_score': '0.276794', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
112,Better Growth Stock: Novo Nordisk vs. Eli Lilly,https://www.fool.com/investing/2023/11/16/better-growth-stock-novo-nordisk-vs-eli-lilly/,20231116T140000,['Prosper Junior Bakiny'],These companies have been attracting plenty of attention lately.,https://media.ycharts.com/charts/d9d350c38d32aecb1b4fde9093a7d584.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.684621'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}]",0.337772,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.302553', 'ticker_sentiment_score': '0.331175', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.302553', 'ticker_sentiment_score': '0.137641', 'ticker_sentiment_label': 'Neutral'}]"
113,"If You Invested $10,000 in Eli Lilly in 2013, This Is How Much You Would Have Today",https://www.fool.com/investing/2023/11/16/if-you-invested-10000-in-eli-lilly-in-2013-this-is/,20231116T115000,['David Jagielski'],Is it too late to invest in Eli Lilly's stock?,https://media.ycharts.com/charts/720f3a8e125c4a8e83a87ee57ad11aea.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.779048'}]",0.289943,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.506832', 'ticker_sentiment_score': '0.433512', 'ticker_sentiment_label': 'Bullish'}]"
114,Is First Trust Capital Strength ETF  ( FTCS )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2184361/is-first-trust-capital-strength-etf-ftcs-a-strong-etf-right-now,20231115T112005,['Zacks Equity Research'],Smart Beta ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default201.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999953'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.319017,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.052174', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CSCO', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.052174', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TJX', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.052174', 'ticker_sentiment_label': 'Neutral'}]"
115,"Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, J&J and AbbVie",https://www.zacks.com/stock/news/2183791/zacks-industry-outlook-highlights-eli-lilly-novo-nordisk-jj-and-abbvie,20231114T124200,['Zacks Equity Research'],"Eli Lilly, Novo Nordisk, J&J and AbbVie are part of the Zacks Industry Outlook article.",https://staticx-tuner.zacks.com/images/articles/main/ff/2922.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.996023'}, {'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.890401'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.17517,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.023556', 'ticker_sentiment_score': '-0.021479', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.140621', 'ticker_sentiment_score': '0.116722', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.047092', 'ticker_sentiment_score': '0.030471', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KVUE', 'relevance_score': '0.047092', 'ticker_sentiment_score': '0.060093', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.16375', 'ticker_sentiment_score': '0.056556', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.16375', 'ticker_sentiment_score': '0.136116', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SGEN', 'relevance_score': '0.023556', 'ticker_sentiment_score': '0.11584', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.023556', 'ticker_sentiment_score': '0.11584', 'ticker_sentiment_label': 'Neutral'}]"
116,Stock Market Indexes Stumble As Moody's Cuts U.S. Rating; Boeing Soars On Deal News,https://www.investors.com/market-trend/stock-market-today/stock-market-indexes-stumble-as-moodys-cuts-us-rating/,20231113T155300,"[""Investor's Business Daily"", 'RUSS BRITT']",Stock Market Indexes Stumble As Moody's Cuts U.S. Rating. Boeing ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2019/06/stock-boeing-777x-02-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.986564'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.976913'}]",0.038317,Neutral,"[{'ticker': 'CPRT', 'relevance_score': '0.093836', 'ticker_sentiment_score': '0.158305', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.093836', 'ticker_sentiment_score': '0.102489', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSEM', 'relevance_score': '0.093836', 'ticker_sentiment_score': '-0.230537', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NVDA', 'relevance_score': '0.093836', 'ticker_sentiment_score': '0.084639', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.093836', 'ticker_sentiment_score': '0.040664', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.093836', 'ticker_sentiment_score': '0.057395', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.093836', 'ticker_sentiment_score': '0.040664', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCO', 'relevance_score': '0.140348', 'ticker_sentiment_score': '-0.101647', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAMT', 'relevance_score': '0.093836', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.140348', 'ticker_sentiment_score': '0.047442', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.231773', 'ticker_sentiment_score': '0.007149', 'ticker_sentiment_label': 'Neutral'}]"
117,4 Large Drug Stocks Likely to Sail Through Industry Woes,https://www.zacks.com/commentary/2183148/4-large-drug-stocks-likely-to-sail-through-industry-woes,20231113T150300,['Kinjel Shah'],"Drug, biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), J&J (JNJ) and AbbVie (ABBV) are worth retaining in your portfolio.",https://staticx-tuner.zacks.com/images/articles/main/b2/19786.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}, {'topic': 'Earnings', 'relevance_score': '0.986564'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.890401'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.179759,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.024546', 'ticker_sentiment_score': '0.067704', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.097954', 'ticker_sentiment_score': '0.099631', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.04907', 'ticker_sentiment_score': '0.092705', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KVUE', 'relevance_score': '0.04907', 'ticker_sentiment_score': '0.102773', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.146469', 'ticker_sentiment_score': '0.118959', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.122269', 'ticker_sentiment_score': '0.108175', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SGEN', 'relevance_score': '0.024546', 'ticker_sentiment_score': '0.067704', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.024546', 'ticker_sentiment_score': '0.067704', 'ticker_sentiment_label': 'Neutral'}]"
118,Eli Lilly Unusual Options Activity - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/11/35751599/eli-lilly-unusual-options-activity,20231113T150130,['Benzinga Insights'],"Deep-pocketed investors have adopted a bearish approach towards Eli Lilly LLY, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.114342,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.76367', 'ticker_sentiment_score': '0.095214', 'ticker_sentiment_label': 'Neutral'}]"
119,POINT Biopharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights,https://www.globenewswire.com/news-release/2023/11/13/2778941/0/en/POINT-Biopharma-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Business-Highlights.html,20231113T123000,['POINT Biopharma'],Announced a definitive agreement to be acquired by Lilly for a purchase price of $12.50 per share in cash ( an aggregate of approximately $1.4 billion ). transaction expected to close near the end of 2023 Announced a definitive agreement to be acquired by Lilly for a purchase price of $12.50 per ...,https://ml.globenewswire.com/Resource/Download/8b9200ff-b90a-4f3d-965f-7f0a8729aa2b,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.992549'}, {'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.9973'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.5'}]",0.134391,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.218226', 'ticker_sentiment_score': '0.231825', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PNT', 'relevance_score': '0.132004', 'ticker_sentiment_score': '0.076126', 'ticker_sentiment_label': 'Neutral'}]"
120,Better Buy Now: Novo Nordisk vs. Eli Lilly,https://www.fool.com/investing/2023/11/13/better-buy-now-novo-nordisk-vs-eli-lilly/,20231113T111700,['Cory Renauer'],"Both of these companies are reporting positive news for their competing weight-loss drugs, but which is the better stock to buy now?",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F754828%2Finvestors-evaluating-a-stock-purchase-getty.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.18026,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.26928', 'ticker_sentiment_score': '0.145472', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.22574', 'ticker_sentiment_score': '0.2449', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.045743', 'ticker_sentiment_score': '0.029926', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.045743', 'ticker_sentiment_score': '0.029926', 'ticker_sentiment_label': 'Neutral'}]"
121,"'Market's Had A Very Solid Winning Streak Of Late': Jim Cramer Eyes Key Retailers And CPI Data In Critical Earnings Week Ahead - Target  ( NYSE:TGT ) , Monday.Com  ( NASDAQ:MNDY ) , Novo Nordisk  ( NYSE:NVO ) , ServiceNow  ( NYSE:NOW ) ",https://www.benzinga.com/news/earnings/23/11/35738440/markets-had-a-very-solid-winning-streak-of-late-jim-cramer-eyes-key-retailers-and-cpi-data-in-criti,20231111T191808,['Nabaparna Bhattacharya'],"CNBC market analyst Jim Cramer emphasized the importance of the upcoming week for investors, spotlighting significant data and earnings reports due on Wall Street.",https://cdn.benzinga.com/files/images/story/2023/11/11/shutterstock_730916710.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.905476'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.321595,Somewhat-Bullish,"[{'ticker': 'TGT', 'relevance_score': '0.33628', 'ticker_sentiment_score': '-0.193667', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NVO', 'relevance_score': '0.228073', 'ticker_sentiment_score': '0.288575', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NOW', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.228073', 'ticker_sentiment_score': '0.288575', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ACN', 'relevance_score': '0.228073', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HD', 'relevance_score': '0.228073', 'ticker_sentiment_score': '0.087309', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'M', 'relevance_score': '0.228073', 'ticker_sentiment_score': '-0.142726', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.33628', 'ticker_sentiment_score': '-0.193667', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
122,Cautious Investor? 2 Safe Stocks You Also Can Count on For Growth,https://www.fool.com/investing/2023/11/11/cautious-investor-2-safe-stocks-you-also-can-count/,20231111T100000,['Adria Cimino'],These stocks offer the best of both worlds.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F754495%2Fgettyimages-1253877215.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Earnings', 'relevance_score': '0.98396'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.44085,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.2842', 'ticker_sentiment_score': '0.355549', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'DICE', 'relevance_score': '0.058047', 'ticker_sentiment_score': '-0.059248', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.115787', 'ticker_sentiment_score': '0.207342', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
123,Here's how Eli Lilly might bring a game-changing Alzheimer's drug to market,https://www.marketwatch.com/story/heres-how-eli-lilly-might-bring-a-game-changing-alzheimers-drug-to-market-6895dbc5,20231110T172100,['Philip van Doorn'],"Also: Bad and good results this earnings season, new tax rules, stock picks and how you too can be a mortgage lender.",https://images.mktw.net/im-885116?width=700&height=634,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.967321'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.016892,Neutral,"[{'ticker': 'GOOG', 'relevance_score': '0.029436', 'ticker_sentiment_score': '0.146671', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.058831', 'ticker_sentiment_score': '0.156001', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.058831', 'ticker_sentiment_score': '0.156001', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.058831', 'ticker_sentiment_score': '0.156001', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'C', 'relevance_score': '0.029436', 'ticker_sentiment_score': '-0.049921', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.058831', 'ticker_sentiment_score': '0.051005', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GRPN', 'relevance_score': '0.029436', 'ticker_sentiment_score': '-0.069702', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UA', 'relevance_score': '0.029436', 'ticker_sentiment_score': '-0.069702', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.058831', 'ticker_sentiment_score': '0.156001', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.058831', 'ticker_sentiment_score': '0.156001', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'T', 'relevance_score': '0.029436', 'ticker_sentiment_score': '0.052464', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'U', 'relevance_score': '0.029436', 'ticker_sentiment_score': '-0.069702', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.029436', 'ticker_sentiment_score': '0.035336', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.058831', 'ticker_sentiment_score': '0.051005', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARM', 'relevance_score': '0.058831', 'ticker_sentiment_score': '0.017097', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RDFN', 'relevance_score': '0.029436', 'ticker_sentiment_score': '-0.014175', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.058831', 'ticker_sentiment_score': '0.056382', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.029436', 'ticker_sentiment_score': '-0.049921', 'ticker_sentiment_label': 'Neutral'}]"
124,"Who's afraid of Ozempic? From restaurants to package makers, companies work to calm investors' GLP-1 jitters.",https://www.marketwatch.com/story/whos-afraid-of-ozempic-from-restaurants-to-package-makers-companies-work-to-calm-investors-glp-1-jitters-0599dba5,20231110T161300,['Eleanor Laise'],"With Eli Lilly's Zepbound set to enter the fray, companies are flooded with weight-loss drug questions ...",https://images.mktw.net/im-884373/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.990678'}]",0.0,Neutral,"[{'ticker': 'MDLZ', 'relevance_score': '0.077677', 'ticker_sentiment_score': '0.002046', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.05183', 'ticker_sentiment_score': '0.024949', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TFX', 'relevance_score': '0.05183', 'ticker_sentiment_score': '-0.113802', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CCK', 'relevance_score': '0.05183', 'ticker_sentiment_score': '-0.025973', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DASH', 'relevance_score': '0.05183', 'ticker_sentiment_score': '-0.03176', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FMS', 'relevance_score': '0.05183', 'ticker_sentiment_score': '0.071582', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HSY', 'relevance_score': '0.05183', 'ticker_sentiment_score': '0.056973', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BUD', 'relevance_score': '0.05183', 'ticker_sentiment_score': '-0.046958', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.077677', 'ticker_sentiment_score': '0.07861', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FSNUF', 'relevance_score': '0.025929', 'ticker_sentiment_score': '0.065219', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.077677', 'ticker_sentiment_score': '0.025463', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KDP', 'relevance_score': '0.05183', 'ticker_sentiment_score': '-0.010993', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.05183', 'ticker_sentiment_score': '0.024949', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DRI', 'relevance_score': '0.05183', 'ticker_sentiment_score': '0.162516', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PEP', 'relevance_score': '0.05183', 'ticker_sentiment_score': '-0.054643', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMG', 'relevance_score': '0.05183', 'ticker_sentiment_score': '0.119502', 'ticker_sentiment_label': 'Neutral'}]"
125,Where Will Eli Lilly Be in 5 Years?,https://www.fool.com/investing/2023/11/10/where-will-eli-lilly-be-in-5-years/,20231110T152300,['Alex Carchidi'],"If management has its way, Eli Lilly's earnings and share price will be way up.",https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.183459,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.320279', 'ticker_sentiment_score': '0.242431', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.054857', 'ticker_sentiment_score': '0.140999', 'ticker_sentiment_label': 'Neutral'}]"
126,Market Rally Pauses As Yields Rebound: Weekly Review,https://www.investors.com/news/stock-market-rally-pauses-as-yields-rebound-datadog-affirm-among-earnings-winners-weekly-review/,20231110T120000,"[""Investor's Business Daily"", 'IBD STAFF']","The stock market rally saw the Dow Jones, S&P 500 and Nasdaq snap long win streaks, slashing or erasing weekly gains. The Russell 2000 tumbled amid weak breadth. Earnings generally remained positive.",https://www.investors.com/wp-content/uploads/2017/01/INCOME_yield_013017_shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.997405'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",-0.017348,Neutral,"[{'ticker': 'APP', 'relevance_score': '0.046724', 'ticker_sentiment_score': '0.091746', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CELH', 'relevance_score': '0.046724', 'ticker_sentiment_score': '0.114644', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FLYW', 'relevance_score': '0.070036', 'ticker_sentiment_score': '-0.032924', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TTD', 'relevance_score': '0.046724', 'ticker_sentiment_score': '-0.070037', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.070036', 'ticker_sentiment_score': '0.075537', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DDOG', 'relevance_score': '0.162489', 'ticker_sentiment_score': '-0.016092', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOUR', 'relevance_score': '0.070036', 'ticker_sentiment_score': '-0.032924', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXON', 'relevance_score': '0.046724', 'ticker_sentiment_score': '-0.161943', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'FN', 'relevance_score': '0.046724', 'ticker_sentiment_score': '0.060043', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DUOL', 'relevance_score': '0.093289', 'ticker_sentiment_score': '0.005589', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BNTX', 'relevance_score': '0.093289', 'ticker_sentiment_score': '0.006543', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DT', 'relevance_score': '0.046724', 'ticker_sentiment_score': '0.018995', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OXY', 'relevance_score': '0.070036', 'ticker_sentiment_score': '-0.170289', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSLA', 'relevance_score': '0.070036', 'ticker_sentiment_score': '-0.077475', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FANG', 'relevance_score': '0.070036', 'ticker_sentiment_score': '-0.170289', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'GFS', 'relevance_score': '0.046724', 'ticker_sentiment_score': '0.013948', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TDG', 'relevance_score': '0.093289', 'ticker_sentiment_score': '0.02077', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.116461', 'ticker_sentiment_score': '0.016621', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AOSL', 'relevance_score': '0.046724', 'ticker_sentiment_score': '0.013948', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MTSI', 'relevance_score': '0.046724', 'ticker_sentiment_score': '0.013948', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.093289', 'ticker_sentiment_score': '0.042954', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNOW', 'relevance_score': '0.046724', 'ticker_sentiment_score': '0.018995', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.046724', 'ticker_sentiment_score': '-0.127835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NXPI', 'relevance_score': '0.046724', 'ticker_sentiment_score': '0.013948', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.070036', 'ticker_sentiment_score': '0.006148', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSY', 'relevance_score': '0.046724', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LCID', 'relevance_score': '0.046724', 'ticker_sentiment_score': '-0.127835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'POWI', 'relevance_score': '0.046724', 'ticker_sentiment_score': '0.013948', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DIOD', 'relevance_score': '0.046724', 'ticker_sentiment_score': '0.013948', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.046724', 'ticker_sentiment_score': '0.114644', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.046724', 'ticker_sentiment_score': '0.006', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARM', 'relevance_score': '0.046724', 'ticker_sentiment_score': '0.013948', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LI', 'relevance_score': '0.046724', 'ticker_sentiment_score': '0.073194', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AFRM', 'relevance_score': '0.116461', 'ticker_sentiment_score': '-0.038586', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.046724', 'ticker_sentiment_score': '-0.127835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.070036', 'ticker_sentiment_score': '0.006148', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.070036', 'ticker_sentiment_score': '-0.085312', 'ticker_sentiment_label': 'Neutral'}]"
127,The Stock-Split Stock Behind Ozempic and Wegovy Could Be Yours for Just $100,https://www.fool.com/investing/2023/11/10/the-stock-split-stock-behind-ozempic-and-wegovy-co/,20231110T115400,['Adam Spatacco'],Novo Nordisk just reported financial and operating results through the first nine months of the year. One thing is clear: Demand is not an issue.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F753587%2Fa-doctor-writing-a-prescription.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999997'}]",0.247377,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.135921', 'ticker_sentiment_score': '0.09358', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.068209', 'ticker_sentiment_score': '0.076597', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.50649', 'ticker_sentiment_score': '0.335147', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.068209', 'ticker_sentiment_score': '0.076597', 'ticker_sentiment_label': 'Neutral'}]"
128,Eli Lilly Was Hoping for 5 Big Drug Launches This Year. Here's How It Has Done Thus Far.,https://www.fool.com/investing/2023/11/10/eli-lilly-was-hoping-for-5-big-drug-launches-this/,20231110T104000,['David Jagielski'],Is the company on track to meet its targets for the year?,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.332652,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.558244', 'ticker_sentiment_score': '0.510774', 'ticker_sentiment_label': 'Bullish'}]"
129,Beam Therapeutics  ( BEAM )  Q3 Earnings & Revenues Beat Estimates,https://www.zacks.com/stock/news/2181878/beam-therapeutics-beam-q3-earnings-revenues-beat-estimates,20231109T180400,['Zacks Equity Research'],"Beam Therapeutics' (BEAM) third-quarter 2023 earnings and revenues surpass expectations. The company focuses on developing genome-editing candidate, BEAM-101.",https://staticx-tuner.zacks.com/images/articles/main/86/1981.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.986413'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.098887,Neutral,"[{'ticker': 'BEAM', 'relevance_score': '0.719257', 'ticker_sentiment_score': '0.065189', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.263942', 'ticker_sentiment_score': '0.155939', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DVAX', 'relevance_score': '0.314151', 'ticker_sentiment_score': '0.171554', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LGND', 'relevance_score': '0.314151', 'ticker_sentiment_score': '0.17605', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VERV', 'relevance_score': '0.053749', 'ticker_sentiment_score': '0.137734', 'ticker_sentiment_label': 'Neutral'}]"
130,Why Eli Lilly Stock Is Slumping Today,https://www.fool.com/investing/2023/11/09/why-eli-lilly-stock-is-slumping-today/,20231109T160816,['Keith Speights'],Good news for Lilly is somehow translating to bad news for its share price.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.154953,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.769861', 'ticker_sentiment_score': '0.21387', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
131,The $2 Billion Bet AstraZeneca Is Making In Weight Loss,https://www.investors.com/news/technology/azn-stock-astrazeneca-earnings-q3-2023/,20231109T152800,"[""Investor's Business Daily"", 'ALLISON GATLIN']",AZN Stock Jumps On $2 Billion Bet In Weight-Loss Drugs Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2020/12/Stock-AstraZeneca-03-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.983783'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}]",0.097418,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.18046', 'ticker_sentiment_score': '0.238014', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AZN', 'relevance_score': '0.828945', 'ticker_sentiment_score': '0.133769', 'ticker_sentiment_label': 'Neutral'}]"
132,3 Healthcare Stocks That Have More Than Doubled in Value Since the Fed Started Raising Interest Rates,https://www.fool.com/investing/2023/11/09/3-healthcare-stocks-that-have-more-than-doubled/,20231109T152300,['David Jagielski'],Can these promising growth stocks continue rising in value?,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.995973'}]",0.358261,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.395012', 'ticker_sentiment_score': '0.468633', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'TMDX', 'relevance_score': '0.395012', 'ticker_sentiment_score': '0.340277', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AXSM', 'relevance_score': '0.175433', 'ticker_sentiment_score': '0.140973', 'ticker_sentiment_label': 'Neutral'}]"
133,"Zacks Earnings Trends Highlights: Pfizer, Eli Lilly, General Motors and Tesla",https://www.zacks.com/stock/news/2181525/zacks-earnings-trends-highlights-pfizer-eli-lilly-general-motors-and-tesla,20231109T135000,['Zacks Investment Research'],"Pfizer, Eli Lilly, General Motors and Tesla have been highlighted in this Earnings Trends article.",https://staticx-tuner.zacks.com/images/articles/main/38/20242.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.999999'}]",0.043493,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.188193', 'ticker_sentiment_score': '-0.028304', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.188193', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.188193', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.188193', 'ticker_sentiment_score': '-0.028304', 'ticker_sentiment_label': 'Neutral'}]"
134,2 Growth Stocks That Already Jumped 50% in November and Could Keep Climbing Higher,https://www.fool.com/investing/2023/11/09/2-growth-stocks-that-jumped-up-more-than-50-last-w/,20231109T105700,['Cory Renauer'],Recent gains could be the start of a longer bull run.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F754292%2Fcouple-at-home-with-device-getty.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.839681'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.279639,Somewhat-Bullish,"[{'ticker': 'BEAM', 'relevance_score': '0.052112', 'ticker_sentiment_score': '0.08358', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.206245', 'ticker_sentiment_score': '0.050014', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TMDX', 'relevance_score': '0.527831', 'ticker_sentiment_score': '0.428868', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'VERV', 'relevance_score': '0.398939', 'ticker_sentiment_score': '0.360258', 'ticker_sentiment_label': 'Bullish'}]"
135,Earnings Estimates Come Under Pressure,https://www.zacks.com/commentary/2181217/earnings-estimates-come-under-pressure,20231108T232200,['Sheraz Mian'],"While Q3 results have been better than expected, there is a notable acceleration in negative estimate revisions over the last few weeks, contrasting the largely favorable revisions trend of the preceding six months.",https://staticx-tuner.zacks.com/images/articles/main/3b/649.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.026631,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.195287', 'ticker_sentiment_score': '-0.029102', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.195287', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.195287', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.195287', 'ticker_sentiment_score': '-0.029102', 'ticker_sentiment_label': 'Neutral'}]"
136,Earnings Estimates Come Under Pressure,https://www.zacks.com/commentary/2181196/earnings-estimates-come-under-pressure,20231108T232000,['Sheraz Mian'],"While Q3 results have been better than expected, there is a notable acceleration in negative estimate revisions over the last few weeks, contrasting the largely favorable revisions trend of the preceding six months.",https://staticx-tuner.zacks.com/images/articles/main/37/20536.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.026631,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.195287', 'ticker_sentiment_score': '-0.029102', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.195287', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.195287', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.195287', 'ticker_sentiment_score': '-0.029102', 'ticker_sentiment_label': 'Neutral'}]"
137,Nektar Therapeutics  ( NKTR )  Incurs Wider-Than-Expected Q3 Loss,https://www.zacks.com/stock/news/2181024/nektar-therapeutics-nktr-incurs-wider-than-expected-q3-loss,20231108T164700,['Zacks Equity Research'],Nektar (NKTR) misses third-quarter estimates for the bottom line but beats the same for the top line.,https://staticx-tuner.zacks.com/images/articles/main/f5/284.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.96136'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.033098,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.155451', 'ticker_sentiment_score': '-0.014417', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DVAX', 'relevance_score': '0.305058', 'ticker_sentiment_score': '0.167698', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MEIP', 'relevance_score': '0.256179', 'ticker_sentiment_score': '0.150065', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NKTR', 'relevance_score': '0.486627', 'ticker_sentiment_score': '-0.141876', 'ticker_sentiment_label': 'Neutral'}]"
138,Pharma ETFs in Focus Post Q3 Earnings,https://www.zacks.com/stock/news/2180987/pharma-etfs-in-focus-post-q3-earnings,20231108T161000,['Sweta Killa'],"Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.",https://staticx-tuner.zacks.com/images/articles/main/6e/37920.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999989'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.095657,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.150357', 'ticker_sentiment_score': '0.047923', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SKXJF', 'relevance_score': '0.075516', 'ticker_sentiment_score': '0.072219', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSKYF', 'relevance_score': '0.075516', 'ticker_sentiment_score': '0.072219', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.113062', 'ticker_sentiment_score': '0.048088', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.075516', 'ticker_sentiment_score': '-0.043588', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.150357', 'ticker_sentiment_score': '0.070615', 'ticker_sentiment_label': 'Neutral'}]"
139,Eli Lilly Slashed Its Earnings Guidance and Its Stock Went Up 5% Anyway. What's Next?,https://www.fool.com/investing/2023/11/08/eli-lilly-slashed-its-earnings-guidance-and-its-st/,20231108T132000,['Alex Carchidi'],Aggressive investments in growth have left the pharma giant with smaller profits this year.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.99246'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.255444,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.236972', 'ticker_sentiment_score': '0.248432', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.060085', 'ticker_sentiment_score': '0.192043', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DICE', 'relevance_score': '0.060085', 'ticker_sentiment_score': '0.17703', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
140,Grab these 2 funds with rich 11%-12% yields while you can,https://www.marketwatch.com/story/grab-these-2-funds-with-rich-11-12-yields-while-you-can-f2856fb2,20231108T121800,['Michael Brush'],"If you invest for income, consider taking advantage of these unusual opportunities.",https://images.mktw.net/im-879591/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.166559,Somewhat-Bullish,"[{'ticker': 'BLK', 'relevance_score': '0.13459', 'ticker_sentiment_score': '0.232625', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HESG', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.208956', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.13459', 'ticker_sentiment_score': '0.166414', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.13459', 'ticker_sentiment_score': '0.166414', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MORN', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.060686', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.13459', 'ticker_sentiment_score': '0.166414', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.089965', 'ticker_sentiment_score': '0.219686', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
141,Eli Lilly Unusual Options Activity - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/11/35646341/eli-lilly-unusual-options-activity,20231107T150119,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bearish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.066696,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.877669', 'ticker_sentiment_score': '0.200316', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'C', 'relevance_score': '0.102449', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.102449', 'ticker_sentiment_score': '-0.026742', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.102449', 'ticker_sentiment_score': '-0.137194', 'ticker_sentiment_label': 'Neutral'}]"
142,Eli Lilly and Company  ( LLY )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2179968/eli-lilly-and-company-lly-is-attracting-investor-attention-here-is-what-you-should-know,20231107T140011,['Zacks Equity Research'],"Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",https://staticx-tuner.zacks.com/images/default_article_images/default33.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999998'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}]",0.23135,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.529767', 'ticker_sentiment_score': '0.113399', 'ticker_sentiment_label': 'Neutral'}]"
143,"Humana, Eli Lilly And A Major Mining Stock On CNBC's 'Final Trades' - Humana  ( NYSE:HUM ) , Freeport-McMoRan  ( NYSE:FCX ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/11/35636844/humana-eli-lilly-and-a-major-mining-stock-on-cnbcs-final-trades,20231107T135038,['Lisa Levin'],"On CNBC's ""Halftime Report Final Trades,"" Bryn Talkington of Requisite Capital Management named Freeport-McMoRan Inc. FCX, adding that she likes the stock here in the mid-30s. Freeport-McMoRan reported third-quarter revenue growth of 16.4% year-over-year to $5.82 billion, topping the consensus of ...",https://cdn.benzinga.com/files/images/story/2023/11/07/trader_shutter.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '0.684621'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.283844,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.70749', 'ticker_sentiment_score': '0.737406', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'HUM', 'relevance_score': '0.70749', 'ticker_sentiment_score': '0.414028', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'FCX', 'relevance_score': '0.70749', 'ticker_sentiment_score': '0.664989', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'VRTS', 'relevance_score': '0.207571', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
144,3 Ultra-Safe Dividend Stocks to Buy Hand Over Fist in November,https://www.fool.com/investing/2023/11/07/3-ultra-safe-dividend-stocks-to-buy-hand-over-fist/,20231107T115900,['George Budwell'],"These three blue chips ought to be reliable, long-term income generators.",https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}]",0.285064,Somewhat-Bullish,"[{'ticker': 'KO', 'relevance_score': '0.364275', 'ticker_sentiment_score': '0.49306', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.306963', 'ticker_sentiment_score': '0.174211', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'XOM', 'relevance_score': '0.247838', 'ticker_sentiment_score': '0.190692', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.062926', 'ticker_sentiment_score': '-0.011203', 'ticker_sentiment_label': 'Neutral'}]"
145,These Are The 5 Top S&P 500 Performers Today,https://www.investors.com/news/sp-500-eli-lilly-among-top-performers-monday/,20231106T212100,"[""Investor's Business Daily"", 'ED CARSON']","S&P 500: Eli Lilly, Power Generators Lead Top Performers Monday Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2018/04/stock-Eli-Lilly-01-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.316726'}]",-0.036685,Neutral,"[{'ticker': 'BAC', 'relevance_score': '0.062434', 'ticker_sentiment_score': '-0.1561', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CEG', 'relevance_score': '0.185781', 'ticker_sentiment_score': '-0.027555', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'D', 'relevance_score': '0.124486', 'ticker_sentiment_score': '0.029698', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PARA', 'relevance_score': '0.245959', 'ticker_sentiment_score': '-0.189767', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'BNTX', 'relevance_score': '0.245959', 'ticker_sentiment_score': '0.121294', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.062434', 'ticker_sentiment_score': '0.07422', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SEDG', 'relevance_score': '0.304679', 'ticker_sentiment_score': '-0.347763', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NCLH', 'relevance_score': '0.245959', 'ticker_sentiment_score': '-0.152669', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'WFC', 'relevance_score': '0.062434', 'ticker_sentiment_score': '-0.234378', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'ALB', 'relevance_score': '0.361626', 'ticker_sentiment_score': '-0.432338', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'LLY', 'relevance_score': '0.245959', 'ticker_sentiment_score': '0.098865', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CNC', 'relevance_score': '0.185781', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.185781', 'ticker_sentiment_score': '0.03801', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BKNG', 'relevance_score': '0.361626', 'ticker_sentiment_score': '0.138421', 'ticker_sentiment_label': 'Neutral'}]"
146,What Happened With Eli Lilly and Company Stock Today? - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/news/23/11/35629456/what-happened-with-eli-lilly-and-company-stock-today,20231106T212050,['Ryan Gustafson'],Eli Lilly and Company LLY shares traded higher on Monday. The stock has been trending higher since the company reported third-quarter earnings. What To Know: Eli Lilly posted third-quarter financial results on Nov. 2 before the open of the market.,https://cdn.benzinga.com/files/images/story/2023/11/06/medicine-8287535_12803.jpg?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '0.904684'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.172618,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.958533', 'ticker_sentiment_score': '0.32459', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.229149', 'ticker_sentiment_score': '-0.15635', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
147,Magnificent Seven Stocks Ignite New Rally - And These Buy Points,https://www.investors.com/research/how-to-find-the-best-stocks-to-buy/magnificent-seven-stocks-ignite-new-rally-buy-points-in-amazon-stock-nvidia-dkng-and-more/,20231106T184300,"[""Investor's Business Daily"", 'MATTHEW GALGANI']","The Magnificent Seven stocks - Alphabet ( GOOGL ) , Amazon ( AMZN ) , Apple ( AAPL ) , Meta Platforms ( META ) , Microsoft ( MSFT ) , Nvidia ( NVDA ) and Tesla ( TSLA ) - continue to drive the new market rally.",https://www.investors.com/wp-content/uploads/2023/11/Stock-greenishbull-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.9545'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.290351,Somewhat-Bullish,"[{'ticker': 'DKNG', 'relevance_score': '0.262522', 'ticker_sentiment_score': '0.074998', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.198493', 'ticker_sentiment_score': '0.124461', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.262522', 'ticker_sentiment_score': '0.145885', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.38489', 'ticker_sentiment_score': '0.257561', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.096124', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.096124', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOW', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.060657', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.239698', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ZS', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.239698', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMZN', 'relevance_score': '0.549265', 'ticker_sentiment_score': '0.347422', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'OLLI', 'relevance_score': '0.198493', 'ticker_sentiment_score': '0.249764', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
148,Cathie Wood's ARKK Had Its Best Week Due To 11 Huge Winners,https://www.investors.com/news/cathie-wood-ark-innovation-just-had-its-best-week-ever-thanks-to-11-huge-winners/,20231106T124500,"['ED CARSON', ""Investor's Business Daily""]","Cathie Wood's Ark Innovation ETF ( ARKK ) typically outpaces the overall market to the upside and downside. Last week, the S&P 500, Dow Jones and Nasdaq had their best gains of 2023. But the Ark Innovation ETF had its best week ever, up 18.6%. Credit massive moves among key components.",https://www.investors.com/wp-content/uploads/2021/11/Stock-CathieWoods-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.995973'}]",0.216493,Somewhat-Bullish,"[{'ticker': 'BEAM', 'relevance_score': '0.185543', 'ticker_sentiment_score': '0.068227', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DKNG', 'relevance_score': '0.275177', 'ticker_sentiment_score': '0.089746', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SHOP', 'relevance_score': '0.215757', 'ticker_sentiment_score': '-0.055256', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROKU', 'relevance_score': '0.275177', 'ticker_sentiment_score': '0.342629', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.155051', 'ticker_sentiment_score': '0.120388', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.124325', 'ticker_sentiment_score': '0.149851', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.062352', 'ticker_sentiment_score': '0.27244', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VERV', 'relevance_score': '0.185543', 'ticker_sentiment_score': '0.121474', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COIN', 'relevance_score': '0.245649', 'ticker_sentiment_score': '0.080792', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SQ', 'relevance_score': '0.124325', 'ticker_sentiment_score': '-0.128882', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NTLA', 'relevance_score': '0.09341', 'ticker_sentiment_score': '-0.024447', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLTR', 'relevance_score': '0.185543', 'ticker_sentiment_score': '0.085341', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.062352', 'ticker_sentiment_score': '0.19217', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
149,MBCC: Diversify Your Portfolio With These 3 Large Cap ETFs,https://stocknews.com/news/mbcc-voo-gvip-diversify-your-portfolio-with-these-3-large-cap-etfs/,20231106T115116,['StockNews.com Staff'],MBCC: Diversify Your Portfolio With These 3 Large Cap ...,https://stocknews.com/wp-content/uploads/2021/07/shutterstock_276782663-1-scaled.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.890401'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.818451'}]",0.179383,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.08687', 'ticker_sentiment_score': '0.111289', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.057977', 'ticker_sentiment_score': '0.143993', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.057977', 'ticker_sentiment_score': '0.143993', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.057977', 'ticker_sentiment_score': '0.08807', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VST', 'relevance_score': '0.057977', 'ticker_sentiment_score': '0.042011', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.057977', 'ticker_sentiment_score': '0.08807', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKE', 'relevance_score': '0.057977', 'ticker_sentiment_score': '0.08807', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRT', 'relevance_score': '0.057977', 'ticker_sentiment_score': '0.042011', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.057977', 'ticker_sentiment_score': '0.124106', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PANW', 'relevance_score': '0.057977', 'ticker_sentiment_score': '0.042011', 'ticker_sentiment_label': 'Neutral'}]"
150,Eli Lilly and Company  ( NYSE:LLY )  Rating Increased to Buy at StockNews.com,https://www.defenseworld.net/2023/11/05/eli-lilly-and-company-nyselly-rating-increased-to-buy-at-stocknews-com.html,20231105T065846,['Defense World Staff'],Eli Lilly and Company ( NYSE:LLY ) Rating Increased to Buy at ... Defense World ...,https://www.marketbeat.com/logos/logo_eli_lilly.jpg,Stocknews.com,n/a,www.defenseworld.net,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.961735'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.161647'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.283079,Somewhat-Bullish,"[{'ticker': 'GS', 'relevance_score': '0.043421', 'ticker_sentiment_score': '0.043973', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.826537', 'ticker_sentiment_score': '0.463085', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JEF', 'relevance_score': '0.043421', 'ticker_sentiment_score': '0.043973', 'ticker_sentiment_label': 'Neutral'}]"
151,"Fed Holds Rates Steady, Powell's Cautious Stance Soothes Investors, Labor Market Softens: The Week In The Markets - Apple  ( NASDAQ:AAPL ) , Advanced Micro Devices  ( NASDAQ:AMD ) ",https://www.benzinga.com/markets/equities/23/11/35601229/fed-holds-rates-steady-powells-cautious-stance-soothes-investors-labor-market-softens-the-week-i,20231103T200339,['Piero Cingari'],"Markets bounced back decisively this week, shrugging off prior volatile months marked by heightened geopolitical tensions. The resurgence of risk sentiment ignited a relief rally in both equities and bonds, with investors embracing the Federal Reserve's decision to hold steady on interest rates.",https://cdn.benzinga.com/files/images/story/2023/11/03/shutterstock_176534375.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.890401'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.99737'}]",0.135775,Neutral,"[{'ticker': 'OXY', 'relevance_score': '0.129168', 'ticker_sentiment_score': '-0.093536', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.192694', 'ticker_sentiment_score': '0.209739', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'QCOM', 'relevance_score': '0.129168', 'ticker_sentiment_score': '0.364054', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.129168', 'ticker_sentiment_score': '0.185591', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BDX', 'relevance_score': '0.064797', 'ticker_sentiment_score': '-0.080072', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.129168', 'ticker_sentiment_score': '0.364054', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.129168', 'ticker_sentiment_score': '0.185591', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.129168', 'ticker_sentiment_score': '-0.093536', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.129168', 'ticker_sentiment_score': '-0.093536', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.129168', 'ticker_sentiment_score': '-0.093536', 'ticker_sentiment_label': 'Neutral'}]"
152,Market Rally Back In Force As Yields Plunge: Weekly Review,https://www.investors.com/news/stock-market-rally-back-in-force-as-treasury-yields-plunge-arista-palantir-are-winners/,20231103T165559,"[""Investor's Business Daily"", 'IBD STAFF']","The stock market rally took off this past week as Treasury yields plunged on generally weak economic data and soothing words from Fed Chief Jerome Powell Nasdaq staged a follow-through day to confirm the market rally on Wednesday, with the S&P 500 and Dow Jones following through on Thursday.",https://www.investors.com/wp-content/uploads/2020/04/Stock-bullfightingbear-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '0.999897'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.004916,Neutral,"[{'ticker': 'XPEV', 'relevance_score': '0.035476', 'ticker_sentiment_score': '-0.060946', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROKU', 'relevance_score': '0.070882', 'ticker_sentiment_score': '0.015254', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.070882', 'ticker_sentiment_score': '-0.061816', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANET', 'relevance_score': '0.106148', 'ticker_sentiment_score': '-0.040029', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LSCC', 'relevance_score': '0.035476', 'ticker_sentiment_score': '0.11532', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SRPT', 'relevance_score': '0.053192', 'ticker_sentiment_score': '0.124905', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.053192', 'ticker_sentiment_score': '0.078879', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.035476', 'ticker_sentiment_score': '0.043443', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DASH', 'relevance_score': '0.053192', 'ticker_sentiment_score': '-0.044243', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.035476', 'ticker_sentiment_score': '-0.352867', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'ALGM', 'relevance_score': '0.035476', 'ticker_sentiment_score': '0.11532', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.070882', 'ticker_sentiment_score': '-0.040517', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SHOP', 'relevance_score': '0.158635', 'ticker_sentiment_score': '-0.062061', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRUS', 'relevance_score': '0.035476', 'ticker_sentiment_score': '0.11532', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.053192', 'ticker_sentiment_score': '-0.044087', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.035476', 'ticker_sentiment_score': '0.11532', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.088537', 'ticker_sentiment_score': '0.057142', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.053192', 'ticker_sentiment_score': '0.078879', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PINS', 'relevance_score': '0.035476', 'ticker_sentiment_score': '-0.028361', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HMC', 'relevance_score': '0.035476', 'ticker_sentiment_score': '-0.022873', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ON', 'relevance_score': '0.017742', 'ticker_sentiment_score': '0.107', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLTR', 'relevance_score': '0.088537', 'ticker_sentiment_score': '-0.014717', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DKNG', 'relevance_score': '0.106148', 'ticker_sentiment_score': '-0.024925', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.106148', 'ticker_sentiment_score': '-0.0443', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.017742', 'ticker_sentiment_score': '-0.021613', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RELY', 'relevance_score': '0.053192', 'ticker_sentiment_score': '0.006008', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.035476', 'ticker_sentiment_score': '0.147308', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COR', 'relevance_score': '0.053192', 'ticker_sentiment_score': '0.167262', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.035476', 'ticker_sentiment_score': '0.15563', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ORCL', 'relevance_score': '0.035476', 'ticker_sentiment_score': '-0.001911', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CBOE', 'relevance_score': '0.035476', 'ticker_sentiment_score': '0.13248', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAH', 'relevance_score': '0.035476', 'ticker_sentiment_score': '0.16532', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CCJ', 'relevance_score': '0.088537', 'ticker_sentiment_score': '0.001072', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MELI', 'relevance_score': '0.035476', 'ticker_sentiment_score': '-0.019707', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCK', 'relevance_score': '0.035476', 'ticker_sentiment_score': '0.16532', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ETSY', 'relevance_score': '0.053192', 'ticker_sentiment_score': '-0.020024', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FTNT', 'relevance_score': '0.053192', 'ticker_sentiment_score': '-0.136003', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NIO', 'relevance_score': '0.035476', 'ticker_sentiment_score': '-0.060946', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TM', 'relevance_score': '0.035476', 'ticker_sentiment_score': '-0.022873', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARGX', 'relevance_score': '0.035476', 'ticker_sentiment_score': '0.043443', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NET', 'relevance_score': '0.053192', 'ticker_sentiment_score': '-0.136003', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QRVO', 'relevance_score': '0.035476', 'ticker_sentiment_score': '0.11532', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REGN', 'relevance_score': '0.035476', 'ticker_sentiment_score': '0.043443', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LI', 'relevance_score': '0.035476', 'ticker_sentiment_score': '-0.060946', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:JPY', 'relevance_score': '0.017742', 'ticker_sentiment_score': '-0.021613', 'ticker_sentiment_label': 'Neutral'}]"
153,Check Out What Whales Are Doing With LLY - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/11/35596155/check-out-what-whales-are-doing-with-lly,20231103T163034,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bearish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.109292,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.768168', 'ticker_sentiment_score': '-0.031531', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.086556', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.086556', 'ticker_sentiment_score': '-0.11944', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.172097', 'ticker_sentiment_score': '-0.160872', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
154,Eli Lilly Beats on Q3 Earnings: ETFs to Buy,https://www.zacks.com/stock/news/2178224/eli-lilly-beats-on-q3-earnings-etfs-to-buy,20231103T150500,['Sweta Killa'],"Eli Lilly (LLY) posted robust third-quarter 2023 earnings results, beating estimates on both the top and bottom lines. Its Mounjaro anti-obesity drug continued its robust performance.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.904684'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999965'}]",0.251672,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.354952', 'ticker_sentiment_score': '0.326152', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
155,Eli Lilly Just Added Another Potential Billion-Dollar Product: Is It a Buy?,https://www.fool.com/investing/2023/11/03/eli-lilly-just-added-another-potential-billion/,20231103T134500,['Prosper Junior Bakiny'],The answer is relatively clear.,https://media.ycharts.com/charts/9c3f474fdbe7c0a502a6d65cb8316359.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.312241,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.679765', 'ticker_sentiment_score': '0.439171', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.111724', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.111724', 'ticker_sentiment_label': 'Neutral'}]"
156,Jim Cramer's top 10 things to watch in the stock market Friday,https://www.cnbc.com/2023/11/03/jim-cramers-top-10-things-to-watch-in-the-stock-market-friday.html,20231103T131615,['Jim Cramer'],"U.S. stocks climb higher in premarket trading Friday, as employment growth slows in October.",https://image.cnbcfm.com/api/v1/image/107328239-1698967149761-gettyimages-1760543444-AFP_33ZR2GX.jpeg?v=1698967981&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.999612'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",0.060538,Neutral,"[{'ticker': 'AAPL', 'relevance_score': '0.169279', 'ticker_sentiment_score': '0.016245', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.169279', 'ticker_sentiment_score': '0.013336', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TJX', 'relevance_score': '0.113329', 'ticker_sentiment_score': '0.046423', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.169279', 'ticker_sentiment_score': '0.051902', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FTNT', 'relevance_score': '0.169279', 'ticker_sentiment_score': '-0.127897', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.169279', 'ticker_sentiment_score': '0.193369', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ROST', 'relevance_score': '0.113329', 'ticker_sentiment_score': '0.046423', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SWKS', 'relevance_score': '0.113329', 'ticker_sentiment_score': '-0.057772', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.169279', 'ticker_sentiment_score': '-0.115078', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CLX', 'relevance_score': '0.169279', 'ticker_sentiment_score': '-0.084688', 'ticker_sentiment_label': 'Neutral'}]"
157,"Company News for Nov 03, 2023",https://www.zacks.com/stock/news/2178063/company-news-for-nov-03-2023,20231103T123200,['Zacks Equity Research'],"Companies In The Article: LLY, SBUX, SHOP, ...",https://staticx-tuner.zacks.com/images/articles/main/5a/2120.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.197521,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.608634', 'ticker_sentiment_score': '0.219943', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SHOP', 'relevance_score': '0.608634', 'ticker_sentiment_score': '0.275993', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CYBR', 'relevance_score': '0.608634', 'ticker_sentiment_score': '0.308198', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SBUX', 'relevance_score': '0.608634', 'ticker_sentiment_score': '0.36078', 'ticker_sentiment_label': 'Bullish'}]"
158,Tech Futures Fall On Apple's Holiday Warning,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-apple-falls-on-holiday-outlook-jobs-report-due/,20231103T115257,"['ED CARSON', ""Investor's Business Daily""]",Dow Jones Futures: Apple Falls On Holiday Outlook. Jobs Report Due Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/02/Stock-lion-closeup-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Blockchain', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.999892'}]",0.081629,Neutral,"[{'ticker': 'DKNG', 'relevance_score': '0.065625', 'ticker_sentiment_score': '0.118196', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.043778', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROKU', 'relevance_score': '0.043778', 'ticker_sentiment_score': '0.139678', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.237288', 'ticker_sentiment_score': '-0.053779', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.021897', 'ticker_sentiment_score': '0.111303', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DASH', 'relevance_score': '0.043778', 'ticker_sentiment_score': '0.139678', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COIN', 'relevance_score': '0.109157', 'ticker_sentiment_score': '-0.030444', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KTOS', 'relevance_score': '0.065625', 'ticker_sentiment_score': '-0.192494', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'SHOP', 'relevance_score': '0.043778', 'ticker_sentiment_score': '0.139678', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.021897', 'ticker_sentiment_score': '0.210413', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FTNT', 'relevance_score': '0.087424', 'ticker_sentiment_score': '-0.088869', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOW', 'relevance_score': '0.021897', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.109157', 'ticker_sentiment_score': '0.122039', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVNA', 'relevance_score': '0.065625', 'ticker_sentiment_score': '-0.102509', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'YELP', 'relevance_score': '0.043778', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TEAM', 'relevance_score': '0.065625', 'ticker_sentiment_score': '-0.102509', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NET', 'relevance_score': '0.087424', 'ticker_sentiment_score': '-0.088869', 'ticker_sentiment_label': 'Neutral'}]"
159,Ozempic Sales Soar 56% in Q3. But Is Eli Lilly a Better Stock to Buy Than Novo Nordisk?,https://www.fool.com/investing/2023/11/03/ozempic-sales-soar-eli-lilly-better-stock-buy/,20231103T095100,['Keith Speights'],Lilly's Mounjaro is gaining ground on Novo Nordisk's Ozempic.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '0.995921'}, {'topic': 'Technology', 'relevance_score': '0.5'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.281598,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.584822', 'ticker_sentiment_score': '0.510244', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.395903', 'ticker_sentiment_score': '0.420562', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'DICE', 'relevance_score': '0.059049', 'ticker_sentiment_score': '0.030302', 'ticker_sentiment_label': 'Neutral'}]"
160,"Market Roars, Palantir Spikes; Apple Falls Late With Jobs Data Due",https://www.investors.com/market-trend/stock-market-today/dow-jones-jumps-in-broad-market-rally-palantir-spikes-apple-falls-late-jobs-report-looms/,20231102T205457,"[""Investor's Business Daily"", 'ED CARSON']","Dow Jones Jumps In Broad Market Rally, Palantir Spikes. Apple ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2023/02/Stock-lion-closeup-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.999892'}]",0.119067,Neutral,"[{'ticker': 'DKNG', 'relevance_score': '0.089965', 'ticker_sentiment_score': '0.128806', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROKU', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.140057', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.222429', 'ticker_sentiment_score': '-0.052875', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.022536', 'ticker_sentiment_score': '0.111722', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DASH', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.140057', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COIN', 'relevance_score': '0.112322', 'ticker_sentiment_score': '-0.064837', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KTOS', 'relevance_score': '0.067536', 'ticker_sentiment_score': '-0.091222', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SHOP', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.140057', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.022536', 'ticker_sentiment_score': '0.21104', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FTNT', 'relevance_score': '0.089965', 'ticker_sentiment_score': '-0.147365', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOW', 'relevance_score': '0.022536', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.112322', 'ticker_sentiment_score': '0.12332', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVNA', 'relevance_score': '0.067536', 'ticker_sentiment_score': '0.090835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'YELP', 'relevance_score': '0.067536', 'ticker_sentiment_score': '0.090835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TEAM', 'relevance_score': '0.067536', 'ticker_sentiment_score': '-0.184365', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NET', 'relevance_score': '0.089965', 'ticker_sentiment_score': '-0.147365', 'ticker_sentiment_label': 'Neutral'}]"
161,Eli Lilly  ( LLY )  Q3 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/11/02/eli-lilly-lly-q3-2023-earnings-call-transcript/,20231102T183027,['Motley Fool Transcribing'],"LLY earnings call for the period ending September 30, 2023.",https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.918141'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.413559'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.242095,Somewhat-Bullish,"[{'ticker': 'EVR', 'relevance_score': '0.004174', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.004174', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.004174', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.004174', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.004174', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DICE', 'relevance_score': '0.02087', 'ticker_sentiment_score': '0.105955', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.112338', 'ticker_sentiment_score': '0.108904', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NHPEF', 'relevance_score': '0.004174', 'ticker_sentiment_score': '0.244586', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.004174', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SGTX', 'relevance_score': '0.004174', 'ticker_sentiment_score': '0.090053', 'ticker_sentiment_label': 'Neutral'}]"
162,"Treasuries, Stocks Extend Gains Following Fed Meeting as Apple, Jobs Report Loom - ConocoPhillips  ( NYSE:COP ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/markets/23/11/35571776/treasuries-stocks-extend-gains-following-fed-meeting-as-apple-jobs-report-loom,20231102T174043,['Schwab Center for Financial Research'],"( Thursday market open ) The World Series is over, but Wall Street remains in the thick of this week's triple play of a Fed meeting, Apple ( NASDAQ: AAPL ) earnings and Friday's October jobs report. So far, stocks are building up a lead as worries lessen about future Federal Reserve rate hikes.",https://cdn.benzinga.com/files/images/story/2023/11/02/shutterstock_534465157_8.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.9545'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",-0.009665,Neutral,"[{'ticker': 'ROKU', 'relevance_score': '0.045353', 'ticker_sentiment_score': '0.26219', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ZBH', 'relevance_score': '0.045353', 'ticker_sentiment_score': '0.086519', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.157778', 'ticker_sentiment_score': '-0.029655', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COP', 'relevance_score': '0.045353', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ILMN', 'relevance_score': '0.045353', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIVN', 'relevance_score': '0.045353', 'ticker_sentiment_score': '0.086519', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAH', 'relevance_score': '0.045353', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SHOP', 'relevance_score': '0.045353', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.045353', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EBAY', 'relevance_score': '0.045353', 'ticker_sentiment_score': '0.086519', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.045353', 'ticker_sentiment_score': '0.055727', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BDX', 'relevance_score': '0.045353', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.045353', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.045353', 'ticker_sentiment_score': '0.086519', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.045353', 'ticker_sentiment_score': '0.055727', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.045353', 'ticker_sentiment_score': '-0.187044', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'MAR', 'relevance_score': '0.045353', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
163,IBD Stock Of The Day Lilly Surges As Diabetes Drug Sales Rocket 652%,https://www.investors.com/research/ibd-stock-of-the-day/eli-lilly-stock-eli-lilly-earnings-q3-2023/,20231102T172052,"['ALLISON GATLIN', ""Investor's Business Daily""]",Eli Lilly Stock Jumps As Diabetes Blockbuster Mounjaro Grows 652% Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/11/SOTD-11-2-23LLY.png,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}]",0.127876,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.676859', 'ticker_sentiment_score': '0.255979', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
164,Why Cramer thinks owning Apple is 'not about quarters',https://www.cnbc.com/2023/11/02/why-cramer-thinks-owning-apple-is-not-about-quarters-.html,20231102T151347,['Jeff Marks'],The Investing Club holds its Morning Meeting every weekday at 10:20 a.m. ET.,https://image.cnbcfm.com/api/v1/image/107327788-16989356331698935627-31853227147-1080pnbcnews.jpg?v=1698935632&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999499'}, {'topic': 'Earnings', 'relevance_score': '0.818451'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.187231,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.323078', 'ticker_sentiment_score': '0.184499', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SBUX', 'relevance_score': '0.245339', 'ticker_sentiment_score': '0.148627', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.397517', 'ticker_sentiment_score': '0.214573', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
165,"Dow Jones Adds 330 Points, Yields Fall; Apple Rises To Key Level As Earnings Loom",https://www.investors.com/market-trend/stock-market-today/dow-jones-adds-280-points-apple-rises-to-key-level-as-earnings-loom/,20231102T150831,"['VIDYA RAMAKRISHNAN', ""Investor's Business Daily""]","Dow Jones Adds 330 Points, Yields Fall. Apple Rises To Key Level ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2023/09/Stock-AppleEvent-0923-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.99992'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.890401'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}]",0.201525,Somewhat-Bullish,"[{'ticker': 'PYPL', 'relevance_score': '0.106305', 'ticker_sentiment_score': '-0.095159', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROKU', 'relevance_score': '0.210731', 'ticker_sentiment_score': '0.039069', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.158868', 'ticker_sentiment_score': '0.223792', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.158868', 'ticker_sentiment_score': '0.116797', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABNB', 'relevance_score': '0.158868', 'ticker_sentiment_score': '-0.117247', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.053271', 'ticker_sentiment_score': '0.191746', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DT', 'relevance_score': '0.106305', 'ticker_sentiment_score': '0.122415', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SHOP', 'relevance_score': '0.106305', 'ticker_sentiment_score': '0.05605', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TOL', 'relevance_score': '0.106305', 'ticker_sentiment_score': '0.116966', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LEN', 'relevance_score': '0.106305', 'ticker_sentiment_score': '0.116966', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.158868', 'ticker_sentiment_score': '-0.117247', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.158868', 'ticker_sentiment_score': '0.116797', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMI', 'relevance_score': '0.106305', 'ticker_sentiment_score': '0.113617', 'ticker_sentiment_label': 'Neutral'}]"
166,Why Eli Lilly Stock Is Jumping Today,https://www.fool.com/investing/2023/11/02/why-eli-lilly-stock-is-jumping-today/,20231102T145932,['Keith Speights'],Investors liked the drugmaker's Q3 update.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.996718'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.264589,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.432291', 'ticker_sentiment_score': '0.310227', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DICE', 'relevance_score': '0.113597', 'ticker_sentiment_score': '0.026202', 'ticker_sentiment_label': 'Neutral'}]"
167,"Eli Lilly  ( LLY )  Q3 Earnings & Sales Top, EPS View Cut, Stock Up",https://www.zacks.com/stock/news/2177427/eli-lilly-lly-q3-earnings-sales-top-eps-view-cut-stock-up,20231102T145800,['Zacks Equity Research'],Eli Lilly (LLY) beats third-quarter estimates for earnings as well as sales. It cut its earnings guidance for 2023 on charges related to acquisitions and collaboration deals.,https://staticx-tuner.zacks.com/images/articles/main/f2/4113.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.214378'}, {'topic': 'Technology', 'relevance_score': '0.5'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.121745,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.305921', 'ticker_sentiment_score': '0.159031', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DVAX', 'relevance_score': '0.169875', 'ticker_sentiment_score': '0.108192', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MEIP', 'relevance_score': '0.141893', 'ticker_sentiment_score': '0.096619', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.113731', 'ticker_sentiment_score': '0.132648', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DICE', 'relevance_score': '0.057011', 'ticker_sentiment_score': '0.001002', 'ticker_sentiment_label': 'Neutral'}]"
168,Some Surprise Names Led The S&P 500 In October,https://www.investors.com/news/some-surprise-names-led-the-sp-500-in-october/,20231102T143038,"['HARRISON MILLER', ""Investor's Business Daily""]","The market started November with a few sparks after a difficult October, which saw the benchmark indexes fell for their third month in a row. The S&P 500 had a few bright spots and some major drags. Some unexpected names led the index in October, while banks and solar companies tumbled.",https://www.investors.com/wp-content/uploads/2020/03/stock-NYSE-stylized-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.999186'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.795202'}]",0.058374,Neutral,"[{'ticker': 'ENPH', 'relevance_score': '0.147216', 'ticker_sentiment_score': '-0.028563', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.195419', 'ticker_sentiment_score': '0.317985', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.147216', 'ticker_sentiment_score': '0.265376', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ANET', 'relevance_score': '0.098456', 'ticker_sentiment_score': '0.191235', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NRG', 'relevance_score': '0.098456', 'ticker_sentiment_score': '-0.149541', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DG', 'relevance_score': '0.098456', 'ticker_sentiment_score': '-0.034619', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LSCC', 'relevance_score': '0.098456', 'ticker_sentiment_score': '-0.139935', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TXN', 'relevance_score': '0.098456', 'ticker_sentiment_score': '-0.139935', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALGN', 'relevance_score': '0.098456', 'ticker_sentiment_score': '-0.188681', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'STM', 'relevance_score': '0.098456', 'ticker_sentiment_score': '-0.139935', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.147216', 'ticker_sentiment_score': '0.110453', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SEDG', 'relevance_score': '0.147216', 'ticker_sentiment_score': '-0.053608', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.098456', 'ticker_sentiment_score': '0.191235', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PGR', 'relevance_score': '0.195419', 'ticker_sentiment_score': '0.186755', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ON', 'relevance_score': '0.049322', 'ticker_sentiment_score': '-0.131089', 'ticker_sentiment_label': 'Neutral'}]"
169,Why Eli Lilly's  ( LLY )  Stock Is Trading Higher Today - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/general/biotech/23/11/35563592/eli-lillys-q3-performance-shows-diabetes-drug-strength-but-cuts-annual-profit-guidance-related-to,20231102T140256,['Vandana Singh'],"Eli Lilly And Co LLY has reported Q3 sales of $9.49 billion, up 37% Y/Y, beating the consensus of $8.95 billion, driven by growth from Mounjaro, Verzenio, and Jardiance, as well as $1.42 billion from the sale of rights for the olanzapine portfolio ( Zyprexa ) .",https://cdn.benzinga.com/files/images/story/2023/11/02/mounjaro-medication-for-weight-loss.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.266143'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.021727,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.855251', 'ticker_sentiment_score': '-0.025088', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DICE', 'relevance_score': '0.165031', 'ticker_sentiment_score': '-0.107722', 'ticker_sentiment_label': 'Neutral'}]"
170,Lilly Smashes Third-Quarter Forecasts As Diabetes Blockbuster Grows 652%,https://www.investors.com/news/technology/eli-lilly-stock-eli-lilly-earnings-q3-2023/,20231102T130052,"[""Investor's Business Daily"", 'ALLISON GATLIN']",Eli Lilly Stock Rises As Diabetes Blockbuster Mounjaro Grows 652% Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2018/04/stock-Eli-Lilly-01-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.918141'}]",0.206804,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.81619', 'ticker_sentiment_score': '0.532435', 'ticker_sentiment_label': 'Bullish'}]"
171,"Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings - Roku  ( NASDAQ:ROKU ) , Wendy's  ( NASDAQ:WEN ) , Paramount Global  ( NASDAQ:PARA ) , Peloton Interactive  ( NASDAQ:PTON ) ",https://www.benzinga.com/news/earnings/23/11/35559421/us-stocks-on-track-for-solid-start-amid-lingering-fed-optimism-traders-eye-earnings-from-market-bel,20231102T111924,['Shanthi Rexaline'],"After the Federal Reserve's decision, the stock market rally is poised to gain momentum on Thursday, with stock futures indicating an uptick. Positive earnings reports may bolster this rally, and the decline in bond yields, driven by rising rate-cut expectations, could be viewed favorably by ...",https://cdn.benzinga.com/files/images/story/2023/nyse_shutter_2.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '0.999975'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.162501,Somewhat-Bullish,"[{'ticker': 'ROKU', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WEN', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.132611', 'ticker_sentiment_score': '0.091357', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PARA', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PTON', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CROX', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EXPE', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'H', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.044386', 'ticker_sentiment_score': '0.152804', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CLX', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMND', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DBX', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SQ', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLTR', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DKNG', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PYPL', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TNDM', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COP', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CI', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LYV', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SWKS', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOX', 'relevance_score': '0.044386', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ETSY', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FTNT', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FSLY', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BHC', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REGN', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MAR', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.088635', 'ticker_sentiment_score': '0.184545', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
172,"Lilly Reports Third-Quarter 2023 Financial Results, Highlights Strong Sales Growth and Business Development Activity",https://www.prnewswire.com/news-releases/lilly-reports-third-quarter-2023-financial-results-highlights-strong-sales-growth-and-business-development-activity-301975008.html,20231102T103000,['Eli Lilly and Company'],"( i ) Lilly defines New Products as select products launched since 2022, which currently consist of Jaypirca, Mounjaro and Omvoh. ( ii ) Lilly defines Growth Products as select products launched prior to 2022, which currently consist of Cyramza, Emgality, Jardiance, Olumiant, Retevmo, Taltz, ...",https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999975'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.54554'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.154756,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.326438', 'ticker_sentiment_score': '0.217745', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CURN', 'relevance_score': '0.012004', 'ticker_sentiment_score': '0.005193', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DICE', 'relevance_score': '0.024005', 'ticker_sentiment_score': '-0.047936', 'ticker_sentiment_label': 'Neutral'}]"
173,"Fear Continues To Grip Markets After Fed's Rate Decision - Apple  ( NASDAQ:AAPL ) , ConocoPhillips  ( NYSE:COP ) ",https://www.benzinga.com/news/earnings/23/11/35555667/fear-continues-to-grip-markets-after-feds-rate-decision,20231102T090137,['Lisa Levin'],"The CNN Money Fear and Greed index remained in the ""Fear"" zone on Wednesday. U.S. stocks closed higher on Wednesday after the Federal Reserve maintained interest rates for a second straight time. Bond yields, meanwhile, fell following the interest-rate decision.",https://cdn.benzinga.com/files/images/story/2023/11/02/image23.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}]",-0.070395,Neutral,"[{'ticker': 'YUM', 'relevance_score': '0.238133', 'ticker_sentiment_score': '0.484014', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.238133', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.238133', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COP', 'relevance_score': '0.238133', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KHC', 'relevance_score': '0.238133', 'ticker_sentiment_score': '0.484014', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.238133', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WBD', 'relevance_score': '0.120431', 'ticker_sentiment_score': '-0.477873', 'ticker_sentiment_label': 'Bearish'}]"
174,Rally Gains Steam As Powell Signals No More Rate Hikes,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rally-gains-steam-as-fed-chief-powell-signals-no-more-rate-hikes/,20231101T205533,"['ED CARSON', ""Investor's Business Daily""]","Dow Jones futures were little changed hours, along with S&P 500 futures and Nasdaq futures, after Fed chief Jerome Powell signaled the rates will stay on hold into next year. Roku ( ROKU ) and MercadoLibre were among a slew of earnings Wednesday night, with Palantir Technologies ( PLTR ) , Eli ...",https://www.investors.com/wp-content/uploads/2018/10/stock-Jerome-Powell-03-fed.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.769861'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.928769'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.142972,Neutral,"[{'ticker': 'META', 'relevance_score': '0.080458', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROKU', 'relevance_score': '0.107135', 'ticker_sentiment_score': '0.099701', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.107135', 'ticker_sentiment_score': '0.012043', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.107135', 'ticker_sentiment_score': '-0.028084', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COR', 'relevance_score': '0.107135', 'ticker_sentiment_score': '0.01197', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.02686', 'ticker_sentiment_score': '0.172995', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.263657', 'ticker_sentiment_score': '0.132174', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SHOP', 'relevance_score': '0.080458', 'ticker_sentiment_score': '0.056724', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MELI', 'relevance_score': '0.107135', 'ticker_sentiment_score': '0.071799', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.02686', 'ticker_sentiment_score': '0.215006', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MCK', 'relevance_score': '0.160099', 'ticker_sentiment_score': '-0.041109', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.133692', 'ticker_sentiment_score': '0.008339', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REGN', 'relevance_score': '0.053689', 'ticker_sentiment_score': '-0.079734', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.107135', 'ticker_sentiment_score': '0.053395', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MAR', 'relevance_score': '0.053689', 'ticker_sentiment_score': '-0.079734', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLTR', 'relevance_score': '0.080458', 'ticker_sentiment_score': '-0.027407', 'ticker_sentiment_label': 'Neutral'}]"
175,Earnings Due For These Stealth Weight-Loss Drug Plays,https://www.investors.com/news/mckesson-earnings-stealth-glp-1-weight-loss-drug-play-mckesson-rivals/,20231101T172402,"[""Investor's Business Daily"", 'JED GRAHAM']",McKesson Earnings Due For Stealth GLP-1 Weight-Loss Drug Play ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2022/08/Stock-McKesson-03-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.999897'}, {'topic': 'Earnings', 'relevance_score': '0.95493'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.264294,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.160633', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.160633', 'ticker_sentiment_score': '0.190892', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CAH', 'relevance_score': '0.387674', 'ticker_sentiment_score': '0.298988', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MCK', 'relevance_score': '0.735092', 'ticker_sentiment_score': '0.315229', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.160633', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COR', 'relevance_score': '0.456884', 'ticker_sentiment_score': '0.340649', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
176,LLY: Eli Lilly & Co.  ( LLY )  Earnings Forecast,https://stocknews.com/news/lly-abbv-taro-rdy-eli-lilly-co-lly-earnings-forecast/,20231101T170704,['StockNews.com Staff'],"Pharmaceutical major Eli Lilly and Company ( LLY ) is scheduled to release its third-quarter results on November 2. While its earnings are expected to decline year-over-year, its revenue will likely improve. In this piece, I have discussed why waiting for an opportune entry point in the stock ...",https://stocknews.com/wp-content/uploads/2021/03/shutterstock_530971462-1-scaled.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.998356'}]",0.126292,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.520477', 'ticker_sentiment_score': '0.098165', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TARO', 'relevance_score': '0.080458', 'ticker_sentiment_score': '0.023811', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.080458', 'ticker_sentiment_score': '0.023811', 'ticker_sentiment_label': 'Neutral'}]"
177,Curious about Lilly  ( LLY )  Q3 Performance? Explore Wall Street Estimates for Key Metrics,https://www.zacks.com/stock/news/2176355/curious-about-lilly-lly-q3-performance-explore-wall-street-estimates-for-key-metrics,20231101T125000,['Zacks Equity Research'],"Evaluate the expected performance of Lilly (LLY) for the quarter ended September 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.",https://staticx-tuner.zacks.com/images/default_article_images/default199.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.95493'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.081403,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.356609', 'ticker_sentiment_score': '0.060128', 'ticker_sentiment_label': 'Neutral'}]"
178,"Incyte  ( INCY )  Beats on Q3 Earnings, Misses Revenue Estimates",https://www.zacks.com/stock/news/2175739/incyte-incy-beats-on-q3-earnings-misses-revenue-estimates,20231031T161400,['Zacks Equity Research'],"Incyte's (INCY) third-quarter 2023 earnings beat estimates, while revenues miss the same. The company tightens Jakafi net product revenue guidance for 2023.",https://staticx-tuner.zacks.com/images/articles/main/37/2337.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.938238'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.141345,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.169378', 'ticker_sentiment_score': '0.047996', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DVAX', 'relevance_score': '0.25168', 'ticker_sentiment_score': '0.155569', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'INCY', 'relevance_score': '0.513062', 'ticker_sentiment_score': '0.125213', 'ticker_sentiment_label': 'Neutral'}]"
179,Amgen's stock hit by expectations its obesity pipeline is facing a longer wait,https://www.marketwatch.com/story/amgens-stock-jumps-premarket-after-earnings-beat-and-company-again-raises-guidance-d4015936,20231031T155900,['Ciara Linnane'],Amgen Inc.'s stock fell 3.3% Tuesday despite an earnings beat and raised guidance. Obesity drugs were to blame.,https://images.mktw.net/im-814193/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.980716'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.104098,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.146469', 'ticker_sentiment_score': '0.114297', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.146469', 'ticker_sentiment_score': '-0.199329', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AMGN', 'relevance_score': '0.288044', 'ticker_sentiment_score': '-0.031612', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.073546', 'ticker_sentiment_score': '0.091052', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.146469', 'ticker_sentiment_score': '0.114297', 'ticker_sentiment_label': 'Neutral'}]"
180,5 Hot Earnings Charts,https://www.zacks.com/stock/news/2175700/5-hot-earnings-charts,20231031T155400,['Tracey Ryniec'],These 5 companies have red hot charts and they have outstanding earnings surprise histories.,https://staticx-tuner.zacks.com/images/articles/main/66/49902.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Earnings', 'relevance_score': '0.890401'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}]",0.217484,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.344712', 'ticker_sentiment_score': '0.202108', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HURN', 'relevance_score': '0.407844', 'ticker_sentiment_score': '0.205683', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BKNG', 'relevance_score': '0.468029', 'ticker_sentiment_score': '0.141673', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BLDR', 'relevance_score': '0.344712', 'ticker_sentiment_score': '0.22045', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
181,Eli Lilly Stock Has Quadrupled in 3 Years. Could a Weight-Loss Drug Approval Make It Happen Again?,https://www.fool.com/investing/2023/10/31/eli-lilly-stock-quadrupled-weight-loss-drug/,20231031T141233,['James Brumley'],"Mounjaro may be a winner, but all its upside is already priced in. An approval poses the risk of profit-taking.",https://g.foolcdn.com/editorial/images/752576/investing-screen-analysis-investor-growth-stocks.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.996023'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.116269,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.33628', 'ticker_sentiment_score': '0.166002', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PEP', 'relevance_score': '0.03468', 'ticker_sentiment_score': '-0.144117', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.03468', 'ticker_sentiment_score': '0.074345', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.03468', 'ticker_sentiment_score': '-0.144117', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PNT', 'relevance_score': '0.03468', 'ticker_sentiment_score': '0.143011', 'ticker_sentiment_label': 'Neutral'}]"
182,"Pfizer  ( PFE )  Reports Q3 Loss, Lags Revenue Estimates",https://www.zacks.com/stock/news/2175168/pfizer-pfe-reports-q3-loss-lags-revenue-estimates,20231031T120508,['Zacks Equity Research'],"Pfizer (PFE) delivered earnings and revenue surprises of 46.88% and 3.93%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?",https://staticx-tuner.zacks.com/images/default_article_images/default26.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999981'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.112098,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.140076', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.40348', 'ticker_sentiment_score': '0.074066', 'ticker_sentiment_label': 'Neutral'}]"
183,Dow Jones Rises As Apple Climbs Ahead Of Earnings; GM Reportedly Settles With UAW,https://www.investors.com/market-trend/stock-market-today/dow-jones-rises-as-apple-climbs-ahead-of-earnings-gm-settles-with-uaw/,20231030T150805,"[""Investor's Business Daily"", 'VIDYA RAMAKRISHNAN']",Dow Jones Rises As Apple Climbs Ahead Of Earnings. GM ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2019/06/stock-WallStreet-06-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.999896'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.904684'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.069208,Neutral,"[{'ticker': 'AAPL', 'relevance_score': '0.158868', 'ticker_sentiment_score': '-0.073442', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LSCC', 'relevance_score': '0.106305', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.053271', 'ticker_sentiment_score': '0.142686', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.210731', 'ticker_sentiment_score': '0.050436', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.106305', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RMBS', 'relevance_score': '0.106305', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAH', 'relevance_score': '0.106305', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.158868', 'ticker_sentiment_score': '-0.073442', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DTST', 'relevance_score': '0.053271', 'ticker_sentiment_score': '-0.047015', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.106305', 'ticker_sentiment_score': '0.076727', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.158868', 'ticker_sentiment_score': '-0.073442', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WDC', 'relevance_score': '0.106305', 'ticker_sentiment_score': '-0.052684', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.106305', 'ticker_sentiment_score': '0.076727', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.106305', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WOLF', 'relevance_score': '0.106305', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ON', 'relevance_score': '0.053271', 'ticker_sentiment_score': '0.032999', 'ticker_sentiment_label': 'Neutral'}]"
184,Pre-Markets in Green to Start a Crucial Week of Events,https://www.zacks.com/stock/news/2174622/pre-markets-in-green-to-start-a-crucial-week-of-events,20231030T150600,['Zacks Equity Research'],"It's the start of the busiest week of Q3 earnings season, and pre-market futures are up. Perhaps this is a sign of optimism for expected earnings, or perhaps it's looking favorably on a parade of economic reports out this week.",https://staticx-tuner.zacks.com/images/articles/main/01/36484.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.838487'}]",0.169225,Somewhat-Bullish,"[{'ticker': 'MDNDF', 'relevance_score': '0.087185', 'ticker_sentiment_score': '0.20895', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SBUX', 'relevance_score': '0.173333', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COP', 'relevance_score': '0.173333', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.173333', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.173333', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.173333', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ON', 'relevance_score': '0.087185', 'ticker_sentiment_score': '0.129182', 'ticker_sentiment_label': 'Neutral'}]"
185,"Busy Week for Earnings, Fed, Reports; MCD, ON Beat in Q3",https://www.zacks.com/stock/news/2174606/busy-week-for-earnings-fed-reports-mcd-on-beat-in-q3,20231030T143500,['Mark Vickery'],Mid-October near-term highs have given way to lower trading levels for the most part in the past couple weeks.,https://staticx-tuner.zacks.com/images/articles/main/59/2364.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.890401'}]",0.162295,Somewhat-Bullish,"[{'ticker': 'MDNDF', 'relevance_score': '0.084127', 'ticker_sentiment_score': '0.154679', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SBUX', 'relevance_score': '0.167322', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COP', 'relevance_score': '0.167322', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.167322', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.167322', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.167322', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ON', 'relevance_score': '0.084127', 'ticker_sentiment_score': '0.154679', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
186,This Is What Whales Are Betting On Eli Lilly - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/10/35490808/this-is-what-whales-are-betting-on-eli-lilly,20231030T134615,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bearish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.09017,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.773597', 'ticker_sentiment_score': '0.015813', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.096283', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.096283', 'ticker_sentiment_score': '-0.122172', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.096283', 'ticker_sentiment_score': '-0.122172', 'ticker_sentiment_label': 'Neutral'}]"
187,"Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week - Lattice Semiconductor  ( NASDAQ:LSCC ) , Exact Sciences  ( NASDAQ:EXAS ) , Amgen  ( NASDAQ:AMGN ) , STMicroelectronics  ( NYSE:STM ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35484208/apple-amd-palantir-earnings-on-deck-this-week-as-market-seeks-positive-catalysts-in,20231030T074015,['Shanthi Rexaline'],"The third-quarter earnings season has largely been mixed so far, reflecting the impact of the economic uncertainties on profit growth. That said, data suggests S&P 500 companies may be on track to break a fourth-quarter earnings-declining streak.",https://cdn.benzinga.com/files/images/story/2023/Stocks_Photo_by_Phongphan_on_Shutterstock_16.jpeg?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.891286'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.999813'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.155659,Somewhat-Bullish,"[{'ticker': 'DD', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSTR', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MTH', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.195087', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.026184', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LSCC', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.043264', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EXAS', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KHC', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CLX', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CHKP', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VNO', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WDC', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.129284', 'ticker_sentiment_score': '-0.016206', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'YUMC', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.195087', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EA', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DKNG', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.0864', 'ticker_sentiment_score': '-0.10532', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BLCO', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAH', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SIRI', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOX', 'relevance_score': '0.043264', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'YUM', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FSLR', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.195087', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CAR', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.185074', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EAT', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SOFI', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BHC', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MAR', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVS', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WEN', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.185074', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'D', 'relevance_score': '0.043264', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PARA', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PTON', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EXPE', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'H', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRO', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SRGRF', 'relevance_score': '0.043264', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TXN', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.284455', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'THC', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BUD', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.284455', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NCLH', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.129284', 'ticker_sentiment_score': '0.104299', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PINS', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPWR', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ON', 'relevance_score': '0.043264', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLTR', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PYPL', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.0864', 'ticker_sentiment_score': '-0.10532', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JBLU', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LYV', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SWKS', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.284455', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WOLF', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REGN', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.0864', 'ticker_sentiment_score': '0.284455', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
188,"Bulls And Bears: Tesla, Chevron, Eli Lilly And Dogecoin Co-founder's 3 Favorite Cryptos",https://www.benzinga.com/trading-ideas/long-ideas/23/10/35465080/benzinga-bulls-and-bears-tesla-chevron-eli-lilly-and-dogecoin-co-founders-3-favorite-cry,20231028T124902,['Michael Cohen'],"Benzinga examined the prospects for many investors' favorite stocks over the last week - here's a look at some of our top stories. This week saw significant declines in major averages, with the Dow, S&P 500, and Nasdaq dropping by 2.1%, 2.5%, and 2.6%, respectively.",https://cdn.benzinga.com/files/images/story/2023/10/27/bulls_bears6.png?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.1194,Neutral,"[{'ticker': 'GOOG', 'relevance_score': '0.124164', 'ticker_sentiment_score': '-0.205346', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'META', 'relevance_score': '0.124164', 'ticker_sentiment_score': '-0.205346', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NVDA', 'relevance_score': '0.124164', 'ticker_sentiment_score': '-0.205346', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSLA', 'relevance_score': '0.185306', 'ticker_sentiment_score': '-0.134878', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.185306', 'ticker_sentiment_score': '0.26513', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.124164', 'ticker_sentiment_score': '0.1605', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HES', 'relevance_score': '0.303926', 'ticker_sentiment_score': '0.381027', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.124164', 'ticker_sentiment_score': '0.1605', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.185306', 'ticker_sentiment_score': '0.273737', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CRYPTO:ETH', 'relevance_score': '0.124164', 'ticker_sentiment_score': '0.216949', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CRYPTO:DOGE', 'relevance_score': '0.185306', 'ticker_sentiment_score': '0.273737', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
189,"Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?",https://www.fool.com/investing/2023/10/28/roche-lilly-or-pfizer-whos-the-winner-in-ibd-wars/,20231028T124500,['Jim Halley'],The three companies are spending big on IBD therapies.,https://g.foolcdn.com/editorial/images/752299/group-of-medical-practitioners-having-a-seminar-in-board-room.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Earnings', 'relevance_score': '0.999975'}]",0.135664,Neutral,"[{'ticker': 'BBY', 'relevance_score': '0.036532', 'ticker_sentiment_score': '0.138123', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.216537', 'ticker_sentiment_score': '0.11901', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROIV', 'relevance_score': '0.036532', 'ticker_sentiment_score': '0.072581', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.353059', 'ticker_sentiment_score': '0.078417', 'ticker_sentiment_label': 'Neutral'}]"
190,Eli Lilly and Company  ( NYSE:LLY )  Stock Rating Lowered by StockNews.com,https://www.defenseworld.net/2023/10/28/eli-lilly-and-company-nyselly-stock-rating-lowered-by-stocknews-com.html,20231028T054845,['Defense World Staff'],Eli Lilly and Company ( NYSE:LLY ) Stock Rating Lowered by ... Defense World ...,https://www.marketbeat.com/logos/logo_eli_lilly.jpg,Stocknews.com,n/a,www.defenseworld.net,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.986564'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.223325,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.769861', 'ticker_sentiment_score': '0.36356', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'TFC', 'relevance_score': '0.039878', 'ticker_sentiment_score': '0.045582', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.039878', 'ticker_sentiment_score': '0.045582', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.039878', 'ticker_sentiment_score': '0.045582', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.039878', 'ticker_sentiment_score': '0.045582', 'ticker_sentiment_label': 'Neutral'}]"
191,"Apple, Fed Meeting, Caterpillar, Jobs Report; Investing Action Plan",https://www.investors.com/research/investing-action-plan/apple-fed-meeting-caterpillar-jobs-report-investing-action-plan/,20231027T215300,"['ALAN R. ELLIOTT', ""Investor's Business Daily""]","Apple, Fed Meeting, Caterpillar, Jobs Report. Investing Action Plan Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2023/10/Stock-mannequinapple-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.99999'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.100088,Neutral,"[{'ticker': 'CVS', 'relevance_score': '0.052493', 'ticker_sentiment_score': '0.008988', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROKU', 'relevance_score': '0.052493', 'ticker_sentiment_score': '0.075', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.069951', 'ticker_sentiment_score': '0.015119', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANET', 'relevance_score': '0.052493', 'ticker_sentiment_score': '0.003991', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.017509', 'ticker_sentiment_score': '0.117232', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CROX', 'relevance_score': '0.035009', 'ticker_sentiment_score': '0.066673', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.104759', 'ticker_sentiment_score': '0.056462', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.069951', 'ticker_sentiment_score': '0.019329', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.052493', 'ticker_sentiment_score': '0.093934', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BUD', 'relevance_score': '0.035009', 'ticker_sentiment_score': '0.121518', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.104759', 'ticker_sentiment_score': '0.069871', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SHOP', 'relevance_score': '0.035009', 'ticker_sentiment_score': '0.012525', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.035009', 'ticker_sentiment_score': '0.176478', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'QCOM', 'relevance_score': '0.035009', 'ticker_sentiment_score': '-0.017404', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.052493', 'ticker_sentiment_score': '-0.048998', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.035009', 'ticker_sentiment_score': '0.01861', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SHEN', 'relevance_score': '0.035009', 'ticker_sentiment_score': '-0.004844', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DBX', 'relevance_score': '0.052493', 'ticker_sentiment_score': '0.152599', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PAYC', 'relevance_score': '0.035009', 'ticker_sentiment_score': '0.055611', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SQ', 'relevance_score': '0.035009', 'ticker_sentiment_score': '0.02226', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PYPL', 'relevance_score': '0.035009', 'ticker_sentiment_score': '0.045334', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.052493', 'ticker_sentiment_score': '0.003991', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CF', 'relevance_score': '0.052493', 'ticker_sentiment_score': '0.016038', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SYK', 'relevance_score': '0.035009', 'ticker_sentiment_score': '0.055832', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COR', 'relevance_score': '0.052493', 'ticker_sentiment_score': '0.006', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CBOE', 'relevance_score': '0.035009', 'ticker_sentiment_score': '0.250018', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CAH', 'relevance_score': '0.052493', 'ticker_sentiment_score': '0.006', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SWKS', 'relevance_score': '0.035009', 'ticker_sentiment_score': '0.071169', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCK', 'relevance_score': '0.052493', 'ticker_sentiment_score': '0.006', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ETSY', 'relevance_score': '0.052493', 'ticker_sentiment_score': '0.092997', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FTNT', 'relevance_score': '0.035009', 'ticker_sentiment_score': '0.080794', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.104759', 'ticker_sentiment_score': '0.012288', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.052493', 'ticker_sentiment_score': '0.093934', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.017509', 'ticker_sentiment_score': '0.020325', 'ticker_sentiment_label': 'Neutral'}]"
192,"Bears Roam Wall Street As Middle East Conflict, Earnings Outlook Raise Concerns Despite Strong Q3 US Economic Growth: This Week In Markets - CVS Health  ( NYSE:CVS ) , Enphase Energy  ( NASDAQ:ENPH ) , Alphabet  ( NASDAQ:GOOGL ) , Apple  ( NASDAQ:AAPL ) ",https://www.benzinga.com/news/earnings/23/10/35474151/bears-roam-wall-street-as-middle-east-conflict-earnings-outlook-raise-concerns-despite-strong-q3-us,20231027T203357,['Piero Cingari'],"It has been another week of volatility in the stock market, characterized by mounting fears of a wider Middle East conflict and a more cautious fourth-quarter earnings outlook announced by U.S. corporations.",https://cdn.benzinga.com/files/images/story/2023/Bearish_stock_chart..jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.995921'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.795202'}]",0.151583,Somewhat-Bullish,"[{'ticker': 'BLK', 'relevance_score': '0.046816', 'ticker_sentiment_score': '0.123827', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVS', 'relevance_score': '0.09347', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDLZ', 'relevance_score': '0.09347', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.09347', 'ticker_sentiment_score': '-0.055253', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.046816', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABNB', 'relevance_score': '0.09347', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALGN', 'relevance_score': '0.09347', 'ticker_sentiment_score': '0.057667', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.046816', 'ticker_sentiment_score': '0.094925', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.09347', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.09347', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PDD', 'relevance_score': '0.09347', 'ticker_sentiment_score': '0.204728', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SBUX', 'relevance_score': '0.09347', 'ticker_sentiment_score': '-0.055253', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.09347', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.09347', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.09347', 'ticker_sentiment_score': '-0.055253', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPGI', 'relevance_score': '0.09347', 'ticker_sentiment_score': '-0.055253', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WTW', 'relevance_score': '0.09347', 'ticker_sentiment_score': '0.204728', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BKNG', 'relevance_score': '0.09347', 'ticker_sentiment_score': '-0.055253', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WHR', 'relevance_score': '0.09347', 'ticker_sentiment_score': '0.057667', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.139804', 'ticker_sentiment_score': '0.004048', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.09347', 'ticker_sentiment_score': '-0.119207', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COP', 'relevance_score': '0.09347', 'ticker_sentiment_score': '-0.055253', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROL', 'relevance_score': '0.09347', 'ticker_sentiment_score': '0.204728', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MCD', 'relevance_score': '0.09347', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.09347', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.09347', 'ticker_sentiment_score': '0.233308', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.27535', 'ticker_sentiment_score': '0.25509', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
193,"Pharma Stock Roundup: SNY, MRK, NVS Report Q3 Earnings, FDA Okays PFE, LLY Products",https://www.zacks.com/stock/news/2173795/pharma-stock-roundup-sny-mrk-nvs-report-q3-earnings-fda-okays-pfe-lly-products,20231027T140500,['Kinjel Shah'],"Merck (MRK), Sanofi (SNY) and Novartis (NVS) report third-quarter results. FDA approves Pfizer's (PFE) Penbraya and Eli ...",https://staticx-tuner.zacks.com/images/articles/main/13/11325.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.9545'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.187911,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.149656', 'ticker_sentiment_score': '-0.049789', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROIV', 'relevance_score': '0.075161', 'ticker_sentiment_score': '0.095328', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.294093', 'ticker_sentiment_score': '0.163231', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BNTX', 'relevance_score': '0.037622', 'ticker_sentiment_score': '0.076864', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.149656', 'ticker_sentiment_score': '0.017879', 'ticker_sentiment_label': 'Neutral'}]"
194,Weight-Loss Beating Continues For Devices Makers; Why It's Overdone,https://www.investors.com/news/technology/weight-loss-drugs-spook-medical-device-stocks-an-overreaction/,20231027T130000,"['ALLISON GATLIN', ""Investor's Business Daily""]",Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/10/IT2c103023-300x171.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.997405'}, {'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.093424,Neutral,"[{'ticker': 'INSP', 'relevance_score': '0.034907', 'ticker_sentiment_score': '-0.017925', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZBH', 'relevance_score': '0.034907', 'ticker_sentiment_score': '0.125221', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.017458', 'ticker_sentiment_score': '-0.108231', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.087122', 'ticker_sentiment_score': '0.080517', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RMD', 'relevance_score': '0.034907', 'ticker_sentiment_score': '0.125221', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MASI', 'relevance_score': '0.034907', 'ticker_sentiment_score': '0.23697', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMGN', 'relevance_score': '0.034907', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DVA', 'relevance_score': '0.087122', 'ticker_sentiment_score': '0.002112', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.034907', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EW', 'relevance_score': '0.034907', 'ticker_sentiment_score': '0.23697', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FSNUF', 'relevance_score': '0.017458', 'ticker_sentiment_score': '0.047327', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.069748', 'ticker_sentiment_score': '0.111489', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PODD', 'relevance_score': '0.034907', 'ticker_sentiment_score': '0.099119', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SLNO', 'relevance_score': '0.017458', 'ticker_sentiment_score': '0.014131', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.05234', 'ticker_sentiment_score': '0.026937', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DXCM', 'relevance_score': '0.121738', 'ticker_sentiment_score': '0.072049', 'ticker_sentiment_label': 'Neutral'}]"
195,Earnings Preview: Eli Lilly  ( LLY )  Q3 Earnings Expected to Decline,https://www.zacks.com/stock/news/2172796/earnings-preview-eli-lilly-lly-q3-earnings-expected-to-decline,20231026T140225,['Zacks Equity Research'],Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,https://staticx-tuner.zacks.com/images/default_article_images/default56.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.112273,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.260652', 'ticker_sentiment_score': '0.009872', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.175539', 'ticker_sentiment_score': '-0.025752', 'ticker_sentiment_label': 'Neutral'}]"
196,Will Eli Lilly Stock Be Worth More Than Tesla Stock by 2030?,https://www.fool.com/investing/2023/10/26/will-eli-lilly-stock-be-worth-more-than-tesla-stoc/,20231026T130500,['David Jagielski'],The difference in market cap between these two companies is approximately $150 billion right now.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.839681'}]",0.152907,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.559221', 'ticker_sentiment_score': '0.379866', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.479385', 'ticker_sentiment_score': '0.254853', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
197,Merck  ( MRK )  Q3 Earnings and Revenues Beat Estimates,https://www.zacks.com/stock/news/2172414/merck-mrk-q3-earnings-and-revenues-beat-estimates,20231026T115013,['Zacks Equity Research'],"Merck (MRK) delivered earnings and revenue surprises of 9.79% and 3.80%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?",https://staticx-tuner.zacks.com/images/default_article_images/default78.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999953'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.116826,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.139265', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
198,Eli Lilly  ( LLY )  to Report Q3 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2172391/eli-lilly-lly-to-report-q3-earnings-whats-in-the-cards,20231026T114000,['Zacks Equity Research'],"On Eli Lilly's (LLY) third-quarter conference call, investor focus is likely to be on the sales of its new diabetes drug, Mounjaro.",https://staticx-tuner.zacks.com/images/articles/main/ca/2357.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999992'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}]",0.10472,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.417304', 'ticker_sentiment_score': '0.022949', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.173958', 'ticker_sentiment_score': '0.050098', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.216473', 'ticker_sentiment_score': '0.025286', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.216473', 'ticker_sentiment_score': '-0.026882', 'ticker_sentiment_label': 'Neutral'}]"
199,Eli Lilly  ( LLY )  Stock Moves -1.01%: What You Should Know,https://www.zacks.com/stock/news/2172042/eli-lilly-lly-stock-moves--101-what-you-should-know,20231025T214517,['Zacks Equity Research'],"Eli Lilly (LLY) closed at $586.46 in the latest trading session, marking a -1.01% move from the prior day.",https://staticx-tuner.zacks.com/images/default_article_images/default267.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.995921'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.130817,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.532556', 'ticker_sentiment_score': '0.203855', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
200,Doug Kass: Investing in a Storm,https://realmoney.thestreet.com/investing/doug-kass-investing-in-a-storm-16136395,20231025T180000,['Doug Kass'],"If we have had one consistent message over the last two years, it is that there is a broadening list of uncertainties that could lead to a wide range of outcomes and result in lower stock market valuations.",https://s.thestreet.com/files/tsc/v2008/photos/contrib/uploads/86042ef9-7321-11ee-b0ee-31878339afac_564x376.png,The Street,GoogleRSS,realmoney.thestreet.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.972193'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.088054,Neutral,"[{'ticker': 'PARA', 'relevance_score': '0.02671', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WOOF', 'relevance_score': '0.02671', 'ticker_sentiment_score': '-0.05074', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVEI', 'relevance_score': '0.02671', 'ticker_sentiment_score': '-0.05074', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNBR', 'relevance_score': '0.02671', 'ticker_sentiment_score': '-0.05074', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OXY', 'relevance_score': '0.02671', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.02671', 'ticker_sentiment_score': '-0.05074', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.02671', 'ticker_sentiment_score': '-0.05074', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DWAC', 'relevance_score': '0.02671', 'ticker_sentiment_score': '-0.05074', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GRBK', 'relevance_score': '0.02671', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MPW', 'relevance_score': '0.02671', 'ticker_sentiment_score': '-0.05074', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.02671', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HRMY', 'relevance_score': '0.02671', 'ticker_sentiment_score': '-0.05074', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.02671', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CHGG', 'relevance_score': '0.02671', 'ticker_sentiment_score': '-0.05074', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.02671', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FRHC', 'relevance_score': '0.02671', 'ticker_sentiment_score': '-0.05074', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.02671', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XPOF', 'relevance_score': '0.02671', 'ticker_sentiment_score': '-0.05074', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.013357', 'ticker_sentiment_score': '-0.04612', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NYT', 'relevance_score': '0.013357', 'ticker_sentiment_score': '-0.106941', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKE', 'relevance_score': '0.02671', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.02671', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LEE', 'relevance_score': '0.02671', 'ticker_sentiment_score': '-0.05074', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROL', 'relevance_score': '0.02671', 'ticker_sentiment_score': '-0.05074', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IOT', 'relevance_score': '0.02671', 'ticker_sentiment_score': '-0.05074', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FRPT', 'relevance_score': '0.02671', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.013357', 'ticker_sentiment_score': '0.116961', 'ticker_sentiment_label': 'Neutral'}]"
201,Investors Scurry To Buy 14 Soaring Stocks As Market Sells Off,https://www.investors.com/etfs-and-funds/sectors/sp500-investors-scurry-to-buy-soaring-stocks-as-market-sells-off/,20231025T120000,"[""Investor's Business Daily"", 'MATT KRANTZ']","Don't assume that all S&P 500 stocks are struggling. A small group are actually thriving, thank you.",https://www.investors.com/wp-content/uploads/2016/07/IC_cash_071516_adobe.jpeg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.298627,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.330876', 'ticker_sentiment_score': '0.297051', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SPGI', 'relevance_score': '0.068112', 'ticker_sentiment_score': '0.103744', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PGR', 'relevance_score': '0.202366', 'ticker_sentiment_score': '0.315056', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CEG', 'relevance_score': '0.202366', 'ticker_sentiment_score': '0.172375', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
202,This Is What Whales Are Betting On Eli Lilly - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/10/35396723/this-is-what-whales-are-betting-on-eli-lilly,20231024T150109,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 21 strange trades. If we consider the specifics of each trade, it is accurate to state that 28% of the investors opened trades with bullish ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.107079,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.718485', 'ticker_sentiment_score': '-0.030766', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.122269', 'ticker_sentiment_score': '-0.132548', 'ticker_sentiment_label': 'Neutral'}]"
203,Eli Lilly and Company  ( LLY )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2170716/eli-lilly-and-company-lly-is-a-trending-stock-facts-to-know-before-betting-on-it,20231024T130009,['Zacks Equity Research'],"Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default56.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999998'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}]",0.237864,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.525907', 'ticker_sentiment_score': '0.112892', 'ticker_sentiment_label': 'Neutral'}]"
204,"Why Coke, others, may be spared, as a $100 billion opportunity in weight loss drugs unfolds says JPMorgan",https://www.marketwatch.com/story/the-weight-loss-drugs-are-coming-for-these-companies-but-heres-why-coke-others-may-be-spared-says-jpmorgan-c6c24538,20231024T104200,['Barbara Kollmeyer'],"JPMorgan says the weight-loss drug industry is now a ""$100 billion plus opportunity."" Coke is one of the stocks they say is likely to get hit less hard.",https://images.mktw.net/im-874075?width=700&height=763,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}]",0.129162,Neutral,"[{'ticker': 'KO', 'relevance_score': '0.126784', 'ticker_sentiment_score': '0.038342', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTLT', 'relevance_score': '0.084722', 'ticker_sentiment_score': '0.067688', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.084722', 'ticker_sentiment_score': '0.116945', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.126784', 'ticker_sentiment_score': '0.019258', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.084722', 'ticker_sentiment_score': '-0.045214', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.126784', 'ticker_sentiment_score': '0.095915', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HPNN', 'relevance_score': '0.042421', 'ticker_sentiment_score': '0.243126', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TXN', 'relevance_score': '0.084722', 'ticker_sentiment_score': '0.116945', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVTR', 'relevance_score': '0.084722', 'ticker_sentiment_score': '0.067688', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DASH', 'relevance_score': '0.084722', 'ticker_sentiment_score': '0.140662', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DHR', 'relevance_score': '0.084722', 'ticker_sentiment_score': '0.067688', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.126784', 'ticker_sentiment_score': '0.182706', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.042421', 'ticker_sentiment_score': '0.243126', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KDP', 'relevance_score': '0.084722', 'ticker_sentiment_score': '0.142685', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.084722', 'ticker_sentiment_score': '0.116945', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.084722', 'ticker_sentiment_score': '0.083395', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RGEN', 'relevance_score': '0.084722', 'ticker_sentiment_score': '0.067688', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.084722', 'ticker_sentiment_score': '-0.10898', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PODD', 'relevance_score': '0.084722', 'ticker_sentiment_score': '0.211781', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SFM', 'relevance_score': '0.084722', 'ticker_sentiment_score': '0.142685', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.084722', 'ticker_sentiment_score': '0.140662', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DXCM', 'relevance_score': '0.084722', 'ticker_sentiment_score': '0.211781', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WMT', 'relevance_score': '0.084722', 'ticker_sentiment_score': '-0.10898', 'ticker_sentiment_label': 'Neutral'}]"
205,Eli Lilly Unusual Options Activity For October 23 - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/10/35383700/eli-lilly-unusual-options-activity-for-october-23,20231023T204542,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bearish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.07335,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.805954', 'ticker_sentiment_score': '0.178416', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WFC', 'relevance_score': '0.103331', 'ticker_sentiment_score': '-0.124574', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.103331', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
206,Should First Trust Capital Strength ETF  ( FTCS )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2170081/should-first-trust-capital-strength-etf-ftcs-be-on-your-investing-radar,20231023T102005,['Zacks Equity Research'],Style Box ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default296.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.262161,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.127795', 'ticker_sentiment_score': '0.060366', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CSCO', 'relevance_score': '0.127795', 'ticker_sentiment_score': '0.060366', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TJX', 'relevance_score': '0.127795', 'ticker_sentiment_score': '0.060366', 'ticker_sentiment_label': 'Neutral'}]"
207,"Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market? - Alphabet  ( NASDAQ:GOOGL ) , Logitech International  ( NASDAQ:LOGI ) , Archer-Daniels Midland  ( NYSE:ADM ) , Novartis  ( NYSE:NVS ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35367409/amazon-alphabet-meta-intel-q3-earnings-this-week-will-mega-caps-shatter-forecasts-a,20231023T071517,['Shanthi Rexaline'],"After the first week of earnings, analysts have tempered their expectations for profit growth, anticipating a continuation of the profit-declining trend.",https://cdn.benzinga.com/files/images/story/2023/Q3_Earnings.jpeg?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '0.744043'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '0.998645'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.117862,Neutral,"[{'ticker': 'LOGI', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADM', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STM', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.104228', 'ticker_sentiment_score': '-0.100479', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DFS', 'relevance_score': '0.104228', 'ticker_sentiment_score': '-0.182444', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSLA', 'relevance_score': '0.104228', 'ticker_sentiment_score': '-0.182444', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'MA', 'relevance_score': '0.052226', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ORLY', 'relevance_score': '0.104228', 'ticker_sentiment_score': '-0.172658', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'STX', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NSC', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XRX', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AA', 'relevance_score': '0.104228', 'ticker_sentiment_score': '-0.182444', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'META', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MO', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOC', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPOT', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOK', 'relevance_score': '0.104228', 'ticker_sentiment_score': '-0.182444', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PKG', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EW', 'relevance_score': '0.104228', 'ticker_sentiment_score': '-0.172658', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'XOM', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RCL', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CHTR', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HPE', 'relevance_score': '0.104228', 'ticker_sentiment_score': '-0.182444', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'VZ', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'F', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HPQ', 'relevance_score': '0.052226', 'ticker_sentiment_score': '-0.16858', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TXN', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BYD', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HTZ', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.155786', 'ticker_sentiment_score': '0.065554', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PHM', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IBM', 'relevance_score': '0.104228', 'ticker_sentiment_score': '-0.172658', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LLY', 'relevance_score': '0.104228', 'ticker_sentiment_score': '-0.100479', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COF', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GD', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GE', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KLAC', 'relevance_score': '0.104228', 'ticker_sentiment_score': '-0.172658', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'GOOG', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CL', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LUV', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNAP', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CP', 'relevance_score': '0.104228', 'ticker_sentiment_score': '-0.172658', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'BMY', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TMUS', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HAL', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SEDG', 'relevance_score': '0.104228', 'ticker_sentiment_score': '-0.182444', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'INTC', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CCZ', 'relevance_score': '0.052226', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ODFL', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
208,3 Unstoppable Stocks to Buy Sooner Rather Than Later,https://www.fool.com/investing/2023/10/22/3-unstoppable-stocks-to-buy-sooner-rather-than-lat/,20231022T105500,"['and Prosper Junior Bakiny', 'David Jagielski', 'Keith Speights']",Now is the time to invest in these great stocks.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.796627'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.172773,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.287441', 'ticker_sentiment_score': '0.100872', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.166743', 'ticker_sentiment_score': '0.014889', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.326283', 'ticker_sentiment_score': '0.046633', 'ticker_sentiment_label': 'Neutral'}]"
209,The top 10 things to watch in the stock market Friday,https://www.cnbc.com/2023/10/20/the-top-10-things-to-watch-in-the-stock-market-friday.html,20231020T131905,['Jeff Marks'],"Will the yield on the 10-year Treasury breach 5% Friday, and how will markets react?",https://image.cnbcfm.com/api/v1/image/107123736-1663957784492-gettyimages-482832746-000070312695_Unapproved.jpeg?v=1697807945&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.997405'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.995015'}]",0.173123,Somewhat-Bullish,"[{'ticker': 'F', 'relevance_score': '0.13459', 'ticker_sentiment_score': '0.176393', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GM', 'relevance_score': '0.13459', 'ticker_sentiment_score': '0.176393', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.067536', 'ticker_sentiment_score': '0.145206', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.13459', 'ticker_sentiment_score': '-0.06791', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNP', 'relevance_score': '0.13459', 'ticker_sentiment_score': '0.174759', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.200688', 'ticker_sentiment_score': '0.159599', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SLB', 'relevance_score': '0.067536', 'ticker_sentiment_score': '0.07438', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.13459', 'ticker_sentiment_score': '0.123096', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.067536', 'ticker_sentiment_score': '-0.114966', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.13459', 'ticker_sentiment_score': '0.012275', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.200688', 'ticker_sentiment_score': '0.229', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
210,"Pharma Stock Roundup: JNJ Posts Upbeat Q3 Earnings, PFE, NVO Revise 2023 View",https://www.zacks.com/stock/news/2169495/pharma-stock-roundup-jnj-posts-upbeat-q3-earnings-pfe-nvo-revise-2023-view,20231020T130200,['Kinjel Shah'],J&J (JNJ) reports strong third-quarter results. Merck's (MRK) new deal with Japan's Daiichi Sankyo to jointly develop the latter's three DXd ADC candidates.,https://staticx-tuner.zacks.com/images/articles/main/f5/952.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.994953'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.102884,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.064362', 'ticker_sentiment_score': '-0.153214', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'SKXJF', 'relevance_score': '0.128306', 'ticker_sentiment_score': '-0.016733', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSKYF', 'relevance_score': '0.128306', 'ticker_sentiment_score': '-0.016733', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.032207', 'ticker_sentiment_score': '-0.277037', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NVO', 'relevance_score': '0.222546', 'ticker_sentiment_score': '0.12752', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.253316', 'ticker_sentiment_score': '-0.128908', 'ticker_sentiment_label': 'Neutral'}]"
211,Eli Lilly and Company  ( NYSE:LLY )  Rating Lowered to Hold at StockNews.com,https://www.defenseworld.net/2023/10/20/eli-lilly-and-company-nyselly-rating-lowered-to-hold-at-stocknews-com.html,20231020T064041,['Defense World Staff'],Eli Lilly and Company ( NYSE:LLY ) Rating Lowered to Hold at ... Defense World ...,https://www.marketbeat.com/logos/logo_eli_lilly.jpg,Stocknews.com,n/a,www.defenseworld.net,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999999'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.988915'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.203596,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.794507', 'ticker_sentiment_score': '0.33678', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'XXII', 'relevance_score': '0.043898', 'ticker_sentiment_score': '0.024569', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RBCPF', 'relevance_score': '0.043898', 'ticker_sentiment_score': '0.024569', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.043898', 'ticker_sentiment_score': '0.024569', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.043898', 'ticker_sentiment_score': '0.024569', 'ticker_sentiment_label': 'Neutral'}]"
212,Pressure Mounts As Yields Flirt With 5%; Fear Gauge Offers Hope,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-pressure-mounts-as-yields-flirt-with-5-tesla-dives-this-market-gauge-offers-hope/,20231019T203200,"[""Investor's Business Daily"", 'ED CARSON']",Pressure Mounts As Yields Flirt With 5%. Fear Gauge Offers Hope Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2018/01/FAB-fear-020518-shutterstock.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.95493'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",-0.053454,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.236588', 'ticker_sentiment_score': '0.089875', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.079921', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANET', 'relevance_score': '0.159043', 'ticker_sentiment_score': '-0.05506', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.210961', 'ticker_sentiment_score': '0.005183', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.05333', 'ticker_sentiment_score': '-0.271887', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'UNP', 'relevance_score': '0.05333', 'ticker_sentiment_score': '-0.159029', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'ADBE', 'relevance_score': '0.185103', 'ticker_sentiment_score': '0.021017', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.05333', 'ticker_sentiment_score': '-0.271887', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'SLB', 'relevance_score': '0.106423', 'ticker_sentiment_score': '0.112494', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.106423', 'ticker_sentiment_score': '-0.230299', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PLTR', 'relevance_score': '0.106423', 'ticker_sentiment_score': '0.010019', 'ticker_sentiment_label': 'Neutral'}]"
213,Stock Market Erases Gains And Here Comes Powell; Tesla Stock Has This Problem,https://www.investors.com/market-trend/stock-market-today/stock-market-erases-gains-here-comes-powell-teslas-chart-becomes-deformed/,20231019T144700,"['JUAN CARLOS ARANCIBIA', ""Investor's Business Daily""]",Stock Market Erases Gains And Here Comes Powell. Tesla Stock ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2022/06/Stock-jeromepowell2022-03-gov.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.795202'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.055338,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.175009', 'ticker_sentiment_score': '0.326468', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.175009', 'ticker_sentiment_score': '-0.021979', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BX', 'relevance_score': '0.1172', 'ticker_sentiment_score': '-0.076821', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.1172', 'ticker_sentiment_score': '-0.089813', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.175009', 'ticker_sentiment_score': '0.012121', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LVS', 'relevance_score': '0.1172', 'ticker_sentiment_score': '0.244611', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMGN', 'relevance_score': '0.1172', 'ticker_sentiment_score': '-0.089813', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.1172', 'ticker_sentiment_score': '-0.089813', 'ticker_sentiment_label': 'Neutral'}]"
214,1 Market-Beating Stock to Buy Near Its 52-Week High,https://www.fool.com/investing/2023/10/19/1-market-beating-stock-to-buy-near-52-week-high/,20231019T133000,['Prosper Junior Bakiny'],This stock has been firing on all cylinders -- and it isn't about to stop.,https://media.ycharts.com/charts/a1505ef731280b97dff5e5bf069c8c9a.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.282021,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.268', 'ticker_sentiment_score': '0.214712', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ACCD', 'relevance_score': '0.054607', 'ticker_sentiment_score': '-0.063291', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.108958', 'ticker_sentiment_score': '0.011564', 'ticker_sentiment_label': 'Neutral'}]"
215,"4 Ways to Grow $100,000 Into $1 Million for Retirement",https://www.fool.com/investing/2023/10/19/4-ways-to-grow-100000-into-1-million-for-retiremen/,20231019T131300,['Jim Halley'],Investing for big-time growth doesn't have to be risky.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}, {'topic': 'Earnings', 'relevance_score': '0.999966'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.206499,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.115787', 'ticker_sentiment_score': '0.122393', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.077343', 'ticker_sentiment_score': '0.050792', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.077343', 'ticker_sentiment_score': '0.055791', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.115787', 'ticker_sentiment_score': '0.097293', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'O', 'relevance_score': '0.115787', 'ticker_sentiment_score': '0.0852', 'ticker_sentiment_label': 'Neutral'}]"
216,1 Thing You'd Better Know Before You Invest in the Stocks Behind Ozempic and Mounjaro,https://www.fool.com/investing/2023/10/19/1-thing-you-better-know-before-invest-in-ozempic/,20231019T130000,['Adam Spatacco'],Eli Lilly and Novo Nordisk are both battling demand issues for flagship treatments.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F750321%2Fgettyimages-1404901940.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}]",0.215497,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.52706', 'ticker_sentiment_score': '0.344682', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WBD', 'relevance_score': '0.038162', 'ticker_sentiment_score': '0.041449', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.58401', 'ticker_sentiment_score': '0.334632', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
217,Eli Lilly Unusual Options Activity - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/10/35310788/eli-lilly-unusual-options-activity,20231018T144640,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 25 strange trades. If we consider the specifics of each trade, it is accurate to state that 52% of the investors opened trades with bullish ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.132907,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.767534', 'ticker_sentiment_score': '0.094594', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.118647', 'ticker_sentiment_score': '-0.130868', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.118647', 'ticker_sentiment_score': '-0.130868', 'ticker_sentiment_label': 'Neutral'}]"
218,Eli Lilly  ( LLY )  Registers a Bigger Fall Than the Market: Important Facts to Note,https://www.zacks.com/stock/news/2167524/eli-lilly-lly-registers-a-bigger-fall-than-the-market-important-facts-to-note,20231017T214518,['Zacks Equity Research'],"Eli Lilly (LLY) reachead $608.31 at the closing of the latest trading day, reflecting a -1.35% change compared to its last close.",https://staticx-tuner.zacks.com/images/default_article_images/default147.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.961735'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.093858,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.52949', 'ticker_sentiment_score': '0.142668', 'ticker_sentiment_label': 'Neutral'}]"
219,"Here's what Ozempic, ASML and India's fintech industry all have in common - and how one ETF takes advantage of all three",https://www.marketwatch.com/story/heres-what-ozempic-asml-and-indias-fintech-industry-all-have-in-common-and-how-one-etf-takes-advantage-of-all-three-70d1260a,20231017T125500,['Philip van Doorn'],C Worldwide Thematic Specialist Morten Springborg says his firm has outperformed by taking a much longer-term approach than is usual for money managers.,https://images.mktw.net/im-869481/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.996718'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}]",0.140845,Neutral,"[{'ticker': 'SMAWF', 'relevance_score': '0.030958', 'ticker_sentiment_score': '0.104133', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.030958', 'ticker_sentiment_score': '-0.170054', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NVO', 'relevance_score': '0.061869', 'ticker_sentiment_score': '0.046002', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HDB', 'relevance_score': '0.123367', 'ticker_sentiment_score': '0.048738', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.061869', 'ticker_sentiment_score': '0.068006', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATLKY', 'relevance_score': '0.030958', 'ticker_sentiment_score': '0.020023', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ASML', 'relevance_score': '0.153863', 'ticker_sentiment_score': '0.054463', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.092688', 'ticker_sentiment_score': '-0.029482', 'ticker_sentiment_label': 'Neutral'}]"
220,Ozempic Sales Are Skyrocketing Faster Than Expected. Here's Why That's Great News for Eli Lilly Stock.,https://www.fool.com/investing/2023/10/17/ozempic-sales-are-skyrocketing-faster-than-expecte/,20231017T095000,['Keith Speights'],What's good for Novo Nordisk's Ozempic is also good for Eli Lilly's Mounjaro.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.309608,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.455525', 'ticker_sentiment_score': '0.390074', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.350564', 'ticker_sentiment_score': '0.462387', 'ticker_sentiment_label': 'Bullish'}]"
221,Are Ozempic and Similar Treatments Impacting Food and Beverage Stocks? Here's What Pepsi's CFO Said About It,https://www.fool.com/investing/2023/10/14/are-ozempic-and-similar-treatments-impacting-food/,20231014T120300,['Adam Spatacco'],PepsiCo's Q3 earnings may have shed some light on the long-standing speculation about Ozempic's impact on consumer staples.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F750584%2Fgettyimages-1630177922.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.875462'}]",0.185148,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.066784', 'ticker_sentiment_score': '0.065477', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.38489', 'ticker_sentiment_score': '0.263266', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KO', 'relevance_score': '0.066784', 'ticker_sentiment_score': '0.025221', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.198493', 'ticker_sentiment_score': '0.103525', 'ticker_sentiment_label': 'Neutral'}]"
222,3 Dividend Growth Stocks You Can Buy and Hold Forever,https://www.fool.com/investing/2023/10/14/3-dividend-growth-stocks-you-can-buy-and-hold-fore/,20231014T105200,"['Keith Speights', 'and Prosper Junior Bakiny', 'David Jagielski']",Investors can sit back and let the dividends flow in with these great stocks.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.803643'}]",0.201977,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.353338', 'ticker_sentiment_score': '0.11404', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.278561', 'ticker_sentiment_score': '0.130001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.316337', 'ticker_sentiment_score': '0.229411', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
223,Jamie Dimon says it's 'the most dangerous time the world has seen in decades.' Here are all the ripple effects.,https://www.marketwatch.com/story/how-to-find-financial-opportunities-in-what-jamie-dimon-calls-the-most-dangerous-time-the-world-has-seen-in-decades-8a363023,20231013T163000,['Philip van Doorn'],"Also, hope for housing, close looks at choices for bond investors, a busted IPO and sound advice from the Moneyist.",https://images.mktw.net/im-867562?width=700&height=466,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.310843'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.079738,Neutral,"[{'ticker': 'JPM', 'relevance_score': '0.06623', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.06623', 'ticker_sentiment_score': '0.136302', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.06623', 'ticker_sentiment_score': '0.253983', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.06623', 'ticker_sentiment_score': '0.136302', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.099202', 'ticker_sentiment_score': '0.103922', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RDFN', 'relevance_score': '0.033144', 'ticker_sentiment_score': '0.199051', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PXD', 'relevance_score': '0.06623', 'ticker_sentiment_score': '0.253983', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WMT', 'relevance_score': '0.06623', 'ticker_sentiment_score': '-0.027173', 'ticker_sentiment_label': 'Neutral'}]"
224,Eli Lilly's  ( LLY )  Mirikizumab Meets Crohn's Disease Study Goals,https://www.zacks.com/stock/news/2165822/eli-lillys-lly-mirikizumab-meets-crohns-disease-study-goals,20231013T162900,['Zacks Equity Research'],"Based on this data, Eli Lilly (LLY) will initiate regulatory submissions worldwide next year seeking regulatory approval for mirikizumab in Crohn's disease.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.769861'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.155568,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.601928', 'ticker_sentiment_score': '0.327734', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CORT', 'relevance_score': '0.387875', 'ticker_sentiment_score': '0.254298', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.387875', 'ticker_sentiment_score': '0.276863', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
225,"Market Rallies, Hits Resistance: Weekly Review",https://www.investors.com/news/stock-market-rallies-hits-resistance-novo-nordisk-jpmorgan-exxon-in-focus/,20231013T152200,"['IBD STAFF', ""Investor's Business Daily""]","Stock Market Rallies, Hits Resistance. Novo Nordisk, JPMorgan ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2016/03/BIGPIC-032316-shutterstock.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'IPO', 'relevance_score': '0.451494'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.99793'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.999819'}]",-0.049165,Neutral,"[{'ticker': 'C', 'relevance_score': '0.146916', 'ticker_sentiment_score': '0.069711', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'F', 'relevance_score': '0.073773', 'ticker_sentiment_score': '0.178146', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.288893', 'ticker_sentiment_score': '-0.020212', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.146916', 'ticker_sentiment_score': '-0.029637', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DAL', 'relevance_score': '0.110462', 'ticker_sentiment_score': '-0.157722', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'DVA', 'relevance_score': '0.073773', 'ticker_sentiment_score': '-0.067843', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.288893', 'ticker_sentiment_score': '-0.108098', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FSNUF', 'relevance_score': '0.036926', 'ticker_sentiment_score': '-0.06527', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.146916', 'ticker_sentiment_score': '0.069711', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WBA', 'relevance_score': '0.073773', 'ticker_sentiment_score': '-0.160534', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'XOM', 'relevance_score': '0.218817', 'ticker_sentiment_score': '0.093971', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.146916', 'ticker_sentiment_score': '-0.029637', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PXD', 'relevance_score': '0.110462', 'ticker_sentiment_score': '0.085682', 'ticker_sentiment_label': 'Neutral'}]"
226,Momo Buys On Iran Hinting At Second Front And Israel Issuing An Impossible Evacuation Order - JPMorgan Chase  ( NYSE:JPM ) ,https://www.benzinga.com/markets/23/10/35242061/momo-buys-on-iran-hinting-at-second-front-and-israel-issuing-an-impossible-evacuation-order,20231013T143030,['The Arora Report'],"To gain an edge, this is what you need to know today. Please click here for a chart of SPDR S&P 500 ETF Trust SPY which represents the benchmark stock market index S&P 500 ( SPX ) . The chart shows that the stock market pulled back to the top band of the top support zone on rising yields.",https://cdn.benzinga.com/files/nicholas-cappello-wb63zqj5gne-unsplash_11_22.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}]",0.245115,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.070002', 'ticker_sentiment_score': '0.126617', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.070002', 'ticker_sentiment_score': '0.126617', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.070002', 'ticker_sentiment_score': '0.126617', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.070002', 'ticker_sentiment_score': '0.126617', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.104835', 'ticker_sentiment_score': '0.203487', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PNC', 'relevance_score': '0.070002', 'ticker_sentiment_score': '0.243734', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.139467', 'ticker_sentiment_score': '0.171594', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.070002', 'ticker_sentiment_score': '0.154912', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'IVZ', 'relevance_score': '0.035035', 'ticker_sentiment_score': '0.3556', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.070002', 'ticker_sentiment_score': '0.243734', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.070002', 'ticker_sentiment_score': '0.126617', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.070002', 'ticker_sentiment_score': '0.126617', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.070002', 'ticker_sentiment_score': '0.243734', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.070002', 'ticker_sentiment_score': '0.154912', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
227,"Pharma Stock Roundup: LLY Meets IBD Study Goal, PFE, MRK Give Cancer Pipeline Updates",https://www.zacks.com/stock/news/2165526/pharma-stock-roundup-lly-meets-ibd-study-goal-pfe-mrk-give-cancer-pipeline-updates,20231013T134100,['Kinjel Shah'],"Eli Lilly's (LLY) mirikizumab meets the main goals in a Crohn's disease study. PFE, MRK and JNJ provide updates on cancer drugs in their pipeline.",https://staticx-tuner.zacks.com/images/articles/main/07/905.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.09506,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.158519', 'ticker_sentiment_score': '-0.068286', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.079656', 'ticker_sentiment_score': '-0.10015', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.119235', 'ticker_sentiment_score': '-0.11971', 'ticker_sentiment_label': 'Neutral'}]"
228,"The Zacks Analyst Blog Highlights Meta Platforms, Eli Lilly, Caterpillar, Citigroup and Micron Technology",https://www.zacks.com/stock/news/2165420/the-zacks-analyst-blog-highlights-meta-platforms-eli-lilly-caterpillar-citigroup-and-micron-technology,20231013T110400,['Zacks Equity Research'],"Meta Platforms, Eli Lilly, Caterpillar, Citigroup and Micron Technology are part of the Zacks top Analyst Blog.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.278022,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.429671', 'ticker_sentiment_score': '0.175974', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MU', 'relevance_score': '0.128822', 'ticker_sentiment_score': '0.034897', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.429671', 'ticker_sentiment_score': '0.378135', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'C', 'relevance_score': '0.128822', 'ticker_sentiment_score': '0.034897', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.31482', 'ticker_sentiment_score': '0.216191', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
229,Lilly  ( LLY )  Up on NVO's Ozempic Early Success in Kidney Study,https://www.zacks.com/stock/news/2165095/lilly-lly-up-on-nvos-ozempic-early-success-in-kidney-study,20231012T161300,['Zacks Equity Research'],Eli Lilly's (LLY) Mounjaro is also being evaluated in clinical studies for patients who are obese or overweight and have CKD. Investors are probably expecting similar success with Mounjaro's CKD study.,https://staticx-tuner.zacks.com/images/articles/main/cc/389.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.156478,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.43494', 'ticker_sentiment_score': '0.235223', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AUPH', 'relevance_score': '0.318897', 'ticker_sentiment_score': '0.15358', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.130571', 'ticker_sentiment_score': '-0.039629', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALPN', 'relevance_score': '0.257668', 'ticker_sentiment_score': '0.217631', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
230,"Top Research Reports for Meta Platforms, Eli Lilly & Caterpillar",https://www.zacks.com/research-daily/2164849/top-research-reports-for-meta-platforms-eli-lilly-caterpillar,20231012T144800,['Sheraz Mian'],"Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Eli Lilly and Company (LLY) and Caterpillar Inc. (CAT).",https://staticx-tuner.zacks.com/images/default_article_images/default261.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.339006,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.338582', 'ticker_sentiment_score': '0.215333', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.338582', 'ticker_sentiment_score': '0.563225', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'CAT', 'relevance_score': '0.173333', 'ticker_sentiment_score': '0.269458', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
231,This Is What Whales Are Betting On Eli Lilly - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/10/35221521/this-is-what-whales-are-betting-on-eli-lilly,20231012T141720,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 43 strange trades. If we consider the specifics of each trade, it is accurate to state that 46% of the investors opened trades with bullish ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.090713,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.767534', 'ticker_sentiment_score': '-0.094486', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.118647', 'ticker_sentiment_score': '-0.130868', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.118647', 'ticker_sentiment_score': '-0.130868', 'ticker_sentiment_label': 'Neutral'}]"
232,3 Super Safe Dividend Stocks That Have Been Making Payments for Decades,https://www.fool.com/investing/2023/10/12/3-super-safe-dividend-stocks-that-have-been-making/,20231012T131500,['David Jagielski'],These are income-generating investments that you can buy and forget about.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.623304'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.744043'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.357903,Bullish,"[{'ticker': 'ATVI', 'relevance_score': '0.055492', 'ticker_sentiment_score': '0.169913', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.323785', 'ticker_sentiment_score': '0.411306', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.272181', 'ticker_sentiment_score': '0.190477', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KO', 'relevance_score': '0.323785', 'ticker_sentiment_score': '0.332113', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
233,Lilly  ( LLY )  Moves 4.5% Higher: Will This Strength Last?,https://www.zacks.com/stock/news/2164784/lilly-lly-moves-45-higher-will-this-strength-last,20231012T130400,['Zacks Equity Research'],Lilly (LLY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.,https://staticx-tuner.zacks.com/images/default_article_images/default52.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.972476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.156527,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.551295', 'ticker_sentiment_score': '0.13081', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.045165', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.551295', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
234,Futures Rise With CPI Inflation Due,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rally-at-key-levels-as-inflation-data-looms-novo-nordisk-soars/,20231012T120700,"[""Investor's Business Daily"", 'ED CARSON']",Dow Jones Futures Rise: Market Rally At Key Levels As Inflation ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2019/12/FAP2020-bull-123019-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.998626'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.002419,Neutral,"[{'ticker': 'DKNG', 'relevance_score': '0.108222', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.188193', 'ticker_sentiment_score': '0.038691', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.027134', 'ticker_sentiment_score': '0.215241', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'F', 'relevance_score': '0.081276', 'ticker_sentiment_score': '-0.035159', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.108222', 'ticker_sentiment_score': '0.014356', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADBE', 'relevance_score': '0.135043', 'ticker_sentiment_score': '0.057918', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.16171', 'ticker_sentiment_score': '0.006935', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.027134', 'ticker_sentiment_score': '0.071256', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STRL', 'relevance_score': '0.054236', 'ticker_sentiment_score': '0.134779', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DAL', 'relevance_score': '0.108222', 'ticker_sentiment_score': '-0.158279', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'DVA', 'relevance_score': '0.054236', 'ticker_sentiment_score': '-0.161835', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'FOREX:GBP', 'relevance_score': '0.027134', 'ticker_sentiment_score': '0.125029', 'ticker_sentiment_label': 'Neutral'}]"
235,Dow Jones Rises After Fed Minutes As House Vote On New Speaker Looms; Meta Breaks Out,https://www.investors.com/market-trend/stock-market-today/dow-jones-rises-after-fed-minutes-as-house-vote-on-new-speaker-looms-meta-breaks-out/,20231011T195200,"['VIDYA RAMAKRISHNAN', ""Investor's Business Daily""]",Dow Jones Rises After Fed Minutes As House Vote On New ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2019/01/stock-FederalReserve-snow-11-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.769861'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.999981'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}]",0.062531,Neutral,"[{'ticker': 'META', 'relevance_score': '0.100308', 'ticker_sentiment_score': '0.04817', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAVA', 'relevance_score': '0.100308', 'ticker_sentiment_score': '-0.081807', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HZNP', 'relevance_score': '0.050254', 'ticker_sentiment_score': '0.236385', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.100308', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.050254', 'ticker_sentiment_score': '-0.076389', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADBE', 'relevance_score': '0.100308', 'ticker_sentiment_score': '0.197599', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.149966', 'ticker_sentiment_score': '0.235216', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FAST', 'relevance_score': '0.100308', 'ticker_sentiment_score': '0.032902', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.199037', 'ticker_sentiment_score': '0.209207', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DXCM', 'relevance_score': '0.100308', 'ticker_sentiment_score': '0.04772', 'ticker_sentiment_label': 'Neutral'}]"
236,9 'Unstoppable' Stocks Deliver Big Gains And No Pain To Investors,https://www.investors.com/etfs-and-funds/sectors/sp500-unstoppable-stocks-deliver-big-gains-and-no-pain-to-investors/,20231011T120000,"[""Investor's Business Daily"", 'MATT KRANTZ']",Risk and reward are supposed to be attached at the hip for S&P 500 stocks. But a small group of stocks are delivering all gain and no pain.,https://www.investors.com/wp-content/uploads/2021/04/Stock-moneypile-03-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.234598,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.313817', 'ticker_sentiment_score': '0.318471', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.238133', 'ticker_sentiment_score': '0.148118', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PANW', 'relevance_score': '0.313817', 'ticker_sentiment_score': '0.269171', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
237,Could Visa Be the Next Company to Join the Trillion-Dollar Market Cap Club?,https://www.fool.com/investing/2023/10/11/could-visa-be-the-next-company-to-join-the-trillio/,20231011T101500,['Brett Schafer'],The leading payments network has a dominant market position and multiple tailwinds at its back.,https://media.ycharts.com/charts/69d5d477ea3f1cb7afb2b0bbedb0fbf2.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.997874'}]",0.213948,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.044469', 'ticker_sentiment_score': '0.052358', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.044469', 'ticker_sentiment_score': '0.052358', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.044469', 'ticker_sentiment_score': '0.052358', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.044469', 'ticker_sentiment_score': '0.052358', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.044469', 'ticker_sentiment_score': '0.052358', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.800342', 'ticker_sentiment_score': '0.362684', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BRK-A', 'relevance_score': '0.088799', 'ticker_sentiment_score': '0.026428', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.088799', 'ticker_sentiment_score': '0.026428', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.044469', 'ticker_sentiment_score': '0.052358', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSM', 'relevance_score': '0.044469', 'ticker_sentiment_score': '0.139733', 'ticker_sentiment_label': 'Neutral'}]"
238,Weight-Loss Drugs Aren't To Blame For The Snack Pullback. Pepsi Offers This Reason.,https://www.investors.com/news/weight-loss-drugs-blame-snack-pullback-pepsi-reason/,20231010T191900,"[""Investor's Business Daily"", 'MIKE JUANG']",Weight-Loss Drugs Aren't To Blame For The Snack Pullback. Pepsi ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2021/09/Stock-pepsico-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.904684'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",-0.002395,Neutral,"[{'ticker': 'GOOG', 'relevance_score': '0.069094', 'ticker_sentiment_score': '0.031013', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDLZ', 'relevance_score': '0.205225', 'ticker_sentiment_score': '-0.118387', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.137671', 'ticker_sentiment_score': '-0.090393', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.205225', 'ticker_sentiment_score': '0.16512', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KHC', 'relevance_score': '0.137671', 'ticker_sentiment_score': '-0.090393', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.205225', 'ticker_sentiment_score': '0.16512', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PEP', 'relevance_score': '0.397098', 'ticker_sentiment_score': '-0.065275', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.205225', 'ticker_sentiment_score': '0.006449', 'ticker_sentiment_label': 'Neutral'}]"
239,This Dividend Stock Just Got Hit With a Short Report. Is Now a Buying Opportunity?,https://www.fool.com/investing/2023/10/08/this-dividend-stock-just-got-hit-with-a-short-repo/,20231008T114500,['Adam Spatacco'],"Coca-Cola is the latest subject of the Bear Cave, an online publisher of reports on stock to sell short.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F749343%2Fgettyimages-1135420212.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.067672,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.059415', 'ticker_sentiment_score': '0.033065', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CELH', 'relevance_score': '0.089019', 'ticker_sentiment_score': '-0.007551', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.029728', 'ticker_sentiment_score': '-0.087974', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.497657', 'ticker_sentiment_score': '0.177699', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MNST', 'relevance_score': '0.029728', 'ticker_sentiment_score': '-0.031027', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.089019', 'ticker_sentiment_score': '0.022185', 'ticker_sentiment_label': 'Neutral'}]"
240,What To Do After Bullish Reversal; 11 Stocks In Buy Areas,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-what-to-do-after-bullish-upside-reversal-nvidia-leads-11-new-buys/,20231007T152400,"[""Investor's Business Daily"", 'ED CARSON']",Dow Jones Futures: What To Do After Bullish Move. Nvidia Leads 11 ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/09/Stock-bullsstampede-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",0.097665,Neutral,"[{'ticker': 'META', 'relevance_score': '0.096769', 'ticker_sentiment_score': '0.065197', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.215574', 'ticker_sentiment_score': '0.06704', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANET', 'relevance_score': '0.16849', 'ticker_sentiment_score': '0.087305', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRWD', 'relevance_score': '0.144708', 'ticker_sentiment_score': '0.074294', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.048474', 'ticker_sentiment_score': '-0.105995', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DAL', 'relevance_score': '0.048474', 'ticker_sentiment_score': '-0.105995', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.048474', 'ticker_sentiment_score': '-0.105995', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.048474', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QLYS', 'relevance_score': '0.120794', 'ticker_sentiment_score': '0.050776', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.329551', 'ticker_sentiment_score': '-0.048394', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.215574', 'ticker_sentiment_score': '0.120202', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CDNS', 'relevance_score': '0.120794', 'ticker_sentiment_score': '0.053142', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRT', 'relevance_score': '0.120794', 'ticker_sentiment_score': '0.10785', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CME', 'relevance_score': '0.096769', 'ticker_sentiment_score': '0.132936', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PANW', 'relevance_score': '0.144708', 'ticker_sentiment_score': '0.04702', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.024248', 'ticker_sentiment_score': '0.087163', 'ticker_sentiment_label': 'Neutral'}]"
241,3 No-Brainer Growth Stocks to Buy in October,https://www.fool.com/investing/2023/10/07/3-no-brainer-growth-stocks-to-buy-in-october/,20231007T105300,"['David Jagielski', 'and Prosper Junior Bakiny', 'Keith Speights']",The time is right to invest in these great stocks.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.996718'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}]",0.274002,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.232439', 'ticker_sentiment_score': '0.217617', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.156207', 'ticker_sentiment_score': '0.168497', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.269776', 'ticker_sentiment_score': '0.307637', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
242,"Shutdown Averted, Treasury Yields Flirt With 5%, Strong Payrolls Add to Fed Tightening Risk: The Week In The Markets - BlackRock  ( NYSE:BLK ) , Alphabet  ( NASDAQ:GOOGL ) , Citigroup  ( NYSE:C ) , PNC Finl Servs Gr  ( NYSE:PNC ) ",https://www.benzinga.com/markets/equities/23/10/35132440/shutdown-averted-treasury-yields-flirt-with-5-strong-payrolls-add-to-fed-tightening-risk-the-wee,20231006T201449,['Piero Cingari'],A week filled with significant events impacting the markets culminated in an unexpectedly strong September jobs report. Government Shutdown Averted. House Ousts McCarthy: The U.S. Congress managed to avoid a dramatic government shutdown just hours before the midnight deadline Oct. 1 by passing a ...,https://cdn.benzinga.com/files/images/story/2023/Wall_Street_subway_sign_1.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.993856'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.185601,Somewhat-Bullish,"[{'ticker': 'BLK', 'relevance_score': '0.096477', 'ticker_sentiment_score': '-0.038825', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.096477', 'ticker_sentiment_score': '-0.038825', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PNC', 'relevance_score': '0.096477', 'ticker_sentiment_score': '-0.038825', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.096477', 'ticker_sentiment_score': '-0.038825', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.096477', 'ticker_sentiment_score': '-0.013809', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.161895', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.096477', 'ticker_sentiment_score': '-0.038825', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DPZ', 'relevance_score': '0.096477', 'ticker_sentiment_score': '-0.038825', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.096477', 'ticker_sentiment_score': '-0.038825', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WBA', 'relevance_score': '0.096477', 'ticker_sentiment_score': '-0.038825', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.096477', 'ticker_sentiment_score': '0.154064', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'INFY', 'relevance_score': '0.096477', 'ticker_sentiment_score': '-0.038825', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.096477', 'ticker_sentiment_score': '0.154064', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.096477', 'ticker_sentiment_score': '0.154064', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.096477', 'ticker_sentiment_score': '0.154064', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KO', 'relevance_score': '0.096477', 'ticker_sentiment_score': '-0.013809', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'USEG', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.160857', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DAL', 'relevance_score': '0.096477', 'ticker_sentiment_score': '-0.038825', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NEE', 'relevance_score': '0.096477', 'ticker_sentiment_score': '0.154064', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DMPZF', 'relevance_score': '0.048327', 'ticker_sentiment_score': '-0.036489', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.144275', 'ticker_sentiment_score': '0.201446', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PEP', 'relevance_score': '0.144275', 'ticker_sentiment_score': '-0.029978', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PGR', 'relevance_score': '0.096477', 'ticker_sentiment_score': '-0.038825', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FAST', 'relevance_score': '0.096477', 'ticker_sentiment_score': '-0.038825', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PXD', 'relevance_score': '0.144275', 'ticker_sentiment_score': '0.201446', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WMT', 'relevance_score': '0.096477', 'ticker_sentiment_score': '-0.013809', 'ticker_sentiment_label': 'Neutral'}]"
243,Stock Market Ends On High Note; Tesla In Focus: Weekly Review,https://www.investors.com/news/stock-market-ends-on-high-note-even-as-yields-soar-tesla-in-focus/,20231006T165100,"['IBD STAFF', ""Investor's Business Daily""]",Stock Market Ends On High Note. Tesla In Focus: Weekly Review Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2020/10/A1MAIN-bullsbears-100220-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.161647'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}]",-0.070958,Neutral,"[{'ticker': 'AEHR', 'relevance_score': '0.063933', 'ticker_sentiment_score': '-0.112094', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XPEV', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.047383', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.25168', 'ticker_sentiment_score': '-0.025746', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LNTH', 'relevance_score': '0.095771', 'ticker_sentiment_score': '-0.003391', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NIO', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.047383', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.095771', 'ticker_sentiment_score': '-0.13469', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.095771', 'ticker_sentiment_score': '-0.003391', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LI', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.047383', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PXD', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
244,These IBD 50 Companies Set To Report Blowout Earnings Growth Of Up To 320%,https://www.investors.com/stock-lists/ibd-50/growth-stocks-in-the-ibd-50-set-to-report-blowout-earnings-growth-of-up-to-320/,20231006T151400,"[""Investor's Business Daily"", 'VIDYA RAMAKRISHNAN']",These IBD 50 Companies Set To Report Blowout Earnings Growth ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/08/Stock-Meta-zuckerberg-01-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.999997'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.196789,Somewhat-Bullish,"[{'ticker': 'META', 'relevance_score': '0.190167', 'ticker_sentiment_score': '0.02906', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IBKR', 'relevance_score': '0.127456', 'ticker_sentiment_score': '0.047573', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MOD', 'relevance_score': '0.127456', 'ticker_sentiment_score': '0.092994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.127456', 'ticker_sentiment_score': '-0.092944', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.127456', 'ticker_sentiment_score': '0.103737', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.127456', 'ticker_sentiment_score': '0.103737', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNPS', 'relevance_score': '0.25168', 'ticker_sentiment_score': '0.223661', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CDNS', 'relevance_score': '0.127456', 'ticker_sentiment_score': '0.140811', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMPH', 'relevance_score': '0.127456', 'ticker_sentiment_score': '0.103737', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APOS', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.040134', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DUOL', 'relevance_score': '0.127456', 'ticker_sentiment_score': '0.279301', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
245,Looking At Eli Lilly's Recent Unusual Options Activity - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/10/35127079/looking-at-eli-lillys-recent-unusual-options-activity,20231006T143057,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bullish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.183058,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.68039', 'ticker_sentiment_score': '0.334566', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
246,Investors Heavily Search Eli Lilly and Company  ( LLY ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2161417/investors-heavily-search-eli-lilly-and-company-lly-here-is-what-you-need-to-know,20231006T130011,['Zacks Equity Research'],"Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default257.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}]",0.237233,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.524949', 'ticker_sentiment_score': '0.137715', 'ticker_sentiment_label': 'Neutral'}]"
247,Structure Therapeutics  ( GPCR )  Stock Up 9% This Week: Here's Why,https://www.zacks.com/stock/news/2161548/structure-therapeutics-gpcr-stock-up-9-this-week-heres-why,20231006T124500,['Zacks Equity Research'],"Structure Therapeutics (GPCR) rises 9% on encouraging initial data from the early-stage study of its pipeline candidate, GSBR-1290, in healthy overweight or obese individuals.",https://staticx-tuner.zacks.com/images/articles/main/37/2337.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.107026,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.192694', 'ticker_sentiment_score': '0.064498', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANIK', 'relevance_score': '0.129168', 'ticker_sentiment_score': '0.081787', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GPCR', 'relevance_score': '0.374312', 'ticker_sentiment_score': '0.201286', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.192694', 'ticker_sentiment_score': '0.213236', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
248,Should You Sell This Stock After Another Regulatory Headwind?,https://www.fool.com/investing/2023/10/06/should-you-sell-this-stock-after-another-regulator/,20231006T100900,['Prosper Junior Bakiny'],"This company has grabbed plenty of headlines this year, and they haven't all been good.",https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.036239,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.451494', 'ticker_sentiment_score': '-0.054592', 'ticker_sentiment_label': 'Neutral'}]"
249,Futures: Jobs Report Looms; 7 Stocks Boasting This Bullish Trait,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-stocks-slash-sharp-losses-with-jobs-report-due-nvidia-meta-at-key-levels/,20231005T220200,"[""Investor's Business Daily"", 'ED CARSON']",Dow Jones Futures: Stocks Slash Losses With Jobs Report Due ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2016/03/BIGPIC-032316-shutterstock.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.088702,Neutral,"[{'ticker': 'AEHR', 'relevance_score': '0.134741', 'ticker_sentiment_score': '-0.107243', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QLYS', 'relevance_score': '0.161349', 'ticker_sentiment_score': '0.130037', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.081092', 'ticker_sentiment_score': '0.043715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.213988', 'ticker_sentiment_score': '0.063194', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANET', 'relevance_score': '0.187775', 'ticker_sentiment_score': '0.057362', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.291077', 'ticker_sentiment_score': '0.134277', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.161349', 'ticker_sentiment_score': '0.086501', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.081092', 'ticker_sentiment_score': '0.047788', 'ticker_sentiment_label': 'Neutral'}]"
250,LLY: Which Pharma Stock Has More Potential Gains This Month: Pfizer  ( PFE )  or Eli Lilly & Co.  ( LLY ) ?,https://stocknews.com/news/lly-pfe-dna-which-pharma-stock-has-more-potential-gains-this-month-pfizer/,20231005T160624,['StockNews.com Staff'],LLY: Which Pharma Stock Has More Potential Gains This Month ... ...,https://stocknews.com/wp-content/uploads/2021/01/cvs-rad-wba-scaled.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Earnings', 'relevance_score': '0.999701'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.225284,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.623194', 'ticker_sentiment_score': '0.372587', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'DNA', 'relevance_score': '0.117104', 'ticker_sentiment_score': '0.071413', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.47672', 'ticker_sentiment_score': '0.330028', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
251,What Are The Best Stocks To Invest In? 2 Healthcare Stocks To Know,https://stockmarket.com/featured/what-are-the-best-stocks-to-invest-in-2-healthcare-stocks-to-know-2023-10-05,20231005T143817,['Brandon Michael'],"The healthcare sector is an expansive domain that entails a wide range of companies. These companies are involved in the provision of medical services, the manufacture of medical equipment, and the development of pharmaceuticals. This sector plays a pivotal role in the well-being of society.",https://u3j7m9h7.rocketcdn.me/wp-content/uploads/2023/10/LLY-stock.jpg,StockMarket.com,n/a,stockmarket.com,"[{'topic': 'Earnings', 'relevance_score': '0.858979'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999921'}]",0.215872,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.259727', 'ticker_sentiment_score': '-0.021809', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.321393', 'ticker_sentiment_score': '0.230452', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HCSG', 'relevance_score': '0.066047', 'ticker_sentiment_score': '0.16363', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
252,Here's the Best Big Pharma Stock of the Decade so Far  ( and It's Not Even Close ) ,https://www.fool.com/investing/2023/10/05/heres-the-best-big-pharma-stock-of-the-decade-so-f/,20231005T095000,['Keith Speights'],"This stock puts the ""big"" in big pharma after massive gains in recent years.",https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}]",0.257867,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.391486', 'ticker_sentiment_score': '0.447177', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'REGN', 'relevance_score': '0.116348', 'ticker_sentiment_score': '0.285979', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.230235', 'ticker_sentiment_score': '0.258954', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
253,Eli Lilly  ( LLY )  Surpasses Market Returns: Some Facts Worth Knowing,https://www.zacks.com/stock/news/2160336/eli-lilly-lly-surpasses-market-returns-some-facts-worth-knowing,20231004T214517,['Zacks Equity Research'],"Eli Lilly (LLY) concluded the recent trading session at $531.46, signifying a +1.19% move from its prior day's close.",https://staticx-tuner.zacks.com/images/default_article_images/default271.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.995921'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.155745,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.584103', 'ticker_sentiment_score': '0.306572', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
254,ALX Oncology  ( ALXO )  Up 56% on Upbeat Gastric Cancer Study Data,https://www.zacks.com/stock/news/2160251/alx-oncology-alxo-up-56-on-upbeat-gastric-cancer-study-data,20231004T153900,['Zacks Equity Research'],Interim data from a mid-stage study shows that a combination regimen of ALX Oncology's (ALXO) lead candidate achieved 52% ORR in certain gastric cancer patients.,https://staticx-tuner.zacks.com/images/articles/main/2a/3899.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.928139'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.098205,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.109455', 'ticker_sentiment_score': '0.010137', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VAXX', 'relevance_score': '0.163539', 'ticker_sentiment_score': '0.068133', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALXO', 'relevance_score': '0.508593', 'ticker_sentiment_score': '0.138526', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANVS', 'relevance_score': '0.163539', 'ticker_sentiment_score': '0.037885', 'ticker_sentiment_label': 'Neutral'}]"
255,Check Out What Whales Are Doing With LLY - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/10/35091248/check-out-what-whales-are-doing-with-lly,20231004T144718,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bullish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.113107,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.815635', 'ticker_sentiment_score': '0.30677', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.105604', 'ticker_sentiment_score': '-0.125418', 'ticker_sentiment_label': 'Neutral'}]"
256,"Lilly  ( LLY )  to Buy POINT Biopharma, Strengthen Cancer Portfolio",https://www.zacks.com/stock/news/2159864/lilly-lly-to-buy-point-biopharma-strengthen-cancer-portfolio,20231004T122100,['Zacks Equity Research'],"Eli Lilly's (LLY) acquisition of POINT Biopharma, if successfully closed, is likely to bolster its portfolio of cancer drugs.",https://staticx-tuner.zacks.com/images/articles/main/86/1981.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.095777,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.202932', 'ticker_sentiment_score': '0.095028', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALPN', 'relevance_score': '0.268294', 'ticker_sentiment_score': '0.245629', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
257,Lilly Announces Leadership Transitions,https://markets.businessinsider.com/news/stocks/lilly-announces-leadership-transitions-1032677321,20231004T104500,['markets.businessinsider.com'],"INDIANAPOLIS, Oct. 4, 2023 /PRNewswire/ -- Eli Lilly and Company ( NYSE: LLY ) today announced changes to its executive leadership team. Mike Mason, executive vice president and president of Lilly Diabetes and Obesity, will retire from Lilly at the end of 2023 after 34 years with the company.",https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg,Business Insider,RSS,markets.businessinsider.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.451494'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.145632,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.600823', 'ticker_sentiment_score': '0.193581', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CURN', 'relevance_score': '0.028023', 'ticker_sentiment_score': '0.005719', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.028023', 'ticker_sentiment_score': '0.160467', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GILD', 'relevance_score': '0.028023', 'ticker_sentiment_score': '-0.049462', 'ticker_sentiment_label': 'Neutral'}]"
258,Lilly Announces Leadership Transitions,https://www.prnewswire.com/news-releases/lilly-announces-leadership-transitions-301946467.html,20231004T104500,['Eli Lilly and Company'],"INDIANAPOLIS, Oct. 4, 2023 /PRNewswire/ -- Eli Lilly and Company ( NYSE: LLY ) today announced changes to its executive leadership team. Mike Mason, executive vice president and president of Lilly Diabetes and Obesity, will retire from Lilly at the end of 2023 after 34 years with the company.",https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.451494'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.152655,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.5948', 'ticker_sentiment_score': '0.192587', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CURN', 'relevance_score': '0.027667', 'ticker_sentiment_score': '0.00571', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.027667', 'ticker_sentiment_score': '0.159271', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GILD', 'relevance_score': '0.027667', 'ticker_sentiment_score': '-0.049386', 'ticker_sentiment_label': 'Neutral'}]"
259,"Crude Oil Moves Higher; POINT Biopharma Global Shares Jump - Eli Lilly  ( NYSE:LLY ) , ALX Oncology Holdings  ( NASDAQ:ALXO ) ",https://www.benzinga.com/news/earnings/23/10/35070704/crude-oil-moves-higher-point-biopharma-global-shares-jump,20231003T183639,['Lisa Levin'],"U.S. stocks extended losses toward the end of trading, with the S&P 500 falling around 1.5% on Tuesday. The Dow traded down 1.43% to 32,954.84 while the NASDAQ fell 1.98% to 13,044.24. The S&P 500 also fell, dropping, 1.53% to 4,222.58. Utilities shares rose by 0.6% on Tuesday.",https://cdn.benzinga.com/files/images/story/2023/10/03/crude_oil_6-_logo.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.031619,Neutral,"[{'ticker': 'SDC', 'relevance_score': '0.138066', 'ticker_sentiment_score': '0.210098', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'OCEA', 'relevance_score': '0.138066', 'ticker_sentiment_score': '-0.020108', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IAFNF', 'relevance_score': '0.069294', 'ticker_sentiment_score': '0.168847', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PNT', 'relevance_score': '0.205807', 'ticker_sentiment_score': '0.383353', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.138066', 'ticker_sentiment_score': '0.299965', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SPGI', 'relevance_score': '0.069294', 'ticker_sentiment_score': '-0.010074', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WEWOW', 'relevance_score': '0.138066', 'ticker_sentiment_score': '0.045802', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALXO', 'relevance_score': '0.138066', 'ticker_sentiment_score': '0.092743', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VERY', 'relevance_score': '0.069294', 'ticker_sentiment_score': '0.168847', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
260,"Nasdaq Down Over 200 Points; US Job Openings Rise In August - Eli Lilly  ( NYSE:LLY ) , Femasys  ( NASDAQ:FEMY ) ",https://www.benzinga.com/news/earnings/23/10/35068428/nasdaq-down-over-200-points-us-job-openings-rise-in-august,20231003T162053,['Lisa Levin'],"U.S. stocks extended losses midway through trading, with the Nasdaq Composite falling more than 200 points on Tuesday. The Dow traded down 1.06% to 33,078.27 while the NASDAQ fell 1.60% to 13,094.83. The S&P 500 also fell, dropping, 1.27% to 4,233.76. Materials shares fell by just 0.1% on Tuesday.",https://cdn.benzinga.com/files/images/story/2023/10/03/image49.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}]",-0.029242,Neutral,"[{'ticker': 'SDC', 'relevance_score': '0.144275', 'ticker_sentiment_score': '0.21516', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'OCEA', 'relevance_score': '0.144275', 'ticker_sentiment_score': '-0.020654', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IAFNF', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.169389', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PNT', 'relevance_score': '0.214937', 'ticker_sentiment_score': '0.395006', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.144275', 'ticker_sentiment_score': '0.306941', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SPRC', 'relevance_score': '0.144275', 'ticker_sentiment_score': '0.310635', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SPGI', 'relevance_score': '0.072435', 'ticker_sentiment_score': '-0.010113', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FEMY', 'relevance_score': '0.144275', 'ticker_sentiment_score': '0.090726', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VERY', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.169389', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
261,Dow Jones Sinks After Strong Jobs Data; Warren Buffett Sells More Stock,https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-after-strong-jobs-data-yields-spook-stocks-as-warren-buffett-sells-more-stock/,20231003T145600,"[""Investor's Business Daily"", 'VIDYA RAMAKRISHNAN']",Dow Jones Sinks After Strong Jobs Data. Warren Buffett Sells More ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2020/08/Stock-WallStreetSign-flag08-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.999896'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",-0.062796,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.120733', 'ticker_sentiment_score': '-0.0151', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMG', 'relevance_score': '0.120733', 'ticker_sentiment_score': '0.174497', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FVRR', 'relevance_score': '0.120733', 'ticker_sentiment_score': '0.174497', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.120733', 'ticker_sentiment_score': '-0.0151', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.060541', 'ticker_sentiment_score': '0.208085', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'INTC', 'relevance_score': '0.120733', 'ticker_sentiment_score': '-0.0151', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PNT', 'relevance_score': '0.180236', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.120733', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKE', 'relevance_score': '0.120733', 'ticker_sentiment_score': '-0.0151', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABNB', 'relevance_score': '0.180236', 'ticker_sentiment_score': '-0.285442', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LBRT', 'relevance_score': '0.120733', 'ticker_sentiment_score': '-0.109773', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.060541', 'ticker_sentiment_score': '-0.01501', 'ticker_sentiment_label': 'Neutral'}]"
262,"Top Stories Tuesday, Oct 3: 'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals - Apple  ( NASDAQ:AAPL ) , ALX Oncology Holdings  ( NASDAQ:ALXO ) ",https://www.benzinga.com/news/23/10/35064552/airbnb-has-foundational-cracks-disney-follows-netflix-on-subscription-sharing-crackdown-microsofts-n,20231003T141120,['Vandana Singh'],"In a significant development, Microsoft Corp's MSFT CEO, Satya Nadella, has voiced concerns over the competitive landscape of content acquisition essential for training artificial intelligence ( AI ) .",https://cdn.benzinga.com/files/images/story/2023/10/03/airbnbtoronto5.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.058194,Neutral,"[{'ticker': 'TGT', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.263048', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GOOG', 'relevance_score': '0.189076', 'ticker_sentiment_score': '0.273786', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.038162', 'ticker_sentiment_score': '0.139139', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPOT', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.144617', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.21709', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.076236', 'ticker_sentiment_score': '-0.067693', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MU', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.143767', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABNB', 'relevance_score': '0.114137', 'ticker_sentiment_score': '-0.017859', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DAL', 'relevance_score': '0.076236', 'ticker_sentiment_score': '-0.098084', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ASML', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.14478', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.076236', 'ticker_sentiment_score': '-0.038103', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PNT', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.179376', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VTRS', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.067102', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.179376', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ALXO', 'relevance_score': '0.076236', 'ticker_sentiment_score': '-0.146817', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GME', 'relevance_score': '0.114137', 'ticker_sentiment_score': '-0.130984', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.021659', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.114137', 'ticker_sentiment_score': '-0.064201', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TAK', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:NXC', 'relevance_score': '0.038162', 'ticker_sentiment_score': '-0.036553', 'ticker_sentiment_label': 'Neutral'}]"
263,"Vericity, POINT Biopharma Global, Oddity Tech And Other Big Stocks Moving Higher On Tuesday - Fiverr Intl  ( NYSE:FVRR ) , Clean Energy Fuels  ( NASDAQ:CLNE ) ",https://www.benzinga.com/news/23/10/35064944/vericity-point-biopharma-global-oddity-tech-and-other-big-stocks-moving-higher-on-tuesday,20231003T140934,['Lisa Levin'],"U.S. stocks traded lower, with the Nasdaq Composite falling more than 100 points on Tuesday. Here are some big stocks recording gains in today's session. Vericity, Inc. VERY shares climbed 87% to $11.11 after iA Financial Group announced it will acquire the company. POINT Biopharma Global Inc.",https://cdn.benzinga.com/files/images/story/2023/10/03/vericity_-_logo.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}]",0.295453,Somewhat-Bullish,"[{'ticker': 'FVRR', 'relevance_score': '0.405651', 'ticker_sentiment_score': '0.340386', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'IAFNF', 'relevance_score': '0.140896', 'ticker_sentiment_score': '0.217305', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LNTH', 'relevance_score': '0.405651', 'ticker_sentiment_score': '-0.020303', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PNT', 'relevance_score': '0.405651', 'ticker_sentiment_score': '0.546995', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.405651', 'ticker_sentiment_score': '0.301297', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SMR', 'relevance_score': '0.277433', 'ticker_sentiment_score': '0.616912', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'WRBY', 'relevance_score': '0.405651', 'ticker_sentiment_score': '0.716185', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'MSC', 'relevance_score': '0.277433', 'ticker_sentiment_score': '-0.460934', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'ODD', 'relevance_score': '0.277433', 'ticker_sentiment_score': '0.371281', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SYNA', 'relevance_score': '0.405651', 'ticker_sentiment_score': '-0.293274', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'VERY', 'relevance_score': '0.140896', 'ticker_sentiment_score': '0.217305', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CLNE', 'relevance_score': '0.405651', 'ticker_sentiment_score': '0.747204', 'ticker_sentiment_label': 'Bullish'}]"
264,"Dow Falls Over 100 Points; McCormick Sales Miss Views - AERWINS Technologies  ( NASDAQ:AWIN ) , Dixie Gr  ( NASDAQ:DXYN ) ",https://www.benzinga.com/news/earnings/23/10/35064200/dow-falls-over-100-points-mccormick-sales-miss-views,20231003T134205,['Lisa Levin'],"U.S. stocks traded lower this morning, with the Dow Jones falling more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.37% to 33,310.99 while the NASDAQ fell 0.58% to 13,230.96. The S&P 500 also fell, dropping, 0.47% to 4,268.18.",https://cdn.benzinga.com/files/images/story/2023/10/03/image21.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.684621'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}]",-0.029034,Neutral,"[{'ticker': 'SDC', 'relevance_score': '0.209365', 'ticker_sentiment_score': '0.148236', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWIN', 'relevance_score': '0.209365', 'ticker_sentiment_score': '0.22361', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'IAFNF', 'relevance_score': '0.070517', 'ticker_sentiment_score': '0.169043', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PNT', 'relevance_score': '0.209365', 'ticker_sentiment_score': '0.387902', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.140485', 'ticker_sentiment_score': '0.302654', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SPRC', 'relevance_score': '0.140485', 'ticker_sentiment_score': '0.306305', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DXYN', 'relevance_score': '0.140485', 'ticker_sentiment_score': '-0.204669', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'SPGI', 'relevance_score': '0.070517', 'ticker_sentiment_score': '-0.010088', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VERY', 'relevance_score': '0.070517', 'ticker_sentiment_score': '0.169043', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
265,Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings,https://www.zacks.com/stock/news/2159086/want-better-returns-dont-ignore-these-2-medical-stocks-set-to-beat-earnings,20231003T125006,['Zacks Equity Research'],Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.,https://staticx-tuner.zacks.com/images/default_article_images/default341.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999973'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.363038,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.390904', 'ticker_sentiment_score': '0.418501', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ZTS', 'relevance_score': '0.390904', 'ticker_sentiment_score': '0.4042', 'ticker_sentiment_label': 'Bullish'}]"
266,Lilly's  ( LLY )  Eczema Candidate Lebrikizumab Faces FDA Rejection,https://www.zacks.com/stock/news/2159031/lillys-lly-eczema-candidate-lebrikizumab-faces-fda-rejection,20231003T114300,['Zacks Equity Research'],"Lilly (LLY) gets a CRL for the eczema candidate, lebrikizumab, based on inspection findings at a third-party manufacturer.",https://staticx-tuner.zacks.com/images/articles/main/52/873.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.241153,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.470894', 'ticker_sentiment_score': '0.295921', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CORT', 'relevance_score': '0.11123', 'ticker_sentiment_score': '0.058093', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AUPH', 'relevance_score': '0.273399', 'ticker_sentiment_score': '0.146338', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALPN', 'relevance_score': '0.220308', 'ticker_sentiment_score': '0.180672', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
267,Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies - PR Newswire,https://www.prnewswire.com/news-releases/lilly-to-acquire-point-biopharma-to-expand-oncology-capabilities-into-next-generation-radioligand-therapies-301945243.html,20231003T104500,[],Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies PR ...,,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.986714'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.99998'}, {'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}]",0.224114,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.380775', 'ticker_sentiment_score': '0.285753', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.020866', 'ticker_sentiment_score': '0.156872', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.020866', 'ticker_sentiment_score': '0.111541', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LNTH', 'relevance_score': '0.020866', 'ticker_sentiment_score': '0.108764', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PNT', 'relevance_score': '0.083323', 'ticker_sentiment_score': '-0.014694', 'ticker_sentiment_label': 'Neutral'}]"
268,This fund shows that industry expertise can help you make a lot of money in the stock market,https://www.marketwatch.com/story/this-fund-shows-that-industry-expertise-can-help-you-make-a-lot-of-money-in-the-stock-market-5d104b1d,20231002T162800,['Philip van Doorn'],The managers of the Janus Henderson Global Life Sciences Fund have direct experience to help them separate promising innovators from flashes in the pan.,https://images.mktw.net/im-861100?width=700&height=593,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.986564'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.174392,Somewhat-Bullish,"[{'ticker': 'ETNB', 'relevance_score': '0.083107', 'ticker_sentiment_score': '-0.074703', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.084583', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JHG', 'relevance_score': '0.205807', 'ticker_sentiment_score': '0.11181', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.083107', 'ticker_sentiment_score': '0.089042', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDGL', 'relevance_score': '0.083107', 'ticker_sentiment_score': '-0.03668', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AKRO', 'relevance_score': '0.083107', 'ticker_sentiment_score': '-0.074703', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.083107', 'ticker_sentiment_score': '0.238236', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
269,"Stocks off to a choppy start this week, as bond yields push higher",https://www.cnbc.com/2023/10/02/stocks-off-to-a-choppy-start-this-week-as-bond-yields-push-higher.html,20231002T150747,['Jeff Marks'],The Investing Club holds its Morning Meeting every weekday at 10:20 a.m. ET.,https://image.cnbcfm.com/api/v1/image/107310037-1696258414393-1696257499-31430485476-hd.jpg?v=1696260270&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.997902'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.5'}]",0.137563,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.388879', 'ticker_sentiment_score': '0.155401', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CTRA', 'relevance_score': '0.239698', 'ticker_sentiment_score': '0.107077', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DHR', 'relevance_score': '0.388879', 'ticker_sentiment_score': '0.155401', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
270,ACM Research and Advance Auto Parts have been highlighted as Zacks Bull and Bear of the Day,https://www.zacks.com/stock/news/2158590/acm-research-and-advance-auto-parts-have-been-highlighted-as-zacks-bull-and-bear-of-the-day,20231002T122500,['Zacks Equity Research'],"Chicago, IL - October 2, 2023 - Zacks Equity Research shares ACM Research ( ACMR Quick QuoteACMR - ) as the Bull of the Day and Advance Auto Parts ( AAP Quick QuoteAAP - ) as the Bear of the Day.",https://staticx-tuner.zacks.com/images/articles/main/cb/577.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.152207,Somewhat-Bullish,"[{'ticker': 'AAP', 'relevance_score': '0.242027', 'ticker_sentiment_score': '-0.080033', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.087631', 'ticker_sentiment_score': '0.027321', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ACMR', 'relevance_score': '0.225224', 'ticker_sentiment_score': '0.251365', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.01756', 'ticker_sentiment_score': '0.155341', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.139771', 'ticker_sentiment_score': '0.043998', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.105064', 'ticker_sentiment_score': '0.040069', 'ticker_sentiment_label': 'Neutral'}]"
271,These 5 Stocks Are Showing Bullish Action After Strong Runs,https://www.investors.com/news/sp-500-5-stocks-are-setting-up-buying-opportunity-after-strong-runs/,20230930T120000,"['ED CARSON', ""Investor's Business Daily""]",S&P 500: These 5 Stocks Are Setting Up This Buying Opportunity ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2019/08/stock-bounce-back-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.99977'}, {'topic': 'Earnings', 'relevance_score': '0.999162'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.5'}]",0.178128,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.515891', 'ticker_sentiment_score': '0.062102', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BKNG', 'relevance_score': '0.400265', 'ticker_sentiment_score': '0.192539', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.459624', 'ticker_sentiment_score': '0.243203', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
272,"Nektar  ( NKTR ) , Cellular Biomedicine Join for Lung Cancer Studies",https://www.zacks.com/stock/news/2156973/nektar-nktr-cellular-biomedicine-join-for-lung-cancer-studies,20230928T115800,['Zacks Equity Research'],Nektar (NKTR) enters into a deal with Cellular Biomedicine Group to develop NKTR-255 in combination with C-TIL05 to treat advanced NSCLC.,https://staticx-tuner.zacks.com/images/articles/main/f5/284.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.007194,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.368773', 'ticker_sentiment_score': '-0.05567', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANIK', 'relevance_score': '0.127119', 'ticker_sentiment_score': '0.066031', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANVS', 'relevance_score': '0.251032', 'ticker_sentiment_score': '-0.056004', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKTR', 'relevance_score': '0.528475', 'ticker_sentiment_score': '0.186757', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
273,"Top Stories Wednesday, Sep 27: Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds - Alibaba Gr Holding  ( NYSE:BABA ) ",https://www.benzinga.com/news/23/09/34949379/apple-defends-its-19b-google-search-deal-hollywoods-writers-secure-credit-for-ai-training-chinas-amb,20230927T134747,['Vandana Singh'],Alibaba Group Holding Limited BABA stock is trading higher Wednesday as the company's logistics arm Cainiao Smart Logistics Network Ltd filed for its Hong Kong initial public offering on Tuesday. The first-time share sale could fetch a minimum of $1 billion.,https://cdn.benzinga.com/files/images/story/2023/09/27/google_search_iphone.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.108179'}]",0.148277,Neutral,"[{'ticker': 'BABA', 'relevance_score': '0.111144', 'ticker_sentiment_score': '0.095986', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.07423', 'ticker_sentiment_score': '0.159668', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TGT', 'relevance_score': '0.07423', 'ticker_sentiment_score': '0.077628', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.184176', 'ticker_sentiment_score': '0.084378', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.111144', 'ticker_sentiment_score': '0.025411', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PARA', 'relevance_score': '0.07423', 'ticker_sentiment_score': '0.159668', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.07423', 'ticker_sentiment_score': '0.07364', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.07423', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TRI', 'relevance_score': '0.111144', 'ticker_sentiment_score': '0.053298', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.07423', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSM', 'relevance_score': '0.07423', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSNLF', 'relevance_score': '0.07423', 'ticker_sentiment_score': '-0.051384', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMG', 'relevance_score': '0.07423', 'ticker_sentiment_score': '0.273503', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AZN', 'relevance_score': '0.07423', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PAYX', 'relevance_score': '0.111144', 'ticker_sentiment_score': '0.070338', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.147818', 'ticker_sentiment_score': '-0.038811', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.147818', 'ticker_sentiment_score': '0.067619', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.07423', 'ticker_sentiment_score': '0.083661', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.07423', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
274,Eli Lilly  ( LLY )  Stock Moves -0.41%: What You Should Know,https://www.zacks.com/stock/news/2155702/eli-lilly-lly-stock-moves--041-what-you-should-know,20230926T214518,['Zacks Equity Research'],"Eli Lilly (LLY) closed the most recent trading day at $550.01, moving -0.41% from the previous trading session.",https://staticx-tuner.zacks.com/images/default_article_images/default275.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.111179,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.608634', 'ticker_sentiment_score': '0.226675', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
275,2 Magnificent Dividend Stocks to Buy Right Now,https://www.fool.com/investing/2023/09/26/2-magnificent-dividend-stocks-to-buy-right-now/,20230926T170000,['George Budwell'],These two expensive dividend stocks are worth the price of admission.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F748811%2Ftime-to-buy.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}]",0.356891,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.318897', 'ticker_sentiment_score': '0.337037', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.257668', 'ticker_sentiment_score': '0.442075', 'ticker_sentiment_label': 'Bullish'}]"
276,Check Out What Whales Are Doing With LLY - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/09/34916986/check-out-what-whales-are-doing-with-lly,20230926T161540,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 13 strange trades. If we consider the specifics of each trade, it is accurate to state that 53% of the investors opened trades with bullish ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.099287,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.831658', 'ticker_sentiment_score': '0.269075', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.12165', 'ticker_sentiment_score': '-0.132256', 'ticker_sentiment_label': 'Neutral'}]"
277,Eli Lilly Unusual Options Activity For September 25 - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/09/34874544/eli-lilly-unusual-options-activity-for-september-25,20230925T173109,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 19 strange trades. If we consider the specifics of each trade, it is accurate to state that 52% of the investors opened trades with bullish ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.134794,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.767534', 'ticker_sentiment_score': '0.156028', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.118647', 'ticker_sentiment_score': '-0.130868', 'ticker_sentiment_label': 'Neutral'}]"
278,FDA Expands Lilly  ( LLY )  Jardiance Label in Chronic Kidney Disease,https://www.zacks.com/stock/news/2155039/fda-expands-lilly-lly-jardiance-label-in-chronic-kidney-disease,20230925T160400,['Zacks Equity Research'],"Following the latest approval, Lilly's (LLY) Jardiance can access a target market that affects more than 35 million adults in the United States.",https://staticx-tuner.zacks.com/images/articles/main/ff/2922.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.96136'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.147868,Neutral,"[{'ticker': 'ANVS', 'relevance_score': '0.186738', 'ticker_sentiment_score': '0.043115', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.568953', 'ticker_sentiment_score': '0.173008', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AZN', 'relevance_score': '0.306198', 'ticker_sentiment_score': '0.071326', 'ticker_sentiment_label': 'Neutral'}]"
279,Eli Lilly and Company  ( LLY )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2154763/eli-lilly-and-company-lly-is-attracting-investor-attention-here-is-what-you-should-know,20230925T130011,['Zacks Equity Research'],"Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default343.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}]",0.243948,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.520209', 'ticker_sentiment_score': '0.143271', 'ticker_sentiment_label': 'Neutral'}]"
280,"3 Artificial Intelligence  ( AI )  Stocks That Could Soar More Than Nvidia, According to Wall Street",https://www.fool.com/investing/2023/09/25/artificial-intelligence-ai-stocks-soar-nvidia/,20230925T095000,['Keith Speights'],None of these stocks have outperformed Nvidia so far this year. But the next 12 months could be a different story.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.234495,Somewhat-Bullish,"[{'ticker': 'NVDA', 'relevance_score': '0.230235', 'ticker_sentiment_score': '0.264104', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SOUN', 'relevance_score': '0.230235', 'ticker_sentiment_score': '0.239579', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SFTBF', 'relevance_score': '0.05833', 'ticker_sentiment_score': '-0.031977', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.05833', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ORCL', 'relevance_score': '0.05833', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SDGR', 'relevance_score': '0.391486', 'ticker_sentiment_score': '0.356966', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BMY', 'relevance_score': '0.05833', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HMC', 'relevance_score': '0.05833', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.05833', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
281,3 Magnificent Growth Stocks to Buy Right Now,https://www.fool.com/investing/2023/09/24/3-magnificent-growth-stocks-to-buy-right-now/,20230924T105000,"['David Jagielski', 'and Prosper Junior Bakiny', 'Keith Speights']","If you're looking for growth, these stocks could be just the ticket.",https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.744043'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.459462'}]",0.352979,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.166743', 'ticker_sentiment_score': '0.245837', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.12546', 'ticker_sentiment_score': '0.201716', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AZN', 'relevance_score': '0.287441', 'ticker_sentiment_score': '0.437472', 'ticker_sentiment_label': 'Bullish'}]"
282,"'Stocks In Monopolistic Bull Market': Wall Street Analyst Contemplates A Bright Future For Next Phase - Alphabet  ( NASDAQ:GOOG ) , Alphabet  ( NASDAQ:GOOGL ) , Meta Platforms  ( NASDAQ:META ) , NVIDIA  ( NASDAQ:NVDA ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/09/34825151/stocks-in-monopolistic-bull-market-wall-street-analyst-contemplates-a-bright-future,20230922T144619,['Piero Cingari'],"This year's bull market in stocks is a reflection of a bull market in monopolies and oligopolies, according to Bank of America's Chief Investment Strategist Michael Hartnett. While the S&P 500 boasts a commendable 14% year-to-date ( YTD ) increase, a closer look reveals the real action lies ...",https://cdn.benzinga.com/files/images/story/2023/Bull.Shutterstock.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.905476'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}]",0.232814,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.188193', 'ticker_sentiment_score': '0.103319', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.188193', 'ticker_sentiment_score': '0.103319', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.188193', 'ticker_sentiment_score': '0.103319', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.188193', 'ticker_sentiment_score': '-0.057826', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.188193', 'ticker_sentiment_score': '0.103319', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.188193', 'ticker_sentiment_score': '0.411679', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.188193', 'ticker_sentiment_score': '0.103319', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.188193', 'ticker_sentiment_score': '0.070762', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.188193', 'ticker_sentiment_score': '0.103319', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BX', 'relevance_score': '0.188193', 'ticker_sentiment_score': '0.070762', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VTRS', 'relevance_score': '0.188193', 'ticker_sentiment_score': '-0.057826', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.188193', 'ticker_sentiment_score': '0.070762', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.188193', 'ticker_sentiment_score': '0.070762', 'ticker_sentiment_label': 'Neutral'}]"
283,Are Wall Street Analysts Wrong About Eli Lilly Stock?,https://www.fool.com/investing/2023/09/22/are-wall-street-analysts-wrong-about-eli-lilly/,20230922T134500,['David Jagielski'],"Based on analysts' projections, you might think the pharmaceutical giant isn't worth investing in right now.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F747921%2Fupside-for-eli-lillys-stock-based-on-most-recent-analyst-estimates.png&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.99989'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.658903'}]",0.21918,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.366061', 'ticker_sentiment_score': '0.23249', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
284,"Here's a rapid-fire update on all 35 stocks in the Club's portfolio, including a new buy",https://www.cnbc.com/2023/09/21/rapid-fire-update-on-all-35-stocks-in-jim-cramers-club-portfolio.html,20230921T192259,['Kevin Stankiewicz'],Jim Cramer ran through all 35 Club stocks during our September Monthly Meeting on Thursday.,https://image.cnbcfm.com/api/v1/image/107200467-1677528554270-NUP_200782_00122.jpg?v=1695324179&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.209065,Somewhat-Bullish,"[{'ticker': 'DD', 'relevance_score': '0.07959', 'ticker_sentiment_score': '0.090866', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.07959', 'ticker_sentiment_score': '0.090866', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.099394', 'ticker_sentiment_score': '0.095909', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'F', 'relevance_score': '0.039844', 'ticker_sentiment_score': '0.086994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FL', 'relevance_score': '0.059736', 'ticker_sentiment_score': '0.08825', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WYNN', 'relevance_score': '0.059736', 'ticker_sentiment_score': '0.08825', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NATI', 'relevance_score': '0.039844', 'ticker_sentiment_score': '0.086994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CLX', 'relevance_score': '0.039844', 'ticker_sentiment_score': '0.086994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DHR', 'relevance_score': '0.07959', 'ticker_sentiment_score': '0.090866', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.039844', 'ticker_sentiment_score': '0.086994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.07959', 'ticker_sentiment_score': '0.090866', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.059736', 'ticker_sentiment_score': '0.08825', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.059736', 'ticker_sentiment_score': '0.08825', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.059736', 'ticker_sentiment_score': '0.08825', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STZ', 'relevance_score': '0.039844', 'ticker_sentiment_score': '0.086994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PANW', 'relevance_score': '0.059736', 'ticker_sentiment_score': '0.08825', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.039844', 'ticker_sentiment_score': '0.086994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUM', 'relevance_score': '0.039844', 'ticker_sentiment_score': '0.086994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.039844', 'ticker_sentiment_score': '0.086994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.07959', 'ticker_sentiment_score': '0.090866', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TJX', 'relevance_score': '0.039844', 'ticker_sentiment_score': '0.086994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HON', 'relevance_score': '0.059736', 'ticker_sentiment_score': '0.08825', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.059736', 'ticker_sentiment_score': '0.08825', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SWK', 'relevance_score': '0.019928', 'ticker_sentiment_score': '0.080807', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ORCL', 'relevance_score': '0.07959', 'ticker_sentiment_score': '0.090866', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EMR', 'relevance_score': '0.039844', 'ticker_sentiment_score': '0.086994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LIN', 'relevance_score': '0.059736', 'ticker_sentiment_score': '0.08825', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.039844', 'ticker_sentiment_score': '0.086994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.039844', 'ticker_sentiment_score': '0.086994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PXD', 'relevance_score': '0.039844', 'ticker_sentiment_score': '0.086994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.07959', 'ticker_sentiment_score': '0.090866', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.039844', 'ticker_sentiment_score': '0.086994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTRA', 'relevance_score': '0.039844', 'ticker_sentiment_score': '0.086994', 'ticker_sentiment_label': 'Neutral'}]"
285,"Top Stories Wednesday, Sep 20: Elon Musk-Backed Neuralink Starts Participant Enrollment For Paralysis, Eli Lilly Cracks Down on Counterfeit Weight Loss Drugs, Meta Looks to Capitalize on India's In-App Payment Surge - Apple  ( NASDAQ:AAPL ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/news/23/09/34763015/elon-musk-backed-neuralink-starts-participant-enrollment-for-paralysis-eli-lilly-cracks-down-on-coun,20230920T135614,['Vandana Singh'],"Elon Musk's brain-computer interface company, Neuralink, has initiated recruiting its first test subjects for human trials aimed at assisting individuals with paralysis in controlling devices.",https://cdn.benzinga.com/files/images/story/2023/09/20/neuralink_elon_musk_jr_morty_and_jlstock_on_shutterstock.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.684621'}]",0.062611,Neutral,"[{'ticker': 'GOOG', 'relevance_score': '0.068896', 'ticker_sentiment_score': '0.008111', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.137278', 'ticker_sentiment_score': '-0.091478', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.17112', 'ticker_sentiment_score': '-0.066313', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPRY', 'relevance_score': '0.068896', 'ticker_sentiment_score': '-0.149649', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'F', 'relevance_score': '0.068896', 'ticker_sentiment_score': '-0.318343', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'GS', 'relevance_score': '0.068896', 'ticker_sentiment_score': '0.100352', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QUBSF', 'relevance_score': '0.03448', 'ticker_sentiment_score': '0.15318', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'COTY', 'relevance_score': '0.068896', 'ticker_sentiment_score': '0.260647', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GIS', 'relevance_score': '0.103183', 'ticker_sentiment_score': '0.050609', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.068896', 'ticker_sentiment_score': '0.246494', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.103183', 'ticker_sentiment_score': '-0.029223', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PINS', 'relevance_score': '0.068896', 'ticker_sentiment_score': '0.094322', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HOOD', 'relevance_score': '0.068896', 'ticker_sentiment_score': '0.057162', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PM', 'relevance_score': '0.068896', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.068896', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.068896', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
286,"3 Healthcare Stocks That Turned $100,000 Into $1 Million in 10 Years",https://www.fool.com/investing/2023/09/20/3-healthcare-stocks-that-turned-100000-into-1-mill/,20230920T093900,['David Jagielski'],Are these highly successful stocks still good buys today?,https://media.ycharts.com/charts/baf7a2c02e6b9383f1853d6d4357574c.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.658903'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.995973'}]",0.327785,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.280294', 'ticker_sentiment_score': '0.164338', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WST', 'relevance_score': '0.22595', 'ticker_sentiment_score': '0.23179', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DXCM', 'relevance_score': '0.22595', 'ticker_sentiment_score': '0.206779', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
287,6 Healthcare Stocks Analysts Still Like,https://www.barrons.com/articles/healthcare-stocks-analysts-like-8b0f4dd2,20230920T070000,['Josh Nathan-Kazis'],"This has been an epically bad year for the healthcare sector, but there are still a few stocks out there that Wall Street analysts like. Some of them are even more beaten down than the rest of the industry. The S&P 500 Health Care sector index is down 3% this year, vastly behind the S&P 500, ...",https://images.barrons.com/im-81046107?width=639&height=426,Barrons,n/a,www.barrons.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.918141'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.054264,Neutral,"[{'ticker': 'TECH', 'relevance_score': '0.240489', 'ticker_sentiment_score': '0.079998', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.16171', 'ticker_sentiment_score': '0.059347', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.16171', 'ticker_sentiment_score': '0.059347', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.16171', 'ticker_sentiment_score': '0.059347', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZTS', 'relevance_score': '0.459624', 'ticker_sentiment_score': '0.130657', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIO', 'relevance_score': '0.16171', 'ticker_sentiment_score': '0.059347', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DXCM', 'relevance_score': '0.16171', 'ticker_sentiment_score': '0.059347', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.16171', 'ticker_sentiment_score': '0.059347', 'ticker_sentiment_label': 'Neutral'}]"
288,Eli Lilly  ( LLY )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2152758/eli-lilly-lly-gains-as-market-dips-what-you-should-know,20230919T214518,['Zacks Equity Research'],"In the latest trading session, Eli Lilly (LLY) closed at $574.96, marking a +0.64% move from the previous day.",https://staticx-tuner.zacks.com/images/default_article_images/default122.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.961735'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.124548,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.5633', 'ticker_sentiment_score': '0.108351', 'ticker_sentiment_label': 'Neutral'}]"
289,Eli Lilly Unusual Options Activity - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/09/34734299/eli-lilly-unusual-options-activity,20230919T151547,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bearish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://www.benzinga.com/files/images/story/2023/1695136544_0.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.118395,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.753462', 'ticker_sentiment_score': '0.070095', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.102449', 'ticker_sentiment_score': '-0.124255', 'ticker_sentiment_label': 'Neutral'}]"
290,Should Invesco Large Cap Growth ETF  ( PWB )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2151646/should-invesco-large-cap-growth-etf-pwb-be-on-your-investing-radar,20230918T102006,['Zacks Equity Research'],Style Box ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default224.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999998'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.302328,Somewhat-Bullish,"[{'ticker': 'ADBE', 'relevance_score': '0.119235', 'ticker_sentiment_score': '0.0608', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.119235', 'ticker_sentiment_score': '0.0608', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ORCL', 'relevance_score': '0.119235', 'ticker_sentiment_score': '0.0608', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.29234', 'ticker_sentiment_score': '0.265446', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
291,"1 Growth Stock That Could Turn $1,000 Into $2,500 by 2030",https://www.fool.com/investing/2023/09/16/1-growth-stock-that-could-turn-1000-into-2500-by-2/,20230916T111500,['Prosper Junior Bakiny'],The stock has delivered market-beating returns in the past. It can do it again.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.684621'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.224724,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.414559', 'ticker_sentiment_score': '0.230381', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.108466', 'ticker_sentiment_score': '0.068966', 'ticker_sentiment_label': 'Neutral'}]"
292,Nektar  ( NKTR )  Up on Positive New Data From Eczema Study,https://www.zacks.com/stock/news/2148794/nektar-nktr-up-on-positive-new-data-from-eczema-study,20230914T115400,['Zacks Equity Research'],"Nektar (NKTR) gains on positive new data for its pipeline candidate, rezpegaldesleukin, evaluated from an early-stage study for treating atopic dermatitis.",https://staticx-tuner.zacks.com/images/articles/main/2a/3899.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.004815,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.383905', 'ticker_sentiment_score': '-0.057357', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANIK', 'relevance_score': '0.132733', 'ticker_sentiment_score': '0.067432', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANVS', 'relevance_score': '0.261818', 'ticker_sentiment_score': '-0.057928', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKTR', 'relevance_score': '0.261818', 'ticker_sentiment_score': '0.02199', 'ticker_sentiment_label': 'Neutral'}]"
293,2 Stocks That Moved the Market in August,https://www.fool.com/investing/2023/09/14/2-stocks-that-moved-the-market-in-august/,20230914T095500,['Ryan Downie'],These two stocks illustrate the most important trends in the market right now.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F747424%2Fgettyimages-1346195016.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}, {'topic': 'Earnings', 'relevance_score': '0.744043'}, {'topic': 'Technology', 'relevance_score': '0.5'}, {'topic': 'Blockchain', 'relevance_score': '0.310843'}]",0.03242,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.128822', 'ticker_sentiment_score': '0.199274', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SQ', 'relevance_score': '0.213048', 'ticker_sentiment_score': '0.083228', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.08609', 'ticker_sentiment_score': '0.043966', 'ticker_sentiment_label': 'Neutral'}]"
294,Eli Lilly  ( LLY )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2148585/eli-lilly-lly-stock-sinks-as-market-gains-what-you-should-know,20230913T214518,['Zacks Equity Research'],"Eli Lilly (LLY) closed the most recent trading day at $598.88, moving -0.07% from the previous trading session.",https://staticx-tuner.zacks.com/images/default_article_images/default309.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.176825,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.6809', 'ticker_sentiment_score': '0.259595', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
295,Is First Trust Capital Strength ETF  ( FTCS )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2148129/is-first-trust-capital-strength-etf-ftcs-a-strong-etf-right-now,20230913T102005,['Zacks Equity Research'],Smart Beta ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default275.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999965'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.313262,Somewhat-Bullish,"[{'ticker': 'CPRT', 'relevance_score': '0.114682', 'ticker_sentiment_score': '0.055415', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.114682', 'ticker_sentiment_score': '0.055415', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NTAP', 'relevance_score': '0.114682', 'ticker_sentiment_score': '0.055415', 'ticker_sentiment_label': 'Neutral'}]"
296,Check Out What Whales Are Doing With LLY - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/09/34496053/check-out-what-whales-are-doing-with-lly,20230912T154653,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bullish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.143764,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.75957', 'ticker_sentiment_score': '0.218609', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.103778', 'ticker_sentiment_score': '-0.124737', 'ticker_sentiment_label': 'Neutral'}]"
297,NVS vs. LLY: Which Stock Is the Better Value Option?,https://www.zacks.com/stock/news/2147891/nvs-vs-lly-which-stock-is-the-better-value-option,20230912T154007,['Zacks Equity Research'],Investors interested in Large Cap Pharmaceuticals stocks are likely familiar with Novartis ( NVS Quick QuoteNVS - ) and Eli Lilly ( LLY Quick QuoteLLY - ) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.,https://staticx-tuner.zacks.com/images/default_article_images/default45.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.511391,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.757528', 'ticker_sentiment_score': '0.612371', 'ticker_sentiment_label': 'Bullish'}]"
298,Jim Cramer says this software stock is a buy here after earnings-driven decline,https://www.cnbc.com/2023/09/12/jim-cramer-says-this-software-stock-is-a-buy-here-.html,20230912T151429,['Jeff Marks'],The Investing Club holds its Morning Meeting every weekday at 10:20 a.m. ET.,https://image.cnbcfm.com/api/v1/image/107299151-16945293921694529386-31166084386-1080pnbcnews.jpg?v=1694530658&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.967645'}, {'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.166134,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.433523', 'ticker_sentiment_score': '0.201767', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ORCL', 'relevance_score': '0.49637', 'ticker_sentiment_score': '0.219566', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.297661', 'ticker_sentiment_score': '0.153721', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
299,We're selling shares in this outperforming drugmaker and locking in a huge gain,https://www.cnbc.com/2023/09/12/were-selling-shares-in-this-healthcare-stock-and-locking-in-some-major-gains.html,20230912T130403,['Jeff Marks'],This trim today is about discipline after an incredible run in a stock.,https://image.cnbcfm.com/api/v1/image/107261717-1687534870894-gettyimages-492437674-Par8299504.jpeg?v=1694523843&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.986714'}]",0.329256,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.7887', 'ticker_sentiment_score': '0.518668', 'ticker_sentiment_label': 'Bullish'}]"
300,Eli Lilly and Company  ( LLY )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2147650/eli-lilly-and-company-lly-is-attracting-investor-attention-here-is-what-you-should-know,20230912T130011,['Zacks Equity Research'],"Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default214.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.230595,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.525907', 'ticker_sentiment_score': '0.17223', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
301,LLY: Prescribe to Profits With These 3 Pharma Stocks,https://stocknews.com/news/lly-mrk-teva-prescribe-to-profits-with-these-3-pharma-stocks/,20230912T125425,['StockNews.com Staff'],"The pharmaceutical industry is a robust and continually evolving sector, poised for sustained growth in the coming years, driven by several factors, including an aging global population, the rising incidence of chronic illnesses, and technological advancements.",https://stocknews.com/wp-content/uploads/2021/01/cvs-rad-wba-scaled.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.998356'}, {'topic': 'Earnings', 'relevance_score': '0.99999'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.258224,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.199977', 'ticker_sentiment_score': '0.224082', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ALVO', 'relevance_score': '0.057698', 'ticker_sentiment_score': '0.085962', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TEVA', 'relevance_score': '0.171892', 'ticker_sentiment_score': '0.153254', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SGTX', 'relevance_score': '0.028868', 'ticker_sentiment_score': '0.258329', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
302,Should You Still Buy the S&P 500's Best-Performing August Stocks?,https://www.fool.com/investing/2023/09/12/should-you-still-buy-the-sp-500s-best-performing-a/,20230912T095000,['Keith Speights'],These high-flying S&P 500 stocks could have more room to run.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}, {'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.278345,Somewhat-Bullish,"[{'ticker': 'JNPR', 'relevance_score': '0.062271', 'ticker_sentiment_score': '0.140499', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.415535', 'ticker_sentiment_score': '0.445579', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ANET', 'relevance_score': '0.185306', 'ticker_sentiment_score': '0.282323', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
303,Wall Street Has Found Its Next High-Flying Stock-Split Stock. Here's Why I'm Not Buying the Hype.,https://www.fool.com/investing/2023/09/12/wall-street-has-next-high-flying-stock-split-stock/,20230912T090600,['Sean Williams'],"Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, and Monster Beverage have all split their shares since July 2021. Next week, another industry leader will join this exclusive club.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F747197%2Fstock-certificate-investment-retire-heirloom-donate-capital-gains-tax-getty.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.999976'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.147951,Neutral,"[{'ticker': 'GOOG', 'relevance_score': '0.032164', 'ticker_sentiment_score': '0.147186', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.032164', 'ticker_sentiment_score': '0.147186', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.032164', 'ticker_sentiment_score': '0.147186', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MNST', 'relevance_score': '0.032164', 'ticker_sentiment_score': '0.270996', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.399856', 'ticker_sentiment_score': '0.150249', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.064276', 'ticker_sentiment_score': '0.142446', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.032164', 'ticker_sentiment_score': '0.147186', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.064276', 'ticker_sentiment_score': '0.142446', 'ticker_sentiment_label': 'Neutral'}]"
304,Investors May Not Have Seen the Best From Eli Lilly Stock Yet. Here's Why.,https://www.fool.com/investing/2023/09/10/investors-may-not-have-seen-the-best-from-eli-lill/,20230910T101200,['Adam Spatacco'],"Mounjaro has been on the market for roughly one year and is already generating billions in sales for Eli Lilly. But with that said, its best days could be ahead.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F745741%2Fgettyimages-1315185865.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.839681'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}]",0.15603,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.609866', 'ticker_sentiment_score': '0.228644', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.303926', 'ticker_sentiment_score': '0.023955', 'ticker_sentiment_label': 'Neutral'}]"
305,3 Unstoppable Growth Stocks to Buy Right Now,https://www.fool.com/investing/2023/09/09/3-unstoppable-growth-stocks-to-buy-right-now/,20230909T105500,"['and Prosper Junior Bakiny', 'David Jagielski', 'Keith Speights']",These healthcare stocks show no signs of slowing down.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.967645'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}]",0.247559,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.285526', 'ticker_sentiment_score': '0.177763', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.165598', 'ticker_sentiment_score': '0.085992', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REGN', 'relevance_score': '0.165598', 'ticker_sentiment_score': '0.085386', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.244904', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
306,Only 2 Mega-Cap Monster Stocks Have Risen in Each of the Last 5 Years: Are They Buys Now?,https://www.fool.com/investing/2023/09/09/here-are-the-only-2-mega-cap-monster-stocks-that-h/,20230909T095200,['Keith Speights'],There's no guarantee their winning streaks will continue. But don't be surprised if they do.,https://media.ycharts.com/charts/6c63e09bdd88a1417b73b666ca53fea7.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.234418,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.429541', 'ticker_sentiment_score': '0.24195', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.05654', 'ticker_sentiment_score': '0.115259', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.05654', 'ticker_sentiment_score': '0.115259', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.277118', 'ticker_sentiment_score': '0.275632', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
307,"Drug And Tech Services Stocks Surge To New Highs, Buy Zones With Strong Technical Ratings",https://www.investors.com/stock-lists/new-highs/drug-and-tech-services-stocks-surge-to-new-highs-with-strong-technical-ratings/,20230908T162700,"['VIDYA RAMAKRISHNAN', ""Investor's Business Daily""]","Drug And Tech Services Stocks Surge To New Highs, Buy Zones ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2020/10/Stock-EliLilly-03-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.744043'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.977154'}]",0.362345,Bullish,"[{'ticker': 'ACN', 'relevance_score': '0.303175', 'ticker_sentiment_score': '0.366788', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.303175', 'ticker_sentiment_score': '0.436939', 'ticker_sentiment_label': 'Bullish'}]"
308,"Top Stories Friday, Sep 8: Did Elon Musk Admit 90% Decline In Twitter's Value Since Acquisition?, Apple's Zero-Click Vulnerabilities Uncovered By Internet Watchdog Group, Gas Prices Jump As Strikes Start At Major Chevron Australia LNG Projects - Apple  ( NASDAQ:AAPL ) , Albertsons Companies  ( NYSE:ACI ) ",https://www.benzinga.com/news/23/09/34363050/did-elon-musk-admit-90-decline-in-twitters-value-since-acquisition-apples-zero-click-vulnerabilities,20230908T143216,['Vandana Singh'],"Elon Musk's $44 billion acquisition of Twitter ( now X ) has been mired in controversies, but his latest admission could be a sign of just how bad it has turned out for him so far.",https://cdn.benzinga.com/files/images/story/2023/09/08/elon_musk_should_run_from_the_twitter_deal_ljupco_smokovski_by_shutterstock_and_wikimedia_commons.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.108179'}]",0.02421,Neutral,"[{'ticker': 'GOOG', 'relevance_score': '0.139064', 'ticker_sentiment_score': '-0.231492', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AAPL', 'relevance_score': '0.069798', 'ticker_sentiment_score': '-0.008128', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.069798', 'ticker_sentiment_score': '0.035368', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPOT', 'relevance_score': '0.069798', 'ticker_sentiment_score': '0.113506', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ILMN', 'relevance_score': '0.069798', 'ticker_sentiment_score': '0.090027', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ACI', 'relevance_score': '0.069798', 'ticker_sentiment_score': '0.126595', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KR', 'relevance_score': '0.207275', 'ticker_sentiment_score': '0.07092', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.069798', 'ticker_sentiment_score': '-0.102437', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.069798', 'ticker_sentiment_score': '0.024304', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZM', 'relevance_score': '0.069798', 'ticker_sentiment_score': '0.024304', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HOFT', 'relevance_score': '0.104531', 'ticker_sentiment_score': '-0.033671', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SFBQF', 'relevance_score': '0.069798', 'ticker_sentiment_score': '0.307496', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SFTBF', 'relevance_score': '0.034933', 'ticker_sentiment_score': '0.298086', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.069798', 'ticker_sentiment_score': '0.19613', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
309,Here's How Much You'd Have If You Invested $1000 in Eli Lilly a Decade Ago,https://www.zacks.com/stock/news/2146456/heres-how-much-youd-have-if-you-invested-1000-in-eli-lilly-a-decade-ago,20230908T123003,['Zacks Equity Research'],Holding on to popular or trending stocks for the long-term can make your portfolio a winner.,https://staticx-tuner.zacks.com/images/default_article_images/default107.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}, {'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.160458,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.618121', 'ticker_sentiment_score': '0.260381', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'INCY', 'relevance_score': '0.053629', 'ticker_sentiment_score': '0.024871', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ELAN', 'relevance_score': '0.212115', 'ticker_sentiment_score': '0.040331', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AKUS', 'relevance_score': '0.053629', 'ticker_sentiment_score': '0.046012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DICE', 'relevance_score': '0.053629', 'ticker_sentiment_score': '0.046012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVBXF', 'relevance_score': '0.053629', 'ticker_sentiment_score': '0.024871', 'ticker_sentiment_label': 'Neutral'}]"
310,'Smart Money' Investors Pour $2 Billion Into Just 5 Stocks,https://www.investors.com/etfs-and-funds/sectors/sp500-smart-money-investors-pour-billions-into-just-stocks/,20230908T120000,"[""Investor's Business Daily"", 'MATT KRANTZ']",If you're wondering which S&P 500 stocks the best mutual funds are buying - you might be surprised by how selective the list is.,https://www.investors.com/wp-content/uploads/2023/04/Stock-moneyoncalendar-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.999998'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.389708,Bullish,"[{'ticker': 'META', 'relevance_score': '0.165031', 'ticker_sentiment_score': '0.067127', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.165031', 'ticker_sentiment_score': '0.331673', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AVGO', 'relevance_score': '0.110462', 'ticker_sentiment_score': '0.169375', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CSCO', 'relevance_score': '0.165031', 'ticker_sentiment_score': '0.28802', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.165031', 'ticker_sentiment_score': '0.153286', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ADBE', 'relevance_score': '0.110462', 'ticker_sentiment_score': '0.169375', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.271576', 'ticker_sentiment_score': '0.323372', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BLD', 'relevance_score': '0.165031', 'ticker_sentiment_score': '0.253387', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
311,Stocks Could Revive In September - But Don't Count On It,https://www.investors.com/etfs-and-funds/personal-finance/best-funds-stocks-could-revive-september/,20230908T110000,"['ADAM SHELL', ""Investor's Business Daily""]","Despite a late-month rally, both the S&P 500 and Nasdaq saw their five-month winning streaks snapped in August. The market suffered a broad but mild pullback, hurting even the best funds. The only stock fund sector to post a gain was natural resources, while the previously white-hot science and ...",https://www.investors.com/wp-content/uploads/2021/04/Stock-marketBoard-29-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.838487'}, {'topic': 'IPO', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}]",0.102673,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.057628', 'ticker_sentiment_score': '-0.221314', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'META', 'relevance_score': '0.086348', 'ticker_sentiment_score': '-0.231339', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NVDA', 'relevance_score': '0.199741', 'ticker_sentiment_score': '0.067152', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.057628', 'ticker_sentiment_score': '-0.221314', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSLA', 'relevance_score': '0.057628', 'ticker_sentiment_score': '-0.221314', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LLY', 'relevance_score': '0.057628', 'ticker_sentiment_score': '0.0871', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AEP', 'relevance_score': '0.057628', 'ticker_sentiment_score': '0.0861', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.028833', 'ticker_sentiment_score': '0.035485', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.057628', 'ticker_sentiment_score': '0.0871', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NEE', 'relevance_score': '0.057628', 'ticker_sentiment_score': '0.0861', 'ticker_sentiment_label': 'Neutral'}]"
312,How Stocks Pass Quality Test Of This Best Mutual Fund,https://www.investors.com/etfs-and-funds/mutual-funds/best-mutual-fund-pass-the-quality-test-administered-by-quality-gmo-fund/,20230908T110000,"[""Investor's Business Daily"", 'ADAM SHELL']","It doesn't take a Ph.D. in finance to figure out what the investing game plan is for GMO Quality IV Fund ( GQEFX ) , a best mutual fund. In a nutshell? Buy quality stocks. When administering the quality test, Tom Hancock, 60, portfolio manager of GMO Quality, looks for companies that can pretty ...",https://www.investors.com/wp-content/uploads/2023/09/MFprof091123-959x1024.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.977154'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Economy - Macro', 'relevance_score': '0.310843'}]",0.290466,Somewhat-Bullish,"[{'ticker': 'KLAC', 'relevance_score': '0.059562', 'ticker_sentiment_score': '0.070045', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.059562', 'ticker_sentiment_score': '0.082998', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.08924', 'ticker_sentiment_score': '0.085824', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.029802', 'ticker_sentiment_score': '0.066133', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.059562', 'ticker_sentiment_score': '0.082998', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.118793', 'ticker_sentiment_score': '0.290329', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LRCX', 'relevance_score': '0.059562', 'ticker_sentiment_score': '0.070045', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MORN', 'relevance_score': '0.029802', 'ticker_sentiment_score': '-0.044174', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ACN', 'relevance_score': '0.08924', 'ticker_sentiment_score': '-0.003161', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.206308', 'ticker_sentiment_score': '0.095155', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.08924', 'ticker_sentiment_score': '0.112787', 'ticker_sentiment_label': 'Neutral'}]"
313,Why Is Lilly  ( LLY )  Up 6.4% Since Last Earnings Report?,https://www.zacks.com/stock/news/2146118/why-is-lilly-lly-up-64-since-last-earnings-report,20230907T153055,['Zacks Equity Research'],Lilly (LLY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,https://staticx-tuner.zacks.com/images/default_article_images/default86.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999965'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.986714'}]",0.123567,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.323078', 'ticker_sentiment_score': '0.218553', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
314,Novo Nordisk  ( NVO )  Launches Wegovy in UK Amid Supply Issues,https://www.zacks.com/stock/news/2145039/novo-nordisk-nvo-launches-wegovy-in-uk-amid-supply-issues,20230905T175200,['Zacks Equity Research'],Novo Nordisk (NVO) announces the controlled and limited launch of Wegovy in the U.K. amid rising demand for weight loss treatment and supply constraints.,https://staticx-tuner.zacks.com/images/articles/main/de/2471.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.203008,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.13459', 'ticker_sentiment_score': '0.075687', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DVAX', 'relevance_score': '0.089965', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.465709', 'ticker_sentiment_score': '0.358427', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.17879', 'ticker_sentiment_score': '0.076714', 'ticker_sentiment_label': 'Neutral'}]"
315,LLY: 3 Pharma Stocks Smart Money Is Following in September,https://stocknews.com/news/lly-zts-taro-sgtx-3-pharma-stocks-smart-money-is-following-in-september/,20230905T174052,['StockNews.com Staff'],"The pharmaceutical sector is poised for sustained expansion in the foreseeable future, propelled by factors such as the aging demographic, growing chronic illnesses, and technological advancements.",https://stocknews.com/wp-content/uploads/2022/07/shutterstock_1110645284.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.217128,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.308891', 'ticker_sentiment_score': '-0.023044', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZTS', 'relevance_score': '0.28432', 'ticker_sentiment_score': '0.2611', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.052801', 'ticker_sentiment_score': '0.125623', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TARO', 'relevance_score': '0.131499', 'ticker_sentiment_score': '0.017201', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SGTX', 'relevance_score': '0.052801', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
316,Eli Lilly Unusual Options Activity For September 05 - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/09/34239112/eli-lilly-unusual-options-activity-for-september-05,20230905T144611,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bearish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.132384,Neutral,"[{'ticker': 'GS', 'relevance_score': '0.098659', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.784902', 'ticker_sentiment_score': '0.172799', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WFC', 'relevance_score': '0.098659', 'ticker_sentiment_score': '-0.122943', 'ticker_sentiment_label': 'Neutral'}]"
317,Why AbCellera Biologics Is Still A Buy Despite Dropping Royalties: Analyst On Long-Term Prospects - AbCellera Biologics  ( NASDAQ:ABCL ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/08/34153752/why-abcellera-biologics-is-still-a-buy-despite-dropping-royalties-analyst-on-long-t,20230831T191855,['Nabaparna Bhattacharya'],"Benchmark analyst Robert Wasserman reiterated a Buy rating on AbCellera Biologics Inc. ABCL, lowering the price target to $12 on reduced valuations for other drug discovery stocks.",https://cdn.benzinga.com/files/images/story/2023/08/31/abcl.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.026109,Neutral,"[{'ticker': 'ABCL', 'relevance_score': '0.451494', 'ticker_sentiment_score': '-0.133584', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.451494', 'ticker_sentiment_score': '-0.0361', 'ticker_sentiment_label': 'Neutral'}]"
318,Why Is Incyte  ( INCY )  Down 0.7% Since Last Earnings Report?,https://www.zacks.com/stock/news/2143111/why-is-incyte-incy-down-07-since-last-earnings-report,20230831T153128,['Zacks Equity Research'],Incyte (INCY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,https://staticx-tuner.zacks.com/images/default_article_images/default332.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.976671'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}]",0.149755,Neutral,"[{'ticker': 'BMRN', 'relevance_score': '0.039679', 'ticker_sentiment_score': '0.057849', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.079261', 'ticker_sentiment_score': '0.126034', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INCY', 'relevance_score': '0.482217', 'ticker_sentiment_score': '0.221574', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'REPL', 'relevance_score': '0.079261', 'ticker_sentiment_score': '0.141818', 'ticker_sentiment_label': 'Neutral'}]"
319,Eli Lilly Unusual Options Activity For August 31 - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/08/34146280/eli-lilly-unusual-options-activity-for-august-31,20230831T143149,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 10 strange trades. If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.054682,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.871674', 'ticker_sentiment_score': '0.103251', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.109956', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.109956', 'ticker_sentiment_score': '-0.127126', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.109956', 'ticker_sentiment_score': '-0.127126', 'ticker_sentiment_label': 'Neutral'}]"
320,Eli Lilly and Company  ( LLY )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2142870/eli-lilly-and-company-lly-is-a-trending-stock-facts-to-know-before-betting-on-it,20230831T130011,['Zacks Equity Research'],"Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.",https://staticx-tuner.zacks.com/images/default_article_images/default311.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}]",0.224118,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.529767', 'ticker_sentiment_score': '0.154338', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
321,Medicare wants to cut the price on an Eli Lilly drug. What is means for LLY shares,https://www.cnbc.com/2023/08/30/medicare-wants-to-cut-the-price-on-an-eli-lilly-drug-what-is-means-for-lly-shares.html,20230830T182319,['Kevin Stankiewicz'],"Lilly's Jardiance is among the first 10 prescription drugs subject a new, contentious negotiation process between Medicare and drugmakers.",https://image.cnbcfm.com/api/v1/image/107235494-1683201790787-gettyimages-1252633286-ELI_LILLY_HQ.jpeg?v=1693419799&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.972756'}, {'topic': 'Earnings', 'relevance_score': '0.214378'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.064079,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.224013', 'ticker_sentiment_score': '0.047114', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.032425', 'ticker_sentiment_score': '0.025807', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.097062', 'ticker_sentiment_score': '0.028923', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.064797', 'ticker_sentiment_score': '0.027117', 'ticker_sentiment_label': 'Neutral'}]"
322,3 Dividend Stocks That Have Doubled Since 2020,https://www.fool.com/investing/2023/08/30/3-dividend-stocks-that-have-doubled-since-2020/,20230830T174806,['David Jagielski'],Are these stocks still good buys today?,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.623304'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.857896'}]",0.216779,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.264515', 'ticker_sentiment_score': '0.416858', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'DKS', 'relevance_score': '0.264515', 'ticker_sentiment_score': '0.102285', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.264515', 'ticker_sentiment_score': '0.008073', 'ticker_sentiment_label': 'Neutral'}]"
323,U.S. Dividend Growth Decelerated Once Again in Q2,https://www.kiplinger.com/dividend-growth-stocks-statistics,20230830T164443,['Dan Burrows'],"U.S. dividend growth continued its ""steady deceleration"" during the April through June period to mark a sixth consecutive quarter of slower dividend increases, according to a study by the Janus Henderson Global Dividend Index.",https://cdn.mos.cms.futurecdn.net/m64vRwQXLgXEMnELD6mvZj-415-80.jpg,Kiplinger,n/a,www.kiplinger.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.384877,Bullish,"[{'ticker': 'JHG', 'relevance_score': '0.357293', 'ticker_sentiment_score': '0.340964', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.122894', 'ticker_sentiment_score': '0.127082', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLD', 'relevance_score': '0.122894', 'ticker_sentiment_score': '0.47036', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BX', 'relevance_score': '0.122894', 'ticker_sentiment_score': '-0.039028', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.18343', 'ticker_sentiment_score': '-0.049974', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.18343', 'ticker_sentiment_score': '0.160958', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
324,"Global dividends hit record $568 billion, but pace of U.S. payouts slows for sixth straight quarter",https://www.marketwatch.com/story/global-dividends-hit-record-568-billion-but-pace-of-u-s-payouts-slows-for-sixth-straight-quarter-5bfb63a2,20230830T055700,['Jamie Chisholm'],"In its quarterly survey of the world's 1,200 biggest companies Janus Henderson said that 88% increased their dividends or kept them the same over the period.",https://images.mktw.net/im-843623?width=700&height=581,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}]",0.333916,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.165031', 'ticker_sentiment_score': '0.178039', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.165031', 'ticker_sentiment_score': '0.178039', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BX', 'relevance_score': '0.165031', 'ticker_sentiment_score': '0.312637', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'INTC', 'relevance_score': '0.165031', 'ticker_sentiment_score': '0.312637', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'XOM', 'relevance_score': '0.165031', 'ticker_sentiment_score': '0.178039', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JHG', 'relevance_score': '0.245339', 'ticker_sentiment_score': '0.191932', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.165031', 'ticker_sentiment_score': '0.161823', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.165031', 'ticker_sentiment_score': '0.161823', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
325,Better Pharma Growth Stock: Eli Lilly vs. Merck,https://www.fool.com/investing/2023/08/29/better-pharma-growth-stock-eli-lilly-vs-merck/,20230829T141500,['Alex Carchidi'],"This is a close contest, but there's a clear winner.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F745536%2Fliving-trust-and-estate-planning.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.972476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.334927,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.47672', 'ticker_sentiment_score': '0.411131', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'RXDX', 'relevance_score': '0.063594', 'ticker_sentiment_score': '0.061711', 'ticker_sentiment_label': 'Neutral'}]"
326,Better Buy: Biogen vs. Eli Lilly,https://www.fool.com/investing/2023/08/29/better-buy-biogen-vs-eli-lilly/,20230829T140700,['Prosper Junior Bakiny'],This battle of biotech giants has a clear winner.,https://media.ycharts.com/charts/8788a5006dcd88a2e55605d386dfc22a.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.249145,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.571178', 'ticker_sentiment_score': '0.379726', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'RETA', 'relevance_score': '0.05257', 'ticker_sentiment_score': '0.040754', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.608634', 'ticker_sentiment_score': '0.207174', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
327,Why Wegovy's Sales Potential Could Be Massively Understated,https://www.fool.com/investing/2023/08/29/wegovy-sales-potentialy-massively-understated/,20230829T094700,['David Jagielski'],Promising results from clinical trials could result in more uses for the popular weight-loss drug.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.990893'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.202794,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.169676', 'ticker_sentiment_score': '0.12484', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.331765', 'ticker_sentiment_score': '0.278156', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
328,"Top Stories: Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal - Bayer  ( OTC:BAYRY ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/news/23/08/34069633/hawaiian-electric-says-power-lines-not-responsible-for-deadly-lahaina-fire-china-targets-stock-marke,20230828T143708,['Vandana Singh'],"Walmart Inc WMT has reportedly resolved the University of California's light-bulb patent lawsuit. The university accused the retail behemoth of infringing its patents associated with ""filament"" LED light bulbs ( invented at the Santa Barbara-based school system ) .",https://cdn.benzinga.com/files/images/story/2023/08/28/china_money-938269_1920.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.995077'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.684621'}]",0.1191,Neutral,"[{'ticker': 'XPEV', 'relevance_score': '0.101869', 'ticker_sentiment_score': '0.081093', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BYDDF', 'relevance_score': '0.068016', 'ticker_sentiment_score': '-0.014083', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAYZF', 'relevance_score': '0.068016', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GDC', 'relevance_score': '0.101869', 'ticker_sentiment_score': '0.189831', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMGN', 'relevance_score': '0.068016', 'ticker_sentiment_score': '0.076907', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BZUN', 'relevance_score': '0.068016', 'ticker_sentiment_score': '0.062686', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HAWEL', 'relevance_score': '0.034039', 'ticker_sentiment_score': '0.002973', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RNSDF', 'relevance_score': '0.101869', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BV', 'relevance_score': '0.068016', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JBL', 'relevance_score': '0.101869', 'ticker_sentiment_score': '-0.008576', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BYDIY', 'relevance_score': '0.034039', 'ticker_sentiment_score': '-0.013381', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HZNP', 'relevance_score': '0.068016', 'ticker_sentiment_score': '0.076907', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SFTBF', 'relevance_score': '0.068016', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.068016', 'ticker_sentiment_score': '0.09125', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HE', 'relevance_score': '0.034039', 'ticker_sentiment_score': '0.002973', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.068016', 'ticker_sentiment_score': '-0.015336', 'ticker_sentiment_label': 'Neutral'}]"
329,3 Top Growth Stocks I'd Buy Right Now Without Hesitation,https://www.fool.com/investing/2023/08/28/3-top-growth-stocks-id-buy-right-now-without/,20230828T123000,['Prosper Junior Bakiny'],These drugmakers are all leaders in their respective niches.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}]",0.254456,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.275867', 'ticker_sentiment_score': '0.183392', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.18602', 'ticker_sentiment_score': '0.127057', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.275867', 'ticker_sentiment_score': '0.18988', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
330,Is It Time to Take Some Gains in Novo Nordisk Stock? Not So Fast.,https://www.fool.com/investing/2023/08/28/is-it-time-to-take-some-gains-in-novo-nordisk/,20230828T120000,['Adam Spatacco'],"Novo Nordisk stock has been on a tear, but the company's latest financial report suggests it may just be getting started.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F744929%2Fgettyimages-667828974.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}, {'topic': 'Earnings', 'relevance_score': '0.744043'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.225393,Somewhat-Bullish,"[{'ticker': 'BCS', 'relevance_score': '0.043186', 'ticker_sentiment_score': '0.089587', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.043186', 'ticker_sentiment_score': '0.075567', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.043186', 'ticker_sentiment_score': '0.089587', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.613743', 'ticker_sentiment_score': '0.376283', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.448603', 'ticker_sentiment_score': '0.274888', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.043186', 'ticker_sentiment_score': '0.075567', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.043186', 'ticker_sentiment_score': '0.075567', 'ticker_sentiment_label': 'Neutral'}]"
331,Warren Buffett Bets His Fortune On One Of 9 'Can't Lose' Stocks,https://www.investors.com/etfs-and-funds/sectors/sp500-warren-buffetts-top-personal-pick-is-one-of-cant-lose-stocks/,20230828T120000,"['MATT KRANTZ', ""Investor's Business Daily""]",What do investors do when they can get 5% and take no risk? Find low-risk S&P 500 stocks they can make even more on - a tall order only a few can meet.,https://www.investors.com/wp-content/uploads/2019/05/stock-Buffett-Warren-02-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.294498,Somewhat-Bullish,"[{'ticker': 'AXON', 'relevance_score': '0.198493', 'ticker_sentiment_score': '0.263334', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.198493', 'ticker_sentiment_score': '0.222467', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SPGI', 'relevance_score': '0.066784', 'ticker_sentiment_score': '0.152425', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LPLA', 'relevance_score': '0.066784', 'ticker_sentiment_score': '0.116767', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.198493', 'ticker_sentiment_score': '0.097544', 'ticker_sentiment_label': 'Neutral'}]"
332,Is It Too Late to Buy Eli Lilly Stock?,https://www.fool.com/investing/2023/08/27/is-it-too-late-to-buy-eli-lilly-stock/,20230827T112000,['Kody Kester'],Shares of the pharmaceutical company have crushed the market so far this year.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F745378%2Fa-customer-shops-at-a-pharmacy.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.999996'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.977154'}]",0.276759,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.485711', 'ticker_sentiment_score': '0.398654', 'ticker_sentiment_label': 'Bullish'}]"
333,Is Alexandria Real Estate Equities a Buy?,https://www.fool.com/investing/2023/08/26/is-alexandria-real-estate-equities-a-buy/,20230826T091800,"['Brent Nyitray', 'CFA']","Great company, attractive valuation, lousy sector.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F745252%2Flaboratory-space.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Earnings', 'relevance_score': '0.744043'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.5'}]",0.190154,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.126784', 'ticker_sentiment_score': '0.045025', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BXP', 'relevance_score': '0.126784', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARE', 'relevance_score': '0.31006', 'ticker_sentiment_score': '0.173989', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MRNA', 'relevance_score': '0.126784', 'ticker_sentiment_score': '0.045025', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.126784', 'ticker_sentiment_score': '0.045025', 'ticker_sentiment_label': 'Neutral'}]"
334,This Is What Whales Are Betting On Eli Lilly - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/08/34046457/this-is-what-whales-are-betting-on-eli-lilly,20230825T164612,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bearish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.108613,Neutral,"[{'ticker': 'GS', 'relevance_score': '0.097854', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.823771', 'ticker_sentiment_score': '0.329774', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
335,Q2 Earnings & Market Sell-Off Impact: 5 Must-See ETF Charts,https://www.zacks.com/stock/news/2140941/q2-earnings-market-sell-off-impact-5-must-see-etf-charts,20230825T154600,['Sweta Killa'],Let's delve into some of the best ETF charts of Q2 earnings.,https://staticx-tuner.zacks.com/images/articles/main/84/124.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.112573,Neutral,"[{'ticker': 'IVZ', 'relevance_score': '0.120834', 'ticker_sentiment_score': '0.170068', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.120834', 'ticker_sentiment_score': '0.20179', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DIS', 'relevance_score': '0.080728', 'ticker_sentiment_score': '0.026402', 'ticker_sentiment_label': 'Neutral'}]"
336,Novo Nordisk's  ( NVO )  Shares Jump 17% in a Month: Here's Why,https://www.zacks.com/stock/news/2140987/novo-nordisks-nvo-shares-jump-17-in-a-month-heres-why,20230825T154100,['Zacks Equity Research'],"Novo Nordisk's (NVO) commercial and pipeline progress with its popular obesity drug, Wegovy, continues to drive the share price momentum.",https://staticx-tuner.zacks.com/images/articles/main/de/2471.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.174873,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.274012', 'ticker_sentiment_score': '0.050638', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.376329', 'ticker_sentiment_score': '0.013168', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.376329', 'ticker_sentiment_score': '0.002604', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.111488', 'ticker_sentiment_score': '0.062546', 'ticker_sentiment_label': 'Neutral'}]"
337,This New Development Is Helping to Send Eli Lilly and Novo Nordisk Stocks Soaring,https://www.fool.com/investing/2023/08/24/new-development-is-helping-to-send-lilly-and-novo/,20230824T142300,['Alex Carchidi'],Some of their winning medicines could soon compete in new markets.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}]",0.165139,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.316439', 'ticker_sentiment_score': '0.14072', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.316439', 'ticker_sentiment_score': '0.129364', 'ticker_sentiment_label': 'Neutral'}]"
338,"Got $5,000? Invest in These 2 Unstoppable Growth Stocks.",https://www.fool.com/investing/2023/08/23/got-5000-invest-in-these-2-unstoppable-growth/,20230823T135300,['David Jagielski'],"Both of these companies are coming off strong quarters, with more growth on the horizon.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F745045%2Fatt-verizon-great-news.png&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.650727'}]",0.17332,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.300946', 'ticker_sentiment_score': '0.184459', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABNB', 'relevance_score': '0.411656', 'ticker_sentiment_score': '0.183939', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
339,"If You Invested $1000 in Eli Lilly a Decade Ago, This is How Much It'd Be Worth Now",https://www.zacks.com/stock/news/2139535/if-you-invested-1000-in-eli-lilly-a-decade-ago-this-is-how-much-itd-be-worth-now,20230823T123004,['Zacks Equity Research'],Holding on to popular or trending stocks for the long-term can make your portfolio a winner.,https://staticx-tuner.zacks.com/images/default_article_images/default176.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}, {'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.151101,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.620262', 'ticker_sentiment_score': '0.243841', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'INCY', 'relevance_score': '0.05387', 'ticker_sentiment_score': '0.024879', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ELAN', 'relevance_score': '0.213048', 'ticker_sentiment_score': '0.040471', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AKUS', 'relevance_score': '0.05387', 'ticker_sentiment_score': '0.046014', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DICE', 'relevance_score': '0.05387', 'ticker_sentiment_score': '0.046014', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVBXF', 'relevance_score': '0.05387', 'ticker_sentiment_score': '0.024879', 'ticker_sentiment_label': 'Neutral'}]"
340,Should First Trust Capital Strength ETF  ( FTCS )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2139484/should-first-trust-capital-strength-etf-ftcs-be-on-your-investing-radar,20230823T102007,['Zacks Equity Research'],Style Box ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default270.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.275785,Somewhat-Bullish,"[{'ticker': 'CPRT', 'relevance_score': '0.12546', 'ticker_sentiment_score': '0.062163', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.12546', 'ticker_sentiment_score': '0.062163', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NTAP', 'relevance_score': '0.12546', 'ticker_sentiment_score': '0.062163', 'ticker_sentiment_label': 'Neutral'}]"
341,"The Zacks Analyst Blog Highlights Eli Lilly, UnitedHealth, Walmart, Applied Materials and BCE",https://www.zacks.com/stock/news/2139471/the-zacks-analyst-blog-highlights-eli-lilly-unitedhealth-walmart-applied-materials-and-bce,20230823T090000,['Zacks Investment Research'],"Eli Lilly, UnitedHealth, Walmart, Applied Materials and BCE are included in this Analyst Blog.",https://staticx-tuner.zacks.com/images/articles/main/26/123.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}]",0.229674,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.361802', 'ticker_sentiment_score': '0.005112', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMAT', 'relevance_score': '0.149192', 'ticker_sentiment_score': '0.039024', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCE', 'relevance_score': '0.149192', 'ticker_sentiment_score': '0.039024', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.293214', 'ticker_sentiment_score': '0.231328', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WMT', 'relevance_score': '0.427425', 'ticker_sentiment_score': '0.140223', 'ticker_sentiment_label': 'Neutral'}]"
342,"Top Research Reports for Eli Lilly, UnitedHealth & Walmart",https://www.zacks.com/research-daily/2139028/top-research-reports-for-eli-lilly-unitedhealth-walmart,20230822T163700,['Sheraz Mian'],"Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), UnitedHealth Group Incorporated (UNH) and Walmart Inc. (WMT).",https://staticx-tuner.zacks.com/images/default_article_images/default331.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.280834,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.210274', 'ticker_sentiment_score': '-0.066892', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.10607', 'ticker_sentiment_score': '0.348757', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WMT', 'relevance_score': '0.310843', 'ticker_sentiment_score': '0.161578', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
343,Could This 1 Problem Put a Dent in Novo Nordisk and Eli Lilly Stock?,https://www.fool.com/investing/2023/08/22/could-this-put-a-dent-in-novo-nordisk-and-lilly/,20230822T141500,['Alex Carchidi'],Chasing indications for NASH has been a pitfall for many pharma companies.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}]",-0.012148,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.282886', 'ticker_sentiment_score': '0.047858', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.33628', 'ticker_sentiment_score': '0.14984', 'ticker_sentiment_label': 'Neutral'}]"
344,You're An Amazing Stock Picker If You Bought 8 Stocks This Month,https://www.investors.com/etfs-and-funds/sectors/sp500-youre-an-amazing-stock-picker-if-you-bought-these-eight-stocks-this-month/,20230822T120000,"['MATT KRANTZ', ""Investor's Business Daily""]",The S&P 500's big plunge in August caught most investors off guard. So it's quite a win if you scooped up the handful of gainers in the tough month.,https://www.investors.com/wp-content/uploads/2021/01/Stock-moneysqueeze-02-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.127369,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.369319', 'ticker_sentiment_score': '0.36315', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SPGI', 'relevance_score': '0.076602', 'ticker_sentiment_score': '0.086649', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.152499', 'ticker_sentiment_score': '-0.01656', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANET', 'relevance_score': '0.227007', 'ticker_sentiment_score': '0.146244', 'ticker_sentiment_label': 'Neutral'}]"
345,"Zacks Industry Outlook Highlights Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca",https://www.zacks.com/stock/news/2139000/zacks-industry-outlook-highlights-eli-lilly-jj-novo-nordisk-novartis-and-astrazeneca,20230822T113800,['Zacks Equity Research'],"Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca are part of the Zacks Industry Outlook article ...",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999186'}, {'topic': 'Earnings', 'relevance_score': '0.998663'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.769861'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.21098,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.023556', 'ticker_sentiment_score': '-0.021479', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.117371', 'ticker_sentiment_score': '0.150464', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.140621', 'ticker_sentiment_score': '0.153621', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.047092', 'ticker_sentiment_score': '0.10432', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KDNY', 'relevance_score': '0.023556', 'ticker_sentiment_score': '0.162638', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.186738', 'ticker_sentiment_score': '0.163086', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SGEN', 'relevance_score': '0.047092', 'ticker_sentiment_score': '0.095788', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RXDX', 'relevance_score': '0.023556', 'ticker_sentiment_score': '0.087245', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.047092', 'ticker_sentiment_score': '0.095788', 'ticker_sentiment_label': 'Neutral'}]"
346,These 3 Large-Cap Pharma Stocks Have Been Red-Hot,https://www.zacks.com/stock/news/2138896/these-3-large-cap-pharma-stocks-have-been-red-hot,20230821T232400,['Derek Lewis'],"Large-cap pharmaceuticals have enjoyed buying pressure over the last month, delivering outsized gains to investors. And these three stocks have helped lead the charge.",https://staticx-tuner.zacks.com/images/articles/main/08/595.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.994953'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.372854,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.556784', 'ticker_sentiment_score': '0.545635', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.497733', 'ticker_sentiment_score': '0.50286', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.434763', 'ticker_sentiment_score': '0.528557', 'ticker_sentiment_label': 'Bullish'}]"
347,Check Out What Whales Are Doing With LLY - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/08/33964297/check-out-what-whales-are-doing-with-lly,20230821T141600,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bearish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.125257,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.816694', 'ticker_sentiment_score': '0.056418', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.096283', 'ticker_sentiment_score': '-0.122172', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.096283', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.096283', 'ticker_sentiment_score': '-0.122172', 'ticker_sentiment_label': 'Neutral'}]"
348,5 Large Drug Stocks to Watch as New Drug Approvals & M&A Gain Pace,https://www.zacks.com/commentary/2138567/5-large-drug-stocks-to-watch-as-new-drug-approvals-ma-gain-pace,20230821T135100,['Kinjel Shah'],"Drug, biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), J&J (JNJ), Novo Nordisk (NVO), Novartis (NVS) and AstraZeneca (AZN) are worth retaining in your portfolio.",https://staticx-tuner.zacks.com/images/articles/main/f5/952.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.989041'}, {'topic': 'Earnings', 'relevance_score': '0.999346'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.769861'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.21083,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.02415', 'ticker_sentiment_score': '0.065303', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.09638', 'ticker_sentiment_score': '0.108914', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.144131', 'ticker_sentiment_score': '0.136652', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.072362', 'ticker_sentiment_score': '0.096477', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KDNY', 'relevance_score': '0.02415', 'ticker_sentiment_score': '0.142076', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.191359', 'ticker_sentiment_score': '0.15572', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SGEN', 'relevance_score': '0.048278', 'ticker_sentiment_score': '0.068994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RXDX', 'relevance_score': '0.02415', 'ticker_sentiment_score': '0.065303', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.048278', 'ticker_sentiment_score': '0.068994', 'ticker_sentiment_label': 'Neutral'}]"
349,3 Fantastic Stocks to Buy in a New Bull Market,https://www.fool.com/investing/2023/08/20/3-fantastic-stocks-to-buy-in-a-new-bull-market/,20230820T105400,"['Keith Speights', 'David Jagielski', 'and Prosper Junior Bakiny']",These stocks could be just the ticket if a sustained new bull market is beginning.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F744322%2Fsocial-security-benefits-application-retirement-income-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.818451'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}]",0.31275,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.27454', 'ticker_sentiment_score': '0.263821', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SGEN', 'relevance_score': '0.040011', 'ticker_sentiment_score': '-0.034538', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.198059', 'ticker_sentiment_score': '0.299075', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.311829', 'ticker_sentiment_score': '0.310757', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
350,Amphastar Pharma  ( AMPH )  Stock Skyrockets 89% YTD: Here's Why,https://www.zacks.com/stock/news/2138342/amphastar-pharma-amph-stock-skyrockets-89-ytd-heres-why,20230818T175400,['Zacks Equity Research'],Amphastar Pharma (AMPH) shares are up 89.1% year to date due to the acquisition of Baqsimi from Lilly. The company also receives FDA approval for Naloxone.,https://staticx-tuner.zacks.com/images/articles/main/12/31139.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.993781'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.5'}]",0.155182,Somewhat-Bullish,"[{'ticker': 'APG', 'relevance_score': '0.111488', 'ticker_sentiment_score': '0.031045', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.220809', 'ticker_sentiment_score': '0.078806', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CORT', 'relevance_score': '0.111488', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMPH', 'relevance_score': '0.471856', 'ticker_sentiment_score': '0.146717', 'ticker_sentiment_label': 'Neutral'}]"
351,AbbVie  ( ABBV )  Gets EU Approval for Migraine Prevention Drug,https://www.zacks.com/stock/news/2137725/abbvie-abbv-gets-eu-approval-for-migraine-prevention-drug,20230817T154300,['Zacks Equity Research'],"Following the approval, AbbVie's (ABBV) Aquipta is the first and the only oral CGRP receptor antagonist approved in the EU to prevent episodic and chronic migraines.",https://staticx-tuner.zacks.com/images/articles/main/36/1919.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.229048,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.169365', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.33628', 'ticker_sentiment_score': '0.177232', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.169365', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.080245', 'ticker_sentiment_label': 'Neutral'}]"
352,Eli Lilly  ( LLY )  Stock Up Almost 50% Year to Date: Here's Why,https://www.zacks.com/stock/news/2137633/eli-lilly-lly-stock-up-almost-50-year-to-date-heres-why,20230817T153400,['Zacks Equity Research'],"Sales of Lilly's (LLY) new drug, Mounjaro are already benefiting from strong demand trends. Lilly expects regulatory decisions for some key pipeline candidates this year, which are key to growth.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.996675'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.219105,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.513062', 'ticker_sentiment_score': '0.265643', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMPH', 'relevance_score': '0.169378', 'ticker_sentiment_score': '0.193592', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.127456', 'ticker_sentiment_score': '-0.011961', 'ticker_sentiment_label': 'Neutral'}]"
353,3 of Eli Lilly's Top Drugs Grew by Over 40% in Q2. Trulicity Wasn't One of Them.,https://www.fool.com/investing/2023/08/17/3-of-eli-lillys-top-drugs-grew-by-over-40-in-q2/,20230817T135300,['David Jagielski'],This already big healthcare business is about to get even bigger.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F743965%2Feli-lilly-best-selling-drugs-in-q2.png&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.962106'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.209757,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.406745', 'ticker_sentiment_score': '0.213249', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.070935', 'ticker_sentiment_score': '0.172701', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
354,Investors Heavily Search Eli Lilly and Company  ( LLY ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2137415/investors-heavily-search-eli-lilly-and-company-lly-here-is-what-you-need-to-know,20230817T130011,['Zacks Equity Research'],"Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.",https://staticx-tuner.zacks.com/images/default_article_images/default254.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}]",0.241338,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.521151', 'ticker_sentiment_score': '0.171293', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
355,Why This Nugget Of Bad Weight-Loss News Isn't Weighing On Lilly,https://www.investors.com/news/technology/eli-lilly-stock-why-this-nugget-of-bad-weight-loss-news-is-not-weighing-on-lilly-novo/,20230817T120000,"[""Investor's Business Daily"", 'ALLISON GATLIN']",Prescriptions of popular weight-loss and diabetes drugs rocketed in the first six months of the year - giving already sky-high Novo Nordisk ( NVO ) stock and Eli Lilly ( LLY ) stock more room to run. The companies make drugs that mimic a gut hormone called GLP-1.,https://www.investors.com/wp-content/uploads/2023/07/Stock-mounjaro-injection-01-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}, {'topic': 'Earnings', 'relevance_score': '0.744043'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.216481,Somewhat-Bullish,"[{'ticker': 'EVR', 'relevance_score': '0.074692', 'ticker_sentiment_score': '-0.014156', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.426225', 'ticker_sentiment_score': '0.260773', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CAH', 'relevance_score': '0.148731', 'ticker_sentiment_score': '0.175789', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.426225', 'ticker_sentiment_score': '0.240922', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
356,"Eli Lilly's Stock Spikes, Yet Team Jim Cramer Holds Back On Recommending Immediate Buying: 'Wait For A Pullback' - Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/news/23/08/33891387/eli-lillys-stock-spikes-yet-team-jim-cramer-holds-back-on-recommending-immediate-buying-wait-for-a-p,20230817T101152,['Benzinga Neuro'],"Jim Cramer does not recommend investors to buy Eli Lilly LLY stocks yet, despite the recent jump, CNBC reports. Responding to an email query, Cramer mentioned a new 12-month price target of $600 for Eli Lilly. Despite the promising outlook, the rapid ascent of Eli Lilly's stock has led to ...",https://cdn.benzinga.com/files/images/story/2023/Photo:_Courtesy_of_Scott_Beale_on_Flickr_17.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.167202,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.60326', 'ticker_sentiment_score': '0.078253', 'ticker_sentiment_label': 'Neutral'}]"
357,This Is What Whales Are Betting On Eli Lilly - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/08/33882341/this-is-what-whales-are-betting-on-eli-lilly,20230816T200145,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 12 strange trades. If we consider the specifics of each trade, it is accurate to state that 25% of the investors opened trades with bullish ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.142041,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.825367', 'ticker_sentiment_score': '0.089358', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.213988', 'ticker_sentiment_score': '-0.188691', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
358,3 Reasons to Buy Eli Lilly Stock,https://www.fool.com/investing/2023/08/16/3-reasons-to-buy-eli-lilly-stock/,20230816T140000,['Prosper Junior Bakiny'],Shares of the giant drugmaker aren't far off their 52-week high.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.938793'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.350201,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.356865', 'ticker_sentiment_score': '0.495295', 'ticker_sentiment_label': 'Bullish'}]"
359,Is Tesla's CFO Change Something to Worry About?,https://www.fool.com/investing/2023/08/15/is-teslas-cfo-change-something-to-worry-about/,20230815T131200,['Motley Fool Staff'],"We also talk about Eli Lilly hitting an all-time high, Burger King driving sales growth, and Zoom's work-from-home policy.",https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.983605'}]",0.125521,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.127832', 'ticker_sentiment_score': '0.082511', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QSR', 'relevance_score': '0.028524', 'ticker_sentiment_score': '0.113879', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.014264', 'ticker_sentiment_score': '-0.023932', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZM', 'relevance_score': '0.141893', 'ticker_sentiment_score': '0.112272', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.014264', 'ticker_sentiment_score': '0.024593', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.014264', 'ticker_sentiment_score': '-0.05698', 'ticker_sentiment_label': 'Neutral'}]"
360,"The Zacks Analyst Blog Highlights URNJ, IHE and PXE",https://www.zacks.com/stock/news/2136421/the-zacks-analyst-blog-highlights-urnj-ihe-and-pxe,20230815T130100,['Zacks Equity Research'],"URNJ, IHE and PXE are part of the Zacks top Analyst Blog.",https://staticx-tuner.zacks.com/images/articles/main/c5/13179.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999336'}, {'topic': 'Earnings', 'relevance_score': '0.917436'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.1667,Somewhat-Bullish,"[{'ticker': 'IVZ', 'relevance_score': '0.146321', 'ticker_sentiment_score': '0.263707', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.097854', 'ticker_sentiment_score': '0.106542', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCO', 'relevance_score': '0.049019', 'ticker_sentiment_score': '-0.035118', 'ticker_sentiment_label': 'Neutral'}]"
361,Prescribing Profits: 3 Stocks to Ride the Healthcare Relative Strength,https://www.zacks.com/commentary/2136342/prescribing-profits-3-stocks-to-ride-the-healthcare-relative-strength,20230814T185400,['Ethan Feller'],"Over the last month, Healthcare has been the second strongest sector in the market ...",https://staticx-tuner.zacks.com/images/articles/main/ab/11156.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.996023'}, {'topic': 'Earnings', 'relevance_score': '0.999687'}]",0.2609,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.367683', 'ticker_sentiment_score': '0.226398', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CAH', 'relevance_score': '0.333257', 'ticker_sentiment_score': '0.19747', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ALGN', 'relevance_score': '0.262321', 'ticker_sentiment_score': '0.313769', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HCSG', 'relevance_score': '0.038162', 'ticker_sentiment_score': '0.096407', 'ticker_sentiment_label': 'Neutral'}]"
362,Nektar  ( NKTR )  Stock Surges 75% in a Week: Here's Why,https://www.zacks.com/stock/news/2136313/nektar-nktr-stock-surges-75-in-a-week-heres-why,20230814T154200,['Zacks Equity Research'],"Nektar's (NKTR) shares rally almost 75% in a week on corrected efficacy data for rezpeg studies, earlier miscalculated by Eli Lilly.",https://staticx-tuner.zacks.com/images/articles/main/f5/284.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.049599,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.545493', 'ticker_sentiment_score': '-0.046491', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CORT', 'relevance_score': '0.132004', 'ticker_sentiment_score': '0.069616', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JAZZ', 'relevance_score': '0.196877', 'ticker_sentiment_score': '0.106863', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKTR', 'relevance_score': '0.322233', 'ticker_sentiment_score': '-0.016403', 'ticker_sentiment_label': 'Neutral'}]"
363,Check Out What Whales Are Doing With LLY - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/08/33836966/check-out-what-whales-are-doing-with-lly,20230814T153136,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bearish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.085026,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.855019', 'ticker_sentiment_score': '0.201693', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BCS', 'relevance_score': '0.096671', 'ticker_sentiment_score': '-0.122295', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.096671', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.096671', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
364,MacroGenics'  ( MGNX )  Shares Jump 19% in One Week: Here's Why,https://www.zacks.com/stock/news/2136295/macrogenics-mgnx-shares-jump-19-in-one-week-heres-why,20230814T151900,['Zacks Equity Research'],MacroGenics (MGNX) shares increase after it reported a surge in Q2 earnings per share. A $50-million milestone payment from Sanofi was also triggered last month.,https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.998645'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.108179'}]",0.171413,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.219809', 'ticker_sentiment_score': '0.085665', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MGNX', 'relevance_score': '0.764396', 'ticker_sentiment_score': '0.291637', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'INCY', 'relevance_score': '0.219809', 'ticker_sentiment_score': '-0.160161', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'SNY', 'relevance_score': '0.374714', 'ticker_sentiment_score': '0.184453', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
365,3 Sector ETFs That Beat The Market Last Week,https://www.zacks.com/stock/news/2136240/3-sector-etfs-that-beat-the-market-last-week,20230814T151500,['Sweta Killa'],Wall Street wrapped up the last week with mixed performances. The pharma and energy sectors were the biggest winners last week.,https://staticx-tuner.zacks.com/images/articles/main/c5/13179.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999917'}, {'topic': 'Earnings', 'relevance_score': '0.917436'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.164349,Somewhat-Bullish,"[{'ticker': 'IVZ', 'relevance_score': '0.195419', 'ticker_sentiment_score': '0.365306', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.098456', 'ticker_sentiment_score': '0.106736', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCO', 'relevance_score': '0.049322', 'ticker_sentiment_score': '-0.035126', 'ticker_sentiment_label': 'Neutral'}]"
366,Pharma ETFs in Focus Post Q2 Earnings,https://www.zacks.com/stock/news/2135877/pharma-etfs-in-focus-post-q2-earnings,20230811T161500,['Sweta Killa'],Second-quarter earnings beat ratio of 86.6% and revenue beat ratio of 84.9% for the healthcare sector are impressive.,https://staticx-tuner.zacks.com/images/articles/main/6e/37920.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999989'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.147203,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.152983', 'ticker_sentiment_score': '0.128429', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.115048', 'ticker_sentiment_score': '0.096776', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.076847', 'ticker_sentiment_score': '0.045476', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.115048', 'ticker_sentiment_score': '0.125234', 'ticker_sentiment_label': 'Neutral'}]"
367,Why Shares of Eli Lilly Jumped This Week,https://www.fool.com/investing/2023/08/11/why-shares-of-eli-lilly-jumped-this-week/,20230811T150456,['Jim Halley'],The company's second-quarter report showed a big revenue surge.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.99737'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.298122,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.628066', 'ticker_sentiment_score': '0.440134', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SPGI', 'relevance_score': '0.141726', 'ticker_sentiment_score': '0.150021', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
368,"Market Rally On The Ropes, AI Stocks Tumble: Weekly Review",https://www.investors.com/news/market-rally-on-the-ropes-ai-stocks-tumble/,20230811T143600,"[""Investor's Business Daily"", 'IBD STAFF']","The stock market rally came under more pressure, as the Nasdaq fell below its 50-day moving average. Tame inflation data failed to help, as Treasury yields rebounded. AI-related stocks such as Palantir ( PLTR ) , Super Micro Computer ( SMCI ) and Datadog ( DDOG ) plunged on results or guidance.",https://www.investors.com/wp-content/uploads/2017/12/Stock-boxerPunch-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",-0.14537,Neutral,"[{'ticker': 'CELH', 'relevance_score': '0.038874', 'ticker_sentiment_score': '-0.112747', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PRIM', 'relevance_score': '0.058282', 'ticker_sentiment_score': '-0.014134', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATKR', 'relevance_score': '0.058282', 'ticker_sentiment_score': '-0.048567', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PARA', 'relevance_score': '0.058282', 'ticker_sentiment_score': '-0.071184', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TTD', 'relevance_score': '0.058282', 'ticker_sentiment_score': '-0.011014', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.077656', 'ticker_sentiment_score': '-0.081754', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DDOG', 'relevance_score': '0.096984', 'ticker_sentiment_score': '-0.148539', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AKAM', 'relevance_score': '0.058282', 'ticker_sentiment_score': '-0.013003', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HPQ', 'relevance_score': '0.019443', 'ticker_sentiment_score': '-0.089532', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GLBE', 'relevance_score': '0.038874', 'ticker_sentiment_score': '-0.163617', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AWON', 'relevance_score': '0.019443', 'ticker_sentiment_score': '-0.062999', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZUL', 'relevance_score': '0.038874', 'ticker_sentiment_score': '-0.162002', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'DUOL', 'relevance_score': '0.058282', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PENN', 'relevance_score': '0.058282', 'ticker_sentiment_score': '-0.140996', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MTW', 'relevance_score': '0.038874', 'ticker_sentiment_score': '0.094684', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TDC', 'relevance_score': '0.058282', 'ticker_sentiment_score': '-0.037021', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TDG', 'relevance_score': '0.077656', 'ticker_sentiment_score': '0.085672', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TPR', 'relevance_score': '0.058282', 'ticker_sentiment_score': '0.094982', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.096984', 'ticker_sentiment_score': '-0.08629', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZTS', 'relevance_score': '0.058282', 'ticker_sentiment_score': '0.228016', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TGLS', 'relevance_score': '0.058282', 'ticker_sentiment_score': '-0.048567', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLTR', 'relevance_score': '0.077656', 'ticker_sentiment_score': '-0.097367', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BABA', 'relevance_score': '0.058282', 'ticker_sentiment_score': '0.104594', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DKNG', 'relevance_score': '0.038874', 'ticker_sentiment_score': '-0.136924', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.058282', 'ticker_sentiment_score': '-0.049206', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.096984', 'ticker_sentiment_score': '-0.064067', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ACM', 'relevance_score': '0.058282', 'ticker_sentiment_score': '-0.014134', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LCID', 'relevance_score': '0.077656', 'ticker_sentiment_score': '-0.151098', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CPA', 'relevance_score': '0.038874', 'ticker_sentiment_score': '-0.162002', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CPRI', 'relevance_score': '0.058282', 'ticker_sentiment_score': '0.094982', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HPE', 'relevance_score': '0.038874', 'ticker_sentiment_score': '-0.098598', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STRL', 'relevance_score': '0.038874', 'ticker_sentiment_score': '-0.013969', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LI', 'relevance_score': '0.038874', 'ticker_sentiment_score': '-0.045746', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SWAV', 'relevance_score': '0.058282', 'ticker_sentiment_score': '-0.196909', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'FOREX:GBP', 'relevance_score': '0.038874', 'ticker_sentiment_score': '-0.013969', 'ticker_sentiment_label': 'Neutral'}]"
369,"Pharma Stock Roundup: LLY, BAYRY Post Q2 Results, NVO's Wegovy Cuts Heart Attack Risk",https://www.zacks.com/stock/news/2135700/pharma-stock-roundup-lly-bayry-post-q2-results-nvos-wegovy-cuts-heart-attack-risk,20230811T134800,['Kinjel Shah'],"Eli Lilly (LLY), Bayer (BAYRY) and Novo Nordisk (NVO) announce second-quarter results.",https://staticx-tuner.zacks.com/images/articles/main/52/873.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.890401'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.026645,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.19117', 'ticker_sentiment_score': '0.017665', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.265172', 'ticker_sentiment_score': '0.018517', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.038592', 'ticker_sentiment_score': '-0.116146', 'ticker_sentiment_label': 'Neutral'}]"
370,Up 45% This Year What's Driving The Growth For Eli Lilly Stock?,https://www.forbes.com/sites/greatspeculations/2023/08/11/up-45-this-year-whats-driving-the-growth-for-eli-lilly-stock/,20230811T130059,['Trefis Team'],"The stock has been on a strong run for the last few years, primarily due to its pipeline potential.",https://imageio.forbes.com/specials-images/imageserve/64d5b80da1e0358160d9eed8/0x0.jpg?format=jpg&width=1200,Forbes,Markets,www.forbes.com,"[{'topic': 'Earnings', 'relevance_score': '0.967645'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.189969,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.630684', 'ticker_sentiment_score': '0.245631', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.059636', 'ticker_sentiment_score': '-0.010001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.177584', 'ticker_sentiment_score': '0.017294', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.059636', 'ticker_sentiment_score': '-0.010001', 'ticker_sentiment_label': 'Neutral'}]"
371,"Ex-Fund Manager Regrets Missing The Boat On A Stock Which Rallied 16% This Week: 'I Should Have Followed My Instincts' - Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/08/33741202/ex-fund-manager-regrets-missing-the-boat-on-a-stock-which-rallied-16-this-week-i-sh,20230811T090430,['Shanthi Rexaline'],"Eli Lilly & Co. LLY shares were on a tear this week, thanks to the company's strong quarterly results and positive clinical readout from Novo Nordisk A/S NVO, which has a rival offering. Former hedge fund manager Whitney Tilson in his firm's Empire Financial Research newsletter weighed in on the ...",https://cdn.benzinga.com/files/images/story/2023/Eli_Lilly_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.158502,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.614086', 'ticker_sentiment_score': '0.435453', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.614086', 'ticker_sentiment_score': '0.539672', 'ticker_sentiment_label': 'Bullish'}]"
372,"Novo Nordisk Soars To New High On Weight-Loss Drug Trial Results - Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/news/earnings/23/08/33706415/novo-nordisk-soars-to-new-high-on-weight-loss-drug-trial-results,20230810T155131,['MarketBeat'],"Weight-loss drugs are the pharmaceutical industry's equivalent of AI, in the sense of being a product with the capability to send shares soaring.",https://cdn.benzinga.com/files/images/story/2023/08/10/novo_nordisk_kalundborg_20130729_003_9720766202.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.157158,Somewhat-Bullish,"[{'ticker': 'BAC', 'relevance_score': '0.158868', 'ticker_sentiment_score': '0.069492', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.158868', 'ticker_sentiment_score': '0.144693', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.495963', 'ticker_sentiment_score': '0.28481', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
373,"Obesity Drug Wegovy Sales Jump 365% In H1 As Novo Nordisk Reports Solid Results, Raises FY23 Guidance - Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/general/biotech/23/08/33696236/obesity-drug-wegovy-sales-jump-365-in-h1-as-novo-nordisk-reports-solid-results-raises-fy23-guidan,20230810T074935,['Shanthi Rexaline'],Danish pharma giant Novo Nordisk A/S NVO reported a strong increase in first-half sales and profits and also hiked its guidance for the full year for the second time this year. What Happened: Novo Nordisk said its net sales for the first half of the year climbed 29% year-over-year to 107.67 ...,https://cdn.benzinga.com/files/images/story/2023/Ozempic_weight_loss_pill_3.jpeg?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.32879,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.215894', 'ticker_sentiment_score': '0.088493', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.588876', 'ticker_sentiment_score': '0.437917', 'ticker_sentiment_label': 'Bullish'}]"
374,Looking At Eli Lilly's Recent Unusual Options Activity - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/08/33681823/looking-at-eli-lillys-recent-unusual-options-activity,20230809T204616,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 73 strange trades. If we consider the specifics of each trade, it is accurate to state that 31% of the investors opened trades with bullish ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.085706,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.827318', 'ticker_sentiment_score': '-0.128982', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.108466', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.108466', 'ticker_sentiment_score': '-0.126529', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.108466', 'ticker_sentiment_score': '-0.126529', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.108466', 'ticker_sentiment_score': '-0.126529', 'ticker_sentiment_label': 'Neutral'}]"
375,We are buying one health-care stock and raising our price target on another,https://www.cnbc.com/2023/08/09/we-are-buying-one-health-care-stock-and-raising-our-price-target-on-another.html,20230809T161113,['Jim Cramer'],"While the broader sector has gone out of favor, the fundamentals of this holding remain strong.",https://image.cnbcfm.com/api/v1/image/107200472-1677528554272-NUP_200782_00307.jpg?v=1691597473&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.94762'}]",0.33711,Somewhat-Bullish,"[{'ticker': 'GEHC', 'relevance_score': '0.33628', 'ticker_sentiment_score': '0.342058', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.457274', 'ticker_sentiment_score': '0.416499', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.272029', 'ticker_sentiment_score': '0.292932', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
376,We're optimistic about this struggling entertainment stock despite an expected weak quarter,https://www.cnbc.com/2023/08/09/were-optimistic-about-disney-dis-stock-despite-an-expected-weak-quarter.html,20230809T155418,['Morgan Chittum'],"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",https://image.cnbcfm.com/api/v1/image/107026308-1646668947631-107026308-16466688712022-03-07t152235z_133006093_rc2pxs9buome_rtrmadp_0_usa-stocks.jpg?v=1691510733&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.890401'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.891286'}, {'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.5'}]",0.148434,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.434763', 'ticker_sentiment_score': '0.180602', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PENN', 'relevance_score': '0.152018', 'ticker_sentiment_score': '0.082879', 'ticker_sentiment_label': 'Neutral'}]"
377,65% Profit On Eli Lilly - 20% Reduction In Heart Attacks And Strokes With Weight Loss Drug - Raising The Target - Novo Nordisk  ( NYSE:NVO ) ,https://www.benzinga.com/23/08/33670747/65-profit-on-eli-lilly-20-reduction-in-heart-attacks-and-strokes-with-weight-loss-drug-raising-the-t,20230809T150956,['The Arora Report'],Signal Limited is a Signal ( s ) with a great record in similar situations but does not meet all of the stringent criteria for a Signal. Typically Signal Limited has higher risk-reward compared to a Signal over the short term.,https://cdn.benzinga.com/files/640px-eli_lilly_corporate_center_indianapolis_indiana_usa.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.012093,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.554014', 'ticker_sentiment_score': '0.143412', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVS', 'relevance_score': '0.110209', 'ticker_sentiment_score': '0.015962', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.110209', 'ticker_sentiment_score': '0.117806', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.270973', 'ticker_sentiment_score': '-0.004059', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.110209', 'ticker_sentiment_score': '0.117806', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.110209', 'ticker_sentiment_score': '0.015962', 'ticker_sentiment_label': 'Neutral'}]"
378,Dow Awaits Key Inflation Report; DIS Earnings Loom; Disney's ESPN Entered Gaming Tuesday,https://www.investors.com/market-trend/stock-market-today/dow-jones-awaits-key-inflation-report-disneys-espn-enters-gaming-as-dis-earnings-loom/,20230809T150600,"['VIDYA RAMAKRISHNAN', ""Investor's Business Daily""]",Dow Awaits Key Inflation Report. Disney's ESPN Enters Gaming As DIS Earnings Loom Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2019/01/Stock-DisneyLogoSign-07-shut.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Financial Markets', 'relevance_score': '0.997902'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}]",-0.082513,Neutral,"[{'ticker': 'DKNG', 'relevance_score': '0.160099', 'ticker_sentiment_score': '-0.10183', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PENN', 'relevance_score': '0.238133', 'ticker_sentiment_score': '-0.136764', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARRY', 'relevance_score': '0.160099', 'ticker_sentiment_score': '-0.077906', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.160099', 'ticker_sentiment_score': '-0.095878', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.160099', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AKAM', 'relevance_score': '0.160099', 'ticker_sentiment_score': '0.175914', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.160099', 'ticker_sentiment_score': '0.120196', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIVN', 'relevance_score': '0.160099', 'ticker_sentiment_score': '-0.198434', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CHGG', 'relevance_score': '0.160099', 'ticker_sentiment_score': '-0.03443', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RBLX', 'relevance_score': '0.160099', 'ticker_sentiment_score': '-0.10183', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.160099', 'ticker_sentiment_score': '-0.077906', 'ticker_sentiment_label': 'Neutral'}]"
379,Eli Lilly Soars on Blockbuster Q2 Earnings: ETFs to Tap,https://www.zacks.com/stock/news/2134352/eli-lilly-soars-on-blockbuster-q2-earnings-etfs-to-tap,20230809T142600,['Sweta Killa'],Eli Lilly (LLY) experienced its most significant surge in stock prices in over two decades following the release of an impressive second-quarter 2023 earnings report and an optimistic outlook. ETFs having the largest exposure to the drug maker could be compelling picks to tap the strong growth.,https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999997'}, {'topic': 'Earnings', 'relevance_score': '0.947132'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.288398,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.462648', 'ticker_sentiment_score': '0.426362', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'DICE', 'relevance_score': '0.044718', 'ticker_sentiment_score': '-0.02685', 'ticker_sentiment_label': 'Neutral'}]"
380,"Eli Lilly Analysts Bump Up Forecasts On Q2 Print: 'Beyond Mounjaro, Alzheimer's Franchise Remains A Key Pillar To Future Growth' - Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/08/33667559/eli-lilly-analysts-bump-up-forecasts-on-q2-print-beyond-mounjaro-alzheimers-franchi,20230809T140313,['Priya Nigam'],"Shares of Eli Lilly And Co LLY Tuesday spiked, after the company reported strong second-quarter results. The results came amid an exciting earnings season. Here are some key analyst takeaways from the earnings release. Analyst Louise Chen maintained an Overweight rating, while raising the price ...",https://cdn.benzinga.com/files/images/story/2023/08/09/eli_lilly_shutter.jpg?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.250813,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.688777', 'ticker_sentiment_score': '0.485706', 'ticker_sentiment_label': 'Bullish'}]"
381,"Company News for Aug 9, 2023",https://www.zacks.com/stock/news/2134313/company-news-for-aug-9-2023,20230809T133700,['Zacks Equity Research'],Companies in The News ...,https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.890401'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.273264,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.524949', 'ticker_sentiment_score': '0.28151', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ATKR', 'relevance_score': '0.524949', 'ticker_sentiment_score': '0.537327', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'UA', 'relevance_score': '0.279015', 'ticker_sentiment_score': '0.213902', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HZNP', 'relevance_score': '0.524949', 'ticker_sentiment_score': '0.323578', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
382,"Nektar Therapeutics  ( NKTR )  Q2 Loss Narrows, Sales Miss",https://www.zacks.com/stock/news/2134281/nektar-therapeutics-nktr-q2-loss-narrows-sales-miss,20230809T132500,['Zacks Equity Research'],Nektar (NKTR) incurs a narrower-than-expected second-quarter loss but misses on revenues.,https://staticx-tuner.zacks.com/images/articles/main/67/1932.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.857896'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",-0.028569,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.193078', 'ticker_sentiment_score': '0.035708', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ACAD', 'relevance_score': '0.240014', 'ticker_sentiment_score': '0.079349', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXSM', 'relevance_score': '0.240014', 'ticker_sentiment_score': '0.080237', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKTR', 'relevance_score': '0.458799', 'ticker_sentiment_score': '-0.078625', 'ticker_sentiment_label': 'Neutral'}]"
383,Jim Cramer's top 10 things to watch in the stock market Wednesday,https://www.cnbc.com/2023/08/09/jim-cramers-top-10-things-to-watch-in-the-stock-market-wednesday.html,20230809T131228,['Jim Cramer'],Club name Eli Lilly (LLY) may be much bigger than we think because it can make enough Mounjaro.,https://image.cnbcfm.com/api/v1/image/107277199-16903924192023-03-29t000000z_926919308_rc2w30aq63my_rtrmadp_0_usa-health.jpeg?v=1691586748&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '0.839681'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.086159,Neutral,"[{'ticker': 'TGT', 'relevance_score': '0.197413', 'ticker_sentiment_score': '0.088683', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.099476', 'ticker_sentiment_score': '0.061414', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.049835', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.099476', 'ticker_sentiment_score': '0.191915', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.099476', 'ticker_sentiment_score': '0.047084', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WYNN', 'relevance_score': '0.099476', 'ticker_sentiment_score': '-0.142029', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.099476', 'ticker_sentiment_score': '0.066587', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PENN', 'relevance_score': '0.099476', 'ticker_sentiment_score': '0.061414', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.099476', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.148731', 'ticker_sentiment_score': '0.073043', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.099476', 'ticker_sentiment_score': '0.031509', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATVI', 'relevance_score': '0.099476', 'ticker_sentiment_score': '0.066587', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.148731', 'ticker_sentiment_score': '0.057023', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UPS', 'relevance_score': '0.099476', 'ticker_sentiment_score': '0.191915', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PXD', 'relevance_score': '0.099476', 'ticker_sentiment_score': '0.022763', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.099476', 'ticker_sentiment_score': '0.021713', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTRA', 'relevance_score': '0.099476', 'ticker_sentiment_score': '0.022763', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.099476', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
384,"After This Pharma Stock Surges To Record High, Cramer Says It's 'Going Higher Still' - Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/08/33664620/after-this-pharma-stock-surges-to-record-high-cramer-says-its-going-higher-still,20230809T123437,['Shanthi Rexaline'],"Eli Lilly & Co. LLY jumped nearly 15% to a new record on Tuesday, as the biopharma's stock rode on two catalysts. Lilly reported second-quarter earnings and revenue that were way ahead of expectations and it raised its full-year guidance.",https://cdn.benzinga.com/files/images/story/2023/Eli_Lilly.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.239034,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.776097', 'ticker_sentiment_score': '0.26966', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.31482', 'ticker_sentiment_score': '0.408241', 'ticker_sentiment_label': 'Bullish'}]"
385,Eli Lilly Has Tentpoles In Weight Loss And Alzheimer's; But Is It A Buy?,https://www.investors.com/news/technology/eli-lilly-stock-buy-now/,20230809T120000,"[""Investor's Business Daily"", 'ALLISON GATLIN']",Eli Lilly Has Tentpoles In Weight Loss And Alzheimer's. But Is It A Buy? Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2018/04/stock-Eli-Lilly-01-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.995869'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999999'}]",0.166399,Somewhat-Bullish,"[{'ticker': 'GLDAF', 'relevance_score': '0.026474', 'ticker_sentiment_score': '0.022403', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.680543', 'ticker_sentiment_score': '0.300199', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MRNA', 'relevance_score': '0.026474', 'ticker_sentiment_score': '-0.142778', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.105604', 'ticker_sentiment_score': '-0.001124', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.026474', 'ticker_sentiment_score': '0.155279', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.079304', 'ticker_sentiment_score': '0.218136', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
386,"China's Economic Woes, Crude Oil, Bond Auctions, Prime Day 2, Trading Lilly",https://realmoney.thestreet.com/investing/china-s-economic-woes-crude-oil-bond-auctions-prime-day-2-trading-lilly-16130612,20230809T113723,['Stephen Guilfoyle'],"Readers will rise on Wednesday morning and likely take note that Asian equity markets are mixed, while the rally is on in Europe. First the good news.",https://s.thestreet.com/files/tsc/v2008/photos/contrib/uploads/fe6851d2-36a4-11ee-b533-57ee8ff8d83b.png,The Street,GoogleRSS,realmoney.thestreet.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.998962'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}]",0.05042,Neutral,"[{'ticker': 'ADBE', 'relevance_score': '0.052226', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APG', 'relevance_score': '0.026127', 'ticker_sentiment_score': '-0.099455', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.095078', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.078269', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
387,"CBOE Volatility Index Increases Ahead Of Inflation Data - DISH Network  ( NASDAQ:DISH ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/news/earnings/23/08/33655418/cboe-volatility-index-increases-ahead-of-inflation-data,20230809T094119,['Lisa Levin'],"The S&P 500 settled lower on Tuesday, after credit rating agency Moody's downgraded 10 small- to mid-sized lenders. The S&P 500 Banks index has lost 2.5% year-to-date, versus a 17.2% surge recorded by the S&P 500 index in the same period. The banks index dipped 1.1% during the Tuesday's session.",https://cdn.benzinga.com/files/images/story/2023/08/09/image17.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",-0.029151,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.31282', 'ticker_sentiment_score': '0.464839', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'MCO', 'relevance_score': '0.159569', 'ticker_sentiment_score': '0.026784', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.31282', 'ticker_sentiment_score': '-0.29671', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'DISH', 'relevance_score': '0.31282', 'ticker_sentiment_score': '0.464839', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SATS', 'relevance_score': '0.31282', 'ticker_sentiment_score': '0.464839', 'ticker_sentiment_label': 'Bullish'}]"
388,"Zacks Investment Ideas feature highlights: DraftKings, Eli Lilly and Emerson Electric",https://www.zacks.com/stock/news/2134149/zacks-investment-ideas-feature-highlights-draftkings-eli-lilly-and-emerson-electric,20230809T090000,['Zacks Investment Research'],"DraftKings, Eli Lilly and Emerson Electric have been highlighted in this Investment Ideas article.",https://staticx-tuner.zacks.com/images/articles/main/c1/3138.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",0.469524,Bullish,"[{'ticker': 'DKNG', 'relevance_score': '0.41849', 'ticker_sentiment_score': '0.570158', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.363388', 'ticker_sentiment_score': '0.459627', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'EMR', 'relevance_score': '0.306198', 'ticker_sentiment_score': '0.211845', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
389,"Eli Lilly Clears Technical Benchmark, Hitting 90-Plus RS Rating",https://www.investors.com/ibd-data-stories/eli-lilly-clears-technical-benchmark-hitting-90-plus-rs-rating/,20230809T070000,"[""INVESTOR'S BUSINESS DAILY"", ""Investor's Business Daily""]","Eli Lilly ( LLY ) had its Relative Strength ( RS ) Rating upgraded from 89 to 95 Wednesday. When you're researching the best stocks to buy and watch, be sure to pay attention to relative price strength. This exclusive rating from Investor's Business Daily tracks price performance with a 1 ( ...",https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.744043'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.413971,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.468029', 'ticker_sentiment_score': '0.39033', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'AWON', 'relevance_score': '0.165031', 'ticker_sentiment_score': '0.281169', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AZN', 'relevance_score': '0.323078', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.323078', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
390,Market Rally Faces Key Test; Two Big AI Losers Late,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rally-faces-key-test-as-these-magnificent-7-stocks-struggle/,20230808T210200,"[""Investor's Business Daily"", 'ED CARSON']",Dow Jones Futures: Market Rally Faces Key Test As These 'Magnificent 7' Stocks Struggle Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2016/03/Extra-Tip-030316-shutterstock.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.947132'}]",-0.029482,Neutral,"[{'ticker': 'CELH', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.1058', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.33628', 'ticker_sentiment_score': '0.044709', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.086556', 'ticker_sentiment_score': '-0.073445', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.020758', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.086556', 'ticker_sentiment_score': '-0.172173', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'DDOG', 'relevance_score': '0.057767', 'ticker_sentiment_score': '-0.188316', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'SLB', 'relevance_score': '0.057767', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDB', 'relevance_score': '0.057767', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DUOL', 'relevance_score': '0.028903', 'ticker_sentiment_score': '0.250396', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.143758', 'ticker_sentiment_score': '-0.049176', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.228073', 'ticker_sentiment_score': '0.046276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.143758', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCO', 'relevance_score': '0.028903', 'ticker_sentiment_score': '-0.292343', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'UPST', 'relevance_score': '0.086556', 'ticker_sentiment_score': '-0.172173', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.028903', 'ticker_sentiment_score': '0.090132', 'ticker_sentiment_label': 'Neutral'}]"
391,Homebuilder Flashes Bullish Signs Even After 72% Gain; 5 Others To Watch,https://www.investors.com/research/growth-stocks-outperforming-homebuilder-flashes-bullish-signs-after-72-gain/,20230808T204100,"[""Investor's Business Daily"", 'VIDYA RAMAKRISHNAN']",Growth stocks Outperforming: Homebuilder Flashes Bullish Signs After 72% Gain Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2022/12/Stock-kbhomes-01-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.333333'}]",0.293981,Somewhat-Bullish,"[{'ticker': 'KBH', 'relevance_score': '0.281153', 'ticker_sentiment_score': '0.209996', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.18967', 'ticker_sentiment_score': '0.237466', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PAY', 'relevance_score': '0.18967', 'ticker_sentiment_score': '0.029391', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRT', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.004283', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.18967', 'ticker_sentiment_score': '0.237466', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
392,"Stock Market Today: Stocks Drop on Troubling China Data, Bank Ratings Worries",https://www.kiplinger.com/investing/stocks/stock-market-today-stocks-drop-on-troubling-china-data-bank-ratings-worries,20230808T201322,['Karee Venema'],Tuesday was a down day on Wall Street with stocks getting walloped across the board. Concerns over China's economy and the possibility that several big U.S. banks could see their credit ratings downgraded weighed on sentiment.,https://cdn.mos.cms.futurecdn.net/ojxp8hQGmnfMF88xC7pDuU-415-80.jpg,Kiplinger,n/a,www.kiplinger.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.310843'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.928769'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.141442,Neutral,"[{'ticker': 'BYND', 'relevance_score': '0.199584', 'ticker_sentiment_score': '-0.029088', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IBKR', 'relevance_score': '0.067158', 'ticker_sentiment_score': '-0.075578', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STT', 'relevance_score': '0.133841', 'ticker_sentiment_score': '-0.025627', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.133841', 'ticker_sentiment_score': '-0.025627', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.133841', 'ticker_sentiment_score': '0.20324', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.263942', 'ticker_sentiment_score': '0.304394', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MCO', 'relevance_score': '0.067158', 'ticker_sentiment_score': '-0.021132', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BK', 'relevance_score': '0.133841', 'ticker_sentiment_score': '-0.025627', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.133841', 'ticker_sentiment_score': '-0.025627', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PNFP', 'relevance_score': '0.133841', 'ticker_sentiment_score': '-0.025627', 'ticker_sentiment_label': 'Neutral'}]"
393,"Promise around Eli Lilly's expected obesity drug, great earnings adds some $60 billion in market cap",https://www.cnbc.com/2023/08/08/promise-of-eli-lillys-expected-obesity-drug-great-q2-adds-60-billion-in-market-cap.html,20230808T185125,['Kevin Stankiewicz'],"In addition to strong earnings, Eli Lilly's prospects were brightened by encouraging trial results from its obesity-drug competitor Novo Nordisk.",https://image.cnbcfm.com/api/v1/image/107261723-1687535077484-gettyimages-1302141489-cailly03.jpeg?v=1691520685&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.190287,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.856646', 'ticker_sentiment_score': '0.32115', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
394,3 Stocks to Buy Following Beat-and-Raise Quarters,https://www.zacks.com/commentary/2133840/3-stocks-to-buy-following-beat-and-raise-quarters,20230808T182700,['Derek Lewis'],All three of these stocks saw buying pressure following better-than-expected results. Should investors ride the earnings momentum?,https://staticx-tuner.zacks.com/images/articles/main/bb/14622.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",0.461735,Bullish,"[{'ticker': 'DKNG', 'relevance_score': '0.465901', 'ticker_sentiment_score': '0.58781', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.413587', 'ticker_sentiment_score': '0.512001', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'EMR', 'relevance_score': '0.359014', 'ticker_sentiment_score': '0.289992', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
395,"Moody's Downgrades Hits Banks, but Health Care Glows as Lilly, Novo Nordisk Boosted by Earnings, Data - Eli Lilly  ( NYSE:LLY ) , Walt Disney  ( NYSE:DIS ) ",https://www.benzinga.com/markets/23/08/33639889/moodys-downgrades-hits-banks-but-health-care-glows-as-lilly-novo-nordisk-boosted-by-earnings-data,20230808T175513,['Schwab Center for Financial Research'],"( Tuesday market open ) Several months after the opening salvo, regional banks came back into focus Tuesday morning after Moody's cut ratings on several of them and warned that more downgrades might be on the way-even for big banks.",https://cdn.benzinga.com/files/images/story/2023/08/08/shutterstock_1850213713_0.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.999996'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999956'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",-0.038678,Neutral,"[{'ticker': 'BABA', 'relevance_score': '0.041358', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.062003', 'ticker_sentiment_score': '-0.045036', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.041358', 'ticker_sentiment_score': '0.028909', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.041358', 'ticker_sentiment_score': '0.028909', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCO', 'relevance_score': '0.123632', 'ticker_sentiment_score': '-0.027633', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAH', 'relevance_score': '0.041358', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HD', 'relevance_score': '0.041358', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.020686', 'ticker_sentiment_score': '0.09421', 'ticker_sentiment_label': 'Neutral'}]"
396,Eli Lilly  ( LLY )  Q2 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/08/08/eli-lilly-lly-q2-2023-earnings-call-transcript/,20230808T173024,['Motley Fool Transcribing'],"LLY earnings call for the period ending June 30, 2023.",https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.999921'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.161647'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}]",0.232242,Somewhat-Bullish,"[{'ticker': 'EVR', 'relevance_score': '0.003595', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.003595', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.003595', 'ticker_sentiment_score': '0.106334', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.003595', 'ticker_sentiment_score': '0.106334', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DICE', 'relevance_score': '0.003595', 'ticker_sentiment_score': '0.114835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.003595', 'ticker_sentiment_score': '0.106334', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.003595', 'ticker_sentiment_score': '0.113982', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DNOW', 'relevance_score': '0.003595', 'ticker_sentiment_score': '0.165696', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BCS', 'relevance_score': '0.003595', 'ticker_sentiment_score': '0.106334', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.003595', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APG', 'relevance_score': '0.003595', 'ticker_sentiment_score': '0.069107', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.089676', 'ticker_sentiment_score': '0.098307', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LBTSF', 'relevance_score': '0.003595', 'ticker_sentiment_score': '0.041881', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.003595', 'ticker_sentiment_score': '-0.01451', 'ticker_sentiment_label': 'Neutral'}]"
397,"Eli Lilly  ( LLY )  Q2 Earnings Beat, Mounjaro Powers Sales Growth",https://www.zacks.com/stock/news/2133799/eli-lilly-lly-q2-earnings-beat-mounjaro-powers-sales-growth,20230808T162600,['Zacks Equity Research'],Eli Lilly (LLY) beats second-quarter estimates for earnings and sales. It raises its financial guidance for 2023.,https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '0.999336'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.158466,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.370018', 'ticker_sentiment_score': '0.256279', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.104531', 'ticker_sentiment_score': '0.006701', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SGTX', 'relevance_score': '0.034933', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DICE', 'relevance_score': '0.139064', 'ticker_sentiment_score': '0.072846', 'ticker_sentiment_label': 'Neutral'}]"
398,"Dow Falls 1%; Eli Lilly Raises Annual Guidance - Bright Minds Biosciences  ( NASDAQ:DRUG ) , Nuburu  ( AMEX:BURU ) ",https://www.benzinga.com/news/earnings/23/08/33635763/dow-falls-1-eli-lilly-raises-annual-guidance,20230808T160659,['Lisa Levin'],"U.S. stocks were lower midway through trading, with the Dow Jones falling over 1% on Tuesday. The Dow traded down 1.05% to 35,099.88 while the NASDAQ fell 1.47% to 13,788.21. The S&P 500, also fell, dropping, 1.09% to 4,469.36.",https://cdn.benzinga.com/files/images/story/2023/08/08/eli_lilly_-_logo_0.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.5'}]",-0.215033,Somewhat-Bearish,"[{'ticker': 'LLY', 'relevance_score': '0.329551', 'ticker_sentiment_score': '-0.048869', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KMI', 'relevance_score': '0.084722', 'ticker_sentiment_score': '-0.146856', 'ticker_sentiment_label': 'Neutral'}]"
399,Here's what is behind the stock market's selloff and what we're doing about it,https://www.cnbc.com/2023/08/08/heres-what-is-behind-the-stock-markets-selloff-and-what-were-doing-about-it.html,20230808T160533,['Morgan Chittum'],"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",https://image.cnbcfm.com/api/v1/image/107197030-1676850083877-gettyimages-1459193203-nasdaqstockreadytopastq4expectations005.jpeg?v=1691423872&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.961735'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",-0.024593,Neutral,"[{'ticker': 'WFC', 'relevance_score': '0.222157', 'ticker_sentiment_score': '-0.018069', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.149192', 'ticker_sentiment_score': '-0.013544', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.222157', 'ticker_sentiment_score': '-0.018069', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.074926', 'ticker_sentiment_score': '-0.010332', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.427425', 'ticker_sentiment_score': '-0.029609', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCO', 'relevance_score': '0.149192', 'ticker_sentiment_score': '-0.013544', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTRA', 'relevance_score': '0.149192', 'ticker_sentiment_score': '-0.013544', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PANW', 'relevance_score': '0.361802', 'ticker_sentiment_score': '-0.026362', 'ticker_sentiment_label': 'Neutral'}]"
400,"Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Are On Fire Today",https://www.fool.com/investing/2023/08/08/why-eli-lilly-novo-nordisk-and-viking-therapeutics/,20230808T154513,['George Budwell'],"Novo Nordisk's popular weight loss drug also confers a significant cardioprotective effect, according to a new study.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F743009%2Fa-smiling-couple-that-just-moved-into-a-new-home-looking-at-a-tablet-device-while-sitting-on-the-stairs.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.172858,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.43852', 'ticker_sentiment_score': '0.326973', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VKTX', 'relevance_score': '0.43852', 'ticker_sentiment_score': '0.177484', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.50186', 'ticker_sentiment_score': '0.240549', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
401,U.S. Trade Deficit Decreased in June,https://www.zacks.com/stock/news/2133713/us-trade-deficit-decreased-in-june,20230808T145000,['Zacks Equity Research'],"For the first time in a while, we're looking at market volatility lasting more than a session or two. Despite splendid stock market performance year to date overall, highs have normally been met with short pullbacks and resets.",https://staticx-tuner.zacks.com/images/articles/main/3a/10705.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.928139'}]",0.174262,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.219312', 'ticker_sentiment_score': '0.383834', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'QSR', 'relevance_score': '0.110717', 'ticker_sentiment_score': '0.071187', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIVN', 'relevance_score': '0.110717', 'ticker_sentiment_score': '-0.007706', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UPS', 'relevance_score': '0.165409', 'ticker_sentiment_score': '0.195393', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
402,"Stock Market Tumbles As Earnings, China Send Chill; Only This Sector Escapes Selling",https://www.investors.com/market-trend/stock-market-today/stock-market-tumbles-as-earnings-china-send-chill-only-this-sector-escapes-selling/,20230808T143100,"['JUAN CARLOS ARANCIBIA', ""Investor's Business Daily""]","Stock Market Tumbles As Earnings, China Send Chill. Only This Sector Escapes Selling Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2018/02/stock-UPS-03-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.999896'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}]",-0.175818,Somewhat-Bearish,"[{'ticker': 'BYND', 'relevance_score': '0.121959', 'ticker_sentiment_score': '-0.126658', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TDG', 'relevance_score': '0.121959', 'ticker_sentiment_score': '0.218806', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DDOG', 'relevance_score': '0.121959', 'ticker_sentiment_score': '-0.068647', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.182047', 'ticker_sentiment_score': '0.106967', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCO', 'relevance_score': '0.061159', 'ticker_sentiment_score': '-0.072732', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UPS', 'relevance_score': '0.182047', 'ticker_sentiment_score': '-0.352995', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'MDB', 'relevance_score': '0.121959', 'ticker_sentiment_score': '-0.272802', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'FIVN', 'relevance_score': '0.121959', 'ticker_sentiment_score': '-0.272802', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LI', 'relevance_score': '0.121959', 'ticker_sentiment_score': '0.19568', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PLTR', 'relevance_score': '0.121959', 'ticker_sentiment_score': '-0.003571', 'ticker_sentiment_label': 'Neutral'}]"
403,"Pre-Markets Give Back Some Gains; UPS, LLY, QSR Report",https://www.zacks.com/stock/news/2133689/pre-markets-give-back-some-gains-ups-lly-qsr-report,20230808T142100,['Mark Vickery'],"Off mid-July highs for the year, we've been a bit more bipolar -- and decidedly to the downside since the start of August.",https://staticx-tuner.zacks.com/images/articles/main/ae/518.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.983605'}]",0.169441,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.210731', 'ticker_sentiment_score': '0.228021', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'QSR', 'relevance_score': '0.106305', 'ticker_sentiment_score': '0.153398', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'RIVN', 'relevance_score': '0.106305', 'ticker_sentiment_score': '-0.008685', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UPS', 'relevance_score': '0.210731', 'ticker_sentiment_score': '0.228021', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
404,Jim Cramer's top 10 things to watch in the stock market Tuesday,https://www.cnbc.com/2023/08/08/jim-cramers-top-10-things-to-watch-in-the-stock-market-tuesday.html,20230808T131647,['Jim Cramer'],Club name Eli Lilly (LLY) delivers a big quarterly beat and guidance raise. Lilly shares soar nearly 9%.,https://image.cnbcfm.com/api/v1/image/107261722-1687535077965-gettyimages-1302141479-cailly01.jpeg?v=1691500607&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.967645'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}]",0.141901,Neutral,"[{'ticker': 'HUM', 'relevance_score': '0.098054', 'ticker_sentiment_score': '0.262769', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TJX', 'relevance_score': '0.146618', 'ticker_sentiment_score': '0.174462', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CFG', 'relevance_score': '0.098054', 'ticker_sentiment_score': '-0.035529', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HON', 'relevance_score': '0.098054', 'ticker_sentiment_score': '0.164122', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.04912', 'ticker_sentiment_score': '-0.179642', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'MS', 'relevance_score': '0.098054', 'ticker_sentiment_score': '-0.035529', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.098054', 'ticker_sentiment_score': '0.109351', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BK', 'relevance_score': '0.098054', 'ticker_sentiment_score': '-0.035529', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FITB', 'relevance_score': '0.098054', 'ticker_sentiment_score': '-0.035529', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.098054', 'ticker_sentiment_score': '0.14651', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.194632', 'ticker_sentiment_score': '0.058954', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.146618', 'ticker_sentiment_score': '0.115895', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCO', 'relevance_score': '0.04912', 'ticker_sentiment_score': '-0.032927', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.146618', 'ticker_sentiment_score': '-0.075316', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.146618', 'ticker_sentiment_score': '0.196861', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CTRA', 'relevance_score': '0.098054', 'ticker_sentiment_score': '0.087409', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PANW', 'relevance_score': '0.146618', 'ticker_sentiment_score': '-0.229766', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'WMT', 'relevance_score': '0.146618', 'ticker_sentiment_score': '0.174462', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
405,"Eli Lilly Shares Ride Higher On Strong Q2 Performance, Diabetes and Weight Loss Treatment Mounjaro Nears $1B Revenue - Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/general/biotech/23/08/33626827/eli-lilly-shares-ride-higher-on-strong-q2-performance-diabetes-treatment-mounjaro-nears-1b-rev,20230808T125217,['Vandana Singh'],"Eli Lilly And Co LLY has reported Q2 sales of $$8.31 billion, up 28% Y/Y, beating the consensus of $7.58 billion, due to volume-driven growth from Mounjaro, Verzenio, Jardiance, Taltz. Excluding revenue from Baqsimi and COVID-19 antibodies in 2022, revenue in Q2 2023 increased 22%.",https://cdn.benzinga.com/files/images/story/2023/08/08/mounjaro-medication-for-weight-loss.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.962106'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.074723,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.654522', 'ticker_sentiment_score': '-0.174295', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NVO', 'relevance_score': '0.294093', 'ticker_sentiment_score': '-0.127433', 'ticker_sentiment_label': 'Neutral'}]"
406,"Eli Lilly Set To Report Earnings: $7.5B In Revenue Expected, Options Market Implies 4.5% Move - Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/news/earnings/23/08/33615880/eli-lilly-set-to-report-earnings-7-5b-in-revenue-expected-options-market-implies-4-5-move,20230808T124830,['Priya Nigam'],"Eli Lilly and Company LLY is scheduled to release quarterly earnings results before the opening bell on Aug. 8, 2023. On CNBC's ""Options Action,"" Mike Khouw of Optimize Advisors said Eli Lilly was one of the busier names in the health care sector and traded well over 2x its average daily options ...",https://cdn.benzinga.com/files/images/story/2023/08/08/bz_pharma_briefs.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.857896'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.209887,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.874135', 'ticker_sentiment_score': '0.580229', 'ticker_sentiment_label': 'Bullish'}]"
407,Lilly Trounces Forecasts Thanks To Diabetes Powerhouse Mounjaro,https://www.investors.com/news/technology/eli-lilly-stock-eli-lilly-earnings-q2-2023/,20230808T124600,"['ALLISON GATLIN', ""Investor's Business Daily""]",Eli Lilly Stock Rockets As Diabetes Powerhouse Mounjaro Drives Beat And Raise Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2020/10/Stock-EliLilly-03-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}]",0.274315,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.907043', 'ticker_sentiment_score': '0.599325', 'ticker_sentiment_label': 'Bullish'}]"
408,Eli Lilly  ( LLY )  Q2 Earnings and Revenues Top Estimates,https://www.zacks.com/stock/news/2133506/eli-lilly-lly-q2-earnings-and-revenues-top-estimates,20230808T120507,['Zacks Equity Research'],"Lilly (LLY) delivered earnings and revenue surprises of 6.57% and 10.05%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?",https://staticx-tuner.zacks.com/images/default_article_images/default293.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.999992'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.168725,Somewhat-Bullish,"[{'ticker': 'LFLY', 'relevance_score': '0.205807', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.398148', 'ticker_sentiment_score': '0.207252', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
409,"Small-Cap Slide Ahead? US Stocks Set For Weaker Open On Inflation Anxiety: Analysts Warn 'Mild' Recession Still Likely - Twilio  ( NYSE:TWLO ) , Paramount Global  ( NASDAQ:PARA ) , Expeditors Intl  ( NASDAQ:EXPD ) , Akamai Techs  ( NASDAQ:AKAM ) , Rivian Automotive  ( NASDAQ:RIVN ) , Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , Warner Music Gr  ( NASDAQ:WMG ) , Lucid Gr  ( NASDAQ:LCID ) , Beyond Meat  ( NASDAQ:BYND ) , Fox  ( NASDAQ:FOXA ) , GLOBALFOUNDRIES  ( NASDAQ:GFS ) , Eli Lilly  ( NYSE:LLY ) , Lyft  ( NASDAQ:LYFT ) , United Parcel Service  ( NYSE:UPS ) , Chegg  ( NYSE:CHGG ) , Novavax  ( NASDAQ:NVAX ) , Upstart Hldgs  ( NASDAQ:UPST ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/23/08/33623872/small-cap-slide-ahead-us-stocks-set-for-weaker-open-on-inflation-anxiety-analysts-warn-mild-recessi,20230808T112612,['Shanthi Rexaline'],"Trading in the U.S. index futures suggests stocks may pull back notably at the open on Tuesday. The reversal comes after the major indices charted a recovery on Monday despite the underlying anxieties. The earnings news flow will likely be the driver of the market, given the absence of any ...",https://cdn.benzinga.com/files/images/story/2023/WallStreet.Shutterstock_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Financial Markets', 'relevance_score': '0.998962'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",-0.033681,Neutral,"[{'ticker': 'PARA', 'relevance_score': '0.100099', 'ticker_sentiment_score': '-0.013107', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EXPD', 'relevance_score': '0.100099', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AKAM', 'relevance_score': '0.100099', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIVN', 'relevance_score': '0.100099', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.050148', 'ticker_sentiment_score': '-0.019036', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMG', 'relevance_score': '0.100099', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LCID', 'relevance_score': '0.100099', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BYND', 'relevance_score': '0.100099', 'ticker_sentiment_score': '-0.013107', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GFS', 'relevance_score': '0.100099', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.100099', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CHGG', 'relevance_score': '0.100099', 'ticker_sentiment_score': '-0.013107', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LPLA', 'relevance_score': '0.050148', 'ticker_sentiment_score': '0.193271', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVAX', 'relevance_score': '0.100099', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UPST', 'relevance_score': '0.100099', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
410,"Lilly Reports Second-Quarter 2023 Financial Results, Highlights Accelerating Revenue Growth and Key Pipeline Advancements",https://www.prnewswire.com/news-releases/lilly-reports-second-quarter-2023-financial-results-highlights-accelerating-revenue-growth-and-key-pipeline-advancements-301895134.html,20230808T104500,['Eli Lilly and Company'],"Lilly Reports Second-Quarter 2023 Financial Results, Highlights Accelerating Revenue Growth and Key Pipeline ... PR ...",https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.54554'}]",0.14755,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.275462', 'ticker_sentiment_score': '0.125139', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CURN', 'relevance_score': '0.012225', 'ticker_sentiment_score': '0.001736', 'ticker_sentiment_label': 'Neutral'}]"
411,"The U.S. may not have added any jobs at all in July, one Wall Street strategist says",https://www.marketwatch.com/story/why-one-wall-street-strategist-says-the-u-s-may-not-have-added-any-jobs-at-all-in-july-f0a607d2,20230808T104400,['Steve Goldstein'],"One Wall Street strategist finds fault with the July jobs report, and says the U.S. might have actually lost jobs last month.",https://images.mktw.net/im-831493?width=700&height=569,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.614606'}]",0.026318,Neutral,"[{'ticker': 'SCBFF', 'relevance_score': '0.039548', 'ticker_sentiment_score': '0.076791', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PARA', 'relevance_score': '0.079', 'ticker_sentiment_score': '0.054743', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.079', 'ticker_sentiment_score': '-0.092361', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIVN', 'relevance_score': '0.079', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SATS', 'relevance_score': '0.079', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMG', 'relevance_score': '0.079', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BYND', 'relevance_score': '0.079', 'ticker_sentiment_score': '0.054743', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZM', 'relevance_score': '0.079', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APE', 'relevance_score': '0.039548', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.079', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCO', 'relevance_score': '0.039548', 'ticker_sentiment_score': '-0.198659', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'UPS', 'relevance_score': '0.118257', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UPST', 'relevance_score': '0.079', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLTR', 'relevance_score': '0.079', 'ticker_sentiment_score': '0.054743', 'ticker_sentiment_label': 'Neutral'}]"
412,U.S. stock futures slip after weak China data damps sentiment,https://www.marketwatch.com/story/u-s-stock-futures-slip-after-weak-china-data-damps-sentiment-e0513efd,20230808T084300,['Jamie Chisholm'],A risk-off tone was enveloping global markets -- suppressing U.S. futures -- after weak China trade data heightened concerns about a slowing global economy.,https://images.mktw.net/im-599322/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",-0.137284,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.221819', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCO', 'relevance_score': '0.112008', 'ticker_sentiment_score': '0.025613', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOLD', 'relevance_score': '0.221819', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UA', 'relevance_score': '0.112008', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APE', 'relevance_score': '0.112008', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.221819', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.112008', 'ticker_sentiment_score': '0.335637', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
413,"Fear & Greed Index Remains In 'Greed' Zone Ahead Of Key Inflation Reports - Campbell Soup  ( NYSE:CPB ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/news/earnings/23/08/33615971/fear-greed-index-remains-in-greed-zone-ahead-of-key-inflation-reports,20230808T070620,['Lisa Levin'],"The CNN Money Fear and Greed index showed an improvement in overall sentiment among U.S. investors on Monday. The Dow Jones added more than 400 points on Monday, as investors assessed more corporate earnings reports. Shares of Tyson Foods, Inc.",https://cdn.benzinga.com/files/images/story/2023/08/08/image21.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",-0.169976,Somewhat-Bearish,"[{'ticker': 'SOVO', 'relevance_score': '0.305058', 'ticker_sentiment_score': '0.303678', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CPB', 'relevance_score': '0.305058', 'ticker_sentiment_score': '0.303678', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.305058', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WBD', 'relevance_score': '0.155451', 'ticker_sentiment_score': '-0.170861', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'UPS', 'relevance_score': '0.305058', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSN', 'relevance_score': '0.305058', 'ticker_sentiment_score': '0.303678', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TTWO', 'relevance_score': '0.305058', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
414,"Indices Fight Back; PLTR Meets, SWKS and PARA Beat",https://www.zacks.com/stock/news/2133338/indices-fight-back-pltr-meets-swks-and-para-beat,20230807T221200,['Mark Vickery'],"The Dow climbed back +408 points on the day, +1.16%, while the Nasdaq gained +84 points, +0.61%.",https://staticx-tuner.zacks.com/images/articles/main/2c/48500.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.904684'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.222782,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.130571', 'ticker_sentiment_score': '0.066884', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CHGG', 'relevance_score': '0.194763', 'ticker_sentiment_score': '0.279034', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SWKS', 'relevance_score': '0.130571', 'ticker_sentiment_score': '0.153238', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UA', 'relevance_score': '0.065506', 'ticker_sentiment_score': '0.057056', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PARA', 'relevance_score': '0.130571', 'ticker_sentiment_score': '0.132741', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLTR', 'relevance_score': '0.130571', 'ticker_sentiment_score': '0.102875', 'ticker_sentiment_label': 'Neutral'}]"
415,"Backloaded: Weekly Calendar Awards Those Who Wait As Disney, CPI, PPI Due Wednesday-Friday - Amazon.com  ( NASDAQ:AMZN ) , Walt Disney  ( NYSE:DIS ) ",https://www.benzinga.com/markets/23/08/33605159/backloaded-weekly-calendar-awards-those-who-wait-as-disney-cpi-ppi-due-wednesday-friday,20230807T162600,['Schwab Center for Financial Research'],"( Monday market open ) After U.S. stocks suffered their worst week since March, investors trudge back Monday to a market that's limping technically and appears to lack clear catalysts to reignite bullish sparks. Major indexes come into the week on a four-session losing streak but rebounded ...",https://cdn.benzinga.com/files/images/story/2023/08/07/shutterstock_156562427_14.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.99489'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.999941'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.021787,Neutral,"[{'ticker': 'BABA', 'relevance_score': '0.043342', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APE', 'relevance_score': '0.021679', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.086556', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NYT', 'relevance_score': '0.021679', 'ticker_sentiment_score': '-0.060802', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WYNN', 'relevance_score': '0.043342', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UA', 'relevance_score': '0.021679', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.043342', 'ticker_sentiment_score': '0.189533', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOX', 'relevance_score': '0.021679', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
416,"Monday's Market Minute: A Busy Week Ahead On Wall Street - Alibaba Gr Holding  ( NYSE:BABA ) , AMC Enter Hldgs  ( NYSE:AMC ) ",https://www.benzinga.com/markets/penny-stocks/23/08/33604821/mondays-market-minute-a-busy-week-ahead-on-wall-street,20230807T161310,['TD Ameritrade Network'],"Looks like another week with the focus primarily on earnings and economic data. This week we have roughly three dozen S&P 500 companies reporting, so let's begin there. At the top of the list of names before the bell today is Tyson TSN, with Palantir PLTR, Lucid Motors LCID, and Chegg CHGG on the ...",https://cdn.benzinga.com/files/images/story/2023/08/07/shutterstock_156562427_13.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}]",-0.10712,Neutral,"[{'ticker': 'BABA', 'relevance_score': '0.28387', 'ticker_sentiment_score': '-0.037188', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRON', 'relevance_score': '0.28387', 'ticker_sentiment_score': '-0.037188', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LCID', 'relevance_score': '0.28387', 'ticker_sentiment_score': '-0.037188', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WEN', 'relevance_score': '0.28387', 'ticker_sentiment_score': '-0.037188', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.28387', 'ticker_sentiment_score': '-0.037188', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIVN', 'relevance_score': '0.28387', 'ticker_sentiment_score': '-0.037188', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CHGG', 'relevance_score': '0.28387', 'ticker_sentiment_score': '-0.037188', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RL', 'relevance_score': '0.28387', 'ticker_sentiment_score': '-0.037188', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WYNN', 'relevance_score': '0.28387', 'ticker_sentiment_score': '-0.037188', 'ticker_sentiment_label': 'Neutral'}]"
417,"New Data May Push Insurers to Cover Novo, Lilly Obesity Drugs",https://www.barrons.com/amp/articles/novo-nordisk-wegovy-study-prevent-heart-attack-ae09e586,20230807T155500,['Josh Nathan-Kazis'],Does Novo's Weight Loss Drug Prevent Heart Attacks? Investors Will Soon Know. ...,https://images.barrons.com/im-830942/social,Barrons,n/a,www.barrons.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.08702,Neutral,"[{'ticker': 'CVS', 'relevance_score': '0.089629', 'ticker_sentiment_score': '0.066176', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.464174', 'ticker_sentiment_score': '0.018716', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.089629', 'ticker_sentiment_score': '0.126477', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.347492', 'ticker_sentiment_score': '0.211106', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.044885', 'ticker_sentiment_score': '0.042606', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.044885', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.089629', 'ticker_sentiment_score': '0.066176', 'ticker_sentiment_label': 'Neutral'}]"
418,"Drug, Biotech Stocks' Q2 Earnings on Aug 8: LLY, LGND & More",https://www.zacks.com/stock/news/2133204/drug-biotech-stocks-q2-earnings-on-aug-8-lly-lgnd-more,20230807T153200,['Kinjel Shah'],"Let us look at five drug/biotech companies, LLY, LGND, NVAX, EBS and BLUE, which are gearing up for their earnings release.",https://staticx-tuner.zacks.com/images/articles/main/49/1007.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.05295,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.373611', 'ticker_sentiment_score': '-0.087915', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LGND', 'relevance_score': '0.329866', 'ticker_sentiment_score': '-0.016443', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVAX', 'relevance_score': '0.284972', 'ticker_sentiment_score': '0.045863', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BLUE', 'relevance_score': '0.284972', 'ticker_sentiment_score': '-0.004157', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EBS', 'relevance_score': '0.373611', 'ticker_sentiment_score': '-0.185083', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
419,"National Debt, Real Jobs, US Dollar Index, Charting the Markets, Inflation Watch",https://realmoney.thestreet.com/investing/national-debt-real-jobs-us-dollar-index-charting-the-markets-inflation-watch-16130411,20230807T114043,['Stephen Guilfoyle'],"Where do we begin to explain? The past week was so full of bits and pieces of market-impacting information that writing up a neat and tidy summary becomes impossible. As far as earnings are concerned, last week was the busiest week of this particular reporting season.",https://s.thestreet.com/files/tsc/v2008/photos/contrib/uploads/bba2111c-3515-11ee-b533-c99241691170.png,The Street,GoogleRSS,realmoney.thestreet.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.998626'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.451494'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.997902'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.999981'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.031336,Neutral,"[{'ticker': 'NVDA', 'relevance_score': '0.023124', 'ticker_sentiment_score': '0.012672', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.03468', 'ticker_sentiment_score': '0.061277', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DDOG', 'relevance_score': '0.023124', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIVN', 'relevance_score': '0.023124', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSN', 'relevance_score': '0.023124', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.023124', 'ticker_sentiment_score': '0.012672', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DDS', 'relevance_score': '0.023124', 'ticker_sentiment_score': '-0.148913', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.023124', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCO', 'relevance_score': '0.011563', 'ticker_sentiment_score': '0.030173', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UPS', 'relevance_score': '0.023124', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RL', 'relevance_score': '0.023124', 'ticker_sentiment_score': '-0.148913', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.03468', 'ticker_sentiment_score': '0.061277', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLTR', 'relevance_score': '0.023124', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.069294', 'ticker_sentiment_score': '-0.020381', 'ticker_sentiment_label': 'Neutral'}]"
420,2 Top Biotech Stocks to Buy in August,https://www.fool.com/investing/2023/08/06/2-top-biotech-stocks-to-buy-in-august/,20230806T131500,['Prosper Junior Bakiny'],Both companies are performing exceedingly well.,https://media.ycharts.com/charts/8b7caf0e6140dc8f707e88787653f233.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.684621'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.300281,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.43465', 'ticker_sentiment_score': '0.482343', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.206157', 'ticker_sentiment_score': '0.254022', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
421,Futures: What To Do After Market Skids; 5 Stocks Near Buy Points,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-what-to-as-market-rally-skids-5-stocks-near-buy-points/,20230805T175900,"['ED CARSON', ""Investor's Business Daily""]",Futures: What To Do After Market Skids. 5 Stocks Near Buy Points Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2018/05/Stock-bullBearFrankfurt-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.95493'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",-0.014526,Neutral,"[{'ticker': 'TOL', 'relevance_score': '0.109655', 'ticker_sentiment_score': '-0.015602', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CELH', 'relevance_score': '0.065926', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.131403', 'ticker_sentiment_score': '-0.013453', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.109655', 'ticker_sentiment_score': '-0.23234', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AVGO', 'relevance_score': '0.131403', 'ticker_sentiment_score': '-0.072143', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.238345', 'ticker_sentiment_score': '0.037044', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.043979', 'ticker_sentiment_score': '0.030212', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.021998', 'ticker_sentiment_score': '0.121988', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.065926', 'ticker_sentiment_score': '-0.037216', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DAL', 'relevance_score': '0.131403', 'ticker_sentiment_score': '0.050009', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLTR', 'relevance_score': '0.065926', 'ticker_sentiment_score': '-0.017083', 'ticker_sentiment_label': 'Neutral'}]"
422,3 Fantastic Growth Stocks to Buy in August,https://www.fool.com/investing/2023/08/05/3-fantastic-growth-stocks-to-buy-in-august/,20230805T105500,"['Keith Speights', 'and Prosper Junior Bakiny', 'David Jagielski']",These stocks could be poised to soar.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F742339%2Fbear-market-stocks-plunge-crash-invest-correction-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.839681'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.271353,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.344473', 'ticker_sentiment_score': '0.196689', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.262052', 'ticker_sentiment_score': '0.324917', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AXSM', 'relevance_score': '0.176502', 'ticker_sentiment_score': '0.079316', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.044469', 'ticker_sentiment_score': '0.167724', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
423,"Stock Market Week: Disney's Funk, Honda Motor, Foreign Airline Earnings",https://www.investors.com/research/investing-action-plan/stock-market-week-will-disneys-funk-continue-honda-foreign-airlines-to-report-earnings/,20230804T233900,"[""Investor's Business Daily"", 'IBD STAFF']","It was a rough and busy week for the stock market. The Stock Trader's Almanac notes that the first nine trading days of August are historically weak, and the big benchmarks were due for a modest pullback. Breadth of leadership remains largely intact as earnings season downshifts with a couple of ...",https://www.investors.com/wp-content/uploads/2021/08/ETFLEADERS-nyse-080621-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.990678'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.999998'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.059646,Neutral,"[{'ticker': 'ATKR', 'relevance_score': '0.048572', 'ticker_sentiment_score': '0.104498', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TTD', 'relevance_score': '0.048572', 'ticker_sentiment_score': '0.081134', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ICHR', 'relevance_score': '0.048572', 'ticker_sentiment_score': '0.104498', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WYNN', 'relevance_score': '0.096964', 'ticker_sentiment_score': '-0.00216', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABNB', 'relevance_score': '0.096964', 'ticker_sentiment_score': '0.040245', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IONQ', 'relevance_score': '0.048572', 'ticker_sentiment_score': '-0.01196', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZUL', 'relevance_score': '0.096964', 'ticker_sentiment_score': '0.00647', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MTW', 'relevance_score': '0.048572', 'ticker_sentiment_score': '0.104498', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.048572', 'ticker_sentiment_score': '0.093412', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JAZZ', 'relevance_score': '0.048572', 'ticker_sentiment_score': '0.11897', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TDG', 'relevance_score': '0.048572', 'ticker_sentiment_score': '0.104498', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.072802', 'ticker_sentiment_score': '0.053322', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CACI', 'relevance_score': '0.072802', 'ticker_sentiment_score': '0.110619', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HMC', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.020976', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BABA', 'relevance_score': '0.048572', 'ticker_sentiment_score': '-0.084503', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ORCL', 'relevance_score': '0.072802', 'ticker_sentiment_score': '0.038336', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VSH', 'relevance_score': '0.048572', 'ticker_sentiment_score': '0.065242', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAH', 'relevance_score': '0.096964', 'ticker_sentiment_score': '0.040245', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SWKS', 'relevance_score': '0.048572', 'ticker_sentiment_score': '0.070206', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSN', 'relevance_score': '0.096964', 'ticker_sentiment_score': '0.090305', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MELI', 'relevance_score': '0.072802', 'ticker_sentiment_score': '0.038336', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VECO', 'relevance_score': '0.048572', 'ticker_sentiment_score': '0.061276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LEN', 'relevance_score': '0.072802', 'ticker_sentiment_score': '0.038336', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CPA', 'relevance_score': '0.096964', 'ticker_sentiment_score': '0.00647', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JACK', 'relevance_score': '0.072802', 'ticker_sentiment_score': '-0.015375', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GLNG', 'relevance_score': '0.048572', 'ticker_sentiment_score': '0.104498', 'ticker_sentiment_label': 'Neutral'}]"
424,Market Rally At Inflection Point; What To Do Now,https://www.investors.com/market-trend/stock-market-today/market-rally-at-inflection-point-warren-buffett-berkshire-earnings-due/,20230804T214400,"['ED CARSON', ""Investor's Business Daily""]",Market Rally At Inflection Point. What To Do Now Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/07/marketdiem_warrenbuffett.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.947132'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",-0.02176,Neutral,"[{'ticker': 'TOL', 'relevance_score': '0.110462', 'ticker_sentiment_score': '-0.015646', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CELH', 'relevance_score': '0.066414', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.132368', 'ticker_sentiment_score': '-0.013506', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.110462', 'ticker_sentiment_score': '-0.232962', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AVGO', 'relevance_score': '0.132368', 'ticker_sentiment_score': '-0.072416', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.240057', 'ticker_sentiment_score': '0.037257', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.044304', 'ticker_sentiment_score': '0.030241', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.022161', 'ticker_sentiment_score': '0.041195', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.066414', 'ticker_sentiment_score': '-0.037234', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DAL', 'relevance_score': '0.132368', 'ticker_sentiment_score': '0.050203', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLTR', 'relevance_score': '0.066414', 'ticker_sentiment_score': '-0.017091', 'ticker_sentiment_label': 'Neutral'}]"
425,"S&P 500 Drops After Fitch Downgrades US Government's Credit Rating; Apple Flunks On iPhone Sales, While Amazon Shares Climb To 12-Month High - Alibaba Gr Holding  ( NYSE:BABA ) , PayPal Holdings  ( NASDAQ:PYPL ) , Sony Group  ( NYSE:SONY ) , Novo Nordisk  ( NYSE:NVO ) , Walt Disney  ( NYSE:DIS ) , Lucid Gr  ( NASDAQ:LCID ) , Fox  ( NASDAQ:FOXA ) , Starbucks  ( NASDAQ:SBUX ) , Qualcomm  ( NASDAQ:QCOM ) , Advanced Micro Devices  ( NASDAQ:AMD ) , Eli Lilly  ( NYSE:LLY ) , United Parcel Service  ( NYSE:UPS ) , Robinhood Markets  ( NASDAQ:HOOD ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/government/23/08/33582860/s-p-500-drops-after-fitch-downgrades-us-governments-credit-rating-apple-flunks-on-iphone-sales-while,20230804T202840,['Natan Ponieman'],"As Treasury yields rose and America's credit rating got a hard blow from Fitch Ratings Inc., the S&P 500 slipped. When yields on Treasury bonds rise, investors lean towards selling their equity assets in favor of bonds, taking down the stock market gauge. The S&P 500 lost 2.3% on a weekly basis.",https://cdn.benzinga.com/files/images/story/2023/shutterstock_176534375_0.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.986714'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.993856'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",-0.044039,Neutral,"[{'ticker': 'BABA', 'relevance_score': '0.10607', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PYPL', 'relevance_score': '0.10607', 'ticker_sentiment_score': '-0.093324', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.10607', 'ticker_sentiment_score': '0.050697', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DIS', 'relevance_score': '0.10607', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNEJF', 'relevance_score': '0.10607', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LCID', 'relevance_score': '0.10607', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.10607', 'ticker_sentiment_score': '0.090783', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.10607', 'ticker_sentiment_score': '0.036144', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APE', 'relevance_score': '0.053153', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.10607', 'ticker_sentiment_score': '0.036144', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.10607', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UPS', 'relevance_score': '0.10607', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.158519', 'ticker_sentiment_score': '0.16072', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
426,"Cooler Summer: July Jobs Growth Slowed, But Investors Cast Wary Eye On Fast-Rising Wages",https://www.benzinga.com/markets/23/08/33577192/cooler-summer-july-jobs-growth-slowed-but-investors-cast-wary-eye-on-fast-rising-wages,20230804T154148,['Alex Coffey'],"( Friday market open ) U.S. employers added jobs in June and July at the slowest pace in nearly three years. However, major indexes wavered after the news as investors grappled with stronger-than-expected wage growth. The U.S. economy created 187,000 jobs in July, the Labor Department said ...",https://cdn.benzinga.com/files/images/story/2023/08/04/shutterstock_93231562.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.999855'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.038511,Neutral,"[{'ticker': 'BABA', 'relevance_score': '0.040725', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.181743', 'ticker_sentiment_score': '0.042138', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APE', 'relevance_score': '0.020369', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.081345', 'ticker_sentiment_score': '-0.012266', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WYNN', 'relevance_score': '0.040725', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UA', 'relevance_score': '0.020369', 'ticker_sentiment_score': '-0.014154', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.181743', 'ticker_sentiment_score': '0.221213', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOX', 'relevance_score': '0.020369', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BNTX', 'relevance_score': '0.040725', 'ticker_sentiment_score': '0.144577', 'ticker_sentiment_label': 'Neutral'}]"
427,Rising Dividend Make Zoetis A Doggone Winner - Zoetis  ( NYSE:ZTS ) ,https://www.benzinga.com/news/earnings/23/08/33572209/rising-dividend-make-zoetis-a-doggone-winner,20230804T145400,['MarketBeat'],"When Zoetis Inc. ZTS reports second-quarter financials next week, the market will be expecting its best revenue growth in a year and a 9% jump in profits. If history repeats, the results will be even better.",https://cdn.benzinga.com/files/images/story/2023/08/04/zoetis_logo.svg_.png?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.972476'}]",0.293144,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.100941', 'ticker_sentiment_score': '0.138752', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZTS', 'relevance_score': '0.514619', 'ticker_sentiment_score': '0.461668', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'CTLT', 'relevance_score': '0.050572', 'ticker_sentiment_score': '0.12931', 'ticker_sentiment_label': 'Neutral'}]"
428,Palantir Stock Holds Near Highs Ahead Of Q2 Results; Fast-Growing Celsius Battles Near Key Support Level,https://www.investors.com/research/earnings-preview/palantir-stock-holds-near-highs-ahead-of-q2-results-fast-growing-celsius-battles-near-key-support-level/,20230804T142000,"['KEN SHREVE', ""Investor's Business Daily""]",Palantir Stock Holds Near Highs Ahead Of Q2 Results. Fast-Growing Celsius Battles Near Key Support Level Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/08/EARNwatchT080723.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.99986'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.165713,Somewhat-Bullish,"[{'ticker': 'DT', 'relevance_score': '0.07104', 'ticker_sentiment_score': '0.031112', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CELH', 'relevance_score': '0.210884', 'ticker_sentiment_score': '0.118642', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TTD', 'relevance_score': '0.07104', 'ticker_sentiment_score': '0.130774', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.07104', 'ticker_sentiment_score': '0.220712', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DDOG', 'relevance_score': '0.07104', 'ticker_sentiment_score': '0.220712', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.176373', 'ticker_sentiment_score': '0.121129', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GLBE', 'relevance_score': '0.07104', 'ticker_sentiment_score': '0.130774', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.07104', 'ticker_sentiment_score': '0.06128', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUBS', 'relevance_score': '0.07104', 'ticker_sentiment_score': '0.031112', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLTR', 'relevance_score': '0.07104', 'ticker_sentiment_score': '0.220712', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
429,Beat the Dow Jones With This Unstoppable Dividend Stock,https://www.fool.com/investing/2023/08/04/beat-the-dow-jones-with-this-unstoppable-dividend/,20230804T114500,['Prosper Junior Bakiny'],"This company has been on a roll, and there is more where that came from.",https://media.ycharts.com/charts/eef2378438db60a37f6fbf9fbecf3c80.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.94762'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.891286'}]",0.252361,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.40225', 'ticker_sentiment_score': '0.171664', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
430,"Amazon And Apple Awaited: Risk-Off Trading Continues Ahead Of Earnings, Friday Jobs Data - Apple  ( NASDAQ:AAPL ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/markets/23/08/33551938/amazon-and-apple-awaited-risk-off-trading-continues-ahead-of-earnings-friday-jobs-data,20230803T145735,['Alex Coffey'],"( Thursday market open ) After an interruption due to Fitch Ratings' surprise downgrade of U.S. credit, Wall Street returns to its regularly scheduled programming with Amazon AMZN and Apple AAPL reporting earnings this afternoon.",https://cdn.benzinga.com/files/images/story/2023/08/03/shutterstock_1723527190_10.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.990678'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.999813'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",-0.007309,Neutral,"[{'ticker': 'BABA', 'relevance_score': '0.044182', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.196877', 'ticker_sentiment_score': '-0.024218', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'D', 'relevance_score': '0.022099', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ORCL', 'relevance_score': '0.044182', 'ticker_sentiment_score': '0.024693', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WYNN', 'relevance_score': '0.044182', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRBG', 'relevance_score': '0.044182', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOX', 'relevance_score': '0.022099', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BNTX', 'relevance_score': '0.044182', 'ticker_sentiment_score': '0.145771', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.044182', 'ticker_sentiment_score': '0.024693', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APE', 'relevance_score': '0.022099', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ENB', 'relevance_score': '0.044182', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.044182', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.17538', 'ticker_sentiment_score': '0.019028', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.022099', 'ticker_sentiment_score': '0.182716', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
431,Is Pfizer Stock A Buy Or A Sell With Covid Revenue In The Rearview?,https://www.investors.com/news/technology/pfizer-stock-buy-now/,20230803T120000,"[""Investor's Business Daily"", 'ALLISON GATLIN']","Pfizer ( PFE ) stock has tumbled this year as demand for Covid products wanes and amid a fresh challenge in the obesity treatment space. During the second quarter, Pfizer's sales plummeted by half and missed forecasts. Adjusted earnings also tumbled, but beat forecasts by a penny.",https://www.investors.com/wp-content/uploads/2019/05/PFE-evergreen-051419-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.999974'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.99977'}]",-0.002439,Neutral,"[{'ticker': 'BHVN', 'relevance_score': '0.085426', 'ticker_sentiment_score': '0.040966', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.057011', 'ticker_sentiment_score': '-0.016', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.057011', 'ticker_sentiment_score': '-0.016', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SGEN', 'relevance_score': '0.057011', 'ticker_sentiment_score': '-0.077277', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.085426', 'ticker_sentiment_score': '-0.043011', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRBU', 'relevance_score': '0.057011', 'ticker_sentiment_score': '0.039945', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.647462', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.057011', 'ticker_sentiment_score': '-0.014054', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BNTX', 'relevance_score': '0.057011', 'ticker_sentiment_score': '-0.186991', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
432,"Risk-Off Mood Pervades Following Surprise Downgrade Of U.S. Treasuries By Fitch Ratings - Apple  ( NASDAQ:AAPL ) , Advanced Micro Devices  ( NASDAQ:AMD ) ",https://www.benzinga.com/markets/23/08/33523169/risk-off-mood-pervades-following-surprise-downgrade-of-u-s-treasuries-by-fitch-ratings,20230802T142423,['Alex Coffey'],"( Wednesday market open ) A defensive, ""risk-off"" mood gripped global markets early Wednesday after Fitch Ratings' surprise downgrade of its rating for U.S. Treasuries to AA+ from AAA. The move sparked a rapid retreat from riskier assets, but the bond market saw little initial reaction.",https://cdn.benzinga.com/files/images/story/2023/08/02/shutterstock_444525001.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '0.999993'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",-0.041163,Neutral,"[{'ticker': 'BABA', 'relevance_score': '0.039516', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.039516', 'ticker_sentiment_score': '0.323005', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.252584', 'ticker_sentiment_score': '-0.005781', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DG', 'relevance_score': '0.039516', 'ticker_sentiment_score': '0.029494', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'D', 'relevance_score': '0.019764', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'H', 'relevance_score': '0.039516', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ORCL', 'relevance_score': '0.039516', 'ticker_sentiment_score': '0.004886', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WYNN', 'relevance_score': '0.039516', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.019764', 'ticker_sentiment_score': '0.026687', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRBG', 'relevance_score': '0.039516', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'K', 'relevance_score': '0.039516', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.039516', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COIN', 'relevance_score': '0.039516', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOX', 'relevance_score': '0.019764', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BNTX', 'relevance_score': '0.039516', 'ticker_sentiment_score': '0.144099', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.039516', 'ticker_sentiment_score': '0.004886', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.039516', 'ticker_sentiment_score': '0.027982', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APE', 'relevance_score': '0.019764', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.059243', 'ticker_sentiment_score': '0.168349', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ENB', 'relevance_score': '0.039516', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.039516', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.233743', 'ticker_sentiment_score': '-0.02732', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.039516', 'ticker_sentiment_score': '0.029494', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.019764', 'ticker_sentiment_score': '-0.068344', 'ticker_sentiment_label': 'Neutral'}]"
433,Eli Lilly  ( LLY )  to Report Q2 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2131138/eli-lilly-lly-to-report-q2-earnings-whats-in-the-cards,20230802T140900,['Zacks Equity Research'],Higher demand for its key drugs is likely to have offset generic competition for several drugs and may have boosted Eli Lilly's (LLY) second-quarter sales.,https://staticx-tuner.zacks.com/images/articles/main/52/873.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '0.998917'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.125832,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.573213', 'ticker_sentiment_score': '0.133978', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KOD', 'relevance_score': '0.157483', 'ticker_sentiment_score': '-0.020223', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SGTX', 'relevance_score': '0.07913', 'ticker_sentiment_score': '0.126012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DICE', 'relevance_score': '0.118452', 'ticker_sentiment_score': '0.089027', 'ticker_sentiment_label': 'Neutral'}]"
434,Ozempic Could Have a New Multibillion-Dollar Market Opportunity. Is Novo Nordisk Stock a No-Brainer Buy?,https://www.fool.com/investing/2023/08/02/ozempic-could-have-a-new-multibillion-dollar-marke/,20230802T095000,['Keith Speights'],Novo Nordisk received some good news in a recent physician survey.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F741914%2Fwoman-checks-a-laptop.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.210583,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.274628', 'ticker_sentiment_score': '0.357991', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'MDGL', 'relevance_score': '0.111747', 'ticker_sentiment_score': '0.10348', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.472821', 'ticker_sentiment_score': '0.292779', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
435,This Is What Whales Are Betting On Eli Lilly - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/08/33502650/this-is-what-whales-are-betting-on-eli-lilly,20230801T190107,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 11 strange trades. If we consider the specifics of each trade, it is accurate to state that 45% of the investors opened trades with bullish ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.066465,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.818658', 'ticker_sentiment_score': '0.164607', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.118064', 'ticker_sentiment_score': '-0.130604', 'ticker_sentiment_label': 'Neutral'}]"
436,"Mixed Brew: Pfizer, Merck Earnings Head Opposite Ways, But Uber And Caterpillar Slug Line Drives - Alaska Air Gr  ( NYSE:ALK ) , Apple  ( NASDAQ:AAPL ) ",https://www.benzinga.com/markets/23/08/33501240/mixed-brew-pfizer-merck-earnings-head-opposite-ways-but-uber-and-caterpillar-slug-line-drives,20230801T173623,['Alex Coffey'],"( Tuesday market open ) The new month starts with stocks tinted red, but this week's main events are just getting underway. A rise in Treasury yields might have investors nervous early Tuesday as the 10-year yield popped back above 4% ahead of key U.S. economic data.",https://cdn.benzinga.com/files/images/story/2023/08/01/shutterstock_306271739_8.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '0.999995'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",-0.012069,Neutral,"[{'ticker': 'DD', 'relevance_score': '0.038623', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.077156', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'D', 'relevance_score': '0.019317', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KHC', 'relevance_score': '0.038623', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'H', 'relevance_score': '0.038623', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WYNN', 'relevance_score': '0.038623', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'K', 'relevance_score': '0.038623', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.038623', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CLX', 'relevance_score': '0.038623', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COIN', 'relevance_score': '0.038623', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.077156', 'ticker_sentiment_score': '-0.033955', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BNTX', 'relevance_score': '0.038623', 'ticker_sentiment_score': '0.143726', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SHOP', 'relevance_score': '0.038623', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.096361', 'ticker_sentiment_score': '0.033233', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNP', 'relevance_score': '0.038623', 'ticker_sentiment_score': '-0.109184', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.096361', 'ticker_sentiment_score': '0.038798', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.038623', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.076226', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BABA', 'relevance_score': '0.038623', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PYPL', 'relevance_score': '0.038623', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.038623', 'ticker_sentiment_score': '0.020817', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JBLU', 'relevance_score': '0.038623', 'ticker_sentiment_score': '0.073541', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'YELL', 'relevance_score': '0.019317', 'ticker_sentiment_score': '-0.102643', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRBG', 'relevance_score': '0.038623', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOX', 'relevance_score': '0.019317', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'YUM', 'relevance_score': '0.038623', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APE', 'relevance_score': '0.019317', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.077156', 'ticker_sentiment_score': '0.113864', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ENB', 'relevance_score': '0.038623', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.077156', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MAR', 'relevance_score': '0.038623', 'ticker_sentiment_score': '0.213208', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
437,Incyte  ( INCY )  Beats on Q2 Earnings and Revenue Estimates,https://www.zacks.com/stock/news/2130522/incyte-incy-beats-on-q2-earnings-and-revenue-estimates,20230801T140500,['Zacks Equity Research'],"Incyte (INCY) reports impressive Q2 earnings on strong uptake in Jakafi and Opzelura sales. The company raises the bottom end of full-year guidance, setting a new range of $2.58-$2.63 billion.",https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.145466,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.206685', 'ticker_sentiment_score': '0.055609', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INCY', 'relevance_score': '0.605524', 'ticker_sentiment_score': '0.181687', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'REPL', 'relevance_score': '0.155786', 'ticker_sentiment_score': '0.170522', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
438,"Merck  ( MRK )  Reports Q2 Loss, Tops Revenue Estimates",https://www.zacks.com/stock/news/2130247/merck-mrk-reports-q2-loss-tops-revenue-estimates,20230801T114512,['Zacks Equity Research'],"Merck (MRK) delivered earnings and revenue surprises of 5.07% and 4.50%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?",https://staticx-tuner.zacks.com/images/default_article_images/default277.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999992'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.143717,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.139669', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
439,This AI Stock Leads 5 Names Near Buy Points,https://www.investors.com/news/ai-stock-marvell-eli-lilly-lead-5-names-near-buy-points-as-sp-500-rallies-on/,20230729T151200,"['JED GRAHAM', ""Investor's Business Daily""]","AI Stock Marvell, Eli Lilly Lead 5 Names Near Buy Points As S&P 500 Rallies On Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2021/08/Stock-MarvellTech-AlaskaChips-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.928769'}]",0.166271,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.068995', 'ticker_sentiment_score': '0.083276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DTST', 'relevance_score': '0.068995', 'ticker_sentiment_score': '0.06821', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.068995', 'ticker_sentiment_score': '0.107398', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.068995', 'ticker_sentiment_score': '0.083276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.03453', 'ticker_sentiment_score': '0.147683', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NCLH', 'relevance_score': '0.068995', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TDG', 'relevance_score': '0.238133', 'ticker_sentiment_score': '0.126577', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.334913', 'ticker_sentiment_score': '0.238719', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'RCL', 'relevance_score': '0.068995', 'ticker_sentiment_score': '-0.077249', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'URI', 'relevance_score': '0.270898', 'ticker_sentiment_score': '0.172497', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMZN', 'relevance_score': '0.068995', 'ticker_sentiment_score': '0.150668', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MRVL', 'relevance_score': '0.204936', 'ticker_sentiment_score': '0.130001', 'ticker_sentiment_label': 'Neutral'}]"
440,2 Healthcare Stocks That Could Make You Richer,https://www.fool.com/investing/2023/07/29/2-healthcare-stocks-that-could-make-you-richer/,20230729T133000,['Jim Halley'],Investors see the obvious potential in both companies.,https://media.ycharts.com/charts/fa20cd2edfa55a611a3d436206d7890b.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '0.995973'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.260102,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.559221', 'ticker_sentiment_score': '0.394737', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ZTS', 'relevance_score': '0.300088', 'ticker_sentiment_score': '0.351899', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'DICE', 'relevance_score': '0.051221', 'ticker_sentiment_score': '0.016', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.102231', 'ticker_sentiment_score': '0.098131', 'ticker_sentiment_label': 'Neutral'}]"
441,"Investing Action Plan: Apple, Amazon And An Upturn In Optimism",https://www.investors.com/research/investing-action-plan/stock-market-action-plan-apple-amazon-and-an-upturn-in-optimism/,20230728T222500,"[""Investor's Business Daily"", 'IBD STAFF']","A good week for optimism left the stock market in strong standing as it heads into early August. Chips showed strength, riding the rising trend in AI computing. Department stores also soared as markets begin to look toward the back-to-school and holiday shopping seasons.",https://www.investors.com/wp-content/uploads/2021/08/Stock-BullPaintedRushing-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.999998'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.150949,Somewhat-Bullish,"[{'ticker': 'CVS', 'relevance_score': '0.06515', 'ticker_sentiment_score': '0.077233', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.086791', 'ticker_sentiment_score': '0.167143', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ANET', 'relevance_score': '0.04346', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.04346', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EXPE', 'relevance_score': '0.06515', 'ticker_sentiment_score': '0.099257', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABNB', 'relevance_score': '0.06515', 'ticker_sentiment_score': '0.099257', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.04346', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FNKO', 'relevance_score': '0.04346', 'ticker_sentiment_score': '-0.114905', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.04346', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'THC', 'relevance_score': '0.06515', 'ticker_sentiment_score': '-0.036363', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SHOP', 'relevance_score': '0.04346', 'ticker_sentiment_score': '0.014851', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OXY', 'relevance_score': '0.06515', 'ticker_sentiment_score': '0.112516', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.04346', 'ticker_sentiment_score': '0.085123', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.04346', 'ticker_sentiment_score': '0.00594', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TDG', 'relevance_score': '0.04346', 'ticker_sentiment_score': '0.083325', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.086791', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.06515', 'ticker_sentiment_score': '0.084501', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EA', 'relevance_score': '0.04346', 'ticker_sentiment_score': '0.057574', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SQ', 'relevance_score': '0.04346', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ON', 'relevance_score': '0.04346', 'ticker_sentiment_score': '0.024659', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PYPL', 'relevance_score': '0.04346', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCA', 'relevance_score': '0.04346', 'ticker_sentiment_score': '-0.035863', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MELI', 'relevance_score': '0.04346', 'ticker_sentiment_score': '0.073301', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FTNT', 'relevance_score': '0.06515', 'ticker_sentiment_score': '0.05805', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.04346', 'ticker_sentiment_score': '0.003966', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ENB', 'relevance_score': '0.06515', 'ticker_sentiment_score': '0.071468', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RCL', 'relevance_score': '0.06515', 'ticker_sentiment_score': '0.089474', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.108368', 'ticker_sentiment_score': '0.184585', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MAR', 'relevance_score': '0.06515', 'ticker_sentiment_score': '0.099257', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRVL', 'relevance_score': '0.04346', 'ticker_sentiment_score': '0.083325', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.021738', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
442,"Pharma Stock Roundup: AZN, SNY, ABBV Q2 Results, MRK, MRNA Cancer Jab in Phase III",https://www.zacks.com/stock/news/2129541/pharma-stock-roundup-azn-sny-abbv-q2-results-mrk-mrna-cancer-jab-in-phase-iii,20230728T153200,['Kinjel Shah'],"AstraZeneca (AZN), Sanofi (SNY) and AbbVie (ABBV) announce second-quarter results.",https://staticx-tuner.zacks.com/images/articles/main/55/1135.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.99393'}, {'topic': 'Earnings', 'relevance_score': '0.997845'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.083678,Neutral,"[{'ticker': 'AZN', 'relevance_score': '0.136422', 'ticker_sentiment_score': '0.045555', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KVUE', 'relevance_score': '0.163354', 'ticker_sentiment_score': '0.076801', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.054794', 'ticker_sentiment_score': '-0.022006', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.190096', 'ticker_sentiment_score': '0.052047', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.082111', 'ticker_sentiment_score': '-0.048804', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.054794', 'ticker_sentiment_score': '-0.070823', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.10933', 'ticker_sentiment_score': '0.070211', 'ticker_sentiment_label': 'Neutral'}]"
443,JNJ: Top 3 Pharma Stocks You Can't Miss out On,https://stocknews.com/news/jnj-lly-rdy-sgtx-top-3-pharma-stocks-you-cant-miss-out-on/,20230727T174832,['StockNews.com Staff'],"Medical innovations like precision medicine, cell and gene therapy, and immuno-oncology fuel new ways of preventing and detecting various diseases and creating tailwinds for the pharmaceutical industry. In addition, technology is powering the industry in activities like drug discovery, ...",https://stocknews.com/wp-content/uploads/2022/07/shutterstock_1110645284.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.254334,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.046051', 'ticker_sentiment_score': '0.151337', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.227219', 'ticker_sentiment_score': '0.275098', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AWON', 'relevance_score': '0.023035', 'ticker_sentiment_score': '0.092513', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SGTX', 'relevance_score': '0.046051', 'ticker_sentiment_score': '-0.065874', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.182678', 'ticker_sentiment_score': '0.211152', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
444,Lilly's Diabetes Drug Tirzepatide Demonstrates Significant And Superior Weight Loss In Two Studies,https://markets.businessinsider.com/news/stocks/lilly-s-diabetes-drug-tirzepatide-demonstrates-significant-and-superior-weight-loss-in-two-studies-1032484975,20230727T134850,['markets.businessinsider.com'],( RTTNews ) - Eli Lilly and Co. ( LLY ) announced on Thursday that its diabetes drug Tirzepatide demonstrated significant and superior weight loss compared to placebo in two pivotal studies dubbed SURMOUNT-3 and SURMOUNT-4.,https://markets.businessinsider.com/Images/FacebookIcon.jpg,Business Insider,RSS,markets.businessinsider.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.073862,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.350564', 'ticker_sentiment_score': '0.166229', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
445,Eli Lilly vs. Novo Nordisk: What's the Better Weight-Loss Stock to Buy?,https://www.fool.com/investing/2023/07/27/eli-lilly-vs-novo-nordisk-whats-the-better-weight/,20230727T121500,['David Jagielski'],These two drug companies have seen red-hot demand for their weight-loss treatments.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}]",0.220902,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.474763', 'ticker_sentiment_score': '0.337416', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.328091', 'ticker_sentiment_score': '0.330435', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOREX:DKK', 'relevance_score': '0.056275', 'ticker_sentiment_score': '0.121033', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:NOK', 'relevance_score': '0.056275', 'ticker_sentiment_score': '0.121033', 'ticker_sentiment_label': 'Neutral'}]"
446,Eli Lilly and Company  ( LLY )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2127673/eli-lilly-and-company-lly-is-attracting-investor-attention-here-is-what-you-should-know,20230726T130011,['Zacks Equity Research'],"Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.",https://staticx-tuner.zacks.com/images/default_article_images/default200.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.623304'}]",0.23933,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.522096', 'ticker_sentiment_score': '0.165228', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
447,This Is What Whales Are Betting On Eli Lilly - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/07/33377583/this-is-what-whales-are-betting-on-eli-lilly,20230725T200053,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 27 strange trades. If we consider the specifics of each trade, it is accurate to state that 62% of the investors opened trades with bullish ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.130134,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.815635', 'ticker_sentiment_score': '0.020237', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.209365', 'ticker_sentiment_score': '-0.185555', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
448,Is Eli Lilly Stock Still a Top-Growth Play?,https://www.fool.com/investing/2023/07/25/is-eli-lilly-stock-still-a-top-growth-play/,20230725T184000,['George Budwell'],The drugmaker may be running out of steam.,https://media.ycharts.com/charts/83057752bff6906fa3b93d5218f82916.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.818451'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.14465,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.583927', 'ticker_sentiment_score': '0.1515', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.072', 'ticker_sentiment_score': '-0.047465', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.072', 'ticker_sentiment_score': '-0.047465', 'ticker_sentiment_label': 'Neutral'}]"
449,"Biogen to slash 1,000 jobs as it looks to save $700 million",https://www.marketwatch.com/story/biogen-tops-earnings-estimates-and-says-it-will-shift-resources-to-higher-value-areas-8d6f9f2d,20230725T144400,"['', 'Eleanor Laise', 'Ciara Linnane']","Biotech giant's cost-cutting effort comes amid the launch of its Alzheimer's treatment, Leqembi.",https://images.mktw.net/im-536766/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Earnings', 'relevance_score': '0.99237'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.262557,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.204072', 'ticker_sentiment_score': '0.079963', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SAGE', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.053347', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESALF', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.120547', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.56217', 'ticker_sentiment_score': '0.357617', 'ticker_sentiment_label': 'Bullish'}]"
450,Biogen Tops Second-Quarter Estimates With Alzheimer's Drug Not Yet Profitable,https://www.investors.com/news/technology/biogen-stock-alzheimers-drug-not-yet-profitable-as-company-tops-earnings-views/,20230725T132400,"[""Investor's Business Daily"", 'KIT NORTON']",Biogen Stock: Alzheimer's Drug Not Yet Profitable As Company Tops Earnings Views Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2020/04/Stock-biogen-02-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}, {'topic': 'Earnings', 'relevance_score': '0.999346'}]",0.081645,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.097457', 'ticker_sentiment_score': '0.189652', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SBUX', 'relevance_score': '0.04882', 'ticker_sentiment_score': '0.173971', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ESALF', 'relevance_score': '0.14573', 'ticker_sentiment_score': '0.011796', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.729556', 'ticker_sentiment_score': '0.066848', 'ticker_sentiment_label': 'Neutral'}]"
451,"All Eyes On Biogen's Alzheimer's Drug, Big Potential Payday, Ahead Of Earnings",https://www.investors.com/news/technology/biogen-stock-all-eyes-are-on-alzheimers-drug-big-potential-payday-ahead-of-earnings/,20230724T214600,"['KIT NORTON', ""Investor's Business Daily""]","Biogen ( BIIB ) reports second-quarter financials Tuesday, with analysts expecting both profit and revenue to fall as all eyes are on the company's recently fully approved Alzheimer's drug, Leqembi.",https://www.investors.com/wp-content/uploads/2020/04/Stock-biogen-02-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}, {'topic': 'Earnings', 'relevance_score': '0.938793'}]",0.139753,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.121343', 'ticker_sentiment_score': '0.201001', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SBUX', 'relevance_score': '0.060848', 'ticker_sentiment_score': '0.175054', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ESALF', 'relevance_score': '0.181137', 'ticker_sentiment_score': '0.00891', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.778056', 'ticker_sentiment_score': '0.193697', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
452,Eli Lilly  ( LLY )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2126465/eli-lilly-lly-stock-sinks-as-market-gains-what-you-should-know,20230724T214517,['Zacks Equity Research'],"Eli Lilly (LLY) closed the most recent trading day at $459.32, moving -0.59% from the previous trading session.",https://staticx-tuner.zacks.com/images/default_article_images/default314.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.95493'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.248583,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.605266', 'ticker_sentiment_score': '0.334654', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
453,"Russia Is Seizing European Company Assets - What US Businesses Are Still At Risk? - Deere  ( NYSE:DE ) , United Airlines Holdings  ( NASDAQ:UAL ) , Ford Motor  ( NYSE:F ) , Danone  ( OTC:DANOY ) , Johnson & Johnson  ( NYSE:JNJ ) , Merck & Co  ( NYSE:MRK ) , HP  ( NYSE:HPQ ) , Kellogg  ( NYSE:K ) , Pfizer  ( NYSE:PFE ) , Abbott Laboratories  ( NYSE:ABT ) , Starbucks  ( NASDAQ:SBUX ) , IBM  ( NYSE:IBM ) , Qualcomm  ( NASDAQ:QCOM ) , Carlsberg  ( OTC:CABGY ) , Eli Lilly  ( NYSE:LLY ) , United Parcel Service  ( NYSE:UPS ) , FedEx  ( NYSE:FDX ) , Uber Technologies  ( NYSE:UBER ) , Dell Technologies  ( NYSE:DELL ) , General Electric  ( NYSE:GE ) , Netflix  ( NASDAQ:NFLX ) , Whirlpool  ( NYSE:WHR ) , Kimberly-Clark  ( NYSE:KMB ) , NVIDIA  ( NASDAQ:NVDA ) , Coca-Cola  ( NYSE:KO ) , Micron Technology  ( NASDAQ:MU ) , Colgate-Palmolive  ( NYSE:CL ) , Nike  ( NYSE:NKE ) , Delta Air Lines  ( NYSE:DAL ) , Tupperware Brands  ( NYSE:TUP ) , McDonald's  ( NYSE:MCD ) , Restaurant Brands Intl  ( NYSE:QSR ) , Intel  ( NASDAQ:INTC ) , Procter & Gamble  ( NYSE:PG ) , PepsiCo  ( NASDAQ:PEP ) , Cloudflare  ( NYSE:NET ) , Philip Morris Intl  ( NYSE:PM ) ",https://www.benzinga.com/markets/asia/23/07/33354641/russia-is-seizing-european-company-assets-what-us-businesses-are-still-at-risk,20230724T204518,['Natan Ponieman'],"In recent months, Russia began seizing assets from companies based in Western countries. The most recent development came last week, when the Russian government seized the local operations of two of the world's largest consumer packaged goods manufacturers.","https://cdn.benzinga.com/files/images/story/2023/Krasnoyarsk,,Russia,-,March,10,,2022:,Closed,Entrance,To,The.jpeg?width=1200&height=800&fit=crop",Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.161647'}]",-0.08344,Neutral,"[{'ticker': 'DE', 'relevance_score': '0.09186', 'ticker_sentiment_score': '-0.180664', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'UAL', 'relevance_score': '0.09186', 'ticker_sentiment_score': '0.043597', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.09186', 'ticker_sentiment_score': '-0.107235', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.046006', 'ticker_sentiment_score': '0.041207', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.09186', 'ticker_sentiment_score': '-0.187684', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'HPQ', 'relevance_score': '0.09186', 'ticker_sentiment_score': '0.043597', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'K', 'relevance_score': '0.09186', 'ticker_sentiment_score': '-0.17789', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PFE', 'relevance_score': '0.09186', 'ticker_sentiment_score': '-0.187684', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'ABT', 'relevance_score': '0.09186', 'ticker_sentiment_score': '-0.187684', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'SBUX', 'relevance_score': '0.09186', 'ticker_sentiment_score': '0.043597', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.09186', 'ticker_sentiment_score': '-0.201709', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CABGY', 'relevance_score': '0.09186', 'ticker_sentiment_score': '0.057129', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.09186', 'ticker_sentiment_score': '-0.187684', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'FDX', 'relevance_score': '0.09186', 'ticker_sentiment_score': '-0.090179', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.09186', 'ticker_sentiment_score': '0.043597', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GE', 'relevance_score': '0.09186', 'ticker_sentiment_score': '-0.180664', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NFLX', 'relevance_score': '0.09186', 'ticker_sentiment_score': '0.043597', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WHR', 'relevance_score': '0.09186', 'ticker_sentiment_score': '-0.180664', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'KMB', 'relevance_score': '0.09186', 'ticker_sentiment_score': '-0.160696', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NVDA', 'relevance_score': '0.09186', 'ticker_sentiment_score': '-0.201709', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'KO', 'relevance_score': '0.09186', 'ticker_sentiment_score': '-0.17789', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NKE', 'relevance_score': '0.09186', 'ticker_sentiment_score': '0.043597', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAL', 'relevance_score': '0.09186', 'ticker_sentiment_score': '0.043597', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QSR', 'relevance_score': '0.09186', 'ticker_sentiment_score': '-0.090179', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.09186', 'ticker_sentiment_score': '-0.201709', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PEP', 'relevance_score': '0.09186', 'ticker_sentiment_score': '-0.17789', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'FOJCF', 'relevance_score': '0.046006', 'ticker_sentiment_score': '0.222285', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PM', 'relevance_score': '0.09186', 'ticker_sentiment_score': '-0.060254', 'ticker_sentiment_label': 'Neutral'}]"
454,"Pharma Stock Roundup: JNJ, NVS Upbeat Q2 Results, FDA Nod to SNY & AZN RSV Antibody",https://www.zacks.com/stock/news/2125478/pharma-stock-roundup-jnj-nvs-upbeat-q2-results-fda-nod-to-sny-azn-rsv-antibody,20230721T152100,['Kinjel Shah'],"FDA approves AstraZeneca (AZN) and Sanofi's (SNY) RSV antibody, Beyfortus. J&J (JNJ) and Novartis (NVS) announce strong second-quarter results.",https://staticx-tuner.zacks.com/images/articles/main/cc/389.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.138048,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.364275', 'ticker_sentiment_score': '0.007839', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.041975', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.287441', 'ticker_sentiment_score': '0.119372', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.041975', 'ticker_sentiment_score': '-0.117304', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.166743', 'ticker_sentiment_score': '0.099188', 'ticker_sentiment_label': 'Neutral'}]"
455,The Investing Club's top 10 things to watch in the stock market Friday,https://www.cnbc.com/2023/07/21/the-investing-clubs-top-10-things-to-watch-in-the-stock-market-friday.html,20230721T132942,['Jeff Marks'],"Morgan Stanley now projects the global obesity market will reach $77 billion in 2030, with bullish implications for Club name Eli Lilly (LLY).",https://image.cnbcfm.com/api/v1/image/107261721-1687535078142-gettyimages-1302141463-cailly04.jpeg?v=1689946182&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.986714'}, {'topic': 'Earnings', 'relevance_score': '0.928769'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.177965,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.228781', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.073016', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.075279', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.202366', 'ticker_sentiment_score': '0.098429', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.203409', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.267559', 'ticker_sentiment_score': '0.122745', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SLB', 'relevance_score': '0.068112', 'ticker_sentiment_score': '0.048503', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.069374', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PANW', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.161306', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
456,Eli Lilly's Solid Portfolio Alzheimer's & Diabetes Drugs To Aid Sales Growth: Analyst - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/07/33307839/eli-lillys-solid-portfolio-alzheimers-diabetes-drugs-to-aid-sales-growth-analyst,20230720T173643,['Nabaparna Bhattacharya'],"Truist Securities analyst Robyn Karnauskas reiterated a Buy rating on Eli Lilly And Company LLY, raising the price target to $525 from $430. The analyst believes LLY is building a solid franchise in Alzheimer's disease ( AD ) and diabetes/obesity led by donanemab and Mounjaro, with a robust ...",https://cdn.benzinga.com/files/images/story/2023/07/20/lly.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}]",0.163093,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.645516', 'ticker_sentiment_score': '0.411552', 'ticker_sentiment_label': 'Bullish'}]"
457,IBD Stock Of The Day: Weight-Loss Kingpin Retakes 50-Day Line,https://www.investors.com/research/ibd-stock-of-the-day/novo-nordisk-stock-bounds-above-50-day-line-weight-loss-drugs-drive-enthusiasm/,20230720T171000,"[""Investor's Business Daily"", 'ALLISON GATLIN']",Novo Nordisk Stock Stock Bounds Above 50-Day Line. Weight-Loss Drugs Drive Enthusiasm Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/07/NVO-SOTD-chart1.png,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}]",0.160127,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.296582', 'ticker_sentiment_score': '0.246581', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.154758', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MASI', 'relevance_score': '0.060694', 'ticker_sentiment_score': '-0.35758', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'ABT', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.154758', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.553595', 'ticker_sentiment_score': '0.192666', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.154758', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
458,2 Healthcare Stocks That Could Join the $1 Trillion Club by 2033,https://www.fool.com/investing/2023/07/20/2-healthcare-stocks-that-could-join-the-1-trillion/,20230720T140000,['David Jagielski'],These are buy-and-forget type investments that you can hang on to for years.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F740180%2Fa-person-on-the-couch-keying-credit-card-information-into-a-laptop.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.285202,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.313218', 'ticker_sentiment_score': '0.26185', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.427597', 'ticker_sentiment_score': '0.377284', 'ticker_sentiment_label': 'Bullish'}]"
459,My Take: 4 Strong Growth Stocks to Buy This Week,https://www.fool.com/investing/2023/07/20/my-take-4-strong-growth-stocks-to-buy-this-week/,20230720T111500,['Jim Halley'],The key to growth stocks is finding ones with significant tailwinds.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.99999'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.333333'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}]",0.102478,Neutral,"[{'ticker': 'GLDAF', 'relevance_score': '0.038655', 'ticker_sentiment_score': '0.009749', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.191473', 'ticker_sentiment_score': '0.22264', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'STAG', 'relevance_score': '0.115602', 'ticker_sentiment_score': '0.017416', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RCL', 'relevance_score': '0.265584', 'ticker_sentiment_score': '-0.074662', 'ticker_sentiment_label': 'Neutral'}]"
460,Eli Lilly  ( LLY )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2123240/eli-lilly-lly-outpaces-stock-market-gains-what-you-should-know,20230718T214522,['Zacks Investment Research'],"In the latest trading session, Eli Lilly (LLY) closed at $451.20, marking a +0.91% move from the previous day.",https://staticx-tuner.zacks.com/images/default_article_images/default355.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.972476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.196924,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.615462', 'ticker_sentiment_score': '0.340544', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
461,Stocks Rally On Microsoft AI Push; Here Comes Tesla,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rallies-on-microsoft-ai-push-netflix-tesla-earnings-on-tap/,20230718T205200,"[""Investor's Business Daily"", 'ED CARSON']","Dow Jones Futures: Market Rallies On Microsoft AI Push. Netflix, Tesla Earnings On Tap Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2021/05/Stock-microsoft-sign-04-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.999992'}]",0.145296,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.144708', 'ticker_sentiment_score': '-0.053949', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.096769', 'ticker_sentiment_score': '0.07998', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.120794', 'ticker_sentiment_score': '0.098795', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IBKR', 'relevance_score': '0.096769', 'ticker_sentiment_score': '-0.090687', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATKR', 'relevance_score': '0.144708', 'ticker_sentiment_score': '0.009985', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OMC', 'relevance_score': '0.096769', 'ticker_sentiment_score': '-0.052296', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VZ', 'relevance_score': '0.048474', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BKR', 'relevance_score': '0.048474', 'ticker_sentiment_score': '0.088079', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.072655', 'ticker_sentiment_score': '0.041232', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARCB', 'relevance_score': '0.072655', 'ticker_sentiment_score': '0.016169', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.329551', 'ticker_sentiment_score': '0.106469', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HAL', 'relevance_score': '0.048474', 'ticker_sentiment_score': '0.088079', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.284696', 'ticker_sentiment_score': '0.135109', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.048474', 'ticker_sentiment_score': '0.106991', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.16849', 'ticker_sentiment_score': '0.053541', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.048474', 'ticker_sentiment_score': '0.071185', 'ticker_sentiment_label': 'Neutral'}]"
462,"Microsoft, Eli Lilly Bolster Stock Market Upside; This Sector Is Smashing The Dow Jones Industrial Average's Performance",https://www.investors.com/market-trend/stock-market-today/microsoft-eli-lilly-bolster-stock-market-upside-this-sector-is-smashing-the-dow-jones-industrial-averages-performance/,20230718T191100,"[""Investor's Business Daily"", 'DAVID SAITO-CHUNG']","Microsoft, Eli Lilly Bolster Stock Market Upside. This Sector Is Smashing The Dow Jones Industrial Average's ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2023/04/Stock-truckgrill-illustration-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.275345,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.166743', 'ticker_sentiment_score': '0.083972', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FRC', 'relevance_score': '0.041975', 'ticker_sentiment_score': '-0.087338', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATVI', 'relevance_score': '0.083833', 'ticker_sentiment_score': '0.069517', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.247838', 'ticker_sentiment_score': '0.305936', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SCHW', 'relevance_score': '0.12546', 'ticker_sentiment_score': '0.072479', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.041975', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBNY', 'relevance_score': '0.041975', 'ticker_sentiment_score': '-0.087338', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARCB', 'relevance_score': '0.12546', 'ticker_sentiment_score': '0.101546', 'ticker_sentiment_label': 'Neutral'}]"
463,Eli Lilly Unusual Options Activity For July 18 - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/07/33272463/eli-lilly-unusual-options-activity-for-july-18,20230718T181546,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bullish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.096968,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.813694', 'ticker_sentiment_score': '0.259487', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.105141', 'ticker_sentiment_score': '-0.125244', 'ticker_sentiment_label': 'Neutral'}]"
464,Alzheimer's Drugs May Be a Big-Pharma Payday. Lilly and Biogen Are Facing Off.,https://www.barrons.com/articles/alzheimers-drugs-competition-lilly-biogen-4cdc6c6,20230718T181300,['Josh Nathan-Kazis'],"After two years of false starts and regulatory stumbles, two huge biopharma companies are getting ready for a showdown over the market for new Alzheimer's disease therapies. Billions of dollars in sales hang in the balance.",https://images.barrons.com/im-819219?width=639&height=426,Barrons,n/a,www.barrons.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.050493,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.288327', 'ticker_sentiment_score': '-0.040484', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PRTA', 'relevance_score': '0.098054', 'ticker_sentiment_score': '0.029485', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESALF', 'relevance_score': '0.146618', 'ticker_sentiment_score': '0.079058', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.241924', 'ticker_sentiment_score': '0.22259', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
465,LLY: Should Investors Start Watching Eli Lilly & Co.  ( LLY )  This Week?,https://stocknews.com/news/lly-nvs-nvo-nbix-should-investors-start-watching-eli-lilly-co-lly-this/,20230718T171105,[],"With the pharmaceutical market expected to grow significantly in the coming years, Eli Lilly and Company ( LLY ) and its pursuit of strategic acquisitions in this large and growing market could be a boon for shareholders. LLY's chair and CEO, David A.",https://stocknews.com/wp-content/uploads/2021/11/shutterstock_654542473-1-scaled.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}, {'topic': 'Earnings', 'relevance_score': '0.999922'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.292841,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.738815', 'ticker_sentiment_score': '0.497271', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVS', 'relevance_score': '0.089462', 'ticker_sentiment_score': '0.034712', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.089462', 'ticker_sentiment_score': '0.034712', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SGTX', 'relevance_score': '0.133841', 'ticker_sentiment_score': '0.040475', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DICE', 'relevance_score': '0.133841', 'ticker_sentiment_score': '0.245617', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NBIX', 'relevance_score': '0.089462', 'ticker_sentiment_score': '0.034712', 'ticker_sentiment_label': 'Neutral'}]"
466,The Tentpole Markets Driving Stock Of The Day Lilly To Break Out,https://www.investors.com/research/ibd-stock-of-the-day/eli-lilly-stock-ibd-stock-of-the-day-breaks-out-with-tentpoles-in-two-key-markets/,20230718T171100,"[""Investor's Business Daily"", 'ALLISON GATLIN']","Eli Lilly Stock, IBD Stock Of The Day, Breaks Out With Tentpoles In Two Key Markets Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2023/07/LLY-SOTD-chart1b.png,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}]",0.145959,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.472338', 'ticker_sentiment_score': '0.404567', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'MASI', 'relevance_score': '0.050359', 'ticker_sentiment_score': '-0.356747', 'ticker_sentiment_label': 'Bearish'}]"
467,"A key bank stock soars, but Cramer sticks to his discipline",https://www.cnbc.com/2023/07/18/a-key-bank-stock-soars-but-cramer-sticks-to-his-discipline-.html,20230718T154838,['Paulina Likos'],"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",https://image.cnbcfm.com/api/v1/image/107272992-16896911021689691096-30357700151-1080pnbcnews.jpg?v=1689692456&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.98396'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.206813,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.413199', 'ticker_sentiment_score': '0.242912', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.553265', 'ticker_sentiment_score': '0.289522', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
468,Is It Too Late to Buy Eli Lilly Stock?,https://www.fool.com/investing/2023/07/18/eli-lillys-anti-obesity-pipeline-expanded-again-ti/,20230718T092600,['Cory Renauer'],Shares of the pharmaceutical giant are already up 36% this year.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F739948%2Findividual-investor-devices-getty.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.077259,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.562529', 'ticker_sentiment_score': '0.01725', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.112269', 'ticker_sentiment_score': '-0.072649', 'ticker_sentiment_label': 'Neutral'}]"
469,Jim Cramer's top 10 things to watch in the stock market Monday,https://www.cnbc.com/2023/07/17/jim-cramers-top-10-things-to-watch-in-the-stock-market-monday.html,20230717T133302,['Jim Cramer'],The Dow opens lower Monday after Friday completed a five-session winning streak and the best weekly performance since March.,https://image.cnbcfm.com/api/v1/image/107243731-1684454364693-gettyimages-1254161031-AFP_33EX9LE.jpeg?v=1689600782&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.839681'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",0.176423,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.062926', 'ticker_sentiment_score': '0.336895', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.062926', 'ticker_sentiment_score': '0.038005', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.187221', 'ticker_sentiment_score': '0.120623', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.187221', 'ticker_sentiment_score': '0.232817', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'C', 'relevance_score': '0.062926', 'ticker_sentiment_score': '0.138093', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FL', 'relevance_score': '0.12546', 'ticker_sentiment_score': '0.043689', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.187221', 'ticker_sentiment_score': '0.039112', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.187221', 'ticker_sentiment_score': '0.027836', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.187221', 'ticker_sentiment_score': '0.18402', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HAL', 'relevance_score': '0.247838', 'ticker_sentiment_score': '0.034741', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.12546', 'ticker_sentiment_score': '-0.08858', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATVI', 'relevance_score': '0.062926', 'ticker_sentiment_score': '0.119867', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.12546', 'ticker_sentiment_score': '0.043689', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PANW', 'relevance_score': '0.187221', 'ticker_sentiment_score': '0.091199', 'ticker_sentiment_label': 'Neutral'}]"
470,"Company News for Jul 17, 2023",https://www.zacks.com/stock/news/2122025/company-news-for-jul-17-2023,20230717T131400,['Zacks Investment Research'],"Companies in The News Are: C, ERIC, STT, LLY.",https://staticx-tuner.zacks.com/images/articles/main/e1/1010.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",-0.03594,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.595343', 'ticker_sentiment_score': '0.230629', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'STT', 'relevance_score': '0.595343', 'ticker_sentiment_score': '-0.360663', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'C', 'relevance_score': '0.595343', 'ticker_sentiment_score': '-0.08837', 'ticker_sentiment_label': 'Neutral'}]"
471,"Eli Lilly  ( LLY )  to Buy Versanis, Strengthen Obesity Portfolio",https://www.zacks.com/stock/news/2122028/eli-lilly-lly-to-buy-versanis-strengthen-obesity-portfolio,20230717T131400,['Zacks Investment Research'],"For the purchase of Versanis, Lilly (LLY) agrees to pay up to $1.93 billion in cash.",https://staticx-tuner.zacks.com/images/articles/main/cc/389.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.890401'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.187894,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.355588', 'ticker_sentiment_score': '0.333145', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LGND', 'relevance_score': '0.355588', 'ticker_sentiment_score': '0.208854', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ALKS', 'relevance_score': '0.355588', 'ticker_sentiment_score': '0.220591', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.218161', 'ticker_sentiment_score': '0.202989', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
472,Eli Lilly Stock: Bear Vs. Bull,https://www.fool.com/investing/2023/07/17/eli-lilly-stock-bear-vs-bull/,20230717T124500,['Prosper Junior Bakiny'],Can the company maintain the momentum it's had in recent years?,https://media.ycharts.com/charts/496ef2fd889e7569cdea58950f5adffd.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.34706,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.426567', 'ticker_sentiment_score': '0.391556', 'ticker_sentiment_label': 'Bullish'}]"
473,Futures Fall As This Risk Builds; Tesla Rises On Cybertruck News,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-risk-builds-tesla-cybertruck-news/,20230717T121900,"['ED CARSON', ""Investor's Business Daily""]",Futures Fall As This Risk Builds. Tesla Rises On Cybertruck News Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2020/06/Stock-TeslaCyberTruck-06-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.96136'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.141265,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.044573', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.046228', 'ticker_sentiment_score': '0.130412', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.046228', 'ticker_sentiment_score': '0.161326', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.183372', 'ticker_sentiment_score': '0.093546', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.046228', 'ticker_sentiment_score': '0.161326', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.43789', 'ticker_sentiment_score': '0.041521', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TTD', 'relevance_score': '0.046228', 'ticker_sentiment_score': '-0.01689', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.046228', 'ticker_sentiment_score': '0.050917', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATVI', 'relevance_score': '0.092302', 'ticker_sentiment_score': '-0.01797', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.046228', 'ticker_sentiment_score': '0.050917', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RMBS', 'relevance_score': '0.046228', 'ticker_sentiment_score': '0.050917', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.023124', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.023124', 'ticker_sentiment_score': '-0.123913', 'ticker_sentiment_label': 'Neutral'}]"
474,"Market Rally Had A Great Week, But Here's What To Do Now",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rally-had-great-week-what-to-do-now-tesla-earnings-due/,20230714T212900,"['ED CARSON', ""Investor's Business Daily""]","Dow Jones futures will open Sunday evening, along with S&P 500 futures and Nasdaq futures. Tesla earnings headline the week ahead. The stock market rally had a powerful week, with the S&P 500 and Nasdaq composite running to fresh 52-week highs. A lot of stocks offered buying opportunities.",https://www.investors.com/wp-content/uploads/2021/01/Stock-Tesla-modelY-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.96136'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.207876,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.112797', 'ticker_sentiment_score': '0.04878', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.05654', 'ticker_sentiment_score': '0.128937', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.05654', 'ticker_sentiment_score': '0.144948', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.22335', 'ticker_sentiment_score': '0.096901', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.05654', 'ticker_sentiment_score': '0.144948', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.405215', 'ticker_sentiment_score': '0.220232', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMD', 'relevance_score': '0.05654', 'ticker_sentiment_score': '0.051081', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.05654', 'ticker_sentiment_score': '0.051081', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RMBS', 'relevance_score': '0.05654', 'ticker_sentiment_score': '0.051081', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.028288', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.028288', 'ticker_sentiment_score': '-0.124736', 'ticker_sentiment_label': 'Neutral'}]"
475,This Is What Whales Are Betting On Eli Lilly - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/07/33236518/this-is-what-whales-are-betting-on-eli-lilly,20230714T204701,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 35 strange trades. If we consider the specifics of each trade, it is accurate to state that 42% of the investors opened trades with bullish ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.059788,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.742397', 'ticker_sentiment_score': '-0.089327', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.112532', 'ticker_sentiment_score': '-0.128191', 'ticker_sentiment_label': 'Neutral'}]"
476,Market Rallies Strongly As Inflation Fears Ebb: Weekly Review,https://www.investors.com/news/sp-500-nasdaq-hit-fresh-52-week-highs-as-inflation-fears-ebb-salesforce-delta-jpmorgan-in-focus/,20230714T153500,"['IBD STAFF', ""Investor's Business Daily""]","S&P 500, Nasdaq Hit Fresh 52-Week Highs As Inflation Fears Ebb. Salesforce, Delta, JPMorgan In Focus Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2017/08/WallStreetFinance-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.999973'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '0.99793'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.053421,Neutral,"[{'ticker': 'XPEV', 'relevance_score': '0.04877', 'ticker_sentiment_score': '0.064275', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROKU', 'relevance_score': '0.073098', 'ticker_sentiment_score': '0.046286', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.097358', 'ticker_sentiment_score': '0.151658', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'D', 'relevance_score': '0.024396', 'ticker_sentiment_score': '-0.035558', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.240251', 'ticker_sentiment_score': '0.159654', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.04877', 'ticker_sentiment_score': '0.011001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.04877', 'ticker_sentiment_score': '-0.066601', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.169505', 'ticker_sentiment_score': '0.081106', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SHOP', 'relevance_score': '0.097358', 'ticker_sentiment_score': '0.048402', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.073098', 'ticker_sentiment_score': '0.12297', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.121527', 'ticker_sentiment_score': '0.162856', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.097358', 'ticker_sentiment_score': '0.032691', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.073098', 'ticker_sentiment_score': '-0.04125', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INMD', 'relevance_score': '0.04877', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PANW', 'relevance_score': '0.073098', 'ticker_sentiment_score': '-0.079365', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.04877', 'ticker_sentiment_score': '0.136887', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.024396', 'ticker_sentiment_score': '-0.035558', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAM', 'relevance_score': '0.04877', 'ticker_sentiment_score': '-0.039493', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DAL', 'relevance_score': '0.145583', 'ticker_sentiment_score': '0.080103', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AEHR', 'relevance_score': '0.04877', 'ticker_sentiment_score': '0.143964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FRC', 'relevance_score': '0.024396', 'ticker_sentiment_score': '0.132428', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.04877', 'ticker_sentiment_score': '0.033994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATVI', 'relevance_score': '0.04877', 'ticker_sentiment_score': '-0.003', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZS', 'relevance_score': '0.073098', 'ticker_sentiment_score': '-0.079365', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NET', 'relevance_score': '0.073098', 'ticker_sentiment_score': '-0.079365', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.097358', 'ticker_sentiment_score': '0.069525', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.04877', 'ticker_sentiment_score': '0.051042', 'ticker_sentiment_label': 'Neutral'}]"
477,Eli Lilly and Company  ( LLY )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2121193/eli-lilly-and-company-lly-is-a-trending-stock-facts-to-know-before-betting-on-it,20230714T130011,['Zacks Investment Research'],"Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default70.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}]",0.22641,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.526867', 'ticker_sentiment_score': '0.11889', 'ticker_sentiment_label': 'Neutral'}]"
478,Get Ready For A Slew Of New Weight-Loss Drugs,https://www.investors.com/news/technology/weight-loss-drugs-to-watch-rivals-ramp-up-to-unseat-the-undisputed-leaders/,20230713T173700,"['ALLISON GATLIN', ""Investor's Business Daily""]",Weight Loss Drugs To Watch: New Rivals Are Ramping Up To Unseat The Undisputed Leaders Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/05/Stock-Ozempic-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.069257,Neutral,"[{'ticker': 'BAC', 'relevance_score': '0.05387', 'ticker_sentiment_score': '-0.014998', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EXAS', 'relevance_score': '0.013477', 'ticker_sentiment_score': '-0.158', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NVO', 'relevance_score': '0.120834', 'ticker_sentiment_score': '0.105707', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GLDAF', 'relevance_score': '0.013477', 'ticker_sentiment_score': '0.017854', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.067309', 'ticker_sentiment_score': '-0.005041', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.094125', 'ticker_sentiment_score': '0.044119', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.02695', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.02695', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.147407', 'ticker_sentiment_score': '0.12034', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCO', 'relevance_score': '0.040416', 'ticker_sentiment_score': '-0.03469', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GPCR', 'relevance_score': '0.02695', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MORN', 'relevance_score': '0.040416', 'ticker_sentiment_score': '0.023243', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CPUH', 'relevance_score': '0.013477', 'ticker_sentiment_score': '0.146003', 'ticker_sentiment_label': 'Neutral'}]"
479,3 health-care stocks are in the headlines. How the news impacts our investments,https://www.cnbc.com/2023/07/13/3-health-care-stocks-are-in-the-news-how-the-news-impacts-our-stocks.html,20230713T172330,['Kevin Stankiewicz'],"The latest developments on Johnson & Johnson (JNJ), Humana (HUM) and Eli Lilly (LLY), and how they affect our thinking on the stocks.",https://image.cnbcfm.com/api/v1/image/107159736-1669909545060-gettyimages-1240322299-JJ_DUATO.jpeg?v=1689269010&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.10705,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.817578', 'ticker_sentiment_score': '0.233466', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HUM', 'relevance_score': '0.817578', 'ticker_sentiment_score': '0.233466', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.817578', 'ticker_sentiment_score': '0.233466', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
480,Why Isn't Biogen Stock Soaring After This Major FDA Approval?,https://www.fool.com/investing/2023/07/13/why-isnt-biogen-stock-soaring-after-this-major-fda/,20230713T121500,['David Jagielski'],Is the stock a good contrarian buy?,https://media.ycharts.com/charts/63cdcbb47f048e1cdbcc7d5648f53742.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.459462'}, {'topic': 'Earnings', 'relevance_score': '0.77141'}]",0.139212,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.062926', 'ticker_sentiment_score': '0.073235', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESALF', 'relevance_score': '0.062926', 'ticker_sentiment_score': '0.107702', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.364275', 'ticker_sentiment_score': '0.092217', 'ticker_sentiment_label': 'Neutral'}]"
481,Eli Lilly  ( LLY )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2120215/eli-lilly-lly-gains-but-lags-market-what-you-should-know,20230712T214521,['Zacks Investment Research'],"Eli Lilly (LLY) closed the most recent trading day at $440.60, moving +0.28% from the previous trading session.",https://staticx-tuner.zacks.com/images/default_article_images/default303.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.972476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.172462,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.541943', 'ticker_sentiment_score': '0.290007', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
482,"Top Analyst Reports for Visa, UnitedHealth & Eli Lilly",https://www.zacks.com/research-daily/2119944/top-analyst-reports-for-visa-unitedhealth-eli-lilly,20230712T181200,['Zacks Investment Research'],"Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), UnitedHealth Group Incorporated (UNH) and Eli Lilly and Company (LLY).",https://staticx-tuner.zacks.com/images/default_article_images/default170.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.795202'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.231457,Somewhat-Bullish,"[{'ticker': 'AMD', 'relevance_score': '0.127795', 'ticker_sentiment_score': '0.118095', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.370602', 'ticker_sentiment_score': '0.251917', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'COST', 'relevance_score': '0.127795', 'ticker_sentiment_score': '0.118095', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HSBC', 'relevance_score': '0.127795', 'ticker_sentiment_score': '0.118095', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.252332', 'ticker_sentiment_score': '0.188717', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'V', 'relevance_score': '0.312423', 'ticker_sentiment_score': '0.222511', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
483,Novo Nordisk  ( NVO )  Falls on EMA Safety Review of Obesity Drugs,https://www.zacks.com/stock/news/2119748/novo-nordisk-nvo-falls-on-ema-safety-review-of-obesity-drugs,20230712T115700,['Zacks Investment Research'],Novo Nordisk's (NVO) important diabetes care and obesity drugs are under review by the EMA's safety committee for the risk of suicidal behavior with its use. The stock falls 3%.,https://staticx-tuner.zacks.com/images/articles/main/de/2471.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.093054,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.221212', 'ticker_sentiment_score': '0.204404', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.177802', 'ticker_sentiment_score': '0.145259', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.305871', 'ticker_sentiment_score': '0.136628', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.221212', 'ticker_sentiment_score': '0.288341', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
484,"3 Reasons to Buy Eli Lilly, and 1 Reason to Sell",https://www.fool.com/investing/2023/07/11/3-reasons-to-buy-eli-lilly-and-1-reason-to-sell/,20230711T093400,['Kody Kester'],This drugmaker is a compelling dividend growth play.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F738973%2Fa-doctor-and-patient-at-an-appointment.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.999763'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.995077'}]",0.321361,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.291644', 'ticker_sentiment_score': '0.427527', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.059636', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
485,Eli Lilly Unusual Options Activity For July 10 - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/07/33170163/eli-lilly-unusual-options-activity-for-july-10,20230710T163259,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bearish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}]",0.087629,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.778186', 'ticker_sentiment_score': '0.19156', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
486,Top 10 things to watch in the stock market Friday including a jobs shocker,https://www.cnbc.com/2023/07/07/top-10-things-to-watch-in-the-stock-market-friday-including-a-jobs-shocker.html,20230707T131534,['Jeff Marks'],Surprising jobs miss in June after Thursday's blowout ADP hiring number.,https://image.cnbcfm.com/api/v1/image/107264533-1688040218973-gettyimages-1503701959-_53a3781.jpeg?v=1688735810&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.98396'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.857896'}]",0.110613,Neutral,"[{'ticker': 'HUM', 'relevance_score': '0.184246', 'ticker_sentiment_score': '-0.044079', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.092748', 'ticker_sentiment_score': '-0.188431', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'COST', 'relevance_score': '0.13873', 'ticker_sentiment_score': '0.157044', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MA', 'relevance_score': '0.046452', 'ticker_sentiment_score': '0.086734', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.273297', 'ticker_sentiment_score': '0.125334', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.046452', 'ticker_sentiment_score': '-0.014818', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.229149', 'ticker_sentiment_score': '0.096492', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.13873', 'ticker_sentiment_score': '0.099888', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.092748', 'ticker_sentiment_score': '0.091745', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.092748', 'ticker_sentiment_score': '0.23397', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.092748', 'ticker_sentiment_score': '-0.030494', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.092748', 'ticker_sentiment_score': '0.23397', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
487,Eli Lilly  ( LLY )  Stock Moves -0.53%: What You Should Know,https://www.zacks.com/stock/news/2117759/eli-lilly-lly-stock-moves--053-what-you-should-know,20230706T214523,['Zacks Investment Research'],"In the latest trading session, Eli Lilly (LLY) closed at $463.21, marking a -0.53% move from the previous day.",https://staticx-tuner.zacks.com/images/default_article_images/default57.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.972476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.186825,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.677342', 'ticker_sentiment_score': '0.206888', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
488,Check Out What Whales Are Doing With LLY - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/07/33119364/check-out-what-whales-are-doing-with-lly,20230705T164602,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 33 strange trades. If we consider the specifics of each trade, it is accurate to state that 57% of the investors opened trades with bullish ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}]",0.115851,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.795859', 'ticker_sentiment_score': '0.294747', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
489,Why Shares of Ventyx Biosciences Rose Monday,https://www.fool.com/investing/2023/07/03/why-shares-of-ventyx-biosciences-rose-monday/,20230703T180959,['Jim Halley'],The company has several promising autoimmune therapies.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F737440%2Fmature-couple-relaxing-on-beach-at-sunset.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.208988,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.156461', 'ticker_sentiment_score': '0.159735', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'RXDX', 'relevance_score': '0.156461', 'ticker_sentiment_score': '0.159735', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VTYX', 'relevance_score': '0.306963', 'ticker_sentiment_score': '0.291679', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DICE', 'relevance_score': '0.156461', 'ticker_sentiment_score': '0.159735', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
490,"Eli Lilly Could Be Making The Next Ozempic, but Should You Buy the Stock?",https://www.fool.com/investing/2023/07/02/eli-lilly-could-be-making-the-next-ozempic-but/,20230702T121500,['Alex Carchidi'],Clinical data suggests that a powerful candidate is advancing through its pipeline.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F738110%2Fdividends-cart-full-of-money-on-hundred-dollar-bills.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.744043'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.228447,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.337044', 'ticker_sentiment_score': '0.261532', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.172507', 'ticker_sentiment_score': '0.292654', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
491,Pfizer Just Canned One of Its Ozempic Killers. What's Next?,https://www.fool.com/investing/2023/07/01/pfizer-just-canned-one-of-its-ozempic-killers-what/,20230701T115500,['Alex Carchidi'],It's going to have quite the hard time getting a foothold in the market now.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F737706%2Folder-woman-laptop-serious-gettyimages-1408920944.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.203262,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.210274', 'ticker_sentiment_score': '0.120406', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.053153', 'ticker_sentiment_score': '0.070703', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.158519', 'ticker_sentiment_score': '0.161634', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.261117', 'ticker_sentiment_score': '0.070557', 'ticker_sentiment_label': 'Neutral'}]"
492,Eli Lilly Unusual Options Activity For June 30 - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/06/33083909/eli-lilly-unusual-options-activity-for-june-30,20230630T190227,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 33 strange trades. If we consider the specifics of each trade, it is accurate to state that 48% of the investors opened trades with bullish ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}]",0.109464,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.720958', 'ticker_sentiment_score': '-0.030808', 'ticker_sentiment_label': 'Neutral'}]"
493,Market Rally Roars Back Toward Highs: Weekly Review,https://www.investors.com/news/stock-market-rally-roars-back-toward-highs-carnival-delta-micron-nvidia-in-focus/,20230630T174800,"['IBD STAFF', ""Investor's Business Daily""]","The stock market rally ran toward 2023 highs again with broad-based gains, as many of the major indexes rebound from or near their 21-day moving averages. A number of stocks flashed buy signals, either from traditional breakouts or from pullbacks or early entries.",https://www.investors.com/wp-content/uploads/2016/02/KPBLOG01-022916-shutterstock.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.769861'}, {'topic': 'Financial Markets', 'relevance_score': '0.998356'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}]",-0.036714,Neutral,"[{'ticker': 'ALK', 'relevance_score': '0.027103', 'ticker_sentiment_score': '0.056744', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.214225', 'ticker_sentiment_score': '0.050157', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.054175', 'ticker_sentiment_score': '0.060008', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BTAI', 'relevance_score': '0.054175', 'ticker_sentiment_score': '-0.108088', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNOW', 'relevance_score': '0.134892', 'ticker_sentiment_score': '0.053234', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RETA', 'relevance_score': '0.054175', 'ticker_sentiment_score': '-0.108088', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MLTX', 'relevance_score': '0.054175', 'ticker_sentiment_score': '-0.108088', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MU', 'relevance_score': '0.054175', 'ticker_sentiment_score': '-0.213002', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'FGEN', 'relevance_score': '0.081184', 'ticker_sentiment_score': '-0.112409', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAL', 'relevance_score': '0.081184', 'ticker_sentiment_score': '0.062078', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DAL', 'relevance_score': '0.081184', 'ticker_sentiment_score': '0.064969', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.1081', 'ticker_sentiment_score': '0.042', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GIS', 'relevance_score': '0.054175', 'ticker_sentiment_score': '0.048179', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.054175', 'ticker_sentiment_score': '0.043954', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LCID', 'relevance_score': '0.1081', 'ticker_sentiment_score': '-0.120334', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKLA', 'relevance_score': '0.081184', 'ticker_sentiment_score': '-0.110643', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.1081', 'ticker_sentiment_score': '-0.046751', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STZ', 'relevance_score': '0.134892', 'ticker_sentiment_score': '0.023747', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WOR', 'relevance_score': '0.054175', 'ticker_sentiment_score': '-0.135257', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REGN', 'relevance_score': '0.054175', 'ticker_sentiment_score': '-0.108088', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIDE', 'relevance_score': '0.081184', 'ticker_sentiment_score': '-0.110643', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SGTX', 'relevance_score': '0.054175', 'ticker_sentiment_score': '-0.108088', 'ticker_sentiment_label': 'Neutral'}]"
494,Sigilon  ( SGTX )  Skyrockets 441% on Buyout Offer From Eli Lilly,https://www.zacks.com/stock/news/2115393/sigilon-sgtx-skyrockets-441-on-buyout-offer-from-eli-lilly,20230630T130700,['Zacks Investment Research'],"Eli Lilly (LLY) is set to acquire Sigilon (SGTX) for $14.92 per share, in cash, along with a contingent value right of $111.64 per share.",https://staticx-tuner.zacks.com/images/articles/main/2a/3899.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.818451'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.29841,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.458593', 'ticker_sentiment_score': '0.388242', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SGTX', 'relevance_score': '0.458593', 'ticker_sentiment_score': '0.235862', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.239895', 'ticker_sentiment_score': '0.178092', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
495,Will Eli Lilly Stock Continue To Rise After 40% Gains In The Ongoing Inflation Shock?,https://www.forbes.com/sites/greatspeculations/2023/06/30/will-eli-lilly-stock-continue-to-rise-after-40-gains-in-the-ongoing-inflation-shock/,20230630T120016,['Trefis Team'],"Eli Lilly stock (NYSE: LLY) currently trades at $459 per share, roughly 150% above its level in March 2021..",https://imageio.forbes.com/specials-images/imageserve/649e5b6d7bde6c9da4324234/0x0.jpg?format=jpg&width=1200,Forbes,Markets,www.forbes.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.769861'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}, {'topic': 'Earnings', 'relevance_score': '0.650727'}]",0.055627,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.637608', 'ticker_sentiment_score': '0.105885', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.090645', 'ticker_sentiment_score': '0.032582', 'ticker_sentiment_label': 'Neutral'}]"
496,Eli Lilly  ( LLY )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2115008/eli-lilly-lly-outpaces-stock-market-gains-what-you-should-know,20230629T214524,['Zacks Investment Research'],"Eli Lilly (LLY) closed at $464.49 in the latest trading session, marking a +1.26% move from the prior day.",https://staticx-tuner.zacks.com/images/default_article_images/default170.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.972476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.234644,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.656549', 'ticker_sentiment_score': '0.331278', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
497,Sigilon Therapeutics Shares Are Shooting Higher Today - What's Going On - Sigilon Therapeutics  ( NASDAQ:SGTX ) ,https://www.benzinga.com/general/biotech/23/06/33058147/sigilon-therapeutics-shares-are-shooting-higher-today-whats-going-on,20230629T134100,['Vandana Singh'],Sigilon Therapeutics Inc SGTX shares are skyrocketing after Eli Lilly And Co LLY agreed to acquire the company for a purchase price of $14.92 per share in cash ( an aggregate of approximately $34.6 million ) .,https://cdn.benzinga.com/files/images/story/2023/06/29/sgtx.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.23209,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.744196', 'ticker_sentiment_score': '0.487443', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SGTX', 'relevance_score': '0.504646', 'ticker_sentiment_score': '0.479214', 'ticker_sentiment_label': 'Bullish'}]"
498,Investors Heavily Search Eli Lilly and Company  ( LLY ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2114696/investors-heavily-search-eli-lilly-and-company-lly-here-is-what-you-need-to-know,20230629T130010,['Zacks Investment Research'],"Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.",https://staticx-tuner.zacks.com/images/default_article_images/default301.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}]",0.237332,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.526867', 'ticker_sentiment_score': '0.156666', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
499,Lilly to Acquire Sigilon Therapeutics,https://www.prnewswire.com/news-releases/lilly-to-acquire-sigilon-therapeutics-301866460.html,20230629T104500,['Eli Lilly and Company'],"INDIANAPOLIS and CAMBRIDGE, Mass., June 29, 2023 /PRNewswire/ -- Eli Lilly and Company ( NYSE: LLY ) and Sigilon Therapeutics, Inc. ( Nasdaq: SGTX ) today announced a definitive agreement for Lilly to acquire Sigilon, a biopharmaceutical company that seeks to develop functional cures for ...",https://mma.prnewswire.com/media/2143637/Sigilon_Therapeutics_logo_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.905476'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.99998'}, {'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.277547,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.475953', 'ticker_sentiment_score': '0.388311', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'META', 'relevance_score': '0.022099', 'ticker_sentiment_score': '0.157747', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CCORF', 'relevance_score': '0.022099', 'ticker_sentiment_score': '0.109575', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SGTX', 'relevance_score': '0.06623', 'ticker_sentiment_score': '-0.035161', 'ticker_sentiment_label': 'Neutral'}]"
500,Better Artificial Intelligence Stock: GSK or Eli Lilly?,https://www.fool.com/investing/2023/06/28/better-artificial-intelligence-stock-gsk-or-eli-li/,20230628T191500,['George Budwell'],Which of these AI-powered drugmakers is the better buy right now?,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F737911%2Felectric-car-with-headlights-glowing-and-plugged-into-a-charging-station.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.302191,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.405963', 'ticker_sentiment_score': '0.268514', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
501,BIIB: 3 Stocks to Own as Alzheimer's Drugs Bring Relief,https://stocknews.com/news/biib-esaly-lly-3-stocks-to-own-as-alzheimers-drugs-bring-relief/,20230627T170416,[],"Rapidly aging populations pose a huge challenge to society, governments and public services. Older populations put an immense strain on healthcare expenditure, and the financial costs of dementia are large and growing.",https://stocknews.com/wp-content/uploads/2022/07/shutterstock_1006149949-scaled.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}]",0.159635,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.372077', 'ticker_sentiment_score': '0.296096', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ESALF', 'relevance_score': '0.077218', 'ticker_sentiment_score': '-0.01942', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.439153', 'ticker_sentiment_score': '0.257919', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
502,NVS or LLY: Which Is the Better Value Stock Right Now?,https://www.zacks.com/stock/news/2113711/nvs-or-lly-which-is-the-better-value-stock-right-now,20230627T154012,['Zacks Investment Research'],NVS vs. LLY: Which Stock Is the Better Value Option?,https://staticx-tuner.zacks.com/images/default_article_images/default19.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.435263,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.539306', 'ticker_sentiment_score': '0.395642', 'ticker_sentiment_label': 'Bullish'}]"
503,"Dow Jones Rises On Consumer Confidence, New Orders; Tesla Bounces On Record Deliveries Views",https://www.investors.com/market-trend/stock-market-today/dow-jones-rises-on-consumer-confidence-new-orders-tesla-rises-on-record-deliveries-views/,20230627T145900,"[""Investor's Business Daily"", 'VIDYA RAMAKRISHNAN']","Dow Jones Rises On Consumer Confidence, New Orders. Tesla ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2020/04/stock-tesla-store-04-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.995973'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}]",0.040972,Neutral,"[{'ticker': 'ATCN', 'relevance_score': '0.063425', 'ticker_sentiment_score': '0.07848', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.12645', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.12645', 'ticker_sentiment_score': '0.002356', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.188683', 'ticker_sentiment_score': '0.090169', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.063425', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.063425', 'ticker_sentiment_score': '-0.100222', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKE', 'relevance_score': '0.12645', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.063425', 'ticker_sentiment_score': '-0.100222', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DAL', 'relevance_score': '0.12645', 'ticker_sentiment_score': '0.002356', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATEC', 'relevance_score': '0.12645', 'ticker_sentiment_score': '0.093878', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DT', 'relevance_score': '0.188683', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.249744', 'ticker_sentiment_score': '-0.117071', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WBA', 'relevance_score': '0.12645', 'ticker_sentiment_score': '-0.42709', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'LLY', 'relevance_score': '0.12645', 'ticker_sentiment_score': '0.013174', 'ticker_sentiment_label': 'Neutral'}]"
504,Pfizer  ( PFE )  Stock Down on Halting Development of Obesity Drug,https://www.zacks.com/stock/news/2113685/pfizer-pfe-stock-down-on-halting-development-of-obesity-drug,20230627T142500,['Zacks Investment Research'],Shares of Pfizer's (PFE) fell 3.7% on Monday after management's decision to terminate the development of an experimental obesity pill following concerns over liver safety.,https://staticx-tuner.zacks.com/images/articles/main/89/447.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.134196,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.266828', 'ticker_sentiment_score': '0.032554', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.329992', 'ticker_sentiment_score': '0.255555', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.449219', 'ticker_sentiment_score': '0.094777', 'ticker_sentiment_label': 'Neutral'}]"
505,Check Out What Whales Are Doing With LLY - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/06/33025335/check-out-what-whales-are-doing-with-lly,20230627T140413,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 12 strange trades. If we consider the specifics of each trade, it is accurate to state that 41% of the investors opened trades with bullish ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}]",0.144605,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.674691', 'ticker_sentiment_score': '0.052232', 'ticker_sentiment_label': 'Neutral'}]"
506,Eli Lilly  ( LLY )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2112610/eli-lilly-lly-gains-as-market-dips-what-you-should-know,20230623T214526,['Zacks Investment Research'],"Eli Lilly (LLY) closed the most recent trading day at $458.84, moving +0.25% from the previous trading session.",https://staticx-tuner.zacks.com/images/default_article_images/default248.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.972476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.224539,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.716023', 'ticker_sentiment_score': '0.321418', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
507,"Early Entry, Early Profit Saved Boeing Stock",https://www.investors.com/research/swing-trading/early-entry-early-profits-save-boeing-stock/,20230623T200400,"['DOMINIC GESSEL', ""Investor's Business Daily""]",We added several positions in the past few weeks hoping to catch the rotation out of the Nasdaq. Boeing stock did not take off like we hoped but we stayed on top of it. Our early entry and early profit saved BA stock from a crash landing.,https://www.investors.com/wp-content/uploads/2023/06/wSWING-062623.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.459462'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}]",0.157699,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.160099', 'ticker_sentiment_score': '0.289236', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EADSF', 'relevance_score': '0.160099', 'ticker_sentiment_score': '-0.204975', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'MCK', 'relevance_score': '0.160099', 'ticker_sentiment_score': '0.289236', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SPR', 'relevance_score': '0.160099', 'ticker_sentiment_score': '-0.048882', 'ticker_sentiment_label': 'Neutral'}]"
508,Stock Market Pulls Back After Weeks Of Gains: Weekly Review,https://www.investors.com/news/stock-market-pulls-back-after-several-weeks-of-gains/,20230623T140800,"[""Investor's Business Daily"", 'IBD STAFF']","The stock market rally pulled back after several weeks of gains, but only modestly, especially on the Nasdaq. Fed chief Jerome Powell reiterated expectations for renewed rate hikes after several more central banks upped rates, but not China. FedEx ( FDX ) headlined a relatively limited number of ...",https://www.investors.com/wp-content/uploads/2017/01/BIGpic_bull_011017_shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",-0.034447,Neutral,"[{'ticker': 'GOOG', 'relevance_score': '0.052226', 'ticker_sentiment_score': '-0.117554', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EXAS', 'relevance_score': '0.155786', 'ticker_sentiment_score': '0.126597', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DICE', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.061164', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDB', 'relevance_score': '0.104228', 'ticker_sentiment_score': '-0.12707', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ACN', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.035343', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KBH', 'relevance_score': '0.104228', 'ticker_sentiment_score': '-0.00229', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.052226', 'ticker_sentiment_score': '0.227682', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SPR', 'relevance_score': '0.104228', 'ticker_sentiment_score': '-0.378384', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'CMC', 'relevance_score': '0.155786', 'ticker_sentiment_score': '-0.152057', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LLY', 'relevance_score': '0.155786', 'ticker_sentiment_score': '0.073837', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DRI', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.158842', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FDX', 'relevance_score': '0.206685', 'ticker_sentiment_score': '-0.042636', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.104228', 'ticker_sentiment_score': '-0.378384', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'NUE', 'relevance_score': '0.104228', 'ticker_sentiment_score': '-0.125987', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STLD', 'relevance_score': '0.104228', 'ticker_sentiment_score': '-0.125987', 'ticker_sentiment_label': 'Neutral'}]"
509,A 20-year fund manager shares 8 mega-trend stocks he's betting will take market share - and the 5 he's shorting,https://www.businessinsider.com/top-stocks-to-buy-mega-trends-themes-shorts-fund-manager-2023-6,20230623T093000,['Laila Maidan'],8 Mega-Trend Stocks to Buy and 5 to Short: 20-Year Fund Manager - Business Insider ...,,Business Insider,GoogleRSS,www.businessinsider.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Financial Markets', 'relevance_score': '0.995015'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}]",0.088664,Neutral,"[{'ticker': 'LCID', 'relevance_score': '0.062515', 'ticker_sentiment_score': '-0.053224', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LULU', 'relevance_score': '0.062515', 'ticker_sentiment_score': '0.263423', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.062515', 'ticker_sentiment_score': '0.091025', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.216307', 'ticker_sentiment_score': '0.131406', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RMAX', 'relevance_score': '0.062515', 'ticker_sentiment_score': '-0.101111', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NIO', 'relevance_score': '0.062515', 'ticker_sentiment_score': '0.08202', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.093653', 'ticker_sentiment_score': '0.036019', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZTS', 'relevance_score': '0.062515', 'ticker_sentiment_score': '0.211234', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABNB', 'relevance_score': '0.062515', 'ticker_sentiment_score': '0.133068', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RDFN', 'relevance_score': '0.031282', 'ticker_sentiment_score': '-0.095622', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UA', 'relevance_score': '0.062515', 'ticker_sentiment_score': '-0.162905', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PANW', 'relevance_score': '0.062515', 'ticker_sentiment_score': '0.134069', 'ticker_sentiment_label': 'Neutral'}]"
510,Lilly  ( LLY )  Gets FDA Nod for Pediatric Use of Diabetes Drugs,https://www.zacks.com/stock/news/2111998/lilly-lly-gets-fda-nod-for-pediatric-use-of-diabetes-drugs,20230622T170000,['Zacks Investment Research'],"Following FDA's label expansion approval, Lilly's (LLY) Jardiance and Synjardy are the first SGLT2 inhibitors approved for use in children aged 10 years and older with type 2 diabetes.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.998645'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.254762,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.431065', 'ticker_sentiment_score': '0.214642', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ANIP', 'relevance_score': '0.431065', 'ticker_sentiment_score': '0.217361', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LGND', 'relevance_score': '0.295867', 'ticker_sentiment_score': '0.055665', 'ticker_sentiment_label': 'Neutral'}]"
511,DICE Therapeutics  ( DICE )  Up 37% on Buyout Offer from Eli Lilly,https://www.zacks.com/stock/news/2111417/dice-therapeutics-dice-up-37-on-buyout-offer-from-eli-lilly,20230621T164900,['Zacks Investment Research'],DICE Therapeutics (DICE) is set to be acquired by pharma-giant Eli Lilly (LLY) in an all-cash transaction for $2.4 billion. The transaction will likely close by third-quarter 2023.,https://staticx-tuner.zacks.com/images/articles/main/2a/3899.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.947132'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.163285,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.622414', 'ticker_sentiment_score': '0.310202', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ANIP', 'relevance_score': '0.443626', 'ticker_sentiment_score': '0.238075', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DICE', 'relevance_score': '0.719159', 'ticker_sentiment_score': '0.237649', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
512,Is Eli Lilly's Dice Therapeutics Acquisition a Needle-Moving Event?,https://www.fool.com/investing/2023/06/21/is-eli-lillys-dice-therapeutics-acquisition-a-need/,20230621T153000,['George Budwell'],"The pharma giant's latest acquisition might be on the small side, but it could yield an important new growth driver in the years ahead.",https://media.ycharts.com/charts/9b44c811b7fadf756d08313f8f1d8660.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.210139,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.578355', 'ticker_sentiment_score': '0.320112', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DICE', 'relevance_score': '0.279015', 'ticker_sentiment_score': '0.323837', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
513,Alexandria  ( ARE )  Divests 5 Non-Core Properties for $365M,https://www.zacks.com/stock/news/2111229/alexandria-are-divests-5-non-core-properties-for-365m,20230621T125800,['Zacks Investment Research'],"Keeping up with its capital-recycling strategy, Alexandria (ARE) announces the disposition of five non-core assets in Greater Boston, spanning 428,663 rentable square feet, for $365 million.",https://staticx-tuner.zacks.com/images/articles/main/03/844.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.5'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}]",0.262726,Somewhat-Bullish,"[{'ticker': 'HST', 'relevance_score': '0.109705', 'ticker_sentiment_score': '0.062192', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.217346', 'ticker_sentiment_score': '0.206908', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ARE', 'relevance_score': '0.054983', 'ticker_sentiment_score': '0.124913', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.054983', 'ticker_sentiment_score': '0.124913', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VTR', 'relevance_score': '0.217346', 'ticker_sentiment_score': '0.093917', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.054983', 'ticker_sentiment_score': '0.124913', 'ticker_sentiment_label': 'Neutral'}]"
514,Cross-Sector Comparison: Is Estee Lauder A Better Pick Over LLY Stock?,https://www.forbes.com/sites/greatspeculations/2023/06/20/cross-sector-comparison-is-estee-lauder-a-better-pick-over-lly-stock/,20230620T130004,['Trefis Team'],"Although these companies are from different sectors, we compare them because they have a similar operating income of $8-10 billion.",https://imageio.forbes.com/specials-images/imageserve/64913a4292fef2da768901ca/0x0.jpg?format=jpg&width=1200,Forbes,Markets,www.forbes.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.752319'}, {'topic': 'Earnings', 'relevance_score': '0.992549'}]",0.164015,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.445848', 'ticker_sentiment_score': '0.235367', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'POOL', 'relevance_score': '0.033703', 'ticker_sentiment_score': '0.129442', 'ticker_sentiment_label': 'Neutral'}]"
515,Verve  ( VERV )  Up 9.9% in a Week on Collaboration With Eli Lilly,https://www.zacks.com/stock/news/2110592/verve-verv-up-99-in-a-week-on-collaboration-with-eli-lilly,20230620T125400,['Zacks Investment Research'],Verve's (VERV) shares rise on collaboration with Eli Lilly to develop gene editing treatment for cardiovascular disease.,https://staticx-tuner.zacks.com/images/articles/main/f5/284.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}]",0.171941,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.359447', 'ticker_sentiment_score': '0.162133', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.273807', 'ticker_sentiment_score': '0.174364', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AKRO', 'relevance_score': '0.359447', 'ticker_sentiment_score': '0.069149', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VERV', 'relevance_score': '0.440549', 'ticker_sentiment_score': '0.162096', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
516,Why Investors Need to Take Advantage of These 2 Medical Stocks Now,https://www.zacks.com/stock/news/2110463/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now,20230620T125006,['Zacks Investment Research'],Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.,https://staticx-tuner.zacks.com/images/default_article_images/default168.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999682'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.34801,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.329992', 'ticker_sentiment_score': '0.294766', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.390904', 'ticker_sentiment_score': '0.395317', 'ticker_sentiment_label': 'Bullish'}]"
517,Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology,https://www.prnewswire.com/news-releases/lilly-to-acquire-dice-therapeutics-to-advance-innovation-in-immunology-301854537.html,20230620T104500,['Eli Lilly and Company'],"INDIANAPOLIS and SOUTH SAN FRANCISCO, Calif., June 20, 2023 /PRNewswire/ -- Eli Lilly and Company ( NYSE: LLY ) and DICE Therapeutics, Inc. ( NASDAQ: DICE ) today announced a definitive agreement for Lilly to acquire DICE.",https://mma.prnewswire.com/media/2105405/DICE_Therapeutics_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.992549'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.99998'}, {'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.284759,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.397098', 'ticker_sentiment_score': '0.316282', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.023057', 'ticker_sentiment_score': '0.157403', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DICE', 'relevance_score': '0.53004', 'ticker_sentiment_score': '0.367723', 'ticker_sentiment_label': 'Bullish'}]"
518,Lilly's  ( LLY )  Migraine Drug Fails Vis-a-Vis Pfizer's Nurtec ODT,https://www.zacks.com/stock/news/2110200/lillys-lly-migraine-drug-fails-vis-a-vis-pfizers-nurtec-odt,20230619T150100,['Zacks Investment Research'],Results from a post-approval study show that treatment with Lilly's (LLY) Emgality failed to achieve statistical superiority over Pfizer's Nurtec ODT in preventing episodic migraine in adults.,https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.199974,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.629492', 'ticker_sentiment_score': '0.336892', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.17715', 'ticker_sentiment_score': '0.040938', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.262994', 'ticker_sentiment_score': '0.096358', 'ticker_sentiment_label': 'Neutral'}]"
519,NVO: Diabetes Epidemic Makes this Stock a Strong Buy,https://stocknews.com/news/lly-sny-diabetes-epidemic-makes-this-stock-a-strong-buy/,20230616T184144,[],"As economies in the so-called emerging world become more Westernized, healthcare professionals around the world are growing more concerned about the health of the populace. As populations' dietary habits change, more and more people are becoming overweight.",https://stocknews.com/wp-content/uploads/2022/02/shutterstock_181864331-scaled.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}]",0.071701,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.149038', 'ticker_sentiment_score': '-0.049845', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.468885', 'ticker_sentiment_score': '0.257328', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SNY', 'relevance_score': '0.099683', 'ticker_sentiment_score': '-0.040959', 'ticker_sentiment_label': 'Neutral'}]"
520,3 Top Stocks to Buy and Hold for the Next Decade,https://www.fool.com/investing/2023/06/16/3-top-stocks-to-buy-and-hold-for-the-next-decade/,20230616T141500,['Joe Tenebruso'],These stalwarts can form the foundation of your portfolio.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F736272%2Fperson-looking-at-charts-on-a-computer-screen.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.399362,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.159569', 'ticker_sentiment_score': '0.150075', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PGPGF', 'relevance_score': '0.053509', 'ticker_sentiment_score': '0.292932', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BCS', 'relevance_score': '0.053509', 'ticker_sentiment_score': '0.028', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.262805', 'ticker_sentiment_score': '0.380094', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BEP', 'relevance_score': '0.211652', 'ticker_sentiment_score': '0.362974', 'ticker_sentiment_label': 'Bullish'}]"
521,Eli Lilly  ( LLY )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2109080/eli-lilly-lly-outpaces-stock-market-gains-what-you-should-know,20230615T214520,['Zacks Investment Research'],"Eli Lilly (LLY) closed at $453.93 in the latest trading session, marking a +1.39% move from the prior day.",https://staticx-tuner.zacks.com/images/default_article_images/default35.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.961735'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.211319,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.620664', 'ticker_sentiment_score': '0.359935', 'ticker_sentiment_label': 'Bullish'}]"
522,"Drug Maker Junshi Seeks Swiss Cure For Cash Woes - BeiGene  ( NASDAQ:BGNE ) , Coherus BioSciences  ( NASDAQ:CHRS ) ",https://www.benzinga.com/markets/penny-stocks/23/06/32879914/drug-maker-junshi-seeks-swiss-cure-for-cash-woes,20230615T170310,['The Bamboo Works'],"Junshi Biosciences reported dismal results in the first quarter, with operating income plunging nearly 60% and its net loss expanding by 37% Hopes of a big revenue boost from an oral Covid drug have been dashed, and the company may not recoup its investment in the short term",https://cdn.benzinga.com/files/junshi_1.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.992549'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.998962'}]",0.074208,Neutral,"[{'ticker': 'BGNE', 'relevance_score': '0.063933', 'ticker_sentiment_score': '-0.042539', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CASBF', 'relevance_score': '0.031992', 'ticker_sentiment_score': '-0.072112', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.021163', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CHRS', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.070322', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HPNN', 'relevance_score': '0.031992', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SHJBF', 'relevance_score': '0.031992', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SZIHF', 'relevance_score': '0.031992', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:CNY', 'relevance_score': '0.031992', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
523,Eli Lilly and Company  ( LLY )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2108738/eli-lilly-and-company-lly-is-attracting-investor-attention-here-is-what-you-should-know,20230615T130014,['Zacks Investment Research'],"Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.",https://staticx-tuner.zacks.com/images/default_article_images/default233.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.623304'}]",0.232946,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.520209', 'ticker_sentiment_score': '0.127496', 'ticker_sentiment_label': 'Neutral'}]"
524,2 Market-Beating Stocks With More Upside Potential,https://www.fool.com/investing/2023/06/15/2-market-beating-stocks-with-more-upside-potential/,20230615T124500,['Prosper Junior Bakiny'],It's not too late to take a position in these two impressive companies.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F736211%2Flow-risk-safe-safer-conservative-caution-cautious.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.938793'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.13332,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.514619', 'ticker_sentiment_score': '0.214899', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.296463', 'ticker_sentiment_score': '0.269906', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
525,"Top Stock Reports for Apple, UnitedHealth & Eli Lilly",https://www.zacks.com/research-daily/2107650/top-stock-reports-for-apple-unitedhealth-eli-lilly,20230613T160200,['Zacks Investment Research'],"Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), UnitedHealth Group Incorporated (UNH) and Eli Lilly and Company (LLY).",https://staticx-tuner.zacks.com/images/default_article_images/default167.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.875462'}]",0.268137,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.313218', 'ticker_sentiment_score': '0.25835', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.481177', 'ticker_sentiment_score': '0.344266', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'INTC', 'relevance_score': '0.128135', 'ticker_sentiment_score': '0.137706', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.252987', 'ticker_sentiment_score': '0.21939', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BDX', 'relevance_score': '0.128135', 'ticker_sentiment_score': '0.137706', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.128135', 'ticker_sentiment_score': '0.137706', 'ticker_sentiment_label': 'Neutral'}]"
526,"Eli Lilly and  ( NYSE:LLY )  Downgraded to ""Buy"" at StockNews.com",https://www.defenseworld.net/2023/06/13/eli-lilly-and-nyselly-downgraded-to-buy-at-stocknews-com.html,20230613T073246,['Defense World Staff'],StockNews.com downgraded shares of Eli Lilly and ( NYSE:LLY - Get Rating ) from a strong-buy rating to a buy rating in a report issued on Monday morning. LLY has been the topic of a number of other reports.,https://www.marketbeat.com/logos/logo_eli_lilly.jpg,Stocknews.com,n/a,www.defenseworld.net,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.264995,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.882596', 'ticker_sentiment_score': '0.445533', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SCGLF', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.114226', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TFC', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.114226', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.114226', 'ticker_sentiment_label': 'Neutral'}]"
527,2 Biotech Stocks That Could Help Make You a Fortune,https://www.fool.com/investing/2023/06/12/2-biotech-stocks-that-could-help-make-a-fortune/,20230612T113000,['Sushree Mohanty'],Biotech stocks with cutting-edge therapies have the potential to generate substantial returns over time.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F735457%2Fa-person-buying-medicines-from-a-pharmacy.jpeg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.999767'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}]",0.275291,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.37552', 'ticker_sentiment_score': '0.263617', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.055751', 'ticker_sentiment_score': '0.137998', 'ticker_sentiment_label': 'Neutral'}]"
528,"Checking In On the Housing Market, the Las Vegas Strip, and the Weight-Loss Industry",https://www.fool.com/investing/2023/06/10/checking-in-on-the-housing-market-the-las-vegas-st/,20230610T140000,['Motley Fool Staff'],Homebuyers and blackjack players are feeling the pinch.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F735402%2Fjoe-biden-wh-photo-by-hannah-foslien.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Financial Markets', 'relevance_score': '0.857896'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.94762'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.333333'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.071934,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.058788', 'ticker_sentiment_score': '0.043007', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CZR', 'relevance_score': '0.023533', 'ticker_sentiment_score': '0.045084', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.011768', 'ticker_sentiment_score': '-0.011989', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.023533', 'ticker_sentiment_score': '0.002771', 'ticker_sentiment_label': 'Neutral'}]"
529,Eli Lilly  ( LLY )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2106636/eli-lilly-lly-gains-but-lags-market-what-you-should-know,20230609T214521,['Zacks Investment Research'],"In the latest trading session, Eli Lilly (LLY) closed at $446.04, marking a +0.09% move from the previous day.",https://staticx-tuner.zacks.com/images/default_article_images/default321.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.204165,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.606946', 'ticker_sentiment_score': '0.284785', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
530,"Bullish Market Trend, But Fed Meeting Looms; 7 Stocks To Watch",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-bullish-market-trend-but-fed-meeting-looms-tesla-nvidia-lead-stocks-to-watch/,20230609T211900,"['ED CARSON', ""Investor's Business Daily""]","Bullish Market Trend, But Fed Meeting Looms. 7 Stocks To Watch Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2022/06/Stock-jeromepowell2022-05-gov.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}]",0.187346,Somewhat-Bullish,"[{'ticker': 'NVDA', 'relevance_score': '0.153192', 'ticker_sentiment_score': '0.088429', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.044019', 'ticker_sentiment_score': '0.139753', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TEX', 'relevance_score': '0.044019', 'ticker_sentiment_score': '0.164645', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ORCL', 'relevance_score': '0.131523', 'ticker_sentiment_score': '0.007182', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.022018', 'ticker_sentiment_score': '0.135632', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROK', 'relevance_score': '0.044019', 'ticker_sentiment_score': '0.164645', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.259497', 'ticker_sentiment_score': '0.2165', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CAT', 'relevance_score': '0.131523', 'ticker_sentiment_score': '0.009546', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADBE', 'relevance_score': '0.044019', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.044019', 'ticker_sentiment_score': '0.115921', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PH', 'relevance_score': '0.044019', 'ticker_sentiment_score': '0.164645', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BA', 'relevance_score': '0.174745', 'ticker_sentiment_score': '0.022478', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.065987', 'ticker_sentiment_score': '0.09945', 'ticker_sentiment_label': 'Neutral'}]"
531,Jim Cramer's top 10 things to watch in the stock market Thursday,https://www.cnbc.com/2023/06/08/jim-cramers-top-10-things-to-watch-in-the-stock-market-thursday.html,20230608T131038,['Jim Cramer'],"Wall Street little changed heading into the open as the Dow, S&P 500 and Nasdaq track modestly lower for the week.",https://image.cnbcfm.com/api/v1/image/107251285-1685991400570-NYSE_Traders-OB-20230605-CC-PRESS-10.jpg?v=1686229838&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.99393'}, {'topic': 'Earnings', 'relevance_score': '0.875462'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}]",0.164598,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.055236', 'ticker_sentiment_score': '0.079999', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRWD', 'relevance_score': '0.110209', 'ticker_sentiment_score': '0.097188', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WYNN', 'relevance_score': '0.164656', 'ticker_sentiment_score': '0.030732', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.110209', 'ticker_sentiment_score': '0.106579', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.055236', 'ticker_sentiment_score': '-0.018067', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.110209', 'ticker_sentiment_score': '0.176157', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CVNA', 'relevance_score': '0.110209', 'ticker_sentiment_score': '-0.044585', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZS', 'relevance_score': '0.218325', 'ticker_sentiment_score': '0.147981', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HD', 'relevance_score': '0.164656', 'ticker_sentiment_score': '-0.026157', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESALF', 'relevance_score': '0.055236', 'ticker_sentiment_score': '0.157032', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GME', 'relevance_score': '0.164656', 'ticker_sentiment_score': '-0.017327', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.055236', 'ticker_sentiment_score': '0.157032', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PANW', 'relevance_score': '0.164656', 'ticker_sentiment_score': '0.120312', 'ticker_sentiment_label': 'Neutral'}]"
532,Check Out What Whales Are Doing With LLY - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/06/32746629/check-out-what-whales-are-doing-with-lly,20230606T200142,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bearish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_11035.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.097611,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.779232', 'ticker_sentiment_score': '0.007965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.097457', 'ticker_sentiment_score': '-0.122548', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.097457', 'ticker_sentiment_score': '-0.122548', 'ticker_sentiment_label': 'Neutral'}]"
533,This Is What Whales Are Betting On Eli Lilly - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/06/32722068/this-is-what-whales-are-betting-on-eli-lilly,20230605T181635,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bearish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.08571,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.814929', 'ticker_sentiment_score': '0.060638', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.095899', 'ticker_sentiment_score': '-0.12205', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.095899', 'ticker_sentiment_score': '-0.12205', 'ticker_sentiment_label': 'Neutral'}]"
534,Could AI Boost Growth at Medtronic?,https://www.fool.com/investing/2023/06/03/could-ai-boost-growth-at-medtronic/,20230603T093000,['Adria Cimino'],Medtronic could become a leader in healthcare AI.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F734525%2Fthe-owner-of-a-florist-business-opening-up-the-store-in-the-morning.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.928769'}]",0.407914,Bullish,"[{'ticker': 'GLDAF', 'relevance_score': '0.056407', 'ticker_sentiment_score': '0.121926', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.056407', 'ticker_sentiment_score': '0.12793', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.056407', 'ticker_sentiment_score': '0.194979', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MDT', 'relevance_score': '0.642329', 'ticker_sentiment_score': '0.546873', 'ticker_sentiment_label': 'Bullish'}]"
535,Eli Lilly and  ( NYSE:LLY )  Upgraded at StockNews.com,https://www.defenseworld.net/2023/06/03/eli-lilly-and-nyselly-upgraded-at-stocknews-com-2.html,20230603T052044,['Defense World Staff'],"Eli Lilly and ( NYSE:LLY - Get Rating ) was upgraded by StockNews.com from a ""buy"" rating to a ""strong-buy"" rating in a research note issued to investors on Saturday. LLY has been the subject of several other research reports.",https://www.marketbeat.com/logos/logo_eli_lilly.jpg,Stocknews.com,n/a,www.defenseworld.net,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999976'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.161647'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.302548,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.884857', 'ticker_sentiment_score': '0.501163', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JEF', 'relevance_score': '0.05234', 'ticker_sentiment_score': '0.051694', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.05234', 'ticker_sentiment_score': '0.051694', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRWD', 'relevance_score': '0.05234', 'ticker_sentiment_score': '0.035894', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.05234', 'ticker_sentiment_score': '0.051694', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.05234', 'ticker_sentiment_score': '0.051694', 'ticker_sentiment_label': 'Neutral'}]"
536,Why The Biotech Buying Bonanza Will Likely Continue,https://www.investors.com/news/technology/biotech-stocks-are-in-blistering-ma-climate-ftc-could-change-that/,20230602T171700,"['ALLISON GATLIN', ""Investor's Business Daily""]",Biotech Stocks Are In A 'Blistering' M&A Climate. The FTC Could ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/06/wJumpB060523.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.94762'}, {'topic': 'Earnings', 'relevance_score': '0.962106'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.993781'}]",0.055036,Neutral,"[{'ticker': 'NVO', 'relevance_score': '0.031529', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RETA', 'relevance_score': '0.031529', 'ticker_sentiment_score': '0.163574', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BLU', 'relevance_score': '0.031529', 'ticker_sentiment_score': '-0.045458', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROIV', 'relevance_score': '0.031529', 'ticker_sentiment_score': '0.161618', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMGN', 'relevance_score': '0.110028', 'ticker_sentiment_score': '-0.017979', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.001427', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARWR', 'relevance_score': '0.031529', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IRWD', 'relevance_score': '0.031529', 'ticker_sentiment_score': '0.117903', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PRTC', 'relevance_score': '0.015767', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VTRS', 'relevance_score': '0.031529', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.031529', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SGEN', 'relevance_score': '0.063008', 'ticker_sentiment_score': '0.016034', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CCCC', 'relevance_score': '0.031529', 'ticker_sentiment_score': '-0.058796', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.047278', 'ticker_sentiment_score': '0.036401', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RPRX', 'relevance_score': '0.031529', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ILMN', 'relevance_score': '0.047278', 'ticker_sentiment_score': '-0.146624', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALNY', 'relevance_score': '0.031529', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APLS', 'relevance_score': '0.031529', 'ticker_sentiment_score': '0.066264', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISEE', 'relevance_score': '0.031529', 'ticker_sentiment_score': '-0.045458', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALPMF', 'relevance_score': '0.015767', 'ticker_sentiment_score': '0.089075', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.078714', 'ticker_sentiment_score': '-0.025629', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.031529', 'ticker_sentiment_score': '0.012717', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HZNP', 'relevance_score': '0.031529', 'ticker_sentiment_score': '-0.047297', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARVN', 'relevance_score': '0.031529', 'ticker_sentiment_score': '-0.058796', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCO', 'relevance_score': '0.031529', 'ticker_sentiment_score': '0.032413', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.031529', 'ticker_sentiment_score': '0.089095', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARGX', 'relevance_score': '0.015767', 'ticker_sentiment_score': '0.110607', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.031529', 'ticker_sentiment_score': '0.012628', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RXDX', 'relevance_score': '0.031529', 'ticker_sentiment_score': '0.022789', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.031529', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
537,Drug Stock Hits All-Time High After Earnings Beat; 44% EPS Growth Expected,https://www.investors.com/research/drug-stock-hits-all-time-high-after-earnings-beat/,20230601T183100,"['KIMBERLEY KOENIG', ""Investor's Business Daily""]",Drug Stock Hits All-Time High After Earnings Beat. 44% EPS Growth ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2022/04/Stock-amphastar-01-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.989041'}, {'topic': 'Earnings', 'relevance_score': '0.938793'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.195363,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.139265', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.0699', 'ticker_sentiment_score': '0.11553', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMPH', 'relevance_score': '0.339046', 'ticker_sentiment_score': '0.128437', 'ticker_sentiment_label': 'Neutral'}]"
538,5 Large Drug Stocks to Watch From a Thriving Industry,https://www.zacks.com/commentary/2101789/5-large-drug-stocks-to-watch-from-a-thriving-industry,20230531T134200,['Zacks Investment Research'],"Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), J&J (JNJ), Novo Nordisk (NVO), Roche (RHHBY) and Novartis (NVS) are worth retaining in your portfolio.",https://staticx-tuner.zacks.com/images/articles/main/d7/2114.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}, {'topic': 'Earnings', 'relevance_score': '0.980716'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.769861'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.18535,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.025845', 'ticker_sentiment_score': '0.027075', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HZNP', 'relevance_score': '0.051663', 'ticker_sentiment_score': '0.028062', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.128684', 'ticker_sentiment_score': '0.162395', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.051663', 'ticker_sentiment_score': '0.170943', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.179407', 'ticker_sentiment_score': '0.167316', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SGEN', 'relevance_score': '0.025845', 'ticker_sentiment_score': '0.027075', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.025845', 'ticker_sentiment_score': '0.027075', 'ticker_sentiment_label': 'Neutral'}]"
539,Nvidia Becomes Ninth Company To Hit $1 Trillion Market Cap - Who Could Be Next To Join Elusive Club? - NVIDIA  ( NASDAQ:NVDA ) ,https://www.benzinga.com/news/23/05/32630114/nvidia-becomes-ninth-company-to-hit-1-trillion-market-cap-who-could-be-next-to-join-elusive-club,20230530T182011,['Chris Katje'],A surge in price for shares of Nvidia Corporation NVDA after the company's quarterly earnings results and guidance has put the semiconductor company in the elusive $1 trillion market capitalization club. Here's a look at the past and current members of the club and who could be next to join.,https://cdn.benzinga.com/files/images/story/2023/05/30/nvidia_bull_chart.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.938793'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.189774,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.042271', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.126339', 'ticker_sentiment_score': '0.112356', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.509206', 'ticker_sentiment_score': '0.198336', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.167904', 'ticker_sentiment_score': '0.022114', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.084423', 'ticker_sentiment_score': '0.276216', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BRK-A', 'relevance_score': '0.042271', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.042271', 'ticker_sentiment_score': '0.220918', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TCTZF', 'relevance_score': '0.084423', 'ticker_sentiment_score': '0.105261', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.084423', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSM', 'relevance_score': '0.084423', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.126339', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.328455', 'ticker_sentiment_score': '0.243474', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AZN', 'relevance_score': '0.084423', 'ticker_sentiment_score': '0.230557', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'XOM', 'relevance_score': '0.126339', 'ticker_sentiment_score': '0.273531', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.042271', 'ticker_sentiment_score': '0.220918', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PCCYF', 'relevance_score': '0.042271', 'ticker_sentiment_score': '0.129274', 'ticker_sentiment_label': 'Neutral'}]"
540,Eli Lilly Unusual Options Activity For May 30 - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/05/32627549/eli-lilly-unusual-options-activity-for-may-30,20230530T151642,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 11 strange trades. If we consider the specifics of each trade, it is accurate to state that 27% of the investors opened trades with bullish ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.114134,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.821469', 'ticker_sentiment_score': '0.097273', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.107016', 'ticker_sentiment_score': '-0.12596', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.107016', 'ticker_sentiment_score': '-0.12596', 'ticker_sentiment_label': 'Neutral'}]"
541,APG: 3 Smart Money Stocks to Invest in Today,https://stocknews.com/news/apg-amph-aqst-3-smart-money-stocks-to-invest-in-today/,20230530T125256,[],"The high interest-rate environment keeps the recession fears alive, keeping the stock market volatile. As the market volatility is not expected to lessen anytime soon, investing in stocks that institutional investors depend on could be wise.",https://stocknews.com/wp-content/uploads/2021/07/shutterstock_548023258-scaled.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999864'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.5'}]",0.236599,Somewhat-Bullish,"[{'ticker': 'APG', 'relevance_score': '0.241817', 'ticker_sentiment_score': '0.18535', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.081737', 'ticker_sentiment_score': '0.16291', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMPH', 'relevance_score': '0.267706', 'ticker_sentiment_score': '0.253047', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AQST', 'relevance_score': '0.318554', 'ticker_sentiment_score': '0.269885', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
542,Better Dividend Stock: Eli Lilly or Novo Nordisk?,https://www.fool.com/investing/2023/05/30/better-dividend-stock-eli-lilly-or-novo-nordisk/,20230530T124500,['George Budwell'],One of these dividend-paying pharma stocks is a markedly better passive income vehicle.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F734316%2Fdividend-concept.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}]",0.254152,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.413708', 'ticker_sentiment_score': '0.411687', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.108222', 'ticker_sentiment_score': '0.158859', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
543,Want to Grow Richer? These Stocks Have Doubled in the Past 5 Years,https://www.fool.com/investing/2023/05/28/want-to-grow-richer-these-stocks-have-doubled-in-5/,20230528T131500,['Kody Kester'],These two pharmaceutical companies have created value for shareholders.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F733859%2Fa-pharmacist-serves-a-customer.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.983783'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}]",0.324069,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.147366', 'ticker_sentiment_score': '0.116756', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.422661', 'ticker_sentiment_score': '0.463723', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.147366', 'ticker_sentiment_score': '0.116756', 'ticker_sentiment_label': 'Neutral'}]"
544,"The dark side of the weight-loss-drug craze: eating disorders, medication shortages, dangerous knockoffs",https://www.marketwatch.com/story/the-dark-side-of-the-weight-loss-drug-craze-eating-disorders-medication-shortages-dangerous-knock-offs-509ed96a,20230526T184600,['Eleanor Laise'],"Teens and older adults at risk, say doctors and researchers, as Novo Nordisk's Wegovy and Ozempic are hyped heavily online.",https://images.mktw.net/im-700559?width=700&height=700,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.093109,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.059686', 'ticker_sentiment_score': '-0.001002', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.019912', 'ticker_sentiment_score': '0.073513', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.158259', 'ticker_sentiment_score': '-0.017708', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.039811', 'ticker_sentiment_score': '0.07352', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.059686', 'ticker_sentiment_score': '-0.043056', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:KMD', 'relevance_score': '0.019912', 'ticker_sentiment_score': '0.073513', 'ticker_sentiment_label': 'Neutral'}]"
545,Should You Pick AbbVie Stock Over LLY?,https://www.forbes.com/sites/greatspeculations/2023/05/26/should-you-pick-abbvie-stock-over-lly/,20230526T110056,['Trefis Team'],"Looking at stock returns, Eli Lilly has outperformed AbbVie and the broader indices.",https://imageio.forbes.com/specials-images/imageserve/647050d373dcd9bff4c0029d/0x0.jpg?format=jpg&width=1200,Forbes,Markets,www.forbes.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.692272'}, {'topic': 'Earnings', 'relevance_score': '0.995973'}]",0.181038,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.750646', 'ticker_sentiment_score': '0.312608', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMED', 'relevance_score': '0.039944', 'ticker_sentiment_score': '0.137703', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.658693', 'ticker_sentiment_score': '0.344858', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
546,Eli Lilly and  ( NYSE:LLY )  Upgraded at StockNews.com,https://www.defenseworld.net/2023/05/26/eli-lilly-and-nyselly-upgraded-at-stocknews-com.html,20230526T052246,['Defense World Staff'],"Eli Lilly and ( NYSE:LLY - Get Rating ) was upgraded by equities researchers at StockNews.com from a ""buy"" rating to a ""strong-buy"" rating in a research note issued to investors on Friday. LLY has been the subject of several other research reports.",https://www.marketbeat.com/logos/logo_eli_lilly.jpg,Stocknews.com,n/a,www.defenseworld.net,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.34449,Somewhat-Bullish,"[{'ticker': 'NVDA', 'relevance_score': '0.046816', 'ticker_sentiment_score': '0.139527', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.046816', 'ticker_sentiment_score': '0.098889', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.046816', 'ticker_sentiment_score': '0.098889', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.046816', 'ticker_sentiment_score': '0.098889', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.841165', 'ticker_sentiment_score': '0.552752', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JEF', 'relevance_score': '0.046816', 'ticker_sentiment_score': '0.098889', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SAMG', 'relevance_score': '0.09347', 'ticker_sentiment_score': '0.251854', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
547,Can Pfizer Stock Double Your Money in 3 Years?,https://www.fool.com/investing/2023/05/25/can-pfizer-stock-double-your-money-in-3-years/,20230525T170000,['George Budwell'],Wall Street may be overlooking the potential of the drugmaker's GLP-1 pipeline assets.,https://media.ycharts.com/charts/9f8b91b2493be85ee6a8c6a50f0fe7d8.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.19451,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.168099', 'ticker_sentiment_score': '0.256404', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.056407', 'ticker_sentiment_score': '0.205985', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.056407', 'ticker_sentiment_score': '0.205985', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.056407', 'ticker_sentiment_score': '0.169961', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.563609', 'ticker_sentiment_score': '0.225026', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
548,"Nvidia's Strong Earnings, Outlook Help Lift Stocks as Debt Ceiling Negotiations Continue - NVIDIA  ( NASDAQ:NVDA ) ",https://www.benzinga.com/news/earnings/23/05/32574771/nvidias-strong-earnings-outlook-help-lift-stocks-as-debt-ceiling-negotiations-continue,20230525T134601,['Alex Coffey'],"( Thursday market open ) Debt ceiling progress remains elusive with a week to go until the ""X-date"" when U.S. coffers run dry, but the stock market has a mixed tone this morning thanks to chipmaker Nvidia NVDA crushing earnings expectations and offering a booming outlook.",https://cdn.benzinga.com/files/images/story/2023/05/25/shutterstock_1980205139.jpg?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.928139'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.999767'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.999483'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",-0.00977,Neutral,"[{'ticker': 'AAP', 'relevance_score': '0.039418', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.059097', 'ticker_sentiment_score': '0.016046', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.11787', 'ticker_sentiment_score': '0.120314', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.059097', 'ticker_sentiment_score': '0.016046', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DG', 'relevance_score': '0.039418', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HRL', 'relevance_score': '0.039418', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNOW', 'relevance_score': '0.039418', 'ticker_sentiment_score': '-0.104411', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BBY', 'relevance_score': '0.039418', 'ticker_sentiment_score': '-0.015721', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.039418', 'ticker_sentiment_score': '0.015802', 'ticker_sentiment_label': 'Neutral'}]"
549,"As Debt Ceiling Talks Wobble, Investors Look To May Fed Minutes, Nvidia Earnings For Direction - AstraZeneca  ( NASDAQ:AZN ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/news/small-cap/23/05/32558704/as-debt-ceiling-talks-wobble-investors-look-to-may-fed-minutes-nvidia-earnings-for-direction,20230524T173357,['Alex Coffey'],( Wednesday market open ) Investors seeking distraction from the ticking debt ceiling countdown clock get some this afternoon in the form of Federal Reserve meeting minutes and Nvidia NVDA earnings.,https://cdn.benzinga.com/files/images/story/2023/05/24/shutterstock_2114917130.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.99489'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.999819'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.998932'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",-0.036391,Neutral,"[{'ticker': 'NVDA', 'relevance_score': '0.110124', 'ticker_sentiment_score': '-0.044357', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DLTR', 'relevance_score': '0.146469', 'ticker_sentiment_score': '-0.001285', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KSS', 'relevance_score': '0.036812', 'ticker_sentiment_score': '0.212222', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BNTX', 'relevance_score': '0.036812', 'ticker_sentiment_score': '0.014591', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAP', 'relevance_score': '0.036812', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.036812', 'ticker_sentiment_score': '-0.00595', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TOL', 'relevance_score': '0.036812', 'ticker_sentiment_score': '0.069953', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.146469', 'ticker_sentiment_score': '0.062192', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.036812', 'ticker_sentiment_score': '0.014591', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BBY', 'relevance_score': '0.073546', 'ticker_sentiment_score': '-0.038247', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.036812', 'ticker_sentiment_score': '0.014591', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVAX', 'relevance_score': '0.036812', 'ticker_sentiment_score': '0.014591', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.036812', 'ticker_sentiment_score': '0.014591', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.036812', 'ticker_sentiment_score': '0.014614', 'ticker_sentiment_label': 'Neutral'}]"
550,Jim Cramer's top 10 things to watch in the stock market Wednesday,https://www.cnbc.com/2023/05/24/jim-cramers-top-10-things-to-watch-in-the-stock-market-wednesday.html,20230524T131249,['Jim Cramer'],No debt ceiling deal with eight days to the earliest default deadline.,https://image.cnbcfm.com/api/v1/image/107133204-1665581701195-gettyimages-1243897074-META_CONNECT_2022.jpeg?v=1684933969&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '0.905476'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '0.839681'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.311526,Somewhat-Bullish,"[{'ticker': 'TOL', 'relevance_score': '0.141726', 'ticker_sentiment_score': '0.026128', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.141726', 'ticker_sentiment_score': '0.096883', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VFC', 'relevance_score': '0.141726', 'ticker_sentiment_score': '0.00659', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.071145', 'ticker_sentiment_score': '0.019896', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.071145', 'ticker_sentiment_score': '0.051556', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.211191', 'ticker_sentiment_score': '0.087943', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANF', 'relevance_score': '0.141726', 'ticker_sentiment_score': '-0.015403', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KSS', 'relevance_score': '0.211191', 'ticker_sentiment_score': '0.23386', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.071145', 'ticker_sentiment_score': '0.248093', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'URBN', 'relevance_score': '0.211191', 'ticker_sentiment_score': '0.629306', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'CTRA', 'relevance_score': '0.141726', 'ticker_sentiment_score': '0.302826', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PANW', 'relevance_score': '0.211191', 'ticker_sentiment_score': '0.6525', 'ticker_sentiment_label': 'Bullish'}]"
551,Eli Lilly Unusual Options Activity For May 23 - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/05/32536944/eli-lilly-unusual-options-activity-for-may-23,20230523T173118,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bearish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.057003,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.875323', 'ticker_sentiment_score': '0.074618', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.186738', 'ticker_sentiment_score': '-0.170387', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'BCS', 'relevance_score': '0.09402', 'ticker_sentiment_score': '-0.121473', 'ticker_sentiment_label': 'Neutral'}]"
552,Jim Cramer's top 10 things to watch in the stock market Tuesday,https://www.cnbc.com/2023/05/23/jim-cramers-top-10-things-to-watch-in-the-stock-market-tuesday.html,20230523T130556,['Jim Cramer'],The Nasdaq looks like it's going to take a breather at the open after gaining ground in three of the last four sessions.,https://image.cnbcfm.com/api/v1/image/107241678-1684240285761-gettyimages-1255158779-AA_16052023_1195811.jpeg?v=1684847156&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.94762'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}]",0.21578,Somewhat-Bullish,"[{'ticker': 'META', 'relevance_score': '0.129516', 'ticker_sentiment_score': '0.065446', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.129516', 'ticker_sentiment_score': '0.093657', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.129516', 'ticker_sentiment_score': '0.065446', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.064973', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.193207', 'ticker_sentiment_score': '0.238987', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.064973', 'ticker_sentiment_score': '0.159282', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.316439', 'ticker_sentiment_score': '0.23884', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PDCE', 'relevance_score': '0.129516', 'ticker_sentiment_score': '0.186915', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.064973', 'ticker_sentiment_score': '-0.055317', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZM', 'relevance_score': '0.129516', 'ticker_sentiment_score': '-0.043055', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.129516', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.193207', 'ticker_sentiment_score': '0.289199', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PANW', 'relevance_score': '0.129516', 'ticker_sentiment_score': '0.065446', 'ticker_sentiment_label': 'Neutral'}]"
553,Here's Why I Still Own Alexandria Real Estate Equities,https://www.fool.com/investing/2023/05/22/heres-why-i-still-own-alexandria-real-estate-equit/,20230522T120000,['Marc Rapport'],"This office owner is not like the rest, which could be a very good thing.",https://media.ycharts.com/charts/c974fdecb1041d3aaea2b84dbeec73ec.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}, {'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.5'}]",0.161178,Somewhat-Bullish,"[{'ticker': 'ARE', 'relevance_score': '0.132855', 'ticker_sentiment_score': '0.161282', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.088799', 'ticker_sentiment_score': '0.102344', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.044469', 'ticker_sentiment_score': '0.097213', 'ticker_sentiment_label': 'Neutral'}]"
554,Looking At Eli Lilly's Recent Unusual Options Activity - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/05/32489729/looking-at-eli-lillys-recent-unusual-options-activity,20230519T163132,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bullish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.2035,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.832201', 'ticker_sentiment_score': '0.338918', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.091509', 'ticker_sentiment_score': '-0.120742', 'ticker_sentiment_label': 'Neutral'}]"
555,1 Major Advantage Biogen May Have Over Pharma Giant Eli Lilly in a Multibillion-Dollar Market,https://www.fool.com/investing/2023/05/19/1-major-advantage-biogen-may-have-over-eli-lilly/,20230519T121500,['David Jagielski'],"Analysts are bullish on Biogen's Alzheimer's drug, Leqembi, projecting it may generate over $10 billion in sales at its peak.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F732639%2Fbuffett17-tmf.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",-0.043939,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.172097', 'ticker_sentiment_score': '-0.167755', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'ESALF', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.070545', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.43789', 'ticker_sentiment_score': '-0.11496', 'ticker_sentiment_label': 'Neutral'}]"
556,Investors Heavily Search Eli Lilly and Company  ( LLY ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2096767/investors-heavily-search-eli-lilly-and-company-lly-here-is-what-you-need-to-know,20230518T130012,['Zacks Investment Research'],"Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.",https://staticx-tuner.zacks.com/images/default_article_images/default19.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.228478,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.529767', 'ticker_sentiment_score': '0.119289', 'ticker_sentiment_label': 'Neutral'}]"
557,This Is What Whales Are Betting On Eli Lilly - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/05/32455742/this-is-what-whales-are-betting-on-eli-lilly,20230517T204737,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 18 strange trades. If we consider the specifics of each trade, it is accurate to state that 44% of the investors opened trades with bullish ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.083529,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.853983', 'ticker_sentiment_score': '-0.061811', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.208464', 'ticker_sentiment_score': '-0.184945', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'MS', 'relevance_score': '0.208464', 'ticker_sentiment_score': '-0.184945', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
558,We're starting a new position in one of the Big 3 global medical imaging and diagnostics companies,https://www.cnbc.com/2023/05/17/were-starting-a-new-position-in-a-medical-imaging-and-diagnostics-leader.html,20230517T173053,"['Jeff Marks', 'Jim Cramer']",This company operates in an $84 billion total addressable market that the company sees growing to around $100 billion by 2024.,https://image.cnbcfm.com/api/v1/image/107090852-1658244731556-NUP_198367_00786_copy.jpg?v=1684344653&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.986714'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.998333'}]",0.250949,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.109622', 'ticker_sentiment_score': '0.120303', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.073209', 'ticker_sentiment_score': '0.110168', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.073209', 'ticker_sentiment_score': '0.110168', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESALF', 'relevance_score': '0.036643', 'ticker_sentiment_score': '0.105451', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GE', 'relevance_score': '0.537702', 'ticker_sentiment_score': '0.344722', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.073209', 'ticker_sentiment_score': '0.110168', 'ticker_sentiment_label': 'Neutral'}]"
559,Is Novo Nordisk Stock a Screaming Buy Right Now?,https://www.fool.com/investing/2023/05/16/is-novo-nordisk-stock-a-screaming-buy-right-now/,20230516T144500,['George Budwell'],The drugmaker's shares have crushed the broader markets over the past two years. Can it keep up this blistering momentum?,https://media.ycharts.com/charts/0a14620fe9c11f813b6d04deedb64941.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.251406,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.173749', 'ticker_sentiment_score': '0.195362', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VKTX', 'relevance_score': '0.05833', 'ticker_sentiment_score': '0.145998', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MORN', 'relevance_score': '0.05833', 'ticker_sentiment_score': '0.060974', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.173749', 'ticker_sentiment_score': '0.099258', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.05833', 'ticker_sentiment_score': '0.145998', 'ticker_sentiment_label': 'Neutral'}]"
560,"Eli Lilly  ( LLY )  Stock Up 18.7% YTD, New Drugs Key to Growth",https://www.zacks.com/stock/news/2095328/eli-lilly-lly-stock-up-187-ytd-new-drugs-key-to-growth,20230515T143500,['Zacks Investment Research'],"Lilly (LLY) expects to launch four new medicines by 2023 end, of which Mounjaro for type II diabetes and cancer drug Jaypirca have already been launched.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.998645'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.126782,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.521961', 'ticker_sentiment_score': '0.119024', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.160633', 'ticker_sentiment_score': '0.040862', 'ticker_sentiment_label': 'Neutral'}]"
561,3 Growth Stocks to Buy and Hold,https://www.fool.com/investing/2023/05/13/3-growth-stocks-to-buy-and-hold/,20230513T120000,"['Prosper Junior Bakiny', 'Keith Speights', 'and David Jagielski']",These three stocks defied the bear market last year.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F732236%2Fmarket-2.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.858979'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.989041'}]",0.327432,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.264761', 'ticker_sentiment_score': '0.296732', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.153226', 'ticker_sentiment_score': '0.034958', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.03853', 'ticker_sentiment_score': '0.084813', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXSM', 'relevance_score': '0.228073', 'ticker_sentiment_score': '0.172527', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
562,Will Eli Lilly Be a Trillion-Dollar Stock by 2030?,https://www.fool.com/investing/2023/05/13/will-eli-lilly-be-a-trillion-dollar-stock-by-2030/,20230513T113500,['Alex Carchidi'],It's a lot more likely than it might sound at first.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F731611%2Fjoe-biden-speech-white-house-photo-by-adam-schultz.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '0.983605'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.246607,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.410338', 'ticker_sentiment_score': '0.250148', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.053749', 'ticker_sentiment_score': '0.085733', 'ticker_sentiment_label': 'Neutral'}]"
563,"Pharma Stock Roundup: BAYRY Mixed Q1 Results, AZN, RHHBY Regulatory/Pipeline Updates",https://www.zacks.com/stock/news/2094647/pharma-stock-roundup-bayry-mixed-q1-results-azn-rhhby-regulatorypipeline-updates,20230512T131200,['Zacks Investment Research'],Bayer (BAYRY) announces mixed Q1 results. AstraZeneca's (AZN) Ultomiris gets approval for a new rare disease indication in the EU.,https://staticx-tuner.zacks.com/images/articles/main/52/873.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.15302,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.108712', 'ticker_sentiment_score': '-0.070737', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCYC', 'relevance_score': '0.162437', 'ticker_sentiment_score': '0.083863', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.108712', 'ticker_sentiment_score': '0.161575', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.108712', 'ticker_sentiment_score': '-0.131021', 'ticker_sentiment_label': 'Neutral'}]"
564,Here's What Eli Lilly's Latest Clinical Win Means For Investors,https://www.fool.com/investing/2023/05/12/heres-what-eli-lillys-latest-clinical-win-means-fo/,20230512T102000,['Prosper Junior Bakiny'],The biotech's prospects continue to get brighter.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F731390%2Fbuffett8-tmf.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}]",0.288748,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.4899', 'ticker_sentiment_score': '0.41971', 'ticker_sentiment_label': 'Bullish'}]"
565,Here's Why Eli Lilly's Alzheimer's Drug Could Be the Real Deal,https://www.fool.com/investing/2023/05/11/heres-why-eli-lillys-alzheimers-drug-could-be-the/,20230511T140700,['David Jagielski'],"Eli Lilly stock may look expensive, but there's still plenty of value here for long-term investors.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F731423%2Fstock-market-crash-plunge-dollar-newspaper-invest-dow-sp-500-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.162855,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.263942', 'ticker_sentiment_score': '0.19747', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.199584', 'ticker_sentiment_score': '0.048343', 'ticker_sentiment_label': 'Neutral'}]"
566,Bearish Headwinds Have Evolved to Bullish Tailwinds: This Industry Soars,https://www.zacks.com/commentary/2093698/bearish-headwinds-have-evolved-to-bullish-tailwinds-this-industry-soars,20230510T171900,['Zacks Investment Research'],The headline inflation figure rose at the slowest rate in more than two years.,https://staticx-tuner.zacks.com/images/articles/charts/52/42185.png?v=200891444,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.838487'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}]",0.110623,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.365166', 'ticker_sentiment_score': '0.377043', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.063091', 'ticker_sentiment_score': '0.085847', 'ticker_sentiment_label': 'Neutral'}]"
567,Nektar Therapeutics  ( NKTR )  Q1 Earnings & Revenues Beat,https://www.zacks.com/stock/news/2093340/nektar-therapeutics-nktr-q1-earnings-revenues-beat,20230510T131600,['Zacks Investment Research'],Nektar's (NKTR) Q1 loss is narrower than expected while revenues beat estimates.,https://staticx-tuner.zacks.com/images/articles/main/85/906.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.007179,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.248851', 'ticker_sentiment_score': '0.041488', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRMR', 'relevance_score': '0.342939', 'ticker_sentiment_score': '0.237657', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ITRM', 'relevance_score': '0.296463', 'ticker_sentiment_score': '0.197268', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NKTR', 'relevance_score': '0.431881', 'ticker_sentiment_score': '0.038063', 'ticker_sentiment_label': 'Neutral'}]"
568,"Top Stock Reports for Eli Lilly, Verizon Communications & United Parcel Service",https://www.zacks.com/research-daily/2092305/top-stock-reports-for-eli-lilly-verizon-communications-united-parcel-service,20230509T152800,['Zacks Investment Research'],"Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Verizon Communications Inc. (VZ) and United Parcel Service, Inc. (UPS).",https://staticx-tuner.zacks.com/images/articles/main/88/118.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}]",0.167637,Somewhat-Bullish,"[{'ticker': 'AMD', 'relevance_score': '0.117774', 'ticker_sentiment_score': '0.016275', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.343279', 'ticker_sentiment_score': '0.230714', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UPS', 'relevance_score': '0.395903', 'ticker_sentiment_score': '0.191342', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVS', 'relevance_score': '0.117774', 'ticker_sentiment_score': '0.016275', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VZ', 'relevance_score': '0.232996', 'ticker_sentiment_score': '0.17161', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CI', 'relevance_score': '0.117774', 'ticker_sentiment_score': '0.016275', 'ticker_sentiment_label': 'Neutral'}]"
569,Pharma ETFs Gain Post Q1 Earnings,https://www.zacks.com/stock/news/2092464/pharma-etfs-gain-post-q1-earnings,20230509T151500,['Zacks Investment Research'],"Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. As such, pharma ETFs have been in the green over the past month.",https://staticx-tuner.zacks.com/images/articles/main/66/1019.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.128662,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.156461', 'ticker_sentiment_score': '0.043614', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.156461', 'ticker_sentiment_score': '0.091412', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.117678', 'ticker_sentiment_score': '0.037251', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.156461', 'ticker_sentiment_score': '0.043614', 'ticker_sentiment_label': 'Neutral'}]"
570,Why Novo Nordisk Stock Is Marching Higher Today,https://www.fool.com/investing/2023/05/08/why-novo-nordisk-stock-is-marching-higher-today/,20230508T165427,['George Budwell'],Wall Street doesn't seem overly concerned about emerging competition for the company's weight-loss medication.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730975%2Fa-digital-rendering-of-a-computer-chip-being-plugged-into-a-circuit-board.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.319204,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.25168', 'ticker_sentiment_score': '0.219698', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.25168', 'ticker_sentiment_score': '0.212424', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
571,Why Did Eli Lilly Stock Jump 15% in April?,https://www.fool.com/investing/2023/05/08/why-did-eli-lilly-stock-jump-15-in-april/,20230508T145649,['Ryan Downie'],Investors are excited about several candidates in the drug company's pipeline.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F731433%2Fgettyimages-1457776650.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.995921'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.190627,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.344712', 'ticker_sentiment_score': '0.390768', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SPGI', 'relevance_score': '0.071145', 'ticker_sentiment_score': '0.263304', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
572,Where Will Eli Lilly Be in 3 Years?,https://www.fool.com/investing/2023/05/08/where-will-eli-lilly-be-in-3-years/,20230508T095700,['Alex Carchidi'],The pharmaceutical giant is likely to grow quickly as it is entering a new age of contested markets.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730975%2Fa-digital-rendering-of-a-computer-chip-being-plugged-into-a-circuit-board.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.875462'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}]",0.213068,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.459624', 'ticker_sentiment_score': '0.288973', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.054236', 'ticker_sentiment_score': '0.040003', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.054236', 'ticker_sentiment_score': '0.040003', 'ticker_sentiment_label': 'Neutral'}]"
573,3 Things About Eli Lilly That Smart Investors Know,https://www.fool.com/investing/2023/05/08/3-things-about-eli-lilly-that-smart-investors-know/,20230508T090500,['Alex Carchidi'],"There are quite a few details to keep track of with this company, and they all matter.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730975%2Fa-digital-rendering-of-a-computer-chip-being-plugged-into-a-circuit-board.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.149688,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.369685', 'ticker_sentiment_score': '0.252615', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.134318', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.134318', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.134318', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.134318', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.063933', 'ticker_sentiment_score': '-0.029181', 'ticker_sentiment_label': 'Neutral'}]"
574,2 Top Healthcare Stocks Defying the Bear Market,https://www.fool.com/investing/2023/05/07/2-top-healthcare-stocks-defying-the-bear-market/,20230507T121400,['Jim Halley'],"These pharmaceutical companies are expected to see a big rise in revenue, thanks to new therapies.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F731141%2Fbear-market-stock-chart-quarter-report-financial-metrics-invest-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.998947'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.172394,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.412523', 'ticker_sentiment_score': '0.230296', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.043264', 'ticker_sentiment_score': '0.160403', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'C', 'relevance_score': '0.043264', 'ticker_sentiment_score': '0.160403', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'RXDX', 'relevance_score': '0.043264', 'ticker_sentiment_score': '-0.014778', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESALF', 'relevance_score': '0.043264', 'ticker_sentiment_score': '0.050951', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.043264', 'ticker_sentiment_score': '0.050951', 'ticker_sentiment_label': 'Neutral'}]"
575,2 Best Biotech Stocks to Buy Right Now,https://www.fool.com/investing/2023/05/06/best-biotech-stocks-to-buy-right-now/,20230506T115500,['Kody Kester'],Buying pharmaceutical companies with all-around drug portfolios and pipelines is the key to success as an investor.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F731019%2Fhealthcare-professionals-talking-to-each-other.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.988787'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}]",0.259399,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.273552', 'ticker_sentiment_score': '0.153935', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMGN', 'relevance_score': '0.273552', 'ticker_sentiment_score': '0.103106', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.069697', 'ticker_sentiment_score': '-0.004056', 'ticker_sentiment_label': 'Neutral'}]"
576,StockNews.com Lowers Eli Lilly and  ( NYSE:LLY )  to Buy,https://www.defenseworld.net/2023/05/06/stocknews-com-lowers-eli-lilly-and-nyselly-to-buy.html,20230506T052044,['Defense World Staff'],"Eli Lilly and ( NYSE:LLY - Get Rating ) was downgraded by StockNews.com from a ""strong-buy"" rating to a ""buy"" rating in a report released on Saturday. LLY has been the subject of a number of other research reports. 3M reaffirmed a ""maintains"" rating on shares of Eli Lilly and in a report on ...",https://www.marketbeat.com/logos/logo_eli_lilly.jpg,Stocknews.com,n/a,www.defenseworld.net,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.752319'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.263771,Somewhat-Bullish,"[{'ticker': 'AMD', 'relevance_score': '0.050679', 'ticker_sentiment_score': '0.163331', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.837979', 'ticker_sentiment_score': '0.43619', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SCGLF', 'relevance_score': '0.050679', 'ticker_sentiment_score': '0.067581', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TFC', 'relevance_score': '0.050679', 'ticker_sentiment_score': '0.067581', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.050679', 'ticker_sentiment_score': '0.067581', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.050679', 'ticker_sentiment_score': '0.163331', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
577,This Is What Whales Are Betting On Eli Lilly - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/05/32247650/this-is-what-whales-are-betting-on-eli-lilly,20230505T200043,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bearish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.099823,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.835459', 'ticker_sentiment_score': '0.02045', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.271777', 'ticker_sentiment_score': '-0.227608', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
578,Market Rally Finishes Strong As Banks Slash Losses: Weekly Review,https://www.investors.com/news/market-rally-finishes-strong-regional-banks-fed-rate-hike-jobs-report-apple-in-focus/,20230505T171600,"[""Investor's Business Daily"", 'IBD STAFF']","Market Rally Finishes Strong. Regional Banks, Fed Rate Hike, Jobs ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2019/08/stock-bounce-back-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",-0.044223,Neutral,"[{'ticker': 'PACW', 'relevance_score': '0.061662', 'ticker_sentiment_score': '-0.118251', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.073962', 'ticker_sentiment_score': '-0.03598', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANET', 'relevance_score': '0.061662', 'ticker_sentiment_score': '0.033363', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LSCC', 'relevance_score': '0.024686', 'ticker_sentiment_score': '0.016674', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SIBN', 'relevance_score': '0.037021', 'ticker_sentiment_score': '0.050395', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SRPT', 'relevance_score': '0.024686', 'ticker_sentiment_score': '-0.169883', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NVO', 'relevance_score': '0.037021', 'ticker_sentiment_score': '-0.180292', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'FOUR', 'relevance_score': '0.037021', 'ticker_sentiment_score': '0.054882', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TGTX', 'relevance_score': '0.037021', 'ticker_sentiment_score': '-0.177177', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSLA', 'relevance_score': '0.024686', 'ticker_sentiment_score': '-0.072612', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.061662', 'ticker_sentiment_score': '0.123653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.049348', 'ticker_sentiment_score': '0.043861', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SHAK', 'relevance_score': '0.037021', 'ticker_sentiment_score': '0.120554', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PAYC', 'relevance_score': '0.024686', 'ticker_sentiment_score': '0.087121', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DKNG', 'relevance_score': '0.024686', 'ticker_sentiment_score': '0.058708', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZBH', 'relevance_score': '0.037021', 'ticker_sentiment_score': '0.050395', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WING', 'relevance_score': '0.049348', 'ticker_sentiment_score': '0.121168', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SYK', 'relevance_score': '0.049348', 'ticker_sentiment_score': '0.051001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAH', 'relevance_score': '0.024686', 'ticker_sentiment_score': '0.156058', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LTHM', 'relevance_score': '0.049348', 'ticker_sentiment_score': '0.029', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'YUM', 'relevance_score': '0.024686', 'ticker_sentiment_score': '0.117442', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MELI', 'relevance_score': '0.024686', 'ticker_sentiment_score': '-0.106947', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'POWI', 'relevance_score': '0.024686', 'ticker_sentiment_score': '0.016674', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FTNT', 'relevance_score': '0.049348', 'ticker_sentiment_score': '0.091994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ACLS', 'relevance_score': '0.024686', 'ticker_sentiment_score': '0.016674', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CZR', 'relevance_score': '0.037021', 'ticker_sentiment_score': '0.059947', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RCL', 'relevance_score': '0.024686', 'ticker_sentiment_score': '0.044442', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BLD', 'relevance_score': '0.037021', 'ticker_sentiment_score': '-0.070548', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUBS', 'relevance_score': '0.024686', 'ticker_sentiment_score': '0.087121', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QRVO', 'relevance_score': '0.024686', 'ticker_sentiment_score': '0.016674', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MAR', 'relevance_score': '0.024686', 'ticker_sentiment_score': '0.044442', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WAL', 'relevance_score': '0.049348', 'ticker_sentiment_score': '-0.117748', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.061662', 'ticker_sentiment_score': '-0.118251', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BLDR', 'relevance_score': '0.049348', 'ticker_sentiment_score': '-0.025045', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DDOG', 'relevance_score': '0.024686', 'ticker_sentiment_score': '0.087121', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'H', 'relevance_score': '0.024686', 'ticker_sentiment_score': '0.044442', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.024686', 'ticker_sentiment_score': '0.087827', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SHOP', 'relevance_score': '0.061662', 'ticker_sentiment_score': '-0.073597', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RUTH', 'relevance_score': '0.037021', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRUS', 'relevance_score': '0.024686', 'ticker_sentiment_score': '0.016674', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LNTH', 'relevance_score': '0.061662', 'ticker_sentiment_score': '0.064522', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NCLH', 'relevance_score': '0.024686', 'ticker_sentiment_score': '0.044442', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.024686', 'ticker_sentiment_score': '0.016674', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IBP', 'relevance_score': '0.037021', 'ticker_sentiment_score': '-0.070548', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.049348', 'ticker_sentiment_score': '-0.047953', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BKNG', 'relevance_score': '0.024686', 'ticker_sentiment_score': '0.044442', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.073962', 'ticker_sentiment_score': '0.027084', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INMD', 'relevance_score': '0.024686', 'ticker_sentiment_score': '0.048434', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SQ', 'relevance_score': '0.024686', 'ticker_sentiment_score': '0.052363', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ON', 'relevance_score': '0.012344', 'ticker_sentiment_score': '0.01536', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COP', 'relevance_score': '0.024686', 'ticker_sentiment_score': '-0.173532', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'SMCI', 'relevance_score': '0.049348', 'ticker_sentiment_score': '0.089995', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XPOF', 'relevance_score': '0.049348', 'ticker_sentiment_score': '-0.121857', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NXPI', 'relevance_score': '0.024686', 'ticker_sentiment_score': '0.016674', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLNT', 'relevance_score': '0.061662', 'ticker_sentiment_score': '-0.122371', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.024686', 'ticker_sentiment_score': '-0.169883', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'QSR', 'relevance_score': '0.049348', 'ticker_sentiment_score': '0.121168', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HOLX', 'relevance_score': '0.049348', 'ticker_sentiment_score': '0.051001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MGM', 'relevance_score': '0.037021', 'ticker_sentiment_score': '0.059947', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ETSY', 'relevance_score': '0.024686', 'ticker_sentiment_score': '-0.106947', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NIO', 'relevance_score': '0.024686', 'ticker_sentiment_score': '-0.072612', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FRC', 'relevance_score': '0.024686', 'ticker_sentiment_score': '-0.109906', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALB', 'relevance_score': '0.037021', 'ticker_sentiment_score': '0.028591', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEN', 'relevance_score': '0.037021', 'ticker_sentiment_score': '0.050395', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INCY', 'relevance_score': '0.037021', 'ticker_sentiment_score': '-0.177177', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'DRI', 'relevance_score': '0.024686', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LI', 'relevance_score': '0.024686', 'ticker_sentiment_score': '-0.072612', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:GBP', 'relevance_score': '0.012344', 'ticker_sentiment_score': '-0.0643', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.012344', 'ticker_sentiment_score': '-0.10007', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.012344', 'ticker_sentiment_score': '0.048552', 'ticker_sentiment_label': 'Neutral'}]"
579,"Which Is the Better Passive Income Stock, Eli Lilly or Bristol Myers Squibb?",https://www.fool.com/investing/2023/05/05/which-is-the-better-passive-income-stock-eli-lilly/,20230505T141500,['Alex Carchidi'],"One offers more income today, and the other aims to offer more in the future.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730633%2Fthree-investors-gather-around-laptop.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.744043'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}]",0.246758,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.369456', 'ticker_sentiment_score': '0.214247', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.04794', 'ticker_sentiment_score': '0.08094', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.143131', 'ticker_sentiment_score': '0.110672', 'ticker_sentiment_label': 'Neutral'}]"
580,This Top Fund Manager Buys Growth Stocks Without Paying Too Much,https://www.investors.com/etfs-and-funds/mutual-funds/top-mutual-fund-manager-buys-growth-without-paying-up/,20230505T110000,"['ADAM SHELL', ""Investor's Business Daily""]","Daniel Morris, manager of top mutual fund Manor Growth Fund ( MNRGX ) , admits he has a conservative streak. He's not the type of stock picker who buys growth stocks at any price. If a company - no matter how peppy their growth rate - is selling at an unreasonable valuation, he won't buy the ...",https://www.investors.com/wp-content/uploads/2022/07/Stock-enphaseenergy-02-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.999967'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.9545'}]",0.296267,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.103331', 'ticker_sentiment_score': '-0.015443', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVS', 'relevance_score': '0.068995', 'ticker_sentiment_score': '0.193001', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ENPH', 'relevance_score': '0.103331', 'ticker_sentiment_score': '0.269611', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'OXY', 'relevance_score': '0.068995', 'ticker_sentiment_score': '0.183334', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.103331', 'ticker_sentiment_score': '-0.015443', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TMO', 'relevance_score': '0.068995', 'ticker_sentiment_score': '0.193001', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.068995', 'ticker_sentiment_score': '0.193001', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MORN', 'relevance_score': '0.137474', 'ticker_sentiment_score': '0.08235', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EOG', 'relevance_score': '0.068995', 'ticker_sentiment_score': '0.183334', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.068995', 'ticker_sentiment_score': '0.193001', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ON', 'relevance_score': '0.068995', 'ticker_sentiment_score': '0.077171', 'ticker_sentiment_label': 'Neutral'}]"
581,Why Novo Nordisk Stock Is Slumping Today,https://www.fool.com/investing/2023/05/04/why-novo-nordisk-stock-is-slumping-today/,20230504T163332,['George Budwell'],A supply shortage for its popular weight-loss drug isn't sitting well with shareholders today.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730934%2Fcleanroom.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.236717,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.282234', 'ticker_sentiment_score': '0.115703', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.282234', 'ticker_sentiment_score': '0.417531', 'ticker_sentiment_label': 'Bullish'}]"
582,Should Investors Buy This Hot Growth Stock?,https://www.fool.com/investing/2023/05/04/should-investors-buy-this-hot-growth-stock/,20230504T141500,['Kody Kester'],This pharmaceutical giant has proved to be a tremendous wealth creator for its shareholders in recent years.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730473%2Fa-doctor-consults-with-their-patient.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.99994'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.918141'}]",0.2182,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.308504', 'ticker_sentiment_score': '0.175385', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.063258', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
583,Here's the Best Reason to Buy Eli Lilly Stock Right Now,https://www.fool.com/investing/2023/05/04/heres-the-best-reason-to-buy-eli-lilly-stock-right/,20230504T132300,['Prosper Junior Bakiny'],It has been an important factor behind the drugmaker's market-shattering returns over the past 12 months.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730363%2Fbuffett22-tmf.png&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.905476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.337696,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.38716', 'ticker_sentiment_score': '0.325068', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
584,Eli Lilly and Company  ( LLY )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2089908/eli-lilly-and-company-lly-is-attracting-investor-attention-here-is-what-you-should-know,20230504T130012,['Zacks Investment Research'],"Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default34.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.623304'}]",0.252701,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.522096', 'ticker_sentiment_score': '0.168363', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
585,These Have Been 3 of the Best-Performing Healthcare Stocks Since 2020,https://www.fool.com/investing/2023/05/04/best-performing-healthcare-stocks-since-2020/,20230504T095700,['David Jagielski'],These stocks are all up more than 150% since the start of 2020.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730363%2Fbuffett22-tmf.png&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.623304'}, {'topic': 'Earnings', 'relevance_score': '0.977154'}]",0.257344,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.245835', 'ticker_sentiment_score': '0.433648', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'MCK', 'relevance_score': '0.338913', 'ticker_sentiment_score': '0.216338', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MRNA', 'relevance_score': '0.197816', 'ticker_sentiment_score': '0.070458', 'ticker_sentiment_label': 'Neutral'}]"
586,Should You Buy Eli Lilly Stock Now?,https://www.fool.com/investing/2023/05/04/should-you-buy-eli-lilly-stock-now/,20230504T091300,['Cory Renauer'],An important clinical trial with Eli Lilly's Alzheimer's disease candidate just produced successful results.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730363%2Fbuffett22-tmf.png&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.177017,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.234911', 'ticker_sentiment_score': '0.159397', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ESALF', 'relevance_score': '0.047654', 'ticker_sentiment_score': '0.032952', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.047654', 'ticker_sentiment_score': '0.058187', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.047654', 'ticker_sentiment_score': '0.032952', 'ticker_sentiment_label': 'Neutral'}]"
587,"Dow Jones Falls, Indexes Fade As Powell Indicates 'Ongoing Assessment' On Rates",https://www.investors.com/market-trend/stock-market-today/fed-raises-rate-by-25-bps-eli-lilly-hits-all-time-high-on-alzheimers-breakthrough-report/,20230503T180700,"['VIDYA RAMAKRISHNAN', ""Investor's Business Daily""]",Fed Raises Rate By 25 BPS. Eli Lilly Hits All-Time High On ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2022/06/Stock-jeromepowell2022-05-gov.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.890401'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.999174'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.938238'}]",0.01219,Neutral,"[{'ticker': 'CVS', 'relevance_score': '0.119235', 'ticker_sentiment_score': '-0.226418', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AAPL', 'relevance_score': '0.119235', 'ticker_sentiment_score': '0.014382', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COP', 'relevance_score': '0.119235', 'ticker_sentiment_score': '-0.076239', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ETSY', 'relevance_score': '0.119235', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.119235', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.119235', 'ticker_sentiment_score': '-0.125448', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALB', 'relevance_score': '0.119235', 'ticker_sentiment_score': '0.218928', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMD', 'relevance_score': '0.235823', 'ticker_sentiment_score': '0.094359', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.119235', 'ticker_sentiment_score': '-0.043682', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RUN', 'relevance_score': '0.119235', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.119235', 'ticker_sentiment_score': '0.076933', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LTHM', 'relevance_score': '0.119235', 'ticker_sentiment_score': '0.218928', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
588,"Dow Jones Falls On Peak-Rate Uncertainty; QCOM Falls While ETSY, RUN Rise After Earnings",https://www.investors.com/market-trend/stock-market-today/fed-raises-rate-by-25-bps-eli-lilly-hits-all-time-high-on-alzheimers-breakthrough-report/,20230503T174600,"['VIDYA RAMAKRISHNAN', ""Investor's Business Daily""]",Dow Jones Rises With Fed Rate Hike Due. Eli Lilly Hits All-Time ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2022/06/Stock-jeromepowell2022-05-gov.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.928139'}, {'topic': 'Financial Markets', 'relevance_score': '0.997902'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.976671'}]",-0.043533,Neutral,"[{'ticker': 'INSP', 'relevance_score': '0.101582', 'ticker_sentiment_score': '-0.048955', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.101582', 'ticker_sentiment_score': '0.013444', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COP', 'relevance_score': '0.101582', 'ticker_sentiment_score': '-0.071182', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RUN', 'relevance_score': '0.101582', 'ticker_sentiment_score': '-0.289159', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LTHM', 'relevance_score': '0.101582', 'ticker_sentiment_score': '0.105008', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ETSY', 'relevance_score': '0.101582', 'ticker_sentiment_score': '-0.289159', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'QCOM', 'relevance_score': '0.101582', 'ticker_sentiment_score': '-0.289159', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'INTC', 'relevance_score': '0.101582', 'ticker_sentiment_score': '-0.097102', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALB', 'relevance_score': '0.101582', 'ticker_sentiment_score': '0.105008', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.250386', 'ticker_sentiment_score': '0.106048', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.101582', 'ticker_sentiment_score': '-0.04093', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LPLA', 'relevance_score': '0.050894', 'ticker_sentiment_score': '-0.122366', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.101582', 'ticker_sentiment_score': '-0.009775', 'ticker_sentiment_label': 'Neutral'}]"
589,"Top Research Reports for Berkshire Hathaway, Tesla & JPMorgan Chase",https://www.zacks.com/research-daily/2089148/top-research-reports-for-berkshire-hathaway-tesla-jpmorgan-chase,20230503T155500,['Zacks Investment Research'],"Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), Tesla, Inc. (TSLA) and JPMorgan Chase & Co. (JPM).",https://staticx-tuner.zacks.com/images/default_article_images/default263.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.838487'}]",0.234064,Somewhat-Bullish,"[{'ticker': 'ABT', 'relevance_score': '0.129168', 'ticker_sentiment_score': '0.120127', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.315628', 'ticker_sentiment_score': '0.226762', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FRC', 'relevance_score': '0.064797', 'ticker_sentiment_score': '0.099709', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.254973', 'ticker_sentiment_score': '0.192468', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BRK-A', 'relevance_score': '0.254973', 'ticker_sentiment_score': '0.192468', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.129168', 'ticker_sentiment_score': '0.120127', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CCZ', 'relevance_score': '0.064797', 'ticker_sentiment_score': '0.099709', 'ticker_sentiment_label': 'Neutral'}]"
590,SNY or LLY: Which Is the Better Value Stock Right Now?,https://www.zacks.com/stock/news/2089192/sny-or-lly-which-is-the-better-value-stock-right-now,20230503T154012,['Zacks Investment Research'],SNY vs. LLY: Which Stock Is the Better Value Option?,https://staticx-tuner.zacks.com/images/default_article_images/default33.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.459248,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.761617', 'ticker_sentiment_score': '0.516532', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SNY', 'relevance_score': '0.809819', 'ticker_sentiment_score': '0.526758', 'ticker_sentiment_label': 'Bullish'}]"
591,Stock Market Climbs As It Waits For What Could Be Pivotal Fed Announcement. Earnings Reports Spark Big Moves.,https://www.investors.com/market-trend/stock-market-today/stock-market-climbs-as-it-waits-for-what-could-be-pivotal-fed-announcement-earnings-reports-spark-big-moves/,20230503T143500,"[""Investor's Business Daily"", 'JUAN CARLOS ARANCIBIA']",Stock Market Climbs As It Waits For What Could Be Pivotal Fed ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/05/SMT_Powell_050323_news.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.998962'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}]",0.060749,Neutral,"[{'ticker': 'YUM', 'relevance_score': '0.100941', 'ticker_sentiment_score': '0.011302', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.100941', 'ticker_sentiment_score': '-0.145199', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.100941', 'ticker_sentiment_score': '0.138876', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BLDR', 'relevance_score': '0.100941', 'ticker_sentiment_score': '0.096927', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KHC', 'relevance_score': '0.100941', 'ticker_sentiment_score': '-0.059528', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.100941', 'ticker_sentiment_score': '-0.257313', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LLY', 'relevance_score': '0.150906', 'ticker_sentiment_score': '0.009424', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EAT', 'relevance_score': '0.100941', 'ticker_sentiment_score': '-0.020974', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EXP', 'relevance_score': '0.100941', 'ticker_sentiment_score': '0.206899', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
592,"Futures Await Fed; AMD Tumbles, Lilly Jumps On Alzheimer's Drug",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fed-rate-hike-due-pacwest-amd-tumble-eli-lilly-drug-slows-alzheimers/,20230503T111600,"[""Investor's Business Daily"", 'ED CARSON']","Dow Jones Futures: Fed Rate Hike Due, PacWest, AMD In Focus. Eli ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2016/02/OPTION-021916-shutterstock.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.1057,Neutral,"[{'ticker': 'AMD', 'relevance_score': '0.246582', 'ticker_sentiment_score': '-0.206252', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LLY', 'relevance_score': '0.186259', 'ticker_sentiment_score': '-0.126046', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PACW', 'relevance_score': '0.305437', 'ticker_sentiment_score': '-0.384791', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'NVDA', 'relevance_score': '0.305437', 'ticker_sentiment_score': '-0.270293', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'WAL', 'relevance_score': '0.186259', 'ticker_sentiment_score': '-0.297329', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
593,"Eli Lilly, Livent, Super Micro Computer And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session - Immunogen  ( NASDAQ:IMGN ) , Lanvin Gr Hldgs  ( NYSE:LANV ) ",https://www.benzinga.com/news/23/05/32182342/eli-lilly-livent-super-micro-computer-and-other-big-stocks-moving-higher-in-wednesdays-pre-market-se,20230503T104951,['Lisa Levin'],"U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today's pre-market trading session. ImmunoGen, Inc. IMGN gained 18.6% to $6.17 in pre-market trading. ImmunoGen recently announced inducement grants under Nasdaq Listing Rule 5635 ( c ) ( 4 ) .",https://cdn.benzinga.com/files/images/story/2023/05/03/eli_lilly_-_logo.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}]",0.236512,Somewhat-Bullish,"[{'ticker': 'TRMD', 'relevance_score': '0.285526', 'ticker_sentiment_score': '0.476787', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NKLA', 'relevance_score': '0.416844', 'ticker_sentiment_score': '0.563101', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SMCI', 'relevance_score': '0.416844', 'ticker_sentiment_score': '0.258894', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.285526', 'ticker_sentiment_score': '-0.186357', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'IMGN', 'relevance_score': '0.285526', 'ticker_sentiment_score': '0.330269', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PSO', 'relevance_score': '0.285526', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LANV', 'relevance_score': '0.416844', 'ticker_sentiment_score': '0.094843', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LTHM', 'relevance_score': '0.285526', 'ticker_sentiment_score': '0.452709', 'ticker_sentiment_label': 'Bullish'}]"
594,An investment chief who manages $1 billion in assets shares 10 investments that will reduce your portfolio's volatility while this bear market lasts longer than expected.,https://www.businessinsider.com/how-to-invest-q1-earnings-bear-stock-market-recession-risk-2023-5,20230503T100000,['James Faris'],10 Ways to Invest As Earnings Fall in a Bear Market: Landsberg - Business Insider ...,,Business Insider,GoogleRSS,www.businessinsider.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.977154'}, {'topic': 'Earnings', 'relevance_score': '0.999855'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.019808,Neutral,"[{'ticker': 'IBKR', 'relevance_score': '0.044141', 'ticker_sentiment_score': '-0.05179', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.044141', 'ticker_sentiment_score': '-0.008', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.044141', 'ticker_sentiment_score': '0.182204', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SYK', 'relevance_score': '0.088147', 'ticker_sentiment_score': '0.159342', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.044141', 'ticker_sentiment_score': '0.167492', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.088147', 'ticker_sentiment_score': '0.104463', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.088147', 'ticker_sentiment_score': '0.104463', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.088147', 'ticker_sentiment_score': '0.104463', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NEE', 'relevance_score': '0.088147', 'ticker_sentiment_score': '0.271074', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
595,"Incyte  ( INCY )  Q1 Earnings Miss Estimates, Revenues Up Y/Y",https://www.zacks.com/stock/news/2088492/incyte-incy-q1-earnings-miss-estimates-revenues-up-yy,20230502T191800,['Zacks Investment Research'],Incyte's (INCY) first-quarter 2023 earnings and revenues miss estimates due to higher patient deductibles and inventory challenges.,https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.904684'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.11794,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.206685', 'ticker_sentiment_score': '0.096132', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INCY', 'relevance_score': '0.568148', 'ticker_sentiment_score': '0.065279', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LGND', 'relevance_score': '0.206685', 'ticker_sentiment_score': '0.019599', 'ticker_sentiment_label': 'Neutral'}]"
596,Is Eli Lilly a Smart Dividend Stock to Buy Now?,https://www.fool.com/investing/2023/05/02/is-eli-lilly-a-smart-dividend-stock-to-buy-now/,20230502T134500,['Alex Carchidi'],"The first quarter seems like it was brutal, but there's more to the story.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730477%2Fsofi-stock-thumb.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.988915'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.265052,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.379051', 'ticker_sentiment_score': '0.329178', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.065685', 'ticker_sentiment_score': '0.251864', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.065685', 'ticker_sentiment_score': '0.251864', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
597,Check Out What Whales Are Doing With LLY - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/05/32128107/check-out-what-whales-are-doing-with-lly,20230501T171620,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 38 strange trades. If we consider the specifics of each trade, it is accurate to state that 52% of the investors opened trades with bullish ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.144189,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.853983', 'ticker_sentiment_score': '0.11875', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.105141', 'ticker_sentiment_score': '-0.125244', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.105141', 'ticker_sentiment_score': '-0.125244', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.105141', 'ticker_sentiment_score': '-0.125244', 'ticker_sentiment_label': 'Neutral'}]"
598,"ImmunoGen  ( IMGN )  Q1 Earnings Beat, Elahere Uptake Encouraging",https://www.zacks.com/stock/news/2087582/immunogen-imgn-q1-earnings-beat-elahere-uptake-encouraging,20230501T150000,['Zacks Investment Research'],"ImmunoGen (IMGN) reports impressive Q1 earnings results on strong adoption of sole-marketed drug Elahere. The company raises financial guidance for 2023. Post the news, shares moved up 25%.",https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.904684'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.155016,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.146692', 'ticker_sentiment_score': '0.185723', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MGNX', 'relevance_score': '0.036869', 'ticker_sentiment_score': '0.009837', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.146692', 'ticker_sentiment_score': '0.120221', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IMGN', 'relevance_score': '0.218488', 'ticker_sentiment_score': '0.020829', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LGND', 'relevance_score': '0.146692', 'ticker_sentiment_score': '0.205863', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
599,"We're taking profits on a drugmaker, raising its price target; adding to cybersecurity stock",https://www.cnbc.com/2023/05/01/taking-profits-on-a-drugmaker-raising-its-price-target-adding-to-cybersecurity-stock.html,20230501T125146,"['Jim Cramer', 'Jeff Marks']","Eli Lilly has been on an absolute tear lately, rallying about 28% from its lows on March 7 to new all-time highs above $400 per share this past Friday.",https://image.cnbcfm.com/api/v1/image/107090864-1658245265138-NUP_198367_01033_copy.jpg?v=1682945506&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.98396'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.176728,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.509206', 'ticker_sentiment_score': '0.236484', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NET', 'relevance_score': '0.042271', 'ticker_sentiment_score': '0.073481', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESALF', 'relevance_score': '0.042271', 'ticker_sentiment_score': '0.073481', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.084423', 'ticker_sentiment_score': '0.077331', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PANW', 'relevance_score': '0.328455', 'ticker_sentiment_score': '0.176348', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
600,Why Eli Lilly Stock Was a Winner Today,https://www.fool.com/investing/2023/04/28/why-eli-lilly-stock-was-a-winner-today/,20230428T221100,['Eric Volkman'],Bullish sentiment washes over the stock a day after first-quarter earnings were published.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729446%2Fa-digital-rendering-of-computer-chips-with-one-labelled-ai.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Earnings', 'relevance_score': '0.839681'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.359064,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.558244', 'ticker_sentiment_score': '0.433626', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'WFC', 'relevance_score': '0.152499', 'ticker_sentiment_score': '0.15893', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.152499', 'ticker_sentiment_score': '0.193864', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
601,Why Eli Lilly Stock Was a Winner Today,https://moneymorning.com/investing/why-eli-lilly-stock-was-a-winner-today/,20230428T221100,"['fool.com', 'Fool.com']","Eli Lilly ( NYSE: LLY ) investors continued to be in a good mood about their stock on Friday. Following the estimates-beating first quarter reported by the big pharmaceutical company the previous morning, they traded the shares up by 1.4% on the final trading day of the week.",https://moneymorning.com/wp-content/blogs.dir/1/files/2023/04/motley-fool-mark.png,Money Morning,RSS,moneymorning.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Earnings', 'relevance_score': '0.839681'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.157168,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.504646', 'ticker_sentiment_score': '0.475648', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'WFC', 'relevance_score': '0.214937', 'ticker_sentiment_score': '-0.257074', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'MS', 'relevance_score': '0.108466', 'ticker_sentiment_score': '0.165003', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
602,Eli Lilly  ( LLY )  Q1 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/04/28/eli-lilly-lly-q1-2023-earnings-call-transcript/,20230428T193431,['Motley Fool Transcribing'],"LLY earnings call for the period ending March 31, 2023.",https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.161647'}, {'topic': 'Finance', 'relevance_score': '0.5'}, {'topic': 'Economy - Macro', 'relevance_score': '0.310843'}]",0.240086,Somewhat-Bullish,"[{'ticker': 'EVR', 'relevance_score': '0.003617', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.003617', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.003617', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.003617', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.061435', 'ticker_sentiment_score': '0.093096', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.003617', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKTR', 'relevance_score': '0.003617', 'ticker_sentiment_score': '0.066702', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.003617', 'ticker_sentiment_score': '0.023305', 'ticker_sentiment_label': 'Neutral'}]"
603,"Pharma Stock Roundup: MRK & Others Post Q1 Results, LLY Drug Shines in Obesity Study",https://www.zacks.com/stock/news/2087081/pharma-stock-roundup-mrk-others-post-q1-results-lly-drug-shines-in-obesity-study,20230428T164700,['Zacks Investment Research'],"Merck (MRK), Eli Lilly (LLY), AstraZeneca (AZN) and others report first-quarter results. J&J (JNJ) provides an update on the IPO of its Consumer Health segment, Kenvue.",https://staticx-tuner.zacks.com/images/articles/main/52/873.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.576289'}, {'topic': 'Financial Markets', 'relevance_score': '0.99393'}, {'topic': 'Earnings', 'relevance_score': '0.999594'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.08586,Neutral,"[{'ticker': 'AZN', 'relevance_score': '0.105449', 'ticker_sentiment_score': '0.06709', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.035241', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.309107', 'ticker_sentiment_score': '0.116556', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMPH', 'relevance_score': '0.035241', 'ticker_sentiment_score': '0.017565', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.105449', 'ticker_sentiment_score': '0.033014', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.070414', 'ticker_sentiment_score': '-0.070296', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.105449', 'ticker_sentiment_score': '0.092897', 'ticker_sentiment_label': 'Neutral'}]"
604,Market Rally Volatile And Tight Amid Big Earnings Moves,https://www.investors.com/news/market-rally-wobbles-amid-big-earnings-moves-from-microsoft-meta-crocs-cloudflare/,20230428T163600,"[""Investor's Business Daily"", 'IBD STAFF']",Market Rally Wobbles Amid Big Earnings Moves From Microsoft ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2016/04/SSA-040816-shutterstock.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.838487'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.999999'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",-0.102594,Neutral,"[{'ticker': 'MEDP', 'relevance_score': '0.054773', 'ticker_sentiment_score': '-0.11609', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MXL', 'relevance_score': '0.036532', 'ticker_sentiment_score': '-0.090238', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TER', 'relevance_score': '0.036532', 'ticker_sentiment_score': '-0.090238', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROKU', 'relevance_score': '0.036532', 'ticker_sentiment_score': '0.069232', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.054773', 'ticker_sentiment_score': '-0.079945', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.036532', 'ticker_sentiment_score': '-0.005866', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.036532', 'ticker_sentiment_score': '-0.136848', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CROX', 'relevance_score': '0.072987', 'ticker_sentiment_score': '-0.030714', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TXN', 'relevance_score': '0.036532', 'ticker_sentiment_score': '-0.090238', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STM', 'relevance_score': '0.054773', 'ticker_sentiment_score': '-0.092033', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.091162', 'ticker_sentiment_score': '-0.00108', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MA', 'relevance_score': '0.036532', 'ticker_sentiment_score': '0.141804', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.072987', 'ticker_sentiment_score': '0.148237', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.054773', 'ticker_sentiment_score': '-0.068368', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMG', 'relevance_score': '0.072987', 'ticker_sentiment_score': '-0.006113', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DXCM', 'relevance_score': '0.054773', 'ticker_sentiment_score': '-0.11609', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GE', 'relevance_score': '0.072987', 'ticker_sentiment_score': '0.029672', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AYX', 'relevance_score': '0.036532', 'ticker_sentiment_score': '-0.1106', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KLAC', 'relevance_score': '0.036532', 'ticker_sentiment_score': '-0.090238', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.036532', 'ticker_sentiment_score': '-0.041307', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.145364', 'ticker_sentiment_score': '-0.098456', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPOT', 'relevance_score': '0.036532', 'ticker_sentiment_score': '-0.066788', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.054773', 'ticker_sentiment_score': '-0.11609', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.072987', 'ticker_sentiment_score': '-0.017451', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ILMN', 'relevance_score': '0.054773', 'ticker_sentiment_score': '-0.11609', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.036532', 'ticker_sentiment_score': '-0.108377', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.072987', 'ticker_sentiment_score': '-0.111796', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.036532', 'ticker_sentiment_score': '-0.067681', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CHDN', 'relevance_score': '0.036532', 'ticker_sentiment_score': '0.169405', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EW', 'relevance_score': '0.054773', 'ticker_sentiment_score': '-0.11609', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FRC', 'relevance_score': '0.091162', 'ticker_sentiment_score': '-0.109548', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.072987', 'ticker_sentiment_score': '-0.093739', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOW', 'relevance_score': '0.036532', 'ticker_sentiment_score': '-0.1106', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.036532', 'ticker_sentiment_score': '-0.077119', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CDNS', 'relevance_score': '0.036532', 'ticker_sentiment_score': '-0.042982', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PI', 'relevance_score': '0.036532', 'ticker_sentiment_score': '-0.090238', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WOLF', 'relevance_score': '0.036532', 'ticker_sentiment_score': '-0.090238', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NET', 'relevance_score': '0.091162', 'ticker_sentiment_score': '-0.095446', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.091162', 'ticker_sentiment_score': '-0.037536', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.036532', 'ticker_sentiment_score': '-0.06261', 'ticker_sentiment_label': 'Neutral'}]"
605,"Club meeting recap: Stocks gain, Eli Lilly, Amazon",https://www.cnbc.com/2023/04/28/club-meeting-recap-stocks-gain-eli-lilly-amazon-.html,20230428T154638,['Kevin Stankiewicz'],"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",https://image.cnbcfm.com/api/v1/image/107232801-1682694114746-1682694030419-CRAMER-MM-042823.jpg?v=1682694531&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.99676'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.23385,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.489659', 'ticker_sentiment_score': '0.304777', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.222157', 'ticker_sentiment_score': '0.172365', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.222157', 'ticker_sentiment_score': '0.172365', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMZN', 'relevance_score': '0.489659', 'ticker_sentiment_score': '0.304777', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
606,Why ImmunoGen  ( IMGN )  Shares Are Surging Today - Immunogen  ( NASDAQ:IMGN ) ,https://www.benzinga.com/general/biotech/23/04/32083714/immunogen-boosts-annual-guidance-on-upbeat-uptake-of-newly-approved-ovarian-cancer-drug,20230428T141220,['Vandana Singh'],"ImmunoGen Inc IMGN shares are surging Friday morning following its impressive first-quarter performance. IMGN reported Q1 revenues of $49.9 million, easily surpassing the consensus of $20.47 million and higher than $38.1 million a year ago.",https://cdn.benzinga.com/files/images/story/2023/04/28/imgn.png?optimize=medium&dpr=2&auto=webp&width=3840,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.263687,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.263942', 'ticker_sentiment_score': '0.121401', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.263942', 'ticker_sentiment_score': '0.287589', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'IMGN', 'relevance_score': '0.499789', 'ticker_sentiment_score': '0.5293', 'ticker_sentiment_label': 'Bullish'}]"
607,Jim Cramer's top 10 things to watch in the stock market Friday,https://www.cnbc.com/2023/04/28/jim-cramers-top-10-things-to-watch-in-the-stock-market-friday.html,20230428T130812,['Jim Cramer'],"The Dow, the S&P 500 and the Nasdaq are set for a lower open after Wall Street's Thursday surge.",https://image.cnbcfm.com/api/v1/image/106953081-1633520870999-gettyimages-1235716390-GEEKWIRE_2021.jpeg?v=1682687292&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.997405'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.972756'}]",0.117816,Neutral,"[{'ticker': 'C', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.236345', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CVX', 'relevance_score': '0.09989', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HON', 'relevance_score': '0.149346', 'ticker_sentiment_score': '0.292734', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.09989', 'ticker_sentiment_score': '0.093669', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LIN', 'relevance_score': '0.149346', 'ticker_sentiment_score': '0.238495', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BCS', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.169851', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NCLH', 'relevance_score': '0.09989', 'ticker_sentiment_score': '-0.031748', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FRC', 'relevance_score': '0.09989', 'ticker_sentiment_score': '-0.010064', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.149346', 'ticker_sentiment_score': '0.038849', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.149346', 'ticker_sentiment_score': '0.02677', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.09989', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.149346', 'ticker_sentiment_score': '0.209518', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'STZ', 'relevance_score': '0.149346', 'ticker_sentiment_score': '-0.017949', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RCL', 'relevance_score': '0.09989', 'ticker_sentiment_score': '-0.031748', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.198221', 'ticker_sentiment_score': '0.076639', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SAM', 'relevance_score': '0.09989', 'ticker_sentiment_score': '-0.176167', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
608,Government Drug Price Curbs Could Sound A Death Knell For Industry,https://www.investors.com/news/technology/biotech-stocks-brace-for-the-worst-as-government-drug-price-negotiations-loom/,20230428T120000,"[""Investor's Business Daily"", 'ALLISON GATLIN']",Biotech Stocks Brace For The Worst As Government Drug Price ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2022/09/Stock-humira-01-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.839681'}, {'topic': 'Earnings', 'relevance_score': '0.684621'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.024097,Neutral,"[{'ticker': 'NVO', 'relevance_score': '0.040668', 'ticker_sentiment_score': '-0.11222', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.027118', 'ticker_sentiment_score': '0.044929', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.027118', 'ticker_sentiment_score': '-0.055277', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.027118', 'ticker_sentiment_score': '-0.076847', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.08123', 'ticker_sentiment_score': '-0.011317', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.027118', 'ticker_sentiment_score': '0.044929', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BNTX', 'relevance_score': '0.027118', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.013561', 'ticker_sentiment_score': '0.077066', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HZNP', 'relevance_score': '0.027118', 'ticker_sentiment_score': '-0.076847', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CLVT', 'relevance_score': '0.027118', 'ticker_sentiment_score': '0.05187', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.067727', 'ticker_sentiment_score': '-0.061364', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCO', 'relevance_score': '0.027118', 'ticker_sentiment_score': '0.0266', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.027118', 'ticker_sentiment_score': '0.052088', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SGEN', 'relevance_score': '0.040668', 'ticker_sentiment_score': '-0.064288', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.067727', 'ticker_sentiment_score': '0.005039', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REGN', 'relevance_score': '0.027118', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.054205', 'ticker_sentiment_score': '-0.077946', 'ticker_sentiment_label': 'Neutral'}]"
609,5 Brand-Name Safe Stocks I Wouldn't Touch With a 10-Foot Pole Right Now,https://www.fool.com/investing/2023/04/28/5-safe-stocks-i-wouldnt-touch-with-a-10-foot-pole/,20230428T092100,['Sean Williams'],"These well-known, time-tested businesses are exceptionally pricey given the current economic outlook.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729606%2Fbusinessman-holding-hands-up-stop-avoid-getty.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.838487'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.999999'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.988787'}]",0.051499,Neutral,"[{'ticker': 'AAPL', 'relevance_score': '0.152499', 'ticker_sentiment_score': '0.126869', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.182506', 'ticker_sentiment_score': '-0.009148', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KHC', 'relevance_score': '0.212248', 'ticker_sentiment_score': '0.097759', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.122269', 'ticker_sentiment_score': '0.004809', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.152499', 'ticker_sentiment_score': '0.085187', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.061315', 'ticker_sentiment_score': '0.176076', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BMY', 'relevance_score': '0.061315', 'ticker_sentiment_score': '0.176076', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
610,5 Brand-Name Safe Stocks I Wouldn't Touch With a 10-Foot Pole Right Now,https://moneymorning.com/investing/5-brand-name-safe-stocks-i-wouldnt-touch-with-a-10-foot-pole-right-now/,20230428T092100,"['fool.com', 'Fool.com']","There's no two ways about it, the last 16 months have been challenging for investors. All three major U.S. stock indexes entered a bear market in 2022, with growth stocks getting hit especially hard. But the volatility equities experienced last year may be about to ramp up once again.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729606%2Fbusinessman-holding-hands-up-stop-avoid-getty.jpg&w=700,Money Morning,RSS,moneymorning.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.838487'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.988787'}]",0.036947,Neutral,"[{'ticker': 'AAPL', 'relevance_score': '0.166551', 'ticker_sentiment_score': '0.013619', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.247558', 'ticker_sentiment_score': '-0.001992', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KHC', 'relevance_score': '0.220809', 'ticker_sentiment_score': '0.007267', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.111488', 'ticker_sentiment_score': '0.00461', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.139104', 'ticker_sentiment_score': '0.080622', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.083735', 'ticker_sentiment_score': '-0.067109', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.083735', 'ticker_sentiment_score': '-0.067109', 'ticker_sentiment_label': 'Neutral'}]"
611,Is Eli Lilly Stock a No-Brainer Buy After Mounjaro's Latest Big Win?,https://www.fool.com/investing/2023/04/27/is-eli-lilly-stock-a-no-brainer-buy-after-mounjaro/,20230427T214900,['Keith Speights'],This big drugmaker could soon make a big splash in the obesity market.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729228%2Frolled-up-cash-money-invest-save-three-hundred-dollars-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.138922,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.73871', 'ticker_sentiment_score': '0.220247', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.052685', 'ticker_sentiment_score': '-0.038003', 'ticker_sentiment_label': 'Neutral'}]"
612,Is Eli Lilly Stock a No-Brainer Buy After Mounjaro's Latest Big Win?,https://moneymorning.com/investing/is-eli-lilly-stock-a-no-brainer-buy-after-mounjaros-latest-big-win/,20230427T214900,"['Fool.com', 'Chris Johnson', 'Nick Black', 'fool.com']","Watch out, Ozempic and Wegovy. You could have a formidable new rival in the weight-loss market soon. Eli Lilly and Company ( NYSE: LLY ) announced overwhelmingly positive results on Thursday from the Surmount-2 phase 3 study evaluating tirzepatide ( marketed as Mounjaro in treating type 2 ...",https://moneymorning.com/wp-content/blogs.dir/1/files/2023/04/motley-fool-mark.png,Money Morning,RSS,moneymorning.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.089619,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.71032', 'ticker_sentiment_score': '0.267376', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.046907', 'ticker_sentiment_score': '-0.037934', 'ticker_sentiment_label': 'Neutral'}]"
613,"Eli Lilly  ( LLY )  Q1 Earnings Miss, Sales Beat, '23 View Raised",https://www.zacks.com/stock/news/2086376/eli-lilly-lly-q1-earnings-miss-sales-beat-23-view-raised,20230427T182500,['Zacks Investment Research'],"Eli Lilly (LLY) reports mixed results for the first quarter of 2023, missing estimates for earnings while beating the same for revenues. Management raises the 2023 outlook.",https://staticx-tuner.zacks.com/images/articles/main/ff/2922.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}]",0.062649,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.374096', 'ticker_sentiment_score': '-0.013136', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INCY', 'relevance_score': '0.029914', 'ticker_sentiment_score': '-0.000933', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.148731', 'ticker_sentiment_score': '0.101897', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.148731', 'ticker_sentiment_score': '0.082232', 'ticker_sentiment_label': 'Neutral'}]"
614,"Indexes Hit Session Highs After Jobs, GDP Data; Amazon Clears Key Level With Earnings Due",https://www.investors.com/market-trend/stock-market-today/dow-jones-rises-after-jobs-gdp-data-amazon-clears-key-price-level/,20230427T175800,"[""Investor's Business Daily"", 'VIDYA RAMAKRISHNAN']","Indexes Hit Session Highs After Jobs, GDP Data. Amazon Clears ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2019/04/Stock-KohlsAmazonReturns-01-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.999355'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.890401'}]",0.031254,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.148731', 'ticker_sentiment_score': '0.105002', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.074692', 'ticker_sentiment_score': '0.080326', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.148731', 'ticker_sentiment_score': '0.102401', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.148731', 'ticker_sentiment_score': '0.105002', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FSLR', 'relevance_score': '0.148731', 'ticker_sentiment_score': '0.107243', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.074692', 'ticker_sentiment_score': '0.085757', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.148731', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.148731', 'ticker_sentiment_score': '0.048903', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.148731', 'ticker_sentiment_score': '-0.213841', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AMD', 'relevance_score': '0.221481', 'ticker_sentiment_score': '-0.009074', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.148731', 'ticker_sentiment_score': '-0.213841', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AMZN', 'relevance_score': '0.426225', 'ticker_sentiment_score': '0.202461', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
615,Why Eli Lilly Stock Is Rising Today,https://www.fool.com/investing/2023/04/27/why-eli-lilly-stock-is-rising-today/,20230427T160650,['Keith Speights'],Investors are applauding the pharmaceutical giant's latest clinical update more than they are its Q1 results.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729329%2Fstacks-of-dollar-bills.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Earnings', 'relevance_score': '0.999981'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.190559,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.68039', 'ticker_sentiment_score': '0.345023', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
616,Why Eli Lilly Stock Is Rising Today,https://moneymorning.com/investing/why-eli-lilly-stock-is-rising-today/,20230427T160650,"['Fool.com', 'fool.com']","Shares of Eli Lilly ( NYSE: LLY ) were trading 2% higher as of 11:50 a.m. ET Thursday after having jumped by as much as 5.9% earlier in the day. The big drugmaker announced its first-quarter results before the market opened. Lilly's Q1 numbers, however, weren't all that great.",https://moneymorning.com/wp-content/blogs.dir/1/files/2023/04/motley-fool-mark.png,Money Morning,RSS,moneymorning.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '0.999981'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.091748,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.631282', 'ticker_sentiment_score': '0.402346', 'ticker_sentiment_label': 'Bullish'}]"
617,Big Tech Charges Higher While Small Caps Lag; Analyst Warns Of Chip Stocks Breakdown,https://www.investors.com/market-trend/stock-market-today/stock-market-mounts-big-tech-rally-after-zuckerberg-touts-meta-turnaround-airlines-hit-turbulence/,20230427T160100,"[""Investor's Business Daily"", 'ALAN FARLEY']",Big Tech Charges Higher While Small Caps Lag. Analyst Warns Of ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2019/07/Stock-chips-43-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.999975'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.996718'}]",-0.014783,Neutral,"[{'ticker': 'META', 'relevance_score': '0.114137', 'ticker_sentiment_score': '0.117905', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CROX', 'relevance_score': '0.114137', 'ticker_sentiment_score': '-0.086817', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.114137', 'ticker_sentiment_score': '0.024021', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AEM', 'relevance_score': '0.114137', 'ticker_sentiment_score': '0.146776', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LUV', 'relevance_score': '0.114137', 'ticker_sentiment_score': '-0.185058', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSCO', 'relevance_score': '0.114137', 'ticker_sentiment_score': '-0.11465', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.076236', 'ticker_sentiment_score': '-0.163488', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.038162', 'ticker_sentiment_score': '-0.075752', 'ticker_sentiment_label': 'Neutral'}]"
618,Looking At Eli Lilly's Recent Unusual Options Activity - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/04/32048230/looking-at-eli-lillys-recent-unusual-options-activity,20230427T141656,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bearish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.092372,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.832645', 'ticker_sentiment_score': '0.012183', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.198221', 'ticker_sentiment_score': '-0.178036', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
619,Why Eli Lilly  ( LLY )  Shares Are Trading Higher Today - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/general/biotech/23/04/32044860/why-eli-lilly-shares-are-trading-higher-today,20230427T135508,['Vandana Singh'],"Eli Lilly And Co LLY has reported Q1 sales of $6.96 billion, down 11% Y/Y, beating the consensus of $6.86 billion, driven by a $1.47 billion decline in revenue from COVID-19 antibodies. Excluding COVID-19 antibodies, revenue in Q1 2023 increased by 10%, driven by volume growth from Mounjaro, ...",https://cdn.benzinga.com/files/images/story/2023/04/27/lly.png?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.962106'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.031179,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.757528', 'ticker_sentiment_score': '-0.133414', 'ticker_sentiment_label': 'Neutral'}]"
620,Is Eli Lilly Stock a Strong Buy After Q1 Earnings?,https://moneymorning.com/investing/is-eli-lilly-stock-a-strong-buy-after-q1-earnings/,20230427T132500,"['fool.com', 'Fool.com']",The stock of Eli Lilly ( NYSE: LLY ) has been on a wild ride in 2023.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fmedia.ycharts.com%2Fcharts%2F0aaf361748d1a92200ced32d5cdb5037.png&w=700,Money Morning,RSS,moneymorning.com,"[{'topic': 'Earnings', 'relevance_score': '0.875462'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}]",-0.064704,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.24289', 'ticker_sentiment_score': '-0.246108', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
621,Is Eli Lilly Stock a Strong Buy After Q1 Earnings?,https://www.fool.com/investing/2023/04/27/is-eli-lilly-stock-a-strong-buy-after-q1-earnings/,20230427T132500,['George Budwell'],Lilly's mixed Q1 report contains some important info for long-term investors.,https://media.ycharts.com/charts/0aaf361748d1a92200ced32d5cdb5037.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.917436'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.995077'}]",-0.019327,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.212425', 'ticker_sentiment_score': '-0.223664', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
622,Eli Lilly's Obesity Treatment Hopeful Just Crushed Sales Estimates,https://www.investors.com/news/technology/eli-lilly-stock-eli-lilly-earnings-q1-2023/,20230427T125700,"['ALLISON GATLIN', ""Investor's Business Daily""]",Eli Lilly Stock Jumps As Diabetes Newcomer Crushes Sales ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2018/12/stock-Eli-Lilly-02-Shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.744043'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}]",0.296207,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.937588', 'ticker_sentiment_score': '0.553125', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'VKTX', 'relevance_score': '0.290607', 'ticker_sentiment_score': '0.104201', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.290607', 'ticker_sentiment_score': '0.104201', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ILMN', 'relevance_score': '0.147818', 'ticker_sentiment_score': '-0.008306', 'ticker_sentiment_label': 'Neutral'}]"
623,Eli Lilly  ( LLY )  Q1 Earnings Lag Estimates,https://www.zacks.com/stock/news/2085706/eli-lilly-lly-q1-earnings-lag-estimates,20230427T120513,['Zacks Investment Research'],"Lilly (LLY) delivered earnings and revenue surprises of -6.36% and 2.17%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?",https://staticx-tuner.zacks.com/images/default_article_images/default278.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999992'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.161759,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.402403', 'ticker_sentiment_score': '0.184805', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
624,"Why US Stocks Are Poised To Open Higher Thursday - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/23/04/32041361/us-stocks-eye-higher-open-as-meta-q1-uplifts-tech-sector-analyst-says-no-earnings-recession-in-card,20230427T110448,['Shanthi Rexaline'],"Tech earnings could come to the market's rescue on Thursday, with all major index futures currently trading higher. Traders could also weigh in on the first-quarter GDP report to take stock of how the economy fared amid a housing market downturn, banking crisis, and rising rate environment.",https://cdn.benzinga.com/files/images/story/2023/04/27/shutterstock_1321462400.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '0.986714'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",-0.045987,Neutral,"[{'ticker': 'MAT', 'relevance_score': '0.092927', 'ticker_sentiment_score': '-0.082361', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROKU', 'relevance_score': '0.184598', 'ticker_sentiment_score': '-0.077057', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.046543', 'ticker_sentiment_score': '0.22746', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMGN', 'relevance_score': '0.092927', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.092927', 'ticker_sentiment_score': '-0.045771', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MA', 'relevance_score': '0.046543', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VNO', 'relevance_score': '0.092927', 'ticker_sentiment_score': '-0.207512', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LLY', 'relevance_score': '0.092927', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COF', 'relevance_score': '0.092927', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PINS', 'relevance_score': '0.092927', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.092927', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KLAC', 'relevance_score': '0.092927', 'ticker_sentiment_score': '-0.082361', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.184598', 'ticker_sentiment_score': '0.081253', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.092927', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAL', 'relevance_score': '0.092927', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LUV', 'relevance_score': '0.092927', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNAP', 'relevance_score': '0.092927', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CP', 'relevance_score': '0.092927', 'ticker_sentiment_score': '-0.082361', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BZH', 'relevance_score': '0.092927', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FSLR', 'relevance_score': '0.092927', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EBAY', 'relevance_score': '0.184598', 'ticker_sentiment_score': '-0.077057', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.092927', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.092927', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WOLF', 'relevance_score': '0.092927', 'ticker_sentiment_score': '-0.262484', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CCZ', 'relevance_score': '0.046543', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HAS', 'relevance_score': '0.046543', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.092927', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
625,"Lilly Reports First-Quarter 2023 Financial Results, Highlights Continued Core Business Growth and Pipeline Momentum",https://www.prnewswire.com/news-releases/lilly-reports-first-quarter-2023-financial-results-highlights-continued-core-business-growth-and-pipeline-momentum-301808936.html,20230427T104500,['Eli Lilly and Company'],"Lilly Reports First-Quarter 2023 Financial Results, Highlights ... PR ...",https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999997'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.413559'}, {'topic': 'Economy - Macro', 'relevance_score': '0.451494'}]",0.145139,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.269419', 'ticker_sentiment_score': '0.204057', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CURN', 'relevance_score': '0.01099', 'ticker_sentiment_score': '0.005157', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMPH', 'relevance_score': '0.01099', 'ticker_sentiment_score': '0.159966', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.01099', 'ticker_sentiment_score': '0.082858', 'ticker_sentiment_label': 'Neutral'}]"
626,"Markets Continue Steady Slide; META, EBAY Beat Q1 Earnings",https://www.zacks.com/stock/news/2085436/markets-continue-steady-slide-meta-ebay-beat-q1-earnings,20230426T220400,['Zacks Investment Research'],"Except the Nasdaq, which snapped a two-day losing streak and was the only major index in the green all day.",https://staticx-tuner.zacks.com/images/articles/main/bb/2726.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.980509'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.149184,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.078173', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.204072', 'ticker_sentiment_score': '0.102374', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EBAY', 'relevance_score': '0.204072', 'ticker_sentiment_score': '0.102374', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.078173', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.078173', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.078173', 'ticker_sentiment_label': 'Neutral'}]"
627,Futures: Meta Spikes Late; First Republic Still Hitting Market,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-meta-soars-megacaps-cant-hide-market-woes-as-first-republic-crashes/,20230426T212300,"['ED CARSON', ""Investor's Business Daily""]","Dow Jones Futures: Meta Soars, But Megacaps Can't Hide Market ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2017/11/stock-bull-tongue-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.997874'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}]",-0.067713,Neutral,"[{'ticker': 'MTH', 'relevance_score': '0.096769', 'ticker_sentiment_score': '-0.009511', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PACW', 'relevance_score': '0.048474', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.072655', 'ticker_sentiment_score': '-0.029157', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.048474', 'ticker_sentiment_score': '-0.044416', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANET', 'relevance_score': '0.048474', 'ticker_sentiment_score': '-0.044416', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.072655', 'ticker_sentiment_score': '-0.049643', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CROX', 'relevance_score': '0.096769', 'ticker_sentiment_score': '0.015863', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAIB', 'relevance_score': '0.024248', 'ticker_sentiment_score': '0.026479', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.096769', 'ticker_sentiment_score': '0.001067', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.024248', 'ticker_sentiment_score': '-0.051374', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.215574', 'ticker_sentiment_score': '-0.154316', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSLA', 'relevance_score': '0.024248', 'ticker_sentiment_score': '0.21267', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MA', 'relevance_score': '0.048474', 'ticker_sentiment_score': '-0.02563', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FRC', 'relevance_score': '0.144708', 'ticker_sentiment_score': '-0.086328', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOW', 'relevance_score': '0.096769', 'ticker_sentiment_score': '-0.039048', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.120794', 'ticker_sentiment_score': '0.025506', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PI', 'relevance_score': '0.096769', 'ticker_sentiment_score': '-0.12955', 'ticker_sentiment_label': 'Neutral'}]"
628,Why Eli Lilly Stock Is Under Pressure Today,https://www.fool.com/investing/2023/04/26/why-eli-lilly-stock-is-under-pressure-today/,20230426T172054,['George Budwell'],Investors are worried that the drugmaker won't hit Wall Street's top- and bottom-line targets when it reports 2023 Q1 earnings tomorrow.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729300%2Fwarren-buffett.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.795202'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}]",-0.019561,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.716023', 'ticker_sentiment_score': '-0.093346', 'ticker_sentiment_label': 'Neutral'}]"
629,"Microsoft's Strong Quarter Lifts Tech, But Banking Worries Keep Market Mainly On Defensive - Alphabet  ( NASDAQ:GOOGL ) , Chipotle Mexican Grill  ( NYSE:CMG ) ",https://www.benzinga.com/markets/23/04/32014643/microsofts-strong-quarter-lifts-tech-but-banking-worries-keep-market-mainly-on-defensive,20230426T154238,['Alex Coffey'],"( Wednesday market open ) When it's earnings season, the trading day seldom ends with the closing bell. If you shut down your screens at 4 p.m. ET yesterday, you might have felt gloomy after the S&P 500® index ( SPX ) posted its lowest close since March 30.",https://cdn.benzinga.com/files/images/story/2023/04/26/shutterstock_2291678851.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.972193'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.041357,Neutral,"[{'ticker': 'DD', 'relevance_score': '0.03777', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MPC', 'relevance_score': '0.03777', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.03777', 'ticker_sentiment_score': '0.066143', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BG', 'relevance_score': '0.03777', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KHC', 'relevance_score': '0.03777', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ITW', 'relevance_score': '0.03777', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.03777', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.168752', 'ticker_sentiment_score': '0.080689', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MA', 'relevance_score': '0.018891', 'ticker_sentiment_score': '-0.059639', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.03777', 'ticker_sentiment_score': '0.16607', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.03777', 'ticker_sentiment_score': '-0.066143', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UPS', 'relevance_score': '0.03777', 'ticker_sentiment_score': '-0.057736', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMG', 'relevance_score': '0.03777', 'ticker_sentiment_score': '0.16607', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CMI', 'relevance_score': '0.03777', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AON', 'relevance_score': '0.03777', 'ticker_sentiment_score': '0.066143', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MO', 'relevance_score': '0.03777', 'ticker_sentiment_score': '-0.066143', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HON', 'relevance_score': '0.03777', 'ticker_sentiment_score': '-0.066143', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.03777', 'ticker_sentiment_score': '-0.066143', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.03777', 'ticker_sentiment_score': '-0.066143', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'YUM', 'relevance_score': '0.03777', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EXC', 'relevance_score': '0.03777', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FRC', 'relevance_score': '0.094241', 'ticker_sentiment_score': '-0.084672', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.03777', 'ticker_sentiment_score': '-0.066143', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CNA', 'relevance_score': '0.03777', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NEM', 'relevance_score': '0.03777', 'ticker_sentiment_score': '-0.066143', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.03777', 'ticker_sentiment_score': '0.066143', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATVI', 'relevance_score': '0.056629', 'ticker_sentiment_score': '-0.051196', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAX', 'relevance_score': '0.03777', 'ticker_sentiment_score': '-0.066143', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.094241', 'ticker_sentiment_score': '-0.009622', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.03777', 'ticker_sentiment_score': '0.089644', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MAR', 'relevance_score': '0.03777', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.018891', 'ticker_sentiment_score': '0.069273', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:NEM', 'relevance_score': '0.018891', 'ticker_sentiment_score': '-0.059639', 'ticker_sentiment_label': 'Neutral'}]"
630,"Drug/Biotech Stocks' Q1 Earnings Due Apr 27: LLY, ABBV & More",https://www.zacks.com/stock/news/2084870/drugbiotech-stocks-q1-earnings-due-apr-27-lly-abbv-more,20230426T132800,['Zacks Investment Research'],Let's look at the five biotech/pharma companies slated to release quarterly results on Apr 27.,https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.193386,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.263942', 'ticker_sentiment_score': '0.031445', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.263942', 'ticker_sentiment_score': '0.127168', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.263942', 'ticker_sentiment_score': '0.095222', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.038407', 'ticker_sentiment_score': '0.106241', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.227361', 'ticker_sentiment_score': '0.046608', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.038407', 'ticker_sentiment_score': '0.106241', 'ticker_sentiment_label': 'Neutral'}]"
631,Why Earnings Season Could Be Great for Eli Lilly  ( LLY ) ,https://www.zacks.com/stock/news/2084816/why-earnings-season-could-be-great-for-eli-lilly-lly,20230426T123200,['Zacks Investment Research'],Eli Lilly (LLY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.,https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.99237'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.449965,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.89699', 'ticker_sentiment_score': '0.693988', 'ticker_sentiment_label': 'Bullish'}]"
632,"A Rotation Into Defensive Stocks? Market Strength Seen In Consumer Defensive And Healthcare On Tuesday - Centene  ( NYSE:CNC ) , AbbVie  ( NYSE:ABBV ) ",https://www.benzinga.com/general/health-care/23/04/31995117/a-rotation-into-defensive-stocks-market-strength-seen-in-consumer-defensive-and-healthcare-on,20230425T172337,['Ryan Glosier'],"The U.S. stock market is seeing some modest selling on Tuesday morning after a series of largely uneventful sessions last week. Two hours into the trading day, the S&P 500 was down around 0.75% and the Nasdaq had pared 0.90%.",https://cdn.benzinga.com/files/images/story/2023/04/25/screenshot_2023-04-25_at_10.51.40_pm.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.928139'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.248484,Somewhat-Bullish,"[{'ticker': 'GIS', 'relevance_score': '0.141171', 'ticker_sentiment_score': '0.185585', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KMB', 'relevance_score': '0.141171', 'ticker_sentiment_score': '0.209855', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SMGBF', 'relevance_score': '0.047278', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.141171', 'ticker_sentiment_score': '0.074575', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.233108', 'ticker_sentiment_score': '0.271429', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CNC', 'relevance_score': '0.141171', 'ticker_sentiment_score': '0.169954', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PEP', 'relevance_score': '0.141171', 'ticker_sentiment_score': '0.105321', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.141171', 'ticker_sentiment_score': '0.234773', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PM', 'relevance_score': '0.141171', 'ticker_sentiment_score': '0.071111', 'ticker_sentiment_label': 'Neutral'}]"
633,"Risk-Off Rerun: Banking Concerns, Nerves Ahead of Microsoft, Alphabet Earnings Bring Pressure - First Republic Bank  ( NYSE:FRC ) , General Electric  ( NYSE:GE ) ",https://www.benzinga.com/markets/23/04/31993957/risk-off-rerun-banking-concerns-nerves-ahead-of-microsoft-alphabet-earnings-bring-pressure,20230425T162543,['Shashank Jacob'],( Tuesday market open ) The rubber hits the road for info tech earnings starting later today when Microsoft MSFT and Alphabet GOOGL open their quarterly books.,https://cdn.benzinga.com/files/images/story/2023/04/25/shutterstock_1049641082_10.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.0,Neutral,"[{'ticker': 'DD', 'relevance_score': '0.037416', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MPC', 'relevance_score': '0.037416', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.07475', 'ticker_sentiment_score': '0.0605', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.037416', 'ticker_sentiment_score': '0.09428', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VZ', 'relevance_score': '0.037416', 'ticker_sentiment_score': '-0.116923', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TXN', 'relevance_score': '0.037416', 'ticker_sentiment_score': '0.054467', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ITW', 'relevance_score': '0.037416', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.037416', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.22165', 'ticker_sentiment_score': '0.031203', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.037416', 'ticker_sentiment_score': '0.037163', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MA', 'relevance_score': '0.018713', 'ticker_sentiment_score': '-0.059563', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.037416', 'ticker_sentiment_score': '0.012571', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.037416', 'ticker_sentiment_score': '-0.066054', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UPS', 'relevance_score': '0.037416', 'ticker_sentiment_score': '0.032976', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMG', 'relevance_score': '0.037416', 'ticker_sentiment_score': '0.012571', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMI', 'relevance_score': '0.037416', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GE', 'relevance_score': '0.111921', 'ticker_sentiment_score': '0.098902', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NSC', 'relevance_score': '0.037416', 'ticker_sentiment_score': '0.079618', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AON', 'relevance_score': '0.037416', 'ticker_sentiment_score': '0.066054', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.018713', 'ticker_sentiment_score': '-0.081542', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUM', 'relevance_score': '0.07475', 'ticker_sentiment_score': '0.030379', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MO', 'relevance_score': '0.037416', 'ticker_sentiment_score': '-0.066054', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.056099', 'ticker_sentiment_score': '0.136', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.037416', 'ticker_sentiment_score': '0.079618', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.056099', 'ticker_sentiment_score': '0.064992', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HON', 'relevance_score': '0.037416', 'ticker_sentiment_score': '-0.066054', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.037416', 'ticker_sentiment_score': '-0.066054', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.037416', 'ticker_sentiment_score': '-0.066054', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FRC', 'relevance_score': '0.037416', 'ticker_sentiment_score': '-0.149281', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.037416', 'ticker_sentiment_score': '0.054467', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.037416', 'ticker_sentiment_score': '-0.066054', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CNA', 'relevance_score': '0.037416', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NEM', 'relevance_score': '0.037416', 'ticker_sentiment_score': '-0.066054', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.07475', 'ticker_sentiment_score': '0.0605', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAX', 'relevance_score': '0.037416', 'ticker_sentiment_score': '-0.066054', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.056099', 'ticker_sentiment_score': '0.156015', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMZN', 'relevance_score': '0.07475', 'ticker_sentiment_score': '0.009103', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.111921', 'ticker_sentiment_score': '0.033378', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MAR', 'relevance_score': '0.037416', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:NEM', 'relevance_score': '0.018713', 'ticker_sentiment_score': '-0.059563', 'ticker_sentiment_label': 'Neutral'}]"
634,2 Monster Stocks to Buy Without Any Hesitation,https://www.fool.com/investing/2023/04/25/2-monster-stocks-to-buy-without-any-hesitation/,20230425T142000,['Jim Halley'],"These stocks have grown revenue, earnings and share price over the past five years.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729189%2Fnio-et5.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.999993'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.247204,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.244846', 'ticker_sentiment_score': '0.243995', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DXCM', 'relevance_score': '0.382193', 'ticker_sentiment_score': '0.273202', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.049732', 'ticker_sentiment_score': '0.166157', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
635,Want Consistently Growing Passive Income? Buy Johnson & Johnson Stock,https://www.fool.com/investing/2023/04/25/want-consistently-growing-passive-income-buy-johns/,20230425T105000,['Kody Kester'],The healthcare juggernaut recently extended its illustrious dividend growth streak.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729022%2Fhealthcare-professionals-talking-to-each-other.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.905476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.77141'}]",0.260736,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.064449', 'ticker_sentiment_score': '0.047025', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.064449', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.128478', 'ticker_sentiment_score': '0.195915', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.064449', 'ticker_sentiment_score': '0.15322', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
636,Better Buy: Novo Nordisk vs. Eli Lilly,https://www.fool.com/investing/2023/04/25/better-buy-novo-nordisk-vs-eli-lilly/,20230425T091700,['Cory Renauer'],Both have chronic weight-management products that are flying off pharmacy shelves.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728900%2Fwarren-buffett-brka-brkb-berkshire-hathaway-motley-fool2.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.769861'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.121794,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.348103', 'ticker_sentiment_score': '0.254834', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.388209', 'ticker_sentiment_score': '0.086866', 'ticker_sentiment_label': 'Neutral'}]"
637,Eli Lilly Unusual Options Activity - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/04/31967887/eli-lilly-unusual-options-activity,20230424T193041,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bullish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.145863,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.818461', 'ticker_sentiment_score': '0.139868', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.191929', 'ticker_sentiment_score': '-0.173828', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
638,"Setting the Bar: After Shares Rallied in Q1, Big-Tech Companies Ready to Share Results This Week",https://www.benzinga.com/markets/23/04/31961561/setting-the-bar-after-shares-rallied-in-q1-big-tech-companies-ready-to-share-results-this-week,20230424T155149,['Alex Coffey'],"( Monday market open ) Earnings season is nearly 20% complete, but this week is when company reports could start having a more dramatic impact on major indexes. That's because ""mega-cap"" companies like Microsoft ( MSFT ) , Alphabet ( GOOGL ) , Amazon ( AMZN ) , and Meta ( META ) are among the ...",https://cdn.benzinga.com/files/images/story/2023/04/24/shutterstock_2074315681_1.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.838487'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.995973'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",-0.002412,Neutral,"[{'ticker': 'DE', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.025566', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROKU', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.054597', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.067029', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.077808', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VZ', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.061159', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BG', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.025566', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADM', 'relevance_score': '0.062379', 'ticker_sentiment_score': '0.026056', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TXN', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.041647', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.225854', 'ticker_sentiment_score': '0.059742', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MA', 'relevance_score': '0.020812', 'ticker_sentiment_score': '-0.060447', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.04161', 'ticker_sentiment_score': '-0.067029', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UPS', 'relevance_score': '0.062379', 'ticker_sentiment_score': '0.080016', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NSC', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.080752', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AON', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.067029', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.020812', 'ticker_sentiment_score': '-0.132938', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUM', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.080752', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MO', 'relevance_score': '0.04161', 'ticker_sentiment_score': '-0.067029', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.062379', 'ticker_sentiment_score': '0.116154', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.080752', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.061159', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HON', 'relevance_score': '0.04161', 'ticker_sentiment_score': '-0.067029', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAG', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.025566', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.04161', 'ticker_sentiment_score': '-0.067029', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.04161', 'ticker_sentiment_score': '-0.067029', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HAL', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.061159', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.062379', 'ticker_sentiment_score': '0.043003', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.083107', 'ticker_sentiment_score': '-0.004117', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CNA', 'relevance_score': '0.020812', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NEM', 'relevance_score': '0.04161', 'ticker_sentiment_score': '-0.067029', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.067029', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAX', 'relevance_score': '0.04161', 'ticker_sentiment_score': '-0.067029', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.083107', 'ticker_sentiment_score': '0.096357', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.144895', 'ticker_sentiment_score': '0.024048', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.080752', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.020812', 'ticker_sentiment_score': '0.177491', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CRYPTO:NEM', 'relevance_score': '0.020812', 'ticker_sentiment_score': '-0.060447', 'ticker_sentiment_label': 'Neutral'}]"
639,Stock Market Dazed And Confused Ahead Of Big Tech Reports; C3.ai Stock Tanks On Downgrade,https://www.investors.com/market-trend/stock-market-today/stock-market-hold-its-breath-ahead-of-big-earnings-week/,20230424T145700,"['KIMBERLEY KOENIG', ""Investor's Business Daily""]",Stock Market Dazed And Confused Ahead Of Big Tech Reports. C3 ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2017/01/INCOME_yield_013017_shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}]",0.026574,Neutral,"[{'ticker': 'GOOG', 'relevance_score': '0.054732', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.16317', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FSLR', 'relevance_score': '0.109206', 'ticker_sentiment_score': '-0.160976', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'C', 'relevance_score': '0.054732', 'ticker_sentiment_score': '-0.146833', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LNTH', 'relevance_score': '0.109206', 'ticker_sentiment_score': '-0.083201', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMCI', 'relevance_score': '0.109206', 'ticker_sentiment_score': '0.157662', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ALB', 'relevance_score': '0.109206', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BBBY', 'relevance_score': '0.109206', 'ticker_sentiment_score': '-0.361937', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'LLY', 'relevance_score': '0.16317', 'ticker_sentiment_score': '-0.114973', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PERI', 'relevance_score': '0.109206', 'ticker_sentiment_score': '-0.080703', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMPH', 'relevance_score': '0.16317', 'ticker_sentiment_score': '-0.114973', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.054732', 'ticker_sentiment_score': '0.233936', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.054732', 'ticker_sentiment_score': '-0.230932', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
640,Eli Lilly  ( LLY )  to Report Q1 Earnings: Will It Beat Estimates?,https://www.zacks.com/stock/news/2083494/eli-lilly-lly-to-report-q1-earnings-will-it-beat-estimates,20230424T144000,['Zacks Investment Research'],Higher demand for its key drugs is likely to have offset generic competition for several drugs and may have boosted Lilly's (LLY) first-quarter sales.,https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999937'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.094861,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.315397', 'ticker_sentiment_score': '0.060391', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.183546', 'ticker_sentiment_score': '-0.02216', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.183546', 'ticker_sentiment_score': '-0.002948', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.228287', 'ticker_sentiment_score': '-0.00174', 'ticker_sentiment_label': 'Neutral'}]"
641,"Top Stories Monday, Apr. 24: Elon Musk Plans Next Starship Launch Within Two Months, NBCUniversal CEO Resigns Amid 'Inappropriate Relationship, Micron Tech Caught Between US-China Tensions - Alibaba Group Holding  ( NYSE:BABA ) , Amphastar Pharma  ( NASDAQ:AMPH ) ",https://www.benzinga.com/general/biotech/23/04/31956134/elon-musk-plans-next-starship-launch-within-two-months-nbcuniversal-ceo-resigns-amid-inappropriat,20230424T143406,['Vandana Singh'],"SpaceX CEO Elon Musk on Saturday said that Starship could be ready to launch again in 1 to 2 months. Starship can be ready to launch again in 1 to 2 months post-repairs of damage at the Starbase launch site, said Elon Musk in a Twitter reply on Saturday.",https://cdn.benzinga.com/files/images/story/2023/04/24/elon_musk_fernandi_putra_and_vitaliy_karimov_on_shutterstock_and_courtesy_photo_on_wikimedia_commons.jpg?width=1200&height=800&fit=crop,Benzinga,Mergers,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.360215'}]",0.150797,Somewhat-Bullish,"[{'ticker': 'BABA', 'relevance_score': '0.080865', 'ticker_sentiment_score': '0.053399', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.169479', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.080865', 'ticker_sentiment_score': '0.096718', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBS', 'relevance_score': '0.080865', 'ticker_sentiment_score': '-0.005373', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MU', 'relevance_score': '0.080865', 'ticker_sentiment_score': '-0.088549', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.080865', 'ticker_sentiment_score': '-0.005373', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TCTZF', 'relevance_score': '0.040484', 'ticker_sentiment_score': '0.051014', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSNLF', 'relevance_score': '0.080865', 'ticker_sentiment_score': '0.104339', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PDD', 'relevance_score': '0.121037', 'ticker_sentiment_score': '-0.006265', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSTK', 'relevance_score': '0.040484', 'ticker_sentiment_score': '0.148446', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RYLPF', 'relevance_score': '0.040484', 'ticker_sentiment_score': '0.130636', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SFTBF', 'relevance_score': '0.080865', 'ticker_sentiment_score': '0.194047', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.099385', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMPH', 'relevance_score': '0.080865', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CCZ', 'relevance_score': '0.080865', 'ticker_sentiment_score': '0.058628', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.160901', 'ticker_sentiment_score': '0.1299', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.040484', 'ticker_sentiment_score': '0.321485', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
642,"Mixed Macro, Fed Debate, Earnings in Full Swing, S&P, Busy Week Ahead",https://realmoney.thestreet.com/investing/mixed-macro-fed-debate-earnings-in-full-swing-s-p-busy-week-ahead-16121922,20230424T122240,['Stephen Guilfoyle'],"Mixed Macro, Fed Debate, Earnings in Full Swing, S&P, Busy Week ... ...",https://s.thestreet.com/files/tsc/v2008/photos/contrib/uploads/be781097-e294-11ed-9ab0-a5674aede514.png,The Street,GoogleRSS,realmoney.thestreet.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.890401'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.999974'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.062085,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.039128', 'ticker_sentiment_score': '-0.005964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.039128', 'ticker_sentiment_score': '0.051653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.039128', 'ticker_sentiment_score': '0.051653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.039128', 'ticker_sentiment_score': '0.051653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.01957', 'ticker_sentiment_score': '0.047022', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.039128', 'ticker_sentiment_score': '-0.005964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.039128', 'ticker_sentiment_score': '-0.005964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.039128', 'ticker_sentiment_score': '0.051653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.039128', 'ticker_sentiment_score': '0.051653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.039128', 'ticker_sentiment_score': '-0.005964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.039128', 'ticker_sentiment_score': '-0.005964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MA', 'relevance_score': '0.01957', 'ticker_sentiment_score': '0.047022', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.039128', 'ticker_sentiment_score': '0.051653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.039128', 'ticker_sentiment_score': '-0.005964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.039128', 'ticker_sentiment_score': '0.051653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.039128', 'ticker_sentiment_score': '0.051653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPGI', 'relevance_score': '0.01957', 'ticker_sentiment_score': '-0.032983', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.039128', 'ticker_sentiment_score': '0.051653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.01957', 'ticker_sentiment_score': '0.077017', 'ticker_sentiment_label': 'Neutral'}]"
643,3 Stocks With Huge Catalysts on the Way,https://www.fool.com/investing/2023/04/22/3-stocks-with-huge-catalysts-on-the-way/,20230422T101800,"['Keith Speights', 'David Jagielski', 'and Prosper Junior Bakiny']",Big news could mean big boosts for these stocks.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728655%2Fartificial-intelligence-ai.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.459462'}]",0.207833,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.427184', 'ticker_sentiment_score': '0.129466', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.089797', 'ticker_sentiment_score': '0.172169', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JAZZ', 'relevance_score': '0.04497', 'ticker_sentiment_score': '0.022927', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXSM', 'relevance_score': '0.178459', 'ticker_sentiment_score': '-0.025594', 'ticker_sentiment_label': 'Neutral'}]"
644,Lilly Hits New High As It Tempts Investors With New Buy Zone,https://www.investors.com/stock-lists/new-highs/eli-lilly-hits-new-high-as-it-tempts-investors-with-buy-zone/,20230421T173800,"[""Investor's Business Daily"", 'KIMBERLEY KOENIG']","Pharma giant Eli Lilly ( LLY ) hit a new high Friday and is in the 5% buy zone, waiting for investors to scoop it up. Fair Isaac ( FICO ) also hit a buy point and new high. Both stocks are also trading at all-time highs. LLY stock rose over 2% and hit the 376.41 buy point of a cup-with-handle ...",https://www.investors.com/wp-content/uploads/2020/10/Stock-EliLilly-Lab01-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.977154'}]",0.320613,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.531326', 'ticker_sentiment_score': '0.197823', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FICO', 'relevance_score': '0.615462', 'ticker_sentiment_score': '0.350968', 'ticker_sentiment_label': 'Bullish'}]"
645,Earnings Round One Ends With Banks A Clear Winner But Uncertain Results Overall As Market Sags,https://www.benzinga.com/news/earnings/23/04/31939743/earnings-round-one-ends-with-banks-a-clear-winner-but-uncertain-results-overall-as-market-sags,20230421T165911,['Alex Coffey'],( Friday market open ) Bulls and bears touch gloves and go to their separate corners at the end of the week before the bell rings to signal another heavy bout of earnings and economic data starting Monday.,https://cdn.benzinga.com/files/images/story/2023/04/21/shutterstock_1723527190_7.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.980716'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",-0.007242,Neutral,"[{'ticker': 'CVX', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.066278', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.019163', 'ticker_sentiment_score': '0.054441', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VZ', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.060464', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TXN', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.07654', 'ticker_sentiment_score': '0.030291', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.07654', 'ticker_sentiment_score': '0.002046', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MA', 'relevance_score': '0.019163', 'ticker_sentiment_score': '-0.059755', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.07654', 'ticker_sentiment_score': '0.019245', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPGI', 'relevance_score': '0.019163', 'ticker_sentiment_score': '-0.074806', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UPS', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.060464', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NSC', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.07988', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AON', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.066278', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUM', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.07988', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MO', 'relevance_score': '0.038314', 'ticker_sentiment_score': '-0.066278', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.07988', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.060464', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HON', 'relevance_score': '0.038314', 'ticker_sentiment_score': '-0.066278', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.07654', 'ticker_sentiment_score': '0.019245', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCSG', 'relevance_score': '0.019163', 'ticker_sentiment_score': '0.046509', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.07654', 'ticker_sentiment_score': '0.019245', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HAL', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.060464', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RF', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.065655', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.038314', 'ticker_sentiment_score': '-0.066278', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NEM', 'relevance_score': '0.038314', 'ticker_sentiment_score': '-0.066278', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.057444', 'ticker_sentiment_score': '0.09604', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.066278', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAX', 'relevance_score': '0.07654', 'ticker_sentiment_score': '0.019245', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.060464', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.07654', 'ticker_sentiment_score': '-0.031302', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.038314', 'ticker_sentiment_score': '0.07988', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:NEM', 'relevance_score': '0.019163', 'ticker_sentiment_score': '-0.059755', 'ticker_sentiment_label': 'Neutral'}]"
646,"NOW Stock Climbs Off Lows Ahead Q1 Results; Microsoft, META Headline Big Week Of Tech Earnings",https://www.investors.com/research/earnings-preview/now-stock-off-lows-q1-earnings-microsoft-meta-headline-big-week-tech-earnings/,20230421T142800,"['KEN SHREVE', ""Investor's Business Daily""]","NOW Stock Climbs Off Lows Ahead Q1 Results. Microsoft, META ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2023/04/EARNwatchT042423.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.137102,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.106384', 'ticker_sentiment_score': '0.185824', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MTH', 'relevance_score': '0.07104', 'ticker_sentiment_score': '0.245023', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GOOG', 'relevance_score': '0.035555', 'ticker_sentiment_score': '0.16494', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.106384', 'ticker_sentiment_score': '0.185824', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'INTC', 'relevance_score': '0.07104', 'ticker_sentiment_score': '0.250091', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CROX', 'relevance_score': '0.07104', 'ticker_sentiment_score': '0.05223', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOW', 'relevance_score': '0.176373', 'ticker_sentiment_score': '0.14735', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.07104', 'ticker_sentiment_score': '0.113634', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALGN', 'relevance_score': '0.07104', 'ticker_sentiment_score': '0.113634', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DXCM', 'relevance_score': '0.035555', 'ticker_sentiment_score': '0.108117', 'ticker_sentiment_label': 'Neutral'}]"
647,Eli Lilly and Company  ( LLY )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2082658/eli-lilly-and-company-lly-is-a-trending-stock-facts-to-know-before-betting-on-it,20230421T130011,['Zacks Investment Research'],"Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default270.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.217029,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.526867', 'ticker_sentiment_score': '0.153503', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
648,Engine Sputtering: Tesla's Disappointing Quarter Weighs On Market As Recession Fears Grow - Tesla  ( NASDAQ:TSLA ) ,https://www.benzinga.com/markets/23/04/31921533/engine-sputtering-teslas-disappointing-quarter-weighs-on-market-as-recession-fears-grow,20230420T175349,['Alex Coffey'],"( Thursday market open ) Disappointing earnings from Tesla TSLA set the tone this morning, helping send major indexes lower overnight. Overall, the hot start to earnings season cooled over the last few days, though there have been some positive highlights.",https://cdn.benzinga.com/files/images/story/2023/04/20/shutterstock_2230479071_1.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.999896'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",-0.067976,Neutral,"[{'ticker': 'AAPL', 'relevance_score': '0.099724', 'ticker_sentiment_score': '-0.040201', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.019995', 'ticker_sentiment_score': '0.054765', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VZ', 'relevance_score': '0.039977', 'ticker_sentiment_score': '0.060828', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.079855', 'ticker_sentiment_score': '0.078477', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.178459', 'ticker_sentiment_score': '-0.127696', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MA', 'relevance_score': '0.019995', 'ticker_sentiment_score': '-0.060107', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNP', 'relevance_score': '0.039977', 'ticker_sentiment_score': '0.012816', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.039977', 'ticker_sentiment_score': '-0.066672', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UPS', 'relevance_score': '0.039977', 'ticker_sentiment_score': '0.060828', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CME', 'relevance_score': '0.039977', 'ticker_sentiment_score': '-0.067241', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NSC', 'relevance_score': '0.039977', 'ticker_sentiment_score': '0.080338', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUM', 'relevance_score': '0.039977', 'ticker_sentiment_score': '0.080338', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MO', 'relevance_score': '0.039977', 'ticker_sentiment_score': '-0.066672', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.039977', 'ticker_sentiment_score': '0.080338', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.039977', 'ticker_sentiment_score': '0.060828', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HON', 'relevance_score': '0.039977', 'ticker_sentiment_score': '-0.066672', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.039977', 'ticker_sentiment_score': '-0.066672', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.039977', 'ticker_sentiment_score': '-0.066672', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HAL', 'relevance_score': '0.039977', 'ticker_sentiment_score': '0.060828', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.039977', 'ticker_sentiment_score': '-0.066672', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NEM', 'relevance_score': '0.039977', 'ticker_sentiment_score': '-0.066672', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.079855', 'ticker_sentiment_score': '-0.017662', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.039977', 'ticker_sentiment_score': '-0.184807', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'BAX', 'relevance_score': '0.039977', 'ticker_sentiment_score': '-0.066672', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FCX', 'relevance_score': '0.099724', 'ticker_sentiment_score': '-0.018711', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.039977', 'ticker_sentiment_score': '0.060828', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.079855', 'ticker_sentiment_score': '0.031735', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.039977', 'ticker_sentiment_score': '0.080338', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:NEM', 'relevance_score': '0.019995', 'ticker_sentiment_score': '-0.060107', 'ticker_sentiment_label': 'Neutral'}]"
649,Investing Your Tax Refund? These 2 Stocks Can Make the Most of Your Money,https://www.fool.com/investing/2023/04/20/investing-your-tax-refund-these-2-stocks-can-make/,20230420T142300,['David Jagielski'],These are fast-growing businesses that also pay recurring dividends.,https://media.ycharts.com/charts/1c3c03061339d1e298fc325910968c49.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.99793'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.318819,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.433877', 'ticker_sentiment_score': '0.457185', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'GOOG', 'relevance_score': '0.065327', 'ticker_sentiment_score': '-0.101309', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.587597', 'ticker_sentiment_score': '0.339776', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.065327', 'ticker_sentiment_score': '0.096123', 'ticker_sentiment_label': 'Neutral'}]"
650,Eli Lilly  ( LLY )  Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release,https://www.zacks.com/stock/news/2082204/eli-lilly-lly-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q1-release,20230420T140223,['Zacks Investment Research'],Lilly (LLY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,https://staticx-tuner.zacks.com/images/default_article_images/default114.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.18243,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.300088', 'ticker_sentiment_score': '0.154972', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
651,Why Investors Need to Take Advantage of These 2 Medical Stocks Now,https://www.zacks.com/stock/news/2081855/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now,20230420T125006,['Zacks Investment Research'],Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.,https://staticx-tuner.zacks.com/images/default_article_images/default198.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.99989'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}]",0.371928,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.317254', 'ticker_sentiment_score': '0.279953', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.317254', 'ticker_sentiment_score': '0.307696', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
652,Is Eli Lilly Stock a Buy Now?,https://www.fool.com/investing/2023/04/20/is-eli-lilly-stock-a-buy-now/,20230420T124500,['Prosper Junior Bakiny'],"Despite setbacks, Eli Lilly continues to be one of the best-performing pharma giants.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728644%2Fautonomous-driving.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.1536,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.402941', 'ticker_sentiment_score': '0.056686', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.052685', 'ticker_sentiment_score': '0.128938', 'ticker_sentiment_label': 'Neutral'}]"
653,Will Sanofi  ( SNY )  Surpass Estimates This Earnings Season?,https://www.zacks.com/stock/news/2081842/will-sanofi-sny-surpass-estimates-this-earnings-season,20230420T124500,['Zacks Investment Research'],Sanofi's (SNY) top line is likely to have been driven by higher sales of Dupixent.,https://staticx-tuner.zacks.com/images/articles/main/8d/2080.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999326'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.176578,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.25142', 'ticker_sentiment_score': '-0.086695', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PRVB', 'relevance_score': '0.152499', 'ticker_sentiment_score': '0.140476', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.202366', 'ticker_sentiment_score': '-0.003174', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.346365', 'ticker_sentiment_score': '0.211334', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
654,Eli Lilly  ( LLY )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2081592/eli-lilly-lly-gains-as-market-dips-what-you-should-know,20230419T214526,['Zacks Investment Research'],"Eli Lilly (LLY) closed at $370.47 in the latest trading session, marking a +0.15% move from the prior day.",https://staticx-tuner.zacks.com/images/default_article_images/default227.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.215076,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.672055', 'ticker_sentiment_score': '0.268422', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
655,Biogen  ( BIIB )  to Report Q1 Earnings: Here's What to Expect,https://www.zacks.com/stock/news/2081377/biogen-biib-to-report-q1-earnings-heres-what-to-expect,20230419T142900,['Zacks Investment Research'],"Biogen's (BIIB) sales in the first quarter are likely to have been hurt by lower sales of multiple sclerosis drugs, while sales of Spinraza are likely to have improved.",https://staticx-tuner.zacks.com/images/articles/main/07/905.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999682'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.132447,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.192387', 'ticker_sentiment_score': '-0.070188', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESALF', 'relevance_score': '0.038843', 'ticker_sentiment_score': '0.167567', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.154455', 'ticker_sentiment_score': '-0.002619', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.33884', 'ticker_sentiment_score': '0.205797', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
656,This Is What Whales Are Betting On Eli Lilly - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/04/31868306/this-is-what-whales-are-betting-on-eli-lilly,20230418T193116,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bullish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.108266,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.866386', 'ticker_sentiment_score': '0.226045', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.197413', 'ticker_sentiment_score': '-0.177493', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
657,Nektar  ( NKTR )  Starts New Restructuring Plan to Curb Cash Burn,https://www.zacks.com/stock/news/2080653/nektar-nktr-starts-new-restructuring-plan-to-curb-cash-burn,20230418T161400,['Zacks Investment Research'],The new restructuring plan will allow Nektar (NKTR) to extend its cash runway into mid-2026. The company plans to reduce its workforce by approximately 60%.,https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.9545'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.157389,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.277748', 'ticker_sentiment_score': '0.026995', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.277748', 'ticker_sentiment_score': '0.147811', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKTR', 'relevance_score': '0.277748', 'ticker_sentiment_score': '0.035422', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.277748', 'ticker_sentiment_score': '0.120638', 'ticker_sentiment_label': 'Neutral'}]"
658,Analyst Says Nektar Therapeutics' Rezpeg Prioritization Likely to Spark Investor Questions - Nektar Therapeutics  ( NASDAQ:NKTR ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/04/31850290/analyst-says-nektar-therapeutics-rezpeg-prioritization-likely-to-spark-investor-que,20230418T112040,['Vandana Singh'],"Nektar Therapeutics NKTR announced a strategic plan to reprioritize assets and restructure costs. Regarding clinical programs, Nektar will prioritize the development of rezpegaldesleukin ( Rezpeg ) , either in collaboration with current partner Eli Lilly And Co LLY or potentially on its own in ...",https://cdn.benzinga.com/files/images/story/2023/04/18/nktr_1.png?optimize=medium&dpr=2&auto=webp&width=3840,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.077452,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.217834', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKTR', 'relevance_score': '0.419733', 'ticker_sentiment_score': '0.059876', 'ticker_sentiment_label': 'Neutral'}]"
659,"J&J's Earnings Are Tuesday. Watch for News on Spinoff, Talc Litigation.",https://www.barrons.com/articles/jnj-earnings-stock-price-a9883ad9,20230417T210000,['Josh Nathan-Kazis'],Johnson & Johnson Reports Earnings Tuesday. Here's What to Watch. ...,https://images.barrons.com/im-764695/social,Barrons,n/a,www.barrons.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.014053,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.699089', 'ticker_sentiment_score': '0.030353', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.699089', 'ticker_sentiment_score': '0.030353', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.961451', 'ticker_sentiment_score': '0.025486', 'ticker_sentiment_label': 'Neutral'}]"
660,SNY vs. LLY: Which Stock Is the Better Value Option?,https://www.zacks.com/stock/news/2079793/sny-vs-lly-which-stock-is-the-better-value-option,20230417T154011,['Zacks Investment Research'],Investors looking for stocks in the Large Cap Pharmaceuticals sector might want to consider either Sanofi ( SNY Quick QuoteSNY - ) or Eli Lilly ( LLY Quick QuoteLLY - ) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.,https://staticx-tuner.zacks.com/images/default_article_images/default102.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.445677,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.622414', 'ticker_sentiment_score': '0.467166', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SNY', 'relevance_score': '0.743396', 'ticker_sentiment_score': '0.500771', 'ticker_sentiment_label': 'Bullish'}]"
661,"Top Analyst Reports for Eli Lilly, Thermo Fisher Scientific & Lockheed Martin",https://www.zacks.com/research-daily/2078975/top-analyst-reports-for-eli-lilly-thermo-fisher-scientific-lockheed-martin,20230414T202900,['Zacks Investment Research'],"Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Thermo Fisher Scientific Inc. (TMO) and Lockheed Martin Corporation (LMT).",https://staticx-tuner.zacks.com/images/articles/main/88/898.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.95493'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}]",0.147716,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.298749', 'ticker_sentiment_score': '0.137041', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.241085', 'ticker_sentiment_score': '0.115655', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CP', 'relevance_score': '0.121959', 'ticker_sentiment_score': '0.07298', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.121959', 'ticker_sentiment_score': '0.07298', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TMO', 'relevance_score': '0.241085', 'ticker_sentiment_score': '0.115655', 'ticker_sentiment_label': 'Neutral'}]"
662,Lilly's  ( LLY )  Ulcerative Colitis Candidate Gets CRL from FDA,https://www.zacks.com/stock/news/2079035/lillys-lly-ulcerative-colitis-candidate-gets-crl-from-fda,20230414T153300,['Zacks Investment Research'],"The FDA rejects Eli Lilly's (LLY) regulatory filing seeking approval for mirikizumab to treat ulcerative colitis indication, citing issues related to the drug's proposed manufacturing.",https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.174476,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.487751', 'ticker_sentiment_score': '0.124896', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.229149', 'ticker_sentiment_score': '0.14066', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.172919', 'ticker_sentiment_score': '0.21675', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
663,"Top Stories Friday, Apr. 14: Big Bank's Big Q1 Performance, Florida Gov. Quietly Slips 6-Week Abortion Ban Into Law, Subway Sandwich Seeks $10B Sale - Axcella Health  ( NASDAQ:AXLA ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/general/biotech/23/04/31806813/big-banks-big-q1-performance-florida-gov-quietly-slips-6-week-abortion-ban-into-law-subway-sandwi,20230414T140132,['Vandana Singh'],Florida Governor Ron DeSantis quietly signed legislation prohibiting abortions after the first six weeks of pregnancy within the state on Thursday.,https://cdn.benzinga.com/files/images/story/2023/04/14/ron_desantis_33090874326.jpg?optimize=medium&dpr=2&auto=webp&width=3840,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.918141'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}]",0.113745,Neutral,"[{'ticker': 'PYPL', 'relevance_score': '0.069294', 'ticker_sentiment_score': '0.027302', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WW', 'relevance_score': '0.069294', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXLA', 'relevance_score': '0.069294', 'ticker_sentiment_score': '0.19224', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WFC', 'relevance_score': '0.103778', 'ticker_sentiment_score': '0.093329', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.069294', 'ticker_sentiment_score': '-0.097367', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DPHAY', 'relevance_score': '0.103778', 'ticker_sentiment_score': '0.107438', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.069294', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FFIE', 'relevance_score': '0.069294', 'ticker_sentiment_score': '-0.027019', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BP', 'relevance_score': '0.103778', 'ticker_sentiment_score': '-0.064311', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.103778', 'ticker_sentiment_score': '0.023959', 'ticker_sentiment_label': 'Neutral'}]"
664,J&J  ( JNJ )  to Initiate Q1 Earnings Season for Pharma Sector,https://www.zacks.com/stock/news/2078827/jj-jnj-to-initiate-q1-earnings-season-for-pharma-sector,20230414T131500,['Zacks Investment Research'],"Growth in J&J's (JNJ) Pharma unit is expected to have been driven by drugs like Darzalex and Stelara. In the MedTech segment, continued recovery in worldwide procedure volume should drive sales.",https://staticx-tuner.zacks.com/images/articles/main/7d/1177.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999973'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.11281,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.247838', 'ticker_sentiment_score': '-0.039123', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.247838', 'ticker_sentiment_score': '0.065892', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.199447', 'ticker_sentiment_score': '0.05386', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.100518', 'ticker_sentiment_score': '0.07225', 'ticker_sentiment_label': 'Neutral'}]"
665,"Pharma Stock Roundup: FDA Rejects LLY's Mirikizumab, NVO Ups 2023 Sales & Profit View",https://www.zacks.com/stock/news/2078816/pharma-stock-roundup-fda-rejects-llys-mirikizumab-nvo-ups-2023-sales-profit-view,20230414T130500,['Zacks Investment Research'],FDA issues CRL to Eli Lilly's (LLY) BLA seeking approval of mirikizumab for ulcerative colitis (UC). Novo Nordisk (NVO) ups sales and profit outlook for 2023.,https://staticx-tuner.zacks.com/images/articles/main/96/702.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.121793,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.090816', 'ticker_sentiment_score': '0.10388', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.18046', 'ticker_sentiment_score': '0.068674', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.090816', 'ticker_sentiment_score': '-0.062191', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESALF', 'relevance_score': '0.090816', 'ticker_sentiment_score': '-0.086357', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.310283', 'ticker_sentiment_score': '0.308212', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.045482', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
666,Eli Lilly  ( LLY )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2078542/eli-lilly-lly-outpaces-stock-market-gains-what-you-should-know,20230413T214526,['Zacks Investment Research'],"In the latest trading session, Eli Lilly (LLY) closed at $375.15, marking a +1.65% move from the previous day.",https://staticx-tuner.zacks.com/images/default_article_images/default174.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.95493'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.218663,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.613743', 'ticker_sentiment_score': '0.262724', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
667,Here's Why You May Add Nektar  ( NKTR )  Stock to Your Portfolio,https://www.zacks.com/stock/news/2078308/heres-why-you-may-add-nektar-nktr-stock-to-your-portfolio,20230413T145900,['Zacks Investment Research'],Here we discuss some reasons why investing in Nektar Therapeutics (NKTR) stock now is a good idea despite its several pipeline setbacks.,https://staticx-tuner.zacks.com/images/articles/main/ab/2180.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.5'}]",0.092134,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.366061', 'ticker_sentiment_score': '0.032486', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRMR', 'relevance_score': '0.266246', 'ticker_sentiment_score': '0.184205', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SRZN', 'relevance_score': '0.16171', 'ticker_sentiment_score': '0.100955', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKTR', 'relevance_score': '0.503668', 'ticker_sentiment_score': '0.137023', 'ticker_sentiment_label': 'Neutral'}]"
0,Here's Why You May Add Nektar  ( NKTR )  Stock to Your Portfolio,https://www.zacks.com/stock/news/2078308/heres-why-you-may-add-nektar-nktr-stock-to-your-portfolio,20230413T145900,['Zacks Investment Research'],Here we discuss some reasons why investing in Nektar Therapeutics (NKTR) stock now is a good idea despite its several pipeline setbacks.,https://staticx-tuner.zacks.com/images/articles/main/ab/2180.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.5'}]",0.092134,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.366061', 'ticker_sentiment_score': '0.032486', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRMR', 'relevance_score': '0.266246', 'ticker_sentiment_score': '0.184205', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SRZN', 'relevance_score': '0.16171', 'ticker_sentiment_score': '0.100955', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKTR', 'relevance_score': '0.503668', 'ticker_sentiment_score': '0.137023', 'ticker_sentiment_label': 'Neutral'}]"
1,Alexandria  ( ARE )  Transfers Partial Interest in 15 Necco Street,https://www.zacks.com/stock/news/2078262/alexandria-are-transfers-partial-interest-in-15-necco-street,20230413T130500,['Zacks Investment Research'],"Amid the solid demand for high-quality life science assets, Alexandria (ARE) closes the strategic partial interest transaction for 15 Necco Street to a U.S. affiliate of Mori Trust Co., Ltd.",https://staticx-tuner.zacks.com/images/articles/main/ab/12496.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.5'}]",0.378319,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.240489', 'ticker_sentiment_score': '0.330245', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TRNO', 'relevance_score': '0.12165', 'ticker_sentiment_score': '0.078436', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VICI', 'relevance_score': '0.181591', 'ticker_sentiment_score': '0.09922', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARE', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.185276', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
2,This Is What Whales Are Betting On Eli Lilly - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/04/31752315/this-is-what-whales-are-betting-on-eli-lilly,20230411T174548,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 13 strange trades. If we consider the specifics of each trade, it is accurate to state that 23% of the investors opened trades with bullish ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.106877,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.805739', 'ticker_sentiment_score': '-0.024076', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.114682', 'ticker_sentiment_score': '0.039986', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.114682', 'ticker_sentiment_score': '-0.129108', 'ticker_sentiment_label': 'Neutral'}]"
3,Club meeting recap: Jim Cramer says stick with health care stocks in uncertain times,https://www.cnbc.com/2023/04/11/club-meeting-recap-jim-cramer-says-stick-with-health-care-stocks.html,20230411T160052,['Paulina Likos'],"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",https://image.cnbcfm.com/api/v1/image/107223220-1681224866175-1681224317318-3ED4-REQ-041123-CramersMorningMeeting.jpg?v=1681225603&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.998333'}, {'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.222786,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.227007', 'ticker_sentiment_score': '0.166886', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HUM', 'relevance_score': '0.369319', 'ticker_sentiment_score': '0.242076', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.076602', 'ticker_sentiment_score': '0.097012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.499102', 'ticker_sentiment_score': '0.293919', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DHR', 'relevance_score': '0.499102', 'ticker_sentiment_score': '0.293919', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.227007', 'ticker_sentiment_score': '0.166886', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
4,Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names,https://www.zacks.com/stock/news/2076792/looking-for-stocks-with-positive-earnings-momentum-check-out-these-2-medical-names,20230411T125008,['Zacks Investment Research'],Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.,https://staticx-tuner.zacks.com/images/default_article_images/default271.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999855'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.357309,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.38588', 'ticker_sentiment_score': '0.32686', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MRNA', 'relevance_score': '0.325637', 'ticker_sentiment_score': '0.309007', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
5,Eli Lilly Unusual Options Activity - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/04/31728923/eli-lilly-unusual-options-activity,20230410T153133,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 15 strange trades. If we consider the specifics of each trade, it is accurate to state that 20% of the investors opened trades with bullish ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.125929,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.772194', 'ticker_sentiment_score': '-0.023724', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.11983', 'ticker_sentiment_score': '0.040853', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.11983', 'ticker_sentiment_score': '-0.131409', 'ticker_sentiment_label': 'Neutral'}]"
6,Here's How Much a $1000 Investment in Eli Lilly Made 10 Years Ago Would Be Worth Today,https://www.zacks.com/stock/news/2075911/heres-how-much-a-1000-investment-in-eli-lilly-made-10-years-ago-would-be-worth-today,20230407T123004,['Zacks Investment Research'],"Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.",https://staticx-tuner.zacks.com/images/default_article_images/default97.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}]",0.144677,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.621336', 'ticker_sentiment_score': '0.1751', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'INCY', 'relevance_score': '0.053992', 'ticker_sentiment_score': '0.034985', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ELAN', 'relevance_score': '0.213517', 'ticker_sentiment_score': '0.058331', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AKUS', 'relevance_score': '0.053992', 'ticker_sentiment_score': '0.034985', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVBXF', 'relevance_score': '0.053992', 'ticker_sentiment_score': '0.034985', 'ticker_sentiment_label': 'Neutral'}]"
7,Manager Of Top T. Rowe Price Fund Is Still 'Pretty Cautious',https://www.investors.com/etfs-and-funds/mutual-funds/best-mutual-funds-manager-of-top-t-rowe-price-fund-is-still-pretty-cautious/,20230407T110000,"['ADAM SHELL', ""Investor's Business Daily""]","Looking for go-anywhere best mutual funds that aren't trapped in a style box and can buy stocks of all sizes and styles? Well, Justin White's T. Rowe Price All-Cap Opportunities Fund ( PRWAX ) checks all those boxes.",https://www.investors.com/wp-content/uploads/2017/04/SILO-MUTUALFUNDS-042417-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.999999'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.99237'}]",0.185197,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.055364', 'ticker_sentiment_score': '-0.00801', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TMUS', 'relevance_score': '0.036926', 'ticker_sentiment_score': '-0.017794', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.073773', 'ticker_sentiment_score': '0.034872', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FRBA', 'relevance_score': '0.018468', 'ticker_sentiment_score': '-0.142914', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MORN', 'relevance_score': '0.055364', 'ticker_sentiment_score': '0.094004', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VZ', 'relevance_score': '0.036926', 'ticker_sentiment_score': '0.105917', 'ticker_sentiment_label': 'Neutral'}]"
8,Eli Lilly  ( LLY )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2075802/eli-lilly-lly-outpaces-stock-market-gains-what-you-should-know,20230406T214522,['Zacks Investment Research'],"In the latest trading session, Eli Lilly (LLY) closed at $368.29, marking a +1.67% move from the previous day.",https://staticx-tuner.zacks.com/images/default_article_images/default346.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.95493'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.252217,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.479683', 'ticker_sentiment_score': '0.321469', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
9,"Action Plan: Bank Earnings In Focus; Delta, UnitedHealth On Tap",https://www.investors.com/research/investing-action-plan/jpmorgan-big-bank-earnings-get-special-attention-delta-unitedhealth-due/,20230406T165500,"[""Investor's Business Daily"", 'IBD STAFF']",JPMorgan and other bank earnings On Tap Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2020/07/Stock-JPmorgan-04-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.983605'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.999336'}]",-0.009668,Neutral,"[{'ticker': 'C', 'relevance_score': '0.179121', 'ticker_sentiment_score': '-0.074109', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PNC', 'relevance_score': '0.222838', 'ticker_sentiment_score': '-0.087508', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.265859', 'ticker_sentiment_score': '-0.100737', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.090134', 'ticker_sentiment_score': '-0.020401', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DAL', 'relevance_score': '0.222838', 'ticker_sentiment_score': '0.031412', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.265859', 'ticker_sentiment_score': '0.094146', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSM', 'relevance_score': '0.090134', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LNTH', 'relevance_score': '0.090134', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.222838', 'ticker_sentiment_score': '-0.087508', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FRC', 'relevance_score': '0.134841', 'ticker_sentiment_score': '-0.061804', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.134841', 'ticker_sentiment_score': '-0.024137', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PODD', 'relevance_score': '0.090134', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FAST', 'relevance_score': '0.090134', 'ticker_sentiment_score': '0.105218', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.134841', 'ticker_sentiment_score': '-0.024137', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SWAV', 'relevance_score': '0.134841', 'ticker_sentiment_score': '-0.024137', 'ticker_sentiment_label': 'Neutral'}]"
10,Check Out What Whales Are Doing With LLY - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/04/31698908/check-out-what-whales-are-doing-with-lly,20230406T141710,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bearish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.144038,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.731269', 'ticker_sentiment_score': '0.141093', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.109956', 'ticker_sentiment_score': '0.03922', 'ticker_sentiment_label': 'Neutral'}]"
11,2 Top Growth Stocks That Can Withstand an Economic Downturn,https://www.fool.com/investing/2023/04/05/2-top-growth-stocks-that-can-withstand-an-economic/,20230405T141500,['George Budwell'],These two drugmakers should march higher in 2023 and beyond.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F727185%2Fresilience-measuring-device.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",0.229741,Somewhat-Bullish,"[{'ticker': 'CPRX', 'relevance_score': '0.144275', 'ticker_sentiment_score': '0.192714', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.350564', 'ticker_sentiment_score': '0.244824', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
12,"Jim Cramer's top 10 things to watch in the stock market Wednesday: New dawn for JNJ, Disney push, Meta upgrade",https://www.cnbc.com/2023/04/05/cramers-things-to-watch-in-stock-market-wednesday.html,20230405T125153,['Jim Cramer'],"Big victory for an embattled Club name, positive analyst calls for META and Apple.",https://image.cnbcfm.com/api/v1/image/106019622-1563210739694gettyimages-837182306.jpeg?v=1680699113&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.744043'}, {'topic': 'Earnings', 'relevance_score': '0.839681'}]",0.190567,Somewhat-Bullish,"[{'ticker': 'HUM', 'relevance_score': '0.127456', 'ticker_sentiment_score': '0.406802', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'META', 'relevance_score': '0.127456', 'ticker_sentiment_score': '0.148853', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.18227', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WFC', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.015428', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.093064', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.25168', 'ticker_sentiment_score': '0.031223', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.190167', 'ticker_sentiment_score': '0.138419', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.127456', 'ticker_sentiment_score': '0.406802', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.127456', 'ticker_sentiment_score': '0.108139', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.127456', 'ticker_sentiment_score': '0.122422', 'ticker_sentiment_label': 'Neutral'}]"
13,These are the only stocks that matter right now | Business,https://www.cnn.com/2023/04/05/investing/premarket-stocks-trading/index.html,20230405T113300,['Nicole Goodkind'],These are the only stocks that matter right now ...,"https://media.cnn.com/api/v1/images/stellar/prod/230330114859-wall-street-0328-restricted.jpg?c=16x9&q=w_800,c_fill",CNN,Markets,www.cnn.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}]",0.00485,Neutral,"[{'ticker': 'APO', 'relevance_score': '0.036255', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.036255', 'ticker_sentiment_score': '0.120113', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.049276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.108466', 'ticker_sentiment_score': '0.149601', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.049276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.049276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.036255', 'ticker_sentiment_score': '0.04654', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.049276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.049276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.108466', 'ticker_sentiment_score': '0.149601', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.156235', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MA', 'relevance_score': '0.036255', 'ticker_sentiment_score': '0.04654', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.049276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.049276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.049276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.049276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WBD', 'relevance_score': '0.108466', 'ticker_sentiment_score': '-0.039882', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HD', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.049276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.108466', 'ticker_sentiment_score': '0.149601', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.049276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:GBP', 'relevance_score': '0.144275', 'ticker_sentiment_score': '-0.010219', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.036255', 'ticker_sentiment_score': '0.093803', 'ticker_sentiment_label': 'Neutral'}]"
14,Why Lilly  ( LLY )  Could Beat Earnings Estimates Again,https://www.zacks.com/stock/news/2074399/why-lilly-lly-could-beat-earnings-estimates-again,20230404T161013,['Zacks Investment Research'],Lilly (LLY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,https://staticx-tuner.zacks.com/images/default_article_images/default110.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.99989'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.314898,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.417304', 'ticker_sentiment_score': '0.451479', 'ticker_sentiment_label': 'Bullish'}]"
15,3 Top Healthcare Stocks to Buy for April,https://www.fool.com/investing/2023/04/04/3-top-healthcare-stocks-to-buy-for-april/,20230404T131200,['Jim Halley'],"These pharmaceutical companies' shares are down, but their prospects are rising.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726723%2Fsenior-man-laptop-covering-face-gettyimages-1472263927.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.182051,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.120885', 'ticker_sentiment_score': '0.126787', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.030331', 'ticker_sentiment_score': '0.196409', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.120885', 'ticker_sentiment_score': '0.142034', 'ticker_sentiment_label': 'Neutral'}]"
16,Investors Heavily Search Eli Lilly and Company  ( LLY ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2074200/investors-heavily-search-eli-lilly-and-company-lly-here-is-what-you-need-to-know,20230404T130011,['Zacks Investment Research'],"Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default327.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}]",0.219616,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.527831', 'ticker_sentiment_score': '0.15401', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
17,Here are our 4 best stocks - and 4 worst stocks - of the first quarter,https://www.cnbc.com/2023/03/31/first-quarter-2023-best-and-worst-stocks-investing-club.html,20230331T211411,"['Jeff Marks', 'Kevin Stankiewicz']","Club holding Nvidia (NVDA) has soared more than 90% this year, while Halliburton (HAL) and other energy stocks slid.",https://image.cnbcfm.com/api/v1/image/105394258-1534194817403gettyimages-902403114.jpeg?v=1680297251&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.857896'}]",0.138959,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.021718', 'ticker_sentiment_score': '0.069859', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUM', 'relevance_score': '0.043421', 'ticker_sentiment_score': '-0.081063', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.065091', 'ticker_sentiment_score': '0.035103', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.129749', 'ticker_sentiment_score': '0.095001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HAL', 'relevance_score': '0.172404', 'ticker_sentiment_score': '0.015995', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HON', 'relevance_score': '0.108271', 'ticker_sentiment_score': '0.010027', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.043421', 'ticker_sentiment_score': '0.158818', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.065091', 'ticker_sentiment_score': '-0.002014', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.193551', 'ticker_sentiment_score': '0.075332', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.043421', 'ticker_sentiment_score': '-0.081063', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DVN', 'relevance_score': '0.043421', 'ticker_sentiment_score': '0.035906', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DHR', 'relevance_score': '0.043421', 'ticker_sentiment_score': '-0.081063', 'ticker_sentiment_label': 'Neutral'}]"
18,"Stock Market Rallies On Micron, Alibaba, Lululemon, Ebbing Bank Fears: Weekly Review",https://www.investors.com/news/stock-market-rallies-on-micron-alibaba-lululemon-ebbing-bank-fears/,20230331T161900,"[""Investor's Business Daily"", 'IBD STAFF']","Stock Market Rallies On Micron, Alibaba, Lululemon, Ebbing Bank ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2019/12/FAP2020-bull-123019-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.769861'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.99793'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",-0.075568,Neutral,"[{'ticker': 'BABA', 'relevance_score': '0.119591', 'ticker_sentiment_score': '0.108066', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XPEV', 'relevance_score': '0.047988', 'ticker_sentiment_score': '0.013941', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PVH', 'relevance_score': '0.071928', 'ticker_sentiment_score': '-0.194038', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'MU', 'relevance_score': '0.119591', 'ticker_sentiment_score': '0.055006', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COIN', 'relevance_score': '0.047988', 'ticker_sentiment_score': '-0.217701', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'BNTX', 'relevance_score': '0.047988', 'ticker_sentiment_score': '-0.246914', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AEHR', 'relevance_score': '0.047988', 'ticker_sentiment_score': '0.001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LOVE', 'relevance_score': '0.047988', 'ticker_sentiment_score': '-0.128613', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LULU', 'relevance_score': '0.119591', 'ticker_sentiment_score': '0.117143', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VKTX', 'relevance_score': '0.047988', 'ticker_sentiment_score': '-0.089987', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.119591', 'ticker_sentiment_score': '0.01402', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NIO', 'relevance_score': '0.047988', 'ticker_sentiment_score': '0.013941', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PAYX', 'relevance_score': '0.047988', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.047988', 'ticker_sentiment_score': '0.001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RH', 'relevance_score': '0.047988', 'ticker_sentiment_score': '-0.128613', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CZBS', 'relevance_score': '0.024005', 'ticker_sentiment_score': '-0.00747', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FIZN', 'relevance_score': '0.024005', 'ticker_sentiment_score': '-0.00747', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WBA', 'relevance_score': '0.047988', 'ticker_sentiment_score': '-0.271998', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LLY', 'relevance_score': '0.047988', 'ticker_sentiment_score': '-0.06901', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTAS', 'relevance_score': '0.047988', 'ticker_sentiment_score': '0.055257', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LI', 'relevance_score': '0.047988', 'ticker_sentiment_score': '0.013941', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.024005', 'ticker_sentiment_score': '-0.053835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.047988', 'ticker_sentiment_score': '-0.178906', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
19,"ImmuneOnco Banks On Cutting-edge Cancer Drugs To Attract IPO Cash - AbbVie  ( NYSE:ABBV ) , Gilead Sciences  ( NASDAQ:GILD ) ",https://www.benzinga.com/markets/penny-stocks/23/03/31608710/immuneonco-banks-on-cutting-edge-cancer-drugs-to-attract-ipo-cash,20230331T132356,['The Bamboo Works'],"ImmuneOnco's main product pipeline is a cancer drug targeting a promising protein pathway, the first such drug to enter clinical tests in China, with more intensive trials due in the fourth quarter Eli Lilly ranks as the company's biggest institutional investor after six rounds of financing",https://cdn.benzinga.com/files/immuneonco-biopharma.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.682689'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '0.818451'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.070068,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.13459', 'ticker_sentiment_score': '0.136324', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.067536', 'ticker_sentiment_score': '0.091222', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.067536', 'ticker_sentiment_score': '0.091222', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.033799', 'ticker_sentiment_score': '-0.086146', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IMAB', 'relevance_score': '0.13459', 'ticker_sentiment_score': '0.157981', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
20,3 Stocks That Could Benefit From the Ozempic Craze,https://www.fool.com/investing/2023/03/30/3-stocks-that-could-benefit-from-the-ozempic-craze/,20230330T134500,['David Jagielski'],Is it time to load up on these weight-loss stocks?,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F725910%2Fstack-of-one-hundred-dollar-bills-cash-money-invest-retire-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.459462'}, {'topic': 'Earnings', 'relevance_score': '0.98396'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.262776,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.258351', 'ticker_sentiment_score': '0.279795', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WW', 'relevance_score': '0.1568', 'ticker_sentiment_score': '0.193641', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.05257', 'ticker_sentiment_score': '0.103841', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.258351', 'ticker_sentiment_score': '0.279265', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
21,"BioRestorative Therapies  ( NASDAQ: BRTX )  Is Targeting The Global Obesity Epidemic With Its Recent IP Portfolio Expansion - Altimmune  ( NASDAQ:ALT ) , BioRestorative Therapies  ( NASDAQ:BRTX ) ",https://www.benzinga.com/general/biotech/23/03/31577969/biorestorative-therapies-nasdaq-brtx-is-targeting-the-global-obesity-epidemic-with-its-recent-ip-,20230330T110025,['Julian Richard'],"BioRestorative Therapies Inc BRTX is expanding its ThermoStem® intellectual property portfolio for treatments targeting obesity, diabetes and other indications related to metabolic syndrome with another patent notice of allowance from the United States Patent Office, adding to its already 19 ...",https://cdn.benzinga.com/files/images/story/2023/03/30/screenshot_2023-03-30_at_4.28.22_pm.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}]",0.01956,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.089629', 'ticker_sentiment_score': '0.057938', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALT', 'relevance_score': '0.13409', 'ticker_sentiment_score': '0.067684', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRTX', 'relevance_score': '0.13409', 'ticker_sentiment_score': '0.107823', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.089629', 'ticker_sentiment_score': '0.057938', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.089629', 'ticker_sentiment_score': '0.057938', 'ticker_sentiment_label': 'Neutral'}]"
22,Why Shares of ProQR Therapeutics Dropped on Wednesday,https://www.fool.com/investing/2023/03/29/why-shares-of-proqr-therapeutics-dropped-on-wednes/,20230329T163055,['Jim Halley'],The clinical-stage biotech released fourth-quarter and full-year earnings.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726002%2Fa-blue-tesla-car-driving-on-an-open-road.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.040549,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.140076', 'ticker_sentiment_score': '0.101178', 'ticker_sentiment_label': 'Neutral'}]"
23,Check Out What Whales Are Doing With LLY - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/03/31554017/check-out-what-whales-are-doing-with-lly,20230329T161536,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 13 strange trades. If we consider the specifics of each trade, it is accurate to state that 46% of the investors opened trades with bullish ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.073611,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.827318', 'ticker_sentiment_score': '0.113338', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.040956', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.120431', 'ticker_sentiment_score': '-0.131687', 'ticker_sentiment_label': 'Neutral'}]"
24,3 Dividend Stocks That Have Been Paying Investors Since the 1800s,https://www.fool.com/investing/2023/03/29/3-dividend-stocks-have-been-paying-since-1800s/,20230329T130000,['David Jagielski'],Investors who crave stability and dividend income will love these stocks.,https://media.ycharts.com/charts/dc8bdd920d6bd1aa50dd065c828870c8.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.252053,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.267559', 'ticker_sentiment_score': '0.203357', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TD', 'relevance_score': '0.330876', 'ticker_sentiment_score': '0.331549', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'XOM', 'relevance_score': '0.202366', 'ticker_sentiment_score': '0.114263', 'ticker_sentiment_label': 'Neutral'}]"
25,Eli Lilly  ( LLY )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2071540/eli-lilly-lly-gains-as-market-dips-what-you-should-know,20230328T214526,['Zacks Investment Research'],"In the latest trading session, Eli Lilly (LLY) closed at $337.65, marking a +0.91% move from the previous day.",https://staticx-tuner.zacks.com/images/default_article_images/default46.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.972476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.138295,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.554916', 'ticker_sentiment_score': '0.10462', 'ticker_sentiment_label': 'Neutral'}]"
26,Is Eli Lilly or Bristol Myers Squibb the Better Value Stock to Buy Right Now?,https://www.fool.com/investing/2023/03/28/is-eli-lilly-or-bristol-myers-squibb-the-better-va/,20230328T141500,['George Budwell'],One of these big pharma stocks is considerably more attractive as a pure-play value investment.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726007%2Fbuy-dice.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.99999'}, {'topic': 'Earnings', 'relevance_score': '0.988787'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.259624,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.412093', 'ticker_sentiment_score': '0.339211', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MORN', 'relevance_score': '0.039289', 'ticker_sentiment_score': '0.083081', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.078482', 'ticker_sentiment_score': '0.362597', 'ticker_sentiment_label': 'Bullish'}]"
27,Novartis Surges After It Goes After Lilly's Second Biggest Moneymaker,https://www.investors.com/news/technology/novartis-stock-rockets-as-it-takes-on-eli-lilly-second-biggest-moneymaker/,20230327T141700,"['ALLISON GATLIN', ""Investor's Business Daily""]",Novartis Stock Rockets As It Takes On Eli Lilly's Second Biggest ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2017/11/STOCK-Novartis-01-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.99793'}]",-0.009803,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.420316', 'ticker_sentiment_score': '-0.134875', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BNTX', 'relevance_score': '0.073546', 'ticker_sentiment_score': '-0.161503', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
28,Why Investors Need to Take Advantage of These 2 Medical Stocks Now,https://www.zacks.com/stock/news/2070703/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now,20230327T125006,['Zacks Investment Research'],Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.,https://staticx-tuner.zacks.com/images/default_article_images/default313.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.29832,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.311631', 'ticker_sentiment_score': '0.323825', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
29,"Top Analyst Reports for Eli Lilly, Honeywell International & American Express",https://www.zacks.com/research-daily/2069503/top-analyst-reports-for-eli-lilly-honeywell-international-american-express,20230323T191200,['Zacks Investment Research'],"Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Co. (LLY), Honeywell International Inc. (HON) and American Express Co. (AXP).",https://staticx-tuner.zacks.com/images/articles/main/52/7634.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.253847,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.239895', 'ticker_sentiment_score': '0.199515', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AXP', 'relevance_score': '0.239895', 'ticker_sentiment_score': '0.199515', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MO', 'relevance_score': '0.121343', 'ticker_sentiment_score': '0.126746', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABNB', 'relevance_score': '0.121343', 'ticker_sentiment_score': '0.126746', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HON', 'relevance_score': '0.239895', 'ticker_sentiment_score': '0.199515', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
30,Will Eli Lilly Be a Trillion-Dollar Stock by 2030?,https://www.fool.com/investing/2023/03/23/will-eli-lilly-be-a-trillion-dollar-stock-by-2030/,20230323T142300,['David Jagielski'],Should you buy shares of this pharmaceutical giant now?,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F725462%2Ffive-people-watching-a-movie.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}, {'topic': 'Earnings', 'relevance_score': '0.87644'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.332808,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.425541', 'ticker_sentiment_score': '0.329731', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.265645', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
31,Roche  ( RHHBY )  & Lilly to Co-Develop Alzheimer's Detection Device,https://www.zacks.com/stock/news/2069631/roche-rhhby-lilly-to-co-develop-alzheimers-detection-device,20230323T135000,['Zacks Investment Research'],Roche (RHHBY) and Lilly announce a collaboration deal to support the development of the former's early diagnosis device for Alzheimer's Disease.,https://staticx-tuner.zacks.com/images/articles/main/d7/2114.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.769861'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.074009,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.243701', 'ticker_sentiment_score': '0.069945', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.320974', 'ticker_sentiment_score': '0.138986', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVTX', 'relevance_score': '0.243701', 'ticker_sentiment_score': '0.062464', 'ticker_sentiment_label': 'Neutral'}]"
32,1 Stock Down 9% in 2023 to Buy and Hold Forever,https://www.fool.com/investing/2023/03/23/1-stock-down-9-in-2023-to-buy-and-hold-forever/,20230323T121500,['Prosper Junior Bakiny'],Investors should see the dip as a buying opportunity.,https://media.ycharts.com/charts/8252894a23fa8015f87c525965a26324.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}]",0.241622,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.699089', 'ticker_sentiment_score': '0.351421', 'ticker_sentiment_label': 'Bullish'}]"
33,Find Out What The Best Mutual Funds Are Doing Right,https://www.investors.com/etfs-and-funds/mutual-funds/best-mutual-funds-2023-what-are-these-funds-doing-right/,20230323T110021,"[""Investor's Business Daily"", 'ADAM SHELL']",Best Mutual Funds 2023: What Are These Funds Doing Right? Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/03/BESTMFs_jump_032423.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.999999'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}]",0.434507,Bullish,"[{'ticker': 'TGT', 'relevance_score': '0.067536', 'ticker_sentiment_score': '0.198804', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BKRIF', 'relevance_score': '0.022536', 'ticker_sentiment_score': '0.325127', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'C', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.178954', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TTE', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.341472', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'COP', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.108026', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IFF', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.178954', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ALGN', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.178954', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.209957', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'OXY', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.108026', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TMO', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.209957', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.209957', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ROST', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.178954', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HD', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.252053', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
34,Is Bristol Myers Squibb Stock A Better Pick Over Its Industry Peer?,https://www.forbes.com/sites/greatspeculations/2023/03/22/is-bristol-myers-squibb-stock-a-better-pick-over-its-industry-peer/,20230322T110025,['Trefis Team'],"Investors have assigned a higher multiple to LLY stock due to its robust pipeline and better profitability, as discussed below If we look at stock returns, Eli Lilly, with 15% returns in the last twelve months, has fared better than BMS, down 5%, and the broader S&P 500 index, down 11%.",https://imageio.forbes.com/specials-images/imageserve/641a948a5ed82cc03c4b2898/0x0.jpg?format=jpg&width=1200,Forbes,Markets,www.forbes.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.658903'}, {'topic': 'Earnings', 'relevance_score': '0.998333'}]",0.245528,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.682689', 'ticker_sentiment_score': '0.427871', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BMY', 'relevance_score': '0.495015', 'ticker_sentiment_score': '0.315124', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PAG', 'relevance_score': '0.044304', 'ticker_sentiment_score': '0.133981', 'ticker_sentiment_label': 'Neutral'}]"
35,Eli Lilly  ( LLY )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2068705/eli-lilly-lly-stock-sinks-as-market-gains-what-you-should-know,20230321T214525,['Zacks Investment Research'],"Eli Lilly (LLY) closed the most recent trading day at $331.08, moving -0.76% from the previous trading session.",https://staticx-tuner.zacks.com/images/default_article_images/default347.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.986564'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.149772,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.484191', 'ticker_sentiment_score': '0.242929', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
36,Looking At Eli Lilly's Recent Unusual Options Activity - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/03/31443601/looking-at-eli-lillys-recent-unusual-options-activity,20230321T170121,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bearish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.120681,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.743396', 'ticker_sentiment_score': '0.073568', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.100308', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.100308', 'ticker_sentiment_score': '0.037758', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.100308', 'ticker_sentiment_score': '-0.123502', 'ticker_sentiment_label': 'Neutral'}]"
37,Beat the Dow Jones With This Unstoppable Dividend Stock,https://www.fool.com/investing/2023/03/21/beat-the-dow-jones-with-this-unstoppable-dividend/,20230321T141500,['Kody Kester'],This drugmaker has trounced the Dow Jones Industrial Average in the last 10 years.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F725116%2Fa-doctor-and-patient-talk-to-each-other-during-an-appointment.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}, {'topic': 'Earnings', 'relevance_score': '0.986564'}, {'topic': 'Finance', 'relevance_score': '0.5'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}]",0.347157,Somewhat-Bullish,"[{'ticker': 'GS', 'relevance_score': '0.063763', 'ticker_sentiment_score': '0.097232', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.424521', 'ticker_sentiment_score': '0.429368', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.063763', 'ticker_sentiment_score': '0.172224', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
38,Here is What to Know Beyond Why Eli Lilly and Company  ( LLY )  is a Trending Stock,https://www.zacks.com/stock/news/2068431/here-is-what-to-know-beyond-why-eli-lilly-and-company-lly-is-a-trending-stock,20230321T130013,['Zacks Investment Research'],"Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.",https://staticx-tuner.zacks.com/images/default_article_images/default142.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.224037,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.526867', 'ticker_sentiment_score': '0.106348', 'ticker_sentiment_label': 'Neutral'}]"
39,Sanofi  ( SNY )  to Reduce Lantus Insulin Price by Up to 78%,https://www.zacks.com/stock/news/2067329/sanofi-sny-to-reduce-lantus-insulin-price-by-up-to-78,20230317T141300,['Zacks Investment Research'],"Sanofi (SNY) plans to lower the prices of its most widely used insulin Lantus by upto 78% in the United States, effective January 2024.",https://staticx-tuner.zacks.com/images/articles/main/b8/1573.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}]",-0.016794,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.472338', 'ticker_sentiment_score': '-0.049168', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LGND', 'relevance_score': '0.306963', 'ticker_sentiment_score': '0.14068', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.306963', 'ticker_sentiment_score': '-0.044763', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.614836', 'ticker_sentiment_score': '-0.138418', 'ticker_sentiment_label': 'Neutral'}]"
40,This Is What Whales Are Betting On Eli Lilly - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/03/31386468/this-is-what-whales-are-betting-on-eli-lilly,20230316T183056,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 23 strange trades. If we consider the specifics of each trade, it is accurate to state that 47% of the investors opened trades with bullish ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.104473,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.744646', 'ticker_sentiment_score': '-0.023372', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCGLF', 'relevance_score': '0.113062', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.113062', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.113062', 'ticker_sentiment_score': '0.03972', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.113062', 'ticker_sentiment_score': '-0.128415', 'ticker_sentiment_label': 'Neutral'}]"
41,"Data Watch: Bank Uncertainty Continues, but Signals on Jobs, Housing, Tech Shed New Light - Credit Suisse Group  ( NYSE:CS ) , FedEx  ( NYSE:FDX ) ",https://www.benzinga.com/markets/penny-stocks/23/03/31385285/data-watch-bank-uncertainty-continues-but-signals-on-jobs-housing-tech-shed-new-light,20230316T171903,['TD Ameritrade Network'],"( Thursday Market Open ) Today provides a ""dry run"" for next week as the European Central Bank ( ECB ) makes an interest rate decision.",https://cdn.benzinga.com/files/images/story/2023/03/16/shutterstock_239067772.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.999326'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.904684'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",-0.04161,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.033894', 'ticker_sentiment_score': '0.03025', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.033894', 'ticker_sentiment_score': '0.03025', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.033894', 'ticker_sentiment_score': '-0.145399', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DG', 'relevance_score': '0.067727', 'ticker_sentiment_score': '0.067901', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.033894', 'ticker_sentiment_score': '0.021804', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.033894', 'ticker_sentiment_score': '-0.145399', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.050822', 'ticker_sentiment_score': '0.031', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.033894', 'ticker_sentiment_score': '0.03025', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.033894', 'ticker_sentiment_score': '-0.032467', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.050822', 'ticker_sentiment_score': '0.031', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FDX', 'relevance_score': '0.050822', 'ticker_sentiment_score': '-0.025018', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HD', 'relevance_score': '0.033894', 'ticker_sentiment_score': '0.03025', 'ticker_sentiment_label': 'Neutral'}]"
42,Caterpillar Stock Appears To Be A Better Pick Over This Pharmaceuticals Giant,https://www.forbes.com/sites/greatspeculations/2023/03/16/caterpillar-stock-appears-to-be-a-better-pick-over-this-pharmaceuticals-giant/,20230316T130038,['Trefis Team'],"We compare their current multiples with the historical ones in the sections below Looking at stock returns, LLY stock has fared better, with a 19% rise in the last twelve months, compared to a 4% rise for CAT and an 8% decline for the broader S&P500 index.",https://imageio.forbes.com/specials-images/imageserve/6412a6c8ffbd9cca4ccfd6f9/0x0.jpg?format=jpg&width=1200,Forbes,Money,www.forbes.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.692272'}, {'topic': 'Earnings', 'relevance_score': '0.998333'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.226694,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.653175', 'ticker_sentiment_score': '0.388789', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'CAT', 'relevance_score': '0.679305', 'ticker_sentiment_score': '0.341918', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FDX', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.137866', 'ticker_sentiment_label': 'Neutral'}]"
43,Eli Lilly  ( LLY )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2066378/eli-lilly-lly-gains-as-market-dips-what-you-should-know,20230315T214522,['Zacks Investment Research'],"In the latest trading session, Eli Lilly (LLY) closed at $329.47, marking a +0.73% move from the previous day.",https://staticx-tuner.zacks.com/images/default_article_images/default291.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.95493'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.101574,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.596978', 'ticker_sentiment_score': '0.183938', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
44,"Novo Nordisk  ( NVO )  Follows Lilly, to Cut Insulin Prices by 75%",https://www.zacks.com/stock/news/2066157/novo-nordisk-nvo-follows-lilly-to-cut-insulin-prices-by-75,20230315T143900,['Zacks Investment Research'],"Novo Nordisk (NVO) plans to lower prices of several pre-filled insulin pens and vials by up to 75% in the United States. However, the company plans not to start this until January 2024.",https://staticx-tuner.zacks.com/images/articles/main/37/2337.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",-0.021446,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.489163', 'ticker_sentiment_score': '-0.040715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.489163', 'ticker_sentiment_score': '0.071631', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.194763', 'ticker_sentiment_score': '0.101442', 'ticker_sentiment_label': 'Neutral'}]"
45,"Eli Lilly, Hewlett Packard Enterprise And 2 Other Stocks Insiders Are Selling - Boyd Gaming  ( NYSE:BYD ) , Chico's FAS  ( NYSE:CHS ) ",https://www.benzinga.com/news/23/03/31337014/eli-lilly-hewlett-packard-enterprise-and-2-other-stocks-insiders-are-selling,20230314T113835,['Lisa Levin'],"The Nasdaq Composite closed higher on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates their concern in the company's prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the ...",https://cdn.benzinga.com/files/images/story/2023/03/14/image_1.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.136282,Neutral,"[{'ticker': 'HPQ', 'relevance_score': '0.348103', 'ticker_sentiment_score': '0.390534', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.427184', 'ticker_sentiment_score': '-0.248821', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'BYD', 'relevance_score': '0.427184', 'ticker_sentiment_score': '0.31901', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HPE', 'relevance_score': '0.427184', 'ticker_sentiment_score': '0.444462', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'CHS', 'relevance_score': '0.348103', 'ticker_sentiment_score': '0.107736', 'ticker_sentiment_label': 'Neutral'}]"
46,Looking At Eli Lilly's Recent Unusual Options Activity - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/markets/options/23/03/31325960/looking-at-eli-lillys-recent-unusual-options-activity,20230313T171545,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 25 strange trades. If we consider the specifics of each trade, it is accurate to state that 64% of the investors opened trades with bullish ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.155635,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.740156', 'ticker_sentiment_score': '0.153732', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SCGLF', 'relevance_score': '0.112008', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.112008', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.112008', 'ticker_sentiment_score': '0.039549', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.112008', 'ticker_sentiment_score': '-0.127971', 'ticker_sentiment_label': 'Neutral'}]"
47,2 Healthcare Stocks You Can Buy and Hold for the Next Decade,https://www.fool.com/investing/2023/03/13/2-healthcare-stocks-you-can-hold-for-next-decade/,20230313T123000,['Jim Halley'],These two healthcare stocks combine steady revenue and dividend growth.,https://media.ycharts.com/charts/24440a13543b665892c9990b499214b5.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.213237,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.213517', 'ticker_sentiment_score': '0.204503', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.315493', 'ticker_sentiment_score': '0.259102', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
48,"Dow Jones Dips, Tech Stocks Pressured; First Republic Plunges 60% As Contagion Fears Hammer Financials",https://www.investors.com/market-trend/stock-market-today/dow-jones-dips-tech-stocks-pressured-contagion-fears-hammer-financial-stocks-first-republic-plunges/,20230310T153600,"[""Investor's Business Daily"", 'KEN SHREVE']","Dow Jones Dips, Tech Stocks Pressured. First Republic Plunges 60 ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2017/10/stock-NYSE-exterior-01-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.977154'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.938793'}]",-0.072426,Neutral,"[{'ticker': 'ULTA', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.152094', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CVX', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SIVB', 'relevance_score': '0.333557', 'ticker_sentiment_score': '-0.121056', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DDOG', 'relevance_score': '0.136888', 'ticker_sentiment_score': '-0.07103', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.136888', 'ticker_sentiment_score': '-0.07103', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ORCL', 'relevance_score': '0.136888', 'ticker_sentiment_score': '-0.203177', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'GS', 'relevance_score': '0.136888', 'ticker_sentiment_score': '-0.184879', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AMGN', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FRC', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.136888', 'ticker_sentiment_score': '-0.079384', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NEM', 'relevance_score': '0.136888', 'ticker_sentiment_score': '-0.07103', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.136888', 'ticker_sentiment_score': '-0.07103', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.136888', 'ticker_sentiment_score': '-0.184879', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TEAM', 'relevance_score': '0.136888', 'ticker_sentiment_score': '-0.07103', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBNY', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRVL', 'relevance_score': '0.136888', 'ticker_sentiment_score': '-0.07103', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:NEM', 'relevance_score': '0.068698', 'ticker_sentiment_score': '-0.056884', 'ticker_sentiment_label': 'Neutral'}]"
49,Eli Lilly  ( LLY )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2063805/eli-lilly-lly-gains-as-market-dips-what-you-should-know,20230309T224524,['Zacks Investment Research'],"Eli Lilly (LLY) closed at $316.85 in the latest trading session, marking a +1.38% move from the prior day.",https://staticx-tuner.zacks.com/images/default_article_images/default83.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.983783'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.092458,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.659949', 'ticker_sentiment_score': '0.150693', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
50,Incyte  ( INCY )  Down 8.3% Since Last Earnings Report: Can It Rebound?,https://www.zacks.com/stock/news/2063682/incyte-incy-down-83-since-last-earnings-report-can-it-rebound,20230309T163051,['Zacks Investment Research'],Incyte (INCY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,https://staticx-tuner.zacks.com/images/default_article_images/default224.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.983605'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.129841,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.152499', 'ticker_sentiment_score': '0.082826', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INCY', 'relevance_score': '0.436009', 'ticker_sentiment_score': '0.119468', 'ticker_sentiment_label': 'Neutral'}]"
51,Lilly's  ( LLY )  Alzheimer Drug Fails Late-Stage Prevention Study,https://www.zacks.com/stock/news/2063562/lillys-lly-alzheimer-drug-fails-late-stage-prevention-study,20230309T143300,['Zacks Investment Research'],Data from a late-stage study showed that treatment with Eli Lilly's (LLY) solanezumab did not result in the clearance of brain amyloid plaque in people with preclinical Alzheimer's disease.,https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.769861'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.009581,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.563158', 'ticker_sentiment_score': '0.06837', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESALF', 'relevance_score': '0.051663', 'ticker_sentiment_score': '0.145478', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.302553', 'ticker_sentiment_score': '0.126126', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.302553', 'ticker_sentiment_score': '0.259817', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
52,"Jim Cramer's top 10 things to watch in the stock market Thursday: Jobs, Fed, crypto",https://www.cnbc.com/2023/03/09/jim-cramers-top-10-things-thursday-jobs-fed-crypto.html,20230309T141828,['Jim Cramer'],Wall Street is set to open higher after two straight days of Fed chief Jerome Powell saying interest rates are likely going to be higher for longer.,https://image.cnbcfm.com/api/v1/image/107016476-1645049238210-gettyimages-1238190289-AFP_9Y73TM.jpeg?v=1678371508&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.972756'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}]",0.169334,Somewhat-Bullish,"[{'ticker': 'META', 'relevance_score': '0.184363', 'ticker_sentiment_score': '0.20657', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SI-P-A', 'relevance_score': '0.061949', 'ticker_sentiment_score': '-0.027137', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.123526', 'ticker_sentiment_score': '0.083564', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SIVB', 'relevance_score': '0.123526', 'ticker_sentiment_score': '-0.033361', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ETSY', 'relevance_score': '0.123526', 'ticker_sentiment_score': '-0.074779', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.061949', 'ticker_sentiment_score': '-0.014189', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.244109', 'ticker_sentiment_score': '0.095431', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FDX', 'relevance_score': '0.123526', 'ticker_sentiment_score': '0.083564', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PXD', 'relevance_score': '0.184363', 'ticker_sentiment_score': '0.135223', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GE', 'relevance_score': '0.123526', 'ticker_sentiment_score': '0.295071', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.061949', 'ticker_sentiment_score': '-0.027137', 'ticker_sentiment_label': 'Neutral'}]"
53,LLY: 5 Best Pharma Stocks to Buy Right Now,https://stocknews.com/news/lly-tak-cprx-pstx-vygr-nvs-5-best-pharma-stocks-to-buy-right-now/,20230309T130814,[],"The pharma industry has thrived amid solid demand and an unprecedented need for COVID-19 vaccines and therapeutics. Moreover, the industry is expanding with new modalities, such as cell and gene therapy and mRNA vaccine technology, new supply chains, and changing product landscape.",https://stocknews.com/wp-content/uploads/2022/07/shutterstock_1110645284.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}]",0.218996,Somewhat-Bullish,"[{'ticker': 'PSTX', 'relevance_score': '0.154455', 'ticker_sentiment_score': '0.060419', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VYGR', 'relevance_score': '0.154455', 'ticker_sentiment_score': '0.045422', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.197771', 'ticker_sentiment_score': '0.01768', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVS', 'relevance_score': '0.044386', 'ticker_sentiment_score': '0.100163', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CPRX', 'relevance_score': '0.197771', 'ticker_sentiment_score': '0.172232', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ESALF', 'relevance_score': '0.022202', 'ticker_sentiment_score': '0.180688', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HCSG', 'relevance_score': '0.022202', 'ticker_sentiment_score': '0.245012', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TAK', 'relevance_score': '0.154455', 'ticker_sentiment_score': '0.1665', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
54,Eli Lilly Is Slashing Insulin Prices by 70%. Here's Why Investors Shouldn't Worry.,https://www.fool.com/investing/2023/03/08/eli-lilly-is-slashing-insulin-prices-by-70-heres/,20230308T144500,['David Jagielski'],This is a move that the company can afford to make.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F723567%2Fbear-vs-bull-market.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Earnings', 'relevance_score': '0.87644'}]",0.110951,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.50605', 'ticker_sentiment_score': '0.21401', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
55,"Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason - SPDR Select Sector Fund - Health Care  ( ARCA:XLV ) , iShares Biotechnology ETF  ( NASDAQ:IBB ) ",https://www.benzinga.com/general/biotech/23/03/31223747/health-care-etfs-have-lost-in-the-last-month-these-top-pharma-stocks-are-the-reason,20230308T003406,['Vandana Singh'],"The Health Care Select Sector SPDR Fund XLV, heavily tilted towards mega-caps, lost around 5.25% over the last month, with substantial companies reporting annual earnings. Shares of Health Care Select Sector SPDR Fund opened at $129.26 on Monday, with a twelve-month low of $118.75 and a ...",https://cdn.benzinga.com/files/images/story/2023/03/07/aapharma_3.png?optimize=medium&dpr=2&auto=webp&width=3840,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}]",0.167756,Somewhat-Bullish,"[{'ticker': 'ABT', 'relevance_score': '0.28387', 'ticker_sentiment_score': '0.10837', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TMO', 'relevance_score': '0.28387', 'ticker_sentiment_score': '0.10837', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.414559', 'ticker_sentiment_score': '-0.040294', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TCRR', 'relevance_score': '0.28387', 'ticker_sentiment_score': '0.410273', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BBIO', 'relevance_score': '0.28387', 'ticker_sentiment_score': '0.565163', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.414559', 'ticker_sentiment_score': '-0.040294', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADAP', 'relevance_score': '0.414559', 'ticker_sentiment_score': '0.453951', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ACRS', 'relevance_score': '0.28387', 'ticker_sentiment_score': '-0.213591', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
56,Why Weight Watchers is buying a company that prescribes popular weight-loss drugs like Ozempic,https://www.marketwatch.com/story/why-weight-watchers-is-buying-a-company-that-prescribes-popular-weight-loss-drugs-like-ozempic-b793b96c,20230307T183300,['Jaimy Lee'],It's the latest example how a new class of therapies has revolutionized the way many Americans think about weight loss.,https://images.mktw.net/im-697468/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}]",0.132856,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.126119', 'ticker_sentiment_score': '0.155405', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WW', 'relevance_score': '0.308504', 'ticker_sentiment_score': '0.179419', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
57,Incyte  ( INCY )  Discontinues Jakafi Combo Myelofibrosis Study,https://www.zacks.com/stock/news/2062555/incyte-incy-discontinues-jakafi-combo-myelofibrosis-study,20230307T144000,['Zacks Investment Research'],Incyte (INCY) decides to scrap the LIMBER-304 study evaluating the efficacy and safety of parsaclisib plus Jakafi for myelofibrosis (MF) following an independent data monitoring committee recommendation.,https://staticx-tuner.zacks.com/images/articles/main/ba/1149.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.254958,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.366061', 'ticker_sentiment_score': '0.308814', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'INCY', 'relevance_score': '0.659096', 'ticker_sentiment_score': '0.317812', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
58,Eli Lilly and Company  ( LLY )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2062512/eli-lilly-and-company-lly-is-attracting-investor-attention-here-is-what-you-should-know,20230307T140012,['Zacks Investment Research'],"Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default93.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.234907,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.523044', 'ticker_sentiment_score': '0.153152', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
59,Diet Company's Telehealth Deal Opens Up Obesity Drug Market,https://www.investors.com/news/ww-stock-soars-sequence-telehealth-deal-entry-market-obesity-drugs/,20230307T121200,"['APARNA NARAYANAN', ""Investor's Business Daily""]",WW Stock Soars As Telehealth Deal Opens Up Hot Market For ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2017/12/NEWAM-pills-122217-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.108754,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.306963', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WW', 'relevance_score': '0.76367', 'ticker_sentiment_score': '0.169689', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.156461', 'ticker_sentiment_score': '0.062304', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.306963', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
60,"Jim Cramer's Investing Club meeting Monday: Fed and jobs, China reopening, Eli Lilly",https://www.cnbc.com/2023/03/06/jim-cramers-investing-club-meeting-monday-fed-jobs-china.html,20230306T165743,['Paulina Likos'],"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",https://image.cnbcfm.com/api/v1/image/107200468-1677528554271-NUP_200782_00153.jpg?v=1678043983&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.98396'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.333333'}]",0.143962,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.366061', 'ticker_sentiment_score': '0.155752', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SBUX', 'relevance_score': '0.224903', 'ticker_sentiment_score': '0.106474', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WYNN', 'relevance_score': '0.224903', 'ticker_sentiment_score': '0.106474', 'ticker_sentiment_label': 'Neutral'}]"
61,"Biogen  ( BIIB ) , Eisai Seek Full Nod for Alzheimer Drug Leqembi",https://www.zacks.com/stock/news/2061981/biogen-biib-eisai-seek-full-nod-for-alzheimer-drug-leqembi,20230306T131600,['Zacks Investment Research'],"The FDA grants priority review to Biogen (BIIB) and Eisai's sBLA seeking traditional approval of Alzheimer's disease drug, Leqembi. The FDA decision is expected on Jul 6, 2023.",https://staticx-tuner.zacks.com/images/articles/main/07/905.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.104187,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.243498', 'ticker_sentiment_score': '0.085303', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESALF', 'relevance_score': '0.243498', 'ticker_sentiment_score': '0.262631', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.301686', 'ticker_sentiment_score': '0.223771', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EFTR', 'relevance_score': '0.412619', 'ticker_sentiment_score': '-0.113309', 'ticker_sentiment_label': 'Neutral'}]"
62,"US Stocks Could Consolidate As S&P 500, Nasdaq Futures Tick Up Ahead Of Fed Chair Powell's Congressional Testimony - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/23/03/31213132/us-stocks-could-consolidate-as-s-p-500-nasdaq-futures-tick-up-ahead-of-fed-chair-powells-congressio,20230306T113650,['Shanthi Rexaline'],"Stocks could pause on Monday after returning to winning ways in the past week, as the focus shifts to Fed Chair Jerome Powell's two-day Congressional testimony this week. U.S. stocks advanced in the week ended March 3, with the S&P 500 Index snapping a three-week losing streak.",https://cdn.benzinga.com/files/images/story/2023/03/06/stock_market_photo_by_feylite_on_shutterstock.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '0.999355'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}]",0.052868,Neutral,"[{'ticker': 'KBH', 'relevance_score': '0.127119', 'ticker_sentiment_score': '-0.141987', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.127119', 'ticker_sentiment_score': '0.008274', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FSLR', 'relevance_score': '0.063763', 'ticker_sentiment_score': '-0.143148', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NTNX', 'relevance_score': '0.127119', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.127119', 'ticker_sentiment_score': '-0.145177', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.127119', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVAX', 'relevance_score': '0.127119', 'ticker_sentiment_score': '-0.220442', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'GS', 'relevance_score': '0.063763', 'ticker_sentiment_score': '0.007017', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.063763', 'ticker_sentiment_score': '0.28674', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.127119', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIDE', 'relevance_score': '0.127119', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SRRK', 'relevance_score': '0.127119', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
63,AI Stock Headlines 5 Leaders Flashing Buy Signals As Market Rally Gains Steam,https://www.investors.com/news/ai-stock-among-5-leaders-flashing-buy-signals-as-market-rally-gains-steam/,20230304T135900,"[""Investor's Business Daily"", 'JED GRAHAM']",AI Stock Headlines 5 Leaders Flashing Buy Signals As Market Rally ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2017/11/Stock-Arista-02-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Financial Markets', 'relevance_score': '0.752319'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.983783'}]",0.192417,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.100308', 'ticker_sentiment_score': '0.08074', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.100308', 'ticker_sentiment_score': '0.08074', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.06697', 'ticker_sentiment_score': '0.122305', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANET', 'relevance_score': '0.294682', 'ticker_sentiment_score': '0.16165', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.06697', 'ticker_sentiment_score': '0.188481', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.199037', 'ticker_sentiment_score': '0.030595', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PSIX', 'relevance_score': '0.033515', 'ticker_sentiment_score': '0.037234', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.06697', 'ticker_sentiment_score': '0.110257', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.263231', 'ticker_sentiment_score': '0.126109', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RCL', 'relevance_score': '0.325637', 'ticker_sentiment_score': '0.047695', 'ticker_sentiment_label': 'Neutral'}]"
64,Eli Lilly  ( LLY )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2061742/eli-lilly-lly-gains-but-lags-market-what-you-should-know,20230303T224524,['Zacks Investment Research'],"Eli Lilly (LLY) closed at $318.43 in the latest trading session, marking a +1.07% move from the prior day.",https://staticx-tuner.zacks.com/images/default_article_images/default127.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.972476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.191082,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.700759', 'ticker_sentiment_score': '0.365062', 'ticker_sentiment_label': 'Bullish'}]"
65,NVS vs. LLY: Which Stock Is the Better Value Option?,https://www.zacks.com/stock/news/2061676/nvs-vs-lly-which-stock-is-the-better-value-option,20230303T164011,['Zacks Investment Research'],Investors looking for stocks in the Large Cap Pharmaceuticals sector might want to consider either Novartis ( NVS Quick QuoteNVS - ) or Eli Lilly ( LLY Quick QuoteLLY - ) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.,https://staticx-tuner.zacks.com/images/default_article_images/default291.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.450939,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.63878', 'ticker_sentiment_score': '0.46671', 'ticker_sentiment_label': 'Bullish'}]"
66,Top 10 things the Club is watching in the stock market Friday,https://www.cnbc.com/2023/03/03/top-10-things-the-club-is-watching-in-the-stock-market-friday.html,20230303T143456,['Jeff Marks'],"The Dow, the S&P 500 and the Nasdaq are looking to close out the week on a possible note.",https://image.cnbcfm.com/api/v1/image/107201933-1677709314320-gettyimages-1017468298-AmerBrands_180814_1318.jpeg?v=1677854364&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.905476'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}]",0.074065,Neutral,"[{'ticker': 'MPC', 'relevance_score': '0.115509', 'ticker_sentiment_score': '-0.079023', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.115509', 'ticker_sentiment_score': '0.119362', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.115509', 'ticker_sentiment_score': '0.055568', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.172507', 'ticker_sentiment_score': '0.08511', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.115509', 'ticker_sentiment_score': '-0.018121', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.172507', 'ticker_sentiment_score': '-0.058316', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KR', 'relevance_score': '0.115509', 'ticker_sentiment_score': '-0.094692', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.070965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.115509', 'ticker_sentiment_score': '-0.017522', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FSLR', 'relevance_score': '0.115509', 'ticker_sentiment_score': '-0.079023', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.115509', 'ticker_sentiment_score': '0.119362', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.040966', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.115509', 'ticker_sentiment_score': '0.021551', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.115509', 'ticker_sentiment_score': '0.119362', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.22861', 'ticker_sentiment_score': '-0.150907', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PXD', 'relevance_score': '0.115509', 'ticker_sentiment_score': '0.045536', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRVL', 'relevance_score': '0.115509', 'ticker_sentiment_score': '0.119362', 'ticker_sentiment_label': 'Neutral'}]"
67,2 Safe Stocks to Buy Hand Over Fist in 2023,https://www.fool.com/investing/2023/03/03/2-safe-stocks-to-buy-hand-over-fist-in-2023/,20230303T105800,['Rachel Warren'],Established companies in industries less vulnerable to cyclical headwinds can offer a measure of safety in a market storm.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F722851%2Fstock-chart-crash-correction-plunge-bounce-bear-market-bar-trend-invest-crypto-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.99393'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.134534,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.303926', 'ticker_sentiment_score': '0.174486', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.468029', 'ticker_sentiment_score': '0.091834', 'ticker_sentiment_label': 'Neutral'}]"
68,3 Incredible Growth Stocks to Buy if the Market Dips,https://www.fool.com/investing/2023/03/02/3-incredible-growth-stocks-to-buy-if-the-market-di/,20230302T154500,['George Budwell'],These top growth stocks sport premium valuations for a very good reason.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F723074%2Fcrashing-arrow.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999864'}, {'topic': 'Earnings', 'relevance_score': '0.795202'}]",0.152965,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.433215', 'ticker_sentiment_score': '0.110269', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDGL', 'relevance_score': '0.113866', 'ticker_sentiment_score': '0.093059', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.113866', 'ticker_sentiment_score': '0.189198', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
69,2 Stocks Down 12% or More This Year to Buy Hand Over Fist,https://www.fool.com/investing/2023/03/02/2-stocks-down-10-or-more-this-year-to-buy-hand-ove/,20230302T145500,['Prosper Junior Bakiny'],Investors might want to act fast before it's too late.,https://media.ycharts.com/charts/6c0ebe8d14613d787d52ce63f1af5fb3.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.15573,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.398148', 'ticker_sentiment_score': '0.194589', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ISRG', 'relevance_score': '0.255641', 'ticker_sentiment_score': '0.280526', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
70,The Warren Buffett Quote Investors Should Never Forget,https://www.fool.com/investing/2023/03/02/the-warren-buffett-quote-investors-should-never-fo/,20230302T133000,['David Jagielski'],Value investors shouldn't focus too much on buying dirt-cheap stocks.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F722460%2Fbuy-sell-stock-market-rolling-dice-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.818451'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.446327,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.209365', 'ticker_sentiment_score': '0.341465', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BRK-A', 'relevance_score': '0.070517', 'ticker_sentiment_score': '0.271226', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WBA', 'relevance_score': '0.140485', 'ticker_sentiment_score': '0.112208', 'ticker_sentiment_label': 'Neutral'}]"
71,"Stock Market Lower As Nasdaq Teeters At Key Level; It's A Big Day For Tesla, EV Stocks",https://www.investors.com/market-trend/stock-market-today/stock-market-extends-slump-why-its-a-big-day-for-ev-stocks/,20230301T165900,"['JUAN CARLOS ARANCIBIA', ""Investor's Business Daily""]",Stock Market Lower As Nasdaq Teeters At Key Level. It's A Big Day ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2020/08/Stock-WallStreetSign-flag08-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.94762'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.928139'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",-0.058181,Neutral,"[{'ticker': 'XPEV', 'relevance_score': '0.102449', 'ticker_sentiment_score': '-0.165541', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'SRPT', 'relevance_score': '0.102449', 'ticker_sentiment_score': '0.153386', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DLTR', 'relevance_score': '0.102449', 'ticker_sentiment_score': '0.164152', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOUR', 'relevance_score': '0.102449', 'ticker_sentiment_score': '0.088745', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIVN', 'relevance_score': '0.102449', 'ticker_sentiment_score': '-0.242157', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'KSS', 'relevance_score': '0.102449', 'ticker_sentiment_score': '-0.082001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.102449', 'ticker_sentiment_score': '-0.058703', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NIO', 'relevance_score': '0.102449', 'ticker_sentiment_score': '-0.165541', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LLY', 'relevance_score': '0.153145', 'ticker_sentiment_score': '0.006839', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MYE', 'relevance_score': '0.102449', 'ticker_sentiment_score': '-0.25517', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'SPGI', 'relevance_score': '0.102449', 'ticker_sentiment_score': '-0.095175', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LPLA', 'relevance_score': '0.102449', 'ticker_sentiment_score': '-0.048363', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LI', 'relevance_score': '0.102449', 'ticker_sentiment_score': '-0.165541', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
72,"Jim Cramer's top 10 things to watch in the stock market Wednesday: China, stocks, retail",https://www.cnbc.com/2023/03/01/jim-cramers-top-10-things-to-watch-in-the-stock-market-wednesday-china-stocks-retail.html,20230301T141911,['Jim Cramer'],"First day of March: the Dow, the S&P 500 and the Nasdaq set to open lower.",https://image.cnbcfm.com/api/v1/image/107174588-1672940639201-gettyimages-1245957129-China_Manufacturing_Industry.jpeg?v=1677680413&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.769861'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.891286'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.905476'}]",0.009788,Neutral,"[{'ticker': 'META', 'relevance_score': '0.115509', 'ticker_sentiment_score': '-0.03979', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.115509', 'ticker_sentiment_score': '-0.03979', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TJX', 'relevance_score': '0.115509', 'ticker_sentiment_score': '0.167245', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HPQ', 'relevance_score': '0.115509', 'ticker_sentiment_score': '-0.166585', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LLY', 'relevance_score': '0.115509', 'ticker_sentiment_score': '-0.059789', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROST', 'relevance_score': '0.115509', 'ticker_sentiment_score': '0.167245', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KSS', 'relevance_score': '0.115509', 'ticker_sentiment_score': '-0.090268', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVAX', 'relevance_score': '0.115509', 'ticker_sentiment_score': '-0.072279', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.115509', 'ticker_sentiment_score': '0.018095', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.115509', 'ticker_sentiment_score': '0.018095', 'ticker_sentiment_label': 'Neutral'}]"
73,"Henlius Swallows Bitter Pill In Watered-Down Licensing Deal - Abbott Laboratories  ( NYSE:ABT ) , Biogen  ( NASDAQ:BIIB ) ",https://www.benzinga.com/news/small-cap/23/02/31090323/henlius-swallows-bitter-pill-in-watered-down-licensing-deal,20230228T134125,['The Bamboo Works'],"Henlius Biotech will receive up to $11 million less than originally agreed under a licensing agreement due to higher-than-expected R&D costs Such alterations aren't uncommon to licensing deals, but can still undermine investor confidence in a company and slow its overseas expansion",https://cdn.benzinga.com/files/helius.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.990999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.026368,Neutral,"[{'ticker': 'ABT', 'relevance_score': '0.073659', 'ticker_sentiment_score': '0.038368', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOSUF', 'relevance_score': '0.036869', 'ticker_sentiment_score': '-0.001968', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OGN', 'relevance_score': '0.110293', 'ticker_sentiment_score': '0.041876', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.110293', 'ticker_sentiment_score': '-0.069296', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IONS', 'relevance_score': '0.036869', 'ticker_sentiment_score': '-0.004846', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INCPF', 'relevance_score': '0.036869', 'ticker_sentiment_score': '-0.104213', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.110293', 'ticker_sentiment_score': '-0.005581', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.073659', 'ticker_sentiment_score': '-0.108217', 'ticker_sentiment_label': 'Neutral'}]"
74,Merck Stock Looks Better Priced Compared To Its Sector Peer,https://www.forbes.com/sites/greatspeculations/2023/02/28/merck-stock-looks-better-priced-compared-to-its-sector-peer/,20230228T110042,['Trefis Team'],"Although investors have assigned a higher P/S multiple for LLY stock owing to its pipeline potential, we believe this gap will narrow in favor of Merck.",https://imageio.forbes.com/specials-images/imageserve/63fdb2e8450a74c61f2bdfe5/0x0.jpg?format=jpg&width=1200,Forbes,Money,www.forbes.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.752319'}, {'topic': 'Earnings', 'relevance_score': '0.999696'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.249455,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.741581', 'ticker_sentiment_score': '0.441575', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'XYL', 'relevance_score': '0.040969', 'ticker_sentiment_score': '0.14184', 'ticker_sentiment_label': 'Neutral'}]"
75,IBD 50 Growth Stock: Diabetes Breakthrough Lifts Denmark Drugmaker,https://www.investors.com/research/growth-stock-novo-nordisk-drug-stock-rises-after-fda-approval-of-diabetes-drug-breakthrough/,20230227T194300,"['VIDYA RAMAKRISHNAN', ""Investor's Business Daily""]",IBD 50 Growth Stock: Diabetes Breakthrough Lifts Novo Nordisk ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2019/09/stock-NovoNordisk-02-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.997902'}]",0.441086,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.154951', 'ticker_sentiment_score': '0.382543', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.374875', 'ticker_sentiment_score': '0.649177', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.154951', 'ticker_sentiment_score': '0.382543', 'ticker_sentiment_label': 'Bullish'}]"
76,LLY: The 5 Safest Stocks You Can Buy in 2023,https://stocknews.com/news/lly-nvs-cmcsa-hca-mye-the-5-safest-stocks-you-can-buy-in-2023/,20230224T115607,[],LLY: The 5 Safest Stocks You Can Buy in ...,https://stocknews.com/wp-content/uploads/2022/03/shutterstock_1444569875-1-scaled.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}]",0.231299,Somewhat-Bullish,"[{'ticker': 'BAC', 'relevance_score': '0.020939', 'ticker_sentiment_score': '-0.27331', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'HCA', 'relevance_score': '0.166312', 'ticker_sentiment_score': '0.182666', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'APG', 'relevance_score': '0.020939', 'ticker_sentiment_score': '0.138022', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.207039', 'ticker_sentiment_score': '0.08802', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MYE', 'relevance_score': '0.104409', 'ticker_sentiment_score': '-0.023311', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVS', 'relevance_score': '0.207039', 'ticker_sentiment_score': '0.088646', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CCZ', 'relevance_score': '0.020939', 'ticker_sentiment_score': '-0.117288', 'ticker_sentiment_label': 'Neutral'}]"
77,"US Stocks Stare At More Losses In a Lackluster Week: Can Inflation Data Salvage Year's Rally? - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/23/02/31044058/us-stocks-stare-at-more-losses-in-a-lackluster-week-can-inflation-data-salvage-years-rally,20230224T111053,['Shanthi Rexaline'],"See-sawing sentiment continues to persist on Wall Street, as index futures signal weakness on Friday after Thursday's positive close. A key inflation reading due ahead of the market opening may largely provide direction to the market in the final trading session of the week.",https://cdn.benzinga.com/files/images/story/2023/02/24/share_market_1_photo_by_gsign76_on_shutterstock.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.451494'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}]",0.029156,Neutral,"[{'ticker': 'NVDA', 'relevance_score': '0.104455', 'ticker_sentiment_score': '-0.148951', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROKU', 'relevance_score': '0.104455', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BYND', 'relevance_score': '0.104455', 'ticker_sentiment_score': '-0.084836', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.104455', 'ticker_sentiment_score': '-0.246857', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'IVZ', 'relevance_score': '0.05234', 'ticker_sentiment_score': '0.064341', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SQ', 'relevance_score': '0.104455', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.104455', 'ticker_sentiment_score': '-0.185833', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
78,United Therapeutics  ( UTHR )  Q4 Earnings & Sales Miss Estimates,https://www.zacks.com/stock/news/2058301/united-therapeutics-uthr-q4-earnings-sales-miss-estimates,20230223T170600,['Zacks Investment Research'],United Therapeutics' (UTHR) fourth-quarter earnings and sales miss estimates. Tyvaso sales continue to drive the company's top line.,https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.976671'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.124287,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.203215', 'ticker_sentiment_score': '0.096154', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MNKD', 'relevance_score': '0.153145', 'ticker_sentiment_score': '0.211115', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UTHR', 'relevance_score': '0.560201', 'ticker_sentiment_score': '0.194372', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EFTR', 'relevance_score': '0.252463', 'ticker_sentiment_score': '0.067425', 'ticker_sentiment_label': 'Neutral'}]"
79,Eli Lilly and Company  ( LLY )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2057385/eli-lilly-and-company-lly-is-attracting-investor-attention-here-is-what-you-should-know,20230222T140011,['Zacks Investment Research'],"Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default272.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.228792,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.53074', 'ticker_sentiment_score': '0.106814', 'ticker_sentiment_label': 'Neutral'}]"
80,This Recession-Proof Company Has a Best-in-Class Dividend,https://www.fool.com/investing/2023/02/22/this-recession-proof-company-has-a-best-in-class-d/,20230222T123000,['George Budwell'],"Pfizer's highly attractive valuation, rock-solid dividend program, and enormous yield put it at the top of its big pharma peer group.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F721691%2Fpills-dollar-symbol.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.904684'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}]",0.166219,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.139265', 'ticker_sentiment_score': '-0.114321', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.139265', 'ticker_sentiment_score': '-0.114321', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.207571', 'ticker_sentiment_score': '0.126829', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.139265', 'ticker_sentiment_score': '-0.114321', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.339046', 'ticker_sentiment_score': '0.41866', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.339046', 'ticker_sentiment_score': '0.229493', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BMY', 'relevance_score': '0.139265', 'ticker_sentiment_score': '-0.114321', 'ticker_sentiment_label': 'Neutral'}]"
81,3 Top Defensive Stocks to Buy Hand Over Fist Right Now,https://www.fool.com/investing/2023/02/21/3-top-defensive-stocks-to-buy-hand-over-fist-right/,20230221T154500,['George Budwell'],These three defensive stocks could cushion your portfolio from market volatility this year.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F721598%2Fpig-with-umbrella.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.769861'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999976'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.258893,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.244846', 'ticker_sentiment_score': '0.156149', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VZ', 'relevance_score': '0.382193', 'ticker_sentiment_score': '0.21812', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LMT', 'relevance_score': '0.099271', 'ticker_sentiment_score': '0.092894', 'ticker_sentiment_label': 'Neutral'}]"
82,Is This Supercharged Growth Stock a Buy?,https://www.fool.com/investing/2023/02/20/is-this-supercharged-growth-stock-a-buy/,20230220T133000,['Kody Kester'],Shares of this drugmaker have trounced the S&P 500 index in the last decade.,https://media.ycharts.com/charts/330602a107da259a2ac0ba02dd5e6482.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.999995'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.977154'}]",0.276352,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.383765', 'ticker_sentiment_score': '0.243173', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.093157', 'ticker_sentiment_label': 'Neutral'}]"
83,Should Income Investors Buy This Dow Jones Stock?,https://www.fool.com/investing/2023/02/17/should-income-investors-buy-this-dow-jones-stock/,20230217T141500,['Kody Kester'],This drugmaker boasts an impressive product portfolio and pipeline.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F720823%2Fa-patient-attends-a-doctor-appointment.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.980716'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}]",0.275331,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.068698', 'ticker_sentiment_score': '0.052506', 'ticker_sentiment_label': 'Neutral'}]"
84,"Top Analyst Reports for Tesla, Eli Lilly & Bank of America",https://www.zacks.com/research-daily/2055447/top-analyst-reports-for-tesla-eli-lilly-bank-of-america,20230216T160000,['Zacks Investment Research'],"Today's Research Daily features new research reports on 16 major stocks, including Tesla, Inc. (TSLA), Eli Lilly and Company (LLY) and Bank of America Corporation (BAC).",https://staticx-tuner.zacks.com/images/default_article_images/default183.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.196944,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.303175', 'ticker_sentiment_score': '0.184961', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABB', 'relevance_score': '0.123844', 'ticker_sentiment_score': '0.09851', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.123844', 'ticker_sentiment_score': '0.09851', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.303175', 'ticker_sentiment_score': '0.184961', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.184834', 'ticker_sentiment_score': '0.126117', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.123844', 'ticker_sentiment_score': '0.09851', 'ticker_sentiment_label': 'Neutral'}]"
85,14 dividend stocks that rose 100% or more in 5 years as the payouts doubled,https://www.marketwatch.com/story/14-dividend-stocks-that-rose-100-or-more-in-5-years-as-the-payouts-doubled-751ed85d,20230216T151700,['Philip van Doorn'],"These dividend stocks have helped investors follow a 'growth, then income' strategy ...",https://images.mktw.net/im-726305/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.999612'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.245552,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.101154', 'ticker_sentiment_score': '0.027603', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.101154', 'ticker_sentiment_score': '0.027603', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.050679', 'ticker_sentiment_score': '0.040632', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSCO', 'relevance_score': '0.101154', 'ticker_sentiment_score': '0.027603', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.151222', 'ticker_sentiment_score': '0.162142', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
86,"US Stocks' Resilience Faces Test As Traders Await Flurry Of Economic Data: Fed May 'Surprise To The Upside' On Rates Again In 2023, Says Analyst - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/23/02/30938492/us-stocks-resilience-faces-test-as-traders-await-flurry-of-economic-data-fed-may-surprise-to-the-up,20230216T113045,['Shanthi Rexaline'],"The resilient market faces another test on Thursday, as traders get to digest another set of economic data and a few Fed speeches. The index futures pointed to a cautious start on Thursday. U.S. stocks closed Wednesday's session higher, encouraged by a stronger-than-expected retail sales report ...",https://cdn.benzinga.com/files/images/story/2023/02/16/share_market_photo_by_vintage_tone_on_shutterstock.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.769861'}, {'topic': 'Financial Markets', 'relevance_score': '0.99793'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}]",0.123987,Neutral,"[{'ticker': 'DKNG', 'relevance_score': '0.086713', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCGLF', 'relevance_score': '0.043421', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMAT', 'relevance_score': '0.086713', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROKU', 'relevance_score': '0.086713', 'ticker_sentiment_score': '0.044599', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QS', 'relevance_score': '0.086713', 'ticker_sentiment_score': '0.054084', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PARA', 'relevance_score': '0.086713', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADI', 'relevance_score': '0.043421', 'ticker_sentiment_score': '0.155479', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'H', 'relevance_score': '0.086713', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RNG', 'relevance_score': '0.086713', 'ticker_sentiment_score': '0.054084', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.043421', 'ticker_sentiment_score': '0.283573', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CMA', 'relevance_score': '0.043421', 'ticker_sentiment_score': '0.149508', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.086713', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FSLY', 'relevance_score': '0.086713', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HAS', 'relevance_score': '0.043421', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
87,V: 3 Large-Cap Stocks to Buy for the Perfect Portfolio in 2023,https://stocknews.com/news/v-lly-mrk-3-large-cap-stocks-to-buy-for-the-perfect-portfolio-in/,20230214T131703,[],V: 3 Large-Cap Stocks to Buy for the Perfect Portfolio in ...,https://stocknews.com/wp-content/uploads/2022/06/shutterstock_1990825910-scaled.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999999'}, {'topic': 'Earnings', 'relevance_score': '0.999967'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.5'}]",0.171257,Somewhat-Bullish,"[{'ticker': 'APG', 'relevance_score': '0.034282', 'ticker_sentiment_score': '0.152715', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.30111', 'ticker_sentiment_score': '0.122046', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.363629', 'ticker_sentiment_score': '0.171438', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MFGI', 'relevance_score': '0.034282', 'ticker_sentiment_score': '0.058513', 'ticker_sentiment_label': 'Neutral'}]"
88,3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off,https://www.fool.com/investing/2023/02/13/supercharged-dividend-stocks-buy-market-selloff/,20230213T103300,['Rachel Warren'],Income stocks can lend portfolio growth in both up and down markets.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F718958%2Fkid-jumping-in-rain-puddles.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Earnings', 'relevance_score': '0.992549'}]",0.132272,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.217639', 'ticker_sentiment_score': '0.195331', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TGT', 'relevance_score': '0.174903', 'ticker_sentiment_score': '0.015925', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.131643', 'ticker_sentiment_score': '0.0024', 'ticker_sentiment_label': 'Neutral'}]"
89,3 Surefire Growth Stocks You Can Buy Right Now,https://www.fool.com/investing/2023/02/11/3-surefire-growth-stocks-you-can-buy-right-now/,20230211T193100,"['and Prosper Junior Bakiny', 'Keith Speights', 'David Jagielski']",Maybe there's no such thing as a sure thing. But these stocks could come close.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F719455%2Faugmented-reality-virtual-reality-metaverse.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.266094,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.298437', 'ticker_sentiment_score': '0.266349', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.173333', 'ticker_sentiment_score': '0.254048', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JAZZ', 'relevance_score': '0.043658', 'ticker_sentiment_score': '-0.00999', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXSM', 'relevance_score': '0.130453', 'ticker_sentiment_score': '0.014849', 'ticker_sentiment_label': 'Neutral'}]"
90,Eli Lilly and Company  ( LLY )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2052241/eli-lilly-and-company-lly-is-a-trending-stock-facts-to-know-before-betting-on-it,20230209T140012,['Zacks Investment Research'],"Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.",https://staticx-tuner.zacks.com/images/default_article_images/default232.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}]",0.217503,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.526867', 'ticker_sentiment_score': '0.122362', 'ticker_sentiment_label': 'Neutral'}]"
91,A Look at Pharma ETFs Post Q4 Earnings,https://www.zacks.com/stock/news/2051723/a-look-at-pharma-etfs-post-q4-earnings,20230208T150500,['Zacks Investment Research'],"Combining the actual results with the estimates for the still-to-report companies, total earnings for the healthcare sector are expected to decline 9% on revenue growth of 4.3%.",https://staticx-tuner.zacks.com/images/articles/main/66/1019.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.133243,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.153961', 'ticker_sentiment_score': '0.032478', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.153961', 'ticker_sentiment_score': '0.100712', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HZNP', 'relevance_score': '0.038717', 'ticker_sentiment_score': '0.070442', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.115787', 'ticker_sentiment_score': '0.027812', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.077343', 'ticker_sentiment_score': '0.024707', 'ticker_sentiment_label': 'Neutral'}]"
92,Is Eli Lilly Stock a Buy Now?,https://www.fool.com/investing/2023/02/08/is-eli-lilly-stock-a-buy-now/,20230208T140000,['Prosper Junior Bakiny'],"There is a lot to like about this drugmaker, but is it enough?",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F719851%2F4-michael-burry-stocks.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.839681'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.977154'}]",0.317167,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.502477', 'ticker_sentiment_score': '0.468308', 'ticker_sentiment_label': 'Bullish'}]"
93,"Incyte's  ( INCY )  Q4 Earnings, Revenues Top on Jakafi, Opzelura",https://www.zacks.com/stock/news/2051064/incytes-incy-q4-earnings-revenues-top-on-jakafi-opzelura,20230207T155000,['Zacks Investment Research'],Incyte (INCY) reports better-than-expected Q4 results on strong demand for lead drug Jakafi and recently approved Opzelura.,https://staticx-tuner.zacks.com/images/articles/charts/cd/36261.jpg?v=516436751,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.183202,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.217834', 'ticker_sentiment_score': '0.106972', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INCY', 'relevance_score': '0.466137', 'ticker_sentiment_score': '0.369921', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SNDX', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.076839', 'ticker_sentiment_label': 'Neutral'}]"
94,1 Company Bucks the Office REIT Trend With Higher Rents and Earnings,https://www.fool.com/investing/2023/02/06/1-company-bucks-the-office-reit-trend-with-higher/,20230206T124600,"['Brent Nyitray', 'CFA']",Life sciences companies may be more immune to work-from-home shifts.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F719158%2Flaboratory-space.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}, {'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.5'}]",0.131174,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.128478', 'ticker_sentiment_score': '0.073705', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARE', 'relevance_score': '0.428632', 'ticker_sentiment_score': '0.165899', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MRNA', 'relevance_score': '0.128478', 'ticker_sentiment_score': '0.073705', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.128478', 'ticker_sentiment_score': '0.073705', 'ticker_sentiment_label': 'Neutral'}]"
95,AbbVie Q4 Preview: What's in Store?,https://www.zacks.com/stock/news/2049808/abbvie-q4-preview-whats-in-store,20230203T223100,['Zacks Investment Research'],"AbbVie has put in a mixed earnings performance, exceeding bottom line estimates in five consecutive quarters but falling short of sales expectations in each instance.",https://staticx-tuner.zacks.com/images/articles/main/d5/8276.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.120009,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.284861', 'ticker_sentiment_score': '0.071777', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.116067', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.116067', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.44074', 'ticker_sentiment_score': '0.242526', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
96,"Market Rally Powers Higher On Tame Fed, Meta: Weekly Review",https://www.investors.com/news/market-rally-powers-higher-on-tame-fed-meta-earnings-apple-google-amazon/,20230203T184300,"['IBD STAFF', ""Investor's Business Daily""]","The stock market rally marched higher as the Fed took a slightly more dovish stance, even though it said rate hikes will continue. Friday's superhot jobs report failed to derail the uptrend. Big earnings or guidance continued to be mixed, but Meta Platforms ( META ) skyrocketed on cost cuts, ...",https://www.investors.com/wp-content/uploads/2021/03/Stock-BullPortrait-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.989041'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",-0.119635,Neutral,"[{'ticker': 'AAPL', 'relevance_score': '0.081622', 'ticker_sentiment_score': '-0.016803', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.020439', 'ticker_sentiment_score': '-0.225104', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NVO', 'relevance_score': '0.040864', 'ticker_sentiment_score': '-0.021831', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HP', 'relevance_score': '0.040864', 'ticker_sentiment_score': '-0.228301', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AWON', 'relevance_score': '0.020439', 'ticker_sentiment_score': '-0.113997', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.061263', 'ticker_sentiment_score': '-0.177453', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'ARCB', 'relevance_score': '0.081622', 'ticker_sentiment_score': '-0.007475', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.020439', 'ticker_sentiment_score': '-0.02026', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALGM', 'relevance_score': '0.040864', 'ticker_sentiment_score': '-0.054915', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DT', 'relevance_score': '0.040864', 'ticker_sentiment_score': '-0.068824', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CHX', 'relevance_score': '0.061263', 'ticker_sentiment_score': '-0.232183', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSLA', 'relevance_score': '0.061263', 'ticker_sentiment_score': '0.186089', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'QCOM', 'relevance_score': '0.040864', 'ticker_sentiment_score': '-0.054915', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.081622', 'ticker_sentiment_score': '0.001048', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.061263', 'ticker_sentiment_score': '-0.022123', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GE', 'relevance_score': '0.061263', 'ticker_sentiment_score': '0.018068', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.040864', 'ticker_sentiment_score': '-0.021831', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.101927', 'ticker_sentiment_score': '-0.085941', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUM', 'relevance_score': '0.061263', 'ticker_sentiment_score': '0.109313', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.101927', 'ticker_sentiment_score': '0.006727', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COP', 'relevance_score': '0.040864', 'ticker_sentiment_score': '0.013907', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CI', 'relevance_score': '0.061263', 'ticker_sentiment_score': '0.109313', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.122165', 'ticker_sentiment_score': '-0.074405', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.040864', 'ticker_sentiment_score': '-0.021831', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LAC', 'relevance_score': '0.040864', 'ticker_sentiment_score': '-0.137563', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DECK', 'relevance_score': '0.040864', 'ticker_sentiment_score': '0.016999', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HZNP', 'relevance_score': '0.040864', 'ticker_sentiment_score': '-0.175455', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'XOM', 'relevance_score': '0.040864', 'ticker_sentiment_score': '0.013907', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GEHC', 'relevance_score': '0.061263', 'ticker_sentiment_score': '0.018068', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.040864', 'ticker_sentiment_score': '-0.175455', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'QRVO', 'relevance_score': '0.040864', 'ticker_sentiment_score': '-0.054915', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.081622', 'ticker_sentiment_score': '-0.012685', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ODFL', 'relevance_score': '0.061263', 'ticker_sentiment_score': '-0.00712', 'ticker_sentiment_label': 'Neutral'}]"
97,"Pharma Stock Roundup: MRK, LLY, PFE Q4 Results, J&J's Loss in Talc Lawsuits",https://www.zacks.com/stock/news/2049538/pharma-stock-roundup-mrk-lly-pfe-q4-results-jjs-loss-in-talc-lawsuits,20230203T141900,['Zacks Investment Research'],"Pfizer (PFE), Merck (MRK), Eli Lilly (LLY) and others report fourth-quarter results. An appeals court dismisses J&J's (JNJ) bankruptcy filing related to its talc lawsuits.",https://staticx-tuner.zacks.com/images/default_article_images/default84.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.997845'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",-0.004868,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.218161', 'ticker_sentiment_score': '0.08198', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.036812', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.036812', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.073546', 'ticker_sentiment_score': '0.012185', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.218161', 'ticker_sentiment_score': '-0.106216', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.146469', 'ticker_sentiment_score': '0.041104', 'ticker_sentiment_label': 'Neutral'}]"
98,LLY: 3 Smart Stocks to Buy for a Potential Recession in 2023,https://stocknews.com/news/lly-ci-wm-3-smart-stocks-to-buy-for-a-potential-recession-in/,20230203T135944,[],LLY: 3 Smart Stocks to Buy for a Potential Recession in ...,https://stocknews.com/wp-content/uploads/2022/03/shutterstock_406072729-scaled.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.838487'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999993'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.218864,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.290763', 'ticker_sentiment_score': '0.182891', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DOW', 'relevance_score': '0.054052', 'ticker_sentiment_score': '0.142768', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CI', 'relevance_score': '0.239698', 'ticker_sentiment_score': '0.216518', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WM', 'relevance_score': '0.187567', 'ticker_sentiment_score': '0.109702', 'ticker_sentiment_label': 'Neutral'}]"
99,Lilly  ( LLY )  Reports Q4 Earnings: What Key Metrics Have to Say,https://www.zacks.com/stock/news/2049362/lilly-lly-reports-q4-earnings-what-key-metrics-have-to-say,20230203T115600,['Zacks Investment Research'],"While the top- and bottom-line numbers for Lilly (LLY) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",https://staticx-tuner.zacks.com/images/default_article_images/default113.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.980922'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.11528,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.291471', 'ticker_sentiment_score': '0.062795', 'ticker_sentiment_label': 'Neutral'}]"
100,Eli Lilly  ( LLY )  Q4 2022 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/02/02/eli-lilly-lly-q4-2022-earnings-call-transcript/,20230203T010020,['Motley Fool Transcribing'],"LLY earnings call for the period ending December 31, 2022.",https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.161647'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.333333'}]",0.248319,Somewhat-Bullish,"[{'ticker': 'EVR', 'relevance_score': '0.003725', 'ticker_sentiment_score': '0.151566', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AHKSF', 'relevance_score': '0.003725', 'ticker_sentiment_score': '0.022087', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.003725', 'ticker_sentiment_score': '0.139213', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.003725', 'ticker_sentiment_score': '0.139213', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.003725', 'ticker_sentiment_score': '0.11925', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.003725', 'ticker_sentiment_score': '0.151566', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AKUS', 'relevance_score': '0.003725', 'ticker_sentiment_score': '0.070813', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.003725', 'ticker_sentiment_score': '0.111552', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APG', 'relevance_score': '0.003725', 'ticker_sentiment_score': '0.152246', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.078099', 'ticker_sentiment_score': '0.14793', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.003725', 'ticker_sentiment_score': '0.139213', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AHHLF', 'relevance_score': '0.003725', 'ticker_sentiment_score': '0.022087', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.003725', 'ticker_sentiment_score': '0.042463', 'ticker_sentiment_label': 'Neutral'}]"
101,Lilly and Novo Stock Sold Off. Don't Blame Their Diet Drugs.,https://www.barrons.com/articles/lilly-novo-stock-diet-drugs-earnings-51675376265,20230202T221800,['Bill Alpert'],"Stock in Eli Lilly and Novo Nordisk outperformed last year, largely because of remarkable demand for new drugs that drive weight loss in patients afflicted with diabetes and obesity. Both stocks were lower this week, after the companies reported December quarter results.",https://images.barrons.com/im-715951/social,Barrons,n/a,www.barrons.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.177168,Somewhat-Bearish,"[{'ticker': 'LLY', 'relevance_score': '0.928139', 'ticker_sentiment_score': '-0.306884', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NVO', 'relevance_score': '0.769861', 'ticker_sentiment_score': '-0.28844', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
102,Eli Lilly's post-earnings decline is creating a buying opportunity for long-term investors,https://www.cnbc.com/2023/02/02/eli-lillys-post-earnings-decline-is-creating-a-buying-opportunity-for-long-term-investors.html,20230202T194352,['Kevin Stankiewicz'],Club holding Eli Lilly's (LLY) post-earnings sell-off is creating a buying opportunity Thursday. Our long-term conviction is not shaken.,https://image.cnbcfm.com/api/v1/image/106301325-1576616813818img_1753r.jpg?v=1675367032&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.414211,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.760593', 'ticker_sentiment_score': '0.622419', 'ticker_sentiment_label': 'Bullish'}]"
103,"Golden Cross Hints 10% S&P 2023 Return; Apple, Google, Amazon On Deck; GM Breaks Out",https://www.investors.com/market-trend/stock-market-today/dow-jones-rises-meta-surges-teslas-china-production-ramps-up-apples-post-earnings-stock-performance-record/,20230202T190500,"[""Investor's Business Daily"", 'VIDYA RAMAKRISHNAN']","Dow Jones Falls, Nasdaq Rockets. Golden Cross Hints 10% 2023 ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2020/04/Stock-Apple-iPhoneSE-01-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.999696'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.983783'}]",0.091578,Neutral,"[{'ticker': 'GOOG', 'relevance_score': '0.052918', 'ticker_sentiment_score': '-0.052731', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.209365', 'ticker_sentiment_score': '-0.00702', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.260004', 'ticker_sentiment_score': '0.086869', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CHX', 'relevance_score': '0.105604', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.105604', 'ticker_sentiment_score': '0.091332', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.105604', 'ticker_sentiment_score': '-0.246613', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CHWY', 'relevance_score': '0.105604', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.157827', 'ticker_sentiment_score': '0.009788', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.105604', 'ticker_sentiment_score': '-0.057089', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.157827', 'ticker_sentiment_score': '0.009788', 'ticker_sentiment_label': 'Neutral'}]"
104,"Lilly  ( LLY )  Beats on Q4 Earnings, Lags on Sales, Raises '23 View",https://www.zacks.com/stock/news/2049148/lilly-lly-beats-on-q4-earnings-lags-on-sales-raises-23-view,20230202T190300,['Zacks Investment Research'],Eli Lilly's (LLY) earnings surpass fourth-quarter estimates while sales slightly miss the mark. The company raises its EPS guidance for 2023.,https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.495866'}]",-0.02413,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.40232', 'ticker_sentiment_score': '0.071129', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INCY', 'relevance_score': '0.032382', 'ticker_sentiment_score': '-0.045715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSVT', 'relevance_score': '0.128995', 'ticker_sentiment_score': '-0.045826', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ETON', 'relevance_score': '0.160847', 'ticker_sentiment_score': '-0.020699', 'ticker_sentiment_label': 'Neutral'}]"
105,Lilly's ambitious diabetes drug Mounjaro fails to impress in the fourth quarter,https://www.marketwatch.com/story/lillys-ambitious-new-drug-mounjaro-fails-to-impress-in-the-fourth-quarter-11675363713,20230202T184900,['Jaimy Lee'],"The new Type 2 diabetes treatment may be in high demand, but sales came in far below Wall Street's expectations.",https://images.mktw.net/im-716050/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}]",0.057254,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.36392', 'ticker_sentiment_score': '0.134761', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.075397', 'ticker_sentiment_score': '0.068061', 'ticker_sentiment_label': 'Neutral'}]"
106,Why Eli Lilly Stock Is Under Pressure Today,https://www.fool.com/investing/2023/02/02/why-eli-lilly-stock-is-under-pressure-today/,20230202T171538,['George Budwell'],The drugmaker's fourth-quarter earnings failed to impress investors.,https://media.ycharts.com/charts/6487abfa4ea252d2e5bf43681fb5b645.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.189307,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.570165', 'ticker_sentiment_score': '0.095102', 'ticker_sentiment_label': 'Neutral'}]"
107,"Jim Cramer's Investing Club meeting Thursday: Meta, Eli Lilly, Estee Lauder",https://www.cnbc.com/2023/02/02/jim-cramers-investing-club-meeting-thursday-meta-eli-lilly.html,20230202T162655,['Krystal Hur'],"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",https://image.cnbcfm.com/api/v1/image/105969521-1560525954111gettyimages-1079804120.jpg?v=1675282232&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.992549'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.111784,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.309864', 'ticker_sentiment_score': '0.106636', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.235062', 'ticker_sentiment_score': '0.085593', 'ticker_sentiment_label': 'Neutral'}]"
108,Economic Data Deluge,https://www.zacks.com/stock/news/2048524/economic-data-deluge,20230202T160400,['Zacks Investment Research'],"This morning, we see really terrific numbers on Q4 Productivity - the key to a strong economy outside employment levels, etc. It's a first read, so subject to revisions in the future, but for now we'll take it: +3.0% is half a percentage point higher than expected, and more than double the ...",https://staticx-tuner.zacks.com/images/articles/main/df/34747.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.077765,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.234307', 'ticker_sentiment_score': '0.059224', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.157483', 'ticker_sentiment_score': '0.044076', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.157483', 'ticker_sentiment_score': '0.044076', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.157483', 'ticker_sentiment_score': '0.044076', 'ticker_sentiment_label': 'Neutral'}]"
109,Goldilocks Econ Data Presides Over Pre-Market,https://www.zacks.com/stock/news/2048497/goldilocks-econ-data-presides-over-pre-market,20230202T153900,['Zacks Investment Research'],"We haven't thrown around the term ""Goldilocks"" too much lately, but this morning, the shoe fits.",https://staticx-tuner.zacks.com/images/articles/main/57/6946.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.0706,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.219477', 'ticker_sentiment_score': '0.051004', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.147366', 'ticker_sentiment_score': '0.038371', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.147366', 'ticker_sentiment_score': '0.038371', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.147366', 'ticker_sentiment_score': '0.038371', 'ticker_sentiment_label': 'Neutral'}]"
110,Why Eli Lilly  ( LLY )  Shares Are Falling Today - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/general/biotech/23/02/30688909/eli-lilly-posts-weaker-q4-sales-on-slower-demand-for-its-covid-19-treatment-overshadowing-annual-,20230202T153647,['Vandana Singh'],"Eli Lilly And Co LLY has reported Q4 sales of $7.30 billion, down 9% Y/Y, missing the consensus of $7.33 billion. Excluding COVID-19 antibodies, revenue in Q4 increased 5%, or 10% on a constant currency basis, driven by volume growth of key growth products, partially offset by lower Alimta revenue.",https://cdn.benzinga.com/files/images/story/2023/02/02/lly.png?optimize=medium&dpr=2&auto=webp&width=3840,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.316726'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.170354,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.772973', 'ticker_sentiment_score': '0.363443', 'ticker_sentiment_label': 'Bullish'}]"
111,Central Banks And More Earnings - Apple  ( NASDAQ:AAPL ) ,https://www.benzinga.com/markets/cryptocurrency/23/02/30690767/central-banks-and-more-earnings,20230202T153612,['GRIT Capital'],"Especially Mark Zuckerberg who stopped hanging out in the metaverse. Cut costs and returned to cash flow positive. Stock up 20% pre-market set to gain $200 billion. Signals a ""couple"" more hikes before a pause Delivers 50 basis point hike Signals more hikes ahead",https://cdn.benzinga.com/files/images/story/2023/02/02/nicholas-cappello-wb63zqj5gne-unsplash_10.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.77141'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.990999'}]",0.12997,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.188928', 'ticker_sentiment_score': '0.031233', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTVA', 'relevance_score': '0.188928', 'ticker_sentiment_score': '-0.442937', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'COP', 'relevance_score': '0.188928', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MET', 'relevance_score': '0.188928', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HON', 'relevance_score': '0.188928', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.188928', 'ticker_sentiment_score': '0.314924', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
112,Looking for a Reliable Dividend Payer? Consider Buying This Blue-Chip Stock,https://www.fool.com/investing/2023/02/02/looking-for-a-reliable-dividend-payer-consider-jnj/,20230202T135949,['Kody Kester'],This company has the most impressive dividend growth streak in the entire healthcare sector.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F718751%2Fa-doctor-takes-a-patients-blood-pressure.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.995973'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.918141'}]",0.219678,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.101367', 'ticker_sentiment_score': '0.0949', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.101367', 'ticker_sentiment_score': '0.133438', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.050786', 'ticker_sentiment_score': '0.159347', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
113,"Pharma Behemoth Skids On Mixed Earnings, But Boosts Outlook",https://www.investors.com/news/technology/lly-stock-eli-lilly-earnings-q4-2022/,20230202T135800,"['ALLISON GATLIN', ""Investor's Business Daily""]","LLY Stock Dives On Mixed Earnings, But Boosts Profit Outlook ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2018/04/stock-Eli-Lilly-01-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.890401'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.918141'}]",0.285541,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.97452', 'ticker_sentiment_score': '0.347478', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BSX', 'relevance_score': '0.250386', 'ticker_sentiment_score': '0.589625', 'ticker_sentiment_label': 'Bullish'}]"
114,Eli Lilly  ( LLY )  Q4 Earnings Surpass Estimates,https://www.zacks.com/stock/news/2048220/eli-lilly-lly-q4-earnings-surpass-estimates,20230202T130508,['Zacks Investment Research'],"Lilly (LLY) delivered earnings and revenue surprises of 14.21% and 0.28%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?",https://staticx-tuner.zacks.com/images/default_article_images/default14.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999997'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.139593,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.399204', 'ticker_sentiment_score': '0.08467', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EHC', 'relevance_score': '0.138464', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
115,Eli Lilly Stock Slips as Hyped-Up Obesity Drug Sales Fall Short. Earnings Still Crushed.,https://www.barrons.com/articles/eli-lilly-earnings-51675339392,20230202T122500,['Jack Denton'],Eli Lilly Stock Falls as Obesity Drug Sales Disappoint. ...,https://images.barrons.com/im-638287/social,Barrons,n/a,www.barrons.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",-0.19533,Somewhat-Bearish,"[{'ticker': 'LLY', 'relevance_score': '0.99188', 'ticker_sentiment_score': '-0.344732', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
116,"Lilly Reports Fourth-Quarter 2022 Financial Results, Core Business Growth and Pipeline Advancements Support Strong Long-Term Outlook",https://www.prnewswire.com/news-releases/lilly-reports-fourth-quarter-2022-financial-results-core-business-growth-and-pipeline-advancements-support-strong-long-term-outlook-301736812.html,20230202T114500,['Eli Lilly and Company'],"Lilly Reports Fourth-Quarter 2022 Financial Results, Core Business ... PR ...",https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.54554'}]",0.128845,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.250768', 'ticker_sentiment_score': '0.139066', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CURN', 'relevance_score': '0.009446', 'ticker_sentiment_score': '0.005093', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AKUS', 'relevance_score': '0.018891', 'ticker_sentiment_score': '0.14688', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FHTX', 'relevance_score': '0.009446', 'ticker_sentiment_score': '-0.072023', 'ticker_sentiment_label': 'Neutral'}]"
117,"Nasdaq Futures Fly As Meta Keeps Tech Earnings' Buoyancy Intact: Will Apple, Amazon, Alphabet Toe In Line?",https://www.benzinga.com/news/earnings/23/02/30684282/nasdaq-futures-fly-as-meta-keeps-tech-earnings-buoyancy-intact-will-apple-amazon-alphabet-toe-in-li,20230202T113423,['Shanthi Rexaline'],"The index futures point to a mixed opening on Thursday, as tech earnings continue to be encouraging. Meta Platform Inc's META strong earnings could set the tempo for the market mood as traders wait to hear from some of its big tech peers after the close.",https://cdn.benzinga.com/files/images/story/2023/02/02/share_market_photo_by_ashdesign_on_shutterstock.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.928139'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '0.988915'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '0.795202'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.049974,Neutral,"[{'ticker': 'BABA', 'relevance_score': '0.093836', 'ticker_sentiment_score': '-0.062628', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUM', 'relevance_score': '0.093836', 'ticker_sentiment_score': '0.15725', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.093836', 'ticker_sentiment_score': '0.116157', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COP', 'relevance_score': '0.093836', 'ticker_sentiment_score': '-0.062628', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'F', 'relevance_score': '0.093836', 'ticker_sentiment_score': '0.116157', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAH', 'relevance_score': '0.093836', 'ticker_sentiment_score': '-0.062628', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALGN', 'relevance_score': '0.093836', 'ticker_sentiment_score': '0.253534', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'IVZ', 'relevance_score': '0.046999', 'ticker_sentiment_score': '0.233609', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BMY', 'relevance_score': '0.093836', 'ticker_sentiment_score': '-0.062628', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BZH', 'relevance_score': '0.093836', 'ticker_sentiment_score': '0.116157', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.093836', 'ticker_sentiment_score': '0.116157', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMA', 'relevance_score': '0.046999', 'ticker_sentiment_score': '-0.095415', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.093836', 'ticker_sentiment_score': '-0.062628', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVNA', 'relevance_score': '0.093836', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.093836', 'ticker_sentiment_score': '0.116157', 'ticker_sentiment_label': 'Neutral'}]"
118,"Tech Futures Jump As Meta Spikes; Apple, Amazon, Google Due",https://www.investors.com/market-trend/stock-market-today/tech-futures-jump-on-meta-spike-after-gratifying-fed-rally-apple-amazon-google/,20230202T113000,"[""Investor's Business Daily"", 'ED CARSON']",Tech Futures Jump As Meta Spikes. Powell Spurs' Gratifying' Rally Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2021/12/Stock-metafacebook-01-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.928139'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.999894'}]",0.048153,Neutral,"[{'ticker': 'AMAT', 'relevance_score': '0.065387', 'ticker_sentiment_score': '-0.091535', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.130335', 'ticker_sentiment_score': '0.037554', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANET', 'relevance_score': '0.065387', 'ticker_sentiment_score': '-0.111734', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATKR', 'relevance_score': '0.043618', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'F', 'relevance_score': '0.043618', 'ticker_sentiment_score': '0.067428', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIDU', 'relevance_score': '0.065387', 'ticker_sentiment_score': '-0.058356', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DT', 'relevance_score': '0.065387', 'ticker_sentiment_score': '-0.002009', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PSTG', 'relevance_score': '0.065387', 'ticker_sentiment_score': '-0.111734', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.087106', 'ticker_sentiment_score': '0.112608', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GFS', 'relevance_score': '0.043618', 'ticker_sentiment_score': '-0.11024', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.043618', 'ticker_sentiment_score': '0.067428', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BX', 'relevance_score': '0.021817', 'ticker_sentiment_score': '0.066384', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.087106', 'ticker_sentiment_score': '-0.10433', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRCX', 'relevance_score': '0.087106', 'ticker_sentiment_score': '-0.065933', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OI', 'relevance_score': '0.043618', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.108761', 'ticker_sentiment_score': '0.076741', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.194415', 'ticker_sentiment_score': '-0.001603', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SYK', 'relevance_score': '0.043618', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HON', 'relevance_score': '0.043618', 'ticker_sentiment_score': '0.070787', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DAL', 'relevance_score': '0.087106', 'ticker_sentiment_score': '0.020907', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.065387', 'ticker_sentiment_score': '-0.091937', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFGC', 'relevance_score': '0.043618', 'ticker_sentiment_score': '-0.11597', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QRVO', 'relevance_score': '0.108761', 'ticker_sentiment_score': '-0.101728', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.108761', 'ticker_sentiment_score': '0.07534', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.021817', 'ticker_sentiment_score': '-0.489692', 'ticker_sentiment_label': 'Bearish'}]"
119,Fed Chief Triggers 'Gratifying' Rally; Meta Spikes On Earnings,https://www.investors.com/market-trend/stock-market-today/fed-chief-powell-triggers-gratifying-market-rally-meta-stock-spikes-on-earnings/,20230201T215700,"[""Investor's Business Daily"", 'ED CARSON']",Fed Chief Triggers 'Gratifying' Rally. Meta Spikes On Earnings Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/02/SMT-jeromepowell-0223-news.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.928139'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.999162'}]",0.067188,Neutral,"[{'ticker': 'AMAT', 'relevance_score': '0.070105', 'ticker_sentiment_score': '-0.092044', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.116574', 'ticker_sentiment_score': '0.100892', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.208166', 'ticker_sentiment_score': '0.020186', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.139669', 'ticker_sentiment_score': '0.037725', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANET', 'relevance_score': '0.070105', 'ticker_sentiment_score': '-0.112384', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATKR', 'relevance_score': '0.04677', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SYK', 'relevance_score': '0.04677', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'F', 'relevance_score': '0.04677', 'ticker_sentiment_score': '0.067964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIDU', 'relevance_score': '0.070105', 'ticker_sentiment_score': '-0.058686', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DAL', 'relevance_score': '0.093379', 'ticker_sentiment_score': '0.021259', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.04677', 'ticker_sentiment_score': '-0.082605', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DT', 'relevance_score': '0.070105', 'ticker_sentiment_score': '-0.002019', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PSTG', 'relevance_score': '0.070105', 'ticker_sentiment_score': '-0.112384', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.023395', 'ticker_sentiment_score': '0.211867', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GFS', 'relevance_score': '0.04677', 'ticker_sentiment_score': '-0.110665', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.04677', 'ticker_sentiment_score': '0.067964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFGC', 'relevance_score': '0.04677', 'ticker_sentiment_score': '-0.116488', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.070105', 'ticker_sentiment_score': '-0.083869', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRCX', 'relevance_score': '0.093379', 'ticker_sentiment_score': '-0.067052', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OI', 'relevance_score': '0.04677', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QRVO', 'relevance_score': '0.116574', 'ticker_sentiment_score': '-0.104617', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.116574', 'ticker_sentiment_score': '0.119794', 'ticker_sentiment_label': 'Neutral'}]"
120,Jim Cramer Gushes Over Pharmaceutical Stock's Chart: 'About The Greatest You've Ever Seen',https://www.thestreet.com/investing/jim-cramer-gushes-over-pharmaceutical-stocks-chart-about-the-greatest-youve-ever-seen,20230201T185600,['Rob Lenihan'],"CNBC's Jim Cramer has a lot to say about Wegovy, Novo Nordisk's fast-selling weight loss treatment.",https://www.thestreet.com/.image/ar_16:9%2Cc_fill%2Ccs_srgb%2Cfl_progressive%2Cg_faces:center%2Cq_auto:good%2Cw_620/MTY4NjUwNjI2NTczNDc3NTEx/lisa-su-advanced-micro-devices-ceo.jpg,The Street,n/a,www.thestreet.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.121011,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.358152', 'ticker_sentiment_score': '0.082824', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.439026', 'ticker_sentiment_score': '0.047903', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.183895', 'ticker_sentiment_score': '0.46325', 'ticker_sentiment_label': 'Bullish'}]"
121,"Drug/Biotech Stocks Q4 Earnings Due on Feb 2: GILD, MRK & Others",https://www.zacks.com/stock/news/2047789/drugbiotech-stocks-q4-earnings-due-on-feb-2-gild-mrk-others,20230201T154400,['Zacks Investment Research'],Let's look at the four biotech/pharma companies slated to release quarterly results on Feb 2.,https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.150526,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.29689', 'ticker_sentiment_score': '0.010826', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.214557', 'ticker_sentiment_score': '-0.001653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.086713', 'ticker_sentiment_score': '-0.138191', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.172404', 'ticker_sentiment_score': '0.034539', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.043421', 'ticker_sentiment_score': '-0.131538', 'ticker_sentiment_label': 'Neutral'}]"
122,"Down 14.5%, Is Pfizer Stock a Screaming Buy?",https://www.fool.com/investing/2023/01/30/down-145-is-pfizer-stock-a-screaming-buy/,20230130T210000,['George Budwell'],Pfizer's declining COVID-19 franchise and upcoming patent expirations have weighed heavily on its stock.,https://media.ycharts.com/charts/1af4d708d83d920a15f7f199f2a1e82f.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.459462'}]",-0.024192,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.130926', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.130926', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.541766', 'ticker_sentiment_score': '-0.040492', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.130926', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
123,Eli Lilly  ( LLY )  Lymphoma Candidate Pirtobrutinib Gets FDA Nod,https://www.zacks.com/stock/news/2046350/eli-lilly-lly-lymphoma-candidate-pirtobrutinib-gets-fda-nod,20230130T151100,['Zacks Investment Research'],The FDA approves Eli Lilly's Jaypirca (pirtobrutinib) under an accelerated approval pathway as a treatment for mantle cell lymphoma (MCL).,https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.928139'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.170594,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.323078', 'ticker_sentiment_score': '0.263727', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.132368', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.261117', 'ticker_sentiment_score': '0.296148', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SNY', 'relevance_score': '0.197413', 'ticker_sentiment_score': '0.207942', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
124,"Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch",https://www.benzinga.com/news/earnings/23/01/30616031/can-market-sustain-upward-momentum-in-tech-heavy-earnings-week-apple-amazon-amd-alphabet-ford-among,20230129T222532,['Shanthi Rexaline'],"With a full week of earnings behind us, it's time to take stock of the fourth-quarter reporting season so far. Overall, the news flow has been mixed, although tech earnings have grossly disappointed. Some of the big tech names that fell short are Intel Corp. INTC and Texas Instruments, Inc.",https://cdn.benzinga.com/files/images/story/2023/01/29/nyse2.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.011859,Neutral,"[{'ticker': 'CVX', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.103015', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.21787', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'F', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TXN', 'relevance_score': '0.054114', 'ticker_sentiment_score': '-0.163012', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AMGN', 'relevance_score': '0.081092', 'ticker_sentiment_score': '0.236315', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.081092', 'ticker_sentiment_score': '0.229106', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.054114', 'ticker_sentiment_score': '-0.115317', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.42603', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'QCOM', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WDC', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRCX', 'relevance_score': '0.027072', 'ticker_sentiment_score': '-0.155247', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'UPS', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GE', 'relevance_score': '0.081092', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BABA', 'relevance_score': '0.054114', 'ticker_sentiment_score': '-0.191833', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'KLAC', 'relevance_score': '0.054114', 'ticker_sentiment_score': '-0.163012', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'WHR', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUM', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COP', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.157789', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CI', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.081092', 'ticker_sentiment_score': '0.226017', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NXPI', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAH', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TMUS', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.157789', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BZH', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.054114', 'ticker_sentiment_score': '-0.163012', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CAT', 'relevance_score': '0.107978', 'ticker_sentiment_score': '0.245104', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'XOM', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GEHC', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QRVO', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.157789', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'REGN', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.081092', 'ticker_sentiment_score': '-0.109957', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.252919', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
125,Jobs report to give further clues about where economy is headed | Business,https://www.cnn.com/2023/01/29/investing/stocks-week-ahead,20230129T121700,['Paul R. La Monica'],Jobs report to give further clues about where economy is headed ...,"https://media.cnn.com/api/v1/images/stellar/prod/230125114419-china-aluminum-production-1122-file-restricted.jpg?c=16x9&q=h_144,w_256,c_fill",CNN,Markets,www.cnn.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.9545'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '0.96136'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.067734,Neutral,"[{'ticker': 'MDLZ', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.045965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MPC', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.045965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.115509', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.028972', 'ticker_sentiment_score': '0.042118', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.045965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CLX', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.045965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.086765', 'ticker_sentiment_score': '0.082737', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PENN', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSNLF', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.045965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.313095', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SBUX', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WBD', 'relevance_score': '0.028972', 'ticker_sentiment_score': '0.076672', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EA', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.045965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RYAOF', 'relevance_score': '0.028972', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.158996', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WHR', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.028972', 'ticker_sentiment_score': '0.043045', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUM', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.058964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.086765', 'ticker_sentiment_score': '-0.009286', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MO', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.058964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPOT', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.045965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COP', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CI', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.158996', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HON', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SWK', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SWKH', 'relevance_score': '0.028972', 'ticker_sentiment_score': '-0.062595', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BEN', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAH', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SIRI', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HSY', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SYY', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.045965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCK', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.058964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PSX', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.045965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.062039', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.045965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.045965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MET', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.058964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.115509', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
126,Jobs report to give further clues about where economy is headed | Business,https://www.cnn.com/2023/01/29/investing/stocks-week-ahead/index.html,20230129T121700,['Paul R. La Monica'],Jobs report to give further clues about where economy is headed ...,"https://media.cnn.com/api/v1/images/stellar/prod/230125114419-china-aluminum-production-1122-file-restricted.jpg?c=16x9&q=h_144,w_256,c_fill",CNN,Markets,www.cnn.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.9545'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '0.96136'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.067734,Neutral,"[{'ticker': 'MDLZ', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.045965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MPC', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.045965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.115509', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.028972', 'ticker_sentiment_score': '0.042118', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.045965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CLX', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.045965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.086765', 'ticker_sentiment_score': '0.082737', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PENN', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSNLF', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.045965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.313095', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SBUX', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WBD', 'relevance_score': '0.028972', 'ticker_sentiment_score': '0.076672', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EA', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.045965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RYAOF', 'relevance_score': '0.028972', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.158996', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WHR', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.028972', 'ticker_sentiment_score': '0.043045', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUM', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.058964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.086765', 'ticker_sentiment_score': '-0.009286', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MO', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.058964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPOT', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.045965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COP', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CI', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.158996', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HON', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SWK', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SWKH', 'relevance_score': '0.028972', 'ticker_sentiment_score': '-0.062595', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BEN', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAH', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SIRI', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HSY', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SYY', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.045965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCK', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.058964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PSX', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.045965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.062039', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.045965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.045965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.067965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MET', 'relevance_score': '0.057907', 'ticker_sentiment_score': '-0.058964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.115509', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
127,"Investing Action Plan - January Wrap: Apple, OPEC, Exxon And The Fed",https://www.investors.com/research/investing-action-plan/stock-market-investing-action-plan-january-wrap-apple-opec-exxon-and-the-fed/,20230127T232000,"['IBD STAFF', ""Investor's Business Daily""]","Investing Action Plan - January Wrap: Apple, OPEC, Exxon And ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2021/04/Stock-marketBoard-29-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.9545'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.999999'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",0.028782,Neutral,"[{'ticker': 'MXL', 'relevance_score': '0.032916', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.147316', 'ticker_sentiment_score': '0.011708', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.032916', 'ticker_sentiment_score': '-0.019423', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HP', 'relevance_score': '0.049356', 'ticker_sentiment_score': '0.060998', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALGN', 'relevance_score': '0.032916', 'ticker_sentiment_score': '-0.021146', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.082167', 'ticker_sentiment_score': '0.00207', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARCB', 'relevance_score': '0.032916', 'ticker_sentiment_score': '0.016309', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.049356', 'ticker_sentiment_score': '-0.001997', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALGM', 'relevance_score': '0.032916', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRUS', 'relevance_score': '0.032916', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.032916', 'ticker_sentiment_score': '0.141926', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.065775', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STX', 'relevance_score': '0.032916', 'ticker_sentiment_score': '0.09927', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WDC', 'relevance_score': '0.032916', 'ticker_sentiment_score': '0.09927', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.049356', 'ticker_sentiment_score': '0.049853', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRCX', 'relevance_score': '0.065775', 'ticker_sentiment_score': '0.092134', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'X', 'relevance_score': '0.032916', 'ticker_sentiment_score': '0.067052', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UPS', 'relevance_score': '0.032916', 'ticker_sentiment_score': '0.151693', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EA', 'relevance_score': '0.032916', 'ticker_sentiment_score': '0.066703', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.032916', 'ticker_sentiment_score': '0.047876', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.032916', 'ticker_sentiment_score': '-0.114718', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.049356', 'ticker_sentiment_score': '0.086646', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZBH', 'relevance_score': '0.032916', 'ticker_sentiment_score': '0.0553', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MO', 'relevance_score': '0.032916', 'ticker_sentiment_score': '0.136576', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WING', 'relevance_score': '0.049356', 'ticker_sentiment_score': '0.091202', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COP', 'relevance_score': '0.049356', 'ticker_sentiment_score': '0.057394', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.065775', 'ticker_sentiment_score': '0.002039', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NXPI', 'relevance_score': '0.032916', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.032916', 'ticker_sentiment_score': '0.047876', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EW', 'relevance_score': '0.032916', 'ticker_sentiment_score': '0.109883', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HAL', 'relevance_score': '0.065775', 'ticker_sentiment_score': '0.092134', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.082167', 'ticker_sentiment_score': '0.076139', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.065775', 'ticker_sentiment_score': '0.100154', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.032916', 'ticker_sentiment_score': '0.047876', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SZIHF', 'relevance_score': '0.016461', 'ticker_sentiment_score': '-0.006118', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QRVO', 'relevance_score': '0.032916', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REGN', 'relevance_score': '0.032916', 'ticker_sentiment_score': '0.047876', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.065775', 'ticker_sentiment_score': '0.092134', 'ticker_sentiment_label': 'Neutral'}]"
128,Biogen  ( BIIB )  & Eisai's Lecanemab Secures EMA's MAA Acceptance,https://www.zacks.com/stock/news/2045510/biogen-biib-eisais-lecanemab-secures-emas-maa-acceptance,20230127T145700,['Zacks Investment Research'],"Biogen (BIIB) and Eisai jointly announce that EMA accepts lecanemab's marketing authorization application (MAA) for the treatment of patients with early-stage Alzheimer's disease, for review.",https://staticx-tuner.zacks.com/images/articles/main/20/15392.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.238586,Somewhat-Bullish,"[{'ticker': 'ACIU', 'relevance_score': '0.239305', 'ticker_sentiment_score': '0.207135', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.239305', 'ticker_sentiment_score': '0.187879', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ESALF', 'relevance_score': '0.239305', 'ticker_sentiment_score': '0.268463', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ACET', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.082826', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.352223', 'ticker_sentiment_score': '0.292167', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
129,"Jim Cramer's top 8 things to watch in the market Friday: Intel sinks, Salesforce board shakeup",https://www.cnbc.com/2023/01/27/cramers-top-8-to-watch-friday-intel-sinks-salesforce-board-shakeup-.html,20230127T142805,['Jim Cramer'],Intel (INTC) catches multiple price target cuts on Wall Street after missing estimates with fourth-quarter earnings and revenue.,https://sc.cnbcfm.com/applications/cnbc.com/staticcontent/img/cnbc_logo.gif?v=1524171804&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.905476'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.120673,Neutral,"[{'ticker': 'NVDA', 'relevance_score': '0.189175', 'ticker_sentiment_score': '0.098228', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.126784', 'ticker_sentiment_score': '0.028174', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HAL', 'relevance_score': '0.189175', 'ticker_sentiment_score': '0.132207', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.126784', 'ticker_sentiment_score': '0.21354', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BCS', 'relevance_score': '0.063594', 'ticker_sentiment_score': '0.178364', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MA', 'relevance_score': '0.063594', 'ticker_sentiment_score': '0.210853', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'QCOM', 'relevance_score': '0.189175', 'ticker_sentiment_score': '0.098228', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.189175', 'ticker_sentiment_score': '-0.21033', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'V', 'relevance_score': '0.189175', 'ticker_sentiment_score': '0.315134', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMD', 'relevance_score': '0.189175', 'ticker_sentiment_score': '0.098228', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.189175', 'ticker_sentiment_score': '0.277087', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AXP', 'relevance_score': '0.126784', 'ticker_sentiment_score': '0.248617', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HAS', 'relevance_score': '0.063594', 'ticker_sentiment_score': '-0.147655', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DVN', 'relevance_score': '0.189175', 'ticker_sentiment_score': '0.132207', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PXD', 'relevance_score': '0.189175', 'ticker_sentiment_score': '0.132207', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTRA', 'relevance_score': '0.126784', 'ticker_sentiment_score': '0.028174', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ON', 'relevance_score': '0.063594', 'ticker_sentiment_score': '-0.00501', 'ticker_sentiment_label': 'Neutral'}]"
130,Eli Lilly  ( LLY )  to Report Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2045353/eli-lilly-lly-to-report-q4-earnings-whats-in-the-cards,20230127T132300,['Zacks Investment Research'],Higher demand for its key drugs is likely to have offset generic competition for several other drugs and may have boosted Lilly's (LLY) fourth-quarter sales.,https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999997'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.073846,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.48783', 'ticker_sentiment_score': '-0.031563', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AKUS', 'relevance_score': '0.12023', 'ticker_sentiment_score': '-0.059723', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.159834', 'ticker_sentiment_score': '0.046002', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.12023', 'ticker_sentiment_score': '0.16817', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SNY', 'relevance_score': '0.199037', 'ticker_sentiment_score': '-0.018772', 'ticker_sentiment_label': 'Neutral'}]"
131,"Pharma Stock Roundup: JNJ Q4 Results Mixed, MRK Keytruda Prostate Cancer Study Ends",https://www.zacks.com/stock/news/2045345/pharma-stock-roundup-jnj-q4-results-mixed-mrk-keytruda-prostate-cancer-study-ends,20230127T131400,['Zacks Investment Research'],J&J (JNJ) reports mixed fourth-quarter results. Merck (MRK) discontinues an advanced prostate cancer study on blockbuster drug Keytruda for futility.,https://staticx-tuner.zacks.com/images/articles/main/ab/2180.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.024501,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.025659', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.04583', 'ticker_sentiment_score': '-0.123346', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.091509', 'ticker_sentiment_score': '0.02241', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.04583', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.091509', 'ticker_sentiment_score': '-0.070621', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.04583', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
132,3 Healthcare Stocks to Buy and Hold for the Next 10 Years,https://www.fool.com/investing/2023/01/27/3-healthcare-stocks-buy-and-hold-for-next-10-years/,20230127T115000,['Jim Halley'],These companies have the therapies to boost revenue for a decade.,https://media.ycharts.com/charts/2cb01602095921051c4c874793d7ea40.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.258138,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.223659', 'ticker_sentiment_score': '0.183519', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.135347', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.090474', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
133,"Jim Cramer's Investing Club meeting Thursday: Stocks rise, Eli Lilly, Meta",https://www.cnbc.com/2023/01/26/jim-cramers-investing-club-meeting-thursday-stocks-rise-eli-lilly.html,20230126T171232,['Krystal Hur'],"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",https://image.cnbcfm.com/api/v1/image/107144956-1667411471504-gettyimages-1234506558-Estee_Lauder_Pop-up_Store.jpeg?v=1674678477&w=600&h=300&vtcrop=y,CNBC,Business,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999767'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.092823,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.479683', 'ticker_sentiment_score': '0.120806', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.252114', 'ticker_sentiment_score': '0.075131', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.085324', 'ticker_sentiment_score': '0.040596', 'ticker_sentiment_label': 'Neutral'}]"
134,Could This New Drug Indication Be a Winner for Eli Lilly?,https://www.fool.com/investing/2023/01/26/could-this-new-indication-be-a-win-for-eli-lilly/,20230126T151500,['Kody Kester'],The FDA could be just months away from approving Eli Lilly and Boehringer Ingelheim's drug candidate to treat a common condition.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F717672%2Fa-person-speaks-to-their-doctor.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.014429,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.377142', 'ticker_sentiment_score': '0.065666', 'ticker_sentiment_label': 'Neutral'}]"
135,Is It Too Late to Buy Eli Lilly Stock?,https://www.fool.com/investing/2023/01/26/is-it-too-late-to-buy-eli-lilly-stock/,20230126T143800,['David Jagielski'],"At a $325 billion market cap, the business is already huge -- does it have much more room to grow?",https://media.ycharts.com/charts/e3d93b569c702bfb0643d2c13d100c2d.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999998'}, {'topic': 'Earnings', 'relevance_score': '0.990893'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.221107,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.3527', 'ticker_sentiment_score': '0.361182', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'MS', 'relevance_score': '0.052112', 'ticker_sentiment_score': '0.036982', 'ticker_sentiment_label': 'Neutral'}]"
136,Investors Heavily Search Eli Lilly and Company  ( LLY ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2044672/investors-heavily-search-eli-lilly-and-company-lly-here-is-what-you-need-to-know,20230126T140013,['Zacks Investment Research'],"Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",https://staticx-tuner.zacks.com/images/default_article_images/default352.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}]",0.21566,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.528798', 'ticker_sentiment_score': '0.097252', 'ticker_sentiment_label': 'Neutral'}]"
137,2 Ultra-Safe Dividend Stocks to Own in 2023,https://www.fool.com/investing/2023/01/25/2-ultra-safe-dividend-stocks-to-own-in-2023/,20230125T143000,['George Budwell'],These two top dividend stocks won't keep you up at night.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F717477%2Fwarren-buffett-5.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.99999'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}]",0.155552,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.362858', 'ticker_sentiment_score': '0.142291', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TGT', 'relevance_score': '0.362858', 'ticker_sentiment_score': '0.033782', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.075161', 'ticker_sentiment_score': '-0.082338', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.075161', 'ticker_sentiment_score': '-0.082338', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.075161', 'ticker_sentiment_score': '-0.082338', 'ticker_sentiment_label': 'Neutral'}]"
138,Eli Lilly  ( LLY )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2043582/eli-lilly-lly-gains-as-market-dips-what-you-should-know,20230124T224522,['Zacks Investment Research'],"Eli Lilly (LLY) closed at $346.39 in the latest trading session, marking a +1.22% move from the prior day.",https://staticx-tuner.zacks.com/images/default_article_images/default239.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.917436'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.129883,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.634884', 'ticker_sentiment_score': '0.165769', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
139,Lilly  ( LLY )  Jardiance Kidney Disease sNDA Gets FDA Acceptance,https://www.zacks.com/stock/news/2042733/lilly-lly-jardiance-kidney-disease-snda-gets-fda-acceptance,20230123T153800,['Zacks Investment Research'],"Eli Lilly's (LLY) sNDA seeks approval for diabetes medicine, Jardiance, to reduce the risk of kidney disease progression and cardiovascular death in adults with CKD.",https://staticx-tuner.zacks.com/images/articles/main/66/1019.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.178231,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.31482', 'ticker_sentiment_score': '0.200449', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SNY', 'relevance_score': '0.238913', 'ticker_sentiment_score': '0.087085', 'ticker_sentiment_label': 'Neutral'}]"
140,Concert  ( CNCE )  Stock Up 17% Last Week on Sun Pharma Buyout Offer,https://www.zacks.com/stock/news/2042653/concert-cnce-stock-up-17-last-week-on-sun-pharma-buyout-offer,20230123T143800,['Zacks Investment Research'],Concert Pharmaceuticals (CNCE) enters into a definitive agreement to be acquired by India-based Sun Pharmaceutical for $576 million. Stock up 17% in the previous week.,https://staticx-tuner.zacks.com/images/articles/main/fc/845.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.495866'}]",0.156398,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.146025', 'ticker_sentiment_score': '0.051642', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CNCE', 'relevance_score': '0.2872', 'ticker_sentiment_score': '0.205842', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ARDX', 'relevance_score': '0.193852', 'ticker_sentiment_score': '0.074456', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.193852', 'ticker_sentiment_score': '0.086378', 'ticker_sentiment_label': 'Neutral'}]"
141,"Google Layoffs 12K Employees, Netflix's Q4 Earnings And CEO Steps Down, FDA Rejects Eli Lilly's Alzheimer's Candidate: Top Stories Friday, Jan. 20",https://www.benzinga.com/general/biotech/23/01/30502994/google-layoffs-12k-employees-netflixs-q4-earnings-and-ceo-steps-down-fda-rejects-eli-lillys-alzhe,20230120T152139,['Vandana Singh'],"Here's a round-up of stories from around the globe and from various media outlets. Alphabet Inc.'s GOOG GOOGL Google prepared to cut 12,000 jobs globally. CEO Sundar Pichai said the eliminations reflected a rigorous review across product areas and functions",https://cdn.benzinga.com/files/images/story/2023/01/20/shutterstock_1160472559.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.961735'}]",0.093373,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.133841', 'ticker_sentiment_score': '0.175549', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABB', 'relevance_score': '0.089462', 'ticker_sentiment_score': '0.107692', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.133841', 'ticker_sentiment_score': '-0.00996', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RAD', 'relevance_score': '0.089462', 'ticker_sentiment_score': '-0.024116', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NTDOF', 'relevance_score': '0.133841', 'ticker_sentiment_score': '-0.028652', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.089462', 'ticker_sentiment_score': '0.055477', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SLB', 'relevance_score': '0.133841', 'ticker_sentiment_score': '0.228368', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'COF', 'relevance_score': '0.089462', 'ticker_sentiment_score': '0.173688', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.089462', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BNTX', 'relevance_score': '0.089462', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
142,Why the FDA didn't grant an approval to Lilly's Alzheimer's drug,https://www.marketwatch.com/story/why-the-fda-didnt-grant-an-approval-to-lillys-alzheimers-drug-11674224605,20230120T142300,['Jaimy Lee'],The regulator wants to see clinical data from at least 100 patients who have taken donanemab for a year ...,https://images.mktw.net/im-707210/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.157711,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.444734', 'ticker_sentiment_score': '0.145698', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESALF', 'relevance_score': '0.263942', 'ticker_sentiment_score': '0.271098', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.199584', 'ticker_sentiment_score': '0.219581', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
143,Stock Market Live: Tech Leads Gains On Google Job Cuts Boost As Stocks Maintain Focus on Fed,https://www.thestreet.com/markets/stock-market-live-tech-leads-stock-gains-on-google-job-cut-boost,20230120T130700,['Martin Baccardax'],Stocks look set to snap a three-day losing streak as tech gets another boost from Google job cuts and Treasury yields hold amid hawkish Fed comments.,https://www.thestreet.com/.image/ar_16:9%2Cc_fill%2Ccs_srgb%2Cfl_progressive%2Cg_faces:center%2Cq_auto:good%2Cw_620/MTY4NjUwODA2OTYyNDk3MTU5/is-procter--gamble-dead-in-the-water.jpg,The Street,n/a,www.thestreet.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.838487'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.166949,Somewhat-Bullish,"[{'ticker': 'JWN', 'relevance_score': '0.136113', 'ticker_sentiment_score': '0.02114', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.136113', 'ticker_sentiment_score': '0.22452', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NFLX', 'relevance_score': '0.224903', 'ticker_sentiment_score': '0.216221', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GOOG', 'relevance_score': '0.136113', 'ticker_sentiment_score': '0.084028', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.090989', 'ticker_sentiment_score': '0.173776', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'COST', 'relevance_score': '0.045569', 'ticker_sentiment_score': '-0.026425', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.090989', 'ticker_sentiment_score': '0.207461', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'INTC', 'relevance_score': '0.090989', 'ticker_sentiment_score': '0.207461', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.136113', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.090989', 'ticker_sentiment_score': '0.173776', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GE', 'relevance_score': '0.090989', 'ticker_sentiment_score': '0.207461', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BA', 'relevance_score': '0.090989', 'ticker_sentiment_score': '0.207461', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.045569', 'ticker_sentiment_score': '0.07234', 'ticker_sentiment_label': 'Neutral'}]"
144,"Tech Stocks Get Netflix Boost Amid Jittery Wider Market On Friday, Dow Stares At 4th Straight Loss",https://www.benzinga.com/news/earnings/23/01/30498229/tech-stocks-get-netflix-boost-amid-jittery-wider-market-on-friday-dow-stares-at-4th-straight-loss,20230120T113003,['Shanthi Rexaline'],"U.S. stocks look set for a positive start on Friday, reversing course from the sell-off seen in the past three sessions. What Happened: Traders may have to contend with Fed speeches and housing market data, which could provide direction to the market.",https://cdn.benzinga.com/files/images/story/2023/01/20/stocks_photo_by_whyframe_on_shutterstock.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.769861'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.769861'}]",0.106735,Neutral,"[{'ticker': 'AA', 'relevance_score': '0.114956', 'ticker_sentiment_score': '-0.176598', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JWN', 'relevance_score': '0.114956', 'ticker_sentiment_score': '-0.022514', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.114956', 'ticker_sentiment_score': '0.250657', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PG', 'relevance_score': '0.114956', 'ticker_sentiment_score': '-0.176598', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LLY', 'relevance_score': '0.114956', 'ticker_sentiment_score': '0.05194', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SLB', 'relevance_score': '0.057628', 'ticker_sentiment_score': '-0.100966', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LPLA', 'relevance_score': '0.057628', 'ticker_sentiment_score': '0.098155', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAL', 'relevance_score': '0.114956', 'ticker_sentiment_score': '-0.176598', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'IVZ', 'relevance_score': '0.057628', 'ticker_sentiment_score': '0.29305', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.114956', 'ticker_sentiment_score': '0.05194', 'ticker_sentiment_label': 'Neutral'}]"
145,"Stocks Mixed, Netflix, Costco, Nordstrom, Eli Lilly In Focus - Five Things To Know",https://www.thestreet.com/markets/stocks-mixed-netflix-costco-nordstrom-eli-lilly-5-things-to-know,20230120T101100,['Martin Baccardax'],"Stock futures mixed with Fed talk, earnings in focus. Netflix surges as blowout subscriber gains offset earnings miss. Costco shares gain as bulk retail unveils $4 billion buyback plan. Nordstrom slumps after slashing profit forecast following weak holiday sales and Eli Lilly slides as FDA ...",https://www.thestreet.com/.image/ar_16:9%2Cc_fill%2Ccs_srgb%2Cfl_progressive%2Cg_faces:center%2Cq_auto:good%2Cw_620/MTY4NjUwODA2OTYyNDk3MTU5/is-procter--gamble-dead-in-the-water.jpg,The Street,n/a,www.thestreet.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.769861'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.999967'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.938238'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.20568,Somewhat-Bullish,"[{'ticker': 'JWN', 'relevance_score': '0.18343', 'ticker_sentiment_score': '0.191051', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.061631', 'ticker_sentiment_score': '0.222574', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NFLX', 'relevance_score': '0.213316', 'ticker_sentiment_score': '0.27661', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'COST', 'relevance_score': '0.213316', 'ticker_sentiment_score': '0.136089', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.061631', 'ticker_sentiment_score': '0.222574', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.030838', 'ticker_sentiment_score': '0.173891', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'INTC', 'relevance_score': '0.061631', 'ticker_sentiment_score': '0.222574', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.18343', 'ticker_sentiment_score': '0.001557', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GE', 'relevance_score': '0.061631', 'ticker_sentiment_score': '0.222574', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BA', 'relevance_score': '0.061631', 'ticker_sentiment_score': '0.222574', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.030838', 'ticker_sentiment_score': '0.069194', 'ticker_sentiment_label': 'Neutral'}]"
146,Futures: Market Rally Breaks Key Levels,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-netflix-jumps-on-subscribers-after-market-rally-breaks-key-levels/,20230119T233900,"['ED CARSON', ""Investor's Business Daily""]","Dow Jones Futures Rise, Netflix Jumps On Subscribers After Market ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2021/10/Stock-netflixsquidgame-01-company.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.818451'}]",0.014602,Neutral,"[{'ticker': 'MEDP', 'relevance_score': '0.153308', 'ticker_sentiment_score': '-0.066739', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.203429', 'ticker_sentiment_score': '0.165234', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DE', 'relevance_score': '0.051386', 'ticker_sentiment_score': '-0.119098', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.025706', 'ticker_sentiment_score': '-0.039491', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROKU', 'relevance_score': '0.077012', 'ticker_sentiment_score': '0.027458', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PARA', 'relevance_score': '0.051386', 'ticker_sentiment_score': '0.026129', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXON', 'relevance_score': '0.102558', 'ticker_sentiment_score': '0.035446', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SLB', 'relevance_score': '0.178459', 'ticker_sentiment_score': '0.120801', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.127999', 'ticker_sentiment_score': '0.04177', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MELI', 'relevance_score': '0.178459', 'ticker_sentiment_score': '-0.055744', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.025706', 'ticker_sentiment_score': '0.213997', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'XOM', 'relevance_score': '0.127999', 'ticker_sentiment_score': '0.09079', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.051386', 'ticker_sentiment_score': '0.010045', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.051386', 'ticker_sentiment_score': '0.010045', 'ticker_sentiment_label': 'Neutral'}]"
147,Eli Lilly  ( LLY )  Dips More Than Broader Markets: What You Should Know,https://www.zacks.com/stock/news/2040970/eli-lilly-lly-dips-more-than-broader-markets-what-you-should-know,20230118T224522,['Zacks Investment Research'],"In the latest trading session, Eli Lilly (LLY) closed at $352.01, marking a -1.6% move from the previous day.",https://staticx-tuner.zacks.com/images/default_article_images/default199.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.917436'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.141588,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.629492', 'ticker_sentiment_score': '0.161884', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
148,LLY: 4 Pharma Stocks You Shouldn't Think Twice About Buying in 2023,https://stocknews.com/news/lly-azn-zts-teva-4-pharma-stocks-you-shouldnt-think-twice-about-buying-in/,20230118T170137,[],LLY: 4 Pharma Stocks You Shouldn't Think Twice About Buying in ... ...,https://stocknews.com/wp-content/uploads/2022/06/shutterstock_757996678-1-scaled.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.779048'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}]",0.26693,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.27838', 'ticker_sentiment_score': '0.164129', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ZTS', 'relevance_score': '0.251536', 'ticker_sentiment_score': '0.164058', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TEVA', 'relevance_score': '0.304886', 'ticker_sentiment_score': '0.347427', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AZN', 'relevance_score': '0.27838', 'ticker_sentiment_score': '0.23199', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CRYPTO:POWR', 'relevance_score': '0.196953', 'ticker_sentiment_score': '0.125076', 'ticker_sentiment_label': 'Neutral'}]"
149,"Futures Rise; Tesla, Moderna Lead Early Movers",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rally-pauses-tesla-jumps/,20230118T131900,"['ED CARSON', ""Investor's Business Daily""]",Dow Jones Futures Rise On Bank Of Japan Surprise. Tesla ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2016/03/BIGPIC-032316-shutterstock.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.947132'}]",0.086229,Neutral,"[{'ticker': 'MEDP', 'relevance_score': '0.046139', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.115011', 'ticker_sentiment_score': '0.006932', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IBKR', 'relevance_score': '0.046139', 'ticker_sentiment_score': '0.128399', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.16048', 'ticker_sentiment_score': '0.016441', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MNST', 'relevance_score': '0.046139', 'ticker_sentiment_score': '0.067662', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.046139', 'ticker_sentiment_score': '0.032696', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.115011', 'ticker_sentiment_score': '-0.019007', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.069161', 'ticker_sentiment_score': '0.019191', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.046139', 'ticker_sentiment_score': '0.125628', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.16048', 'ticker_sentiment_score': '-0.090112', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MELI', 'relevance_score': '0.069161', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.183025', 'ticker_sentiment_score': '0.079555', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.046139', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.069161', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.092124', 'ticker_sentiment_score': '0.030857', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:JPY', 'relevance_score': '0.023079', 'ticker_sentiment_score': '-0.182766', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.046139', 'ticker_sentiment_score': '-0.016013', 'ticker_sentiment_label': 'Neutral'}]"
150,Market Rally Pauses As Tesla Jumps; 3 Stocks Rising Late,https://www.investors.com/market-trend/stock-market-today/market-rally-pauses-tesla-keeps-rebounding-united-airlines-moderna-microsoft-in-focus/,20230117T224800,"[""Investor's Business Daily"", 'ED CARSON']","Market Rally Pauses, Tesla Keeps Rebounding. United Airlines ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2016/03/BIGPIC-032316-shutterstock.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.904684'}]",0.107314,Neutral,"[{'ticker': 'MEDP', 'relevance_score': '0.051111', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.127321', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IBKR', 'relevance_score': '0.051111', 'ticker_sentiment_score': '0.129395', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.177522', 'ticker_sentiment_score': '0.017632', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MNST', 'relevance_score': '0.051111', 'ticker_sentiment_score': '0.067956', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.051111', 'ticker_sentiment_score': '0.032919', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.127321', 'ticker_sentiment_score': '-0.01987', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.076602', 'ticker_sentiment_score': '0.019414', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.051111', 'ticker_sentiment_score': '0.120976', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.177522', 'ticker_sentiment_score': '-0.108165', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MELI', 'relevance_score': '0.076602', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.202366', 'ticker_sentiment_score': '0.08579', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.051111', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.076602', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.102013', 'ticker_sentiment_score': '0.022041', 'ticker_sentiment_label': 'Neutral'}]"
151,BAYRY or LLY: Which Is the Better Value Stock Right Now?,https://www.zacks.com/stock/news/2040284/bayry-or-lly-which-is-the-better-value-stock-right-now,20230117T164010,['Zacks Investment Research'],BAYRY vs. LLY: Which Stock Is the Better Value Option?,https://staticx-tuner.zacks.com/images/default_article_images/default41.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.476014,Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.69701', 'ticker_sentiment_score': '0.516597', 'ticker_sentiment_label': 'Bullish'}]"
152,"Jim Cramer's top 10 things to watch in the market Tuesday: Morgan Stanley beat, Goldman Sachs miss, Estee Lauder boost",https://www.cnbc.com/2023/01/17/cramers-top-10-things-tuesday-morgan-stanley-goldman-sachs-estee-lauder.html,20230117T134848,['Jim Cramer'],Bond yields are up so the stock market is down.,https://image.cnbcfm.com/api/v1/image/107121163-16636733462022-09-20t110046z_916998079_rc2ykw94dd2c_rtrmadp_0_usa-sec-morganstanley.jpeg?v=1673963328&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.999822'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.839681'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.159656,Somewhat-Bullish,"[{'ticker': 'CSCO', 'relevance_score': '0.187705', 'ticker_sentiment_score': '0.10261', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.187705', 'ticker_sentiment_score': '-0.145274', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.063091', 'ticker_sentiment_score': '-0.094594', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.24847', 'ticker_sentiment_score': '-0.098542', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.24847', 'ticker_sentiment_score': '0.357307', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.187705', 'ticker_sentiment_score': '0.069255', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EMR', 'relevance_score': '0.187705', 'ticker_sentiment_score': '0.108611', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.125789', 'ticker_sentiment_score': '0.088272', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.187705', 'ticker_sentiment_score': '0.04044', 'ticker_sentiment_label': 'Neutral'}]"
153,"AbbVie, Eli Lilly Leave UK's Voluntary Medicines Pricing Agreement Over Increasing Prices",https://www.benzinga.com/general/biotech/23/01/30434677/abbvie-eli-lilly-leave-uks-voluntary-medicines-pricing-agreement-over-increasing-prices,20230117T110320,['Vandana Singh'],The Association of the British Pharmaceutical Industry ( ABPI ) said pharmaceutical giants AbbVie Inc ABBV and Eli Lilly And Co LLY have withdrawn from Britain's voluntary medicines pricing agreement.,https://cdn.benzinga.com/files/images/story/2023/01/17/abbvie_bay_area_0384.jpg?optimize=medium&dpr=2&auto=webp&width=3840,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.035881,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.451494', 'ticker_sentiment_score': '0.359035', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.451494', 'ticker_sentiment_score': '0.359035', 'ticker_sentiment_label': 'Bullish'}]"
154,Biogen  ( BIIB )  Partner Eisai Seeks Nod for Lecanemab in Japan,https://www.zacks.com/stock/news/2039800/biogen-biib-partner-eisai-seeks-nod-for-lecanemab-in-japan,20230116T173300,['Zacks Investment Research'],Biogen's (BIIB) partner Eisai files a marketing authorization application for lecanemab for treating early Alzheimer's disease in Japan.,https://staticx-tuner.zacks.com/images/articles/main/20/15392.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.173903,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.175009', 'ticker_sentiment_score': '0.133218', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNDX', 'relevance_score': '0.287537', 'ticker_sentiment_score': '0.106933', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESALF', 'relevance_score': '0.341699', 'ticker_sentiment_score': '0.156', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.394125', 'ticker_sentiment_score': '0.181589', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
155,3 Growth Stocks Poised for Huge Gains in 2023,https://www.fool.com/investing/2023/01/14/3-growth-stocks-poised-for-huge-gains-in-2023/,20230114T125000,['Jim Halley'],These big pharmaceuticals are poised for back-to-back big years.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F716268%2Fsocial-security-cash-benefit-retirement-congress-check-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '0.972756'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.092997,Neutral,"[{'ticker': 'CINC', 'relevance_score': '0.054857', 'ticker_sentiment_score': '0.018996', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.163539', 'ticker_sentiment_score': '0.026667', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.109455', 'ticker_sentiment_score': '0.145658', 'ticker_sentiment_label': 'Neutral'}]"
156,LLY: The 3 Best Retirement Stocks to Buy for Investors Over 55,https://stocknews.com/news/lly-mrk-adm-the-3-best-retirement-stocks-to-buy-for-investors-over/,20230113T200425,[],LLY: The 3 Best Retirement Stocks to Buy for Investors Over ...,https://stocknews.com/wp-content/uploads/2022/05/shutterstock_360001805-scaled.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.928139'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999993'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.228448,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.349424', 'ticker_sentiment_score': '0.222416', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ADM', 'relevance_score': '0.21956', 'ticker_sentiment_score': '0.2351', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PEP', 'relevance_score': '0.055557', 'ticker_sentiment_score': '0.188936', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AKUS', 'relevance_score': '0.055557', 'ticker_sentiment_score': '0.154056', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'IMGO', 'relevance_score': '0.083251', 'ticker_sentiment_score': '0.192831', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
157,Eli Lilly  ( LLY )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2038708/eli-lilly-lly-stock-sinks-as-market-gains-what-you-should-know,20230112T224537,['Zacks Investment Research'],"Eli Lilly (LLY) closed at $359.12 in the latest trading session, marking a -0.36% move from the prior day.",https://staticx-tuner.zacks.com/images/default_article_images/default328.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.159029,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.591634', 'ticker_sentiment_score': '0.252755', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
158,UNH: 3 Large-Cap Stocks Worth Buying in 2023,https://stocknews.com/news/unh-wmt-lly-3-large-cap-stocks-worth-buying-in-2023/,20230112T153942,[],UNH: 3 Large-Cap Stocks Worth Buying in ...,https://stocknews.com/wp-content/uploads/2017/12/best-large-cap.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.838487'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999999'}, {'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.230675,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.279595', 'ticker_sentiment_score': '0.224162', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NFLX', 'relevance_score': '0.051886', 'ticker_sentiment_score': '0.285766', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AKUS', 'relevance_score': '0.051886', 'ticker_sentiment_score': '0.06098', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.255106', 'ticker_sentiment_score': '0.281024', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WMT', 'relevance_score': '0.3277', 'ticker_sentiment_score': '0.278588', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
159,Here is What to Know Beyond Why Eli Lilly and Company  ( LLY )  is a Trending Stock,https://www.zacks.com/stock/news/2038411/here-is-what-to-know-beyond-why-eli-lilly-and-company-lly-is-a-trending-stock,20230112T140011,['Zacks Investment Research'],"Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default56.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}]",0.224417,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.529767', 'ticker_sentiment_score': '0.110035', 'ticker_sentiment_label': 'Neutral'}]"
160,Eli Lilly Had a Strong Year in 2022. It's Expecting an Even Better 2023.,https://www.fool.com/investing/2023/01/11/eli-lilly-had-a-strong-year-in-2022-its-expecting/,20230111T151500,['David Jagielski'],The company has multiple growth catalysts on the horizon that could propel the stock this year and beyond.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F714987%2Fwarren-buffett-at-one-of-berkshires-shareholder-meetings.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.905476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.977154'}]",0.304171,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.509589', 'ticker_sentiment_score': '0.330572', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
161,Biogen's  ( BIIB )  Partner Eisai Files MAA for Lecanemab in Europe,https://www.zacks.com/stock/news/2037886/biogens-biib-partner-eisai-files-maa-for-lecanemab-in-europe,20230111T143800,['Zacks Investment Research'],Biogen's (BIIB) partner Eisai files a marketing authorization application to the European Medicines Agency for lecanemab for treating early Alzheimer's disease in Europe.,https://staticx-tuner.zacks.com/images/articles/main/20/15392.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.14411,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.184363', 'ticker_sentiment_score': '0.138235', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNDX', 'relevance_score': '0.302429', 'ticker_sentiment_score': '0.111322', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESALF', 'relevance_score': '0.359014', 'ticker_sentiment_score': '0.166814', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.359014', 'ticker_sentiment_score': '0.138184', 'ticker_sentiment_label': 'Neutral'}]"
162,"Jim Cramer's Investing Club meeting Tuesday: Microsoft, health care, Emerson Electric",https://www.cnbc.com/2023/01/10/jim-cramers-investing-club-meeting-tuesday-microsoft-health-care.html,20230110T163215,['Krystal Hur'],"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",https://image.cnbcfm.com/api/v1/image/106742803-16026237952020-10-13t203905z_1608884981_rc2whj9ipswl_rtrmadp_0_health-coronavirus-elililly.jpeg?v=1673299786&w=600&h=300&vtcrop=y,CNBC,Business,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.938793'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.186236,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.342093', 'ticker_sentiment_score': '0.191519', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.342093', 'ticker_sentiment_score': '0.191519', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EMR', 'relevance_score': '0.342093', 'ticker_sentiment_score': '0.191519', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.260189', 'ticker_sentiment_score': '0.155282', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
163,Campbell Soup and Eli Lilly have been highlighted as Zacks Bull and Bear of the Day,https://www.zacks.com/stock/news/2037184/campbell-soup-and-eli-lilly-have-been-highlighted-as-zacks-bull-and-bear-of-the-day,20230110T132700,['Zacks Investment Research'],"Chicago, IL - January 10, 2023 - Zacks Equity Research shares Campbell Soup Company ( CPB Quick QuoteCPB - ) as the Bull of the Day and Eli Lilly & Co. ( LLY Quick QuoteLLY - ) as the Bear of the Day.",https://staticx-tuner.zacks.com/images/articles/main/44/1354.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.838487'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999982'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",0.224428,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.136801', 'ticker_sentiment_score': '0.098198', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SUZ', 'relevance_score': '0.106609', 'ticker_sentiment_score': '0.112729', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CPB', 'relevance_score': '0.121727', 'ticker_sentiment_score': '0.103029', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.030543', 'ticker_sentiment_score': '-0.034821', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TS', 'relevance_score': '0.091451', 'ticker_sentiment_score': '0.140619', 'ticker_sentiment_label': 'Neutral'}]"
164,Bear of the Day: Eli Lilly  ( LLY ) ,https://www.zacks.com/commentary/2037063/bear-of-the-day-eli-lilly-lly,20230110T112000,['Zacks Investment Research'],Guidance for this year drags down analyst EPS estimates by nearly 10% to just 9% growth ...,https://staticx-tuner.zacks.com/images/default_article_images/default12.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.988787'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}]",0.071677,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.462743', 'ticker_sentiment_score': '0.091212', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.122581', 'ticker_sentiment_score': '0.033023', 'ticker_sentiment_label': 'Neutral'}]"
165,Is Alexandria Real Estate Equity a Buy?,https://www.fool.com/investing/2023/01/10/is-alexandria-real-estate-equity-a-buy/,20230110T100000,"['CFA', 'Brent Nyitray']","It's a great stock, but investors dislike the sector.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F715027%2Flaboratory-space.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}, {'topic': 'Earnings', 'relevance_score': '0.769861'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.184776,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.115509', 'ticker_sentiment_score': '0.025857', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.023', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AGTEF', 'relevance_score': '0.057907', 'ticker_sentiment_score': '0.018979', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARE', 'relevance_score': '0.115509', 'ticker_sentiment_score': '0.071103', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.115509', 'ticker_sentiment_score': '0.025857', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.115509', 'ticker_sentiment_score': '0.025857', 'ticker_sentiment_label': 'Neutral'}]"
166,"Biogen  ( BIIB ) , Eisai's Lecanemab Gets FDA Nod for Alzheimer's",https://www.zacks.com/stock/news/2036807/biogen-biib-eisais-lecanemab-gets-fda-nod-for-alzheimers,20230109T150400,['Zacks Investment Research'],FDA approves Biogen (BIIB) and Eisai's lecanemab on an accelerated basis. Eisai filed a supplemental biologics license application (sBLA) to the FDA to get a traditional approval for Leqembi.,https://staticx-tuner.zacks.com/images/articles/main/62/5473.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.085516,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.148731', 'ticker_sentiment_score': '0.119928', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANIK', 'relevance_score': '0.245339', 'ticker_sentiment_score': '-0.021119', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESALF', 'relevance_score': '0.245339', 'ticker_sentiment_score': '0.082997', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.29234', 'ticker_sentiment_score': '0.102134', 'ticker_sentiment_label': 'Neutral'}]"
167,3 No-Brainer Dividend Stocks to Buy in 2023,https://www.fool.com/investing/2023/01/07/3-no-brainer-dividend-stocks-to-buy-in-2023/,20230107T111000,"['Keith Speights', 'David Jagielski', 'and Prosper Junior Bakiny']",These stocks have what it takes to win over the long run.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F715209%2Fjoe-biden-speech-white-house-photo-by-adam-schultz.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}, {'topic': 'Earnings', 'relevance_score': '0.650727'}]",0.217747,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.401331', 'ticker_sentiment_score': '0.305948', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.401331', 'ticker_sentiment_score': '0.07875', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.27432', 'ticker_sentiment_score': '0.043835', 'ticker_sentiment_label': 'Neutral'}]"
168,Eli Lilly  ( LLY )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2036450/eli-lilly-lly-gains-but-lags-market-what-you-should-know,20230106T224519,['Zacks Investment Research'],"Eli Lilly (LLY) closed at $362.94 in the latest trading session, marking a +1.12% move from the prior day.",https://staticx-tuner.zacks.com/images/default_article_images/default68.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.875462'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.169362,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.638519', 'ticker_sentiment_score': '0.310088', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
169,"CRISPR, Genetics And AI - Why 2023 Could Be Biotech's Year",https://www.investors.com/news/technology/biotech-stocks-how-crispr-genetics-and-ai-could-drive-a-2023-inflection/,20230106T130000,"[""Investor's Business Daily"", 'ALLISON GATLIN']","Biotech Stocks: How CRISPR, Genetics And AI Could Drive A 2023 ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2018/11/stock-DNA-03-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.995077'}, {'topic': 'Earnings', 'relevance_score': '0.266143'}]",0.07013,Neutral,"[{'ticker': 'RNA', 'relevance_score': '0.126192', 'ticker_sentiment_score': '-0.003591', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BTAI', 'relevance_score': '0.028155', 'ticker_sentiment_score': '0.085398', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.028155', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.028155', 'ticker_sentiment_score': '0.050109', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.028155', 'ticker_sentiment_score': '0.01046', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.07031', 'ticker_sentiment_score': '-0.066329', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.028155', 'ticker_sentiment_score': '-0.042845', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.028155', 'ticker_sentiment_score': '-0.042845', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BNTX', 'relevance_score': '0.042221', 'ticker_sentiment_score': '0.110033', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HESG', 'relevance_score': '0.01408', 'ticker_sentiment_score': '0.178248', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ARWR', 'relevance_score': '0.028155', 'ticker_sentiment_score': '-0.055821', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.028155', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.084324', 'ticker_sentiment_score': '0.024615', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDGL', 'relevance_score': '0.028155', 'ticker_sentiment_score': '-0.058744', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRL', 'relevance_score': '0.028155', 'ticker_sentiment_score': '-0.051348', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.084324', 'ticker_sentiment_score': '-0.052735', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.07031', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TAK', 'relevance_score': '0.028155', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
170,Could Eli Lilly Stock Help You Become a Millionaire?,https://www.fool.com/investing/2023/01/05/could-eli-lilly-stock-help-you-become-millionaire/,20230105T150700,['David Jagielski'],"Over the past 10 years, when including its dividend, Eli Lilly's total return has amounted to an incredible 843%.",https://media.ycharts.com/charts/e1a4c1658b502b98e69a813b271374e4.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.989041'}]",0.322999,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.483434', 'ticker_sentiment_score': '0.422072', 'ticker_sentiment_label': 'Bullish'}]"
171,AstraZeneca Stock Scores Relative Strength Rating Upgrade,https://www.investors.com/news/astrazeneca-stock-scores-relative-strength-rating-upgrade/,20230104T190300,"[""Investor's Business Daily"", 'JULIE MAK', ""INVESTOR'S BUSINESS DAILY""]","On Wednesday, AstraZeneca ( AZN ) stock reached a noteworthy performance benchmark, with its Relative Strength ( RS ) Rating moving into the 90-plus percentile with an upgrade to 92, a rise from 89 the day before. When looking for the best stocks to buy and watch, one factor to watch closely ...",https://www.investors.com/wp-content/uploads/2017/05/IRU77.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.313042,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.33628', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.485711', 'ticker_sentiment_score': '0.356015', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.33628', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
172,AstraZeneca ADR Scores Relative Strength Rating Upgrade,https://www.investors.com/ibd-data-stories/astrazeneca-adr-scores-relative-strength-rating-upgrade/,20230104T080000,"[""Investor's Business Daily"", ""INVESTOR'S BUSINESS DAILY""]","On Wednesday, AstraZeneca ADR ( AZN ) reached a noteworthy performance benchmark, with its Relative Strength ( RS ) Rating moving into the 90-plus percentile with an upgrade to 92, a rise from 89 the day before. When looking for the best stocks to buy and watch, one factor to watch closely is ...",https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.315234,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.345674', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.498188', 'ticker_sentiment_score': '0.355732', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.345674', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
173,Eli Lilly  ( LLY )  Stock Moves -0.23%: What You Should Know,https://www.zacks.com/stock/news/2034841/eli-lilly-lly-stock-moves--023-what-you-should-know,20230103T225023,['Zacks Investment Research'],"In the latest trading session, Eli Lilly (LLY) closed at $364.99, marking a -0.23% move from the previous day.",https://staticx-tuner.zacks.com/images/default_article_images/default16.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.917436'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.011987,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.570165', 'ticker_sentiment_score': '0.010398', 'ticker_sentiment_label': 'Neutral'}]"
174,"How Two Key Question In 2023 Could Spark, Or Slam, This Pharma",https://www.investors.com/research/ibd-stock-of-the-day/lly-stock-the-key-issues-in-2023-that-could-spark-or-topple-shares/,20230103T174500,"['ALLISON GATLIN', ""Investor's Business Daily""]","LLY Stock: The Key Issues In 2023 That Could Spark, Or Topple ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2023/01/LLY-SOTD-chart.png,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}]",0.185346,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.7503', 'ticker_sentiment_score': '0.41491', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'AMGN', 'relevance_score': '0.226477', 'ticker_sentiment_score': '0.101762', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.114409', 'ticker_sentiment_score': '0.112213', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.114409', 'ticker_sentiment_score': '-0.047589', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.226477', 'ticker_sentiment_score': '0.040827', 'ticker_sentiment_label': 'Neutral'}]"
175,1 Large-Cap Biotech Stock to Buy for 2023 and Beyond,https://www.fool.com/investing/2023/01/03/1-large-cap-biotech-stock-to-buy-for-2023-and-beyo/,20230103T143700,['Prosper Junior Bakiny'],This company's best asset may be its pipeline.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F714223%2Fbuffett6-tmf.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.938793'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.330508,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.533481', 'ticker_sentiment_score': '0.494432', 'ticker_sentiment_label': 'Bullish'}]"
176,Good Stocks To Buy For 2023? 3 Healthcare Stocks To Know,https://stockmarket.com/featured/good-stocks-to-buy-for-2023-3-healthcare-stocks-to-know-2023-01-01,20230101T200318,['Joe Samuel'],"Healthcare stocks are shares of companies that operate within the healthcare sector, such as pharmaceutical firms, medical device manufacturers, and healthcare service providers. These stocks can potentially generate significant returns for investors seeking to diversify their portfolios.",https://u3j7m9h7.rocketcdn.me/wp-content/uploads/2023/01/WBA-stock-chart.jpg,StockMarket.com,n/a,stockmarket.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999982'}, {'topic': 'Earnings', 'relevance_score': '0.796627'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.236053,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.30928', 'ticker_sentiment_score': '0.194137', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HCSG', 'relevance_score': '0.12645', 'ticker_sentiment_score': '0.180145', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.30928', 'ticker_sentiment_score': '0.219707', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WBA', 'relevance_score': '0.249744', 'ticker_sentiment_score': '0.180242', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
177,Could This Drug News Give a Lift to Eli Lilly Stock?,https://www.fool.com/investing/2023/01/01/could-this-drug-news-give-lift-to-eli-lilly-stock/,20230101T160000,['Kody Kester'],"In November, Eli Lilly received positive news from the U.S. Food and Drug Administration.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F714790%2Fa-doctor-and-patient-speak-during-an-appointment.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.928769'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.119438,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.390904', 'ticker_sentiment_score': '0.199579', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VTRS', 'relevance_score': '0.201803', 'ticker_sentiment_score': '0.0419', 'ticker_sentiment_label': 'Neutral'}]"
